Typology,Code Disease,Preferred term,Prevalence Type,Prevalence Value
Disease,166024,Multiple epiphyseal dysplasia-macrocephaly-facial dysmorphism syndrome,Cases/families,N/A
Disease,166024,Multiple epiphyseal dysplasia-macrocephaly-facial dysmorphism syndrome,Point prevalence,N/A
Disease,58,Alexander disease,Annual incidence,N/A
Disease,58,Alexander disease,Point prevalence,N/A
Disease,166032,Multiple epiphyseal dysplasia-miniepiphyses syndrome,Cases/families,N/A
Disease,166032,Multiple epiphyseal dysplasia-miniepiphyses syndrome,Point prevalence,N/A
Disease,61,Alpha-mannosidosis,Point prevalence,N/A
Disease,61,Alpha-mannosidosis,Prevalence at birth,N/A
Disease,61,Alpha-mannosidosis,Prevalence at birth,N/A
Disease,61,Alpha-mannosidosis,Prevalence at birth,N/A
Disease,61,Alpha-mannosidosis,Prevalence at birth,N/A
Disease,61,Alpha-mannosidosis,Prevalence at birth,N/A
Disease,61,Alpha-mannosidosis,Prevalence at birth,N/A
Disease,166029,Multiple epiphyseal dysplasia-severe proximal femoral dysplasia syndrome,Cases/families,N/A
Disease,166029,Multiple epiphyseal dysplasia-severe proximal femoral dysplasia syndrome,Point prevalence,N/A
Disease,166038,"Metaphyseal chondrodysplasia, Kaitila type",Cases/families,N/A
Disease,166038,"Metaphyseal chondrodysplasia, Kaitila type",Point prevalence,N/A
Disease,93,Aspartylglucosaminuria,Prevalence at birth,N/A
Disease,93,Aspartylglucosaminuria,Point prevalence,N/A
Disease,93,Aspartylglucosaminuria,Prevalence at birth,N/A
Disease,93,Aspartylglucosaminuria,Prevalence at birth,N/A
Malformation syndrome,166035,Brachydactyly-short stature-retinitis pigmentosa syndrome,Cases/families,N/A
Malformation syndrome,166035,Brachydactyly-short stature-retinitis pigmentosa syndrome,Point prevalence,N/A
Disease,585,Multiple sulfatase deficiency,Cases/families,N/A
Disease,585,Multiple sulfatase deficiency,Point prevalence,N/A
Disease,118,Beta-mannosidosis,Prevalence at birth,N/A
Disease,118,Beta-mannosidosis,Prevalence at birth,N/A
Disease,118,Beta-mannosidosis,Prevalence at birth,N/A
Disease,118,Beta-mannosidosis,Prevalence at birth,N/A
Disease,118,Beta-mannosidosis,Point prevalence,N/A
Disease,141,Canavan disease,Point prevalence,N/A
Disease,141,Canavan disease,Annual incidence,N/A
Disease,141,Canavan disease,Prevalence at birth,N/A
Malformation syndrome,166063,Pontocerebellar hypoplasia type 4,Cases/families,N/A
Malformation syndrome,166063,Pontocerebellar hypoplasia type 4,Point prevalence,N/A
Clinical subtype,166078,Von Willebrand disease type 1,Point prevalence,N/A
Malformation syndrome,166073,Pontocerebellar hypoplasia type 6,Cases/families,N/A
Malformation syndrome,166073,Pontocerebellar hypoplasia type 6,Point prevalence,N/A
Disease,213,Cystinosis,Prevalence at birth,N/A
Disease,213,Cystinosis,Prevalence at birth,N/A
Disease,213,Cystinosis,Prevalence at birth,N/A
Disease,213,Cystinosis,Prevalence at birth,N/A
Disease,213,Cystinosis,Prevalence at birth,N/A
Disease,213,Cystinosis,Prevalence at birth,N/A
Disease,213,Cystinosis,Point prevalence,N/A
Disease,213,Cystinosis,Prevalence at birth,N/A
Disease,213,Cystinosis,Prevalence at birth,N/A
Disease,213,Cystinosis,Prevalence at birth,N/A
Clinical subtype,166084,Von Willebrand disease type 2A,Point prevalence,N/A
Disease,333,Farber disease,Cases/families,N/A
Disease,333,Farber disease,Point prevalence,N/A
Clinical subtype,166081,Von Willebrand disease type 2,Point prevalence,N/A
Disease,349,Fucosidosis,Cases/families,N/A
Disease,349,Fucosidosis,Point prevalence,N/A
Disease,349,Fucosidosis,Prevalence at birth,N/A
Disease,349,Fucosidosis,Prevalence at birth,N/A
Clinical subtype,166090,Von Willebrand disease type 2M,Point prevalence,N/A
Disease,365,Glycogen storage disease due to acid maltase deficiency,Prevalence at birth,N/A
Disease,365,Glycogen storage disease due to acid maltase deficiency,Prevalence at birth,N/A
Disease,365,Glycogen storage disease due to acid maltase deficiency,Prevalence at birth,N/A
Disease,365,Glycogen storage disease due to acid maltase deficiency,Prevalence at birth,N/A
Disease,365,Glycogen storage disease due to acid maltase deficiency,Prevalence at birth,N/A
Disease,365,Glycogen storage disease due to acid maltase deficiency,Prevalence at birth,N/A
Disease,365,Glycogen storage disease due to acid maltase deficiency,Prevalence at birth,N/A
Disease,365,Glycogen storage disease due to acid maltase deficiency,Prevalence at birth,N/A
Disease,365,Glycogen storage disease due to acid maltase deficiency,Prevalence at birth,N/A
Disease,365,Glycogen storage disease due to acid maltase deficiency,Point prevalence,N/A
Disease,365,Glycogen storage disease due to acid maltase deficiency,Prevalence at birth,N/A
Disease,365,Glycogen storage disease due to acid maltase deficiency,Prevalence at birth,N/A
Disease,365,Glycogen storage disease due to acid maltase deficiency,Prevalence at birth,N/A
Disease,365,Glycogen storage disease due to acid maltase deficiency,Point prevalence,N/A
Clinical subtype,166087,Von Willebrand disease type 2B,Point prevalence,N/A
Disease,366,Glycogen storage disease due to glycogen debranching enzyme deficiency,Prevalence at birth,N/A
Disease,366,Glycogen storage disease due to glycogen debranching enzyme deficiency,Point prevalence,N/A
Clinical subtype,166093,Von Willebrand disease type 2N,Point prevalence,N/A
Disease,368,Glycogen storage disease due to muscle glycogen phosphorylase deficiency,Point prevalence,N/A
Clinical subtype,166096,Von Willebrand disease type 3,Point prevalence,N/A
Clinical subtype,166096,Von Willebrand disease type 3,Point prevalence,N/A
Clinical subtype,166096,Von Willebrand disease type 3,Point prevalence,N/A
Clinical subtype,166096,Von Willebrand disease type 3,Point prevalence,N/A
Clinical subtype,166096,Von Willebrand disease type 3,Prevalence at birth,N/A
Clinical subtype,166096,Von Willebrand disease type 3,Point prevalence,N/A
Clinical subtype,166096,Von Willebrand disease type 3,Point prevalence,N/A
Clinical subtype,166096,Von Willebrand disease type 3,Point prevalence,N/A
Clinical subtype,166096,Von Willebrand disease type 3,Point prevalence,N/A
Clinical subtype,166096,Von Willebrand disease type 3,Point prevalence,N/A
Clinical subtype,166096,Von Willebrand disease type 3,Point prevalence,N/A
Clinical subtype,166096,Von Willebrand disease type 3,Point prevalence,N/A
Clinical subtype,166096,Von Willebrand disease type 3,Point prevalence,N/A
Disease,367,Glycogen storage disease due to glycogen branching enzyme deficiency,Prevalence at birth,N/A
Disease,367,Glycogen storage disease due to glycogen branching enzyme deficiency,Point prevalence,N/A
Disease,371,Glycogen storage disease due to muscle phosphofructokinase deficiency,Cases/families,N/A
Disease,371,Glycogen storage disease due to muscle phosphofructokinase deficiency,Point prevalence,N/A
Disease,166105,FASTKD2-related infantile mitochondrial encephalomyopathy,Cases/families,N/A
Disease,166105,FASTKD2-related infantile mitochondrial encephalomyopathy,Point prevalence,N/A
Disease,369,Glycogen storage disease due to liver glycogen phosphorylase deficiency,Point prevalence,N/A
Disease,369,Glycogen storage disease due to liver glycogen phosphorylase deficiency,Prevalence at birth,N/A
Disease,369,Glycogen storage disease due to liver glycogen phosphorylase deficiency,Prevalence at birth,N/A
Disease,447,Paroxysmal nocturnal hemoglobinuria,Annual incidence,N/A
Disease,447,Paroxysmal nocturnal hemoglobinuria,Point prevalence,N/A
Disease,447,Paroxysmal nocturnal hemoglobinuria,Point prevalence,N/A
Disease,166108,Birk-Barel syndrome,Cases/families,N/A
Disease,166108,Birk-Barel syndrome,Point prevalence,N/A
Disease,166113,Bazex syndrome,Cases/families,N/A
Disease,166113,Bazex syndrome,Point prevalence,N/A
Clinical group,535,Rare cutaneous lupus erythematosus,Point prevalence,N/A
Clinical group,535,Rare cutaneous lupus erythematosus,Annual incidence,N/A
Clinical group,535,Rare cutaneous lupus erythematosus,Point prevalence,N/A
Clinical group,535,Rare cutaneous lupus erythematosus,Annual incidence,N/A
Disease,166119,Isolated osteopoikilosis,Point prevalence,N/A
Disease,166119,Isolated osteopoikilosis,Annual incidence,N/A
Disease,487,Krabbe disease,Prevalence at birth,N/A
Disease,487,Krabbe disease,Point prevalence,N/A
Disease,487,Krabbe disease,Prevalence at birth,N/A
Disease,487,Krabbe disease,Prevalence at birth,N/A
Disease,487,Krabbe disease,Prevalence at birth,N/A
Disease,487,Krabbe disease,Prevalence at birth,N/A
Disease,487,Krabbe disease,Prevalence at birth,N/A
Disease,487,Krabbe disease,Prevalence at birth,N/A
Disease,487,Krabbe disease,Prevalence at birth,N/A
Disease,487,Krabbe disease,Prevalence at birth,N/A
Disease,487,Krabbe disease,Prevalence at birth,N/A
Disease,487,Krabbe disease,Prevalence at birth,N/A
Clinical subtype,166260,Dentinogenesis imperfecta type 2,Point prevalence,N/A
Clinical subtype,166265,Dentinogenesis imperfecta type 3,Point prevalence,N/A
Disease,583,Mucopolysaccharidosis type 6,Prevalence at birth,N/A
Disease,583,Mucopolysaccharidosis type 6,Prevalence at birth,N/A
Disease,583,Mucopolysaccharidosis type 6,Prevalence at birth,N/A
Disease,583,Mucopolysaccharidosis type 6,Prevalence at birth,N/A
Disease,583,Mucopolysaccharidosis type 6,Prevalence at birth,N/A
Disease,583,Mucopolysaccharidosis type 6,Point prevalence,N/A
Disease,583,Mucopolysaccharidosis type 6,Prevalence at birth,N/A
Disease,583,Mucopolysaccharidosis type 6,Point prevalence,N/A
Disease,583,Mucopolysaccharidosis type 6,Prevalence at birth,N/A
Disease,583,Mucopolysaccharidosis type 6,Point prevalence,N/A
Disease,583,Mucopolysaccharidosis type 6,Prevalence at birth,N/A
Disease,583,Mucopolysaccharidosis type 6,Prevalence at birth,N/A
Disease,583,Mucopolysaccharidosis type 6,Prevalence at birth,N/A
Disease,583,Mucopolysaccharidosis type 6,Prevalence at birth,N/A
Disease,583,Mucopolysaccharidosis type 6,Prevalence at birth,N/A
Disease,583,Mucopolysaccharidosis type 6,Point prevalence,N/A
Disease,583,Mucopolysaccharidosis type 6,Point prevalence,N/A
Disease,583,Mucopolysaccharidosis type 6,Prevalence at birth,N/A
Disease,583,Mucopolysaccharidosis type 6,Prevalence at birth,N/A
Disease,583,Mucopolysaccharidosis type 6,Prevalence at birth,N/A
Disease,583,Mucopolysaccharidosis type 6,Prevalence at birth,N/A
Disease,583,Mucopolysaccharidosis type 6,Prevalence at birth,N/A
Disease,583,Mucopolysaccharidosis type 6,Prevalence at birth,N/A
Disease,583,Mucopolysaccharidosis type 6,Prevalence at birth,N/A
Disease,583,Mucopolysaccharidosis type 6,Prevalence at birth,N/A
Disease,583,Mucopolysaccharidosis type 6,Prevalence at birth,N/A
Disease,583,Mucopolysaccharidosis type 6,Point prevalence,N/A
Malformation syndrome,166272,Odontochondrodysplasia,Cases/families,N/A
Malformation syndrome,166272,Odontochondrodysplasia,Point prevalence,N/A
Disease,576,Mucolipidosis type II,Prevalence at birth,N/A
Disease,576,Mucolipidosis type II,Point prevalence,N/A
Disease,576,Mucolipidosis type II,Prevalence at birth,N/A
Disease,576,Mucolipidosis type II,Prevalence at birth,N/A
Disease,576,Mucolipidosis type II,Prevalence at birth,N/A
Disease,576,Mucolipidosis type II,Prevalence at birth,N/A
Malformation syndrome,166277,Wormian bone-multiple fractures-dentinogenesis imperfecta-skeletal dysplasia,Cases/families,N/A
Malformation syndrome,166277,Wormian bone-multiple fractures-dentinogenesis imperfecta-skeletal dysplasia,Point prevalence,N/A
Disease,812,Sialidosis type 1,Point prevalence,N/A
Disease,812,Sialidosis type 1,Prevalence at birth,N/A
Disease,166282,Familial sick sinus syndrome,Cases/families,N/A
Disease,166282,Familial sick sinus syndrome,Point prevalence,N/A
Disease,578,Mucolipidosis type IV,Point prevalence,N/A
Disease,578,Mucolipidosis type IV,Prevalence at birth,N/A
Disease,578,Mucolipidosis type IV,Prevalence at birth,N/A
Disease,166286,Porokeratotic eccrine ostial and dermal duct nevus,Cases/families,N/A
Disease,166286,Porokeratotic eccrine ostial and dermal duct nevus,Point prevalence,N/A
Disease,577,Mucolipidosis type III,Annual incidence,N/A
Disease,577,Mucolipidosis type III,Annual incidence,N/A
Disease,577,Mucolipidosis type III,Annual incidence,N/A
Disease,577,Mucolipidosis type III,Point prevalence,N/A
Disease,577,Mucolipidosis type III,Point prevalence,N/A
Disease,577,Mucolipidosis type III,Point prevalence,N/A
Disease,166291,Dirofilariasis,Point prevalence,N/A
Disease,166308,Benign infantile focal epilepsy with midline spikes and waves during sleep,Cases/families,N/A
Disease,166308,Benign infantile focal epilepsy with midline spikes and waves during sleep,Point prevalence,N/A
Disease,166305,Benign infantile seizures associated with mild gastroenteritis,Cases/families,N/A
Disease,166305,Benign infantile seizures associated with mild gastroenteritis,Point prevalence,N/A
Disease,2912,Poliomyelitis,Point prevalence,N/A
Disease,2912,Poliomyelitis,Annual incidence,N/A
Disease,796,Sandhoff disease,Prevalence at birth,N/A
Disease,796,Sandhoff disease,Prevalence at birth,N/A
Disease,796,Sandhoff disease,Prevalence at birth,N/A
Disease,796,Sandhoff disease,Prevalence at birth,N/A
Disease,796,Sandhoff disease,Prevalence at birth,N/A
Disease,796,Sandhoff disease,Prevalence at birth,N/A
Disease,796,Sandhoff disease,Prevalence at birth,N/A
Disease,796,Sandhoff disease,Point prevalence,N/A
Disease,796,Sandhoff disease,Prevalence at birth,N/A
Clinical group,801,Scleroderma,Annual incidence,N/A
Clinical group,801,Scleroderma,Point prevalence,N/A
Clinical group,801,Scleroderma,Annual incidence,N/A
Clinical group,801,Scleroderma,Point prevalence,N/A
Clinical group,801,Scleroderma,Point prevalence,N/A
Disease,461,Recessive X-linked ichthyosis,Annual incidence,N/A
Disease,461,Recessive X-linked ichthyosis,Point prevalence,N/A
Disease,461,Recessive X-linked ichthyosis,Annual incidence,N/A
Disease,584,Mucopolysaccharidosis type 7,Point prevalence,N/A
Disease,584,Mucopolysaccharidosis type 7,Prevalence at birth,N/A
Disease,584,Mucopolysaccharidosis type 7,Prevalence at birth,N/A
Disease,584,Mucopolysaccharidosis type 7,Prevalence at birth,N/A
Disease,584,Mucopolysaccharidosis type 7,Prevalence at birth,N/A
Disease,584,Mucopolysaccharidosis type 7,Prevalence at birth,N/A
Disease,584,Mucopolysaccharidosis type 7,Prevalence at birth,N/A
Disease,584,Mucopolysaccharidosis type 7,Point prevalence,N/A
Disease,584,Mucopolysaccharidosis type 7,Prevalence at birth,N/A
Disease,584,Mucopolysaccharidosis type 7,Prevalence at birth,N/A
Malformation syndrome,881,Turner syndrome,Prevalence at birth,N/A
Malformation syndrome,881,Turner syndrome,Prevalence at birth,N/A
Malformation syndrome,881,Turner syndrome,Prevalence at birth,N/A
Malformation syndrome,881,Turner syndrome,Prevalence at birth,N/A
Malformation syndrome,881,Turner syndrome,Prevalence at birth,N/A
Malformation syndrome,881,Turner syndrome,Prevalence at birth,N/A
Malformation syndrome,881,Turner syndrome,Prevalence at birth,N/A
Malformation syndrome,881,Turner syndrome,Prevalence at birth,N/A
Malformation syndrome,881,Turner syndrome,Prevalence at birth,N/A
Malformation syndrome,881,Turner syndrome,Prevalence at birth,N/A
Malformation syndrome,881,Turner syndrome,Prevalence at birth,N/A
Malformation syndrome,881,Turner syndrome,Prevalence at birth,N/A
Malformation syndrome,881,Turner syndrome,Prevalence at birth,N/A
Malformation syndrome,881,Turner syndrome,Prevalence at birth,N/A
Malformation syndrome,881,Turner syndrome,Prevalence at birth,N/A
Malformation syndrome,881,Turner syndrome,Prevalence at birth,N/A
Malformation syndrome,881,Turner syndrome,Prevalence at birth,N/A
Malformation syndrome,881,Turner syndrome,Prevalence at birth,N/A
Malformation syndrome,881,Turner syndrome,Prevalence at birth,N/A
Malformation syndrome,881,Turner syndrome,Prevalence at birth,N/A
Malformation syndrome,881,Turner syndrome,Prevalence at birth,N/A
Malformation syndrome,881,Turner syndrome,Prevalence at birth,N/A
Malformation syndrome,881,Turner syndrome,Point prevalence,N/A
Disease,95,Friedreich ataxia,Point prevalence,N/A
Disease,95,Friedreich ataxia,Point prevalence,N/A
Disease,95,Friedreich ataxia,Prevalence at birth,N/A
Disease,95,Friedreich ataxia,Point prevalence,N/A
Disease,95,Friedreich ataxia,Prevalence at birth,N/A
Disease,95,Friedreich ataxia,Point prevalence,N/A
Disease,95,Friedreich ataxia,Prevalence at birth,N/A
Disease,95,Friedreich ataxia,Point prevalence,N/A
Disease,95,Friedreich ataxia,Point prevalence,N/A
Disease,95,Friedreich ataxia,Point prevalence,N/A
Disease,95,Friedreich ataxia,Point prevalence,N/A
Disease,95,Friedreich ataxia,Point prevalence,N/A
Disease,95,Friedreich ataxia,Point prevalence,N/A
Disease,95,Friedreich ataxia,Point prevalence,N/A
Disease,95,Friedreich ataxia,Point prevalence,N/A
Disease,95,Friedreich ataxia,Point prevalence,N/A
Disease,95,Friedreich ataxia,Point prevalence,N/A
Disease,848,Beta-thalassemia,Annual incidence,N/A
Disease,848,Beta-thalassemia,Point prevalence,N/A
Disease,848,Beta-thalassemia,Annual incidence,N/A
Disease,848,Beta-thalassemia,Point prevalence,N/A
Disease,846,Alpha-thalassemia,Prevalence at birth,N/A
Disease,846,Alpha-thalassemia,Prevalence at birth,N/A
Disease,846,Alpha-thalassemia,Point prevalence,N/A
Disease,586,Cystic fibrosis,Prevalence at birth,N/A
Disease,586,Cystic fibrosis,Point prevalence,N/A
Disease,586,Cystic fibrosis,Prevalence at birth,N/A
Disease,586,Cystic fibrosis,Point prevalence,N/A
Disease,586,Cystic fibrosis,Prevalence at birth,N/A
Disease,586,Cystic fibrosis,Point prevalence,N/A
Disease,586,Cystic fibrosis,Prevalence at birth,N/A
Disease,586,Cystic fibrosis,Point prevalence,N/A
Disease,586,Cystic fibrosis,Prevalence at birth,N/A
Disease,586,Cystic fibrosis,Point prevalence,N/A
Disease,586,Cystic fibrosis,Prevalence at birth,N/A
Disease,586,Cystic fibrosis,Point prevalence,N/A
Disease,586,Cystic fibrosis,Prevalence at birth,N/A
Disease,586,Cystic fibrosis,Point prevalence,N/A
Disease,586,Cystic fibrosis,Prevalence at birth,N/A
Disease,586,Cystic fibrosis,Point prevalence,N/A
Disease,586,Cystic fibrosis,Prevalence at birth,N/A
Disease,586,Cystic fibrosis,Point prevalence,N/A
Disease,586,Cystic fibrosis,Prevalence at birth,N/A
Disease,586,Cystic fibrosis,Point prevalence,N/A
Disease,586,Cystic fibrosis,Prevalence at birth,N/A
Disease,586,Cystic fibrosis,Point prevalence,N/A
Disease,586,Cystic fibrosis,Prevalence at birth,N/A
Disease,586,Cystic fibrosis,Point prevalence,N/A
Disease,586,Cystic fibrosis,Prevalence at birth,N/A
Disease,586,Cystic fibrosis,Point prevalence,N/A
Disease,586,Cystic fibrosis,Prevalence at birth,N/A
Disease,586,Cystic fibrosis,Point prevalence,N/A
Disease,586,Cystic fibrosis,Prevalence at birth,N/A
Disease,586,Cystic fibrosis,Point prevalence,N/A
Disease,586,Cystic fibrosis,Prevalence at birth,N/A
Disease,586,Cystic fibrosis,Point prevalence,N/A
Disease,586,Cystic fibrosis,Prevalence at birth,N/A
Disease,586,Cystic fibrosis,Point prevalence,N/A
Disease,586,Cystic fibrosis,Prevalence at birth,N/A
Disease,586,Cystic fibrosis,Point prevalence,N/A
Disease,586,Cystic fibrosis,Prevalence at birth,N/A
Disease,586,Cystic fibrosis,Point prevalence,N/A
Disease,586,Cystic fibrosis,Prevalence at birth,N/A
Disease,586,Cystic fibrosis,Point prevalence,N/A
Disease,586,Cystic fibrosis,Prevalence at birth,N/A
Disease,586,Cystic fibrosis,Point prevalence,N/A
Disease,586,Cystic fibrosis,Prevalence at birth,N/A
Disease,586,Cystic fibrosis,Point prevalence,N/A
Disease,586,Cystic fibrosis,Prevalence at birth,N/A
Disease,586,Cystic fibrosis,Point prevalence,N/A
Disease,586,Cystic fibrosis,Prevalence at birth,N/A
Disease,586,Cystic fibrosis,Point prevalence,N/A
Disease,586,Cystic fibrosis,Prevalence at birth,N/A
Disease,586,Cystic fibrosis,Point prevalence,N/A
Disease,586,Cystic fibrosis,Prevalence at birth,N/A
Disease,586,Cystic fibrosis,Point prevalence,N/A
Disease,586,Cystic fibrosis,Prevalence at birth,N/A
Disease,586,Cystic fibrosis,Point prevalence,N/A
Disease,586,Cystic fibrosis,Prevalence at birth,N/A
Disease,586,Cystic fibrosis,Point prevalence,N/A
Disease,586,Cystic fibrosis,Prevalence at birth,N/A
Disease,586,Cystic fibrosis,Point prevalence,N/A
Disease,586,Cystic fibrosis,Prevalence at birth,N/A
Disease,586,Cystic fibrosis,Point prevalence,N/A
Disease,586,Cystic fibrosis,Annual incidence,N/A
Disease,586,Cystic fibrosis,Point prevalence,N/A
Clinical group,262,Duchenne and Becker muscular dystrophy,Point prevalence,N/A
Clinical group,262,Duchenne and Becker muscular dystrophy,Point prevalence,N/A
Clinical group,262,Duchenne and Becker muscular dystrophy,Point prevalence,N/A
Disease,261,Emery-Dreifuss muscular dystrophy,Point prevalence,N/A
Disease,550,MELAS,Point prevalence,N/A
Disease,550,MELAS,Point prevalence,N/A
Disease,550,MELAS,Point prevalence,N/A
Disease,550,MELAS,Point prevalence,N/A
Disease,550,MELAS,Point prevalence,N/A
Disease,269,Facioscapulohumeral dystrophy,Point prevalence,N/A
Disease,269,Facioscapulohumeral dystrophy,Point prevalence,N/A
Disease,269,Facioscapulohumeral dystrophy,Point prevalence,N/A
Disease,269,Facioscapulohumeral dystrophy,Point prevalence,N/A
Disease,269,Facioscapulohumeral dystrophy,Point prevalence,N/A
Disease,269,Facioscapulohumeral dystrophy,Annual incidence,N/A
Disease,480,Kearns-Sayre syndrome,Point prevalence,N/A
Disease,480,Kearns-Sayre syndrome,Point prevalence,N/A
Disease,480,Kearns-Sayre syndrome,Point prevalence,N/A
Disease,480,Kearns-Sayre syndrome,Prevalence at birth,N/A
Category,593,Myofibrillar myopathy,Point prevalence,N/A
Disease,551,MERRF,Prevalence at birth,N/A
Disease,551,MERRF,Point prevalence,N/A
Disease,597,Central core disease,Point prevalence,N/A
Disease,597,Central core disease,Point prevalence,N/A
Clinical group,607,Nemaline myopathy,Prevalence at birth,N/A
Clinical group,607,Nemaline myopathy,Point prevalence,N/A
Disease,163746,Peripheral demyelinating neuropathy-central dysmyelinating leukodystrophy-Waardenburg syndrome-Hirschsprung disease,Cases/families,N/A
Disease,163746,Peripheral demyelinating neuropathy-central dysmyelinating leukodystrophy-Waardenburg syndrome-Hirschsprung disease,Point prevalence,N/A
Disease,684,Paramyotonia congenita of Von Eulenburg,Point prevalence,N/A
Disease,684,Paramyotonia congenita of Von Eulenburg,Point prevalence,N/A
Disease,684,Paramyotonia congenita of Von Eulenburg,Point prevalence,N/A
Disease,684,Paramyotonia congenita of Von Eulenburg,Point prevalence,N/A
Disease,273,Steinert myotonic dystrophy,Point prevalence,N/A
Disease,273,Steinert myotonic dystrophy,Point prevalence,N/A
Disease,273,Steinert myotonic dystrophy,Point prevalence,N/A
Disease,273,Steinert myotonic dystrophy,Point prevalence,N/A
Disease,273,Steinert myotonic dystrophy,Point prevalence,N/A
Disease,273,Steinert myotonic dystrophy,Point prevalence,N/A
Disease,273,Steinert myotonic dystrophy,Point prevalence,N/A
Disease,273,Steinert myotonic dystrophy,Point prevalence,N/A
Disease,273,Steinert myotonic dystrophy,Point prevalence,N/A
Disease,273,Steinert myotonic dystrophy,Point prevalence,N/A
Disease,273,Steinert myotonic dystrophy,Annual incidence,N/A
Disease,273,Steinert myotonic dystrophy,Point prevalence,N/A
Disease,273,Steinert myotonic dystrophy,Point prevalence,N/A
Disease,273,Steinert myotonic dystrophy,Point prevalence,N/A
Disease,273,Steinert myotonic dystrophy,Point prevalence,N/A
Disease,273,Steinert myotonic dystrophy,Point prevalence,N/A
Disease,163937,"X-linked intellectual disability, Najm type",Cases/families,N/A
Disease,163937,"X-linked intellectual disability, Najm type",Point prevalence,N/A
Disease,163934,Atopic keratoconjunctivitis,Point prevalence,N/A
Disease,614,Thomsen and Becker disease,Point prevalence,N/A
Disease,614,Thomsen and Becker disease,Point prevalence,N/A
Disease,614,Thomsen and Becker disease,Point prevalence,N/A
Disease,614,Thomsen and Becker disease,Point prevalence,N/A
Disease,614,Thomsen and Becker disease,Point prevalence,N/A
Disease,614,Thomsen and Becker disease,Point prevalence,N/A
Particular clinical situation in a disease or syndrome,163921,Posttransplant acute limbic encephalitis,Point prevalence,N/A
Disease,163966,"X-linked dominant chondrodysplasia, Chassaing-Lacombe type",Cases/families,N/A
Disease,163966,"X-linked dominant chondrodysplasia, Chassaing-Lacombe type",Point prevalence,N/A
Disease,163971,"X-linked intellectual disability, Cilliers type",Point prevalence,N/A
Disease,163971,"X-linked intellectual disability, Cilliers type",Cases/families,N/A
Malformation syndrome,163976,"X-linked intellectual disability, Van Esch type",Point prevalence,N/A
Malformation syndrome,163976,"X-linked intellectual disability, Van Esch type",Cases/families,N/A
Disease,163979,X-linked intellectual disability-craniofacioskeletal syndrome,Point prevalence,N/A
Disease,163979,X-linked intellectual disability-craniofacioskeletal syndrome,Cases/families,N/A
Disease,163956,"X-linked intellectual disability, Nascimento type",Cases/families,N/A
Disease,163956,"X-linked intellectual disability, Nascimento type",Point prevalence,N/A
Disease,163961,X-linked cerebral-cerebellar-coloboma syndrome,Point prevalence,N/A
Disease,163961,X-linked cerebral-cerebellar-coloboma syndrome,Cases/families,N/A
Disease,324,Fabry disease,Prevalence at birth,N/A
Disease,324,Fabry disease,Prevalence at birth,N/A
Disease,324,Fabry disease,Prevalence at birth,N/A
Disease,324,Fabry disease,Prevalence at birth,N/A
Disease,324,Fabry disease,Prevalence at birth,N/A
Disease,324,Fabry disease,Prevalence at birth,N/A
Disease,324,Fabry disease,Point prevalence,N/A
Disease,324,Fabry disease,Prevalence at birth,N/A
Disease,324,Fabry disease,Point prevalence,N/A
Disease,324,Fabry disease,Prevalence at birth,N/A
Disease,324,Fabry disease,Point prevalence,N/A
Disease,163985,Hyperekplexia-epilepsy syndrome,Cases/families,N/A
Disease,163985,Hyperekplexia-epilepsy syndrome,Point prevalence,N/A
Disease,778,Rett syndrome,Prevalence at birth,N/A
Disease,778,Rett syndrome,Point prevalence,N/A
Disease,778,Rett syndrome,Point prevalence,N/A
Disease,778,Rett syndrome,Point prevalence,N/A
Disease,778,Rett syndrome,Point prevalence,N/A
Disease,778,Rett syndrome,Point prevalence,N/A
Disease,778,Rett syndrome,Prevalence at birth,N/A
Disease,778,Rett syndrome,Point prevalence,N/A
Disease,778,Rett syndrome,Prevalence at birth,N/A
Disease,778,Rett syndrome,Point prevalence,N/A
Disease,778,Rett syndrome,Point prevalence,N/A
Malformation syndrome,72,Angelman syndrome,Point prevalence,N/A
Malformation syndrome,72,Angelman syndrome,Prevalence at birth,N/A
Malformation syndrome,72,Angelman syndrome,Point prevalence,N/A
Malformation syndrome,72,Angelman syndrome,Prevalence at birth,N/A
Malformation syndrome,72,Angelman syndrome,Point prevalence,N/A
Malformation syndrome,72,Angelman syndrome,Prevalence at birth,N/A
Malformation syndrome,72,Angelman syndrome,Point prevalence,N/A
Malformation syndrome,72,Angelman syndrome,Prevalence at birth,N/A
Malformation syndrome,72,Angelman syndrome,Point prevalence,N/A
Malformation syndrome,72,Angelman syndrome,Point prevalence,N/A
Malformation syndrome,72,Angelman syndrome,Prevalence at birth,N/A
Malformation syndrome,72,Angelman syndrome,Point prevalence,N/A
Disease,307,Juvenile myoclonic epilepsy,Point prevalence,N/A
Disease,1941,Juvenile absence epilepsy,Annual incidence,N/A
Disease,1941,Juvenile absence epilepsy,Point prevalence,N/A
Disease,892,Von Hippel-Lindau disease,Prevalence at birth,N/A
Disease,892,Von Hippel-Lindau disease,Point prevalence,N/A
Disease,892,Von Hippel-Lindau disease,Point prevalence,N/A
Disease,892,Von Hippel-Lindau disease,Point prevalence,N/A
Disease,892,Von Hippel-Lindau disease,Prevalence at birth,N/A
Disease,731,Autosomal recessive polycystic kidney disease,Prevalence at birth,N/A
Disease,731,Autosomal recessive polycystic kidney disease,Point prevalence,N/A
Malformation syndrome,138,CHARGE syndrome,Prevalence at birth,N/A
Malformation syndrome,138,CHARGE syndrome,Prevalence at birth,N/A
Malformation syndrome,138,CHARGE syndrome,Point prevalence,N/A
Malformation syndrome,138,CHARGE syndrome,Point prevalence,N/A
Disease,558,Marfan syndrome,Annual incidence,N/A
Disease,558,Marfan syndrome,Point prevalence,N/A
Disease,558,Marfan syndrome,Point prevalence,N/A
Disease,558,Marfan syndrome,Prevalence at birth,N/A
Disease,558,Marfan syndrome,Point prevalence,N/A
Disease,558,Marfan syndrome,Point prevalence,N/A
Disease,165805,Familial mesial temporal lobe epilepsy with febrile seizures,Cases/families,N/A
Disease,165805,Familial mesial temporal lobe epilepsy with febrile seizures,Point prevalence,N/A
Disease,803,Amyotrophic lateral sclerosis,Annual incidence,N/A
Disease,803,Amyotrophic lateral sclerosis,Point prevalence,N/A
Disease,803,Amyotrophic lateral sclerosis,Point prevalence,N/A
Disease,803,Amyotrophic lateral sclerosis,Annual incidence,N/A
Disease,803,Amyotrophic lateral sclerosis,Annual incidence,N/A
Disease,803,Amyotrophic lateral sclerosis,Point prevalence,N/A
Disease,803,Amyotrophic lateral sclerosis,Annual incidence,N/A
Disease,803,Amyotrophic lateral sclerosis,Point prevalence,N/A
Disease,803,Amyotrophic lateral sclerosis,Annual incidence,N/A
Disease,803,Amyotrophic lateral sclerosis,Point prevalence,N/A
Disease,803,Amyotrophic lateral sclerosis,Annual incidence,N/A
Disease,803,Amyotrophic lateral sclerosis,Point prevalence,N/A
Disease,803,Amyotrophic lateral sclerosis,Annual incidence,N/A
Disease,803,Amyotrophic lateral sclerosis,Annual incidence,N/A
Disease,803,Amyotrophic lateral sclerosis,Point prevalence,N/A
Disease,803,Amyotrophic lateral sclerosis,Annual incidence,N/A
Disease,803,Amyotrophic lateral sclerosis,Point prevalence,N/A
Disease,803,Amyotrophic lateral sclerosis,Annual incidence,N/A
Disease,803,Amyotrophic lateral sclerosis,Point prevalence,N/A
Disease,803,Amyotrophic lateral sclerosis,Annual incidence,N/A
Disease,803,Amyotrophic lateral sclerosis,Annual incidence,N/A
Disease,803,Amyotrophic lateral sclerosis,Point prevalence,N/A
Disease,803,Amyotrophic lateral sclerosis,Annual incidence,N/A
Disease,803,Amyotrophic lateral sclerosis,Point prevalence,N/A
Disease,803,Amyotrophic lateral sclerosis,Annual incidence,N/A
Disease,803,Amyotrophic lateral sclerosis,Point prevalence,N/A
Disease,803,Amyotrophic lateral sclerosis,Annual incidence,N/A
Disease,803,Amyotrophic lateral sclerosis,Annual incidence,N/A
Disease,803,Amyotrophic lateral sclerosis,Point prevalence,N/A
Disease,803,Amyotrophic lateral sclerosis,Annual incidence,N/A
Disease,803,Amyotrophic lateral sclerosis,Point prevalence,N/A
Disease,803,Amyotrophic lateral sclerosis,Annual incidence,N/A
Disease,803,Amyotrophic lateral sclerosis,Point prevalence,N/A
Disease,100,Ataxia-telangiectasia,Prevalence at birth,N/A
Disease,100,Ataxia-telangiectasia,Point prevalence,N/A
Disease,100,Ataxia-telangiectasia,Prevalence at birth,N/A
Disease,100,Ataxia-telangiectasia,Point prevalence,N/A
Disease,100,Ataxia-telangiectasia,Point prevalence,N/A
Disease,100,Ataxia-telangiectasia,Point prevalence,N/A
Disease,100,Ataxia-telangiectasia,Point prevalence,N/A
Disease,100,Ataxia-telangiectasia,Point prevalence,N/A
Disease,733,Familial adenomatous polyposis,Point prevalence,N/A
Disease,733,Familial adenomatous polyposis,Point prevalence,N/A
Disease,733,Familial adenomatous polyposis,Annual incidence,N/A
Disease,733,Familial adenomatous polyposis,Point prevalence,N/A
Disease,733,Familial adenomatous polyposis,Annual incidence,N/A
Disease,733,Familial adenomatous polyposis,Point prevalence,N/A
Disease,733,Familial adenomatous polyposis,Annual incidence,N/A
Disease,733,Familial adenomatous polyposis,Point prevalence,N/A
Disease,733,Familial adenomatous polyposis,Prevalence at birth,N/A
Disease,733,Familial adenomatous polyposis,Point prevalence,N/A
Disease,733,Familial adenomatous polyposis,Annual incidence,N/A
Disease,733,Familial adenomatous polyposis,Point prevalence,N/A
Disease,399,Huntington disease,Point prevalence,N/A
Disease,399,Huntington disease,Annual incidence,N/A
Disease,399,Huntington disease,Point prevalence,N/A
Disease,399,Huntington disease,Point prevalence,N/A
Disease,399,Huntington disease,Point prevalence,N/A
Disease,399,Huntington disease,Annual incidence,N/A
Disease,399,Huntington disease,Point prevalence,N/A
Disease,399,Huntington disease,Annual incidence,N/A
Disease,399,Huntington disease,Point prevalence,N/A
Disease,399,Huntington disease,Annual incidence,N/A
Disease,399,Huntington disease,Annual incidence,N/A
Disease,399,Huntington disease,Point prevalence,N/A
Disease,399,Huntington disease,Point prevalence,N/A
Disease,399,Huntington disease,Annual incidence,N/A
Disease,399,Huntington disease,Point prevalence,N/A
Disease,399,Huntington disease,Annual incidence,N/A
Disease,399,Huntington disease,Point prevalence,N/A
Disease,399,Huntington disease,Point prevalence,N/A
Disease,399,Huntington disease,Annual incidence,N/A
Disease,399,Huntington disease,Point prevalence,N/A
Disease,399,Huntington disease,Annual incidence,N/A
Disease,399,Huntington disease,Point prevalence,N/A
Disease,399,Huntington disease,Point prevalence,N/A
Disease,399,Huntington disease,Point prevalence,N/A
Disease,399,Huntington disease,Annual incidence,N/A
Disease,399,Huntington disease,Point prevalence,N/A
Disease,399,Huntington disease,Point prevalence,N/A
Disease,399,Huntington disease,Point prevalence,N/A
Disease,399,Huntington disease,Annual incidence,N/A
Disease,399,Huntington disease,Point prevalence,N/A
Disease,399,Huntington disease,Point prevalence,N/A
Disease,399,Huntington disease,Annual incidence,N/A
Disease,501,Lafora disease,Point prevalence,N/A
Disease,501,Lafora disease,Point prevalence,N/A
Disease,501,Lafora disease,Cases/families,N/A
Disease,501,Lafora disease,Point prevalence,N/A
Malformation syndrome,870,Down syndrome,Prevalence at birth,N/A
Malformation syndrome,870,Down syndrome,Point prevalence,N/A
Malformation syndrome,870,Down syndrome,Prevalence at birth,N/A
Malformation syndrome,870,Down syndrome,Point prevalence,N/A
Malformation syndrome,870,Down syndrome,Prevalence at birth,N/A
Malformation syndrome,870,Down syndrome,Prevalence at birth,N/A
Malformation syndrome,870,Down syndrome,Prevalence at birth,N/A
Malformation syndrome,870,Down syndrome,Prevalence at birth,N/A
Malformation syndrome,870,Down syndrome,Prevalence at birth,N/A
Malformation syndrome,870,Down syndrome,Prevalence at birth,N/A
Malformation syndrome,870,Down syndrome,Prevalence at birth,N/A
Malformation syndrome,870,Down syndrome,Prevalence at birth,N/A
Malformation syndrome,870,Down syndrome,Prevalence at birth,N/A
Malformation syndrome,870,Down syndrome,Prevalence at birth,N/A
Malformation syndrome,870,Down syndrome,Prevalence at birth,N/A
Malformation syndrome,870,Down syndrome,Prevalence at birth,N/A
Malformation syndrome,870,Down syndrome,Prevalence at birth,N/A
Malformation syndrome,870,Down syndrome,Prevalence at birth,N/A
Malformation syndrome,870,Down syndrome,Prevalence at birth,N/A
Malformation syndrome,870,Down syndrome,Prevalence at birth,N/A
Malformation syndrome,870,Down syndrome,Prevalence at birth,N/A
Malformation syndrome,870,Down syndrome,Point prevalence,N/A
Malformation syndrome,870,Down syndrome,Prevalence at birth,N/A
Malformation syndrome,870,Down syndrome,Prevalence at birth,N/A
Disease,512,Metachromatic leukodystrophy,Prevalence at birth,N/A
Disease,512,Metachromatic leukodystrophy,Point prevalence,N/A
Disease,512,Metachromatic leukodystrophy,Prevalence at birth,N/A
Disease,512,Metachromatic leukodystrophy,Prevalence at birth,N/A
Disease,512,Metachromatic leukodystrophy,Prevalence at birth,N/A
Disease,512,Metachromatic leukodystrophy,Prevalence at birth,N/A
Disease,512,Metachromatic leukodystrophy,Prevalence at birth,N/A
Disease,512,Metachromatic leukodystrophy,Prevalence at birth,N/A
Disease,512,Metachromatic leukodystrophy,Prevalence at birth,N/A
Disease,512,Metachromatic leukodystrophy,Prevalence at birth,N/A
Disease,512,Metachromatic leukodystrophy,Prevalence at birth,N/A
Disease,512,Metachromatic leukodystrophy,Prevalence at birth,N/A
Malformation syndrome,567,22q11.2 deletion syndrome,Prevalence at birth,N/A
Malformation syndrome,567,22q11.2 deletion syndrome,Prevalence at birth,N/A
Malformation syndrome,567,22q11.2 deletion syndrome,Prevalence at birth,N/A
Malformation syndrome,567,22q11.2 deletion syndrome,Prevalence at birth,N/A
Malformation syndrome,567,22q11.2 deletion syndrome,Point prevalence,N/A
Malformation syndrome,567,22q11.2 deletion syndrome,Point prevalence,N/A
Disease,166016,"Multiple epiphyseal dysplasia, Lowry type",Cases/families,N/A
Disease,166016,"Multiple epiphyseal dysplasia, Lowry type",Point prevalence,N/A
Disease,232,Sickle cell anemia,Prevalence at birth,N/A
Disease,232,Sickle cell anemia,Prevalence at birth,N/A
Disease,232,Sickle cell anemia,Point prevalence,N/A
Disease,232,Sickle cell anemia,Prevalence at birth,N/A
Disease,232,Sickle cell anemia,Prevalence at birth,N/A
Disease,232,Sickle cell anemia,Point prevalence,N/A
Disease,232,Sickle cell anemia,Prevalence at birth,N/A
Disease,232,Sickle cell anemia,Prevalence at birth,N/A
Disease,232,Sickle cell anemia,Prevalence at birth,N/A
Disease,232,Sickle cell anemia,Prevalence at birth,N/A
Disease,232,Sickle cell anemia,Prevalence at birth,N/A
Disease,232,Sickle cell anemia,Annual incidence,N/A
Disease,536,Systemic lupus erythematosus,Point prevalence,N/A
Disease,536,Systemic lupus erythematosus,Point prevalence,N/A
Disease,536,Systemic lupus erythematosus,Point prevalence,N/A
Disease,536,Systemic lupus erythematosus,Point prevalence,N/A
Disease,536,Systemic lupus erythematosus,Point prevalence,N/A
Disease,536,Systemic lupus erythematosus,Point prevalence,N/A
Disease,536,Systemic lupus erythematosus,Point prevalence,N/A
Disease,536,Systemic lupus erythematosus,Point prevalence,N/A
Disease,536,Systemic lupus erythematosus,Annual incidence,N/A
Disease,536,Systemic lupus erythematosus,Point prevalence,N/A
Disease,536,Systemic lupus erythematosus,Annual incidence,N/A
Malformation syndrome,534,Oculocerebrorenal syndrome of Lowe,Point prevalence,N/A
Malformation syndrome,534,Oculocerebrorenal syndrome of Lowe,Point prevalence,N/A
Malformation syndrome,534,Oculocerebrorenal syndrome of Lowe,Point prevalence,N/A
Disease,790,Retinoblastoma,Annual incidence,N/A
Disease,790,Retinoblastoma,Prevalence at birth,N/A
Disease,790,Retinoblastoma,Prevalence at birth,N/A
Disease,790,Retinoblastoma,Lifetime Prevalence,N/A
Disease,790,Retinoblastoma,Prevalence at birth,N/A
Disease,790,Retinoblastoma,Prevalence at birth,N/A
Disease,790,Retinoblastoma,Point prevalence,N/A
Disease,790,Retinoblastoma,Annual incidence,N/A
Disease,790,Retinoblastoma,Annual incidence,N/A
Disease,790,Retinoblastoma,Annual incidence,N/A
Disease,790,Retinoblastoma,Annual incidence,N/A
Disease,790,Retinoblastoma,Annual incidence,N/A
Disease,790,Retinoblastoma,Annual incidence,N/A
Disease,790,Retinoblastoma,Annual incidence,N/A
Disease,790,Retinoblastoma,Annual incidence,N/A
Disease,790,Retinoblastoma,Annual incidence,N/A
Disease,790,Retinoblastoma,Annual incidence,N/A
Disease,790,Retinoblastoma,Annual incidence,N/A
Disease,790,Retinoblastoma,Annual incidence,N/A
Disease,790,Retinoblastoma,Annual incidence,N/A
Disease,790,Retinoblastoma,Annual incidence,N/A
Disease,790,Retinoblastoma,Annual incidence,N/A
Disease,790,Retinoblastoma,Annual incidence,N/A
Disease,790,Retinoblastoma,Annual incidence,N/A
Disease,790,Retinoblastoma,Annual incidence,N/A
Disease,790,Retinoblastoma,Annual incidence,N/A
Disease,790,Retinoblastoma,Annual incidence,N/A
Disease,790,Retinoblastoma,Annual incidence,N/A
Disease,790,Retinoblastoma,Annual incidence,N/A
Disease,652,Multiple endocrine neoplasia type 1,Point prevalence,N/A
Malformation syndrome,908,Fragile X syndrome,Point prevalence,N/A
Malformation syndrome,908,Fragile X syndrome,Point prevalence,N/A
Malformation syndrome,908,Fragile X syndrome,Prevalence at birth,N/A
Malformation syndrome,908,Fragile X syndrome,Prevalence at birth,N/A
Malformation syndrome,908,Fragile X syndrome,Prevalence at birth,N/A
Malformation syndrome,908,Fragile X syndrome,Prevalence at birth,N/A
Malformation syndrome,908,Fragile X syndrome,Prevalence at birth,N/A
Disease,3099,Rheumatic fever,Annual incidence,N/A
Disease,3099,Rheumatic fever,Annual incidence,N/A
Disease,3099,Rheumatic fever,Annual incidence,N/A
Disease,3099,Rheumatic fever,Annual incidence,N/A
Disease,3099,Rheumatic fever,Annual incidence,N/A
Disease,3099,Rheumatic fever,Annual incidence,N/A
Disease,3099,Rheumatic fever,Annual incidence,N/A
Disease,3099,Rheumatic fever,Annual incidence,N/A
Disease,3099,Rheumatic fever,Point prevalence,N/A
Disease,739,Prader-Willi syndrome,Prevalence at birth,N/A
Disease,739,Prader-Willi syndrome,Point prevalence,N/A
Disease,739,Prader-Willi syndrome,Prevalence at birth,N/A
Disease,739,Prader-Willi syndrome,Point prevalence,N/A
Disease,739,Prader-Willi syndrome,Prevalence at birth,N/A
Disease,739,Prader-Willi syndrome,Point prevalence,N/A
Disease,739,Prader-Willi syndrome,Prevalence at birth,N/A
Disease,739,Prader-Willi syndrome,Point prevalence,N/A
Disease,739,Prader-Willi syndrome,Prevalence at birth,N/A
Disease,739,Prader-Willi syndrome,Point prevalence,N/A
Disease,739,Prader-Willi syndrome,Prevalence at birth,N/A
Disease,739,Prader-Willi syndrome,Point prevalence,N/A
Disease,739,Prader-Willi syndrome,Prevalence at birth,N/A
Disease,739,Prader-Willi syndrome,Point prevalence,N/A
Disease,739,Prader-Willi syndrome,Prevalence at birth,N/A
Disease,739,Prader-Willi syndrome,Point prevalence,N/A
Clinical subtype,47,X-linked agammaglobulinemia,Point prevalence,N/A
Clinical subtype,47,X-linked agammaglobulinemia,Point prevalence,N/A
Clinical subtype,47,X-linked agammaglobulinemia,Point prevalence,N/A
Clinical subtype,47,X-linked agammaglobulinemia,Point prevalence,N/A
Clinical subtype,47,X-linked agammaglobulinemia,Point prevalence,N/A
Clinical subtype,47,X-linked agammaglobulinemia,Point prevalence,N/A
Clinical subtype,47,X-linked agammaglobulinemia,Point prevalence,N/A
Clinical subtype,47,X-linked agammaglobulinemia,Point prevalence,N/A
Clinical subtype,47,X-linked agammaglobulinemia,Point prevalence,N/A
Clinical subtype,47,X-linked agammaglobulinemia,Point prevalence,N/A
Clinical subtype,47,X-linked agammaglobulinemia,Point prevalence,N/A
Clinical subtype,47,X-linked agammaglobulinemia,Point prevalence,N/A
Clinical subtype,47,X-linked agammaglobulinemia,Point prevalence,N/A
Clinical subtype,47,X-linked agammaglobulinemia,Point prevalence,N/A
Clinical subtype,47,X-linked agammaglobulinemia,Point prevalence,N/A
Clinical subtype,47,X-linked agammaglobulinemia,Point prevalence,N/A
Clinical subtype,47,X-linked agammaglobulinemia,Prevalence at birth,N/A
Clinical subtype,47,X-linked agammaglobulinemia,Point prevalence,N/A
Clinical subtype,47,X-linked agammaglobulinemia,Point prevalence,N/A
Disease,580,Mucopolysaccharidosis type 2,Prevalence at birth,N/A
Disease,580,Mucopolysaccharidosis type 2,Prevalence at birth,N/A
Disease,580,Mucopolysaccharidosis type 2,Point prevalence,N/A
Disease,580,Mucopolysaccharidosis type 2,Prevalence at birth,N/A
Disease,580,Mucopolysaccharidosis type 2,Prevalence at birth,N/A
Disease,580,Mucopolysaccharidosis type 2,Prevalence at birth,N/A
Disease,580,Mucopolysaccharidosis type 2,Prevalence at birth,N/A
Disease,580,Mucopolysaccharidosis type 2,Prevalence at birth,N/A
Disease,580,Mucopolysaccharidosis type 2,Prevalence at birth,N/A
Disease,580,Mucopolysaccharidosis type 2,Point prevalence,N/A
Disease,580,Mucopolysaccharidosis type 2,Prevalence at birth,N/A
Disease,580,Mucopolysaccharidosis type 2,Prevalence at birth,N/A
Disease,580,Mucopolysaccharidosis type 2,Prevalence at birth,N/A
Disease,580,Mucopolysaccharidosis type 2,Prevalence at birth,N/A
Disease,580,Mucopolysaccharidosis type 2,Point prevalence,N/A
Disease,580,Mucopolysaccharidosis type 2,Prevalence at birth,N/A
Disease,580,Mucopolysaccharidosis type 2,Point prevalence,N/A
Disease,580,Mucopolysaccharidosis type 2,Prevalence at birth,N/A
Disease,580,Mucopolysaccharidosis type 2,Prevalence at birth,N/A
Disease,580,Mucopolysaccharidosis type 2,Prevalence at birth,N/A
Disease,580,Mucopolysaccharidosis type 2,Prevalence at birth,N/A
Disease,580,Mucopolysaccharidosis type 2,Prevalence at birth,N/A
Disease,580,Mucopolysaccharidosis type 2,Prevalence at birth,N/A
Disease,580,Mucopolysaccharidosis type 2,Prevalence at birth,N/A
Disease,580,Mucopolysaccharidosis type 2,Prevalence at birth,N/A
Disease,580,Mucopolysaccharidosis type 2,Prevalence at birth,N/A
Disease,580,Mucopolysaccharidosis type 2,Point prevalence,N/A
Disease,579,Mucopolysaccharidosis type 1,Prevalence at birth,N/A
Disease,579,Mucopolysaccharidosis type 1,Prevalence at birth,N/A
Disease,579,Mucopolysaccharidosis type 1,Prevalence at birth,N/A
Disease,579,Mucopolysaccharidosis type 1,Prevalence at birth,N/A
Disease,579,Mucopolysaccharidosis type 1,Prevalence at birth,N/A
Disease,579,Mucopolysaccharidosis type 1,Point prevalence,N/A
Disease,579,Mucopolysaccharidosis type 1,Prevalence at birth,N/A
Disease,579,Mucopolysaccharidosis type 1,Point prevalence,N/A
Disease,579,Mucopolysaccharidosis type 1,Prevalence at birth,N/A
Disease,579,Mucopolysaccharidosis type 1,Point prevalence,N/A
Disease,579,Mucopolysaccharidosis type 1,Prevalence at birth,N/A
Disease,579,Mucopolysaccharidosis type 1,Prevalence at birth,N/A
Disease,579,Mucopolysaccharidosis type 1,Prevalence at birth,N/A
Disease,579,Mucopolysaccharidosis type 1,Prevalence at birth,N/A
Disease,579,Mucopolysaccharidosis type 1,Prevalence at birth,N/A
Disease,579,Mucopolysaccharidosis type 1,Prevalence at birth,N/A
Disease,579,Mucopolysaccharidosis type 1,Prevalence at birth,N/A
Disease,579,Mucopolysaccharidosis type 1,Point prevalence,N/A
Disease,579,Mucopolysaccharidosis type 1,Prevalence at birth,N/A
Disease,579,Mucopolysaccharidosis type 1,Prevalence at birth,N/A
Disease,579,Mucopolysaccharidosis type 1,Prevalence at birth,N/A
Disease,579,Mucopolysaccharidosis type 1,Prevalence at birth,N/A
Disease,579,Mucopolysaccharidosis type 1,Prevalence at birth,N/A
Disease,579,Mucopolysaccharidosis type 1,Prevalence at birth,N/A
Disease,579,Mucopolysaccharidosis type 1,Prevalence at birth,N/A
Disease,579,Mucopolysaccharidosis type 1,Prevalence at birth,N/A
Disease,579,Mucopolysaccharidosis type 1,Prevalence at birth,N/A
Disease,579,Mucopolysaccharidosis type 1,Prevalence at birth,N/A
Disease,905,Wilson disease,Prevalence at birth,N/A
Disease,905,Wilson disease,Point prevalence,N/A
Disease,905,Wilson disease,Point prevalence,N/A
Disease,905,Wilson disease,Point prevalence,N/A
Disease,905,Wilson disease,Prevalence at birth,N/A
Disease,905,Wilson disease,Prevalence at birth,N/A
Disease,905,Wilson disease,Point prevalence,N/A
Disease,905,Wilson disease,Prevalence at birth,N/A
Disease,905,Wilson disease,Point prevalence,N/A
Disease,905,Wilson disease,Prevalence at birth,N/A
Disease,905,Wilson disease,Prevalence at birth,N/A
Disease,905,Wilson disease,Annual incidence,N/A
Disease,905,Wilson disease,Point prevalence,N/A
Malformation syndrome,792,X-linked retinoschisis,Point prevalence,N/A
Malformation syndrome,792,X-linked retinoschisis,Point prevalence,N/A
Malformation syndrome,792,X-linked retinoschisis,Point prevalence,N/A
Malformation syndrome,792,X-linked retinoschisis,Point prevalence,N/A
Malformation syndrome,792,X-linked retinoschisis,Point prevalence,N/A
Disease,163525,Subacute cutaneous lupus erythematosus,Annual incidence,N/A
Disease,163525,Subacute cutaneous lupus erythematosus,Point prevalence,N/A
Disease,827,Stargardt disease,Point prevalence,N/A
Disease,906,Wiskott-Aldrich syndrome,Point prevalence,N/A
Disease,906,Wiskott-Aldrich syndrome,Point prevalence,N/A
Disease,906,Wiskott-Aldrich syndrome,Prevalence at birth,N/A
Disease,906,Wiskott-Aldrich syndrome,Point prevalence,N/A
Disease,906,Wiskott-Aldrich syndrome,Point prevalence,N/A
Disease,906,Wiskott-Aldrich syndrome,Point prevalence,N/A
Disease,906,Wiskott-Aldrich syndrome,Prevalence at birth,N/A
Disease,906,Wiskott-Aldrich syndrome,Point prevalence,N/A
Malformation syndrome,904,Williams syndrome,Prevalence at birth,N/A
Malformation syndrome,904,Williams syndrome,Prevalence at birth,N/A
Malformation syndrome,904,Williams syndrome,Point prevalence,N/A
Malformation syndrome,904,Williams syndrome,Point prevalence,N/A
Malformation syndrome,280,Wolf-Hirschhorn syndrome,Prevalence at birth,N/A
Malformation syndrome,280,Wolf-Hirschhorn syndrome,Point prevalence,N/A
Disease,15,Achondroplasia,Prevalence at birth,N/A
Disease,15,Achondroplasia,Prevalence at birth,N/A
Disease,15,Achondroplasia,Prevalence at birth,N/A
Disease,15,Achondroplasia,Prevalence at birth,N/A
Disease,15,Achondroplasia,Prevalence at birth,N/A
Disease,15,Achondroplasia,Prevalence at birth,N/A
Disease,15,Achondroplasia,Prevalence at birth,N/A
Disease,15,Achondroplasia,Prevalence at birth,N/A
Disease,15,Achondroplasia,Prevalence at birth,N/A
Disease,15,Achondroplasia,Prevalence at birth,N/A
Disease,15,Achondroplasia,Prevalence at birth,N/A
Disease,15,Achondroplasia,Prevalence at birth,N/A
Disease,15,Achondroplasia,Prevalence at birth,N/A
Disease,15,Achondroplasia,Prevalence at birth,N/A
Disease,15,Achondroplasia,Prevalence at birth,N/A
Disease,15,Achondroplasia,Prevalence at birth,N/A
Disease,15,Achondroplasia,Prevalence at birth,N/A
Disease,15,Achondroplasia,Prevalence at birth,N/A
Disease,15,Achondroplasia,Prevalence at birth,N/A
Disease,15,Achondroplasia,Prevalence at birth,N/A
Disease,15,Achondroplasia,Prevalence at birth,N/A
Disease,15,Achondroplasia,Prevalence at birth,N/A
Disease,15,Achondroplasia,Prevalence at birth,N/A
Disease,15,Achondroplasia,Prevalence at birth,N/A
Disease,15,Achondroplasia,Prevalence at birth,N/A
Disease,15,Achondroplasia,Prevalence at birth,N/A
Disease,15,Achondroplasia,Prevalence at birth,N/A
Disease,15,Achondroplasia,Prevalence at birth,N/A
Disease,15,Achondroplasia,Prevalence at birth,N/A
Disease,15,Achondroplasia,Prevalence at birth,N/A
Disease,15,Achondroplasia,Point prevalence,N/A
Disease,96,Ataxia with vitamin E deficiency,Point prevalence,N/A
Disease,101,Dentatorubral pallidoluysian atrophy,Point prevalence,N/A
Disease,101,Dentatorubral pallidoluysian atrophy,Point prevalence,N/A
Disease,101,Dentatorubral pallidoluysian atrophy,Point prevalence,N/A
Malformation syndrome,783,Rubinstein-Taybi syndrome,Prevalence at birth,N/A
Malformation syndrome,783,Rubinstein-Taybi syndrome,Point prevalence,N/A
Malformation syndrome,783,Rubinstein-Taybi syndrome,Prevalence at birth,N/A
Malformation syndrome,783,Rubinstein-Taybi syndrome,Point prevalence,N/A
Disease,163649,Spondyloepiphyseal dysplasia-craniosynostosis-cleft palate-cataracts-intellectual disability syndrome,Cases/families,N/A
Disease,163649,Spondyloepiphyseal dysplasia-craniosynostosis-cleft palate-cataracts-intellectual disability syndrome,Point prevalence,N/A
Disease,631,Non-acquired isolated growth hormone deficiency,Point prevalence,N/A
Disease,276,T-B+ severe combined immunodeficiency due to gamma chain deficiency,Point prevalence,N/A
Disease,163654,Spondyloepiphyseal dysplasia-brachydactyly-speech disorder syndrome,Cases/families,N/A
Disease,163654,Spondyloepiphyseal dysplasia-brachydactyly-speech disorder syndrome,Point prevalence,N/A
Disease,481,Kennedy disease,Annual incidence,N/A
Disease,481,Kennedy disease,Prevalence at birth,N/A
Disease,481,Kennedy disease,Point prevalence,N/A
Disease,481,Kennedy disease,Point prevalence,N/A
Disease,481,Kennedy disease,Point prevalence,N/A
Disease,664,Ornithine transcarbamylase deficiency,Point prevalence,N/A
Disease,664,Ornithine transcarbamylase deficiency,Prevalence at birth,N/A
Disease,664,Ornithine transcarbamylase deficiency,Prevalence at birth,N/A
Disease,664,Ornithine transcarbamylase deficiency,Prevalence at birth,N/A
Disease,664,Ornithine transcarbamylase deficiency,Prevalence at birth,N/A
Disease,664,Ornithine transcarbamylase deficiency,Prevalence at birth,N/A
Disease,664,Ornithine transcarbamylase deficiency,Prevalence at birth,N/A
Malformation syndrome,163668,"Spondyloepiphyseal dysplasia, MacDermot type",Cases/families,N/A
Malformation syndrome,163668,"Spondyloepiphyseal dysplasia, MacDermot type",Point prevalence,N/A
Disease,163662,"Spondyloepiphyseal dysplasia, Reardon type",Cases/families,N/A
Disease,163662,"Spondyloepiphyseal dysplasia, Reardon type",Point prevalence,N/A
Disease,394,Homocystinuria due to cystathionine beta-synthase deficiency,Prevalence at birth,N/A
Disease,394,Homocystinuria due to cystathionine beta-synthase deficiency,Point prevalence,N/A
Disease,394,Homocystinuria due to cystathionine beta-synthase deficiency,Prevalence at birth,N/A
Disease,394,Homocystinuria due to cystathionine beta-synthase deficiency,Prevalence at birth,N/A
Disease,394,Homocystinuria due to cystathionine beta-synthase deficiency,Prevalence at birth,N/A
Disease,394,Homocystinuria due to cystathionine beta-synthase deficiency,Prevalence at birth,N/A
Disease,394,Homocystinuria due to cystathionine beta-synthase deficiency,Prevalence at birth,N/A
Disease,394,Homocystinuria due to cystathionine beta-synthase deficiency,Prevalence at birth,N/A
Disease,394,Homocystinuria due to cystathionine beta-synthase deficiency,Prevalence at birth,N/A
Disease,163665,"Spondyloepiphyseal dysplasia tarda, Kohn type",Cases/families,N/A
Disease,163665,"Spondyloepiphyseal dysplasia tarda, Kohn type",Point prevalence,N/A
Malformation syndrome,508,Leprechaunism,Point prevalence,N/A
Malformation syndrome,508,Leprechaunism,Prevalence at birth,N/A
Disease,436,Hypophosphatasia,Point prevalence,N/A
Disease,436,Hypophosphatasia,Point prevalence,N/A
Clinical subtype,163596,Hb Bart's hydrops fetalis,Prevalence at birth,N/A
Clinical subtype,163596,Hb Bart's hydrops fetalis,Point prevalence,N/A
Clinical subtype,163596,Hb Bart's hydrops fetalis,Prevalence at birth,N/A
Disease,429,Hypochondroplasia,Prevalence at birth,N/A
Disease,429,Hypochondroplasia,Point prevalence,N/A
Clinical group,437,Hypophosphatemic rickets,Point prevalence,N/A
Disease,104,Leber hereditary optic neuropathy,Point prevalence,N/A
Disease,104,Leber hereditary optic neuropathy,Point prevalence,N/A
Disease,104,Leber hereditary optic neuropathy,Point prevalence,N/A
Disease,104,Leber hereditary optic neuropathy,Point prevalence,N/A
Disease,104,Leber hereditary optic neuropathy,Point prevalence,N/A
Disease,104,Leber hereditary optic neuropathy,Point prevalence,N/A
Disease,104,Leber hereditary optic neuropathy,Point prevalence,N/A
Clinical subtype,2182,Hydrocephalus with stenosis of the aqueduct of Sylvius,Prevalence at birth,N/A
Clinical subtype,2182,Hydrocephalus with stenosis of the aqueduct of Sylvius,Point prevalence,N/A
Disease,163634,Maffucci syndrome,Cases/families,N/A
Disease,163634,Maffucci syndrome,Point prevalence,N/A
Disease,636,Neurofibromatosis type 1,Point prevalence,N/A
Disease,636,Neurofibromatosis type 1,Point prevalence,N/A
Disease,636,Neurofibromatosis type 1,Point prevalence,N/A
Disease,636,Neurofibromatosis type 1,Point prevalence,N/A
Disease,636,Neurofibromatosis type 1,Prevalence at birth,N/A
Disease,636,Neurofibromatosis type 1,Prevalence at birth,N/A
Disease,636,Neurofibromatosis type 1,Prevalence at birth,N/A
Disease,636,Neurofibromatosis type 1,Prevalence at birth,N/A
Disease,636,Neurofibromatosis type 1,Point prevalence,N/A
Disease,636,Neurofibromatosis type 1,Point prevalence,N/A
Disease,163703,Febrile infection-related epilepsy syndrome,Annual incidence,N/A
Disease,163703,Febrile infection-related epilepsy syndrome,Point prevalence,N/A
Malformation syndrome,649,Norrie disease,Cases/families,N/A
Malformation syndrome,649,Norrie disease,Point prevalence,N/A
Disease,163727,Rolandic epilepsy-paroxysmal exercise-induced dystonia-writer's cramp syndrome,Cases/families,N/A
Disease,163727,Rolandic epilepsy-paroxysmal exercise-induced dystonia-writer's cramp syndrome,Point prevalence,N/A
Disease,163684,Leukoencephalopathy-dystonia-motor neuropathy syndrome,Point prevalence,N/A
Disease,163684,Leukoencephalopathy-dystonia-motor neuropathy syndrome,Cases/families,N/A
Disease,163681,CNTNAP2-related developmental and epileptic encephalopathy,Point prevalence,N/A
Disease,163681,CNTNAP2-related developmental and epileptic encephalopathy,Cases/families,N/A
Disease,379,Chronic granulomatous disease,Prevalence at birth,N/A
Disease,379,Chronic granulomatous disease,Point prevalence,N/A
Disease,379,Chronic granulomatous disease,Prevalence at birth,N/A
Disease,379,Chronic granulomatous disease,Point prevalence,N/A
Disease,379,Chronic granulomatous disease,Prevalence at birth,N/A
Disease,379,Chronic granulomatous disease,Point prevalence,N/A
Disease,379,Chronic granulomatous disease,Prevalence at birth,N/A
Disease,379,Chronic granulomatous disease,Point prevalence,N/A
Disease,379,Chronic granulomatous disease,Prevalence at birth,N/A
Disease,379,Chronic granulomatous disease,Point prevalence,N/A
Disease,379,Chronic granulomatous disease,Prevalence at birth,N/A
Disease,379,Chronic granulomatous disease,Point prevalence,N/A
Disease,379,Chronic granulomatous disease,Prevalence at birth,N/A
Disease,379,Chronic granulomatous disease,Point prevalence,N/A
Disease,379,Chronic granulomatous disease,Prevalence at birth,N/A
Disease,379,Chronic granulomatous disease,Point prevalence,N/A
Disease,379,Chronic granulomatous disease,Prevalence at birth,N/A
Disease,379,Chronic granulomatous disease,Point prevalence,N/A
Disease,379,Chronic granulomatous disease,Point prevalence,N/A
Disease,379,Chronic granulomatous disease,Prevalence at birth,N/A
Disease,379,Chronic granulomatous disease,Point prevalence,N/A
Disease,379,Chronic granulomatous disease,Prevalence at birth,N/A
Disease,379,Chronic granulomatous disease,Point prevalence,N/A
Disease,379,Chronic granulomatous disease,Prevalence at birth,N/A
Disease,379,Chronic granulomatous disease,Point prevalence,N/A
Disease,379,Chronic granulomatous disease,Prevalence at birth,N/A
Disease,379,Chronic granulomatous disease,Point prevalence,N/A
Disease,16,Blue cone monochromatism,Prevalence at birth,N/A
Disease,16,Blue cone monochromatism,Point prevalence,N/A
Disease,644,NARP syndrome,Point prevalence,N/A
Disease,637,Full NF2-related schwannomatosis,Point prevalence,N/A
Disease,637,Full NF2-related schwannomatosis,Prevalence at birth,N/A
Disease,637,Full NF2-related schwannomatosis,Point prevalence,N/A
Disease,637,Full NF2-related schwannomatosis,Prevalence at birth,N/A
Disease,163696,Action myoclonus-renal failure syndrome,Cases/families,N/A
Disease,163696,Action myoclonus-renal failure syndrome,Point prevalence,N/A
Etiological subtype,181,X-linked hypohidrotic ectodermal dysplasia,Prevalence at birth,N/A
Etiological subtype,181,X-linked hypohidrotic ectodermal dysplasia,Point prevalence,N/A
Etiological subtype,181,X-linked hypohidrotic ectodermal dysplasia,Point prevalence,N/A
Disease,163693,2p21 microdeletion syndrome,Cases/families,N/A
Disease,163693,2p21 microdeletion syndrome,Point prevalence,N/A
Disease,163690,Hypotonia-cystinuria syndrome,Point prevalence,N/A
Disease,163690,Hypotonia-cystinuria syndrome,Cases/families,N/A
Disease,337,Fibrodysplasia ossificans progressiva,Point prevalence,N/A
Disease,337,Fibrodysplasia ossificans progressiva,Point prevalence,N/A
Disease,337,Fibrodysplasia ossificans progressiva,Prevalence at birth,N/A
Disease,337,Fibrodysplasia ossificans progressiva,Point prevalence,N/A
Disease,337,Fibrodysplasia ossificans progressiva,Point prevalence,N/A
Disease,337,Fibrodysplasia ossificans progressiva,Point prevalence,N/A
Disease,337,Fibrodysplasia ossificans progressiva,Point prevalence,N/A
Malformation syndrome,377,Gorlin syndrome,Point prevalence,N/A
Malformation syndrome,377,Gorlin syndrome,Prevalence at birth,N/A
Malformation syndrome,377,Gorlin syndrome,Point prevalence,N/A
Malformation syndrome,377,Gorlin syndrome,Point prevalence,N/A
Malformation syndrome,377,Gorlin syndrome,Point prevalence,N/A
Malformation syndrome,377,Gorlin syndrome,Point prevalence,N/A
Malformation syndrome,377,Gorlin syndrome,Point prevalence,N/A
Malformation syndrome,648,Noonan syndrome,Prevalence at birth,N/A
Malformation syndrome,648,Noonan syndrome,Point prevalence,N/A
Malformation syndrome,281,Monosomy 5p syndrome,Prevalence at birth,N/A
Malformation syndrome,281,Monosomy 5p syndrome,Prevalence at birth,N/A
Malformation syndrome,281,Monosomy 5p syndrome,Point prevalence,N/A
Disease,752,"46,XY difference of sex development due to 17-beta-hydroxysteroid dehydrogenase 3 deficiency",Prevalence at birth,N/A
Disease,752,"46,XY difference of sex development due to 17-beta-hydroxysteroid dehydrogenase 3 deficiency",Point prevalence,N/A
Disease,214,Cystinuria,Prevalence at birth,N/A
Disease,214,Cystinuria,Prevalence at birth,N/A
Disease,214,Cystinuria,Prevalence at birth,N/A
Disease,214,Cystinuria,Point prevalence,N/A
Disease,214,Cystinuria,Point prevalence,N/A
Disease,214,Cystinuria,Prevalence at birth,N/A
Disease,214,Cystinuria,Prevalence at birth,N/A
Disease,214,Cystinuria,Prevalence at birth,N/A
Disease,214,Cystinuria,Point prevalence,N/A
Disease,510,Lesch-Nyhan syndrome,Prevalence at birth,N/A
Disease,510,Lesch-Nyhan syndrome,Prevalence at birth,N/A
Disease,510,Lesch-Nyhan syndrome,Prevalence at birth,N/A
Disease,510,Lesch-Nyhan syndrome,Point prevalence,N/A
Disease,510,Lesch-Nyhan syndrome,Prevalence at birth,N/A
Disease,510,Lesch-Nyhan syndrome,Point prevalence,N/A
Disease,510,Lesch-Nyhan syndrome,Point prevalence,N/A
Disease,510,Lesch-Nyhan syndrome,Prevalence at birth,N/A
Disease,510,Lesch-Nyhan syndrome,Point prevalence,N/A
Disease,510,Lesch-Nyhan syndrome,Point prevalence,N/A
Disease,524,Li-Fraumeni syndrome,Point prevalence,N/A
Disease,524,Li-Fraumeni syndrome,Point prevalence,N/A
Disease,524,Li-Fraumeni syndrome,Point prevalence,N/A
Disease,699,Pearson syndrome,Point prevalence,N/A
Disease,699,Pearson syndrome,Cases/families,N/A
Malformation syndrome,640,Hereditary neuropathy with liability to pressure palsies,Point prevalence,N/A
Malformation syndrome,640,Hereditary neuropathy with liability to pressure palsies,Point prevalence,N/A
Disease,60,Alpha-1-antitrypsin deficiency,Point prevalence,N/A
Disease,60,Alpha-1-antitrypsin deficiency,Point prevalence,N/A
Disease,60,Alpha-1-antitrypsin deficiency,Point prevalence,N/A
Disease,60,Alpha-1-antitrypsin deficiency,Prevalence at birth,N/A
Disease,60,Alpha-1-antitrypsin deficiency,Point prevalence,N/A
Disease,60,Alpha-1-antitrypsin deficiency,Prevalence at birth,N/A
Clinical subtype,895,Waardenburg syndrome type 2,Cases/families,N/A
Clinical subtype,895,Waardenburg syndrome type 2,Point prevalence,N/A
Clinical subtype,896,Waardenburg syndrome type 3,Point prevalence,N/A
Malformation syndrome,857,Townes-Brocks syndrome,Prevalence at birth,N/A
Malformation syndrome,857,Townes-Brocks syndrome,Point prevalence,N/A
Clinical subtype,894,Waardenburg syndrome type 1,Point prevalence,N/A
Clinical subtype,894,Waardenburg syndrome type 1,Point prevalence,N/A
Disease,682,Hyperkalemic periodic paralysis,Point prevalence,N/A
Disease,682,Hyperkalemic periodic paralysis,Point prevalence,N/A
Disease,682,Hyperkalemic periodic paralysis,Point prevalence,N/A
Disease,800,Schwartz-Jampel syndrome,Cases/families,N/A
Disease,800,Schwartz-Jampel syndrome,Point prevalence,N/A
Disease,628,Diastrophic dysplasia,Point prevalence,N/A
Disease,628,Diastrophic dysplasia,Prevalence at birth,N/A
Disease,628,Diastrophic dysplasia,Point prevalence,N/A
Disease,673,Malaria,Annual incidence,N/A
Disease,673,Malaria,Point prevalence,N/A
Disease,673,Malaria,Annual incidence,N/A
Disease,673,Malaria,Annual incidence,N/A
Disease,673,Malaria,Annual incidence,N/A
Disease,673,Malaria,Annual incidence,N/A
Disease,673,Malaria,Annual incidence,N/A
Disease,673,Malaria,Annual incidence,N/A
Disease,673,Malaria,Annual incidence,N/A
Disease,673,Malaria,Annual incidence,N/A
Disease,673,Malaria,Annual incidence,N/A
Disease,673,Malaria,Annual incidence,N/A
Disease,673,Malaria,Annual incidence,N/A
Disease,673,Malaria,Annual incidence,N/A
Disease,673,Malaria,Annual incidence,N/A
Disease,673,Malaria,Annual incidence,N/A
Disease,673,Malaria,Annual incidence,N/A
Disease,673,Malaria,Annual incidence,N/A
Disease,673,Malaria,Annual incidence,N/A
Disease,673,Malaria,Annual incidence,N/A
Disease,673,Malaria,Annual incidence,N/A
Disease,673,Malaria,Annual incidence,N/A
Disease,673,Malaria,Annual incidence,N/A
Disease,673,Malaria,Annual incidence,N/A
Disease,673,Malaria,Annual incidence,N/A
Disease,673,Malaria,Annual incidence,N/A
Disease,673,Malaria,Annual incidence,N/A
Disease,673,Malaria,Annual incidence,N/A
Disease,673,Malaria,Annual incidence,N/A
Disease,673,Malaria,Annual incidence,N/A
Disease,673,Malaria,Annual incidence,N/A
Disease,681,Hypokalemic periodic paralysis,Point prevalence,N/A
Disease,681,Hypokalemic periodic paralysis,Point prevalence,N/A
Disease,681,Hypokalemic periodic paralysis,Point prevalence,N/A
Malformation syndrome,126,Blepharophimosis-ptosis-epicanthus inversus syndrome,Point prevalence,N/A
Malformation syndrome,107,BOR syndrome,Point prevalence,N/A
Malformation syndrome,107,BOR syndrome,Point prevalence,N/A
Disease,774,Hereditary hemorrhagic telangiectasia,Point prevalence,N/A
Disease,774,Hereditary hemorrhagic telangiectasia,Point prevalence,N/A
Disease,774,Hereditary hemorrhagic telangiectasia,Point prevalence,N/A
Disease,774,Hereditary hemorrhagic telangiectasia,Point prevalence,N/A
Disease,774,Hereditary hemorrhagic telangiectasia,Point prevalence,N/A
Disease,774,Hereditary hemorrhagic telangiectasia,Point prevalence,N/A
Disease,774,Hereditary hemorrhagic telangiectasia,Point prevalence,N/A
Malformation syndrome,794,Saethre-Chotzen syndrome,Prevalence at birth,N/A
Malformation syndrome,794,Saethre-Chotzen syndrome,Point prevalence,N/A
Malformation syndrome,794,Saethre-Chotzen syndrome,Prevalence at birth,N/A
Malformation syndrome,710,Pfeiffer syndrome,Prevalence at birth,N/A
Malformation syndrome,710,Pfeiffer syndrome,Point prevalence,N/A
Malformation syndrome,710,Pfeiffer syndrome,Prevalence at birth,N/A
Disease,2869,Peutz-Jeghers syndrome,Prevalence at birth,N/A
Disease,2869,Peutz-Jeghers syndrome,Point prevalence,N/A
Disease,2869,Peutz-Jeghers syndrome,Prevalence at birth,N/A
Malformation syndrome,893,WAGR syndrome,Prevalence at birth,N/A
Malformation syndrome,893,WAGR syndrome,Point prevalence,N/A
Disease,912,Zellweger syndrome,Point prevalence,N/A
Disease,912,Zellweger syndrome,Point prevalence,N/A
Disease,912,Zellweger syndrome,Prevalence at birth,N/A
Disease,912,Zellweger syndrome,Prevalence at birth,N/A
Disease,50,Aicardi syndrome,Prevalence at birth,N/A
Disease,50,Aicardi syndrome,Prevalence at birth,N/A
Disease,50,Aicardi syndrome,Point prevalence,N/A
Disease,50,Aicardi syndrome,Point prevalence,N/A
Malformation syndrome,53,Albers-Schnberg osteopetrosis,Point prevalence,N/A
Malformation syndrome,53,Albers-Schnberg osteopetrosis,Point prevalence,N/A
Malformation syndrome,53,Albers-Schnberg osteopetrosis,Point prevalence,N/A
Malformation syndrome,53,Albers-Schnberg osteopetrosis,Point prevalence,N/A
Disease,14,Abetalipoproteinemia,Point prevalence,N/A
Disease,14,Abetalipoproteinemia,Cases/families,N/A
Malformation syndrome,52,Alagille syndrome,Prevalence at birth,N/A
Malformation syndrome,52,Alagille syndrome,Point prevalence,N/A
Malformation syndrome,52,Alagille syndrome,Prevalence at birth,N/A
Malformation syndrome,52,Alagille syndrome,Prevalence at birth,N/A
Malformation syndrome,52,Alagille syndrome,Point prevalence,N/A
Disease,167,Chdiak-Higashi syndrome,Cases/families,N/A
Disease,167,Chdiak-Higashi syndrome,Point prevalence,N/A
Malformation syndrome,195,Cat-eye syndrome,Prevalence at birth,N/A
Malformation syndrome,195,Cat-eye syndrome,Point prevalence,N/A
Malformation syndrome,207,Crouzon syndrome,Prevalence at birth,N/A
Malformation syndrome,207,Crouzon syndrome,Point prevalence,N/A
Malformation syndrome,207,Crouzon syndrome,Point prevalence,N/A
Malformation syndrome,207,Crouzon syndrome,Prevalence at birth,N/A
Disease,205,Crigler-Najjar syndrome,Prevalence at birth,N/A
Disease,205,Crigler-Najjar syndrome,Point prevalence,N/A
Disease,160148,Cap polyposis,Cases/families,N/A
Disease,160148,Cap polyposis,Point prevalence,N/A
Disease,201,Cowden syndrome,Point prevalence,N/A
Disease,201,Cowden syndrome,Point prevalence,N/A
Malformation syndrome,192,Coffin-Lowry syndrome,Point prevalence,N/A
Malformation syndrome,192,Coffin-Lowry syndrome,Point prevalence,N/A
Clinical group,2442,X-linked lymphoproliferative disease,Point prevalence,N/A
Clinical group,2442,X-linked lymphoproliferative disease,Point prevalence,N/A
Clinical subtype,169802,Severe hemophilia A,Point prevalence,N/A
Disease,562,McCune-Albright syndrome,Point prevalence,N/A
Disease,565,Menkes disease,Prevalence at birth,N/A
Disease,565,Menkes disease,Prevalence at birth,N/A
Disease,565,Menkes disease,Prevalence at birth,N/A
Disease,565,Menkes disease,Point prevalence,N/A
Category,2443,Mitochondrial oxidative phosphorylation disorder due to nuclear DNA anomalies,Point prevalence,N/A
Malformation syndrome,474,Jeune syndrome,Prevalence at birth,N/A
Malformation syndrome,474,Jeune syndrome,Prevalence at birth,N/A
Malformation syndrome,474,Jeune syndrome,Point prevalence,N/A
Disease,540,Familial hemophagocytic lymphohistiocytosis,Prevalence at birth,N/A
Disease,540,Familial hemophagocytic lymphohistiocytosis,Point prevalence,N/A
Disease,540,Familial hemophagocytic lymphohistiocytosis,Annual incidence,N/A
Malformation syndrome,568,"Microphthalmia, Lenz type",Point prevalence,N/A
Malformation syndrome,564,Meckel syndrome,Prevalence at birth,N/A
Malformation syndrome,564,Meckel syndrome,Point prevalence,N/A
Malformation syndrome,564,Meckel syndrome,Prevalence at birth,N/A
Malformation syndrome,564,Meckel syndrome,Prevalence at birth,N/A
Malformation syndrome,564,Meckel syndrome,Point prevalence,N/A
Malformation syndrome,564,Meckel syndrome,Prevalence at birth,N/A
Malformation syndrome,289,Ellis Van Creveld syndrome,Prevalence at birth,N/A
Malformation syndrome,289,Ellis Van Creveld syndrome,Prevalence at birth,N/A
Malformation syndrome,289,Ellis Van Creveld syndrome,Prevalence at birth,N/A
Malformation syndrome,289,Ellis Van Creveld syndrome,Point prevalence,N/A
Malformation syndrome,258,Laminin subunit alpha 2-related congenital muscular dystrophy,Point prevalence,N/A
Malformation syndrome,258,Laminin subunit alpha 2-related congenital muscular dystrophy,Point prevalence,N/A
Disease,1247,Schistosomiasis,Point prevalence,N/A
Disease,1247,Schistosomiasis,Point prevalence,N/A
Disease,112,Bartter syndrome,Annual incidence,N/A
Disease,112,Bartter syndrome,Annual incidence,N/A
Disease,112,Bartter syndrome,Prevalence at birth,N/A
Disease,112,Bartter syndrome,Point prevalence,N/A
Malformation syndrome,1646,Chromosome Y microdeletion syndrome,Point prevalence,N/A
Malformation syndrome,1646,Chromosome Y microdeletion syndrome,Point prevalence,N/A
Disease,169464,Primary CD59 deficiency,Cases/families,N/A
Disease,169464,Primary CD59 deficiency,Point prevalence,N/A
Category,99,Autosomal dominant cerebellar ataxia,Point prevalence,N/A
Category,99,Autosomal dominant cerebellar ataxia,Point prevalence,N/A
Category,99,Autosomal dominant cerebellar ataxia,Point prevalence,N/A
Category,99,Autosomal dominant cerebellar ataxia,Point prevalence,N/A
Category,99,Autosomal dominant cerebellar ataxia,Point prevalence,N/A
Category,99,Autosomal dominant cerebellar ataxia,Point prevalence,N/A
Malformation syndrome,116,Beckwith-Wiedemann syndrome,Prevalence at birth,N/A
Malformation syndrome,116,Beckwith-Wiedemann syndrome,Prevalence at birth,N/A
Malformation syndrome,116,Beckwith-Wiedemann syndrome,Prevalence at birth,N/A
Malformation syndrome,116,Beckwith-Wiedemann syndrome,Prevalence at birth,N/A
Malformation syndrome,116,Beckwith-Wiedemann syndrome,Prevalence at birth,N/A
Malformation syndrome,116,Beckwith-Wiedemann syndrome,Point prevalence,N/A
Malformation syndrome,87,Apert syndrome,Point prevalence,N/A
Malformation syndrome,87,Apert syndrome,Prevalence at birth,N/A
Malformation syndrome,87,Apert syndrome,Point prevalence,N/A
Malformation syndrome,87,Apert syndrome,Prevalence at birth,N/A
Malformation syndrome,87,Apert syndrome,Point prevalence,N/A
Malformation syndrome,87,Apert syndrome,Prevalence at birth,N/A
Malformation syndrome,87,Apert syndrome,Point prevalence,N/A
Malformation syndrome,87,Apert syndrome,Prevalence at birth,N/A
Malformation syndrome,87,Apert syndrome,Point prevalence,N/A
Malformation syndrome,87,Apert syndrome,Prevalence at birth,N/A
Disease,97,Familial paroxysmal ataxia,Point prevalence,N/A
Disease,97,Familial paroxysmal ataxia,Point prevalence,N/A
Disease,313,Lamellar ichthyosis,Point prevalence,N/A
Disease,313,Lamellar ichthyosis,Point prevalence,N/A
Disease,313,Lamellar ichthyosis,Point prevalence,N/A
Clinical subtype,169799,Mild hemophilia B,Point prevalence,N/A
Clinical subtype,169796,Moderate hemophilia B,Point prevalence,N/A
Clinical subtype,169793,Severe hemophilia B,Point prevalence,N/A
Disease,1000,Ocular albinism with late-onset sensorineural deafness,Cases/families,N/A
Disease,1000,Ocular albinism with late-onset sensorineural deafness,Point prevalence,N/A
Malformation syndrome,999,Ermine phenotype,Cases/families,N/A
Malformation syndrome,999,Ermine phenotype,Point prevalence,N/A
Disease,171430,Severe congenital nemaline myopathy,Point prevalence,N/A
Disease,171433,Intermediate nemaline myopathy,Point prevalence,N/A
Disease,171436,Typical nemaline myopathy,Point prevalence,N/A
Disease,171439,Childhood-onset nemaline myopathy,Point prevalence,N/A
Clinical group,55,Oculocutaneous albinism,Point prevalence,N/A
Clinical group,55,Oculocutaneous albinism,Prevalence at birth,N/A
Clinical group,55,Oculocutaneous albinism,Point prevalence,N/A
Disease,171442,Adult-onset nemaline myopathy,Point prevalence,N/A
Disease,171607,X-linked spastic paraplegia type 34,Cases/families,N/A
Disease,171607,X-linked spastic paraplegia type 34,Point prevalence,N/A
Malformation syndrome,2771,Bruck syndrome,Cases/families,N/A
Malformation syndrome,2771,Bruck syndrome,Point prevalence,N/A
Disease,171612,Autosomal dominant spastic paraplegia type 37,Cases/families,N/A
Disease,171612,Autosomal dominant spastic paraplegia type 37,Point prevalence,N/A
Disease,171617,Autosomal dominant spastic paraplegia type 38,Cases/families,N/A
Disease,171617,Autosomal dominant spastic paraplegia type 38,Point prevalence,N/A
Malformation syndrome,1349,Mitochondrial DNA-related cardiomyopathy and hearing loss,Cases/families,N/A
Malformation syndrome,1349,Mitochondrial DNA-related cardiomyopathy and hearing loss,Point prevalence,N/A
Disease,171622,Autosomal recessive spastic paraplegia type 32,Cases/families,N/A
Disease,171622,Autosomal recessive spastic paraplegia type 32,Point prevalence,N/A
Disease,171629,Autosomal recessive spastic paraplegia type 35,Cases/families,N/A
Disease,171629,Autosomal recessive spastic paraplegia type 35,Point prevalence,N/A
Malformation syndrome,861,Treacher-Collins syndrome,Prevalence at birth,N/A
Malformation syndrome,861,Treacher-Collins syndrome,Point prevalence,N/A
Malformation syndrome,861,Treacher-Collins syndrome,Prevalence at birth,N/A
Malformation syndrome,861,Treacher-Collins syndrome,Point prevalence,N/A
Malformation syndrome,861,Treacher-Collins syndrome,Prevalence at birth,N/A
Malformation syndrome,861,Treacher-Collins syndrome,Point prevalence,N/A
Disease,308,Progressive myoclonic epilepsy type 1,Prevalence at birth,N/A
Disease,308,Progressive myoclonic epilepsy type 1,Point prevalence,N/A
Clinical group,1991,Cleft lip with or without cleft palate,Prevalence at birth,N/A
Clinical group,1991,Cleft lip with or without cleft palate,Prevalence at birth,N/A
Clinical group,1991,Cleft lip with or without cleft palate,Prevalence at birth,N/A
Malformation syndrome,199,Cornelia de Lange syndrome,Prevalence at birth,N/A
Malformation syndrome,199,Cornelia de Lange syndrome,Prevalence at birth,N/A
Malformation syndrome,199,Cornelia de Lange syndrome,Point prevalence,N/A
Malformation syndrome,2162,Holoprosencephaly,Prevalence at birth,N/A
Malformation syndrome,2162,Holoprosencephaly,Prevalence at birth,N/A
Malformation syndrome,2162,Holoprosencephaly,Prevalence at birth,N/A
Malformation syndrome,2162,Holoprosencephaly,Prevalence at birth,N/A
Malformation syndrome,2162,Holoprosencephaly,Prevalence at birth,N/A
Malformation syndrome,2162,Holoprosencephaly,Prevalence at birth,N/A
Malformation syndrome,2162,Holoprosencephaly,Point prevalence,N/A
Malformation syndrome,2162,Holoprosencephaly,Prevalence at birth,N/A
Disease,930,Idiopathic achalasia,Prevalence at birth,N/A
Disease,930,Idiopathic achalasia,Point prevalence,N/A
Disease,930,Idiopathic achalasia,Point prevalence,N/A
Disease,930,Idiopathic achalasia,Point prevalence,N/A
Disease,930,Idiopathic achalasia,Point prevalence,N/A
Disease,930,Idiopathic achalasia,Point prevalence,N/A
Disease,930,Idiopathic achalasia,Point prevalence,N/A
Disease,930,Idiopathic achalasia,Annual incidence,N/A
Disease,930,Idiopathic achalasia,Annual incidence,N/A
Disease,930,Idiopathic achalasia,Annual incidence,N/A
Disease,930,Idiopathic achalasia,Annual incidence,N/A
Disease,930,Idiopathic achalasia,Annual incidence,N/A
Disease,930,Idiopathic achalasia,Annual incidence,N/A
Malformation syndrome,998,Albinism-deafness syndrome,Cases/families,N/A
Malformation syndrome,998,Albinism-deafness syndrome,Point prevalence,N/A
Malformation syndrome,1727,22q11.2 duplication syndrome,Cases/families,N/A
Malformation syndrome,1727,22q11.2 duplication syndrome,Point prevalence,N/A
Disease,169079,Cernunnos-XLF deficiency,Cases/families,N/A
Disease,169079,Cernunnos-XLF deficiency,Point prevalence,N/A
Malformation syndrome,1715,Trisomy 18p syndrome,Cases/families,N/A
Malformation syndrome,1715,Trisomy 18p syndrome,Point prevalence,N/A
Malformation syndrome,3380,Trisomy 18 syndrome,Prevalence at birth,N/A
Malformation syndrome,3380,Trisomy 18 syndrome,Prevalence at birth,N/A
Malformation syndrome,3380,Trisomy 18 syndrome,Prevalence at birth,N/A
Malformation syndrome,3380,Trisomy 18 syndrome,Prevalence at birth,N/A
Malformation syndrome,3380,Trisomy 18 syndrome,Prevalence at birth,N/A
Malformation syndrome,3380,Trisomy 18 syndrome,Prevalence at birth,N/A
Malformation syndrome,3380,Trisomy 18 syndrome,Prevalence at birth,N/A
Malformation syndrome,3380,Trisomy 18 syndrome,Prevalence at birth,N/A
Malformation syndrome,3380,Trisomy 18 syndrome,Point prevalence,N/A
Malformation syndrome,3380,Trisomy 18 syndrome,Prevalence at birth,N/A
Malformation syndrome,3380,Trisomy 18 syndrome,Prevalence at birth,N/A
Malformation syndrome,3380,Trisomy 18 syndrome,Prevalence at birth,N/A
Malformation syndrome,3380,Trisomy 18 syndrome,Prevalence at birth,N/A
Malformation syndrome,3380,Trisomy 18 syndrome,Prevalence at birth,N/A
Malformation syndrome,3380,Trisomy 18 syndrome,Prevalence at birth,N/A
Malformation syndrome,3380,Trisomy 18 syndrome,Prevalence at birth,N/A
Malformation syndrome,3380,Trisomy 18 syndrome,Prevalence at birth,N/A
Malformation syndrome,3380,Trisomy 18 syndrome,Prevalence at birth,N/A
Malformation syndrome,3380,Trisomy 18 syndrome,Prevalence at birth,N/A
Malformation syndrome,3380,Trisomy 18 syndrome,Prevalence at birth,N/A
Malformation syndrome,3380,Trisomy 18 syndrome,Prevalence at birth,N/A
Malformation syndrome,3380,Trisomy 18 syndrome,Prevalence at birth,N/A
Malformation syndrome,3380,Trisomy 18 syndrome,Point prevalence,N/A
Malformation syndrome,3380,Trisomy 18 syndrome,Prevalence at birth,N/A
Malformation syndrome,3380,Trisomy 18 syndrome,Prevalence at birth,N/A
Malformation syndrome,168984,CLAPO syndrome,Cases/families,N/A
Malformation syndrome,168984,CLAPO syndrome,Point prevalence,N/A
Disease,168999,Malignant melanoma of the mucosa,Annual incidence,N/A
Disease,168999,Malignant melanoma of the mucosa,Point prevalence,N/A
Disease,168999,Malignant melanoma of the mucosa,Lifetime Prevalence,N/A
Disease,168999,Malignant melanoma of the mucosa,Annual incidence,N/A
Disease,168999,Malignant melanoma of the mucosa,Annual incidence,N/A
Malformation syndrome,3378,Trisomy 13 syndrome,Prevalence at birth,N/A
Malformation syndrome,3378,Trisomy 13 syndrome,Prevalence at birth,N/A
Malformation syndrome,3378,Trisomy 13 syndrome,Prevalence at birth,N/A
Malformation syndrome,3378,Trisomy 13 syndrome,Prevalence at birth,N/A
Malformation syndrome,3378,Trisomy 13 syndrome,Prevalence at birth,N/A
Malformation syndrome,3378,Trisomy 13 syndrome,Prevalence at birth,N/A
Malformation syndrome,3378,Trisomy 13 syndrome,Prevalence at birth,N/A
Malformation syndrome,3378,Trisomy 13 syndrome,Prevalence at birth,N/A
Malformation syndrome,3378,Trisomy 13 syndrome,Prevalence at birth,N/A
Malformation syndrome,3378,Trisomy 13 syndrome,Prevalence at birth,N/A
Malformation syndrome,3378,Trisomy 13 syndrome,Point prevalence,N/A
Malformation syndrome,3378,Trisomy 13 syndrome,Prevalence at birth,N/A
Malformation syndrome,3378,Trisomy 13 syndrome,Prevalence at birth,N/A
Malformation syndrome,3378,Trisomy 13 syndrome,Prevalence at birth,N/A
Malformation syndrome,3378,Trisomy 13 syndrome,Prevalence at birth,N/A
Malformation syndrome,3378,Trisomy 13 syndrome,Prevalence at birth,N/A
Malformation syndrome,3378,Trisomy 13 syndrome,Prevalence at birth,N/A
Malformation syndrome,3378,Trisomy 13 syndrome,Prevalence at birth,N/A
Malformation syndrome,3378,Trisomy 13 syndrome,Prevalence at birth,N/A
Malformation syndrome,3378,Trisomy 13 syndrome,Prevalence at birth,N/A
Malformation syndrome,3378,Trisomy 13 syndrome,Point prevalence,N/A
Disease,169100,Immunodeficiency due to CD25 deficiency,Cases/families,N/A
Disease,169100,Immunodeficiency due to CD25 deficiency,Point prevalence,N/A
Disease,169105,Good syndrome,Point prevalence,N/A
Disease,169105,Good syndrome,Cases/families,N/A
Disease,169090,Combined immunodeficiency due to CRAC channel dysfunction,Cases/families,N/A
Disease,169090,Combined immunodeficiency due to CRAC channel dysfunction,Point prevalence,N/A
Malformation syndrome,236,Trisomy 9p syndrome,Cases/families,N/A
Malformation syndrome,236,Trisomy 9p syndrome,Point prevalence,N/A
Disease,169095,Severe combined immunodeficiency due to FOXN1 deficiency,Cases/families,N/A
Disease,169095,Severe combined immunodeficiency due to FOXN1 deficiency,Point prevalence,N/A
Disease,169085,Susceptibility to respiratory infections associated with CD8alpha chain mutation,Point prevalence,N/A
Disease,168829,Primary peritoneal carcinoma,Point prevalence,N/A
Disease,168816,Peritoneal inclusion cyst,Cases/families,N/A
Disease,168816,Peritoneal inclusion cyst,Point prevalence,N/A
Disease,753,"46,XY difference of sex development due to 5-alpha-reductase 2 deficiency",Point prevalence,N/A
Disease,868,Triose phosphate-isomerase deficiency,Cases/families,N/A
Disease,868,Triose phosphate-isomerase deficiency,Point prevalence,N/A
Disease,168811,Malignant peritoneal mesothelioma,Annual incidence,N/A
Disease,168811,Malignant peritoneal mesothelioma,Point prevalence,N/A
Disease,168811,Malignant peritoneal mesothelioma,Annual incidence,N/A
Disease,218,Darier disease,Point prevalence,N/A
Disease,218,Darier disease,Point prevalence,N/A
Disease,218,Darier disease,Point prevalence,N/A
Disease,218,Darier disease,Point prevalence,N/A
Disease,218,Darier disease,Annual incidence,N/A
Malformation syndrome,168796,"Heart-hand syndrome, Slovenian type",Cases/families,N/A
Malformation syndrome,168796,"Heart-hand syndrome, Slovenian type",Point prevalence,N/A
Malformation syndrome,1465,Coffin-Siris syndrome,Cases/families,N/A
Malformation syndrome,1465,Coffin-Siris syndrome,Point prevalence,N/A
Disease,168782,Childhood disintegrative disorder,Point prevalence,N/A
Malformation syndrome,1642,Distal deletion 9p syndrome,Cases/families,N/A
Malformation syndrome,1642,Distal deletion 9p syndrome,Point prevalence,N/A
Disease,168966,Composite lymphoma,Annual incidence,N/A
Disease,168960,Refractory anemia with excess blasts in transformation,Annual incidence,N/A
Malformation syndrome,8,"47,XYY syndrome",Point prevalence,N/A
Malformation syndrome,8,"47,XYY syndrome",Prevalence at birth,N/A
Malformation syndrome,8,"47,XYY syndrome",Prevalence at birth,N/A
Malformation syndrome,8,"47,XYY syndrome",Point prevalence,N/A
Clinical group,168956,Hypereosinophilic syndrome,Annual incidence,N/A
Clinical group,168956,Hypereosinophilic syndrome,Point prevalence,N/A
Clinical group,168956,Hypereosinophilic syndrome,Point prevalence,N/A
Clinical group,168956,Hypereosinophilic syndrome,Annual incidence,N/A
Malformation syndrome,1600,Monosomy 18q syndrome,Prevalence at birth,N/A
Malformation syndrome,1600,Monosomy 18q syndrome,Point prevalence,N/A
Disease,1598,Monosomy 18p syndrome,Point prevalence,N/A
Disease,1598,Monosomy 18p syndrome,Prevalence at birth,N/A
Malformation syndrome,2773,Osteogenesis imperfecta-retinopathy-seizures-intellectual disability syndrome,Cases/families,N/A
Malformation syndrome,2773,Osteogenesis imperfecta-retinopathy-seizures-intellectual disability syndrome,Point prevalence,N/A
Malformation syndrome,2772,Congenital osteogenesis imperfecta-microcephaly-cataracts syndrome,Cases/families,N/A
Malformation syndrome,2772,Congenital osteogenesis imperfecta-microcephaly-cataracts syndrome,Point prevalence,N/A
Disease,2609,Isolated complex I deficiency,Point prevalence,N/A
Disease,626,Large/giant congenital melanocytic nevus,Point prevalence,N/A
Disease,773,Refsum disease,Point prevalence,N/A
Disease,773,Refsum disease,Cases/families,N/A
Malformation syndrome,11,Pentasomy X syndrome,Point prevalence,N/A
Disease,169154,T-B+ severe combined immunodeficiency due to IL-7Ralpha deficiency,Prevalence at birth,N/A
Disease,169154,T-B+ severe combined immunodeficiency due to IL-7Ralpha deficiency,Point prevalence,N/A
Disease,169154,T-B+ severe combined immunodeficiency due to IL-7Ralpha deficiency,Prevalence at birth,N/A
Clinical group,370,Glycogen storage disease due to phosphorylase kinase deficiency,Prevalence at birth,N/A
Clinical group,370,Glycogen storage disease due to phosphorylase kinase deficiency,Point prevalence,N/A
Clinical group,370,Glycogen storage disease due to phosphorylase kinase deficiency,Prevalence at birth,N/A
Clinical group,370,Glycogen storage disease due to phosphorylase kinase deficiency,Prevalence at birth,N/A
Disease,169160,T-B+ severe combined immunodeficiency due to CD3delta/CD3epsilon/CD3zeta,Prevalence at birth,N/A
Disease,169160,T-B+ severe combined immunodeficiency due to CD3delta/CD3epsilon/CD3zeta,Point prevalence,N/A
Clinical group,385,Neurodegeneration with brain iron accumulation,Point prevalence,N/A
Disease,169157,T-B+ severe combined immunodeficiency due to CD45 deficiency,Point prevalence,N/A
Disease,169157,T-B+ severe combined immunodeficiency due to CD45 deficiency,Cases/families,N/A
Disease,1947,"Progressive epilepsy-intellectual disability syndrome, Finnish type",Point prevalence,N/A
Category,352,Galactosemia,Prevalence at birth,N/A
Category,352,Galactosemia,Annual incidence,N/A
Category,352,Galactosemia,Prevalence at birth,N/A
Category,352,Galactosemia,Point prevalence,N/A
Disease,596,X-linked centronuclear myopathy,Prevalence at birth,N/A
Disease,596,X-linked centronuclear myopathy,Point prevalence,N/A
Disease,596,X-linked centronuclear myopathy,Point prevalence,N/A
Disease,610,Bethlem muscular dystrophy,Point prevalence,N/A
Disease,610,Bethlem muscular dystrophy,Point prevalence,N/A
Disease,169186,Autosomal recessive centronuclear myopathy,Point prevalence,N/A
Malformation syndrome,464,Incontinentia pigmenti,Prevalence at birth,N/A
Malformation syndrome,464,Incontinentia pigmenti,Prevalence at birth,N/A
Malformation syndrome,464,Incontinentia pigmenti,Point prevalence,N/A
Malformation syndrome,3307,Tetrasomy 18p syndrome,Point prevalence,N/A
Disease,169189,Autosomal dominant centronuclear myopathy,Point prevalence,N/A
Disease,44,Neonatal adrenoleukodystrophy,Prevalence at birth,N/A
Disease,44,Neonatal adrenoleukodystrophy,Point prevalence,N/A
Disease,56,Alkaptonuria,Point prevalence,N/A
Disease,56,Alkaptonuria,Point prevalence,N/A
Disease,56,Alkaptonuria,Prevalence at birth,N/A
Disease,56,Alkaptonuria,Point prevalence,N/A
Disease,56,Alkaptonuria,Prevalence at birth,N/A
Disease,56,Alkaptonuria,Point prevalence,N/A
Disease,56,Alkaptonuria,Prevalence at birth,N/A
Disease,56,Alkaptonuria,Point prevalence,N/A
Disease,963,Acromegaly,Annual incidence,N/A
Disease,963,Acromegaly,Point prevalence,N/A
Disease,963,Acromegaly,Point prevalence,N/A
Disease,963,Acromegaly,Point prevalence,N/A
Disease,963,Acromegaly,Annual incidence,N/A
Disease,963,Acromegaly,Point prevalence,N/A
Disease,963,Acromegaly,Annual incidence,N/A
Disease,963,Acromegaly,Point prevalence,N/A
Disease,963,Acromegaly,Annual incidence,N/A
Disease,963,Acromegaly,Annual incidence,N/A
Disease,963,Acromegaly,Point prevalence,N/A
Disease,963,Acromegaly,Annual incidence,N/A
Disease,963,Acromegaly,Point prevalence,N/A
Disease,963,Acromegaly,Point prevalence,N/A
Disease,963,Acromegaly,Annual incidence,N/A
Disease,963,Acromegaly,Point prevalence,N/A
Disease,963,Acromegaly,Annual incidence,N/A
Disease,963,Acromegaly,Point prevalence,N/A
Disease,963,Acromegaly,Annual incidence,N/A
Disease,963,Acromegaly,Annual incidence,N/A
Disease,963,Acromegaly,Point prevalence,N/A
Malformation syndrome,1059,Blue rubber bleb nevus,Cases/families,N/A
Malformation syndrome,1059,Blue rubber bleb nevus,Point prevalence,N/A
Disease,1006,Alopecia antibody deficiency,Cases/families,N/A
Disease,1006,Alopecia antibody deficiency,Point prevalence,N/A
Malformation syndrome,1046,Lethal hemolytic anemia-genital anomalies syndrome,Cases/families,N/A
Malformation syndrome,1046,Lethal hemolytic anemia-genital anomalies syndrome,Point prevalence,N/A
Disease,22,Succinic semialdehyde dehydrogenase deficiency,Cases/families,N/A
Disease,22,Succinic semialdehyde dehydrogenase deficiency,Point prevalence,N/A
Clinical subtype,29,Mevalonic aciduria,Cases/families,N/A
Clinical subtype,29,Mevalonic aciduria,Point prevalence,N/A
Malformation syndrome,245,Nager syndrome,Cases/families,N/A
Malformation syndrome,245,Nager syndrome,Point prevalence,N/A
Malformation syndrome,245,Nager syndrome,Prevalence at birth,N/A
Disease,30,Hereditary orotic aciduria,Cases/families,N/A
Disease,30,Hereditary orotic aciduria,Point prevalence,N/A
Malformation syndrome,36,Acrocallosal syndrome,Cases/families,N/A
Malformation syndrome,36,Acrocallosal syndrome,Point prevalence,N/A
Malformation syndrome,915,Aarskog-Scott syndrome,Prevalence at birth,N/A
Malformation syndrome,915,Aarskog-Scott syndrome,Point prevalence,N/A
Malformation syndrome,2614,Nail-patella syndrome,Point prevalence,N/A
Malformation syndrome,2614,Nail-patella syndrome,Point prevalence,N/A
Malformation syndrome,2614,Nail-patella syndrome,Prevalence at birth,N/A
Malformation syndrome,2614,Nail-patella syndrome,Point prevalence,N/A
Disease,33,Isovaleric acidemia,Point prevalence,N/A
Disease,33,Isovaleric acidemia,Prevalence at birth,N/A
Disease,33,Isovaleric acidemia,Prevalence at birth,N/A
Disease,33,Isovaleric acidemia,Prevalence at birth,N/A
Disease,33,Isovaleric acidemia,Prevalence at birth,N/A
Malformation syndrome,819,Smith-Magenis syndrome,Prevalence at birth,N/A
Malformation syndrome,819,Smith-Magenis syndrome,Point prevalence,N/A
Malformation syndrome,819,Smith-Magenis syndrome,Point prevalence,N/A
Malformation syndrome,819,Smith-Magenis syndrome,Prevalence at birth,N/A
Malformation syndrome,819,Smith-Magenis syndrome,Point prevalence,N/A
Malformation syndrome,3085,Retinitis pigmentosa-intellectual disability-deafness-hypogonadism syndrome,Cases/families,N/A
Malformation syndrome,3085,Retinitis pigmentosa-intellectual disability-deafness-hypogonadism syndrome,Point prevalence,N/A
Malformation syndrome,9,Tetrasomy X syndrome,Cases/families,N/A
Malformation syndrome,9,Tetrasomy X syndrome,Point prevalence,N/A
Biological anomaly,168615,Hereditary persistence of alpha-fetoprotein,Cases/families,N/A
Biological anomaly,168615,Hereditary persistence of alpha-fetoprotein,Point prevalence,N/A
Biological anomaly,168612,Congenital deficiency in alpha-fetoprotein,Cases/families,N/A
Biological anomaly,168612,Congenital deficiency in alpha-fetoprotein,Point prevalence,N/A
Malformation syndrome,1442,Ring chromosome 18 syndrome,Cases/families,N/A
Malformation syndrome,1442,Ring chromosome 18 syndrome,Point prevalence,N/A
Disease,168621,"Dysplasia of head of femur, Meyer type",Point prevalence,N/A
Malformation syndrome,1452,Cleidocranial dysplasia,Point prevalence,N/A
Malformation syndrome,1452,Cleidocranial dysplasia,Prevalence at birth,N/A
Malformation syndrome,1452,Cleidocranial dysplasia,Prevalence at birth,N/A
Malformation syndrome,168624,"Familial scaphocephaly syndrome, McGillivray type",Cases/families,N/A
Malformation syndrome,168624,"Familial scaphocephaly syndrome, McGillivray type",Point prevalence,N/A
Malformation syndrome,193,Cohen syndrome,Cases/families,N/A
Malformation syndrome,193,Cohen syndrome,Point prevalence,N/A
Malformation syndrome,1488,Cooper-Jabs syndrome,Cases/families,N/A
Malformation syndrome,1488,Cooper-Jabs syndrome,Point prevalence,N/A
Morphological anomaly,200,Isolated corpus callosum agenesis,Point prevalence,N/A
Morphological anomaly,200,Isolated corpus callosum agenesis,Point prevalence,N/A
Morphological anomaly,200,Isolated corpus callosum agenesis,Prevalence at birth,N/A
Morphological anomaly,200,Isolated corpus callosum agenesis,Prevalence at birth,N/A
Disease,1334,Chronic mucocutaneous candidiasis,Point prevalence,N/A
Clinical subtype,168583,Hereditary North American Indian childhood cirrhosis,Cases/families,N/A
Clinical subtype,168583,Hereditary North American Indian childhood cirrhosis,Point prevalence,N/A
Disease,1369,Congenital cataract-hypertrophic cardiomyopathy-mitochondrial myopathy syndrome,Cases/families,N/A
Disease,1369,Congenital cataract-hypertrophic cardiomyopathy-mitochondrial myopathy syndrome,Point prevalence,N/A
Disease,168577,Hereditary cryohydrocytosis with reduced stomatin,Cases/families,N/A
Disease,168577,Hereditary cryohydrocytosis with reduced stomatin,Point prevalence,N/A
Malformation syndrome,168593,Sudden infant death-dysgenesis of the testes syndrome,Cases/families,N/A
Malformation syndrome,168593,Sudden infant death-dysgenesis of the testes syndrome,Point prevalence,N/A
Malformation syndrome,1406,Charlie M syndrome,Point prevalence,N/A
Malformation syndrome,1406,Charlie M syndrome,Cases/families,N/A
Malformation syndrome,168588,Hyperandrogenism due to cortisone reductase deficiency,Cases/families,N/A
Malformation syndrome,168588,Hyperandrogenism due to cortisone reductase deficiency,Point prevalence,N/A
Disease,1414,Cholestasis-lymphedema syndrome,Cases/families,N/A
Disease,1414,Cholestasis-lymphedema syndrome,Point prevalence,N/A
Disease,168598,Methionine adenosyltransferase I/III deficiency,Cases/families,N/A
Disease,168598,Methionine adenosyltransferase I/III deficiency,Point prevalence,N/A
Disease,168606,Seborrhea-like dermatitis with psoriasiform elements,Cases/families,N/A
Disease,168606,Seborrhea-like dermatitis with psoriasiform elements,Point prevalence,N/A
Disease,168549,Axial spondylometaphyseal dysplasia,Cases/families,N/A
Disease,168549,Axial spondylometaphyseal dysplasia,Point prevalence,N/A
Disease,168552,Spondylometaphyseal dysplasia-bowed forearms-facial dysmorphism syndrome,Cases/families,N/A
Disease,168552,Spondylometaphyseal dysplasia-bowed forearms-facial dysmorphism syndrome,Point prevalence,N/A
Malformation syndrome,1154,Arthrogryposis-oculomotor limitation-electroretinal anomalies syndrome,Point prevalence,N/A
Disease,168555,"Spondylometaphyseal dysplasia, A4 type",Cases/families,N/A
Disease,168555,"Spondylometaphyseal dysplasia, A4 type",Point prevalence,N/A
Disease,168558,"46,XY difference of sex development-adrenal insufficiency due to CYP11A1 deficiency",Cases/families,N/A
Disease,168558,"46,XY difference of sex development-adrenal insufficiency due to CYP11A1 deficiency",Point prevalence,N/A
Malformation syndrome,168563,"46,XY gonadal dysgenesis-motor and sensory neuropathy syndrome",Cases/families,N/A
Malformation syndrome,168563,"46,XY gonadal dysgenesis-motor and sensory neuropathy syndrome",Point prevalence,N/A
Disease,124,Diamond-Blackfan anemia,Prevalence at birth,N/A
Disease,124,Diamond-Blackfan anemia,Prevalence at birth,N/A
Disease,124,Diamond-Blackfan anemia,Prevalence at birth,N/A
Disease,124,Diamond-Blackfan anemia,Prevalence at birth,N/A
Disease,124,Diamond-Blackfan anemia,Point prevalence,N/A
Disease,124,Diamond-Blackfan anemia,Point prevalence,N/A
Disease,168566,Fatal mitochondrial disease due to combined oxidative phosphorylation defect type 3,Cases/families,N/A
Disease,168566,Fatal mitochondrial disease due to combined oxidative phosphorylation defect type 3,Point prevalence,N/A
Malformation syndrome,1310,Caffey disease,Point prevalence,N/A
Malformation syndrome,1310,Caffey disease,Cases/families,N/A
Malformation syndrome,168569,H syndrome,Cases/families,N/A
Malformation syndrome,168569,H syndrome,Point prevalence,N/A
Malformation syndrome,168572,Native American myopathy,Point prevalence,N/A
Disease,125,Bloom syndrome,Prevalence at birth,N/A
Disease,125,Bloom syndrome,Cases/families,N/A
Disease,125,Bloom syndrome,Point prevalence,N/A
Disease,90,Argininemia,Prevalence at birth,N/A
Disease,90,Argininemia,Prevalence at birth,N/A
Disease,90,Argininemia,Point prevalence,N/A
Disease,168443,Spondyloepimetaphyseal dysplasia-hypotrichosis syndrome,Cases/families,N/A
Disease,168443,Spondyloepimetaphyseal dysplasia-hypotrichosis syndrome,Point prevalence,N/A
Malformation syndrome,1065,Aniridia-cerebellar ataxia-intellectual disability syndrome,Cases/families,N/A
Malformation syndrome,1065,Aniridia-cerebellar ataxia-intellectual disability syndrome,Point prevalence,N/A
Disease,168451,Spondyloepimetaphyseal dysplasia-abnormal dentition syndrome,Cases/families,N/A
Disease,168451,Spondyloepimetaphyseal dysplasia-abnormal dentition syndrome,Point prevalence,N/A
Disease,168454,"Spondyloepimetaphyseal dysplasia, Genevive type",Cases/families,N/A
Disease,168454,"Spondyloepimetaphyseal dysplasia, Genevive type",Point prevalence,N/A
Malformation syndrome,1146,Distal arthrogryposis type 1,Point prevalence,N/A
Disease,1143,Neurogenic arthrogryposis multiplex congenita,Prevalence at birth,N/A
Disease,1143,Neurogenic arthrogryposis multiplex congenita,Point prevalence,N/A
Disease,168544,"Spondylometaphyseal dysplasia, Golden type",Cases/families,N/A
Disease,168544,"Spondylometaphyseal dysplasia, Golden type",Point prevalence,N/A
Malformation syndrome,1147,Sheldon-Hall syndrome,Point prevalence,N/A
Malformation syndrome,246,Postaxial acrofacial dysostosis,Cases/families,N/A
Malformation syndrome,246,Postaxial acrofacial dysostosis,Point prevalence,N/A
Malformation syndrome,1770,XY type gonadal dysgenesis-associated anomalies syndrome,Cases/families,N/A
Malformation syndrome,1770,XY type gonadal dysgenesis-associated anomalies syndrome,Point prevalence,N/A
Disease,1775,Dyskeratosis congenita,Point prevalence,N/A
Disease,1764,Familial dysautonomia,Point prevalence,N/A
Disease,1764,Familial dysautonomia,Prevalence at birth,N/A
Malformation syndrome,235,Dubowitz syndrome,Prevalence at birth,N/A
Malformation syndrome,235,Dubowitz syndrome,Point prevalence,N/A
Disease,239,Dyggve-Melchior-Clausen disease,Cases/families,N/A
Disease,239,Dyggve-Melchior-Clausen disease,Point prevalence,N/A
Disease,1672,Diencephalic syndrome,Point prevalence,N/A
Disease,833,Encephalopathy due to sulfite oxidase deficiency,Cases/families,N/A
Disease,833,Encephalopathy due to sulfite oxidase deficiency,Point prevalence,N/A
Category,167714,Unclassified acute myeloid leukemia,Annual incidence,N/A
Disease,167635,Scleromyxedema,Cases/families,N/A
Disease,167635,Scleromyxedema,Point prevalence,N/A
Disease,765,Pyruvate dehydrogenase deficiency,Point prevalence,N/A
Disease,765,Pyruvate dehydrogenase deficiency,Point prevalence,N/A
Disease,395,Homocystinuria due to methylene tetrahydrofolate reductase deficiency,Point prevalence,N/A
Disease,408,Isolated glycerol kinase deficiency,Point prevalence,N/A
Clinical group,148,Multiple carboxylase deficiency,Point prevalence,N/A
Disease,147,Carbamoyl-phosphate synthetase 1 deficiency,Point prevalence,N/A
Disease,147,Carbamoyl-phosphate synthetase 1 deficiency,Prevalence at birth,N/A
Disease,147,Carbamoyl-phosphate synthetase 1 deficiency,Prevalence at birth,N/A
Disease,147,Carbamoyl-phosphate synthetase 1 deficiency,Prevalence at birth,N/A
Disease,147,Carbamoyl-phosphate synthetase 1 deficiency,Prevalence at birth,N/A
Disease,23,Argininosuccinic aciduria,Prevalence at birth,N/A
Disease,23,Argininosuccinic aciduria,Prevalence at birth,N/A
Disease,23,Argininosuccinic aciduria,Point prevalence,N/A
Disease,23,Argininosuccinic aciduria,Prevalence at birth,N/A
Disease,45,Adenosine monophosphate deaminase deficiency,Cases/families,N/A
Disease,45,Adenosine monophosphate deaminase deficiency,Point prevalence,N/A
Clinical subtype,226,Dihydropteridine reductase deficiency,Cases/families,N/A
Clinical subtype,226,Dihydropteridine reductase deficiency,Point prevalence,N/A
Morphological anomaly,217,Isolated Dandy-Walker malformation,Prevalence at birth,N/A
Morphological anomaly,217,Isolated Dandy-Walker malformation,Point prevalence,N/A
Malformation syndrome,1556,Cutis marmorata telangiectatica congenita,Cases/families,N/A
Malformation syndrome,1556,Cutis marmorata telangiectatica congenita,Point prevalence,N/A
Malformation syndrome,1538,Craniosynostosis-Dandy-Walker malformation-hydrocephalus syndrome,Cases/families,N/A
Malformation syndrome,1538,Craniosynostosis-Dandy-Walker malformation-hydrocephalus syndrome,Point prevalence,N/A
Disease,1496,Corpus callosum agenesis-neuronopathy syndrome,Point prevalence,N/A
Disease,1496,Corpus callosum agenesis-neuronopathy syndrome,Point prevalence,N/A
Disease,417,Neonatal severe primary hyperparathyroidism,Point prevalence,N/A
Disease,2233,Hypogonadism-mitral valve prolapse-intellectual disability syndrome,Cases/families,N/A
Disease,2233,Hypogonadism-mitral valve prolapse-intellectual disability syndrome,Point prevalence,N/A
Morphological anomaly,2248,Hypoplastic left heart syndrome,Prevalence at birth,N/A
Morphological anomaly,2248,Hypoplastic left heart syndrome,Prevalence at birth,N/A
Morphological anomaly,2248,Hypoplastic left heart syndrome,Prevalence at birth,N/A
Morphological anomaly,2248,Hypoplastic left heart syndrome,Prevalence at birth,N/A
Morphological anomaly,2248,Hypoplastic left heart syndrome,Prevalence at birth,N/A
Morphological anomaly,2248,Hypoplastic left heart syndrome,Prevalence at birth,N/A
Morphological anomaly,2248,Hypoplastic left heart syndrome,Prevalence at birth,N/A
Morphological anomaly,2248,Hypoplastic left heart syndrome,Prevalence at birth,N/A
Morphological anomaly,2248,Hypoplastic left heart syndrome,Prevalence at birth,N/A
Morphological anomaly,2248,Hypoplastic left heart syndrome,Prevalence at birth,N/A
Morphological anomaly,2248,Hypoplastic left heart syndrome,Prevalence at birth,N/A
Morphological anomaly,2248,Hypoplastic left heart syndrome,Prevalence at birth,N/A
Morphological anomaly,2248,Hypoplastic left heart syndrome,Prevalence at birth,N/A
Morphological anomaly,2248,Hypoplastic left heart syndrome,Prevalence at birth,N/A
Morphological anomaly,2248,Hypoplastic left heart syndrome,Prevalence at birth,N/A
Morphological anomaly,2248,Hypoplastic left heart syndrome,Prevalence at birth,N/A
Morphological anomaly,2248,Hypoplastic left heart syndrome,Prevalence at birth,N/A
Morphological anomaly,2248,Hypoplastic left heart syndrome,Prevalence at birth,N/A
Morphological anomaly,2248,Hypoplastic left heart syndrome,Prevalence at birth,N/A
Morphological anomaly,2248,Hypoplastic left heart syndrome,Prevalence at birth,N/A
Morphological anomaly,2248,Hypoplastic left heart syndrome,Prevalence at birth,N/A
Morphological anomaly,2248,Hypoplastic left heart syndrome,Point prevalence,N/A
Morphological anomaly,2248,Hypoplastic left heart syndrome,Prevalence at birth,N/A
Morphological anomaly,2248,Hypoplastic left heart syndrome,Prevalence at birth,N/A
Disease,446,Neonatal hemochromatosis,Cases/families,N/A
Disease,446,Neonatal hemochromatosis,Point prevalence,N/A
Malformation syndrome,2135,Cutaneous mastocytosis-deafness-microtia syndrome,Cases/families,N/A
Malformation syndrome,2135,Cutaneous mastocytosis-deafness-microtia syndrome,Point prevalence,N/A
Morphological anomaly,2140,Congenital diaphragmatic hernia,Prevalence at birth,N/A
Morphological anomaly,2140,Congenital diaphragmatic hernia,Prevalence at birth,N/A
Morphological anomaly,2140,Congenital diaphragmatic hernia,Prevalence at birth,N/A
Morphological anomaly,2140,Congenital diaphragmatic hernia,Prevalence at birth,N/A
Morphological anomaly,2140,Congenital diaphragmatic hernia,Prevalence at birth,N/A
Morphological anomaly,2140,Congenital diaphragmatic hernia,Prevalence at birth,N/A
Morphological anomaly,2140,Congenital diaphragmatic hernia,Prevalence at birth,N/A
Morphological anomaly,2140,Congenital diaphragmatic hernia,Prevalence at birth,N/A
Morphological anomaly,2140,Congenital diaphragmatic hernia,Prevalence at birth,N/A
Morphological anomaly,2140,Congenital diaphragmatic hernia,Prevalence at birth,N/A
Morphological anomaly,2140,Congenital diaphragmatic hernia,Prevalence at birth,N/A
Morphological anomaly,2140,Congenital diaphragmatic hernia,Prevalence at birth,N/A
Morphological anomaly,2140,Congenital diaphragmatic hernia,Prevalence at birth,N/A
Morphological anomaly,2140,Congenital diaphragmatic hernia,Prevalence at birth,N/A
Morphological anomaly,2140,Congenital diaphragmatic hernia,Prevalence at birth,N/A
Morphological anomaly,2140,Congenital diaphragmatic hernia,Prevalence at birth,N/A
Morphological anomaly,2140,Congenital diaphragmatic hernia,Prevalence at birth,N/A
Morphological anomaly,2140,Congenital diaphragmatic hernia,Prevalence at birth,N/A
Morphological anomaly,2140,Congenital diaphragmatic hernia,Prevalence at birth,N/A
Morphological anomaly,2140,Congenital diaphragmatic hernia,Prevalence at birth,N/A
Morphological anomaly,2140,Congenital diaphragmatic hernia,Prevalence at birth,N/A
Morphological anomaly,2140,Congenital diaphragmatic hernia,Point prevalence,N/A
Malformation syndrome,2185,Congenital hydrocephalus,Prevalence at birth,N/A
Malformation syndrome,2185,Congenital hydrocephalus,Point prevalence,N/A
Malformation syndrome,2185,Congenital hydrocephalus,Prevalence at birth,N/A
Disease,2116,Hartnup disease,Point prevalence,N/A
Disease,2116,Hartnup disease,Prevalence at birth,N/A
Disease,2116,Hartnup disease,Prevalence at birth,N/A
Disease,2116,Hartnup disease,Prevalence at birth,N/A
Disease,2116,Hartnup disease,Point prevalence,N/A
Disease,2118,Hawkinsinuria,Point prevalence,N/A
Disease,2118,Hawkinsinuria,Cases/families,N/A
Disease,351,Galactosialidosis,Point prevalence,N/A
Disease,351,Galactosialidosis,Prevalence at birth,N/A
Disease,351,Galactosialidosis,Cases/families,N/A
Disease,2020,Congenital fiber-type disproportion myopathy,Point prevalence,N/A
Malformation syndrome,2053,Freeman-Sheldon syndrome,Point prevalence,N/A
Malformation syndrome,2053,Freeman-Sheldon syndrome,Cases/families,N/A
Malformation syndrome,295,Fetal parvovirus syndrome,Point prevalence,N/A
Disease,1933,"Mitochondrial DNA depletion syndrome, encephalomyopathic form with methylmalonic aciduria",Cases/families,N/A
Disease,1933,"Mitochondrial DNA depletion syndrome, encephalomyopathic form with methylmalonic aciduria",Point prevalence,N/A
Morphological anomaly,1880,Ebstein malformation of the tricuspid valve,Point prevalence,N/A
Morphological anomaly,1880,Ebstein malformation of the tricuspid valve,Prevalence at birth,N/A
Morphological anomaly,1880,Ebstein malformation of the tricuspid valve,Prevalence at birth,N/A
Morphological anomaly,1880,Ebstein malformation of the tricuspid valve,Prevalence at birth,N/A
Morphological anomaly,1880,Ebstein malformation of the tricuspid valve,Prevalence at birth,N/A
Morphological anomaly,1880,Ebstein malformation of the tricuspid valve,Prevalence at birth,N/A
Morphological anomaly,1880,Ebstein malformation of the tricuspid valve,Prevalence at birth,N/A
Morphological anomaly,1880,Ebstein malformation of the tricuspid valve,Prevalence at birth,N/A
Morphological anomaly,1880,Ebstein malformation of the tricuspid valve,Prevalence at birth,N/A
Morphological anomaly,1880,Ebstein malformation of the tricuspid valve,Prevalence at birth,N/A
Morphological anomaly,1880,Ebstein malformation of the tricuspid valve,Prevalence at birth,N/A
Morphological anomaly,1880,Ebstein malformation of the tricuspid valve,Prevalence at birth,N/A
Morphological anomaly,1880,Ebstein malformation of the tricuspid valve,Prevalence at birth,N/A
Morphological anomaly,1880,Ebstein malformation of the tricuspid valve,Prevalence at birth,N/A
Morphological anomaly,1880,Ebstein malformation of the tricuspid valve,Prevalence at birth,N/A
Morphological anomaly,1880,Ebstein malformation of the tricuspid valve,Prevalence at birth,N/A
Morphological anomaly,1880,Ebstein malformation of the tricuspid valve,Prevalence at birth,N/A
Morphological anomaly,1880,Ebstein malformation of the tricuspid valve,Prevalence at birth,N/A
Morphological anomaly,1880,Ebstein malformation of the tricuspid valve,Prevalence at birth,N/A
Morphological anomaly,1880,Ebstein malformation of the tricuspid valve,Prevalence at birth,N/A
Morphological anomaly,1880,Ebstein malformation of the tricuspid valve,Prevalence at birth,N/A
Morphological anomaly,1880,Ebstein malformation of the tricuspid valve,Prevalence at birth,N/A
Clinical group,255,Dopa-responsive dystonia,Point prevalence,N/A
Clinical group,255,Dopa-responsive dystonia,Point prevalence,N/A
Malformation syndrome,1915,Fetal alcohol syndrome,Prevalence at birth,N/A
Malformation syndrome,1915,Fetal alcohol syndrome,Prevalence at birth,N/A
Malformation syndrome,1915,Fetal alcohol syndrome,Prevalence at birth,N/A
Malformation syndrome,1915,Fetal alcohol syndrome,Prevalence at birth,N/A
Malformation syndrome,1915,Fetal alcohol syndrome,Prevalence at birth,N/A
Malformation syndrome,1915,Fetal alcohol syndrome,Prevalence at birth,N/A
Malformation syndrome,1915,Fetal alcohol syndrome,Prevalence at birth,N/A
Malformation syndrome,1915,Fetal alcohol syndrome,Prevalence at birth,N/A
Malformation syndrome,1915,Fetal alcohol syndrome,Prevalence at birth,N/A
Malformation syndrome,1915,Fetal alcohol syndrome,Prevalence at birth,N/A
Malformation syndrome,1915,Fetal alcohol syndrome,Point prevalence,N/A
Malformation syndrome,1915,Fetal alcohol syndrome,Prevalence at birth,N/A
Malformation syndrome,1915,Fetal alcohol syndrome,Prevalence at birth,N/A
Malformation syndrome,1915,Fetal alcohol syndrome,Prevalence at birth,N/A
Malformation syndrome,1915,Fetal alcohol syndrome,Prevalence at birth,N/A
Malformation syndrome,1915,Fetal alcohol syndrome,Point prevalence,N/A
Malformation syndrome,1885,Isolated ectopia lentis,Point prevalence,N/A
Malformation syndrome,1885,Isolated ectopia lentis,Cases/families,N/A
Morphological anomaly,1851,Multicystic dysplastic kidney,Prevalence at birth,N/A
Morphological anomaly,1851,Multicystic dysplastic kidney,Point prevalence,N/A
Morphological anomaly,660,Omphalocele,Prevalence at birth,N/A
Morphological anomaly,660,Omphalocele,Point prevalence,N/A
Morphological anomaly,660,Omphalocele,Prevalence at birth,N/A
Morphological anomaly,660,Omphalocele,Point prevalence,N/A
Morphological anomaly,660,Omphalocele,Prevalence at birth,N/A
Morphological anomaly,660,Omphalocele,Point prevalence,N/A
Morphological anomaly,660,Omphalocele,Prevalence at birth,N/A
Morphological anomaly,660,Omphalocele,Point prevalence,N/A
Morphological anomaly,660,Omphalocele,Prevalence at birth,N/A
Morphological anomaly,660,Omphalocele,Point prevalence,N/A
Morphological anomaly,660,Omphalocele,Prevalence at birth,N/A
Morphological anomaly,660,Omphalocele,Point prevalence,N/A
Morphological anomaly,660,Omphalocele,Prevalence at birth,N/A
Morphological anomaly,660,Omphalocele,Point prevalence,N/A
Morphological anomaly,660,Omphalocele,Prevalence at birth,N/A
Morphological anomaly,660,Omphalocele,Point prevalence,N/A
Morphological anomaly,660,Omphalocele,Prevalence at birth,N/A
Morphological anomaly,660,Omphalocele,Point prevalence,N/A
Morphological anomaly,660,Omphalocele,Prevalence at birth,N/A
Morphological anomaly,660,Omphalocele,Point prevalence,N/A
Morphological anomaly,660,Omphalocele,Prevalence at birth,N/A
Morphological anomaly,660,Omphalocele,Point prevalence,N/A
Morphological anomaly,660,Omphalocele,Prevalence at birth,N/A
Morphological anomaly,660,Omphalocele,Point prevalence,N/A
Morphological anomaly,660,Omphalocele,Prevalence at birth,N/A
Morphological anomaly,660,Omphalocele,Point prevalence,N/A
Morphological anomaly,660,Omphalocele,Prevalence at birth,N/A
Morphological anomaly,660,Omphalocele,Point prevalence,N/A
Morphological anomaly,660,Omphalocele,Prevalence at birth,N/A
Morphological anomaly,660,Omphalocele,Point prevalence,N/A
Morphological anomaly,660,Omphalocele,Prevalence at birth,N/A
Morphological anomaly,660,Omphalocele,Point prevalence,N/A
Morphological anomaly,660,Omphalocele,Prevalence at birth,N/A
Morphological anomaly,660,Omphalocele,Point prevalence,N/A
Morphological anomaly,660,Omphalocele,Prevalence at birth,N/A
Morphological anomaly,660,Omphalocele,Point prevalence,N/A
Morphological anomaly,660,Omphalocele,Prevalence at birth,N/A
Morphological anomaly,660,Omphalocele,Point prevalence,N/A
Morphological anomaly,660,Omphalocele,Prevalence at birth,N/A
Morphological anomaly,660,Omphalocele,Point prevalence,N/A
Morphological anomaly,660,Omphalocele,Prevalence at birth,N/A
Morphological anomaly,660,Omphalocele,Prevalence at birth,N/A
Morphological anomaly,660,Omphalocele,Point prevalence,N/A
Disease,635,Neuroblastoma,Point prevalence,N/A
Disease,635,Neuroblastoma,Prevalence at birth,N/A
Disease,635,Neuroblastoma,Prevalence at birth,N/A
Disease,635,Neuroblastoma,Prevalence at birth,N/A
Disease,635,Neuroblastoma,Annual incidence,N/A
Disease,2612,Linear nevus sebaceus syndrome,Point prevalence,N/A
Disease,2635,Metatropic dysplasia,Cases/families,N/A
Disease,2635,Metatropic dysplasia,Point prevalence,N/A
Disease,2635,Metatropic dysplasia,Prevalence at birth,N/A
Disease,2655,Thanatophoric dysplasia,Prevalence at birth,N/A
Disease,2655,Thanatophoric dysplasia,Point prevalence,N/A
Disease,2655,Thanatophoric dysplasia,Prevalence at birth,N/A
Disease,2655,Thanatophoric dysplasia,Prevalence at birth,N/A
Disease,2655,Thanatophoric dysplasia,Prevalence at birth,N/A
Disease,2655,Thanatophoric dysplasia,Prevalence at birth,N/A
Disease,2655,Thanatophoric dysplasia,Prevalence at birth,N/A
Disease,2655,Thanatophoric dysplasia,Prevalence at birth,N/A
Disease,2655,Thanatophoric dysplasia,Prevalence at birth,N/A
Disease,606,Proximal myotonic myopathy,Point prevalence,N/A
Disease,606,Proximal myotonic myopathy,Point prevalence,N/A
Disease,606,Proximal myotonic myopathy,Point prevalence,N/A
Disease,606,Proximal myotonic myopathy,Point prevalence,N/A
Malformation syndrome,705,Pendred syndrome,Point prevalence,N/A
Malformation syndrome,2801,Juvenile Paget disease,Cases/families,N/A
Malformation syndrome,2801,Juvenile Paget disease,Point prevalence,N/A
Malformation syndrome,884,Tetrasomy 12p syndrome,Prevalence at birth,N/A
Malformation syndrome,884,Tetrasomy 12p syndrome,Point prevalence,N/A
Disease,2785,Osteopetrosis with renal tubular acidosis,Cases/families,N/A
Disease,2785,Osteopetrosis with renal tubular acidosis,Point prevalence,N/A
Disease,2744,Horizontal gaze palsy with progressive scoliosis,Point prevalence,N/A
Disease,2746,Opsismodysplasia,Cases/families,N/A
Disease,2746,Opsismodysplasia,Point prevalence,N/A
Disease,2971,Peroxisomal acyl-CoA oxidase deficiency,Cases/families,N/A
Disease,2971,Peroxisomal acyl-CoA oxidase deficiency,Point prevalence,N/A
Malformation syndrome,2970,Prune belly syndrome,Prevalence at birth,N/A
Malformation syndrome,2970,Prune belly syndrome,Prevalence at birth,N/A
Malformation syndrome,2970,Prune belly syndrome,Prevalence at birth,N/A
Malformation syndrome,2970,Prune belly syndrome,Prevalence at birth,N/A
Malformation syndrome,2970,Prune belly syndrome,Point prevalence,N/A
Malformation syndrome,744,Proteus syndrome,Prevalence at birth,N/A
Malformation syndrome,744,Proteus syndrome,Point prevalence,N/A
Disease,2903,Familial spontaneous pneumothorax,Point prevalence,N/A
Disease,2901,Neuralgic amyotrophy,Annual incidence,N/A
Disease,2901,Neuralgic amyotrophy,Point prevalence,N/A
Disease,2901,Neuralgic amyotrophy,Annual incidence,N/A
Disease,2901,Neuralgic amyotrophy,Lifetime Prevalence,N/A
Malformation syndrome,718,Isolated Pierre Robin sequence,Point prevalence,N/A
Malformation syndrome,718,Isolated Pierre Robin sequence,Prevalence at birth,N/A
Malformation syndrome,718,Isolated Pierre Robin sequence,Point prevalence,N/A
Malformation syndrome,718,Isolated Pierre Robin sequence,Prevalence at birth,N/A
Malformation syndrome,718,Isolated Pierre Robin sequence,Prevalence at birth,N/A
Malformation syndrome,718,Isolated Pierre Robin sequence,Point prevalence,N/A
Malformation syndrome,718,Isolated Pierre Robin sequence,Prevalence at birth,N/A
Malformation syndrome,718,Isolated Pierre Robin sequence,Point prevalence,N/A
Malformation syndrome,718,Isolated Pierre Robin sequence,Prevalence at birth,N/A
Malformation syndrome,718,Isolated Pierre Robin sequence,Prevalence at birth,N/A
Malformation syndrome,718,Isolated Pierre Robin sequence,Point prevalence,N/A
Malformation syndrome,718,Isolated Pierre Robin sequence,Prevalence at birth,N/A
Malformation syndrome,718,Isolated Pierre Robin sequence,Point prevalence,N/A
Malformation syndrome,718,Isolated Pierre Robin sequence,Prevalence at birth,N/A
Malformation syndrome,718,Isolated Pierre Robin sequence,Prevalence at birth,N/A
Disease,290,Congenital rubella syndrome,Prevalence at birth,N/A
Disease,290,Congenital rubella syndrome,Prevalence at birth,N/A
Disease,290,Congenital rubella syndrome,Prevalence at birth,N/A
Disease,290,Congenital rubella syndrome,Prevalence at birth,N/A
Disease,290,Congenital rubella syndrome,Prevalence at birth,N/A
Disease,290,Congenital rubella syndrome,Prevalence at birth,N/A
Disease,290,Congenital rubella syndrome,Prevalence at birth,N/A
Disease,290,Congenital rubella syndrome,Prevalence at birth,N/A
Disease,290,Congenital rubella syndrome,Prevalence at birth,N/A
Disease,290,Congenital rubella syndrome,Annual incidence,N/A
Disease,290,Congenital rubella syndrome,Prevalence at birth,N/A
Disease,290,Congenital rubella syndrome,Point prevalence,N/A
Malformation syndrome,3071,Costello syndrome,Cases/families,N/A
Malformation syndrome,3071,Costello syndrome,Point prevalence,N/A
Malformation syndrome,3071,Costello syndrome,Point prevalence,N/A
Disease,763,Pycnodysostosis,Point prevalence,N/A
Disease,763,Pycnodysostosis,Point prevalence,N/A
Disease,2983,Difference of sex development-intellectual disability syndrome,Cases/families,N/A
Disease,2983,Difference of sex development-intellectual disability syndrome,Point prevalence,N/A
Morphological anomaly,2301,Congenital short bowel syndrome,Cases/families,N/A
Morphological anomaly,2301,Congenital short bowel syndrome,Point prevalence,N/A
Disease,469,Hereditary fructose intolerance,Point prevalence,N/A
Disease,469,Hereditary fructose intolerance,Prevalence at birth,N/A
Disease,469,Hereditary fructose intolerance,Point prevalence,N/A
Disease,469,Hereditary fructose intolerance,Prevalence at birth,N/A
Disease,469,Hereditary fructose intolerance,Point prevalence,N/A
Disease,469,Hereditary fructose intolerance,Prevalence at birth,N/A
Disease,469,Hereditary fructose intolerance,Point prevalence,N/A
Disease,469,Hereditary fructose intolerance,Prevalence at birth,N/A
Disease,469,Hereditary fructose intolerance,Point prevalence,N/A
Disease,469,Hereditary fructose intolerance,Point prevalence,N/A
Disease,469,Hereditary fructose intolerance,Point prevalence,N/A
Disease,469,Hereditary fructose intolerance,Point prevalence,N/A
Disease,469,Hereditary fructose intolerance,Point prevalence,N/A
Malformation syndrome,2308,Jacobsen syndrome,Prevalence at birth,N/A
Malformation syndrome,2308,Jacobsen syndrome,Point prevalence,N/A
Malformation syndrome,2318,Joubert syndrome with oculorenal defect,Point prevalence,N/A
Malformation syndrome,2318,Joubert syndrome with oculorenal defect,Cases/families,N/A
Disease,2253,Foveal hypoplasia-presenile cataract syndrome,Cases/families,N/A
Disease,2253,Foveal hypoplasia-presenile cataract syndrome,Point prevalence,N/A
Morphological anomaly,2300,Multiple intestinal atresia,Point prevalence,N/A
Morphological anomaly,2300,Multiple intestinal atresia,Prevalence at birth,N/A
Disease,180226,Embryonal carcinoma,Annual incidence,N/A
Malformation syndrome,502,Trichorhinophalangeal syndrome type 2,Point prevalence,N/A
Malformation syndrome,502,Trichorhinophalangeal syndrome type 2,Cases/families,N/A
Disease,180229,Polyembryoma,Annual incidence,N/A
Malformation syndrome,2370,Larsen-like osseous dysplasia-short stature syndrome,Cases/families,N/A
Malformation syndrome,2370,Larsen-like osseous dysplasia-short stature syndrome,Point prevalence,N/A
Disease,477,KID syndrome,Cases/families,N/A
Disease,477,KID syndrome,Point prevalence,N/A
Clinical group,2346,Angioosteohypertrophic syndrome,Prevalence at birth,N/A
Clinical group,2346,Angioosteohypertrophic syndrome,Point prevalence,N/A
Disease,506,Leigh syndrome,Prevalence at birth,N/A
Disease,506,Leigh syndrome,Annual incidence,N/A
Disease,506,Leigh syndrome,Point prevalence,N/A
Disease,506,Leigh syndrome,Point prevalence,N/A
Disease,2414,Congenital pulmonary lymphangiectasia,Cases/families,N/A
Disease,2414,Congenital pulmonary lymphangiectasia,Point prevalence,N/A
Disease,180234,Mixed germ cell tumor,Annual incidence,N/A
Malformation syndrome,2377,Laurence-Moon syndrome,Point prevalence,N/A
Malformation syndrome,2374,Isolated congenital laryngeal web,Point prevalence,N/A
Disease,180242,Malignant tumor of fallopian tubes,Point prevalence,N/A
Disease,180242,Malignant tumor of fallopian tubes,Annual incidence,N/A
Disease,180242,Malignant tumor of fallopian tubes,Annual incidence,N/A
Disease,180242,Malignant tumor of fallopian tubes,Annual incidence,N/A
Clinical subtype,2466,MASA syndrome,Point prevalence,N/A
Disease,180275,Paget disease of the nipple,Annual incidence,N/A
Disease,180275,Paget disease of the nipple,Annual incidence,N/A
Disease,180275,Paget disease of the nipple,Annual incidence,N/A
Disease,180275,Paget disease of the nipple,Annual incidence,N/A
Disease,180275,Paget disease of the nipple,Annual incidence,N/A
Disease,180275,Paget disease of the nipple,Annual incidence,N/A
Disease,180275,Paget disease of the nipple,Annual incidence,N/A
Disease,180275,Paget disease of the nipple,Annual incidence,N/A
Disease,180275,Paget disease of the nipple,Annual incidence,N/A
Disease,180275,Paget disease of the nipple,Annual incidence,N/A
Disease,180275,Paget disease of the nipple,Annual incidence,N/A
Disease,180275,Paget disease of the nipple,Annual incidence,N/A
Disease,180275,Paget disease of the nipple,Annual incidence,N/A
Disease,180275,Paget disease of the nipple,Annual incidence,N/A
Disease,180275,Paget disease of the nipple,Annual incidence,N/A
Disease,180275,Paget disease of the nipple,Annual incidence,N/A
Disease,180275,Paget disease of the nipple,Annual incidence,N/A
Disease,180275,Paget disease of the nipple,Annual incidence,N/A
Disease,180275,Paget disease of the nipple,Annual incidence,N/A
Disease,180275,Paget disease of the nipple,Annual incidence,N/A
Disease,180275,Paget disease of the nipple,Annual incidence,N/A
Disease,180275,Paget disease of the nipple,Annual incidence,N/A
Disease,180275,Paget disease of the nipple,Annual incidence,N/A
Disease,180275,Paget disease of the nipple,Annual incidence,N/A
Malformation syndrome,560,Marshall syndrome,Cases/families,N/A
Malformation syndrome,560,Marshall syndrome,Point prevalence,N/A
Disease,570,Moebius syndrome,Cases/families,N/A
Disease,570,Moebius syndrome,Point prevalence,N/A
Disease,570,Moebius syndrome,Prevalence at birth,N/A
Disease,570,Moebius syndrome,Point prevalence,N/A
Disease,570,Moebius syndrome,Prevalence at birth,N/A
Clinical group,1505,Short rib-polydactyly syndrome,Point prevalence,N/A
Malformation syndrome,2444,Congenital pulmonary airway malformation,Prevalence at birth,N/A
Malformation syndrome,2444,Congenital pulmonary airway malformation,Prevalence at birth,N/A
Malformation syndrome,2444,Congenital pulmonary airway malformation,Prevalence at birth,N/A
Malformation syndrome,2444,Congenital pulmonary airway malformation,Prevalence at birth,N/A
Malformation syndrome,2444,Congenital pulmonary airway malformation,Prevalence at birth,N/A
Malformation syndrome,2444,Congenital pulmonary airway malformation,Prevalence at birth,N/A
Malformation syndrome,2444,Congenital pulmonary airway malformation,Prevalence at birth,N/A
Malformation syndrome,2444,Congenital pulmonary airway malformation,Prevalence at birth,N/A
Malformation syndrome,2444,Congenital pulmonary airway malformation,Prevalence at birth,N/A
Malformation syndrome,2444,Congenital pulmonary airway malformation,Prevalence at birth,N/A
Malformation syndrome,2444,Congenital pulmonary airway malformation,Prevalence at birth,N/A
Malformation syndrome,2444,Congenital pulmonary airway malformation,Prevalence at birth,N/A
Malformation syndrome,2444,Congenital pulmonary airway malformation,Prevalence at birth,N/A
Malformation syndrome,2444,Congenital pulmonary airway malformation,Prevalence at birth,N/A
Malformation syndrome,2444,Congenital pulmonary airway malformation,Point prevalence,N/A
Clinical group,612,Potassium-aggravated myotonia,Point prevalence,N/A
Disease,716,Phenylketonuria,Prevalence at birth,N/A
Disease,716,Phenylketonuria,Point prevalence,N/A
Disease,716,Phenylketonuria,Prevalence at birth,N/A
Disease,716,Phenylketonuria,Point prevalence,N/A
Disease,716,Phenylketonuria,Prevalence at birth,N/A
Disease,716,Phenylketonuria,Point prevalence,N/A
Disease,716,Phenylketonuria,Prevalence at birth,N/A
Disease,716,Phenylketonuria,Point prevalence,N/A
Disease,716,Phenylketonuria,Prevalence at birth,N/A
Disease,716,Phenylketonuria,Point prevalence,N/A
Disease,716,Phenylketonuria,Prevalence at birth,N/A
Disease,716,Phenylketonuria,Point prevalence,N/A
Disease,716,Phenylketonuria,Prevalence at birth,N/A
Disease,716,Phenylketonuria,Point prevalence,N/A
Disease,716,Phenylketonuria,Prevalence at birth,N/A
Disease,716,Phenylketonuria,Point prevalence,N/A
Disease,716,Phenylketonuria,Prevalence at birth,N/A
Disease,716,Phenylketonuria,Point prevalence,N/A
Disease,716,Phenylketonuria,Prevalence at birth,N/A
Disease,716,Phenylketonuria,Point prevalence,N/A
Disease,716,Phenylketonuria,Prevalence at birth,N/A
Disease,716,Phenylketonuria,Point prevalence,N/A
Disease,716,Phenylketonuria,Prevalence at birth,N/A
Disease,716,Phenylketonuria,Point prevalence,N/A
Disease,716,Phenylketonuria,Prevalence at birth,N/A
Disease,716,Phenylketonuria,Point prevalence,N/A
Disease,716,Phenylketonuria,Prevalence at birth,N/A
Disease,716,Phenylketonuria,Point prevalence,N/A
Disease,716,Phenylketonuria,Prevalence at birth,N/A
Disease,716,Phenylketonuria,Point prevalence,N/A
Disease,716,Phenylketonuria,Point prevalence,N/A
Disease,716,Phenylketonuria,Prevalence at birth,N/A
Disease,716,Phenylketonuria,Point prevalence,N/A
Disease,716,Phenylketonuria,Point prevalence,N/A
Disease,716,Phenylketonuria,Point prevalence,N/A
Disease,716,Phenylketonuria,Point prevalence,N/A
Disease,716,Phenylketonuria,Point prevalence,N/A
Disease,716,Phenylketonuria,Point prevalence,N/A
Disease,716,Phenylketonuria,Point prevalence,N/A
Disease,716,Phenylketonuria,Point prevalence,N/A
Disease,716,Phenylketonuria,Point prevalence,N/A
Disease,716,Phenylketonuria,Point prevalence,N/A
Disease,716,Phenylketonuria,Point prevalence,N/A
Disease,716,Phenylketonuria,Point prevalence,N/A
Disease,716,Phenylketonuria,Point prevalence,N/A
Disease,716,Phenylketonuria,Point prevalence,N/A
Disease,716,Phenylketonuria,Point prevalence,N/A
Disease,716,Phenylketonuria,Point prevalence,N/A
Disease,716,Phenylketonuria,Point prevalence,N/A
Disease,716,Phenylketonuria,Point prevalence,N/A
Disease,716,Phenylketonuria,Point prevalence,N/A
Disease,716,Phenylketonuria,Point prevalence,N/A
Disease,716,Phenylketonuria,Point prevalence,N/A
Disease,716,Phenylketonuria,Point prevalence,N/A
Disease,716,Phenylketonuria,Point prevalence,N/A
Disease,716,Phenylketonuria,Point prevalence,N/A
Disease,716,Phenylketonuria,Point prevalence,N/A
Disease,716,Phenylketonuria,Point prevalence,N/A
Disease,716,Phenylketonuria,Point prevalence,N/A
Disease,716,Phenylketonuria,Point prevalence,N/A
Disease,716,Phenylketonuria,Point prevalence,N/A
Disease,716,Phenylketonuria,Point prevalence,N/A
Disease,716,Phenylketonuria,Point prevalence,N/A
Disease,716,Phenylketonuria,Point prevalence,N/A
Disease,716,Phenylketonuria,Point prevalence,N/A
Disease,716,Phenylketonuria,Point prevalence,N/A
Disease,716,Phenylketonuria,Point prevalence,N/A
Disease,716,Phenylketonuria,Point prevalence,N/A
Disease,716,Phenylketonuria,Point prevalence,N/A
Disease,716,Phenylketonuria,Point prevalence,N/A
Disease,716,Phenylketonuria,Point prevalence,N/A
Disease,716,Phenylketonuria,Point prevalence,N/A
Disease,716,Phenylketonuria,Point prevalence,N/A
Disease,716,Phenylketonuria,Point prevalence,N/A
Disease,716,Phenylketonuria,Point prevalence,N/A
Disease,716,Phenylketonuria,Point prevalence,N/A
Disease,716,Phenylketonuria,Point prevalence,N/A
Disease,716,Phenylketonuria,Point prevalence,N/A
Disease,716,Phenylketonuria,Point prevalence,N/A
Disease,716,Phenylketonuria,Point prevalence,N/A
Disease,716,Phenylketonuria,Point prevalence,N/A
Disease,716,Phenylketonuria,Point prevalence,N/A
Disease,716,Phenylketonuria,Point prevalence,N/A
Disease,716,Phenylketonuria,Prevalence at birth,N/A
Disease,716,Phenylketonuria,Prevalence at birth,N/A
Disease,716,Phenylketonuria,Prevalence at birth,N/A
Disease,716,Phenylketonuria,Prevalence at birth,N/A
Disease,716,Phenylketonuria,Prevalence at birth,N/A
Disease,716,Phenylketonuria,Prevalence at birth,N/A
Disease,716,Phenylketonuria,Prevalence at birth,N/A
Disease,716,Phenylketonuria,Prevalence at birth,N/A
Disease,716,Phenylketonuria,Prevalence at birth,N/A
Disease,716,Phenylketonuria,Prevalence at birth,N/A
Disease,716,Phenylketonuria,Prevalence at birth,N/A
Disease,716,Phenylketonuria,Prevalence at birth,N/A
Disease,716,Phenylketonuria,Prevalence at birth,N/A
Disease,716,Phenylketonuria,Prevalence at birth,N/A
Disease,716,Phenylketonuria,Prevalence at birth,N/A
Disease,716,Phenylketonuria,Prevalence at birth,N/A
Disease,716,Phenylketonuria,Prevalence at birth,N/A
Disease,716,Phenylketonuria,Prevalence at birth,N/A
Disease,716,Phenylketonuria,Prevalence at birth,N/A
Disease,716,Phenylketonuria,Prevalence at birth,N/A
Disease,287,Classical Ehlers-Danlos syndrome,Point prevalence,N/A
Disease,1020,Early-onset autosomal dominant Alzheimer disease,Point prevalence,N/A
Disease,63,Alport syndrome,Point prevalence,N/A
Disease,63,Alport syndrome,Prevalence at birth,N/A
Disease,54,X-linked recessive ocular albinism,Prevalence at birth,N/A
Disease,54,X-linked recessive ocular albinism,Point prevalence,N/A
Disease,54,X-linked recessive ocular albinism,Prevalence at birth,N/A
Disease,54,X-linked recessive ocular albinism,Point prevalence,N/A
Disease,54,X-linked recessive ocular albinism,Prevalence at birth,N/A
Disease,54,X-linked recessive ocular albinism,Point prevalence,N/A
Disease,154,Familial isolated dilated cardiomyopathy,Annual incidence,N/A
Disease,154,Familial isolated dilated cardiomyopathy,Point prevalence,N/A
Disease,154,Familial isolated dilated cardiomyopathy,Annual incidence,N/A
Malformation syndrome,84,Fanconi anemia,Point prevalence,N/A
Malformation syndrome,84,Fanconi anemia,Point prevalence,N/A
Malformation syndrome,84,Fanconi anemia,Prevalence at birth,N/A
Malformation syndrome,84,Fanconi anemia,Prevalence at birth,N/A
Malformation syndrome,84,Fanconi anemia,Point prevalence,N/A
Malformation syndrome,84,Fanconi anemia,Point prevalence,N/A
Malformation syndrome,84,Fanconi anemia,Point prevalence,N/A
Disease,70,Proximal spinal muscular atrophy,Annual incidence,N/A
Disease,70,Proximal spinal muscular atrophy,Prevalence at birth,N/A
Disease,70,Proximal spinal muscular atrophy,Point prevalence,N/A
Category,69,Amyloidosis,Point prevalence,N/A
Category,69,Amyloidosis,Point prevalence,N/A
Disease,191,Cockayne syndrome,Annual incidence,N/A
Disease,191,Cockayne syndrome,Prevalence at birth,N/A
Disease,191,Cockayne syndrome,Prevalence at birth,N/A
Disease,191,Cockayne syndrome,Prevalence at birth,N/A
Disease,191,Cockayne syndrome,Prevalence at birth,N/A
Disease,191,Cockayne syndrome,Prevalence at birth,N/A
Disease,191,Cockayne syndrome,Prevalence at birth,N/A
Disease,191,Cockayne syndrome,Point prevalence,N/A
Category,166,Charcot-Marie-Tooth disease/Hereditary motor and sensory neuropathy,Point prevalence,N/A
Category,166,Charcot-Marie-Tooth disease/Hereditary motor and sensory neuropathy,Point prevalence,N/A
Category,166,Charcot-Marie-Tooth disease/Hereditary motor and sensory neuropathy,Point prevalence,N/A
Category,166,Charcot-Marie-Tooth disease/Hereditary motor and sensory neuropathy,Point prevalence,N/A
Category,166,Charcot-Marie-Tooth disease/Hereditary motor and sensory neuropathy,Point prevalence,N/A
Category,166,Charcot-Marie-Tooth disease/Hereditary motor and sensory neuropathy,Point prevalence,N/A
Category,166,Charcot-Marie-Tooth disease/Hereditary motor and sensory neuropathy,Point prevalence,N/A
Category,166,Charcot-Marie-Tooth disease/Hereditary motor and sensory neuropathy,Point prevalence,N/A
Category,166,Charcot-Marie-Tooth disease/Hereditary motor and sensory neuropathy,Point prevalence,N/A
Category,166,Charcot-Marie-Tooth disease/Hereditary motor and sensory neuropathy,Point prevalence,N/A
Category,166,Charcot-Marie-Tooth disease/Hereditary motor and sensory neuropathy,Point prevalence,N/A
Disease,834,Free sialic acid storage disease,Point prevalence,N/A
Disease,834,Free sialic acid storage disease,Cases/families,N/A
Disease,799,Schizencephaly,Prevalence at birth,N/A
Disease,799,Schizencephaly,Prevalence at birth,N/A
Disease,799,Schizencephaly,Point prevalence,N/A
Disease,799,Schizencephaly,Prevalence at birth,N/A
Disease,3151,Multiple sclerosis-ichthyosis-factor VIII deficiency syndrome,Cases/families,N/A
Disease,3151,Multiple sclerosis-ichthyosis-factor VIII deficiency syndrome,Point prevalence,N/A
Clinical group,178566,Mycosis fungoides and variants,Annual incidence,N/A
Clinical group,178566,Mycosis fungoides and variants,Point prevalence,N/A
Disease,813,Silver-Russell syndrome,Annual incidence,N/A
Disease,813,Silver-Russell syndrome,Prevalence at birth,N/A
Disease,813,Silver-Russell syndrome,Point prevalence,N/A
Disease,813,Silver-Russell syndrome,Prevalence at birth,N/A
Disease,813,Silver-Russell syndrome,Point prevalence,N/A
Malformation syndrome,3169,Sirenomelia,Prevalence at birth,N/A
Malformation syndrome,3169,Sirenomelia,Point prevalence,N/A
Malformation syndrome,3169,Sirenomelia,Prevalence at birth,N/A
Malformation syndrome,3169,Sirenomelia,Point prevalence,N/A
Malformation syndrome,3169,Sirenomelia,Prevalence at birth,N/A
Malformation syndrome,3169,Sirenomelia,Prevalence at birth,N/A
Malformation syndrome,3169,Sirenomelia,Prevalence at birth,N/A
Malformation syndrome,3169,Sirenomelia,Prevalence at birth,N/A
Malformation syndrome,3169,Sirenomelia,Prevalence at birth,N/A
Malformation syndrome,3169,Sirenomelia,Prevalence at birth,N/A
Malformation syndrome,3169,Sirenomelia,Prevalence at birth,N/A
Malformation syndrome,3169,Sirenomelia,Prevalence at birth,N/A
Malformation syndrome,3169,Sirenomelia,Prevalence at birth,N/A
Malformation syndrome,3169,Sirenomelia,Prevalence at birth,N/A
Malformation syndrome,3169,Sirenomelia,Prevalence at birth,N/A
Malformation syndrome,3169,Sirenomelia,Prevalence at birth,N/A
Malformation syndrome,3169,Sirenomelia,Prevalence at birth,N/A
Malformation syndrome,3169,Sirenomelia,Prevalence at birth,N/A
Malformation syndrome,3169,Sirenomelia,Point prevalence,N/A
Disease,816,Sjgren-Larsson syndrome,Prevalence at birth,N/A
Disease,816,Sjgren-Larsson syndrome,Point prevalence,N/A
Disease,816,Sjgren-Larsson syndrome,Point prevalence,N/A
Disease,821,Sotos syndrome,Prevalence at birth,N/A
Disease,821,Sotos syndrome,Point prevalence,N/A
Disease,821,Sotos syndrome,Prevalence at birth,N/A
Disease,821,Sotos syndrome,Point prevalence,N/A
Disease,3173,Infantile spasms-broad thumbs syndrome,Cases/families,N/A
Disease,3173,Infantile spasms-broad thumbs syndrome,Point prevalence,N/A
Disease,3204,Stormorken-Sjaastad-Langslet syndrome,Cases/families,N/A
Disease,3204,Stormorken-Sjaastad-Langslet syndrome,Point prevalence,N/A
Malformation syndrome,3205,Sturge-Weber syndrome,Prevalence at birth,N/A
Malformation syndrome,3205,Sturge-Weber syndrome,Point prevalence,N/A
Malformation syndrome,3320,Thrombocytopenia-absent radius syndrome,Prevalence at birth,N/A
Malformation syndrome,3320,Thrombocytopenia-absent radius syndrome,Point prevalence,N/A
Morphological anomaly,3346,Tracheal agenesis,Prevalence at birth,N/A
Morphological anomaly,3346,Tracheal agenesis,Point prevalence,N/A
Disease,858,Congenital toxoplasmosis,Prevalence at birth,N/A
Disease,858,Congenital toxoplasmosis,Prevalence at birth,N/A
Disease,858,Congenital toxoplasmosis,Prevalence at birth,N/A
Disease,858,Congenital toxoplasmosis,Prevalence at birth,N/A
Disease,858,Congenital toxoplasmosis,Prevalence at birth,N/A
Disease,858,Congenital toxoplasmosis,Prevalence at birth,N/A
Disease,858,Congenital toxoplasmosis,Prevalence at birth,N/A
Disease,858,Congenital toxoplasmosis,Prevalence at birth,N/A
Disease,858,Congenital toxoplasmosis,Prevalence at birth,N/A
Disease,858,Congenital toxoplasmosis,Prevalence at birth,N/A
Disease,858,Congenital toxoplasmosis,Prevalence at birth,N/A
Disease,858,Congenital toxoplasmosis,Prevalence at birth,N/A
Disease,858,Congenital toxoplasmosis,Point prevalence,N/A
Disease,858,Congenital toxoplasmosis,Prevalence at birth,N/A
Malformation syndrome,887,VACTERL/VATER association,Prevalence at birth,N/A
Malformation syndrome,887,VACTERL/VATER association,Point prevalence,N/A
Disease,291,Congenital varicella syndrome,Cases/families,N/A
Disease,291,Congenital varicella syndrome,Point prevalence,N/A
Disease,909,Cerebrotendinous xanthomatosis,Point prevalence,N/A
Disease,909,Cerebrotendinous xanthomatosis,Point prevalence,N/A
Disease,909,Cerebrotendinous xanthomatosis,Point prevalence,N/A
Disease,909,Cerebrotendinous xanthomatosis,Point prevalence,N/A
Malformation syndrome,3447,Weaver syndrome,Cases/families,N/A
Malformation syndrome,3447,Weaver syndrome,Point prevalence,N/A
Malformation syndrome,1422,Chondrodysplasia-difference of sex development syndrome,Cases/families,N/A
Malformation syndrome,1422,Chondrodysplasia-difference of sex development syndrome,Point prevalence,N/A
Clinical subtype,178478,Infant botulism,Prevalence at birth,N/A
Clinical subtype,178478,Infant botulism,Annual incidence,N/A
Clinical subtype,178478,Infant botulism,Prevalence at birth,N/A
Clinical subtype,178478,Infant botulism,Prevalence at birth,N/A
Clinical subtype,178478,Infant botulism,Point prevalence,N/A
Clinical subtype,178481,Intestinal botulism,Point prevalence,N/A
Etiological subtype,178475,Wound botulism,Annual incidence,N/A
Etiological subtype,178475,Wound botulism,Point prevalence,N/A
Disease,178461,X-linked myopathy with postural muscle atrophy,Cases/families,N/A
Disease,178461,X-linked myopathy with postural muscle atrophy,Point prevalence,N/A
Disease,178464,Hereditary myopathy with early respiratory failure,Cases/families,N/A
Disease,178464,Hereditary myopathy with early respiratory failure,Point prevalence,N/A
Disease,178396,Hemorrhagic disease due to alpha-1-antitrypsin Pittsburgh mutation,Cases/families,N/A
Disease,178396,Hemorrhagic disease due to alpha-1-antitrypsin Pittsburgh mutation,Point prevalence,N/A
Disease,178400,Distal myopathy with anterior tibial onset,Cases/families,N/A
Disease,178400,Distal myopathy with anterior tibial onset,Point prevalence,N/A
Morphological anomaly,178382,Congenital vertical talus,Point prevalence,N/A
Disease,178389,Osteopetrosis-hypogammaglobulinemia syndrome,Cases/families,N/A
Disease,178389,Osteopetrosis-hypogammaglobulinemia syndrome,Point prevalence,N/A
Disease,62,Alpha-sarcoglycan-related limb-girdle muscular dystrophy R3,Point prevalence,N/A
Disease,62,Alpha-sarcoglycan-related limb-girdle muscular dystrophy R3,Point prevalence,N/A
Malformation syndrome,178364,Syndromic microphthalmia type 5,Cases/families,N/A
Malformation syndrome,178364,Syndromic microphthalmia type 5,Point prevalence,N/A
Disease,715,Glycogen storage disease due to muscle phosphorylase kinase deficiency,Cases/families,N/A
Disease,715,Glycogen storage disease due to muscle phosphorylase kinase deficiency,Point prevalence,N/A
Malformation syndrome,178377,Osteosclerosis-developmental delay-craniosynostosis syndrome,Cases/families,N/A
Malformation syndrome,178377,Osteosclerosis-developmental delay-craniosynostosis syndrome,Point prevalence,N/A
Disease,348,"Fructose-1,6-bisphosphatase deficiency",Prevalence at birth,N/A
Disease,348,"Fructose-1,6-bisphosphatase deficiency",Point prevalence,N/A
Disease,178345,Aromatase excess syndrome,Cases/families,N/A
Disease,178345,Aromatase excess syndrome,Point prevalence,N/A
Disease,178355,Smith-McCort dysplasia,Cases/families,N/A
Disease,178355,Smith-McCort dysplasia,Point prevalence,N/A
Disease,178338,UV-sensitive syndrome,Cases/families,N/A
Disease,178338,UV-sensitive syndrome,Point prevalence,N/A
Disease,3137,Alpha-N-acetylgalactosaminidase deficiency,Cases/families,N/A
Disease,3137,Alpha-N-acetylgalactosaminidase deficiency,Point prevalence,N/A
Disease,117,Behet disease,Annual incidence,N/A
Disease,117,Behet disease,Annual incidence,N/A
Disease,117,Behet disease,Point prevalence,N/A
Disease,117,Behet disease,Annual incidence,N/A
Disease,117,Behet disease,Point prevalence,N/A
Disease,117,Behet disease,Point prevalence,N/A
Disease,117,Behet disease,Point prevalence,N/A
Disease,117,Behet disease,Point prevalence,N/A
Disease,117,Behet disease,Point prevalence,N/A
Disease,117,Behet disease,Point prevalence,N/A
Disease,117,Behet disease,Point prevalence,N/A
Disease,117,Behet disease,Point prevalence,N/A
Disease,117,Behet disease,Point prevalence,N/A
Disease,117,Behet disease,Point prevalence,N/A
Disease,117,Behet disease,Annual incidence,N/A
Disease,117,Behet disease,Point prevalence,N/A
Disease,117,Behet disease,Point prevalence,N/A
Disease,117,Behet disease,Annual incidence,N/A
Disease,732,Polymyositis,Annual incidence,N/A
Disease,732,Polymyositis,Point prevalence,N/A
Disease,732,Polymyositis,Annual incidence,N/A
Disease,732,Polymyositis,Point prevalence,N/A
Disease,732,Polymyositis,Annual incidence,N/A
Disease,732,Polymyositis,Point prevalence,N/A
Disease,732,Polymyositis,Annual incidence,N/A
Disease,732,Polymyositis,Annual incidence,N/A
Disease,221,Dermatomyositis,Annual incidence,N/A
Disease,221,Dermatomyositis,Point prevalence,N/A
Disease,221,Dermatomyositis,Annual incidence,N/A
Disease,221,Dermatomyositis,Point prevalence,N/A
Disease,221,Dermatomyositis,Annual incidence,N/A
Disease,221,Dermatomyositis,Annual incidence,N/A
Disease,221,Dermatomyositis,Point prevalence,N/A
Disease,221,Dermatomyositis,Point prevalence,N/A
Disease,221,Dermatomyositis,Annual incidence,N/A
Disease,221,Dermatomyositis,Point prevalence,N/A
Disease,221,Dermatomyositis,Annual incidence,N/A
Disease,221,Dermatomyositis,Point prevalence,N/A
Disease,221,Dermatomyositis,Annual incidence,N/A
Disease,221,Dermatomyositis,Point prevalence,N/A
Disease,598,Multiminicore myopathy,Point prevalence,N/A
Disease,204,Sporadic Creutzfeldt-Jakob disease,Annual incidence,N/A
Disease,204,Sporadic Creutzfeldt-Jakob disease,Point prevalence,N/A
Disease,204,Sporadic Creutzfeldt-Jakob disease,Annual incidence,N/A
Disease,204,Sporadic Creutzfeldt-Jakob disease,Point prevalence,N/A
Disease,204,Sporadic Creutzfeldt-Jakob disease,Annual incidence,N/A
Disease,204,Sporadic Creutzfeldt-Jakob disease,Point prevalence,N/A
Disease,204,Sporadic Creutzfeldt-Jakob disease,Annual incidence,N/A
Disease,204,Sporadic Creutzfeldt-Jakob disease,Point prevalence,N/A
Disease,204,Sporadic Creutzfeldt-Jakob disease,Annual incidence,N/A
Disease,204,Sporadic Creutzfeldt-Jakob disease,Point prevalence,N/A
Disease,204,Sporadic Creutzfeldt-Jakob disease,Annual incidence,N/A
Disease,204,Sporadic Creutzfeldt-Jakob disease,Point prevalence,N/A
Disease,204,Sporadic Creutzfeldt-Jakob disease,Annual incidence,N/A
Disease,204,Sporadic Creutzfeldt-Jakob disease,Point prevalence,N/A
Disease,204,Sporadic Creutzfeldt-Jakob disease,Annual incidence,N/A
Disease,204,Sporadic Creutzfeldt-Jakob disease,Point prevalence,N/A
Disease,204,Sporadic Creutzfeldt-Jakob disease,Annual incidence,N/A
Disease,204,Sporadic Creutzfeldt-Jakob disease,Point prevalence,N/A
Disease,204,Sporadic Creutzfeldt-Jakob disease,Annual incidence,N/A
Disease,204,Sporadic Creutzfeldt-Jakob disease,Point prevalence,N/A
Disease,204,Sporadic Creutzfeldt-Jakob disease,Annual incidence,N/A
Disease,204,Sporadic Creutzfeldt-Jakob disease,Point prevalence,N/A
Disease,204,Sporadic Creutzfeldt-Jakob disease,Annual incidence,N/A
Disease,204,Sporadic Creutzfeldt-Jakob disease,Point prevalence,N/A
Disease,204,Sporadic Creutzfeldt-Jakob disease,Annual incidence,N/A
Disease,204,Sporadic Creutzfeldt-Jakob disease,Point prevalence,N/A
Disease,204,Sporadic Creutzfeldt-Jakob disease,Annual incidence,N/A
Disease,204,Sporadic Creutzfeldt-Jakob disease,Point prevalence,N/A
Disease,204,Sporadic Creutzfeldt-Jakob disease,Annual incidence,N/A
Disease,204,Sporadic Creutzfeldt-Jakob disease,Point prevalence,N/A
Disease,204,Sporadic Creutzfeldt-Jakob disease,Annual incidence,N/A
Disease,204,Sporadic Creutzfeldt-Jakob disease,Point prevalence,N/A
Disease,204,Sporadic Creutzfeldt-Jakob disease,Annual incidence,N/A
Disease,204,Sporadic Creutzfeldt-Jakob disease,Point prevalence,N/A
Disease,204,Sporadic Creutzfeldt-Jakob disease,Annual incidence,N/A
Disease,204,Sporadic Creutzfeldt-Jakob disease,Point prevalence,N/A
Disease,204,Sporadic Creutzfeldt-Jakob disease,Annual incidence,N/A
Disease,204,Sporadic Creutzfeldt-Jakob disease,Point prevalence,N/A
Disease,204,Sporadic Creutzfeldt-Jakob disease,Annual incidence,N/A
Disease,204,Sporadic Creutzfeldt-Jakob disease,Point prevalence,N/A
Disease,204,Sporadic Creutzfeldt-Jakob disease,Annual incidence,N/A
Disease,204,Sporadic Creutzfeldt-Jakob disease,Point prevalence,N/A
Disease,204,Sporadic Creutzfeldt-Jakob disease,Annual incidence,N/A
Disease,204,Sporadic Creutzfeldt-Jakob disease,Point prevalence,N/A
Disease,204,Sporadic Creutzfeldt-Jakob disease,Annual incidence,N/A
Disease,204,Sporadic Creutzfeldt-Jakob disease,Point prevalence,N/A
Disease,204,Sporadic Creutzfeldt-Jakob disease,Annual incidence,N/A
Disease,204,Sporadic Creutzfeldt-Jakob disease,Point prevalence,N/A
Disease,204,Sporadic Creutzfeldt-Jakob disease,Point prevalence,N/A
Disease,204,Sporadic Creutzfeldt-Jakob disease,Annual incidence,N/A
Disease,178517,Localized pagetoid reticulosis,Point prevalence,N/A
Disease,178512,Folliculotropic mycosis fungoides,Point prevalence,N/A
Disease,178509,Perry syndrome,Cases/families,N/A
Disease,178509,Perry syndrome,Point prevalence,N/A
Disease,178506,"Brain calcification, Rajab type",Cases/families,N/A
Disease,178506,"Brain calcification, Rajab type",Point prevalence,N/A
Disease,611,Inclusion body myositis,Point prevalence,N/A
Disease,611,Inclusion body myositis,Annual incidence,N/A
Disease,611,Inclusion body myositis,Point prevalence,N/A
Disease,611,Inclusion body myositis,Point prevalence,N/A
Disease,611,Inclusion body myositis,Point prevalence,N/A
Disease,611,Inclusion body myositis,Point prevalence,N/A
Disease,611,Inclusion body myositis,Point prevalence,N/A
Clinical subtype,178487,Adult intestinal botulism,Cases/families,N/A
Clinical subtype,178487,Adult intestinal botulism,Point prevalence,N/A
Clinical subtype,177926,Bleeding disorder in hemophilia A carriers,Point prevalence,N/A
Disease,581,Mucopolysaccharidosis type 3,Prevalence at birth,N/A
Disease,581,Mucopolysaccharidosis type 3,Prevalence at birth,N/A
Disease,581,Mucopolysaccharidosis type 3,Prevalence at birth,N/A
Disease,581,Mucopolysaccharidosis type 3,Prevalence at birth,N/A
Disease,581,Mucopolysaccharidosis type 3,Prevalence at birth,N/A
Disease,581,Mucopolysaccharidosis type 3,Prevalence at birth,N/A
Disease,581,Mucopolysaccharidosis type 3,Prevalence at birth,N/A
Disease,581,Mucopolysaccharidosis type 3,Prevalence at birth,N/A
Disease,581,Mucopolysaccharidosis type 3,Point prevalence,N/A
Disease,581,Mucopolysaccharidosis type 3,Prevalence at birth,N/A
Disease,581,Mucopolysaccharidosis type 3,Point prevalence,N/A
Disease,581,Mucopolysaccharidosis type 3,Prevalence at birth,N/A
Disease,581,Mucopolysaccharidosis type 3,Point prevalence,N/A
Disease,581,Mucopolysaccharidosis type 3,Prevalence at birth,N/A
Disease,581,Mucopolysaccharidosis type 3,Prevalence at birth,N/A
Disease,581,Mucopolysaccharidosis type 3,Prevalence at birth,N/A
Disease,581,Mucopolysaccharidosis type 3,Prevalence at birth,N/A
Disease,581,Mucopolysaccharidosis type 3,Prevalence at birth,N/A
Disease,581,Mucopolysaccharidosis type 3,Point prevalence,N/A
Disease,581,Mucopolysaccharidosis type 3,Prevalence at birth,N/A
Disease,581,Mucopolysaccharidosis type 3,Prevalence at birth,N/A
Disease,581,Mucopolysaccharidosis type 3,Prevalence at birth,N/A
Disease,581,Mucopolysaccharidosis type 3,Prevalence at birth,N/A
Disease,581,Mucopolysaccharidosis type 3,Prevalence at birth,N/A
Disease,581,Mucopolysaccharidosis type 3,Prevalence at birth,N/A
Disease,581,Mucopolysaccharidosis type 3,Prevalence at birth,N/A
Disease,581,Mucopolysaccharidosis type 3,Prevalence at birth,N/A
Disease,581,Mucopolysaccharidosis type 3,Point prevalence,N/A
Disease,581,Mucopolysaccharidosis type 3,Prevalence at birth,N/A
Clinical subtype,177929,Bleeding disorder in hemophilia B carriers,Point prevalence,N/A
Clinical group,685,Hereditary spastic paraplegia,Point prevalence,N/A
Clinical group,685,Hereditary spastic paraplegia,Point prevalence,N/A
Clinical group,685,Hereditary spastic paraplegia,Point prevalence,N/A
Clinical group,685,Hereditary spastic paraplegia,Point prevalence,N/A
Clinical group,685,Hereditary spastic paraplegia,Point prevalence,N/A
Clinical group,685,Hereditary spastic paraplegia,Point prevalence,N/A
Clinical group,685,Hereditary spastic paraplegia,Point prevalence,N/A
Clinical group,685,Hereditary spastic paraplegia,Point prevalence,N/A
Clinical group,685,Hereditary spastic paraplegia,Point prevalence,N/A
Clinical group,685,Hereditary spastic paraplegia,Point prevalence,N/A
Disease,666,Osteogenesis imperfecta,Point prevalence,N/A
Disease,666,Osteogenesis imperfecta,Prevalence at birth,N/A
Disease,666,Osteogenesis imperfecta,Prevalence at birth,N/A
Disease,666,Osteogenesis imperfecta,Prevalence at birth,N/A
Disease,666,Osteogenesis imperfecta,Prevalence at birth,N/A
Disease,666,Osteogenesis imperfecta,Prevalence at birth,N/A
Disease,666,Osteogenesis imperfecta,Point prevalence,N/A
Disease,178029,Arginine vasopressin deficiency,Point prevalence,N/A
Disease,423,Malignant hyperthermia of anesthesia,Point prevalence,N/A
Clinical group,418,Congenital adrenal hyperplasia,Annual incidence,N/A
Clinical group,418,Congenital adrenal hyperplasia,Point prevalence,N/A
Clinical group,418,Congenital adrenal hyperplasia,Prevalence at birth,N/A
Clinical group,418,Congenital adrenal hyperplasia,Prevalence at birth,N/A
Clinical group,418,Congenital adrenal hyperplasia,Prevalence at birth,N/A
Clinical group,418,Congenital adrenal hyperplasia,Prevalence at birth,N/A
Clinical group,418,Congenital adrenal hyperplasia,Prevalence at birth,N/A
Clinical group,418,Congenital adrenal hyperplasia,Prevalence at birth,N/A
Clinical group,418,Congenital adrenal hyperplasia,Prevalence at birth,N/A
Clinical group,418,Congenital adrenal hyperplasia,Prevalence at birth,N/A
Clinical group,418,Congenital adrenal hyperplasia,Prevalence at birth,N/A
Clinical group,418,Congenital adrenal hyperplasia,Prevalence at birth,N/A
Clinical group,418,Congenital adrenal hyperplasia,Prevalence at birth,N/A
Clinical group,418,Congenital adrenal hyperplasia,Prevalence at birth,N/A
Clinical group,418,Congenital adrenal hyperplasia,Prevalence at birth,N/A
Clinical group,418,Congenital adrenal hyperplasia,Prevalence at birth,N/A
Clinical group,418,Congenital adrenal hyperplasia,Prevalence at birth,N/A
Clinical group,418,Congenital adrenal hyperplasia,Point prevalence,N/A
Clinical group,418,Congenital adrenal hyperplasia,Prevalence at birth,N/A
Clinical group,216,Neuronal ceroid lipofuscinosis,Point prevalence,N/A
Clinical group,216,Neuronal ceroid lipofuscinosis,Point prevalence,N/A
Clinical group,216,Neuronal ceroid lipofuscinosis,Annual incidence,N/A
Clinical group,216,Neuronal ceroid lipofuscinosis,Prevalence at birth,N/A
Clinical group,216,Neuronal ceroid lipofuscinosis,Prevalence at birth,N/A
Clinical group,216,Neuronal ceroid lipofuscinosis,Point prevalence,N/A
Disease,364,Glycogen storage disease due to glucose-6-phosphatase deficiency,Point prevalence,N/A
Disease,364,Glycogen storage disease due to glucose-6-phosphatase deficiency,Prevalence at birth,N/A
Disease,355,Gaucher disease,Annual incidence,N/A
Disease,355,Gaucher disease,Point prevalence,N/A
Disease,355,Gaucher disease,Prevalence at birth,N/A
Disease,355,Gaucher disease,Point prevalence,N/A
Disease,355,Gaucher disease,Prevalence at birth,N/A
Disease,355,Gaucher disease,Annual incidence,N/A
Disease,355,Gaucher disease,Prevalence at birth,N/A
Disease,355,Gaucher disease,Point prevalence,N/A
Disease,355,Gaucher disease,Prevalence at birth,N/A
Disease,355,Gaucher disease,Prevalence at birth,N/A
Disease,355,Gaucher disease,Prevalence at birth,N/A
Disease,355,Gaucher disease,Prevalence at birth,N/A
Disease,355,Gaucher disease,Prevalence at birth,N/A
Disease,355,Gaucher disease,Prevalence at birth,N/A
Disease,355,Gaucher disease,Prevalence at birth,N/A
Disease,355,Gaucher disease,Point prevalence,N/A
Disease,388,Hirschsprung disease,Prevalence at birth,N/A
Disease,388,Hirschsprung disease,Prevalence at birth,N/A
Disease,388,Hirschsprung disease,Point prevalence,N/A
Disease,388,Hirschsprung disease,Point prevalence,N/A
Disease,388,Hirschsprung disease,Prevalence at birth,N/A
Disease,388,Hirschsprung disease,Prevalence at birth,N/A
Category,177107,Syndromic hypothyroidism,Point prevalence,N/A
Clinical group,448,Hemophilia,Annual incidence,N/A
Clinical group,448,Hemophilia,Point prevalence,N/A
Clinical group,448,Hemophilia,Point prevalence,N/A
Clinical group,304,Epidermolysis bullosa simplex,Point prevalence,N/A
Clinical group,304,Epidermolysis bullosa simplex,Point prevalence,N/A
Clinical group,304,Epidermolysis bullosa simplex,Point prevalence,N/A
Clinical group,304,Epidermolysis bullosa simplex,Point prevalence,N/A
Disease,354,GM1 gangliosidosis,Prevalence at birth,N/A
Disease,354,GM1 gangliosidosis,Prevalence at birth,N/A
Disease,354,GM1 gangliosidosis,Prevalence at birth,N/A
Disease,354,GM1 gangliosidosis,Point prevalence,N/A
Disease,354,GM1 gangliosidosis,Prevalence at birth,N/A
Particular clinical situation in a disease or syndrome,178320,Acute lung injury,Annual incidence,N/A
Particular clinical situation in a disease or syndrome,178320,Acute lung injury,Point prevalence,N/A
Particular clinical situation in a disease or syndrome,178320,Acute lung injury,Annual incidence,N/A
Particular clinical situation in a disease or syndrome,178320,Acute lung injury,Annual incidence,N/A
Disease,178333,land Islands eye disease,Cases/families,N/A
Disease,178333,land Islands eye disease,Point prevalence,N/A
Disease,760,Purine nucleoside phosphorylase deficiency,Cases/families,N/A
Disease,760,Purine nucleoside phosphorylase deficiency,Point prevalence,N/A
Disease,270,Oculopharyngeal muscular dystrophy,Point prevalence,N/A
Disease,270,Oculopharyngeal muscular dystrophy,Point prevalence,N/A
Disease,270,Oculopharyngeal muscular dystrophy,Point prevalence,N/A
Disease,270,Oculopharyngeal muscular dystrophy,Point prevalence,N/A
Malformation syndrome,178303,8q22.1 microdeletion syndrome,Cases/families,N/A
Malformation syndrome,178303,8q22.1 microdeletion syndrome,Point prevalence,N/A
Disease,244,Primary ciliary dyskinesia,Point prevalence,N/A
Disease,244,Primary ciliary dyskinesia,Prevalence at birth,N/A
Disease,178307,Reticulate acropigmentation of Kitamura,Cases/families,N/A
Disease,178307,Reticulate acropigmentation of Kitamura,Point prevalence,N/A
Disease,589,Myasthenia gravis,Annual incidence,N/A
Disease,589,Myasthenia gravis,Point prevalence,N/A
Disease,589,Myasthenia gravis,Point prevalence,N/A
Disease,589,Myasthenia gravis,Annual incidence,N/A
Disease,589,Myasthenia gravis,Point prevalence,N/A
Disease,589,Myasthenia gravis,Annual incidence,N/A
Disease,589,Myasthenia gravis,Lifetime Prevalence,N/A
Disease,589,Myasthenia gravis,Annual incidence,N/A
Disease,589,Myasthenia gravis,Point prevalence,N/A
Disease,589,Myasthenia gravis,Annual incidence,N/A
Disease,589,Myasthenia gravis,Point prevalence,N/A
Disease,589,Myasthenia gravis,Point prevalence,N/A
Disease,589,Myasthenia gravis,Annual incidence,N/A
Disease,589,Myasthenia gravis,Point prevalence,N/A
Disease,589,Myasthenia gravis,Annual incidence,N/A
Disease,589,Myasthenia gravis,Point prevalence,N/A
Disease,589,Myasthenia gravis,Annual incidence,N/A
Disease,589,Myasthenia gravis,Point prevalence,N/A
Disease,589,Myasthenia gravis,Annual incidence,N/A
Disease,589,Myasthenia gravis,Point prevalence,N/A
Disease,589,Myasthenia gravis,Annual incidence,N/A
Disease,589,Myasthenia gravis,Point prevalence,N/A
Disease,589,Myasthenia gravis,Point prevalence,N/A
Disease,589,Myasthenia gravis,Point prevalence,N/A
Disease,589,Myasthenia gravis,Point prevalence,N/A
Disease,589,Myasthenia gravis,Annual incidence,N/A
Disease,805,Tuberous sclerosis complex,Point prevalence,N/A
Disease,805,Tuberous sclerosis complex,Prevalence at birth,N/A
Disease,805,Tuberous sclerosis complex,Point prevalence,N/A
Disease,805,Tuberous sclerosis complex,Point prevalence,N/A
Disease,805,Tuberous sclerosis complex,Point prevalence,N/A
Disease,805,Tuberous sclerosis complex,Prevalence at birth,N/A
Disease,886,Usher syndrome,Point prevalence,N/A
Disease,886,Usher syndrome,Point prevalence,N/A
Disease,886,Usher syndrome,Point prevalence,N/A
Disease,886,Usher syndrome,Point prevalence,N/A
Disease,886,Usher syndrome,Point prevalence,N/A
Disease,886,Usher syndrome,Point prevalence,N/A
Disease,886,Usher syndrome,Point prevalence,N/A
Disease,886,Usher syndrome,Point prevalence,N/A
Disease,886,Usher syndrome,Point prevalence,N/A
Disease,886,Usher syndrome,Point prevalence,N/A
Disease,3440,Waardenburg syndrome,Prevalence at birth,N/A
Disease,3440,Waardenburg syndrome,Point prevalence,N/A
Disease,3440,Waardenburg syndrome,Prevalence at birth,N/A
Disease,3440,Waardenburg syndrome,Point prevalence,N/A
Disease,3440,Waardenburg syndrome,Point prevalence,N/A
Disease,702,Pelizaeus-Merzbacher disease,Point prevalence,N/A
Disease,702,Pelizaeus-Merzbacher disease,Point prevalence,N/A
Disease,702,Pelizaeus-Merzbacher disease,Prevalence at birth,N/A
Clinical group,738,Porphyria,Point prevalence,N/A
Clinical group,738,Porphyria,Lifetime Prevalence,N/A
Clinical group,738,Porphyria,Annual incidence,N/A
Clinical group,768,Familial long QT syndrome,Point prevalence,N/A
Disease,791,Retinitis pigmentosa,Point prevalence,N/A
Disease,791,Retinitis pigmentosa,Point prevalence,N/A
Disease,791,Retinitis pigmentosa,Point prevalence,N/A
Disease,791,Retinitis pigmentosa,Point prevalence,N/A
Disease,791,Retinitis pigmentosa,Point prevalence,N/A
Disease,791,Retinitis pigmentosa,Point prevalence,N/A
Disease,791,Retinitis pigmentosa,Point prevalence,N/A
Disease,791,Retinitis pigmentosa,Point prevalence,N/A
Disease,791,Retinitis pigmentosa,Point prevalence,N/A
Disease,375,Anti-glomerular basement membrane disease,Annual incidence,N/A
Disease,375,Anti-glomerular basement membrane disease,Annual incidence,N/A
Disease,375,Anti-glomerular basement membrane disease,Annual incidence,N/A
Disease,375,Anti-glomerular basement membrane disease,Point prevalence,N/A
Disease,375,Anti-glomerular basement membrane disease,Point prevalence,N/A
Disease,183,Eosinophilic granulomatosis with polyangiitis,Point prevalence,N/A
Disease,183,Eosinophilic granulomatosis with polyangiitis,Annual incidence,N/A
Disease,183,Eosinophilic granulomatosis with polyangiitis,Point prevalence,N/A
Disease,183,Eosinophilic granulomatosis with polyangiitis,Point prevalence,N/A
Disease,183,Eosinophilic granulomatosis with polyangiitis,Annual incidence,N/A
Disease,183,Eosinophilic granulomatosis with polyangiitis,Point prevalence,N/A
Disease,183,Eosinophilic granulomatosis with polyangiitis,Annual incidence,N/A
Disease,183,Eosinophilic granulomatosis with polyangiitis,Point prevalence,N/A
Disease,183,Eosinophilic granulomatosis with polyangiitis,Annual incidence,N/A
Disease,183,Eosinophilic granulomatosis with polyangiitis,Point prevalence,N/A
Disease,183,Eosinophilic granulomatosis with polyangiitis,Annual incidence,N/A
Disease,183,Eosinophilic granulomatosis with polyangiitis,Annual incidence,N/A
Disease,183,Eosinophilic granulomatosis with polyangiitis,Annual incidence,N/A
Disease,183,Eosinophilic granulomatosis with polyangiitis,Annual incidence,N/A
Disease,183,Eosinophilic granulomatosis with polyangiitis,Annual incidence,N/A
Disease,183,Eosinophilic granulomatosis with polyangiitis,Annual incidence,N/A
Disease,183,Eosinophilic granulomatosis with polyangiitis,Point prevalence,N/A
Disease,183,Eosinophilic granulomatosis with polyangiitis,Point prevalence,N/A
Disease,183,Eosinophilic granulomatosis with polyangiitis,Annual incidence,N/A
Disease,1164,Allergic bronchopulmonary aspergillosis,Point prevalence,N/A
Clinical syndrome,2406,Locked-in syndrome,Cases/families,N/A
Clinical syndrome,2406,Locked-in syndrome,Point prevalence,N/A
Disease,509,Leptospirosis,Annual incidence,N/A
Disease,509,Leptospirosis,Point prevalence,N/A
Disease,509,Leptospirosis,Annual incidence,N/A
Disease,509,Leptospirosis,Annual incidence,N/A
Disease,509,Leptospirosis,Annual incidence,N/A
Disease,509,Leptospirosis,Annual incidence,N/A
Disease,509,Leptospirosis,Annual incidence,N/A
Disease,509,Leptospirosis,Annual incidence,N/A
Disease,509,Leptospirosis,Annual incidence,N/A
Disease,509,Leptospirosis,Annual incidence,N/A
Disease,509,Leptospirosis,Annual incidence,N/A
Disease,509,Leptospirosis,Annual incidence,N/A
Disease,509,Leptospirosis,Annual incidence,N/A
Disease,509,Leptospirosis,Annual incidence,N/A
Disease,509,Leptospirosis,Annual incidence,N/A
Disease,509,Leptospirosis,Annual incidence,N/A
Disease,509,Leptospirosis,Annual incidence,N/A
Disease,509,Leptospirosis,Annual incidence,N/A
Disease,509,Leptospirosis,Annual incidence,N/A
Disease,509,Leptospirosis,Annual incidence,N/A
Disease,509,Leptospirosis,Annual incidence,N/A
Disease,509,Leptospirosis,Annual incidence,N/A
Disease,509,Leptospirosis,Annual incidence,N/A
Disease,509,Leptospirosis,Annual incidence,N/A
Disease,509,Leptospirosis,Annual incidence,N/A
Disease,509,Leptospirosis,Annual incidence,N/A
Disease,509,Leptospirosis,Annual incidence,N/A
Disease,761,Immunoglobulin A vasculitis,Annual incidence,N/A
Disease,761,Immunoglobulin A vasculitis,Annual incidence,N/A
Disease,761,Immunoglobulin A vasculitis,Annual incidence,N/A
Disease,761,Immunoglobulin A vasculitis,Annual incidence,N/A
Disease,761,Immunoglobulin A vasculitis,Annual incidence,N/A
Disease,761,Immunoglobulin A vasculitis,Annual incidence,N/A
Disease,761,Immunoglobulin A vasculitis,Annual incidence,N/A
Disease,761,Immunoglobulin A vasculitis,Point prevalence,N/A
Disease,2131,Alternating hemiplegia of childhood,Prevalence at birth,N/A
Disease,2131,Alternating hemiplegia of childhood,Point prevalence,N/A
Category,171901,Primary cutaneous T-cell lymphoma,Annual incidence,N/A
Category,171901,Primary cutaneous T-cell lymphoma,Point prevalence,N/A
Category,171901,Primary cutaneous T-cell lymphoma,Annual incidence,N/A
Category,171901,Primary cutaneous T-cell lymphoma,Annual incidence,N/A
Category,171901,Primary cutaneous T-cell lymphoma,Annual incidence,N/A
Category,171901,Primary cutaneous T-cell lymphoma,Annual incidence,N/A
Category,171901,Primary cutaneous T-cell lymphoma,Annual incidence,N/A
Category,171901,Primary cutaneous T-cell lymphoma,Annual incidence,N/A
Category,171901,Primary cutaneous T-cell lymphoma,Annual incidence,N/A
Category,171901,Primary cutaneous T-cell lymphoma,Annual incidence,N/A
Category,171901,Primary cutaneous T-cell lymphoma,Annual incidence,N/A
Category,171901,Primary cutaneous T-cell lymphoma,Annual incidence,N/A
Category,171901,Primary cutaneous T-cell lymphoma,Annual incidence,N/A
Category,171901,Primary cutaneous T-cell lymphoma,Annual incidence,N/A
Category,171901,Primary cutaneous T-cell lymphoma,Annual incidence,N/A
Category,171901,Primary cutaneous T-cell lymphoma,Annual incidence,N/A
Category,171901,Primary cutaneous T-cell lymphoma,Annual incidence,N/A
Category,171901,Primary cutaneous T-cell lymphoma,Annual incidence,N/A
Category,171901,Primary cutaneous T-cell lymphoma,Annual incidence,N/A
Category,171901,Primary cutaneous T-cell lymphoma,Annual incidence,N/A
Category,171901,Primary cutaneous T-cell lymphoma,Annual incidence,N/A
Category,171901,Primary cutaneous T-cell lymphoma,Annual incidence,N/A
Category,171901,Primary cutaneous T-cell lymphoma,Annual incidence,N/A
Category,171901,Primary cutaneous T-cell lymphoma,Annual incidence,N/A
Disease,713,Glycogen storage disease due to phosphoglycerate kinase 1 deficiency,Cases/families,N/A
Disease,713,Glycogen storage disease due to phosphoglycerate kinase 1 deficiency,Point prevalence,N/A
Category,171915,B-cell non-Hodgkin lymphoma,Annual incidence,N/A
Disease,57,Glycogen storage disease due to aldolase A deficiency,Point prevalence,N/A
Malformation syndrome,249,Fibrous dysplasia of bone,Point prevalence,N/A
Disease,2334,Autosomal dominant keratitis,Point prevalence,N/A
Category,171918,T-cell non-Hodgkin lymphoma,Annual incidence,N/A
Malformation syndrome,171929,Trisomy 10p syndrome,Cases/families,N/A
Malformation syndrome,171929,Trisomy 10p syndrome,Point prevalence,N/A
Category,187,Citrullinemia,Point prevalence,N/A
Disease,46,Adenylosuccinate lyase deficiency,Cases/families,N/A
Disease,46,Adenylosuccinate lyase deficiency,Point prevalence,N/A
Category,442,Congenital hypothyroidism,Prevalence at birth,N/A
Category,442,Congenital hypothyroidism,Point prevalence,N/A
Category,442,Congenital hypothyroidism,Prevalence at birth,N/A
Category,442,Congenital hypothyroidism,Point prevalence,N/A
Category,442,Congenital hypothyroidism,Prevalence at birth,N/A
Category,442,Congenital hypothyroidism,Point prevalence,N/A
Category,442,Congenital hypothyroidism,Prevalence at birth,N/A
Category,442,Congenital hypothyroidism,Prevalence at birth,N/A
Category,442,Congenital hypothyroidism,Prevalence at birth,N/A
Category,442,Congenital hypothyroidism,Prevalence at birth,N/A
Category,442,Congenital hypothyroidism,Point prevalence,N/A
Category,442,Congenital hypothyroidism,Prevalence at birth,N/A
Category,442,Congenital hypothyroidism,Point prevalence,N/A
Category,442,Congenital hypothyroidism,Prevalence at birth,N/A
Category,442,Congenital hypothyroidism,Point prevalence,N/A
Category,442,Congenital hypothyroidism,Prevalence at birth,N/A
Category,442,Congenital hypothyroidism,Prevalence at birth,N/A
Category,442,Congenital hypothyroidism,Point prevalence,N/A
Category,442,Congenital hypothyroidism,Prevalence at birth,N/A
Category,442,Congenital hypothyroidism,Point prevalence,N/A
Category,442,Congenital hypothyroidism,Prevalence at birth,N/A
Category,442,Congenital hypothyroidism,Prevalence at birth,N/A
Category,442,Congenital hypothyroidism,Prevalence at birth,N/A
Category,442,Congenital hypothyroidism,Prevalence at birth,N/A
Category,442,Congenital hypothyroidism,Point prevalence,N/A
Category,442,Congenital hypothyroidism,Prevalence at birth,N/A
Category,442,Congenital hypothyroidism,Point prevalence,N/A
Category,442,Congenital hypothyroidism,Prevalence at birth,N/A
Category,442,Congenital hypothyroidism,Prevalence at birth,N/A
Category,442,Congenital hypothyroidism,Prevalence at birth,N/A
Category,442,Congenital hypothyroidism,Prevalence at birth,N/A
Category,442,Congenital hypothyroidism,Prevalence at birth,N/A
Category,442,Congenital hypothyroidism,Point prevalence,N/A
Category,442,Congenital hypothyroidism,Prevalence at birth,N/A
Category,442,Congenital hypothyroidism,Point prevalence,N/A
Category,442,Congenital hypothyroidism,Prevalence at birth,N/A
Category,442,Congenital hypothyroidism,Point prevalence,N/A
Category,442,Congenital hypothyroidism,Prevalence at birth,N/A
Category,442,Congenital hypothyroidism,Point prevalence,N/A
Category,442,Congenital hypothyroidism,Prevalence at birth,N/A
Category,442,Congenital hypothyroidism,Point prevalence,N/A
Category,442,Congenital hypothyroidism,Prevalence at birth,N/A
Category,442,Congenital hypothyroidism,Point prevalence,N/A
Category,442,Congenital hypothyroidism,Prevalence at birth,N/A
Category,442,Congenital hypothyroidism,Annual incidence,N/A
Category,442,Congenital hypothyroidism,Prevalence at birth,N/A
Category,442,Congenital hypothyroidism,Prevalence at birth,N/A
Disease,43,X-linked adrenoleukodystrophy,Prevalence at birth,N/A
Disease,43,X-linked adrenoleukodystrophy,Point prevalence,N/A
Disease,43,X-linked adrenoleukodystrophy,Prevalence at birth,N/A
Disease,3166,Sialuria,Cases/families,N/A
Disease,3166,Sialuria,Point prevalence,N/A
Disease,2882,Sitosterolemia,Cases/families,N/A
Disease,2882,Sitosterolemia,Point prevalence,N/A
Disease,810,Shigellosis,Point prevalence,N/A
Disease,810,Shigellosis,Annual incidence,N/A
Disease,810,Shigellosis,Annual incidence,N/A
Disease,810,Shigellosis,Annual incidence,N/A
Disease,810,Shigellosis,Annual incidence,N/A
Disease,810,Shigellosis,Annual incidence,N/A
Disease,810,Shigellosis,Annual incidence,N/A
Disease,810,Shigellosis,Annual incidence,N/A
Disease,810,Shigellosis,Annual incidence,N/A
Disease,810,Shigellosis,Annual incidence,N/A
Disease,810,Shigellosis,Annual incidence,N/A
Disease,810,Shigellosis,Annual incidence,N/A
Disease,810,Shigellosis,Annual incidence,N/A
Disease,810,Shigellosis,Annual incidence,N/A
Disease,810,Shigellosis,Annual incidence,N/A
Disease,810,Shigellosis,Annual incidence,N/A
Disease,810,Shigellosis,Annual incidence,N/A
Disease,810,Shigellosis,Annual incidence,N/A
Disease,810,Shigellosis,Annual incidence,N/A
Disease,810,Shigellosis,Annual incidence,N/A
Disease,810,Shigellosis,Annual incidence,N/A
Disease,810,Shigellosis,Annual incidence,N/A
Disease,810,Shigellosis,Annual incidence,N/A
Disease,810,Shigellosis,Annual incidence,N/A
Disease,810,Shigellosis,Annual incidence,N/A
Disease,810,Shigellosis,Annual incidence,N/A
Disease,810,Shigellosis,Annual incidence,N/A
Disease,810,Shigellosis,Annual incidence,N/A
Disease,810,Shigellosis,Annual incidence,N/A
Disease,810,Shigellosis,Annual incidence,N/A
Disease,3165,Eosinophilic fasciitis,Point prevalence,N/A
Disease,3165,Eosinophilic fasciitis,Point prevalence,N/A
Disease,2420,Primary pulmonary lymphoma,Point prevalence,N/A
Disease,727,Microscopic polyangiitis,Annual incidence,N/A
Disease,727,Microscopic polyangiitis,Annual incidence,N/A
Disease,727,Microscopic polyangiitis,Point prevalence,N/A
Disease,727,Microscopic polyangiitis,Annual incidence,N/A
Disease,727,Microscopic polyangiitis,Point prevalence,N/A
Disease,727,Microscopic polyangiitis,Annual incidence,N/A
Disease,727,Microscopic polyangiitis,Point prevalence,N/A
Disease,727,Microscopic polyangiitis,Annual incidence,N/A
Disease,727,Microscopic polyangiitis,Point prevalence,N/A
Disease,727,Microscopic polyangiitis,Annual incidence,N/A
Disease,727,Microscopic polyangiitis,Point prevalence,N/A
Disease,727,Microscopic polyangiitis,Point prevalence,N/A
Disease,727,Microscopic polyangiitis,Point prevalence,N/A
Disease,727,Microscopic polyangiitis,Point prevalence,N/A
Disease,727,Microscopic polyangiitis,Annual incidence,N/A
Disease,727,Microscopic polyangiitis,Annual incidence,N/A
Disease,727,Microscopic polyangiitis,Annual incidence,N/A
Disease,727,Microscopic polyangiitis,Annual incidence,N/A
Disease,727,Microscopic polyangiitis,Annual incidence,N/A
Disease,727,Microscopic polyangiitis,Annual incidence,N/A
Disease,727,Microscopic polyangiitis,Annual incidence,N/A
Disease,900,Granulomatosis with polyangiitis,Annual incidence,N/A
Disease,900,Granulomatosis with polyangiitis,Point prevalence,N/A
Disease,900,Granulomatosis with polyangiitis,Annual incidence,N/A
Disease,900,Granulomatosis with polyangiitis,Point prevalence,N/A
Disease,900,Granulomatosis with polyangiitis,Annual incidence,N/A
Disease,900,Granulomatosis with polyangiitis,Point prevalence,N/A
Disease,900,Granulomatosis with polyangiitis,Annual incidence,N/A
Disease,900,Granulomatosis with polyangiitis,Annual incidence,N/A
Disease,900,Granulomatosis with polyangiitis,Point prevalence,N/A
Disease,900,Granulomatosis with polyangiitis,Annual incidence,N/A
Disease,900,Granulomatosis with polyangiitis,Point prevalence,N/A
Disease,900,Granulomatosis with polyangiitis,Point prevalence,N/A
Disease,900,Granulomatosis with polyangiitis,Annual incidence,N/A
Disease,900,Granulomatosis with polyangiitis,Point prevalence,N/A
Disease,900,Granulomatosis with polyangiitis,Point prevalence,N/A
Disease,900,Granulomatosis with polyangiitis,Annual incidence,N/A
Disease,900,Granulomatosis with polyangiitis,Annual incidence,N/A
Disease,900,Granulomatosis with polyangiitis,Annual incidence,N/A
Disease,900,Granulomatosis with polyangiitis,Annual incidence,N/A
Disease,900,Granulomatosis with polyangiitis,Annual incidence,N/A
Disease,900,Granulomatosis with polyangiitis,Annual incidence,N/A
Disease,900,Granulomatosis with polyangiitis,Point prevalence,N/A
Disease,900,Granulomatosis with polyangiitis,Point prevalence,N/A
Disease,900,Granulomatosis with polyangiitis,Point prevalence,N/A
Disease,900,Granulomatosis with polyangiitis,Annual incidence,N/A
Disease,863,Trichinellosis,Point prevalence,N/A
Disease,863,Trichinellosis,Annual incidence,N/A
Disease,863,Trichinellosis,Annual incidence,N/A
Disease,863,Trichinellosis,Annual incidence,N/A
Disease,863,Trichinellosis,Annual incidence,N/A
Disease,863,Trichinellosis,Annual incidence,N/A
Disease,863,Trichinellosis,Annual incidence,N/A
Disease,863,Trichinellosis,Annual incidence,N/A
Disease,863,Trichinellosis,Annual incidence,N/A
Disease,863,Trichinellosis,Annual incidence,N/A
Disease,134,Beta-ketothiolase deficiency,Point prevalence,N/A
Disease,134,Beta-ketothiolase deficiency,Prevalence at birth,N/A
Disease,134,Beta-ketothiolase deficiency,Prevalence at birth,N/A
Disease,134,Beta-ketothiolase deficiency,Prevalence at birth,N/A
Disease,134,Beta-ketothiolase deficiency,Prevalence at birth,N/A
Disease,171700,Diffuse panbronchiolitis,Point prevalence,N/A
Malformation syndrome,171703,Microcephaly-polymicrogyria-corpus callosum agenesis syndrome,Cases/families,N/A
Malformation syndrome,171703,Microcephaly-polymicrogyria-corpus callosum agenesis syndrome,Point prevalence,N/A
Disease,171706,Short stature-delayed bone age due to thyroid hormone metabolism deficiency,Point prevalence,N/A
Malformation syndrome,171719,Cutis laxa-Marfanoid syndrome,Point prevalence,N/A
Malformation syndrome,171719,Cutis laxa-Marfanoid syndrome,Cases/families,N/A
Disease,1163,Aspergillosis,Point prevalence,N/A
Disease,3467,Hereditary xanthinuria,Cases/families,N/A
Disease,3467,Hereditary xanthinuria,Annual incidence,N/A
Disease,3467,Hereditary xanthinuria,Point prevalence,N/A
Disease,171673,Limbal stem cell deficiency,Point prevalence,N/A
Disease,511,Maple syrup urine disease,Prevalence at birth,N/A
Disease,511,Maple syrup urine disease,Prevalence at birth,N/A
Disease,511,Maple syrup urine disease,Prevalence at birth,N/A
Disease,511,Maple syrup urine disease,Prevalence at birth,N/A
Disease,511,Maple syrup urine disease,Prevalence at birth,N/A
Disease,511,Maple syrup urine disease,Prevalence at birth,N/A
Disease,511,Maple syrup urine disease,Prevalence at birth,N/A
Disease,511,Maple syrup urine disease,Prevalence at birth,N/A
Disease,511,Maple syrup urine disease,Point prevalence,N/A
Disease,511,Maple syrup urine disease,Prevalence at birth,N/A
Disease,511,Maple syrup urine disease,Prevalence at birth,N/A
Disease,511,Maple syrup urine disease,Point prevalence,N/A
Disease,511,Maple syrup urine disease,Prevalence at birth,N/A
Malformation syndrome,171680,Lissencephaly due to TUBA1A mutation,Cases/families,N/A
Malformation syndrome,171680,Lissencephaly due to TUBA1A mutation,Point prevalence,N/A
Disease,32,Glutathione synthetase deficiency,Cases/families,N/A
Disease,32,Glutathione synthetase deficiency,Point prevalence,N/A
Disease,26,Methylmalonic acidemia with homocystinuria,Cases/families,N/A
Disease,26,Methylmalonic acidemia with homocystinuria,Point prevalence,N/A
Disease,171863,Autosomal dominant spastic paraplegia type 42,Cases/families,N/A
Disease,171863,Autosomal dominant spastic paraplegia type 42,Point prevalence,N/A
Clinical subtype,171871,Renal pseudohypoaldosteronism type 1,Prevalence at birth,N/A
Malformation syndrome,322,Exstrophy-epispadias complex,Point prevalence,N/A
Disease,171866,"Spondyloepimetaphyseal dysplasia, aggrecan type",Cases/families,N/A
Disease,171866,"Spondyloepimetaphyseal dysplasia, aggrecan type",Point prevalence,N/A
Morphological anomaly,2368,Gastroschisis,Prevalence at birth,N/A
Morphological anomaly,2368,Gastroschisis,Prevalence at birth,N/A
Morphological anomaly,2368,Gastroschisis,Prevalence at birth,N/A
Morphological anomaly,2368,Gastroschisis,Prevalence at birth,N/A
Morphological anomaly,2368,Gastroschisis,Prevalence at birth,N/A
Morphological anomaly,2368,Gastroschisis,Prevalence at birth,N/A
Morphological anomaly,2368,Gastroschisis,Prevalence at birth,N/A
Morphological anomaly,2368,Gastroschisis,Prevalence at birth,N/A
Morphological anomaly,2368,Gastroschisis,Prevalence at birth,N/A
Morphological anomaly,2368,Gastroschisis,Prevalence at birth,N/A
Morphological anomaly,2368,Gastroschisis,Prevalence at birth,N/A
Morphological anomaly,2368,Gastroschisis,Prevalence at birth,N/A
Morphological anomaly,2368,Gastroschisis,Prevalence at birth,N/A
Morphological anomaly,2368,Gastroschisis,Prevalence at birth,N/A
Morphological anomaly,2368,Gastroschisis,Prevalence at birth,N/A
Morphological anomaly,2368,Gastroschisis,Prevalence at birth,N/A
Morphological anomaly,2368,Gastroschisis,Prevalence at birth,N/A
Morphological anomaly,2368,Gastroschisis,Prevalence at birth,N/A
Morphological anomaly,2368,Gastroschisis,Prevalence at birth,N/A
Morphological anomaly,2368,Gastroschisis,Point prevalence,N/A
Disease,171881,Cap myopathy,Cases/families,N/A
Disease,171881,Cap myopathy,Point prevalence,N/A
Etiological subtype,2512,Autosomal recessive primary microcephaly,Annual incidence,N/A
Etiological subtype,2512,Autosomal recessive primary microcephaly,Point prevalence,N/A
Etiological subtype,2512,Autosomal recessive primary microcephaly,Annual incidence,N/A
Clinical subtype,171876,Generalized pseudohypoaldosteronism type 1,Prevalence at birth,N/A
Category,795,Rare form of salmonellosis,Point prevalence,N/A
Disease,797,Sarcoidosis,Point prevalence,N/A
Disease,797,Sarcoidosis,Point prevalence,N/A
Disease,797,Sarcoidosis,Point prevalence,N/A
Disease,797,Sarcoidosis,Annual incidence,N/A
Disease,797,Sarcoidosis,Point prevalence,N/A
Disease,797,Sarcoidosis,Annual incidence,N/A
Disease,797,Sarcoidosis,Point prevalence,N/A
Disease,797,Sarcoidosis,Annual incidence,N/A
Disease,797,Sarcoidosis,Point prevalence,N/A
Disease,797,Sarcoidosis,Annual incidence,N/A
Disease,797,Sarcoidosis,Annual incidence,N/A
Disease,797,Sarcoidosis,Point prevalence,N/A
Disease,797,Sarcoidosis,Annual incidence,N/A
Disease,797,Sarcoidosis,Point prevalence,N/A
Disease,797,Sarcoidosis,Annual incidence,N/A
Disease,797,Sarcoidosis,Annual incidence,N/A
Disease,797,Sarcoidosis,Point prevalence,N/A
Disease,797,Sarcoidosis,Annual incidence,N/A
Disease,797,Sarcoidosis,Annual incidence,N/A
Disease,797,Sarcoidosis,Point prevalence,N/A
Disease,797,Sarcoidosis,Annual incidence,N/A
Disease,797,Sarcoidosis,Annual incidence,N/A
Disease,797,Sarcoidosis,Point prevalence,N/A
Disease,797,Sarcoidosis,Annual incidence,N/A
Disease,797,Sarcoidosis,Point prevalence,N/A
Disease,797,Sarcoidosis,Annual incidence,N/A
Disease,797,Sarcoidosis,Point prevalence,N/A
Disease,797,Sarcoidosis,Point prevalence,N/A
Disease,797,Sarcoidosis,Point prevalence,N/A
Disease,797,Sarcoidosis,Annual incidence,N/A
Disease,797,Sarcoidosis,Point prevalence,N/A
Disease,797,Sarcoidosis,Point prevalence,N/A
Disease,797,Sarcoidosis,Annual incidence,N/A
Disease,797,Sarcoidosis,Annual incidence,N/A
Clinical group,92,Juvenile idiopathic arthritis,Annual incidence,N/A
Clinical group,92,Juvenile idiopathic arthritis,Annual incidence,N/A
Clinical group,92,Juvenile idiopathic arthritis,Point prevalence,N/A
Clinical group,92,Juvenile idiopathic arthritis,Point prevalence,N/A
Clinical group,92,Juvenile idiopathic arthritis,Point prevalence,N/A
Clinical group,92,Juvenile idiopathic arthritis,Point prevalence,N/A
Clinical group,92,Juvenile idiopathic arthritis,Point prevalence,N/A
Clinical group,92,Juvenile idiopathic arthritis,Annual incidence,N/A
Disease,171829,6q16 microdeletion syndrome,Cases/families,N/A
Disease,171829,6q16 microdeletion syndrome,Point prevalence,N/A
Morphological anomaly,1201,Small bowel atresia,Prevalence at birth,N/A
Morphological anomaly,1201,Small bowel atresia,Prevalence at birth,N/A
Morphological anomaly,1201,Small bowel atresia,Prevalence at birth,N/A
Morphological anomaly,1201,Small bowel atresia,Prevalence at birth,N/A
Morphological anomaly,1201,Small bowel atresia,Prevalence at birth,N/A
Morphological anomaly,1201,Small bowel atresia,Prevalence at birth,N/A
Morphological anomaly,1201,Small bowel atresia,Prevalence at birth,N/A
Morphological anomaly,1201,Small bowel atresia,Prevalence at birth,N/A
Morphological anomaly,1201,Small bowel atresia,Prevalence at birth,N/A
Morphological anomaly,1201,Small bowel atresia,Prevalence at birth,N/A
Morphological anomaly,1201,Small bowel atresia,Prevalence at birth,N/A
Morphological anomaly,1201,Small bowel atresia,Prevalence at birth,N/A
Morphological anomaly,1201,Small bowel atresia,Prevalence at birth,N/A
Morphological anomaly,1201,Small bowel atresia,Prevalence at birth,N/A
Morphological anomaly,1201,Small bowel atresia,Point prevalence,N/A
Malformation syndrome,171844,Blindness-scoliosis-arachnodactyly syndrome,Cases/families,N/A
Malformation syndrome,171844,Blindness-scoliosis-arachnodactyly syndrome,Point prevalence,N/A
Malformation syndrome,171839,Craniosynostosis-hydrocephalus-Arnold-Chiari malformation type I-radioulnar synostosis syndrome,Cases/families,N/A
Malformation syndrome,171839,Craniosynostosis-hydrocephalus-Arnold-Chiari malformation type I-radioulnar synostosis syndrome,Point prevalence,N/A
Malformation syndrome,1202,Larynx atresia,Point prevalence,N/A
Morphological anomaly,1199,Esophageal atresia,Prevalence at birth,N/A
Morphological anomaly,1199,Esophageal atresia,Point prevalence,N/A
Morphological anomaly,1199,Esophageal atresia,Prevalence at birth,N/A
Morphological anomaly,1199,Esophageal atresia,Prevalence at birth,N/A
Morphological anomaly,1199,Esophageal atresia,Prevalence at birth,N/A
Morphological anomaly,1199,Esophageal atresia,Prevalence at birth,N/A
Morphological anomaly,1199,Esophageal atresia,Prevalence at birth,N/A
Morphological anomaly,1199,Esophageal atresia,Prevalence at birth,N/A
Morphological anomaly,1199,Esophageal atresia,Prevalence at birth,N/A
Morphological anomaly,1199,Esophageal atresia,Prevalence at birth,N/A
Morphological anomaly,1199,Esophageal atresia,Prevalence at birth,N/A
Morphological anomaly,1199,Esophageal atresia,Prevalence at birth,N/A
Morphological anomaly,1199,Esophageal atresia,Prevalence at birth,N/A
Morphological anomaly,1199,Esophageal atresia,Prevalence at birth,N/A
Morphological anomaly,1199,Esophageal atresia,Prevalence at birth,N/A
Morphological anomaly,1199,Esophageal atresia,Prevalence at birth,N/A
Morphological anomaly,1199,Esophageal atresia,Prevalence at birth,N/A
Morphological anomaly,1199,Esophageal atresia,Prevalence at birth,N/A
Morphological anomaly,1199,Esophageal atresia,Prevalence at birth,N/A
Morphological anomaly,1199,Esophageal atresia,Prevalence at birth,N/A
Morphological anomaly,1199,Esophageal atresia,Prevalence at birth,N/A
Disease,171851,MEDNIK syndrome,Cases/families,N/A
Disease,171851,MEDNIK syndrome,Point prevalence,N/A
Disease,171848,Polyneuropathy-hearing loss-ataxia-retinitis pigmentosa-cataract syndrome,Cases/families,N/A
Disease,171848,Polyneuropathy-hearing loss-ataxia-retinitis pigmentosa-cataract syndrome,Point prevalence,N/A
Disease,1304,Brucellosis,Annual incidence,N/A
Disease,1304,Brucellosis,Annual incidence,N/A
Disease,1304,Brucellosis,Annual incidence,N/A
Disease,1304,Brucellosis,Annual incidence,N/A
Disease,1304,Brucellosis,Annual incidence,N/A
Disease,1304,Brucellosis,Annual incidence,N/A
Disease,1304,Brucellosis,Annual incidence,N/A
Disease,1304,Brucellosis,Annual incidence,N/A
Disease,1304,Brucellosis,Annual incidence,N/A
Disease,1304,Brucellosis,Annual incidence,N/A
Disease,1304,Brucellosis,Annual incidence,N/A
Disease,1304,Brucellosis,Annual incidence,N/A
Disease,1304,Brucellosis,Annual incidence,N/A
Disease,1304,Brucellosis,Annual incidence,N/A
Disease,1304,Brucellosis,Annual incidence,N/A
Disease,1304,Brucellosis,Annual incidence,N/A
Disease,1304,Brucellosis,Annual incidence,N/A
Disease,1304,Brucellosis,Annual incidence,N/A
Disease,1304,Brucellosis,Annual incidence,N/A
Disease,1304,Brucellosis,Annual incidence,N/A
Disease,1304,Brucellosis,Annual incidence,N/A
Disease,1304,Brucellosis,Annual incidence,N/A
Disease,1304,Brucellosis,Annual incidence,N/A
Disease,1304,Brucellosis,Annual incidence,N/A
Disease,1304,Brucellosis,Annual incidence,N/A
Disease,173,Cholera,Point prevalence,N/A
Disease,173,Cholera,Point prevalence,N/A
Disease,173,Cholera,Annual incidence,N/A
Disease,173,Cholera,Annual incidence,N/A
Disease,173,Cholera,Annual incidence,N/A
Disease,173,Cholera,Annual incidence,N/A
Disease,173,Cholera,Annual incidence,N/A
Disease,173,Cholera,Annual incidence,N/A
Disease,173,Cholera,Annual incidence,N/A
Disease,173,Cholera,Annual incidence,N/A
Disease,173,Cholera,Annual incidence,N/A
Disease,173,Cholera,Annual incidence,N/A
Disease,173,Cholera,Annual incidence,N/A
Malformation syndrome,3303,Tetralogy of Fallot,Prevalence at birth,N/A
Malformation syndrome,3303,Tetralogy of Fallot,Prevalence at birth,N/A
Malformation syndrome,3303,Tetralogy of Fallot,Prevalence at birth,N/A
Malformation syndrome,3303,Tetralogy of Fallot,Prevalence at birth,N/A
Malformation syndrome,3303,Tetralogy of Fallot,Prevalence at birth,N/A
Malformation syndrome,3303,Tetralogy of Fallot,Prevalence at birth,N/A
Malformation syndrome,3303,Tetralogy of Fallot,Prevalence at birth,N/A
Malformation syndrome,3303,Tetralogy of Fallot,Prevalence at birth,N/A
Malformation syndrome,3303,Tetralogy of Fallot,Prevalence at birth,N/A
Malformation syndrome,3303,Tetralogy of Fallot,Prevalence at birth,N/A
Malformation syndrome,3303,Tetralogy of Fallot,Prevalence at birth,N/A
Malformation syndrome,3303,Tetralogy of Fallot,Prevalence at birth,N/A
Malformation syndrome,3303,Tetralogy of Fallot,Prevalence at birth,N/A
Malformation syndrome,3303,Tetralogy of Fallot,Prevalence at birth,N/A
Malformation syndrome,3303,Tetralogy of Fallot,Prevalence at birth,N/A
Malformation syndrome,3303,Tetralogy of Fallot,Prevalence at birth,N/A
Malformation syndrome,3303,Tetralogy of Fallot,Prevalence at birth,N/A
Malformation syndrome,3303,Tetralogy of Fallot,Prevalence at birth,N/A
Malformation syndrome,3303,Tetralogy of Fallot,Prevalence at birth,N/A
Malformation syndrome,3303,Tetralogy of Fallot,Prevalence at birth,N/A
Malformation syndrome,3303,Tetralogy of Fallot,Prevalence at birth,N/A
Malformation syndrome,3303,Tetralogy of Fallot,Prevalence at birth,N/A
Malformation syndrome,3303,Tetralogy of Fallot,Prevalence at birth,N/A
Malformation syndrome,3303,Tetralogy of Fallot,Point prevalence,N/A
Malformation syndrome,3303,Tetralogy of Fallot,Point prevalence,N/A
Disease,200418,Immunodeficiency with factor I anomaly,Cases/families,N/A
Disease,200418,Immunodeficiency with factor I anomaly,Point prevalence,N/A
Disease,730,Autosomal dominant polycystic kidney disease,Point prevalence,N/A
Disease,486,Autosomal dominant severe congenital neutropenia,Point prevalence,N/A
Morphological anomaly,1209,Tricuspid atresia,Prevalence at birth,N/A
Morphological anomaly,1209,Tricuspid atresia,Point prevalence,N/A
Morphological anomaly,1209,Tricuspid atresia,Prevalence at birth,N/A
Morphological anomaly,1209,Tricuspid atresia,Prevalence at birth,N/A
Morphological anomaly,1209,Tricuspid atresia,Prevalence at birth,N/A
Morphological anomaly,1209,Tricuspid atresia,Prevalence at birth,N/A
Morphological anomaly,1209,Tricuspid atresia,Prevalence at birth,N/A
Morphological anomaly,1209,Tricuspid atresia,Prevalence at birth,N/A
Morphological anomaly,1209,Tricuspid atresia,Prevalence at birth,N/A
Morphological anomaly,1209,Tricuspid atresia,Prevalence at birth,N/A
Morphological anomaly,1209,Tricuspid atresia,Prevalence at birth,N/A
Morphological anomaly,1209,Tricuspid atresia,Prevalence at birth,N/A
Morphological anomaly,1209,Tricuspid atresia,Prevalence at birth,N/A
Morphological anomaly,1209,Tricuspid atresia,Prevalence at birth,N/A
Morphological anomaly,1209,Tricuspid atresia,Prevalence at birth,N/A
Morphological anomaly,1209,Tricuspid atresia,Prevalence at birth,N/A
Morphological anomaly,1209,Tricuspid atresia,Prevalence at birth,N/A
Morphological anomaly,1209,Tricuspid atresia,Prevalence at birth,N/A
Morphological anomaly,1209,Tricuspid atresia,Prevalence at birth,N/A
Disease,98,Autosomal recessive spastic ataxia of Charlevoix-Saguenay,Point prevalence,N/A
Disease,98,Autosomal recessive spastic ataxia of Charlevoix-Saguenay,Prevalence at birth,N/A
Morphological anomaly,1478,Interatrial communication,Point prevalence,N/A
Disease,330,Congenital factor XII deficiency,Point prevalence,N/A
Disease,1959,Evans syndrome,Point prevalence,N/A
Disease,284,Alveolar echinococcosis,Annual incidence,N/A
Disease,284,Alveolar echinococcosis,Annual incidence,N/A
Disease,284,Alveolar echinococcosis,Annual incidence,N/A
Disease,284,Alveolar echinococcosis,Annual incidence,N/A
Disease,284,Alveolar echinococcosis,Annual incidence,N/A
Disease,284,Alveolar echinococcosis,Point prevalence,N/A
Disease,1177,Early-onset cerebellar ataxia with retained tendon reflexes,Prevalence at birth,N/A
Disease,1177,Early-onset cerebellar ataxia with retained tendon reflexes,Point prevalence,N/A
Disease,1177,Early-onset cerebellar ataxia with retained tendon reflexes,Point prevalence,N/A
Disease,828,Stickler syndrome,Prevalence at birth,N/A
Disease,828,Stickler syndrome,Point prevalence,N/A
Disease,828,Stickler syndrome,Prevalence at birth,N/A
Disease,828,Stickler syndrome,Point prevalence,N/A
Disease,828,Stickler syndrome,Prevalence at birth,N/A
Clinical group,1431,Paroxysmal dyskinesia,Point prevalence,N/A
Disease,293,Congenital herpes simplex virus infection,Annual incidence,N/A
Disease,293,Congenital herpes simplex virus infection,Point prevalence,N/A
Disease,293,Congenital herpes simplex virus infection,Annual incidence,N/A
Disease,199340,"Muscular dystrophy, Selcen type",Cases/families,N/A
Disease,199340,"Muscular dystrophy, Selcen type",Point prevalence,N/A
Disease,199337,Pancreatic insufficiency-anemia-hyperostosis syndrome,Cases/families,N/A
Disease,199337,Pancreatic insufficiency-anemia-hyperostosis syndrome,Point prevalence,N/A
Disease,234,Dubin-Johnson syndrome,Point prevalence,N/A
Disease,199348,Thiamine-responsive encephalopathy,Cases/families,N/A
Disease,199348,Thiamine-responsive encephalopathy,Point prevalence,N/A
Disease,3287,Takayasu arteritis,Annual incidence,N/A
Disease,3287,Takayasu arteritis,Point prevalence,N/A
Disease,3287,Takayasu arteritis,Annual incidence,N/A
Disease,3287,Takayasu arteritis,Point prevalence,N/A
Disease,3287,Takayasu arteritis,Annual incidence,N/A
Disease,3287,Takayasu arteritis,Point prevalence,N/A
Disease,3287,Takayasu arteritis,Point prevalence,N/A
Disease,3287,Takayasu arteritis,Annual incidence,N/A
Disease,3287,Takayasu arteritis,Point prevalence,N/A
Disease,3287,Takayasu arteritis,Annual incidence,N/A
Disease,3287,Takayasu arteritis,Point prevalence,N/A
Disease,3287,Takayasu arteritis,Annual incidence,N/A
Disease,3287,Takayasu arteritis,Annual incidence,N/A
Disease,3287,Takayasu arteritis,Annual incidence,N/A
Disease,3287,Takayasu arteritis,Annual incidence,N/A
Disease,3287,Takayasu arteritis,Annual incidence,N/A
Disease,3287,Takayasu arteritis,Point prevalence,N/A
Disease,3287,Takayasu arteritis,Point prevalence,N/A
Disease,3287,Takayasu arteritis,Annual incidence,N/A
Disease,3287,Takayasu arteritis,Point prevalence,N/A
Disease,3287,Takayasu arteritis,Annual incidence,N/A
Disease,199343,EAST syndrome,Cases/families,N/A
Disease,199343,EAST syndrome,Point prevalence,N/A
Disease,2800,Extramammary Paget disease,Point prevalence,N/A
Disease,199326,"Isolated autosomal dominant hypomagnesemia, Glaudemans type",Cases/families,N/A
Disease,199326,"Isolated autosomal dominant hypomagnesemia, Glaudemans type",Point prevalence,N/A
Morphological anomaly,1928,Congenital lobar emphysema,Prevalence at birth,N/A
Morphological anomaly,1928,Congenital lobar emphysema,Point prevalence,N/A
Malformation syndrome,199332,Endocrine-cerebro-osteodysplasia syndrome,Cases/families,N/A
Malformation syndrome,199332,Endocrine-cerebro-osteodysplasia syndrome,Point prevalence,N/A
Disease,199329,"Congenital myopathy, Paradas type",Cases/families,N/A
Disease,199329,"Congenital myopathy, Paradas type",Point prevalence,N/A
Disease,3463,Wolfram syndrome,Point prevalence,N/A
Disease,3463,Wolfram syndrome,Point prevalence,N/A
Disease,3463,Wolfram syndrome,Point prevalence,N/A
Disease,3463,Wolfram syndrome,Point prevalence,N/A
Disease,3463,Wolfram syndrome,Point prevalence,N/A
Disease,3463,Wolfram syndrome,Point prevalence,N/A
Disease,549,Legionnaires disease,Annual incidence,N/A
Disease,549,Legionnaires disease,Annual incidence,N/A
Disease,549,Legionnaires disease,Annual incidence,N/A
Disease,549,Legionnaires disease,Annual incidence,N/A
Disease,549,Legionnaires disease,Annual incidence,N/A
Disease,549,Legionnaires disease,Annual incidence,N/A
Disease,549,Legionnaires disease,Annual incidence,N/A
Disease,549,Legionnaires disease,Annual incidence,N/A
Disease,549,Legionnaires disease,Annual incidence,N/A
Disease,549,Legionnaires disease,Annual incidence,N/A
Disease,549,Legionnaires disease,Annual incidence,N/A
Disease,549,Legionnaires disease,Annual incidence,N/A
Disease,549,Legionnaires disease,Annual incidence,N/A
Disease,549,Legionnaires disease,Annual incidence,N/A
Disease,549,Legionnaires disease,Annual incidence,N/A
Disease,549,Legionnaires disease,Annual incidence,N/A
Disease,549,Legionnaires disease,Annual incidence,N/A
Disease,549,Legionnaires disease,Annual incidence,N/A
Disease,549,Legionnaires disease,Annual incidence,N/A
Disease,549,Legionnaires disease,Annual incidence,N/A
Disease,549,Legionnaires disease,Annual incidence,N/A
Disease,549,Legionnaires disease,Annual incidence,N/A
Disease,549,Legionnaires disease,Annual incidence,N/A
Disease,549,Legionnaires disease,Annual incidence,N/A
Disease,549,Legionnaires disease,Annual incidence,N/A
Disease,549,Legionnaires disease,Annual incidence,N/A
Disease,549,Legionnaires disease,Annual incidence,N/A
Disease,549,Legionnaires disease,Annual incidence,N/A
Disease,549,Legionnaires disease,Annual incidence,N/A
Disease,549,Legionnaires disease,Annual incidence,N/A
Disease,549,Legionnaires disease,Annual incidence,N/A
Disease,704,Pemphigus vulgaris,Annual incidence,N/A
Disease,704,Pemphigus vulgaris,Point prevalence,N/A
Disease,704,Pemphigus vulgaris,Annual incidence,N/A
Disease,704,Pemphigus vulgaris,Annual incidence,N/A
Disease,704,Pemphigus vulgaris,Annual incidence,N/A
Disease,704,Pemphigus vulgaris,Annual incidence,N/A
Disease,704,Pemphigus vulgaris,Annual incidence,N/A
Disease,704,Pemphigus vulgaris,Point prevalence,N/A
Disease,199354,Cerebral autosomal recessive arteriopathy-subcortical infarcts-leukoencephalopathy,Point prevalence,N/A
Disease,199351,Adult-onset dystonia-parkinsonism,Cases/families,N/A
Disease,199351,Adult-onset dystonia-parkinsonism,Point prevalence,N/A
Disease,356,Gerstmann-Straussler-Scheinker syndrome,Point prevalence,N/A
Disease,356,Gerstmann-Straussler-Scheinker syndrome,Annual incidence,N/A
Particular clinical situation in a disease or syndrome,268316,Complication in hemodialysis,Annual incidence,N/A
Particular clinical situation in a disease or syndrome,268316,Complication in hemodialysis,Point prevalence,N/A
Clinical subtype,268162,Intermediate maple syrup urine disease,Prevalence at birth,N/A
Clinical subtype,268162,Intermediate maple syrup urine disease,Point prevalence,N/A
Malformation syndrome,2832,Short tarsus-absence of lower eyelashes syndrome,Cases/families,N/A
Malformation syndrome,2832,Short tarsus-absence of lower eyelashes syndrome,Point prevalence,N/A
Clinical subtype,268145,Classic maple syrup urine disease,Prevalence at birth,N/A
Clinical subtype,268145,Classic maple syrup urine disease,Point prevalence,N/A
Clinical subtype,268184,Thiamine-responsive maple syrup urine disease,Prevalence at birth,N/A
Clinical subtype,268184,Thiamine-responsive maple syrup urine disease,Point prevalence,N/A
Disease,2833,Stiff skin syndrome,Cases/families,N/A
Disease,2833,Stiff skin syndrome,Point prevalence,N/A
Morphological anomaly,199293,Congenital microgastria,Point prevalence,N/A
Disease,3452,Whipple disease,Annual incidence,N/A
Disease,3452,Whipple disease,Point prevalence,N/A
Disease,3452,Whipple disease,Point prevalence,N/A
Disease,3452,Whipple disease,Point prevalence,N/A
Disease,2962,De Barsy syndrome,Cases/families,N/A
Disease,2962,De Barsy syndrome,Point prevalence,N/A
Malformation syndrome,2972,Non-eruption of teeth-maxillary hypoplasia-genu valgum syndrome,Cases/families,N/A
Malformation syndrome,2972,Non-eruption of teeth-maxillary hypoplasia-genu valgum syndrome,Point prevalence,N/A
Clinical subtype,2102,GTP cyclohydrolase I deficiency,Cases/families,N/A
Clinical subtype,2102,GTP cyclohydrolase I deficiency,Point prevalence,N/A
Malformation syndrome,2976,"Pseudoleprechaunism syndrome, Patterson type",Cases/families,N/A
Malformation syndrome,2976,"Pseudoleprechaunism syndrome, Patterson type",Point prevalence,N/A
Disease,3002,Immune thrombocytopenia,Point prevalence,N/A
Disease,3002,Immune thrombocytopenia,Point prevalence,N/A
Disease,3002,Immune thrombocytopenia,Annual incidence,N/A
Disease,3002,Immune thrombocytopenia,Annual incidence,N/A
Disease,3002,Immune thrombocytopenia,Annual incidence,N/A
Disease,3002,Immune thrombocytopenia,Point prevalence,N/A
Disease,3002,Immune thrombocytopenia,Annual incidence,N/A
Disease,199267,Infantile digital fibromatosis,Cases/families,N/A
Disease,199267,Infantile digital fibromatosis,Point prevalence,N/A
Malformation syndrome,2946,Brachydactyly-long thumb syndrome,Cases/families,N/A
Malformation syndrome,2946,Brachydactyly-long thumb syndrome,Point prevalence,N/A
Clinical subtype,1848,"Renal agenesis, bilateral",Prevalence at birth,N/A
Clinical subtype,1848,"Renal agenesis, bilateral",Prevalence at birth,N/A
Clinical subtype,1848,"Renal agenesis, bilateral",Prevalence at birth,N/A
Clinical subtype,1848,"Renal agenesis, bilateral",Prevalence at birth,N/A
Clinical subtype,1848,"Renal agenesis, bilateral",Prevalence at birth,N/A
Clinical subtype,1848,"Renal agenesis, bilateral",Prevalence at birth,N/A
Clinical subtype,1848,"Renal agenesis, bilateral",Prevalence at birth,N/A
Clinical subtype,1848,"Renal agenesis, bilateral",Prevalence at birth,N/A
Clinical subtype,1848,"Renal agenesis, bilateral",Prevalence at birth,N/A
Clinical subtype,1848,"Renal agenesis, bilateral",Prevalence at birth,N/A
Clinical subtype,1848,"Renal agenesis, bilateral",Prevalence at birth,N/A
Clinical subtype,1848,"Renal agenesis, bilateral",Prevalence at birth,N/A
Clinical subtype,1848,"Renal agenesis, bilateral",Prevalence at birth,N/A
Clinical subtype,1848,"Renal agenesis, bilateral",Prevalence at birth,N/A
Clinical subtype,1848,"Renal agenesis, bilateral",Prevalence at birth,N/A
Clinical subtype,1848,"Renal agenesis, bilateral",Prevalence at birth,N/A
Clinical subtype,1848,"Renal agenesis, bilateral",Prevalence at birth,N/A
Clinical subtype,1848,"Renal agenesis, bilateral",Point prevalence,N/A
Malformation syndrome,2951,Absent thumb-short stature-immunodeficiency syndrome,Cases/families,N/A
Malformation syndrome,2951,Absent thumb-short stature-immunodeficiency syndrome,Point prevalence,N/A
Disease,3020,Ramsay Hunt syndrome,Annual incidence,N/A
Disease,3020,Ramsay Hunt syndrome,Point prevalence,N/A
Particular clinical situation in a disease or syndrome,264978,Drug or radiation exposure-related interstitial lung disease,Point prevalence,N/A
Malformation syndrome,2956,Acrodysplasia scoliosis,Cases/families,N/A
Malformation syndrome,2956,Acrodysplasia scoliosis,Point prevalence,N/A
Disease,1675,Dihydropyrimidine dehydrogenase deficiency,Point prevalence,N/A
Disease,189427,Cushing syndrome due to bilateral macronodular adrenocortical disease,Point prevalence,N/A
Disease,976,Adenine phosphoribosyltransferase deficiency,Point prevalence,N/A
Disease,976,Adenine phosphoribosyltransferase deficiency,Point prevalence,N/A
Disease,976,Adenine phosphoribosyltransferase deficiency,Point prevalence,N/A
Disease,976,Adenine phosphoribosyltransferase deficiency,Point prevalence,N/A
Malformation syndrome,2958,X-linked intellectual disability-dysmorphism-cerebral atrophy syndrome,Cases/families,N/A
Malformation syndrome,2958,X-linked intellectual disability-dysmorphism-cerebral atrophy syndrome,Point prevalence,N/A
Disease,415,Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome,Point prevalence,N/A
Disease,415,Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome,Point prevalence,N/A
Disease,415,Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome,Cases/families,N/A
Disease,415,Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome,Prevalence at birth,N/A
Clinical subtype,13,6-pyruvoyl-tetrahydropterin synthase deficiency,Point prevalence,N/A
Clinical subtype,13,6-pyruvoyl-tetrahydropterin synthase deficiency,Prevalence at birth,N/A
Clinical subtype,13,6-pyruvoyl-tetrahydropterin synthase deficiency,Prevalence at birth,N/A
Clinical subtype,13,6-pyruvoyl-tetrahydropterin synthase deficiency,Prevalence at birth,N/A
Clinical subtype,13,6-pyruvoyl-tetrahydropterin synthase deficiency,Prevalence at birth,N/A
Malformation syndrome,2935,Crossed polysyndactyly,Cases/families,N/A
Malformation syndrome,2935,Crossed polysyndactyly,Point prevalence,N/A
Malformation syndrome,2934,Polysyndactyly-cardiac malformation syndrome,Cases/families,N/A
Malformation syndrome,2934,Polysyndactyly-cardiac malformation syndrome,Point prevalence,N/A
Malformation syndrome,2941,Porencephaly-cerebellar hypoplasia-internal malformations syndrome,Cases/families,N/A
Malformation syndrome,2941,Porencephaly-cerebellar hypoplasia-internal malformations syndrome,Point prevalence,N/A
Disease,2940,Porencephaly,Point prevalence,N/A
Disease,2940,Porencephaly,Prevalence at birth,N/A
Disease,2940,Porencephaly,Prevalence at birth,N/A
Malformation syndrome,2896,Pitt-Hopkins syndrome,Point prevalence,N/A
Malformation syndrome,2896,Pitt-Hopkins syndrome,Point prevalence,N/A
Malformation syndrome,2900,Leri pleonosteosis,Point prevalence,N/A
Disease,2905,POEMS syndrome,Point prevalence,N/A
Disease,2905,POEMS syndrome,Point prevalence,N/A
Disease,2134,Atypical hemolytic uremic syndrome,Annual incidence,N/A
Disease,2134,Atypical hemolytic uremic syndrome,Point prevalence,N/A
Disease,2134,Atypical hemolytic uremic syndrome,Point prevalence,N/A
Malformation syndrome,2911,Poland syndrome,Prevalence at birth,N/A
Malformation syndrome,2911,Poland syndrome,Point prevalence,N/A
Malformation syndrome,2911,Poland syndrome,Prevalence at birth,N/A
Malformation syndrome,2911,Poland syndrome,Point prevalence,N/A
Clinical syndrome,1934,Early infantile epileptic encephalopathy,Prevalence at birth,N/A
Clinical syndrome,1934,Early infantile epileptic encephalopathy,Prevalence at birth,N/A
Clinical syndrome,1934,Early infantile epileptic encephalopathy,Point prevalence,N/A
Disease,845,Tay-Sachs disease,Prevalence at birth,N/A
Disease,845,Tay-Sachs disease,Annual incidence,N/A
Disease,845,Tay-Sachs disease,Prevalence at birth,N/A
Disease,845,Tay-Sachs disease,Prevalence at birth,N/A
Disease,845,Tay-Sachs disease,Prevalence at birth,N/A
Disease,845,Tay-Sachs disease,Prevalence at birth,N/A
Disease,845,Tay-Sachs disease,Prevalence at birth,N/A
Disease,845,Tay-Sachs disease,Prevalence at birth,N/A
Disease,845,Tay-Sachs disease,Prevalence at birth,N/A
Disease,845,Tay-Sachs disease,Prevalence at birth,N/A
Disease,845,Tay-Sachs disease,Prevalence at birth,N/A
Disease,845,Tay-Sachs disease,Prevalence at birth,N/A
Disease,845,Tay-Sachs disease,Point prevalence,N/A
Disease,845,Tay-Sachs disease,Point prevalence,N/A
Disease,1942,Myoclonic-astatic epilepsy,Point prevalence,N/A
Malformation syndrome,2921,Preaxial polydactyly-colobomata-intellectual disability syndrome,Point prevalence,N/A
Malformation syndrome,2921,Preaxial polydactyly-colobomata-intellectual disability syndrome,Cases/families,N/A
Clinical syndrome,3451,Infantile epileptic spasms syndrome,Point prevalence,N/A
Clinical syndrome,3451,Infantile epileptic spasms syndrome,Prevalence at birth,N/A
Clinical syndrome,3451,Infantile epileptic spasms syndrome,Prevalence at birth,N/A
Clinical syndrome,3451,Infantile epileptic spasms syndrome,Prevalence at birth,N/A
Clinical syndrome,3451,Infantile epileptic spasms syndrome,Prevalence at birth,N/A
Clinical syndrome,3451,Infantile epileptic spasms syndrome,Prevalence at birth,N/A
Clinical syndrome,3451,Infantile epileptic spasms syndrome,Prevalence at birth,N/A
Clinical syndrome,3451,Infantile epileptic spasms syndrome,Prevalence at birth,N/A
Clinical syndrome,3451,Infantile epileptic spasms syndrome,Prevalence at birth,N/A
Clinical syndrome,3451,Infantile epileptic spasms syndrome,Prevalence at birth,N/A
Disease,3299,Tetanus,Annual incidence,N/A
Disease,3299,Tetanus,Annual incidence,N/A
Disease,3299,Tetanus,Annual incidence,N/A
Disease,3299,Tetanus,Annual incidence,N/A
Disease,3299,Tetanus,Annual incidence,N/A
Disease,3299,Tetanus,Annual incidence,N/A
Disease,3299,Tetanus,Annual incidence,N/A
Disease,3299,Tetanus,Annual incidence,N/A
Disease,3299,Tetanus,Annual incidence,N/A
Disease,3299,Tetanus,Annual incidence,N/A
Disease,3299,Tetanus,Annual incidence,N/A
Disease,3299,Tetanus,Annual incidence,N/A
Disease,3299,Tetanus,Annual incidence,N/A
Disease,3299,Tetanus,Annual incidence,N/A
Disease,3299,Tetanus,Annual incidence,N/A
Disease,3299,Tetanus,Annual incidence,N/A
Disease,3299,Tetanus,Annual incidence,N/A
Disease,3299,Tetanus,Annual incidence,N/A
Disease,3299,Tetanus,Annual incidence,N/A
Disease,3299,Tetanus,Annual incidence,N/A
Disease,3299,Tetanus,Annual incidence,N/A
Disease,3299,Tetanus,Annual incidence,N/A
Disease,3299,Tetanus,Annual incidence,N/A
Disease,3299,Tetanus,Point prevalence,N/A
Clinical group,275786,Drug- or toxin-induced pulmonary arterial hypertension,Point prevalence,N/A
Category,275791,Pulmonary arterial hypertension associated with another disease,Point prevalence,N/A
Malformation syndrome,3369,Trigonocephaly-short stature-developmental delay syndrome,Cases/families,N/A
Malformation syndrome,3369,Trigonocephaly-short stature-developmental delay syndrome,Point prevalence,N/A
Disease,3386,American trypanosomiasis,Point prevalence,N/A
Disease,3386,American trypanosomiasis,Point prevalence,N/A
Disease,3386,American trypanosomiasis,Point prevalence,N/A
Disease,3386,American trypanosomiasis,Point prevalence,N/A
Disease,3386,American trypanosomiasis,Point prevalence,N/A
Disease,3386,American trypanosomiasis,Point prevalence,N/A
Disease,3386,American trypanosomiasis,Point prevalence,N/A
Disease,3386,American trypanosomiasis,Point prevalence,N/A
Disease,3386,American trypanosomiasis,Point prevalence,N/A
Disease,3386,American trypanosomiasis,Point prevalence,N/A
Disease,3386,American trypanosomiasis,Point prevalence,N/A
Malformation syndrome,3363,Trichomegaly-retina pigmentary degeneration-dwarfism syndrome,Cases/families,N/A
Malformation syndrome,3363,Trichomegaly-retina pigmentary degeneration-dwarfism syndrome,Point prevalence,N/A
Disease,275761,Lysosomal acid lipase deficiency,Prevalence at birth,N/A
Disease,275761,Lysosomal acid lipase deficiency,Point prevalence,N/A
Morphological anomaly,3366,Non-syndromic metopic craniosynostosis,Prevalence at birth,N/A
Morphological anomaly,3366,Non-syndromic metopic craniosynostosis,Point prevalence,N/A
Malformation syndrome,3365,Trigonocephaly-broad thumbs syndrome,Cases/families,N/A
Malformation syndrome,3365,Trigonocephaly-broad thumbs syndrome,Point prevalence,N/A
Disease,582,Mucopolysaccharidosis type 4,Prevalence at birth,N/A
Disease,582,Mucopolysaccharidosis type 4,Prevalence at birth,N/A
Disease,582,Mucopolysaccharidosis type 4,Point prevalence,N/A
Disease,582,Mucopolysaccharidosis type 4,Prevalence at birth,N/A
Disease,582,Mucopolysaccharidosis type 4,Point prevalence,N/A
Disease,582,Mucopolysaccharidosis type 4,Prevalence at birth,N/A
Disease,582,Mucopolysaccharidosis type 4,Prevalence at birth,N/A
Disease,582,Mucopolysaccharidosis type 4,Prevalence at birth,N/A
Disease,582,Mucopolysaccharidosis type 4,Prevalence at birth,N/A
Disease,582,Mucopolysaccharidosis type 4,Prevalence at birth,N/A
Disease,582,Mucopolysaccharidosis type 4,Prevalence at birth,N/A
Disease,582,Mucopolysaccharidosis type 4,Point prevalence,N/A
Disease,582,Mucopolysaccharidosis type 4,Prevalence at birth,N/A
Disease,582,Mucopolysaccharidosis type 4,Prevalence at birth,N/A
Disease,582,Mucopolysaccharidosis type 4,Prevalence at birth,N/A
Disease,582,Mucopolysaccharidosis type 4,Prevalence at birth,N/A
Disease,582,Mucopolysaccharidosis type 4,Prevalence at birth,N/A
Disease,582,Mucopolysaccharidosis type 4,Prevalence at birth,N/A
Disease,582,Mucopolysaccharidosis type 4,Point prevalence,N/A
Disease,582,Mucopolysaccharidosis type 4,Prevalence at birth,N/A
Disease,582,Mucopolysaccharidosis type 4,Prevalence at birth,N/A
Malformation syndrome,3361,Trichodysplasia-xeroderma syndrome,Cases/families,N/A
Malformation syndrome,3361,Trichodysplasia-xeroderma syndrome,Point prevalence,N/A
Malformation syndrome,3408,Upington disease,Cases/families,N/A
Malformation syndrome,3408,Upington disease,Point prevalence,N/A
Malformation syndrome,3409,Urban-Rogers-Meyer syndrome,Cases/families,N/A
Malformation syndrome,3409,Urban-Rogers-Meyer syndrome,Point prevalence,N/A
Disease,186,Primary biliary cholangitis,Annual incidence,N/A
Disease,186,Primary biliary cholangitis,Point prevalence,N/A
Disease,186,Primary biliary cholangitis,Annual incidence,N/A
Disease,186,Primary biliary cholangitis,Point prevalence,N/A
Disease,186,Primary biliary cholangitis,Annual incidence,N/A
Disease,186,Primary biliary cholangitis,Annual incidence,N/A
Disease,186,Primary biliary cholangitis,Point prevalence,N/A
Disease,186,Primary biliary cholangitis,Annual incidence,N/A
Disease,186,Primary biliary cholangitis,Point prevalence,N/A
Disease,186,Primary biliary cholangitis,Annual incidence,N/A
Disease,186,Primary biliary cholangitis,Point prevalence,N/A
Disease,186,Primary biliary cholangitis,Annual incidence,N/A
Disease,186,Primary biliary cholangitis,Point prevalence,N/A
Disease,186,Primary biliary cholangitis,Annual incidence,N/A
Disease,186,Primary biliary cholangitis,Point prevalence,N/A
Disease,186,Primary biliary cholangitis,Point prevalence,N/A
Disease,186,Primary biliary cholangitis,Annual incidence,N/A
Disease,186,Primary biliary cholangitis,Point prevalence,N/A
Disease,186,Primary biliary cholangitis,Annual incidence,N/A
Disease,186,Primary biliary cholangitis,Point prevalence,N/A
Disease,186,Primary biliary cholangitis,Point prevalence,N/A
Disease,186,Primary biliary cholangitis,Point prevalence,N/A
Disease,186,Primary biliary cholangitis,Point prevalence,N/A
Disease,186,Primary biliary cholangitis,Annual incidence,N/A
Disease,186,Primary biliary cholangitis,Point prevalence,N/A
Disease,186,Primary biliary cholangitis,Point prevalence,N/A
Disease,186,Primary biliary cholangitis,Annual incidence,N/A
Disease,186,Primary biliary cholangitis,Annual incidence,N/A
Disease,397,Giant cell arteritis,Point prevalence,N/A
Disease,397,Giant cell arteritis,Annual incidence,N/A
Disease,397,Giant cell arteritis,Annual incidence,N/A
Disease,397,Giant cell arteritis,Annual incidence,N/A
Disease,397,Giant cell arteritis,Annual incidence,N/A
Disease,397,Giant cell arteritis,Point prevalence,N/A
Disease,397,Giant cell arteritis,Point prevalence,N/A
Disease,397,Giant cell arteritis,Annual incidence,N/A
Disease,2932,Chronic inflammatory demyelinating polyneuropathy,Point prevalence,N/A
Disease,2932,Chronic inflammatory demyelinating polyneuropathy,Annual incidence,N/A
Disease,2932,Chronic inflammatory demyelinating polyneuropathy,Point prevalence,N/A
Disease,2932,Chronic inflammatory demyelinating polyneuropathy,Point prevalence,N/A
Disease,2932,Chronic inflammatory demyelinating polyneuropathy,Point prevalence,N/A
Disease,2932,Chronic inflammatory demyelinating polyneuropathy,Point prevalence,N/A
Disease,2932,Chronic inflammatory demyelinating polyneuropathy,Annual incidence,N/A
Disease,2932,Chronic inflammatory demyelinating polyneuropathy,Point prevalence,N/A
Disease,2932,Chronic inflammatory demyelinating polyneuropathy,Annual incidence,N/A
Disease,2932,Chronic inflammatory demyelinating polyneuropathy,Point prevalence,N/A
Disease,2398,Multiple symmetric lipomatosis,Point prevalence,N/A
Disease,2398,Multiple symmetric lipomatosis,Point prevalence,N/A
Morphological anomaly,3384,Common arterial trunk,Prevalence at birth,N/A
Morphological anomaly,3384,Common arterial trunk,Prevalence at birth,N/A
Morphological anomaly,3384,Common arterial trunk,Prevalence at birth,N/A
Morphological anomaly,3384,Common arterial trunk,Prevalence at birth,N/A
Morphological anomaly,3384,Common arterial trunk,Prevalence at birth,N/A
Morphological anomaly,3384,Common arterial trunk,Prevalence at birth,N/A
Morphological anomaly,3384,Common arterial trunk,Prevalence at birth,N/A
Morphological anomaly,3384,Common arterial trunk,Prevalence at birth,N/A
Morphological anomaly,3384,Common arterial trunk,Prevalence at birth,N/A
Morphological anomaly,3384,Common arterial trunk,Prevalence at birth,N/A
Morphological anomaly,3384,Common arterial trunk,Prevalence at birth,N/A
Morphological anomaly,3384,Common arterial trunk,Prevalence at birth,N/A
Morphological anomaly,3384,Common arterial trunk,Prevalence at birth,N/A
Morphological anomaly,3384,Common arterial trunk,Prevalence at birth,N/A
Morphological anomaly,3384,Common arterial trunk,Prevalence at birth,N/A
Morphological anomaly,3384,Common arterial trunk,Point prevalence,N/A
Disease,3198,Stiff person spectrum disorder,Point prevalence,N/A
Disease,3198,Stiff person spectrum disorder,Point prevalence,N/A
Disease,3198,Stiff person spectrum disorder,Point prevalence,N/A
Disease,275944,Hemolytic disease of the newborn with Kell alloimmunization,Annual incidence,N/A
Disease,275944,Hemolytic disease of the newborn with Kell alloimmunization,Point prevalence,N/A
Category,3388,Neural tube defect,Prevalence at birth,N/A
Category,3388,Neural tube defect,Prevalence at birth,N/A
Category,3388,Neural tube defect,Prevalence at birth,N/A
Category,3388,Neural tube defect,Prevalence at birth,N/A
Category,3388,Neural tube defect,Prevalence at birth,N/A
Category,3388,Neural tube defect,Prevalence at birth,N/A
Category,3388,Neural tube defect,Prevalence at birth,N/A
Category,3388,Neural tube defect,Prevalence at birth,N/A
Category,3388,Neural tube defect,Prevalence at birth,N/A
Category,3388,Neural tube defect,Prevalence at birth,N/A
Category,3388,Neural tube defect,Prevalence at birth,N/A
Category,3388,Neural tube defect,Prevalence at birth,N/A
Category,3388,Neural tube defect,Prevalence at birth,N/A
Category,3388,Neural tube defect,Prevalence at birth,N/A
Category,3388,Neural tube defect,Prevalence at birth,N/A
Category,3388,Neural tube defect,Prevalence at birth,N/A
Category,3388,Neural tube defect,Prevalence at birth,N/A
Category,3388,Neural tube defect,Prevalence at birth,N/A
Category,3388,Neural tube defect,Prevalence at birth,N/A
Category,3388,Neural tube defect,Prevalence at birth,N/A
Category,3388,Neural tube defect,Prevalence at birth,N/A
Category,3388,Neural tube defect,Prevalence at birth,N/A
Category,3388,Neural tube defect,Prevalence at birth,N/A
Malformation syndrome,1723,Mosaic trisomy 2 syndrome,Cases/families,N/A
Malformation syndrome,1723,Mosaic trisomy 2 syndrome,Point prevalence,N/A
Clinical group,275828,Pulmonary arterial hypertension associated with chronic hemolytic anemia,Point prevalence,N/A
Malformation syndrome,1724,Mosaic trisomy 20 syndrome,Point prevalence,N/A
Malformation syndrome,1747,Mosaic trisomy 7 syndrome,Cases/families,N/A
Malformation syndrome,1747,Mosaic trisomy 7 syndrome,Point prevalence,N/A
Malformation syndrome,3329,Tibial aplasia-ectrodactyly syndrome,Point prevalence,N/A
Malformation syndrome,3328,Absent tibia-polydactyly-arachnoid cyst syndrome,Cases/families,N/A
Malformation syndrome,3328,Absent tibia-polydactyly-arachnoid cyst syndrome,Point prevalence,N/A
Malformation syndrome,3327,Thyrocerebrorenal syndrome,Cases/families,N/A
Malformation syndrome,3327,Thyrocerebrorenal syndrome,Point prevalence,N/A
Malformation syndrome,3326,Thymic-renal-anal-lung dysplasia,Cases/families,N/A
Malformation syndrome,3326,Thymic-renal-anal-lung dysplasia,Point prevalence,N/A
Disease,3322,Hoyeraal-Hreidarsson syndrome,Point prevalence,N/A
Disease,3322,Hoyeraal-Hreidarsson syndrome,Cases/families,N/A
Malformation syndrome,3317,Thoracolaryngopelvic dysplasia,Cases/families,N/A
Malformation syndrome,3317,Thoracolaryngopelvic dysplasia,Point prevalence,N/A
Malformation syndrome,3316,Thomas syndrome,Cases/families,N/A
Malformation syndrome,3316,Thomas syndrome,Point prevalence,N/A
Disease,3314,"Thiemann disease, familial form",Cases/families,N/A
Disease,3314,"Thiemann disease, familial form",Point prevalence,N/A
Malformation syndrome,3355,Trichoodontoonychial dysplasia,Cases/families,N/A
Malformation syndrome,3355,Trichoodontoonychial dysplasia,Point prevalence,N/A
Disease,275555,Preeclampsia,Point prevalence,N/A
Malformation syndrome,275543,L1 syndrome,Point prevalence,N/A
Disease,1489,Whooping cough,Annual incidence,N/A
Disease,1489,Whooping cough,Annual incidence,N/A
Disease,1489,Whooping cough,Annual incidence,N/A
Disease,1489,Whooping cough,Annual incidence,N/A
Disease,1489,Whooping cough,Annual incidence,N/A
Disease,1489,Whooping cough,Annual incidence,N/A
Disease,1489,Whooping cough,Annual incidence,N/A
Disease,1489,Whooping cough,Annual incidence,N/A
Disease,1489,Whooping cough,Annual incidence,N/A
Disease,1489,Whooping cough,Annual incidence,N/A
Disease,1489,Whooping cough,Annual incidence,N/A
Disease,1489,Whooping cough,Annual incidence,N/A
Disease,1489,Whooping cough,Annual incidence,N/A
Disease,1489,Whooping cough,Annual incidence,N/A
Disease,1489,Whooping cough,Annual incidence,N/A
Disease,1489,Whooping cough,Annual incidence,N/A
Disease,1489,Whooping cough,Annual incidence,N/A
Disease,1489,Whooping cough,Annual incidence,N/A
Disease,1489,Whooping cough,Annual incidence,N/A
Disease,1489,Whooping cough,Annual incidence,N/A
Disease,1489,Whooping cough,Annual incidence,N/A
Disease,1489,Whooping cough,Annual incidence,N/A
Disease,1489,Whooping cough,Annual incidence,N/A
Disease,1489,Whooping cough,Annual incidence,N/A
Disease,1489,Whooping cough,Annual incidence,N/A
Disease,1489,Whooping cough,Annual incidence,N/A
Disease,1489,Whooping cough,Annual incidence,N/A
Disease,1489,Whooping cough,Annual incidence,N/A
Disease,1489,Whooping cough,Annual incidence,N/A
Disease,1489,Whooping cough,Annual incidence,N/A
Disease,2764,Osteochondritis dissecans,Point prevalence,N/A
Clinical group,3389,Tuberculosis,Annual incidence,N/A
Clinical group,3389,Tuberculosis,Annual incidence,N/A
Clinical group,3389,Tuberculosis,Annual incidence,N/A
Clinical group,3389,Tuberculosis,Annual incidence,N/A
Clinical group,3389,Tuberculosis,Annual incidence,N/A
Clinical group,3389,Tuberculosis,Annual incidence,N/A
Clinical group,3389,Tuberculosis,Annual incidence,N/A
Clinical group,3389,Tuberculosis,Annual incidence,N/A
Clinical group,3389,Tuberculosis,Annual incidence,N/A
Clinical group,3389,Tuberculosis,Annual incidence,N/A
Clinical group,3389,Tuberculosis,Annual incidence,N/A
Clinical group,3389,Tuberculosis,Annual incidence,N/A
Clinical group,3389,Tuberculosis,Annual incidence,N/A
Clinical group,3389,Tuberculosis,Annual incidence,N/A
Clinical group,3389,Tuberculosis,Annual incidence,N/A
Clinical group,3389,Tuberculosis,Annual incidence,N/A
Clinical group,3389,Tuberculosis,Point prevalence,N/A
Clinical group,3389,Tuberculosis,Annual incidence,N/A
Clinical group,3389,Tuberculosis,Annual incidence,N/A
Clinical group,3389,Tuberculosis,Annual incidence,N/A
Clinical group,3389,Tuberculosis,Annual incidence,N/A
Clinical group,3389,Tuberculosis,Annual incidence,N/A
Clinical group,3389,Tuberculosis,Annual incidence,N/A
Clinical group,3389,Tuberculosis,Annual incidence,N/A
Clinical group,3389,Tuberculosis,Annual incidence,N/A
Clinical group,3389,Tuberculosis,Annual incidence,N/A
Clinical group,3389,Tuberculosis,Annual incidence,N/A
Clinical group,3389,Tuberculosis,Annual incidence,N/A
Clinical group,3389,Tuberculosis,Annual incidence,N/A
Clinical group,3389,Tuberculosis,Annual incidence,N/A
Clinical group,3389,Tuberculosis,Annual incidence,N/A
Clinical group,3389,Tuberculosis,Annual incidence,N/A
Clinical group,3389,Tuberculosis,Annual incidence,N/A
Clinical group,3389,Tuberculosis,Annual incidence,N/A
Clinical group,3389,Tuberculosis,Annual incidence,N/A
Clinical group,3389,Tuberculosis,Annual incidence,N/A
Clinical group,3389,Tuberculosis,Annual incidence,N/A
Clinical group,3389,Tuberculosis,Annual incidence,N/A
Clinical group,3389,Tuberculosis,Annual incidence,N/A
Clinical group,3389,Tuberculosis,Annual incidence,N/A
Disease,1679,Diphtheria,Annual incidence,N/A
Disease,279943,Hereditary neutrophilia,Cases/families,N/A
Disease,279943,Hereditary neutrophilia,Point prevalence,N/A
Disease,279934,"Mitochondrial DNA depletion syndrome, hepatocerebral form due to DGUOK deficiency",Point prevalence,N/A
Disease,279934,"Mitochondrial DNA depletion syndrome, hepatocerebral form due to DGUOK deficiency",Cases/families,N/A
Malformation syndrome,3152,Sclerosteosis,Cases/families,N/A
Malformation syndrome,3152,Sclerosteosis,Point prevalence,N/A
Disease,280142,Severe combined immunodeficiency due to LCK deficiency,Cases/families,N/A
Disease,280142,Severe combined immunodeficiency due to LCK deficiency,Point prevalence,N/A
Malformation syndrome,3164,"Omphalocele syndrome, Shprintzen-Goldberg type",Cases/families,N/A
Malformation syndrome,3164,"Omphalocele syndrome, Shprintzen-Goldberg type",Point prevalence,N/A
Malformation syndrome,3168,Sillence syndrome,Cases/families,N/A
Malformation syndrome,3168,Sillence syndrome,Point prevalence,N/A
Disease,280133,Complement component 3 deficiency,Cases/families,N/A
Disease,280133,Complement component 3 deficiency,Point prevalence,N/A
Clinical group,2103,Guillain-Barr syndrome,Annual incidence,N/A
Clinical group,2103,Guillain-Barr syndrome,Annual incidence,N/A
Clinical group,2103,Guillain-Barr syndrome,Point prevalence,N/A
Clinical group,2103,Guillain-Barr syndrome,Point prevalence,N/A
Clinical group,2103,Guillain-Barr syndrome,Annual incidence,N/A
Clinical group,2103,Guillain-Barr syndrome,Point prevalence,N/A
Clinical group,2103,Guillain-Barr syndrome,Annual incidence,N/A
Disease,3156,Senior-Loken syndrome,Point prevalence,N/A
Category,183669,Agammaglobulinemia,Point prevalence,N/A
Category,183669,Agammaglobulinemia,Point prevalence,N/A
Category,183669,Agammaglobulinemia,Point prevalence,N/A
Category,183669,Agammaglobulinemia,Point prevalence,N/A
Category,183669,Agammaglobulinemia,Point prevalence,N/A
Category,183669,Agammaglobulinemia,Point prevalence,N/A
Category,183669,Agammaglobulinemia,Point prevalence,N/A
Category,183669,Agammaglobulinemia,Point prevalence,N/A
Category,183669,Agammaglobulinemia,Point prevalence,N/A
Malformation syndrome,3180,Spondylocamptodactyly syndrome,Cases/families,N/A
Malformation syndrome,3180,Spondylocamptodactyly syndrome,Point prevalence,N/A
Clinical subtype,280210,"Pelizaeus-Merzbacher disease, connatal form",Point prevalence,N/A
Clinical subtype,280219,"Pelizaeus-Merzbacher disease, classic form",Point prevalence,N/A
Malformation syndrome,280200,Microform holoprosencephaly,Point prevalence,N/A
Clinical subtype,183678,Hermansky-Pudlak syndrome due to AP-3 deficiency,Cases/families,N/A
Clinical subtype,183678,Hermansky-Pudlak syndrome due to AP-3 deficiency,Point prevalence,N/A
Disease,449,Hepatoblastoma,Annual incidence,N/A
Disease,449,Hepatoblastoma,Annual incidence,N/A
Disease,449,Hepatoblastoma,Annual incidence,N/A
Disease,449,Hepatoblastoma,Annual incidence,N/A
Disease,449,Hepatoblastoma,Annual incidence,N/A
Disease,449,Hepatoblastoma,Annual incidence,N/A
Disease,449,Hepatoblastoma,Annual incidence,N/A
Disease,449,Hepatoblastoma,Annual incidence,N/A
Disease,449,Hepatoblastoma,Annual incidence,N/A
Disease,449,Hepatoblastoma,Annual incidence,N/A
Disease,449,Hepatoblastoma,Annual incidence,N/A
Disease,449,Hepatoblastoma,Annual incidence,N/A
Disease,449,Hepatoblastoma,Annual incidence,N/A
Disease,449,Hepatoblastoma,Annual incidence,N/A
Disease,449,Hepatoblastoma,Annual incidence,N/A
Disease,449,Hepatoblastoma,Annual incidence,N/A
Disease,449,Hepatoblastoma,Annual incidence,N/A
Disease,449,Hepatoblastoma,Annual incidence,N/A
Disease,449,Hepatoblastoma,Annual incidence,N/A
Disease,449,Hepatoblastoma,Annual incidence,N/A
Disease,449,Hepatoblastoma,Annual incidence,N/A
Disease,449,Hepatoblastoma,Annual incidence,N/A
Disease,449,Hepatoblastoma,Annual incidence,N/A
Clinical subtype,280234,Null syndrome,Point prevalence,N/A
Malformation syndrome,1855,Spondyloenchondrodysplasia,Cases/families,N/A
Malformation syndrome,1855,Spondyloenchondrodysplasia,Point prevalence,N/A
Clinical subtype,280224,"Pelizaeus-Merzbacher disease, transitional form",Point prevalence,N/A
Malformation syndrome,1797,Autosomal dominant spondylocostal dysostosis,Point prevalence,N/A
Clinical subtype,280229,Pelizaeus-Merzbacher disease in female carriers,Point prevalence,N/A
Disease,276580,Autosomal dominant hyperinsulinism due to Kir6.2 deficiency,Point prevalence,N/A
Disease,533,Listeriosis,Point prevalence,N/A
Disease,533,Listeriosis,Annual incidence,N/A
Disease,533,Listeriosis,Annual incidence,N/A
Disease,533,Listeriosis,Annual incidence,N/A
Disease,533,Listeriosis,Annual incidence,N/A
Disease,533,Listeriosis,Annual incidence,N/A
Disease,533,Listeriosis,Annual incidence,N/A
Disease,533,Listeriosis,Annual incidence,N/A
Disease,533,Listeriosis,Annual incidence,N/A
Disease,533,Listeriosis,Annual incidence,N/A
Disease,533,Listeriosis,Annual incidence,N/A
Disease,533,Listeriosis,Annual incidence,N/A
Disease,533,Listeriosis,Annual incidence,N/A
Disease,533,Listeriosis,Annual incidence,N/A
Disease,533,Listeriosis,Annual incidence,N/A
Disease,533,Listeriosis,Annual incidence,N/A
Disease,533,Listeriosis,Annual incidence,N/A
Disease,533,Listeriosis,Annual incidence,N/A
Disease,533,Listeriosis,Annual incidence,N/A
Disease,533,Listeriosis,Annual incidence,N/A
Disease,533,Listeriosis,Annual incidence,N/A
Disease,533,Listeriosis,Annual incidence,N/A
Disease,533,Listeriosis,Annual incidence,N/A
Disease,533,Listeriosis,Annual incidence,N/A
Disease,533,Listeriosis,Annual incidence,N/A
Disease,533,Listeriosis,Annual incidence,N/A
Disease,533,Listeriosis,Annual incidence,N/A
Disease,533,Listeriosis,Annual incidence,N/A
Disease,533,Listeriosis,Annual incidence,N/A
Disease,533,Listeriosis,Annual incidence,N/A
Disease,533,Listeriosis,Annual incidence,N/A
Disease,533,Listeriosis,Annual incidence,N/A
Disease,533,Listeriosis,Annual incidence,N/A
Disease,533,Listeriosis,Annual incidence,N/A
Malformation syndrome,3268,Radioulnar synostosis-microcephaly-scoliosis syndrome,Cases/families,N/A
Malformation syndrome,3268,Radioulnar synostosis-microcephaly-scoliosis syndrome,Point prevalence,N/A
Disease,683,Progressive supranuclear palsy,Annual incidence,N/A
Disease,683,Progressive supranuclear palsy,Point prevalence,N/A
Disease,683,Progressive supranuclear palsy,Point prevalence,N/A
Disease,683,Progressive supranuclear palsy,Point prevalence,N/A
Disease,683,Progressive supranuclear palsy,Point prevalence,N/A
Disease,683,Progressive supranuclear palsy,Point prevalence,N/A
Disease,683,Progressive supranuclear palsy,Point prevalence,N/A
Disease,683,Progressive supranuclear palsy,Annual incidence,N/A
Disease,683,Progressive supranuclear palsy,Annual incidence,N/A
Disease,683,Progressive supranuclear palsy,Annual incidence,N/A
Disease,677,Pancreatoblastoma,Cases/families,N/A
Disease,677,Pancreatoblastoma,Annual incidence,N/A
Disease,677,Pancreatoblastoma,Point prevalence,N/A
Disease,677,Pancreatoblastoma,Annual incidence,N/A
Disease,677,Pancreatoblastoma,Annual incidence,N/A
Disease,677,Pancreatoblastoma,Annual incidence,N/A
Disease,677,Pancreatoblastoma,Annual incidence,N/A
Disease,677,Pancreatoblastoma,Annual incidence,N/A
Disease,677,Pancreatoblastoma,Annual incidence,N/A
Disease,677,Pancreatoblastoma,Annual incidence,N/A
Disease,677,Pancreatoblastoma,Annual incidence,N/A
Disease,677,Pancreatoblastoma,Annual incidence,N/A
Disease,677,Pancreatoblastoma,Annual incidence,N/A
Clinical group,183660,Severe combined immunodeficiency,Prevalence at birth,N/A
Clinical group,183660,Severe combined immunodeficiency,Prevalence at birth,N/A
Clinical group,183660,Severe combined immunodeficiency,Prevalence at birth,N/A
Clinical group,183660,Severe combined immunodeficiency,Prevalence at birth,N/A
Clinical group,183660,Severe combined immunodeficiency,Prevalence at birth,N/A
Clinical group,183660,Severe combined immunodeficiency,Prevalence at birth,N/A
Clinical group,183660,Severe combined immunodeficiency,Point prevalence,N/A
Clinical group,183660,Severe combined immunodeficiency,Prevalence at birth,N/A
Clinical group,183660,Severe combined immunodeficiency,Prevalence at birth,N/A
Disease,279894,Toxic maculopathy due to antimalarial drugs,Point prevalence,N/A
Malformation syndrome,808,Seckel syndrome,Cases/families,N/A
Malformation syndrome,808,Seckel syndrome,Point prevalence,N/A
Malformation syndrome,808,Seckel syndrome,Prevalence at birth,N/A
Disease,844,Lown-Ganong-Levine syndrome,Cases/families,N/A
Disease,844,Lown-Ganong-Levine syndrome,Point prevalence,N/A
Malformation syndrome,3304,Fallot complex-intellectual disability-growth delay syndrome,Cases/families,N/A
Malformation syndrome,3304,Fallot complex-intellectual disability-growth delay syndrome,Point prevalence,N/A
Disease,676,Hereditary chronic pancreatitis,Point prevalence,N/A
Disease,676,Hereditary chronic pancreatitis,Point prevalence,N/A
Disease,676,Hereditary chronic pancreatitis,Point prevalence,N/A
Disease,276198,Spinocerebellar ataxia type 36,Cases/families,N/A
Disease,276198,Spinocerebellar ataxia type 36,Point prevalence,N/A
Disease,634,Netherton syndrome,Prevalence at birth,N/A
Disease,634,Netherton syndrome,Point prevalence,N/A
Malformation syndrome,140,Campomelic dysplasia,Point prevalence,N/A
Malformation syndrome,140,Campomelic dysplasia,Prevalence at birth,N/A
Malformation syndrome,3224,Deafness-genital anomalies-metacarpal and metatarsal synostosis syndrome,Cases/families,N/A
Malformation syndrome,3224,Deafness-genital anomalies-metacarpal and metatarsal synostosis syndrome,Point prevalence,N/A
Disease,276174,Idiopathic recurrent stupor,Point prevalence,N/A
Disease,642,Hereditary sensory and autonomic neuropathy type 4,Point prevalence,N/A
Disease,642,Hereditary sensory and autonomic neuropathy type 4,Point prevalence,N/A
Malformation syndrome,627,Nance-Horan syndrome,Cases/families,N/A
Malformation syndrome,627,Nance-Horan syndrome,Point prevalence,N/A
Malformation syndrome,3230,Deafness-oligodontia syndrome,Point prevalence,N/A
Malformation syndrome,3230,Deafness-oligodontia syndrome,Cases/families,N/A
Disease,326,Congenital factor V deficiency,Point prevalence,N/A
Clinical subtype,276244,Machado-Joseph disease type 3,Point prevalence,N/A
Disease,650,LCAT deficiency,Cases/families,N/A
Disease,650,LCAT deficiency,Point prevalence,N/A
Malformation syndrome,3235,Progressive deafness with stapes fixation,Point prevalence,N/A
Malformation syndrome,3236,Conductive deafness-ptosis-skeletal anomalies syndrome,Cases/families,N/A
Malformation syndrome,3236,Conductive deafness-ptosis-skeletal anomalies syndrome,Point prevalence,N/A
Disease,342,Familial Mediterranean fever,Point prevalence,N/A
Disease,342,Familial Mediterranean fever,Point prevalence,N/A
Disease,342,Familial Mediterranean fever,Point prevalence,N/A
Disease,342,Familial Mediterranean fever,Point prevalence,N/A
Disease,342,Familial Mediterranean fever,Point prevalence,N/A
Disease,342,Familial Mediterranean fever,Annual incidence,N/A
Malformation syndrome,3241,Deafness-craniofacial syndrome,Cases/families,N/A
Malformation syndrome,3241,Deafness-craniofacial syndrome,Point prevalence,N/A
Clinical group,754,Androgen insensitivity syndrome,Prevalence at birth,N/A
Clinical group,754,Androgen insensitivity syndrome,Point prevalence,N/A
Clinical group,754,Androgen insensitivity syndrome,Prevalence at birth,N/A
Clinical group,754,Androgen insensitivity syndrome,Annual incidence,N/A
Clinical group,253,Spondyloepiphyseal dysplasia and spondyloepimetaphyseal dysplasia,Point prevalence,N/A
Disease,327,Congenital factor VII deficiency,Point prevalence,N/A
Malformation syndrome,3238,Cardiospondylocarpofacial syndrome,Cases/families,N/A
Malformation syndrome,3238,Cardiospondylocarpofacial syndrome,Point prevalence,N/A
Malformation syndrome,373,Simpson-Golabi-Behmel syndrome,Point prevalence,N/A
Malformation syndrome,373,Simpson-Golabi-Behmel syndrome,Cases/families,N/A
Malformation syndrome,3246,Symphalangism with multiple anomalies of hands and feet,Cases/families,N/A
Malformation syndrome,3246,Symphalangism with multiple anomalies of hands and feet,Point prevalence,N/A
Malformation syndrome,574,21q deletion syndrome,Cases/families,N/A
Malformation syndrome,574,21q deletion syndrome,Point prevalence,N/A
Malformation syndrome,3242,Renpenning syndrome,Cases/families,N/A
Malformation syndrome,3242,Renpenning syndrome,Point prevalence,N/A
Disease,146,Differentiated thyroid carcinoma,Annual incidence,N/A
Disease,146,Differentiated thyroid carcinoma,Annual incidence,N/A
Disease,146,Differentiated thyroid carcinoma,Point prevalence,N/A
Disease,1331,Familial prostate cancer,Annual incidence,N/A
Malformation syndrome,3250,Proximal symphalangism,Point prevalence,N/A
Morphological anomaly,3248,Isolated distal symphalangism,Cases/families,N/A
Morphological anomaly,3248,Isolated distal symphalangism,Point prevalence,N/A
Malformation syndrome,276422,10q22.3q23.3 microduplication syndrome,Point prevalence,N/A
Disease,276429,Hypnic headache,Point prevalence,N/A
Malformation syndrome,1446,Ring chromosome 22 syndrome,Cases/families,N/A
Malformation syndrome,1446,Ring chromosome 22 syndrome,Point prevalence,N/A
Disease,276556,Hyperinsulinism due to UCP2 deficiency,Cases/families,N/A
Disease,276556,Hyperinsulinism due to UCP2 deficiency,Point prevalence,N/A
Malformation syndrome,276432,Ogden syndrome,Cases/families,N/A
Malformation syndrome,276432,Ogden syndrome,Point prevalence,N/A
Malformation syndrome,475,Joubert syndrome,Point prevalence,N/A
Malformation syndrome,475,Joubert syndrome,Prevalence at birth,N/A
Malformation syndrome,475,Joubert syndrome,Point prevalence,N/A
Malformation syndrome,475,Joubert syndrome,Prevalence at birth,N/A
Disease,276435,Lower motor neuron syndrome with late-adult onset,Cases/families,N/A
Disease,276435,Lower motor neuron syndrome with late-adult onset,Point prevalence,N/A
Disease,911,Combined immunodeficiency due to ZAP70 deficiency,Point prevalence,N/A
Disease,113,Bazex-Dupr-Christol syndrome,Cases/families,N/A
Disease,113,Bazex-Dupr-Christol syndrome,Point prevalence,N/A
Disease,746,Mitochondrial trifunctional protein deficiency,Cases/families,N/A
Disease,746,Mitochondrial trifunctional protein deficiency,Point prevalence,N/A
Disease,746,Mitochondrial trifunctional protein deficiency,Point prevalence,N/A
Disease,943,Malonic aciduria,Cases/families,N/A
Disease,943,Malonic aciduria,Point prevalence,N/A
Disease,621,Hereditary methemoglobinemia,Point prevalence,N/A
Disease,2089,Glycogen storage disease due to hepatic glycogen synthase deficiency,Cases/families,N/A
Disease,2089,Glycogen storage disease due to hepatic glycogen synthase deficiency,Point prevalence,N/A
Disease,412,Dysbetalipoproteinemia,Point prevalence,N/A
Disease,412,Dysbetalipoproteinemia,Point prevalence,N/A
Disease,743,Severe hereditary thrombophilia due to congenital protein S deficiency,Point prevalence,N/A
Disease,743,Severe hereditary thrombophilia due to congenital protein S deficiency,Prevalence at birth,N/A
Category,182130,Tumor of endocrine glands,Annual incidence,N/A
Category,182130,Tumor of endocrine glands,Point prevalence,N/A
Disease,528,Congenital generalized lipodystrophy,Point prevalence,N/A
Disease,528,Congenital generalized lipodystrophy,Point prevalence,N/A
Disease,528,Congenital generalized lipodystrophy,Point prevalence,N/A
Disease,528,Congenital generalized lipodystrophy,Point prevalence,N/A
Disease,528,Congenital generalized lipodystrophy,Point prevalence,N/A
Disease,528,Congenital generalized lipodystrophy,Point prevalence,N/A
Disease,528,Congenital generalized lipodystrophy,Prevalence at birth,N/A
Disease,528,Congenital generalized lipodystrophy,Point prevalence,N/A
Disease,528,Congenital generalized lipodystrophy,Point prevalence,N/A
Disease,528,Congenital generalized lipodystrophy,Point prevalence,N/A
Disease,275,Severe combined immunodeficiency due to DCLRE1C deficiency,Point prevalence,N/A
Category,182090,Pulmonary arterial hypertension,Point prevalence,N/A
Category,182090,Pulmonary arterial hypertension,Point prevalence,N/A
Category,182090,Pulmonary arterial hypertension,Annual incidence,N/A
Category,182090,Pulmonary arterial hypertension,Point prevalence,N/A
Category,182090,Pulmonary arterial hypertension,Annual incidence,N/A
Category,182090,Pulmonary arterial hypertension,Point prevalence,N/A
Category,182090,Pulmonary arterial hypertension,Annual incidence,N/A
Category,182090,Pulmonary arterial hypertension,Point prevalence,N/A
Category,182090,Pulmonary arterial hypertension,Point prevalence,N/A
Category,182090,Pulmonary arterial hypertension,Annual incidence,N/A
Category,182090,Pulmonary arterial hypertension,Annual incidence,N/A
Category,182090,Pulmonary arterial hypertension,Point prevalence,N/A
Category,182095,Interstitial lung disease,Annual incidence,N/A
Category,182095,Interstitial lung disease,Annual incidence,N/A
Category,182095,Interstitial lung disease,Annual incidence,N/A
Category,182095,Interstitial lung disease,Annual incidence,N/A
Category,182095,Interstitial lung disease,Point prevalence,N/A
Malformation syndrome,184,Cherubism,Point prevalence,N/A
Malformation syndrome,184,Cherubism,Cases/families,N/A
Category,1047,Sideroblastic anemia,Point prevalence,N/A
Disease,71,Chylomicron retention disease,Cases/families,N/A
Disease,71,Chylomicron retention disease,Point prevalence,N/A
Clinical group,182067,Glial tumor,Annual incidence,N/A
Clinical group,182067,Glial tumor,Point prevalence,N/A
Clinical group,182067,Glial tumor,Annual incidence,N/A
Clinical group,182067,Glial tumor,Annual incidence,N/A
Clinical group,182067,Glial tumor,Annual incidence,N/A
Disease,1949,Self-limited neonatal epilepsy,Cases/families,N/A
Disease,1949,Self-limited neonatal epilepsy,Point prevalence,N/A
Disease,189,Hidrotic ectodermal dysplasia,Point prevalence,N/A
Malformation syndrome,1473,Uveal coloboma-cleft lip and palate-intellectual disability,Cases/families,N/A
Malformation syndrome,1473,Uveal coloboma-cleft lip and palate-intellectual disability,Point prevalence,N/A
Disease,820,Sneddon syndrome,Annual incidence,N/A
Disease,820,Sneddon syndrome,Point prevalence,N/A
Disease,182050,MYH9-related disease,Point prevalence,N/A
Disease,182050,MYH9-related disease,Point prevalence,N/A
Disease,1945,Self-limited epilepsy with centrotemporal spikes,Point prevalence,N/A
Disease,1945,Self-limited epilepsy with centrotemporal spikes,Annual incidence,N/A
Malformation syndrome,709,Peters plus syndrome,Cases/families,N/A
Malformation syndrome,709,Peters plus syndrome,Point prevalence,N/A
Malformation syndrome,776,Lujan-Fryns syndrome,Point prevalence,N/A
Disease,902,Werner syndrome,Point prevalence,N/A
Disease,902,Werner syndrome,Point prevalence,N/A
Disease,902,Werner syndrome,Point prevalence,N/A
Disease,902,Werner syndrome,Point prevalence,N/A
Disease,20,3-hydroxy-3-methylglutaric aciduria,Point prevalence,N/A
Disease,20,3-hydroxy-3-methylglutaric aciduria,Prevalence at birth,N/A
Disease,20,3-hydroxy-3-methylglutaric aciduria,Prevalence at birth,N/A
Disease,20,3-hydroxy-3-methylglutaric aciduria,Prevalence at birth,N/A
Disease,712,Hemolytic anemia due to glucophosphate isomerase deficiency,Cases/families,N/A
Disease,712,Hemolytic anemia due to glucophosphate isomerase deficiency,Point prevalence,N/A
Disease,871,Familial progressive cardiac conduction defect,Cases/families,N/A
Disease,871,Familial progressive cardiac conduction defect,Point prevalence,N/A
Malformation syndrome,1597,Distal deletion 17q syndrome,Point prevalence,N/A
Malformation syndrome,1590,Distal deletion 13q syndrome,Cases/families,N/A
Malformation syndrome,1590,Distal deletion 13q syndrome,Point prevalence,N/A
Malformation syndrome,1587,Monosomy 13q14 syndrome,Prevalence at birth,N/A
Malformation syndrome,1587,Monosomy 13q14 syndrome,Point prevalence,N/A
Malformation syndrome,1621,3q13 microdeletion syndrome,Cases/families,N/A
Malformation syndrome,1621,3q13 microdeletion syndrome,Point prevalence,N/A
Malformation syndrome,1620,Distal deletion 3p syndrome,Cases/families,N/A
Malformation syndrome,1620,Distal deletion 3p syndrome,Point prevalence,N/A
Malformation syndrome,1627,Deletion 5q35 syndrome,Cases/families,N/A
Malformation syndrome,1627,Deletion 5q35 syndrome,Point prevalence,N/A
Malformation syndrome,1699,Trisomy 12p syndrome,Cases/families,N/A
Malformation syndrome,1699,Trisomy 12p syndrome,Prevalence at birth,N/A
Malformation syndrome,1699,Trisomy 12p syndrome,Point prevalence,N/A
Malformation syndrome,500,Noonan syndrome with multiple lentigines,Cases/families,N/A
Malformation syndrome,500,Noonan syndrome with multiple lentigines,Point prevalence,N/A
Disease,507,Leishmaniasis,Point prevalence,N/A
Disease,507,Leishmaniasis,Annual incidence,N/A
Disease,206546,Symptomatic form of muscular dystrophy of Duchenne and Becker in female carriers,Point prevalence,N/A
Malformation syndrome,233,Duane retraction syndrome,Point prevalence,N/A
Clinical group,657,Congenital isolated hyperinsulinism,Prevalence at birth,N/A
Clinical group,657,Congenital isolated hyperinsulinism,Prevalence at birth,N/A
Clinical group,657,Congenital isolated hyperinsulinism,Prevalence at birth,N/A
Clinical group,657,Congenital isolated hyperinsulinism,Prevalence at birth,N/A
Clinical group,657,Congenital isolated hyperinsulinism,Prevalence at birth,N/A
Clinical group,657,Congenital isolated hyperinsulinism,Prevalence at birth,N/A
Clinical group,657,Congenital isolated hyperinsulinism,Point prevalence,N/A
Clinical group,657,Congenital isolated hyperinsulinism,Point prevalence,N/A
Disease,2495,Meningioma,Annual incidence,N/A
Disease,2495,Meningioma,Point prevalence,N/A
Disease,2495,Meningioma,Annual incidence,N/A
Malformation syndrome,1123,Caudal appendage-deafness syndrome,Cases/families,N/A
Malformation syndrome,1123,Caudal appendage-deafness syndrome,Point prevalence,N/A
Disease,206564,POMGNT1-related limb-girdle muscular dystrophy R15,Cases/families,N/A
Disease,206564,POMGNT1-related limb-girdle muscular dystrophy R15,Point prevalence,N/A
Disease,206559,POMT2-related limb-girdle muscular dystrophy R14,Point prevalence,N/A
Disease,206559,POMT2-related limb-girdle muscular dystrophy R14,Cases/families,N/A
Disease,206572,Overlap myositis,Point prevalence,N/A
Clinical group,2014,Cleft palate,Prevalence at birth,N/A
Clinical group,2014,Cleft palate,Point prevalence,N/A
Clinical group,2014,Cleft palate,Prevalence at birth,N/A
Clinical group,2014,Cleft palate,Point prevalence,N/A
Clinical group,2014,Cleft palate,Prevalence at birth,N/A
Clinical group,2014,Cleft palate,Point prevalence,N/A
Clinical group,2014,Cleft palate,Prevalence at birth,N/A
Clinical group,2014,Cleft palate,Point prevalence,N/A
Clinical group,2014,Cleft palate,Prevalence at birth,N/A
Clinical group,2014,Cleft palate,Point prevalence,N/A
Clinical group,2014,Cleft palate,Prevalence at birth,N/A
Clinical group,2014,Cleft palate,Point prevalence,N/A
Clinical group,2014,Cleft palate,Prevalence at birth,N/A
Clinical group,2014,Cleft palate,Point prevalence,N/A
Clinical group,2014,Cleft palate,Prevalence at birth,N/A
Clinical group,2014,Cleft palate,Point prevalence,N/A
Clinical group,2014,Cleft palate,Prevalence at birth,N/A
Clinical group,2014,Cleft palate,Point prevalence,N/A
Clinical group,2014,Cleft palate,Prevalence at birth,N/A
Clinical group,2014,Cleft palate,Point prevalence,N/A
Clinical group,2014,Cleft palate,Prevalence at birth,N/A
Clinical group,2014,Cleft palate,Point prevalence,N/A
Clinical group,2014,Cleft palate,Prevalence at birth,N/A
Clinical group,2014,Cleft palate,Point prevalence,N/A
Clinical group,2014,Cleft palate,Prevalence at birth,N/A
Clinical group,2014,Cleft palate,Point prevalence,N/A
Clinical group,2014,Cleft palate,Prevalence at birth,N/A
Clinical group,2014,Cleft palate,Point prevalence,N/A
Clinical group,2014,Cleft palate,Prevalence at birth,N/A
Clinical group,2014,Cleft palate,Point prevalence,N/A
Clinical group,2014,Cleft palate,Prevalence at birth,N/A
Clinical group,2014,Cleft palate,Point prevalence,N/A
Clinical group,2014,Cleft palate,Prevalence at birth,N/A
Clinical group,2014,Cleft palate,Point prevalence,N/A
Clinical group,2014,Cleft palate,Prevalence at birth,N/A
Clinical group,2014,Cleft palate,Point prevalence,N/A
Clinical group,2014,Cleft palate,Prevalence at birth,N/A
Clinical group,2014,Cleft palate,Point prevalence,N/A
Clinical group,2014,Cleft palate,Prevalence at birth,N/A
Clinical group,2014,Cleft palate,Point prevalence,N/A
Clinical group,2014,Cleft palate,Prevalence at birth,N/A
Clinical group,2014,Cleft palate,Point prevalence,N/A
Clinical group,2014,Cleft palate,Prevalence at birth,N/A
Clinical group,2014,Cleft palate,Point prevalence,N/A
Clinical group,2014,Cleft palate,Prevalence at birth,N/A
Clinical group,2014,Cleft palate,Point prevalence,N/A
Clinical group,2014,Cleft palate,Prevalence at birth,N/A
Clinical group,2014,Cleft palate,Point prevalence,N/A
Clinical group,2014,Cleft palate,Prevalence at birth,N/A
Clinical group,2014,Cleft palate,Point prevalence,N/A
Clinical group,2014,Cleft palate,Prevalence at birth,N/A
Clinical group,2014,Cleft palate,Point prevalence,N/A
Clinical group,2014,Cleft palate,Prevalence at birth,N/A
Clinical group,2014,Cleft palate,Point prevalence,N/A
Disease,822,Hereditary spherocytosis,Point prevalence,N/A
Disease,822,Hereditary spherocytosis,Prevalence at birth,N/A
Disease,822,Hereditary spherocytosis,Point prevalence,N/A
Disease,910,Xeroderma pigmentosum,Point prevalence,N/A
Disease,910,Xeroderma pigmentosum,Point prevalence,N/A
Disease,910,Xeroderma pigmentosum,Prevalence at birth,N/A
Disease,910,Xeroderma pigmentosum,Prevalence at birth,N/A
Disease,910,Xeroderma pigmentosum,Prevalence at birth,N/A
Disease,910,Xeroderma pigmentosum,Prevalence at birth,N/A
Disease,910,Xeroderma pigmentosum,Prevalence at birth,N/A
Disease,910,Xeroderma pigmentosum,Prevalence at birth,N/A
Disease,910,Xeroderma pigmentosum,Annual incidence,N/A
Etiological subtype,777,X-linked non-syndromic intellectual disability,Point prevalence,N/A
Disease,766,Hemolytic anemia due to red cell pyruvate kinase deficiency,Point prevalence,N/A
Disease,766,Hemolytic anemia due to red cell pyruvate kinase deficiency,Point prevalence,N/A
Disease,766,Hemolytic anemia due to red cell pyruvate kinase deficiency,Point prevalence,N/A
Malformation syndrome,1358,Carey-Fineman-Ziter syndrome,Cases/families,N/A
Malformation syndrome,1358,Carey-Fineman-Ziter syndrome,Point prevalence,N/A
Clinical group,206973,Congenital myotonia,Point prevalence,N/A
Disease,206594,Subacute inflammatory demyelinating polyneuropathy,Point prevalence,N/A
Biological anomaly,206599,Isolated asymptomatic elevation of creatine phosphokinase,Point prevalence,N/A
Malformation syndrome,3206,Stve-Wiedemann syndrome,Point prevalence,N/A
Malformation syndrome,3206,Stve-Wiedemann syndrome,Cases/families,N/A
Malformation syndrome,3206,Stve-Wiedemann syndrome,Prevalence at birth,N/A
Clinical subtype,206583,Adult polyglucosan body disease,Cases/families,N/A
Clinical subtype,206583,Adult polyglucosan body disease,Point prevalence,N/A
Disease,65,Leber congenital amaurosis,Point prevalence,N/A
Disease,65,Leber congenital amaurosis,Prevalence at birth,N/A
Disease,65,Leber congenital amaurosis,Point prevalence,N/A
Disease,65,Leber congenital amaurosis,Point prevalence,N/A
Disease,321,Multiple osteochondromas,Point prevalence,N/A
Disease,321,Multiple osteochondromas,Point prevalence,N/A
Disease,321,Multiple osteochondromas,Point prevalence,N/A
Disease,321,Multiple osteochondromas,Point prevalence,N/A
Disease,321,Multiple osteochondromas,Point prevalence,N/A
Disease,144,Lynch syndrome,Point prevalence,N/A
Clinical group,206647,Myotonic dystrophy,Point prevalence,N/A
Clinical group,206647,Myotonic dystrophy,Point prevalence,N/A
Clinical group,206647,Myotonic dystrophy,Point prevalence,N/A
Clinical group,206647,Myotonic dystrophy,Point prevalence,N/A
Clinical group,206647,Myotonic dystrophy,Point prevalence,N/A
Clinical group,206647,Myotonic dystrophy,Point prevalence,N/A
Clinical group,206647,Myotonic dystrophy,Point prevalence,N/A
Clinical group,206647,Myotonic dystrophy,Point prevalence,N/A
Clinical group,206647,Myotonic dystrophy,Point prevalence,N/A
Clinical group,206647,Myotonic dystrophy,Point prevalence,N/A
Clinical group,206647,Myotonic dystrophy,Point prevalence,N/A
Clinical group,206647,Myotonic dystrophy,Point prevalence,N/A
Disease,110,Bardet-Biedl syndrome,Point prevalence,N/A
Disease,110,Bardet-Biedl syndrome,Prevalence at birth,N/A
Disease,110,Bardet-Biedl syndrome,Point prevalence,N/A
Disease,110,Bardet-Biedl syndrome,Point prevalence,N/A
Malformation syndrome,2326,Kallmann syndrome-heart disease syndrome,Cases/families,N/A
Malformation syndrome,2326,Kallmann syndrome-heart disease syndrome,Point prevalence,N/A
Malformation syndrome,1130,Arachnodactyly-intellectual disability-dysmorphism syndrome,Cases/families,N/A
Malformation syndrome,1130,Arachnodactyly-intellectual disability-dysmorphism syndrome,Point prevalence,N/A
Disease,133,Chronic beryllium disease,Point prevalence,N/A
Malformation syndrome,1552,Currarino syndrome,Point prevalence,N/A
Malformation syndrome,1450,Ring chromosome 8 syndrome,Cases/families,N/A
Malformation syndrome,1450,Ring chromosome 8 syndrome,Point prevalence,N/A
Malformation syndrome,1448,Ring chromosome 6 syndrome,Cases/families,N/A
Malformation syndrome,1448,Ring chromosome 6 syndrome,Point prevalence,N/A
Clinical group,1580,Distal deletion 10p syndrome,Point prevalence,N/A
Malformation syndrome,2062,Progressive non-infectious anterior vertebral fusion,Cases/families,N/A
Malformation syndrome,2062,Progressive non-infectious anterior vertebral fusion,Point prevalence,N/A
Disease,172,Progressive familial intrahepatic cholestasis,Point prevalence,N/A
Malformation syndrome,2427,Macrocephaly-short stature-paraplegia syndrome,Cases/families,N/A
Malformation syndrome,2427,Macrocephaly-short stature-paraplegia syndrome,Point prevalence,N/A
Malformation syndrome,1444,Ring chromosome 20 syndrome,Cases/families,N/A
Malformation syndrome,1444,Ring chromosome 20 syndrome,Point prevalence,N/A
Disease,2349,Muscular pseudohypertrophy-hypothyroidism syndrome,Point prevalence,N/A
Malformation syndrome,1438,Ring chromosome 10 syndrome,Cases/families,N/A
Malformation syndrome,1438,Ring chromosome 10 syndrome,Point prevalence,N/A
Malformation syndrome,2183,Hydrocephalus-obesity-hypogonadism syndrome,Cases/families,N/A
Malformation syndrome,2183,Hydrocephalus-obesity-hypogonadism syndrome,Point prevalence,N/A
Malformation syndrome,1114,Aplasia cutis congenita,Point prevalence,N/A
Malformation syndrome,1114,Aplasia cutis congenita,Prevalence at birth,N/A
Malformation syndrome,1114,Aplasia cutis congenita,Prevalence at birth,N/A
Disease,209004,Axonal polyneuropathy associated with IgG/IgM/IgA monoclonal gammopathy,Point prevalence,N/A
Disease,209004,Axonal polyneuropathy associated with IgG/IgM/IgA monoclonal gammopathy,Annual incidence,N/A
Malformation syndrome,3176,Spina bifida-hypospadias syndrome,Point prevalence,N/A
Malformation syndrome,3176,Spina bifida-hypospadias syndrome,Prevalence at birth,N/A
Malformation syndrome,2184,Hydrocephaly-low insertion umbilicus syndrome,Cases/families,N/A
Malformation syndrome,2184,Hydrocephaly-low insertion umbilicus syndrome,Point prevalence,N/A
Malformation syndrome,1711,Mosaic trisomy 17 syndrome,Cases/families,N/A
Malformation syndrome,1711,Mosaic trisomy 17 syndrome,Point prevalence,N/A
Malformation syndrome,1272,Aym-Gripp syndrome,Cases/families,N/A
Malformation syndrome,1272,Aym-Gripp syndrome,Point prevalence,N/A
Malformation syndrome,1692,Mosaic trisomy 1 syndrome,Cases/families,N/A
Malformation syndrome,1692,Mosaic trisomy 1 syndrome,Point prevalence,N/A
Malformation syndrome,1485,"Arthrogryposis-hyperkeratosis syndrome, lethal form",Cases/families,N/A
Malformation syndrome,1485,"Arthrogryposis-hyperkeratosis syndrome, lethal form",Point prevalence,N/A
Malformation syndrome,1706,Mosaic trisomy 15 syndrome,Point prevalence,N/A
Malformation syndrome,1134,Isolated arrhinia,Cases/families,N/A
Malformation syndrome,1134,Isolated arrhinia,Point prevalence,N/A
Malformation syndrome,920,Ablepharon macrostomia syndrome,Cases/families,N/A
Malformation syndrome,920,Ablepharon macrostomia syndrome,Point prevalence,N/A
Clinical subtype,2204,"Dysplastic cortical hyperostosis, Kozlowski-Tsuruta type",Cases/families,N/A
Clinical subtype,2204,"Dysplastic cortical hyperostosis, Kozlowski-Tsuruta type",Point prevalence,N/A
Malformation syndrome,2963,"Progeroid syndrome, Petty type",Cases/families,N/A
Malformation syndrome,2963,"Progeroid syndrome, Petty type",Point prevalence,N/A
Disease,2619,"Brachydactylous dwarfism, Mseleni type",Point prevalence,N/A
Malformation syndrome,929,Achalasia-microcephaly syndrome,Cases/families,N/A
Malformation syndrome,929,Achalasia-microcephaly syndrome,Point prevalence,N/A
Disease,869,Triple A syndrome,Cases/families,N/A
Disease,869,Triple A syndrome,Point prevalence,N/A
Malformation syndrome,1415,Hardikar syndrome,Cases/families,N/A
Malformation syndrome,1415,Hardikar syndrome,Point prevalence,N/A
Disease,922,Familial nasal acilia,Cases/families,N/A
Disease,922,Familial nasal acilia,Point prevalence,N/A
Etiological subtype,209341,DYNC1H1-related autosomal dominant childhood-onset proximal spinal muscular atrophy,Point prevalence,N/A
Etiological subtype,209341,DYNC1H1-related autosomal dominant childhood-onset proximal spinal muscular atrophy,Cases/families,N/A
Disease,27,Vitamin B12-unresponsive methylmalonic acidemia,Point prevalence,N/A
Disease,209981,IRIDA syndrome,Cases/families,N/A
Disease,209981,IRIDA syndrome,Point prevalence,N/A
Disease,31,Oxoglutaric aciduria,Point prevalence,N/A
Disease,1459,Celiac disease-epilepsy-cerebral calcification syndrome,Cases/families,N/A
Disease,1459,Celiac disease-epilepsy-cerebral calcification syndrome,Point prevalence,N/A
Disease,932,Achondrogenesis,Prevalence at birth,N/A
Disease,932,Achondrogenesis,Point prevalence,N/A
Disease,210136,Pulmonary fibrosis-hepatic hyperplasia-bone marrow hypoplasia syndrome,Cases/families,N/A
Disease,210136,Pulmonary fibrosis-hepatic hyperplasia-bone marrow hypoplasia syndrome,Point prevalence,N/A
Malformation syndrome,2582,Myalgia-eosinophilia syndrome associated with tryptophan,Point prevalence,N/A
Malformation syndrome,950,Acrodysostosis,Point prevalence,N/A
Malformation syndrome,950,Acrodysostosis,Cases/families,N/A
Disease,210128,Urocanic aciduria,Cases/families,N/A
Disease,210128,Urocanic aciduria,Point prevalence,N/A
Malformation syndrome,945,Acalvaria,Prevalence at birth,N/A
Malformation syndrome,945,Acalvaria,Point prevalence,N/A
Disease,209959,Phacoanaphylactic uveitis,Point prevalence,N/A
Malformation syndrome,958,Acro-renal-mandibular syndrome,Cases/families,N/A
Malformation syndrome,958,Acro-renal-mandibular syndrome,Point prevalence,N/A
Disease,209951,Autosomal spastic paraplegia type 18,Cases/families,N/A
Disease,209951,Autosomal spastic paraplegia type 18,Point prevalence,N/A
Malformation syndrome,952,"Acrofacial dysostosis, Weyers type",Point prevalence,N/A
Disease,209973,Benign nocturnal alternating hemiplegia of childhood,Cases/families,N/A
Disease,209973,Benign nocturnal alternating hemiplegia of childhood,Point prevalence,N/A
Malformation syndrome,1738,Trisomy 4p syndrome,Cases/families,N/A
Malformation syndrome,1738,Trisomy 4p syndrome,Point prevalence,N/A
Disease,209970,Episodic ataxia type 7,Cases/families,N/A
Disease,209970,Episodic ataxia type 7,Point prevalence,N/A
Malformation syndrome,1745,Distal duplication 6p syndrome,Cases/families,N/A
Malformation syndrome,1745,Distal duplication 6p syndrome,Point prevalence,N/A
Disease,209908,Isolated childhood apraxia of speech,Cases/families,N/A
Disease,209908,Isolated childhood apraxia of speech,Point prevalence,N/A
Malformation syndrome,1762,Proximal Xq28 duplication syndrome,Point prevalence,N/A
Malformation syndrome,1762,Proximal Xq28 duplication syndrome,Prevalence at birth,N/A
Malformation syndrome,1762,Proximal Xq28 duplication syndrome,Annual incidence,N/A
Disease,209902,Hypercholesterolemia due to cholesterol 7alpha-hydroxylase deficiency,Cases/families,N/A
Disease,209902,Hypercholesterolemia due to cholesterol 7alpha-hydroxylase deficiency,Point prevalence,N/A
Disease,1876,Oculogastrointestinal muscular dystrophy,Cases/families,N/A
Disease,1876,Oculogastrointestinal muscular dystrophy,Point prevalence,N/A
Disease,209943,IRVAN syndrome,Cases/families,N/A
Disease,209943,IRVAN syndrome,Point prevalence,N/A
Malformation syndrome,1946,Amelocerebrohypohidrotic syndrome,Point prevalence,N/A
Disease,1951,Epilepsy-telangiectasia syndrome,Cases/families,N/A
Disease,1951,Epilepsy-telangiectasia syndrome,Point prevalence,N/A
Disease,209916,Extraskeletal myxoid chondrosarcoma,Point prevalence,N/A
Disease,2604,Familial visceral myopathy,Point prevalence,N/A
Disease,209370,Severe neonatal-onset encephalopathy with microcephaly,Cases/families,N/A
Disease,209370,Severe neonatal-onset encephalopathy with microcephaly,Point prevalence,N/A
Disease,2597,Mitochondrial myopathy-lactic acidosis-deafness syndrome,Cases/families,N/A
Disease,2597,Mitochondrial myopathy-lactic acidosis-deafness syndrome,Point prevalence,N/A
Disease,210571,Dystonia 16,Cases/families,N/A
Disease,210571,Dystonia 16,Point prevalence,N/A
Malformation syndrome,1078,Thumb stiffness-brachydactyly-intellectual disability syndrome,Cases/families,N/A
Malformation syndrome,1078,Thumb stiffness-brachydactyly-intellectual disability syndrome,Point prevalence,N/A
Malformation syndrome,1077,Dental ankylosis,Point prevalence,N/A
Clinical subtype,1074,Ankyloblepharon filiforme adnatum-imperforate anus syndrome,Cases/families,N/A
Clinical subtype,1074,Ankyloblepharon filiforme adnatum-imperforate anus syndrome,Point prevalence,N/A
Clinical subtype,1072,Ankyloblepharon filiforme adnatum-cleft palate syndrome,Point prevalence,N/A
Malformation syndrome,1071,Ankyloblepharon-ectodermal defects-cleft lip/palate syndrome,Point prevalence,N/A
Malformation syndrome,1069,Aniridia-absent patella syndrome,Cases/families,N/A
Malformation syndrome,1069,Aniridia-absent patella syndrome,Point prevalence,N/A
Malformation syndrome,1068,Aniridia-intellectual disability syndrome,Cases/families,N/A
Malformation syndrome,1068,Aniridia-intellectual disability syndrome,Point prevalence,N/A
Malformation syndrome,1067,Aniridia-ptosis-intellectual disability-familial obesity syndrome,Cases/families,N/A
Malformation syndrome,1067,Aniridia-ptosis-intellectual disability-familial obesity syndrome,Point prevalence,N/A
Malformation syndrome,1064,Aniridia-renal agenesis-psychomotor retardation syndrome,Cases/families,N/A
Malformation syndrome,1064,Aniridia-renal agenesis-psychomotor retardation syndrome,Point prevalence,N/A
Disease,1062,Hereditary neurocutaneous malformation,Cases/families,N/A
Disease,1062,Hereditary neurocutaneous malformation,Point prevalence,N/A
Disease,210548,Macrocephaly-intellectual disability-autism syndrome,Cases/families,N/A
Disease,210548,Macrocephaly-intellectual disability-autism syndrome,Point prevalence,N/A
Malformation syndrome,1052,Mosaic variegated aneuploidy syndrome,Cases/families,N/A
Malformation syndrome,1052,Mosaic variegated aneuploidy syndrome,Point prevalence,N/A
Disease,3283,His bundle tachycardia,Point prevalence,N/A
Disease,210163,"Congenital lethal myopathy, Compton-North type",Cases/families,N/A
Disease,210163,"Congenital lethal myopathy, Compton-North type",Point prevalence,N/A
Clinical group,1037,Arthrogryposis multiplex congenita,Prevalence at birth,N/A
Clinical group,1037,Arthrogryposis multiplex congenita,Prevalence at birth,N/A
Clinical group,1037,Arthrogryposis multiplex congenita,Prevalence at birth,N/A
Clinical group,1037,Arthrogryposis multiplex congenita,Point prevalence,N/A
Malformation syndrome,210144,"Lethal polymalformative syndrome, Boissel type",Cases/families,N/A
Malformation syndrome,210144,"Lethal polymalformative syndrome, Boissel type",Point prevalence,N/A
Disease,1125,"Ocular motor apraxia, Cogan type",Cases/families,N/A
Disease,1125,"Ocular motor apraxia, Cogan type",Point prevalence,N/A
Disease,67,Amoebiasis due to Entamoeba histolytica,Point prevalence,N/A
Malformation syndrome,1120,Lung agenesis-heart defect-thumb anomalies syndrome,Point prevalence,N/A
Malformation syndrome,1120,Lung agenesis-heart defect-thumb anomalies syndrome,Cases/families,N/A
Disease,2023,Undifferentiated pleomorphic sarcoma,Annual incidence,N/A
Disease,2023,Undifferentiated pleomorphic sarcoma,Annual incidence,N/A
Disease,2023,Undifferentiated pleomorphic sarcoma,Point prevalence,N/A
Disease,416,Primary hyperoxaluria,Point prevalence,N/A
Disease,416,Primary hyperoxaluria,Point prevalence,N/A
Disease,416,Primary hyperoxaluria,Annual incidence,N/A
Disease,1117,Aplasia cutis-myopia syndrome,Cases/families,N/A
Disease,1117,Aplasia cutis-myopia syndrome,Point prevalence,N/A
Malformation syndrome,1110,Aortic arch anomaly-facial dysmorphism-intellectual disability syndrome,Cases/families,N/A
Malformation syndrome,1110,Aortic arch anomaly-facial dysmorphism-intellectual disability syndrome,Point prevalence,N/A
Malformation syndrome,1113,Aphalangy-syndactyly-microcephaly syndrome,Cases/families,N/A
Malformation syndrome,1113,Aphalangy-syndactyly-microcephaly syndrome,Point prevalence,N/A
Malformation syndrome,1112,Aphalangy-hemivertebrae-urogenital-intestinal dysgenesis syndrome,Cases/families,N/A
Malformation syndrome,1112,Aphalangy-hemivertebrae-urogenital-intestinal dysgenesis syndrome,Point prevalence,N/A
Malformation syndrome,1106,Microphthalmia with limb anomalies,Cases/families,N/A
Malformation syndrome,1106,Microphthalmia with limb anomalies,Point prevalence,N/A
Malformation syndrome,83,Antley-Bixler syndrome,Point prevalence,N/A
Malformation syndrome,1104,Anophthalmia plus syndrome,Cases/families,N/A
Malformation syndrome,1104,Anophthalmia plus syndrome,Point prevalence,N/A
Disease,1063,Tufted angioma,Cases/families,N/A
Disease,1063,Tufted angioma,Point prevalence,N/A
Malformation syndrome,991,PAGOD syndrome,Cases/families,N/A
Malformation syndrome,991,PAGOD syndrome,Point prevalence,N/A
Disease,211067,Episodic ataxia type 5,Cases/families,N/A
Disease,211067,Episodic ataxia type 5,Point prevalence,N/A
Malformation syndrome,989,Hypoglossia-hypodactyly syndrome,Cases/families,N/A
Malformation syndrome,989,Hypoglossia-hypodactyly syndrome,Point prevalence,N/A
Category,211062,Hereditary episodic ataxia,Point prevalence,N/A
Disease,51,Aicardi-Goutires syndrome,Point prevalence,N/A
Disease,51,Aicardi-Goutires syndrome,Point prevalence,N/A
Disease,2583,Mycetoma,Point prevalence,N/A
Clinical group,1685,Distomatosis,Point prevalence,N/A
Malformation syndrome,978,ADULT syndrome,Cases/families,N/A
Malformation syndrome,978,ADULT syndrome,Point prevalence,N/A
Disease,1902,Ehrlichiosis,Cases/families,N/A
Disease,1902,Ehrlichiosis,Annual incidence,N/A
Disease,1902,Ehrlichiosis,Point prevalence,N/A
Morphological anomaly,983,Testicular regression syndrome,Point prevalence,N/A
Disease,655,Nephronophthisis,Prevalence at birth,N/A
Disease,655,Nephronophthisis,Point prevalence,N/A
Malformation syndrome,971,Acrorenal syndrome,Cases/families,N/A
Malformation syndrome,971,Acrorenal syndrome,Point prevalence,N/A
Disease,2122,Kaposiform hemangioendothelioma,Point prevalence,N/A
Malformation syndrome,969,Acromicric dysplasia,Cases/families,N/A
Malformation syndrome,969,Acromicric dysplasia,Point prevalence,N/A
Malformation syndrome,974,Adams-Oliver syndrome,Point prevalence,N/A
Malformation syndrome,974,Adams-Oliver syndrome,Cases/families,N/A
Morphological anomaly,973,"Isolated absence/hypoplasia of fingers excluding thumb, unilateral",Cases/families,N/A
Morphological anomaly,973,"Isolated absence/hypoplasia of fingers excluding thumb, unilateral",Point prevalence,N/A
Malformation syndrome,959,Acro-renal-ocular syndrome,Cases/families,N/A
Malformation syndrome,959,Acro-renal-ocular syndrome,Point prevalence,N/A
Disease,407,Glycine encephalopathy,Point prevalence,N/A
Disease,407,Glycine encephalopathy,Prevalence at birth,N/A
Disease,407,Glycine encephalopathy,Prevalence at birth,N/A
Disease,407,Glycine encephalopathy,Prevalence at birth,N/A
Disease,407,Glycine encephalopathy,Prevalence at birth,N/A
Disease,407,Glycine encephalopathy,Point prevalence,N/A
Disease,407,Glycine encephalopathy,Prevalence at birth,N/A
Disease,407,Glycine encephalopathy,Prevalence at birth,N/A
Disease,139414,Congenital panfollicular nevus,Cases/families,N/A
Disease,139414,Congenital panfollicular nevus,Point prevalence,N/A
Disease,663,Mitochondrial DNA-related progressive external ophthalmoplegia,Point prevalence,N/A
Category,137,Congenital disorder of glycosylation,Prevalence at birth,N/A
Category,137,Congenital disorder of glycosylation,Point prevalence,N/A
Disease,220,Denys-Drash syndrome,Cases/families,N/A
Disease,220,Denys-Drash syndrome,Point prevalence,N/A
Malformation syndrome,1031,Enamel-renal syndrome,Cases/families,N/A
Malformation syndrome,1031,Enamel-renal syndrome,Point prevalence,N/A
Clinical subtype,139423,Idiopathic acute transverse myelitis,Annual incidence,N/A
Clinical subtype,139423,Idiopathic acute transverse myelitis,Point prevalence,N/A
Clinical group,85,Congenital dyserythropoietic anemia,Prevalence at birth,N/A
Clinical group,85,Congenital dyserythropoietic anemia,Point prevalence,N/A
Clinical group,85,Congenital dyserythropoietic anemia,Cases/families,N/A
Clinical group,85,Congenital dyserythropoietic anemia,Point prevalence,N/A
Biological anomaly,1035,Beta-mercaptolactate cysteine disulfiduria,Cases/families,N/A
Biological anomaly,1035,Beta-mercaptolactate cysteine disulfiduria,Point prevalence,N/A
Disease,139436,Multicentric reticulohistiocytosis,Cases/families,N/A
Disease,139436,Multicentric reticulohistiocytosis,Point prevalence,N/A
Disease,1021,Amaurosis-hypertrichosis syndrome,Cases/families,N/A
Disease,1021,Amaurosis-hypertrichosis syndrome,Point prevalence,N/A
Disease,177,Rhizomelic chondrodysplasia punctata,Prevalence at birth,N/A
Disease,177,Rhizomelic chondrodysplasia punctata,Prevalence at birth,N/A
Disease,177,Rhizomelic chondrodysplasia punctata,Point prevalence,N/A
Clinical subtype,1023,"Congenital generalized hypertrichosis, Ambras type",Cases/families,N/A
Clinical subtype,1023,"Congenital generalized hypertrichosis, Ambras type",Point prevalence,N/A
Disease,618,Familial melanoma,Annual incidence,N/A
Disease,618,Familial melanoma,Point prevalence,N/A
Category,359,Pediatric-onset glaucoma of genetic origin,Point prevalence,N/A
Category,213500,Ovarian cancer,Point prevalence,N/A
Disease,701,Alopecia universalis,Point prevalence,N/A
Disease,1010,Autosomal dominant palmoplantar keratoderma and congenital alopecia,Cases/families,N/A
Disease,1010,Autosomal dominant palmoplantar keratoderma and congenital alopecia,Point prevalence,N/A
Disease,213512,Malignant mixed Mllerian tumor of the ovary,Annual incidence,N/A
Malformation syndrome,1003,Scalp defects-postaxial polydactyly syndrome,Cases/families,N/A
Malformation syndrome,1003,Scalp defects-postaxial polydactyly syndrome,Point prevalence,N/A
Malformation syndrome,1005,Alopecia-contractures-dwarfism-intellectual disability syndrome,Cases/families,N/A
Malformation syndrome,1005,Alopecia-contractures-dwarfism-intellectual disability syndrome,Point prevalence,N/A
Malformation syndrome,1253,Ascher syndrome,Cases/families,N/A
Malformation syndrome,1253,Ascher syndrome,Point prevalence,N/A
Malformation syndrome,1252,Blepharonasofacial malformation syndrome,Cases/families,N/A
Malformation syndrome,1252,Blepharonasofacial malformation syndrome,Point prevalence,N/A
Malformation syndrome,1248,Maxillonasal dysplasia,Point prevalence,N/A
Disease,175,Cartilage-hair hypoplasia,Point prevalence,N/A
Disease,175,Cartilage-hair hypoplasia,Prevalence at birth,N/A
Disease,175,Cartilage-hair hypoplasia,Point prevalence,N/A
Clinical group,209,Cutis laxa,Prevalence at birth,N/A
Clinical group,209,Cutis laxa,Point prevalence,N/A
Disease,1259,Blepharoptosis-myopia-ectopia lentis syndrome,Cases/families,N/A
Disease,1259,Blepharoptosis-myopia-ectopia lentis syndrome,Point prevalence,N/A
Malformation syndrome,1261,Bonnemann-Meinecke-Reich syndrome,Cases/families,N/A
Malformation syndrome,1261,Bonnemann-Meinecke-Reich syndrome,Point prevalence,N/A
Malformation syndrome,1234,Bartsocas-Papas syndrome,Cases/families,N/A
Malformation syndrome,1234,Bartsocas-Papas syndrome,Point prevalence,N/A
Malformation syndrome,1234,Bartsocas-Papas syndrome,Prevalence at birth,N/A
Disease,213557,Salivary gland type cancer of the breast,Annual incidence,N/A
Disease,213557,Salivary gland type cancer of the breast,Annual incidence,N/A
Disease,213557,Salivary gland type cancer of the breast,Annual incidence,N/A
Disease,213557,Salivary gland type cancer of the breast,Annual incidence,N/A
Disease,213557,Salivary gland type cancer of the breast,Annual incidence,N/A
Disease,213557,Salivary gland type cancer of the breast,Annual incidence,N/A
Disease,213557,Salivary gland type cancer of the breast,Annual incidence,N/A
Disease,213557,Salivary gland type cancer of the breast,Annual incidence,N/A
Disease,213557,Salivary gland type cancer of the breast,Annual incidence,N/A
Disease,213557,Salivary gland type cancer of the breast,Annual incidence,N/A
Disease,213557,Salivary gland type cancer of the breast,Annual incidence,N/A
Disease,213557,Salivary gland type cancer of the breast,Annual incidence,N/A
Disease,213557,Salivary gland type cancer of the breast,Annual incidence,N/A
Disease,213557,Salivary gland type cancer of the breast,Annual incidence,N/A
Disease,213557,Salivary gland type cancer of the breast,Annual incidence,N/A
Disease,213557,Salivary gland type cancer of the breast,Annual incidence,N/A
Disease,213557,Salivary gland type cancer of the breast,Annual incidence,N/A
Disease,213557,Salivary gland type cancer of the breast,Annual incidence,N/A
Disease,213557,Salivary gland type cancer of the breast,Annual incidence,N/A
Disease,213557,Salivary gland type cancer of the breast,Annual incidence,N/A
Disease,213557,Salivary gland type cancer of the breast,Annual incidence,N/A
Disease,213557,Salivary gland type cancer of the breast,Annual incidence,N/A
Disease,213557,Salivary gland type cancer of the breast,Annual incidence,N/A
Malformation syndrome,114,Auriculoosteodysplasia,Cases/families,N/A
Malformation syndrome,114,Auriculoosteodysplasia,Point prevalence,N/A
Malformation syndrome,115,Congenital contractural arachnodactyly,Point prevalence,N/A
Malformation syndrome,1236,Severe microbrachycephaly-intellectual disability-athetoid cerebral palsy syndrome,Cases/families,N/A
Malformation syndrome,1236,Severe microbrachycephaly-intellectual disability-athetoid cerebral palsy syndrome,Point prevalence,N/A
Malformation syndrome,137622,Intractable diarrhea-choanal atresia-eye anomalies syndrome,Cases/families,N/A
Malformation syndrome,137622,Intractable diarrhea-choanal atresia-eye anomalies syndrome,Point prevalence,N/A
Malformation syndrome,1292,Brachymorphism-onychodysplasia-dysphalangism syndrome,Cases/families,N/A
Malformation syndrome,1292,Brachymorphism-onychodysplasia-dysphalangism syndrome,Point prevalence,N/A
Malformation syndrome,137628,Cardiac anomalies-heterotaxy syndrome,Cases/families,N/A
Malformation syndrome,137628,Cardiac anomalies-heterotaxy syndrome,Point prevalence,N/A
Clinical group,3188,Congenital pulmonary veins atresia or stenosis,Point prevalence,N/A
Disease,137625,Glycogen storage disease due to muscle and heart glycogen synthase deficiency,Cases/families,N/A
Disease,137625,Glycogen storage disease due to muscle and heart glycogen synthase deficiency,Point prevalence,N/A
Malformation syndrome,1299,Branchioskeletogenital syndrome,Cases/families,N/A
Malformation syndrome,1299,Branchioskeletogenital syndrome,Point prevalence,N/A
Malformation syndrome,1300,Autosomal dominant popliteal pterygium syndrome,Point prevalence,N/A
Malformation syndrome,1300,Autosomal dominant popliteal pterygium syndrome,Cases/families,N/A
Malformation syndrome,137667,Capillary malformation-arteriovenous malformation,Cases/families,N/A
Malformation syndrome,137667,Capillary malformation-arteriovenous malformation,Point prevalence,N/A
Malformation syndrome,137634,Overgrowth-macrocephaly-facial dysmorphism syndrome,Cases/families,N/A
Malformation syndrome,137634,Overgrowth-macrocephaly-facial dysmorphism syndrome,Point prevalence,N/A
Malformation syndrome,1295,Brachytelephalangy-dysmorphism-Kallmann syndrome,Cases/families,N/A
Malformation syndrome,1295,Brachytelephalangy-dysmorphism-Kallmann syndrome,Point prevalence,N/A
Disease,137631,"Lung fibrosis-immunodeficiency-46,XX gonadal dysgenesis syndrome",Cases/families,N/A
Disease,137631,"Lung fibrosis-immunodeficiency-46,XX gonadal dysgenesis syndrome",Point prevalence,N/A
Malformation syndrome,1296,Lambert syndrome,Cases/families,N/A
Malformation syndrome,1296,Lambert syndrome,Point prevalence,N/A
Malformation syndrome,1297,Branchio-oculo-facial syndrome,Cases/families,N/A
Malformation syndrome,1297,Branchio-oculo-facial syndrome,Point prevalence,N/A
Malformation syndrome,185,Scimitar syndrome,Prevalence at birth,N/A
Malformation syndrome,185,Scimitar syndrome,Point prevalence,N/A
Morphological anomaly,3189,Congenital pulmonary valvar stenosis,Prevalence at birth,N/A
Morphological anomaly,3189,Congenital pulmonary valvar stenosis,Prevalence at birth,N/A
Morphological anomaly,3189,Congenital pulmonary valvar stenosis,Prevalence at birth,N/A
Morphological anomaly,3189,Congenital pulmonary valvar stenosis,Prevalence at birth,N/A
Morphological anomaly,3189,Congenital pulmonary valvar stenosis,Prevalence at birth,N/A
Morphological anomaly,3189,Congenital pulmonary valvar stenosis,Prevalence at birth,N/A
Morphological anomaly,3189,Congenital pulmonary valvar stenosis,Prevalence at birth,N/A
Morphological anomaly,3189,Congenital pulmonary valvar stenosis,Prevalence at birth,N/A
Morphological anomaly,3189,Congenital pulmonary valvar stenosis,Prevalence at birth,N/A
Morphological anomaly,3189,Congenital pulmonary valvar stenosis,Prevalence at birth,N/A
Morphological anomaly,3189,Congenital pulmonary valvar stenosis,Prevalence at birth,N/A
Morphological anomaly,3189,Congenital pulmonary valvar stenosis,Prevalence at birth,N/A
Morphological anomaly,3189,Congenital pulmonary valvar stenosis,Prevalence at birth,N/A
Morphological anomaly,3189,Congenital pulmonary valvar stenosis,Prevalence at birth,N/A
Morphological anomaly,3189,Congenital pulmonary valvar stenosis,Prevalence at birth,N/A
Morphological anomaly,3189,Congenital pulmonary valvar stenosis,Prevalence at birth,N/A
Morphological anomaly,3189,Congenital pulmonary valvar stenosis,Prevalence at birth,N/A
Morphological anomaly,3189,Congenital pulmonary valvar stenosis,Prevalence at birth,N/A
Morphological anomaly,3189,Congenital pulmonary valvar stenosis,Prevalence at birth,N/A
Morphological anomaly,3189,Congenital pulmonary valvar stenosis,Point prevalence,N/A
Morphological anomaly,1464,Univentricular heart,Prevalence at birth,N/A
Morphological anomaly,1464,Univentricular heart,Point prevalence,N/A
Malformation syndrome,1278,Brachydactyly-preaxial hallux varus syndrome,Cases/families,N/A
Malformation syndrome,1278,Brachydactyly-preaxial hallux varus syndrome,Point prevalence,N/A
Disease,213716,Squamous cell carcinoma of the corpus uteri,Annual incidence,N/A
Disease,213716,Squamous cell carcinoma of the corpus uteri,Annual incidence,N/A
Disease,213716,Squamous cell carcinoma of the corpus uteri,Annual incidence,N/A
Disease,213716,Squamous cell carcinoma of the corpus uteri,Annual incidence,N/A
Disease,213716,Squamous cell carcinoma of the corpus uteri,Annual incidence,N/A
Disease,213716,Squamous cell carcinoma of the corpus uteri,Annual incidence,N/A
Disease,213716,Squamous cell carcinoma of the corpus uteri,Annual incidence,N/A
Disease,213716,Squamous cell carcinoma of the corpus uteri,Annual incidence,N/A
Disease,213716,Squamous cell carcinoma of the corpus uteri,Annual incidence,N/A
Disease,213716,Squamous cell carcinoma of the corpus uteri,Annual incidence,N/A
Disease,213716,Squamous cell carcinoma of the corpus uteri,Annual incidence,N/A
Disease,213716,Squamous cell carcinoma of the corpus uteri,Annual incidence,N/A
Disease,213716,Squamous cell carcinoma of the corpus uteri,Annual incidence,N/A
Disease,213716,Squamous cell carcinoma of the corpus uteri,Annual incidence,N/A
Disease,213716,Squamous cell carcinoma of the corpus uteri,Annual incidence,N/A
Disease,213716,Squamous cell carcinoma of the corpus uteri,Annual incidence,N/A
Disease,213716,Squamous cell carcinoma of the corpus uteri,Annual incidence,N/A
Disease,213716,Squamous cell carcinoma of the corpus uteri,Annual incidence,N/A
Disease,213716,Squamous cell carcinoma of the corpus uteri,Annual incidence,N/A
Disease,213716,Squamous cell carcinoma of the corpus uteri,Annual incidence,N/A
Disease,213716,Squamous cell carcinoma of the corpus uteri,Annual incidence,N/A
Disease,213716,Squamous cell carcinoma of the corpus uteri,Annual incidence,N/A
Disease,213716,Squamous cell carcinoma of the corpus uteri,Annual incidence,N/A
Disease,1178,Ataxia-tapetoretinal degeneration syndrome,Point prevalence,N/A
Disease,1572,Common variable immunodeficiency,Point prevalence,N/A
Disease,1572,Common variable immunodeficiency,Annual incidence,N/A
Disease,1572,Common variable immunodeficiency,Point prevalence,N/A
Disease,1572,Common variable immunodeficiency,Point prevalence,N/A
Disease,1572,Common variable immunodeficiency,Point prevalence,N/A
Disease,1572,Common variable immunodeficiency,Point prevalence,N/A
Disease,1572,Common variable immunodeficiency,Point prevalence,N/A
Disease,1572,Common variable immunodeficiency,Point prevalence,N/A
Disease,1572,Common variable immunodeficiency,Point prevalence,N/A
Disease,1572,Common variable immunodeficiency,Point prevalence,N/A
Disease,1572,Common variable immunodeficiency,Point prevalence,N/A
Disease,1572,Common variable immunodeficiency,Point prevalence,N/A
Disease,3261,Autoimmune lymphoproliferative syndrome,Cases/families,N/A
Disease,3261,Autoimmune lymphoproliferative syndrome,Point prevalence,N/A
Malformation syndrome,1133,AREDYLD syndrome,Cases/families,N/A
Malformation syndrome,1133,AREDYLD syndrome,Point prevalence,N/A
Disease,137675,Histiocytoid cardiomyopathy,Point prevalence,N/A
Disease,137675,Histiocytoid cardiomyopathy,Cases/families,N/A
Malformation syndrome,1131,X-linked mandibulofacial dysostosis,Cases/families,N/A
Malformation syndrome,1131,X-linked mandibulofacial dysostosis,Point prevalence,N/A
Disease,137678,Spondyloepiphyseal dysplasia with metatarsal shortening,Cases/families,N/A
Disease,137678,Spondyloepiphyseal dysplasia with metatarsal shortening,Point prevalence,N/A
Particular clinical situation in a disease or syndrome,137698,Cytomegalovirus disease in patients with impaired cell mediated immunity deemed at risk,Point prevalence,N/A
Disease,137754,Aminoacylase 1 deficiency,Point prevalence,N/A
Disease,137754,Aminoacylase 1 deficiency,Cases/families,N/A
Disease,1145,Infantile-onset X-linked spinal muscular atrophy,Cases/families,N/A
Disease,1145,Infantile-onset X-linked spinal muscular atrophy,Point prevalence,N/A
Malformation syndrome,137776,Lethal congenital contracture syndrome type 2,Cases/families,N/A
Malformation syndrome,137776,Lethal congenital contracture syndrome type 2,Point prevalence,N/A
Malformation syndrome,1150,Arthrogryposis multiplex congenita-whistling face syndrome,Cases/families,N/A
Malformation syndrome,1150,Arthrogryposis multiplex congenita-whistling face syndrome,Point prevalence,N/A
Malformation syndrome,1149,Kuskokwim syndrome,Point prevalence,N/A
Malformation syndrome,1149,Kuskokwim syndrome,Cases/families,N/A
Clinical group,137807,Primary cutaneous amyloidosis,Point prevalence,N/A
Clinical group,137807,Primary cutaneous amyloidosis,Point prevalence,N/A
Disease,1159,Progressive pseudorheumatoid dysplasia,Point prevalence,N/A
Malformation syndrome,137783,Lethal congenital contracture syndrome type 3,Cases/families,N/A
Malformation syndrome,137783,Lethal congenital contracture syndrome type 3,Point prevalence,N/A
Disease,1214,Progressive hemifacial atrophy,Point prevalence,N/A
Disease,1214,Progressive hemifacial atrophy,Point prevalence,N/A
Disease,213812,Primitive neuroectodermal tumor of the cervix uteri,Annual incidence,N/A
Category,138044,Rare disease with Pierre Robin syndrome,Prevalence at birth,N/A
Category,138044,Rare disease with Pierre Robin syndrome,Point prevalence,N/A
Disease,1221,Cheilitis glandularis,Point prevalence,N/A
Disease,1221,Cheilitis glandularis,Cases/families,N/A
Disease,213807,Leiomyosarcoma of the cervix uteri,Annual incidence,N/A
Malformation syndrome,1226,Bamforth-Lazarus syndrome,Cases/families,N/A
Malformation syndrome,1226,Bamforth-Lazarus syndrome,Point prevalence,N/A
Malformation syndrome,3082,Intellectual disability-polydactyly-uncombable hair syndrome,Cases/families,N/A
Malformation syndrome,3082,Intellectual disability-polydactyly-uncombable hair syndrome,Point prevalence,N/A
Malformation syndrome,1184,Ataxia-photosensitivity-short stature syndrome,Cases/families,N/A
Malformation syndrome,1184,Ataxia-photosensitivity-short stature syndrome,Point prevalence,N/A
Morphological anomaly,3269,Isolated radio-ulnar synostosis,Cases/families,N/A
Morphological anomaly,3269,Isolated radio-ulnar synostosis,Point prevalence,N/A
Malformation syndrome,137888,Auriculocondylar syndrome,Point prevalence,N/A
Malformation syndrome,137888,Auriculocondylar syndrome,Cases/families,N/A
Malformation syndrome,3309,Tetrasomy 5p syndrome,Point prevalence,N/A
Disease,137898,Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome,Cases/families,N/A
Disease,137898,Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome,Point prevalence,N/A
Malformation syndrome,1188,Ataxia-deafness-intellectual disability syndrome,Cases/families,N/A
Malformation syndrome,1188,Ataxia-deafness-intellectual disability syndrome,Point prevalence,N/A
Disease,1187,Lethal ataxia with deafness and optic atrophy,Cases/families,N/A
Disease,1187,Lethal ataxia with deafness and optic atrophy,Point prevalence,N/A
Malformation syndrome,1190,Atelosteogenesis type I,Point prevalence,N/A
Disease,466,Fatal familial insomnia,Cases/families,N/A
Disease,466,Fatal familial insomnia,Point prevalence,N/A
Clinical subtype,2834,Wrinkly skin syndrome,Cases/families,N/A
Clinical subtype,2834,Wrinkly skin syndrome,Point prevalence,N/A
Clinical subtype,268173,Intermittent maple syrup urine disease,Prevalence at birth,N/A
Clinical subtype,268173,Intermittent maple syrup urine disease,Point prevalence,N/A
Disease,2969,Proteus-like syndrome,Point prevalence,N/A
Disease,199282,Harlequin syndrome,Cases/families,N/A
Disease,199282,Harlequin syndrome,Point prevalence,N/A
Disease,199285,Hereditary hypercarotenemia and vitamin A deficiency,Point prevalence,N/A
Disease,2331,Kawasaki disease,Point prevalence,N/A
Disease,750,Pseudoachondroplasia,Point prevalence,N/A
Malformation syndrome,2975,"46,XX difference of sex development-skeletal anomalies syndrome",Cases/families,N/A
Malformation syndrome,2975,"46,XX difference of sex development-skeletal anomalies syndrome",Point prevalence,N/A
Malformation syndrome,2980,Acrootoocular syndrome,Point prevalence,N/A
Clinical syndrome,2978,Chronic intestinal pseudoobstruction,Point prevalence,N/A
Morphological anomaly,2040,Congenital respiratory-biliary fistula,Cases/families,N/A
Morphological anomaly,2040,Congenital respiratory-biliary fistula,Point prevalence,N/A
Malformation syndrome,199318,15q13.3 microdeletion syndrome,Cases/families,N/A
Malformation syndrome,199318,15q13.3 microdeletion syndrome,Point prevalence,N/A
Morphological anomaly,2357,Bronchogenic cyst,Point prevalence,N/A
Disease,274,Bernard-Soulier syndrome,Cases/families,N/A
Disease,274,Bernard-Soulier syndrome,Point prevalence,N/A
Disease,1195,Congenital atransferrinemia,Cases/families,N/A
Disease,1195,Congenital atransferrinemia,Point prevalence,N/A
Morphological anomaly,199302,Isolated cleft lip,Point prevalence,N/A
Morphological anomaly,199306,Cleft lip/palate,Point prevalence,N/A
Morphological anomaly,199306,Cleft lip/palate,Prevalence at birth,N/A
Morphological anomaly,199306,Cleft lip/palate,Prevalence at birth,N/A
Morphological anomaly,199306,Cleft lip/palate,Prevalence at birth,N/A
Disease,926,Acatalasemia,Point prevalence,N/A
Malformation syndrome,2947,Triphalangeal thumbs-brachyectrodactyly syndrome,Cases/families,N/A
Malformation syndrome,2947,Triphalangeal thumbs-brachyectrodactyly syndrome,Point prevalence,N/A
Category,1531,Craniosynostosis,Prevalence at birth,N/A
Category,1531,Craniosynostosis,Prevalence at birth,N/A
Category,1531,Craniosynostosis,Prevalence at birth,N/A
Category,1531,Craniosynostosis,Prevalence at birth,N/A
Category,1531,Craniosynostosis,Point prevalence,N/A
Malformation syndrome,2952,"Adducted thumbs-arthrogryposis syndrome, Christian type",Cases/families,N/A
Malformation syndrome,2952,"Adducted thumbs-arthrogryposis syndrome, Christian type",Point prevalence,N/A
Disease,740,Hutchinson-Gilford progeria syndrome,Prevalence at birth,N/A
Disease,740,Hutchinson-Gilford progeria syndrome,Point prevalence,N/A
Malformation syndrome,2959,Progeria-short stature-pigmented nevi syndrome,Cases/families,N/A
Malformation syndrome,2959,Progeria-short stature-pigmented nevi syndrome,Point prevalence,N/A
Malformation syndrome,2957,Guttmacher syndrome,Point prevalence,N/A
Malformation syndrome,2957,Guttmacher syndrome,Cases/families,N/A
Disease,3129,Sarcosinemia,Prevalence at birth,N/A
Disease,3129,Sarcosinemia,Prevalence at birth,N/A
Disease,3129,Sarcosinemia,Point prevalence,N/A
Disease,3129,Sarcosinemia,Prevalence at birth,N/A
Malformation syndrome,2924,Isolated polycystic liver disease,Point prevalence,N/A
Malformation syndrome,2926,Digital extensor muscle aplasia-polyneuropathy,Cases/families,N/A
Malformation syndrome,2926,Digital extensor muscle aplasia-polyneuropathy,Point prevalence,N/A
Malformation syndrome,2928,Polyneuropathy-intellectual disability-acromicria-premature menopause syndrome,Cases/families,N/A
Malformation syndrome,2928,Polyneuropathy-intellectual disability-acromicria-premature menopause syndrome,Point prevalence,N/A
Disease,2930,Cronkhite-Canada syndrome,Cases/families,N/A
Disease,2930,Cronkhite-Canada syndrome,Point prevalence,N/A
Disease,2494,Mntrier disease,Point prevalence,N/A
Disease,171,Primary sclerosing cholangitis,Annual incidence,N/A
Disease,171,Primary sclerosing cholangitis,Point prevalence,N/A
Disease,171,Primary sclerosing cholangitis,Point prevalence,N/A
Disease,171,Primary sclerosing cholangitis,Annual incidence,N/A
Disease,171,Primary sclerosing cholangitis,Annual incidence,N/A
Disease,171,Primary sclerosing cholangitis,Point prevalence,N/A
Disease,171,Primary sclerosing cholangitis,Annual incidence,N/A
Disease,171,Primary sclerosing cholangitis,Point prevalence,N/A
Disease,171,Primary sclerosing cholangitis,Annual incidence,N/A
Disease,171,Primary sclerosing cholangitis,Point prevalence,N/A
Disease,171,Primary sclerosing cholangitis,Annual incidence,N/A
Disease,171,Primary sclerosing cholangitis,Point prevalence,N/A
Disease,171,Primary sclerosing cholangitis,Annual incidence,N/A
Disease,171,Primary sclerosing cholangitis,Point prevalence,N/A
Disease,171,Primary sclerosing cholangitis,Annual incidence,N/A
Disease,171,Primary sclerosing cholangitis,Annual incidence,N/A
Disease,171,Primary sclerosing cholangitis,Point prevalence,N/A
Disease,171,Primary sclerosing cholangitis,Point prevalence,N/A
Disease,199247,Corticosteroid-binding globulin deficiency,Point prevalence,N/A
Disease,199241,Pulmonary capillary hemangiomatosis,Cases/families,N/A
Disease,199241,Pulmonary capillary hemangiomatosis,Point prevalence,N/A
Disease,2907,Hereditary acrokeratotic poikiloderma,Point prevalence,N/A
Disease,2907,Hereditary acrokeratotic poikiloderma,Cases/families,N/A
Disease,17,Fatal infantile lactic acidosis with methylmalonic aciduria,Point prevalence,N/A
Disease,3006,Pyridoxine-dependent epilepsy,Prevalence at birth,N/A
Disease,3006,Pyridoxine-dependent epilepsy,Prevalence at birth,N/A
Disease,3006,Pyridoxine-dependent epilepsy,Prevalence at birth,N/A
Disease,3006,Pyridoxine-dependent epilepsy,Prevalence at birth,N/A
Disease,3006,Pyridoxine-dependent epilepsy,Point prevalence,N/A
Disease,780,Rhabdomyosarcoma,Annual incidence,N/A
Disease,780,Rhabdomyosarcoma,Point prevalence,N/A
Disease,3111,Rotor syndrome,Cases/families,N/A
Disease,3111,Rotor syndrome,Point prevalence,N/A
Disease,2382,Lennox-Gastaut syndrome,Annual incidence,N/A
Disease,2382,Lennox-Gastaut syndrome,Point prevalence,N/A
Disease,2806,Subacute sclerosing leukoencephalitis,Point prevalence,N/A
Disease,2806,Subacute sclerosing leukoencephalitis,Annual incidence,N/A
Disease,2806,Subacute sclerosing leukoencephalitis,Annual incidence,N/A
Clinical group,2467,Systemic mastocytosis,Annual incidence,N/A
Clinical group,2467,Systemic mastocytosis,Point prevalence,N/A
Clinical group,2467,Systemic mastocytosis,Annual incidence,N/A
Clinical group,2467,Systemic mastocytosis,Point prevalence,N/A
Clinical group,2467,Systemic mastocytosis,Annual incidence,N/A
Clinical group,2467,Systemic mastocytosis,Point prevalence,N/A
Clinical group,2467,Systemic mastocytosis,Point prevalence,N/A
Disease,264580,Glycogen storage disease due to liver phosphorylase kinase deficiency,Prevalence at birth,N/A
Disease,264580,Glycogen storage disease due to liver phosphorylase kinase deficiency,Point prevalence,N/A
Malformation syndrome,2916,Postaxial polydactyly-dental and vertebral anomalies syndrome,Cases/families,N/A
Malformation syndrome,2916,Postaxial polydactyly-dental and vertebral anomalies syndrome,Point prevalence,N/A
Malformation syndrome,2917,Polydactyly-myopia syndrome,Cases/families,N/A
Malformation syndrome,2917,Polydactyly-myopia syndrome,Point prevalence,N/A
Malformation syndrome,2919,Orofaciodigital syndrome type 5,Cases/families,N/A
Malformation syndrome,2919,Orofaciodigital syndrome type 5,Point prevalence,N/A
Disease,264675,Hereditary pulmonary alveolar proteinosis,Point prevalence,N/A
Malformation syndrome,2920,Oliver syndrome,Cases/families,N/A
Malformation syndrome,2920,Oliver syndrome,Point prevalence,N/A
Disease,264691,Isolated pulmonary capillaritis,Point prevalence,N/A
Disease,1943,Early-onset progressive encephalopathy with migrant continuous myoclonus,Cases/families,N/A
Disease,1943,Early-onset progressive encephalopathy with migrant continuous myoclonus,Point prevalence,N/A
Disease,264688,Congenital chylothorax,Point prevalence,N/A
Disease,264688,Congenital chylothorax,Prevalence at birth,N/A
Morphological anomaly,3374,Unilateral ocular duplication,Point prevalence,N/A
Clinical group,275803,Pulmonary arterial hypertension associated with congenital heart disease,Point prevalence,N/A
Clinical group,275803,Pulmonary arterial hypertension associated with congenital heart disease,Annual incidence,N/A
Clinical group,275803,Pulmonary arterial hypertension associated with congenital heart disease,Point prevalence,N/A
Clinical group,275803,Pulmonary arterial hypertension associated with congenital heart disease,Annual incidence,N/A
Clinical group,275803,Pulmonary arterial hypertension associated with congenital heart disease,Point prevalence,N/A
Clinical group,275803,Pulmonary arterial hypertension associated with congenital heart disease,Point prevalence,N/A
Clinical group,275803,Pulmonary arterial hypertension associated with congenital heart disease,Annual incidence,N/A
Clinical group,275803,Pulmonary arterial hypertension associated with congenital heart disease,Point prevalence,N/A
Clinical group,275803,Pulmonary arterial hypertension associated with congenital heart disease,Point prevalence,N/A
Clinical group,275808,Pulmonary arterial hypertension associated with HIV infection,Point prevalence,N/A
Clinical group,275813,Pulmonary arterial hypertension associated with portal hypertension,Point prevalence,N/A
Malformation syndrome,3377,Trismus-pseudocamptodactyly syndrome,Point prevalence,N/A
Clinical group,275823,Pulmonary arterial hypertension associated with schistosomiasis,Point prevalence,N/A
Malformation syndrome,3368,Trigonocephaly-bifid nose-acral anomalies syndrome,Cases/families,N/A
Malformation syndrome,3368,Trigonocephaly-bifid nose-acral anomalies syndrome,Point prevalence,N/A
Etiological subtype,275777,Heritable pulmonary arterial hypertension,Point prevalence,N/A
Etiological subtype,275777,Heritable pulmonary arterial hypertension,Point prevalence,N/A
Etiological subtype,275777,Heritable pulmonary arterial hypertension,Point prevalence,N/A
Disease,2302,Asbestos intoxication,Point prevalence,N/A
Disease,770,Rabies,Point prevalence,N/A
Disease,770,Rabies,Point prevalence,N/A
Disease,770,Rabies,Annual incidence,N/A
Clinical group,275798,Pulmonary arterial hypertension associated with connective tissue disease,Point prevalence,N/A
Clinical group,275798,Pulmonary arterial hypertension associated with connective tissue disease,Annual incidence,N/A
Clinical group,275798,Pulmonary arterial hypertension associated with connective tissue disease,Point prevalence,N/A
Clinical group,275798,Pulmonary arterial hypertension associated with connective tissue disease,Point prevalence,N/A
Clinical group,275798,Pulmonary arterial hypertension associated with connective tissue disease,Annual incidence,N/A
Clinical group,275798,Pulmonary arterial hypertension associated with connective tissue disease,Point prevalence,N/A
Clinical group,275798,Pulmonary arterial hypertension associated with connective tissue disease,Annual incidence,N/A
Clinical group,275798,Pulmonary arterial hypertension associated with connective tissue disease,Point prevalence,N/A
Disease,267,Calpain-3-related limb-girdle muscular dystrophy R1,Point prevalence,N/A
Disease,267,Calpain-3-related limb-girdle muscular dystrophy R1,Point prevalence,N/A
Disease,267,Calpain-3-related limb-girdle muscular dystrophy R1,Point prevalence,N/A
Disease,267,Calpain-3-related limb-girdle muscular dystrophy R1,Point prevalence,N/A
Morphological anomaly,1329,Complete atrioventricular septal defect,Point prevalence,N/A
Morphological anomaly,1329,Complete atrioventricular septal defect,Prevalence at birth,N/A
Etiological subtype,275766,Idiopathic pulmonary arterial hypertension,Point prevalence,N/A
Etiological subtype,275766,Idiopathic pulmonary arterial hypertension,Point prevalence,N/A
Etiological subtype,275766,Idiopathic pulmonary arterial hypertension,Annual incidence,N/A
Etiological subtype,275766,Idiopathic pulmonary arterial hypertension,Point prevalence,N/A
Etiological subtype,275766,Idiopathic pulmonary arterial hypertension,Annual incidence,N/A
Etiological subtype,275766,Idiopathic pulmonary arterial hypertension,Point prevalence,N/A
Etiological subtype,275766,Idiopathic pulmonary arterial hypertension,Annual incidence,N/A
Etiological subtype,275766,Idiopathic pulmonary arterial hypertension,Point prevalence,N/A
Etiological subtype,275766,Idiopathic pulmonary arterial hypertension,Annual incidence,N/A
Etiological subtype,275766,Idiopathic pulmonary arterial hypertension,Annual incidence,N/A
Etiological subtype,275766,Idiopathic pulmonary arterial hypertension,Point prevalence,N/A
Etiological subtype,275766,Idiopathic pulmonary arterial hypertension,Annual incidence,N/A
Etiological subtype,275766,Idiopathic pulmonary arterial hypertension,Annual incidence,N/A
Etiological subtype,275766,Idiopathic pulmonary arterial hypertension,Annual incidence,N/A
Etiological subtype,275766,Idiopathic pulmonary arterial hypertension,Point prevalence,N/A
Etiological subtype,275766,Idiopathic pulmonary arterial hypertension,Point prevalence,N/A
Disease,2137,Autoimmune hepatitis,Point prevalence,N/A
Disease,2137,Autoimmune hepatitis,Annual incidence,N/A
Disease,2137,Autoimmune hepatitis,Point prevalence,N/A
Disease,2137,Autoimmune hepatitis,Annual incidence,N/A
Disease,2137,Autoimmune hepatitis,Annual incidence,N/A
Disease,2137,Autoimmune hepatitis,Point prevalence,N/A
Disease,2137,Autoimmune hepatitis,Annual incidence,N/A
Disease,2137,Autoimmune hepatitis,Point prevalence,N/A
Disease,2137,Autoimmune hepatitis,Annual incidence,N/A
Disease,2137,Autoimmune hepatitis,Point prevalence,N/A
Disease,2137,Autoimmune hepatitis,Point prevalence,N/A
Disease,2137,Autoimmune hepatitis,Annual incidence,N/A
Disease,2137,Autoimmune hepatitis,Point prevalence,N/A
Disease,2137,Autoimmune hepatitis,Annual incidence,N/A
Disease,2137,Autoimmune hepatitis,Point prevalence,N/A
Disease,2137,Autoimmune hepatitis,Point prevalence,N/A
Disease,2137,Autoimmune hepatitis,Point prevalence,N/A
Disease,276145,Malignant epithelial tumor of salivary glands,Annual incidence,N/A
Disease,276145,Malignant epithelial tumor of salivary glands,Annual incidence,N/A
Disease,276145,Malignant epithelial tumor of salivary glands,Annual incidence,N/A
Disease,276145,Malignant epithelial tumor of salivary glands,Annual incidence,N/A
Disease,276145,Malignant epithelial tumor of salivary glands,Annual incidence,N/A
Disease,276145,Malignant epithelial tumor of salivary glands,Annual incidence,N/A
Disease,276145,Malignant epithelial tumor of salivary glands,Annual incidence,N/A
Disease,276145,Malignant epithelial tumor of salivary glands,Annual incidence,N/A
Disease,276145,Malignant epithelial tumor of salivary glands,Annual incidence,N/A
Disease,276145,Malignant epithelial tumor of salivary glands,Annual incidence,N/A
Disease,276145,Malignant epithelial tumor of salivary glands,Annual incidence,N/A
Disease,276145,Malignant epithelial tumor of salivary glands,Annual incidence,N/A
Disease,276145,Malignant epithelial tumor of salivary glands,Annual incidence,N/A
Disease,276145,Malignant epithelial tumor of salivary glands,Annual incidence,N/A
Disease,276145,Malignant epithelial tumor of salivary glands,Annual incidence,N/A
Disease,276145,Malignant epithelial tumor of salivary glands,Annual incidence,N/A
Disease,276145,Malignant epithelial tumor of salivary glands,Annual incidence,N/A
Disease,276145,Malignant epithelial tumor of salivary glands,Annual incidence,N/A
Disease,276145,Malignant epithelial tumor of salivary glands,Annual incidence,N/A
Disease,276145,Malignant epithelial tumor of salivary glands,Annual incidence,N/A
Disease,276145,Malignant epithelial tumor of salivary glands,Annual incidence,N/A
Disease,276145,Malignant epithelial tumor of salivary glands,Annual incidence,N/A
Disease,276145,Malignant epithelial tumor of salivary glands,Annual incidence,N/A
Disease,276145,Malignant epithelial tumor of salivary glands,Annual incidence,N/A
Clinical group,276161,Multiple endocrine neoplasia,Annual incidence,N/A
Clinical group,276161,Multiple endocrine neoplasia,Point prevalence,N/A
Malformation syndrome,3412,VACTERL with hydrocephalus,Cases/families,N/A
Malformation syndrome,3412,VACTERL with hydrocephalus,Point prevalence,N/A
Disease,276152,Multiple endocrine neoplasia type 4,Point prevalence,N/A
Morphological anomaly,3403,Uhl anomaly,Cases/families,N/A
Morphological anomaly,3403,Uhl anomaly,Prevalence at birth,N/A
Morphological anomaly,3403,Uhl anomaly,Point prevalence,N/A
Malformation syndrome,3404,Ulbright-Hodes syndrome,Cases/families,N/A
Malformation syndrome,3404,Ulbright-Hodes syndrome,Point prevalence,N/A
Disease,276066,Bile acid CoA ligase deficiency and defective amidation,Point prevalence,N/A
Disease,275872,Frontotemporal dementia with motor neuron disease,Point prevalence,N/A
Malformation syndrome,3383,Humerus trochlea aplasia,Cases/families,N/A
Malformation syndrome,3383,Humerus trochlea aplasia,Point prevalence,N/A
Disease,1656,Dermatitis herpetiformis,Point prevalence,N/A
Disease,1656,Dermatitis herpetiformis,Annual incidence,N/A
Disease,1656,Dermatitis herpetiformis,Annual incidence,N/A
Disease,1656,Dermatitis herpetiformis,Point prevalence,N/A
Disease,1656,Dermatitis herpetiformis,Annual incidence,N/A
Disease,1656,Dermatitis herpetiformis,Point prevalence,N/A
Disease,1656,Dermatitis herpetiformis,Annual incidence,N/A
Disease,1656,Dermatitis herpetiformis,Point prevalence,N/A
Disease,1656,Dermatitis herpetiformis,Annual incidence,N/A
Disease,1656,Dermatitis herpetiformis,Point prevalence,N/A
Disease,1656,Dermatitis herpetiformis,Point prevalence,N/A
Disease,275864,Behavioral variant of frontotemporal dementia,Point prevalence,N/A
Disease,2929,Juvenile polyposis syndrome,Annual incidence,N/A
Disease,2929,Juvenile polyposis syndrome,Point prevalence,N/A
Disease,3387,Isolated anterior cervical hypertrichosis,Cases/families,N/A
Disease,3387,Isolated anterior cervical hypertrichosis,Point prevalence,N/A
Disease,131,Budd-Chiari syndrome,Point prevalence,N/A
Disease,131,Budd-Chiari syndrome,Annual incidence,N/A
Disease,131,Budd-Chiari syndrome,Point prevalence,N/A
Disease,131,Budd-Chiari syndrome,Annual incidence,N/A
Disease,131,Budd-Chiari syndrome,Annual incidence,N/A
Disease,131,Budd-Chiari syndrome,Point prevalence,N/A
Disease,131,Budd-Chiari syndrome,Annual incidence,N/A
Disease,131,Budd-Chiari syndrome,Annual incidence,N/A
Disease,131,Budd-Chiari syndrome,Annual incidence,N/A
Disease,131,Budd-Chiari syndrome,Point prevalence,N/A
Disease,131,Budd-Chiari syndrome,Annual incidence,N/A
Disease,131,Budd-Chiari syndrome,Point prevalence,N/A
Disease,646,Niemann-Pick disease type C,Point prevalence,N/A
Disease,646,Niemann-Pick disease type C,Prevalence at birth,N/A
Disease,646,Niemann-Pick disease type C,Prevalence at birth,N/A
Disease,646,Niemann-Pick disease type C,Prevalence at birth,N/A
Disease,646,Niemann-Pick disease type C,Prevalence at birth,N/A
Disease,646,Niemann-Pick disease type C,Prevalence at birth,N/A
Disease,646,Niemann-Pick disease type C,Prevalence at birth,N/A
Disease,646,Niemann-Pick disease type C,Prevalence at birth,N/A
Disease,646,Niemann-Pick disease type C,Prevalence at birth,N/A
Disease,654,Nephroblastoma,Annual incidence,N/A
Disease,654,Nephroblastoma,Point prevalence,N/A
Disease,654,Nephroblastoma,Lifetime Prevalence,N/A
Disease,654,Nephroblastoma,Annual incidence,N/A
Disease,654,Nephroblastoma,Prevalence at birth,N/A
Disease,654,Nephroblastoma,Annual incidence,N/A
Disease,654,Nephroblastoma,Annual incidence,N/A
Disease,654,Nephroblastoma,Annual incidence,N/A
Disease,654,Nephroblastoma,Annual incidence,N/A
Disease,654,Nephroblastoma,Annual incidence,N/A
Disease,654,Nephroblastoma,Annual incidence,N/A
Disease,654,Nephroblastoma,Annual incidence,N/A
Disease,654,Nephroblastoma,Annual incidence,N/A
Disease,654,Nephroblastoma,Annual incidence,N/A
Disease,654,Nephroblastoma,Annual incidence,N/A
Disease,654,Nephroblastoma,Annual incidence,N/A
Disease,654,Nephroblastoma,Annual incidence,N/A
Disease,654,Nephroblastoma,Annual incidence,N/A
Disease,654,Nephroblastoma,Annual incidence,N/A
Disease,654,Nephroblastoma,Annual incidence,N/A
Disease,654,Nephroblastoma,Annual incidence,N/A
Disease,654,Nephroblastoma,Annual incidence,N/A
Disease,654,Nephroblastoma,Annual incidence,N/A
Disease,654,Nephroblastoma,Annual incidence,N/A
Disease,654,Nephroblastoma,Annual incidence,N/A
Disease,654,Nephroblastoma,Annual incidence,N/A
Disease,654,Nephroblastoma,Annual incidence,N/A
Malformation syndrome,3353,Trichodermodysplasia-dental alterations syndrome,Cases/families,N/A
Malformation syndrome,3353,Trichodermodysplasia-dental alterations syndrome,Point prevalence,N/A
Disease,275523,Dianzani autoimmune lymphoproliferative disease,Point prevalence,N/A
Disease,275523,Dianzani autoimmune lymphoproliferative disease,Cases/families,N/A
Malformation syndrome,3351,Trichodental syndrome,Cases/families,N/A
Malformation syndrome,3351,Trichodental syndrome,Point prevalence,N/A
Disease,275517,Autoimmune lymphoproliferative syndrome-recurrent viral infections due to CASP8 deficiency,Point prevalence,N/A
Disease,275517,Autoimmune lymphoproliferative syndrome-recurrent viral infections due to CASP8 deficiency,Cases/families,N/A
Malformation syndrome,3352,Tricho-dento-osseous syndrome,Cases/families,N/A
Malformation syndrome,3352,Tricho-dento-osseous syndrome,Point prevalence,N/A
Disease,3350,Tremor-nystagmus-duodenal ulcer syndrome,Cases/families,N/A
Disease,3350,Tremor-nystagmus-duodenal ulcer syndrome,Point prevalence,N/A
Malformation syndrome,3344,Weismann-Netter syndrome,Cases/families,N/A
Malformation syndrome,3344,Weismann-Netter syndrome,Point prevalence,N/A
Clinical syndrome,3347,Mounier-Khn syndrome,Cases/families,N/A
Clinical syndrome,3347,Mounier-Khn syndrome,Point prevalence,N/A
Malformation syndrome,3341,Torticollis-keloids-cryptorchidism-renal dysplasia syndrome,Cases/families,N/A
Malformation syndrome,3341,Torticollis-keloids-cryptorchidism-renal dysplasia syndrome,Point prevalence,N/A
Malformation syndrome,3342,Arterial tortuosity syndrome,Cases/families,N/A
Malformation syndrome,3342,Arterial tortuosity syndrome,Point prevalence,N/A
Malformation syndrome,3339,Oculoectodermal syndrome,Cases/families,N/A
Malformation syndrome,3339,Oculoectodermal syndrome,Point prevalence,N/A
Disease,271861,Hereditary ATTR amyloidosis,Point prevalence,N/A
Disease,271861,Hereditary ATTR amyloidosis,Point prevalence,N/A
Disease,271861,Hereditary ATTR amyloidosis,Point prevalence,N/A
Disease,271861,Hereditary ATTR amyloidosis,Point prevalence,N/A
Disease,271861,Hereditary ATTR amyloidosis,Point prevalence,N/A
Disease,271861,Hereditary ATTR amyloidosis,Point prevalence,N/A
Disease,271861,Hereditary ATTR amyloidosis,Point prevalence,N/A
Disease,271861,Hereditary ATTR amyloidosis,Point prevalence,N/A
Disease,271861,Hereditary ATTR amyloidosis,Point prevalence,N/A
Disease,271861,Hereditary ATTR amyloidosis,Point prevalence,N/A
Disease,271861,Hereditary ATTR amyloidosis,Point prevalence,N/A
Disease,271861,Hereditary ATTR amyloidosis,Point prevalence,N/A
Disease,271861,Hereditary ATTR amyloidosis,Point prevalence,N/A
Disease,271861,Hereditary ATTR amyloidosis,Point prevalence,N/A
Disease,271861,Hereditary ATTR amyloidosis,Point prevalence,N/A
Disease,271861,Hereditary ATTR amyloidosis,Point prevalence,N/A
Disease,271861,Hereditary ATTR amyloidosis,Point prevalence,N/A
Disease,271861,Hereditary ATTR amyloidosis,Point prevalence,N/A
Disease,271861,Hereditary ATTR amyloidosis,Point prevalence,N/A
Disease,271861,Hereditary ATTR amyloidosis,Point prevalence,N/A
Disease,271861,Hereditary ATTR amyloidosis,Point prevalence,N/A
Disease,271861,Hereditary ATTR amyloidosis,Point prevalence,N/A
Disease,271861,Hereditary ATTR amyloidosis,Point prevalence,N/A
Disease,271861,Hereditary ATTR amyloidosis,Point prevalence,N/A
Disease,271861,Hereditary ATTR amyloidosis,Point prevalence,N/A
Disease,271861,Hereditary ATTR amyloidosis,Point prevalence,N/A
Disease,271861,Hereditary ATTR amyloidosis,Point prevalence,N/A
Disease,271861,Hereditary ATTR amyloidosis,Point prevalence,N/A
Disease,271861,Hereditary ATTR amyloidosis,Point prevalence,N/A
Disease,271861,Hereditary ATTR amyloidosis,Point prevalence,N/A
Disease,271861,Hereditary ATTR amyloidosis,Lifetime Prevalence,N/A
Disease,271861,Hereditary ATTR amyloidosis,Point prevalence,N/A
Disease,271861,Hereditary ATTR amyloidosis,Point prevalence,N/A
Disease,271861,Hereditary ATTR amyloidosis,Point prevalence,N/A
Disease,271861,Hereditary ATTR amyloidosis,Point prevalence,N/A
Disease,271861,Hereditary ATTR amyloidosis,Point prevalence,N/A
Disease,271861,Hereditary ATTR amyloidosis,Point prevalence,N/A
Disease,271861,Hereditary ATTR amyloidosis,Point prevalence,N/A
Disease,271861,Hereditary ATTR amyloidosis,Point prevalence,N/A
Disease,271861,Hereditary ATTR amyloidosis,Point prevalence,N/A
Disease,271861,Hereditary ATTR amyloidosis,Point prevalence,N/A
Malformation syndrome,3338,Toriello-Carey syndrome,Cases/families,N/A
Malformation syndrome,3338,Toriello-Carey syndrome,Point prevalence,N/A
Malformation syndrome,3469,XK aprosencephaly syndrome,Cases/families,N/A
Malformation syndrome,3469,XK aprosencephaly syndrome,Point prevalence,N/A
Malformation syndrome,3472,Yunis-Varon syndrome,Cases/families,N/A
Malformation syndrome,3472,Yunis-Varon syndrome,Point prevalence,N/A
Disease,3471,Young syndrome,Point prevalence,N/A
Disease,3319,Congenital amegakaryocytic thrombocytopenia,Point prevalence,N/A
Disease,3319,Congenital amegakaryocytic thrombocytopenia,Cases/families,N/A
Disease,3319,Congenital amegakaryocytic thrombocytopenia,Prevalence at birth,N/A
Malformation syndrome,3473,Zimmermann-Laband syndrome,Cases/families,N/A
Malformation syndrome,3473,Zimmermann-Laband syndrome,Point prevalence,N/A
Malformation syndrome,3459,Wilson-Turner syndrome,Cases/families,N/A
Malformation syndrome,3459,Wilson-Turner syndrome,Point prevalence,N/A
Disease,3464,Woodhouse-Sakati syndrome,Cases/families,N/A
Disease,3464,Woodhouse-Sakati syndrome,Point prevalence,N/A
Disease,3466,WT limb-blood syndrome,Cases/families,N/A
Disease,3466,WT limb-blood syndrome,Point prevalence,N/A
Malformation syndrome,3465,Worster-Drought syndrome,Point prevalence,N/A
Clinical group,2749,Oromandibular-limb hypogenesis syndrome,Point prevalence,N/A
Malformation syndrome,2995,Baraitser-Winter cerebrofrontofacial syndrome,Cases/families,N/A
Malformation syndrome,2995,Baraitser-Winter cerebrofrontofacial syndrome,Point prevalence,N/A
Malformation syndrome,3200,Arthrogryposis-ectodermal dysplasia syndrome,Cases/families,N/A
Malformation syndrome,3200,Arthrogryposis-ectodermal dysplasia syndrome,Point prevalence,N/A
Malformation syndrome,1570,Symbrachydactyly of hands and feet,Cases/families,N/A
Malformation syndrome,1570,Symbrachydactyly of hands and feet,Point prevalence,N/A
Disease,3243,Sweet syndrome,Point prevalence,N/A
Malformation syndrome,1827,Acromelic frontonasal dysplasia,Cases/families,N/A
Malformation syndrome,1827,Acromelic frontonasal dysplasia,Point prevalence,N/A
Clinical group,2076,X-linked intellectual disability-epilepsy syndrome,Point prevalence,N/A
Histopathological subtype,268980,Isolated focal cortical dysplasia type Ib,Point prevalence,N/A
Histopathological subtype,268987,Isolated focal cortical dysplasia type Ic,Point prevalence,N/A
Malformation syndrome,3424,Velo-facial-skeletal syndrome,Cases/families,N/A
Malformation syndrome,3424,Velo-facial-skeletal syndrome,Point prevalence,N/A
Histopathological subtype,268973,Isolated focal cortical dysplasia type Ia,Point prevalence,N/A
Histopathological subtype,269008,Isolated focal cortical dysplasia type IIb,Point prevalence,N/A
Malformation syndrome,3433,Microcephaly-brachydactyly-kyphoscoliosis syndrome,Cases/families,N/A
Malformation syndrome,3433,Microcephaly-brachydactyly-kyphoscoliosis syndrome,Point prevalence,N/A
Clinical subtype,268994,Isolated focal cortical dysplasia type II,Point prevalence,N/A
Malformation syndrome,3429,Verloove Vanhorick-Brubakk syndrome,Cases/families,N/A
Malformation syndrome,3429,Verloove Vanhorick-Brubakk syndrome,Point prevalence,N/A
Histopathological subtype,269001,Isolated focal cortical dysplasia type IIa,Point prevalence,N/A
Malformation syndrome,2460,Van den Ende-Gupta syndrome,Cases/families,N/A
Malformation syndrome,2460,Van den Ende-Gupta syndrome,Point prevalence,N/A
Morphological anomaly,268940,Bilateral polymicrogyria,Point prevalence,N/A
Morphological anomaly,268943,Unilateral polymicrogyria,Point prevalence,N/A
Malformation syndrome,3416,Hyperostosis corticalis generalisata,Cases/families,N/A
Malformation syndrome,3416,Hyperostosis corticalis generalisata,Point prevalence,N/A
Category,268926,Midline cerebral malformation,Point prevalence,N/A
Morphological anomaly,268936,Isolated arhinencephaly,Point prevalence,N/A
Clinical subtype,268961,Isolated focal cortical dysplasia type I,Point prevalence,N/A
Clinical subtype,268947,Unilateral focal polymicrogyria,Point prevalence,N/A
Malformation syndrome,3417,Van den Bosch syndrome,Cases/families,N/A
Malformation syndrome,3417,Van den Bosch syndrome,Point prevalence,N/A
Clinical group,268950,Cerebral cortical dysplasia,Point prevalence,N/A
Morphological anomaly,269229,Pontine tegmental cap dysplasia,Cases/families,N/A
Morphological anomaly,269229,Pontine tegmental cap dysplasia,Point prevalence,N/A
Disease,3453,Autoimmune polyendocrinopathy type 1,Point prevalence,N/A
Disease,3453,Autoimmune polyendocrinopathy type 1,Point prevalence,N/A
Disease,3453,Autoimmune polyendocrinopathy type 1,Point prevalence,N/A
Category,269224,Global cerebellar malformation,Point prevalence,N/A
Malformation syndrome,3448,Weaver-Williams syndrome,Cases/families,N/A
Malformation syndrome,3448,Weaver-Williams syndrome,Point prevalence,N/A
Morphological anomaly,269221,Isolated bilateral hemispheric cerebellar hypoplasia,Point prevalence,N/A
Malformation syndrome,3449,Weill-Marchesani syndrome,Point prevalence,N/A
Morphological anomaly,269218,Isolated unilateral hemispheric cerebellar hypoplasia,Point prevalence,N/A
Malformation syndrome,3456,Wildervanck syndrome,Point prevalence,N/A
Clinical subtype,269510,Congenital non-communicating hydrocephalus,Point prevalence,N/A
Malformation syndrome,3454,Wieacker-Wolff syndrome,Cases/families,N/A
Malformation syndrome,3454,Wieacker-Wolff syndrome,Point prevalence,N/A
Malformation syndrome,3455,Wiedemann-Rautenstrauch syndrome,Cases/families,N/A
Malformation syndrome,3455,Wiedemann-Rautenstrauch syndrome,Point prevalence,N/A
Clinical subtype,269505,Congenital communicating hydrocephalus,Point prevalence,N/A
Morphological anomaly,269203,Isolated cerebellar vermis agenesis,Point prevalence,N/A
Morphological anomaly,269197,Glioependymal/ependymal cyst,Point prevalence,N/A
Malformation syndrome,3434,MMEP syndrome,Point prevalence,N/A
Clinical subtype,269215,Isolated Dandy-Walker malformation without hydrocephalus,Point prevalence,N/A
Clinical subtype,269212,Isolated Dandy-Walker malformation with hydrocephalus,Point prevalence,N/A
Clinical subtype,269209,Isolated partial cerebellar vermis agenesis,Point prevalence,N/A
Clinical subtype,269206,Isolated total cerebellar vermis agenesis,Point prevalence,N/A
Disease,1856,Spondyloperipheral dysplasia-short ulna syndrome,Point prevalence,N/A
Disease,1856,Spondyloperipheral dysplasia-short ulna syndrome,Cases/families,N/A
Clinical subtype,280302,Autoimmune pancreatitis type 1,Point prevalence,N/A
Disease,280333,Alpha-dystroglycan-related limb-girdle muscular dystrophy R16,Cases/families,N/A
Disease,280333,Alpha-dystroglycan-related limb-girdle muscular dystrophy R16,Point prevalence,N/A
Malformation syndrome,280325,Distal deletion 12p syndrome,Cases/families,N/A
Malformation syndrome,280325,Distal deletion 12p syndrome,Point prevalence,N/A
Clinical subtype,280293,Pelizaeus-Merzbacher-like disease due to AIMP1 mutation,Point prevalence,N/A
Clinical subtype,280288,Pelizaeus-Merzbacher-like disease due to HSPD1 mutation,Point prevalence,N/A
Malformation syndrome,3194,Corneodermatoosseous syndrome,Cases/families,N/A
Malformation syndrome,3194,Corneodermatoosseous syndrome,Point prevalence,N/A
Disease,280365,Autosomal semi-dominant severe lipodystrophic laminopathy,Cases/families,N/A
Disease,280365,Autosomal semi-dominant severe lipodystrophic laminopathy,Point prevalence,N/A
Disease,280379,Erythropoietic uroporphyria associated with myeloid malignancy,Point prevalence,N/A
Disease,3197,Hereditary hyperekplexia,Cases/families,N/A
Disease,3197,Hereditary hyperekplexia,Point prevalence,N/A
Malformation syndrome,3199,Stimmler syndrome,Cases/families,N/A
Malformation syndrome,3199,Stimmler syndrome,Point prevalence,N/A
Malformation syndrome,3184,Steatocystoma multiplex-natal teeth syndrome,Point prevalence,N/A
Malformation syndrome,3186,Holoprosencephaly-radial heart renal anomalies syndrome,Cases/families,N/A
Malformation syndrome,3186,Holoprosencephaly-radial heart renal anomalies syndrome,Point prevalence,N/A
Malformation syndrome,3191,Subaortic stenosis-short stature syndrome,Cases/families,N/A
Malformation syndrome,3191,Subaortic stenosis-short stature syndrome,Point prevalence,N/A
Morphological anomaly,3193,Supravalvular aortic stenosis,Prevalence at birth,N/A
Morphological anomaly,3193,Supravalvular aortic stenosis,Point prevalence,N/A
Disease,280356,PLIN1-related familial partial lipodystrophy,Cases/families,N/A
Disease,280356,PLIN1-related familial partial lipodystrophy,Point prevalence,N/A
Malformation syndrome,3214,"Deaf blind hypopigmentation syndrome, Yemenite type",Cases/families,N/A
Malformation syndrome,3214,"Deaf blind hypopigmentation syndrome, Yemenite type",Point prevalence,N/A
Malformation syndrome,280403,Familial omphalocele syndrome with facial dysmorphism,Cases/families,N/A
Malformation syndrome,280403,Familial omphalocele syndrome with facial dysmorphism,Point prevalence,N/A
Disease,280406,Familial steroid-resistant nephrotic syndrome with sensorineural deafness,Cases/families,N/A
Disease,280406,Familial steroid-resistant nephrotic syndrome with sensorineural deafness,Point prevalence,N/A
Malformation syndrome,3201,Ventricular extrasystoles with syncopal episodes-perodactyly-Robin sequence syndrome,Point prevalence,N/A
Disease,280384,Recessive intellectual disability-motor dysfunction-multiple joint contractures syndrome,Cases/families,N/A
Disease,280384,Recessive intellectual disability-motor dysfunction-multiple joint contractures syndrome,Point prevalence,N/A
Disease,280397,Familial Alzheimer-like prion disease,Cases/families,N/A
Disease,280397,Familial Alzheimer-like prion disease,Point prevalence,N/A
Malformation syndrome,280576,Nestor-Guillermo progeria syndrome,Cases/families,N/A
Malformation syndrome,280576,Nestor-Guillermo progeria syndrome,Point prevalence,N/A
Malformation syndrome,3220,Deafness-enamel hypoplasia-nail defects syndrome,Cases/families,N/A
Malformation syndrome,3220,Deafness-enamel hypoplasia-nail defects syndrome,Point prevalence,N/A
Malformation syndrome,3219,Fountain syndrome,Cases/families,N/A
Malformation syndrome,3219,Fountain syndrome,Point prevalence,N/A
Disease,3222,Phosphoribosylpyrophosphate synthetase superactivity,Cases/families,N/A
Disease,3222,Phosphoribosylpyrophosphate synthetase superactivity,Point prevalence,N/A
Malformation syndrome,280586,"Chondrodysplasia with joint dislocations, gPAPP type",Cases/families,N/A
Malformation syndrome,280586,"Chondrodysplasia with joint dislocations, gPAPP type",Point prevalence,N/A
Disease,3217,Deafness-small bowel diverticulosis-neuropathy syndrome,Cases/families,N/A
Disease,3217,Deafness-small bowel diverticulosis-neuropathy syndrome,Point prevalence,N/A
Disease,280553,Fatal infantile hypertonic myofibrillar myopathy,Cases/families,N/A
Disease,280553,Fatal infantile hypertonic myofibrillar myopathy,Point prevalence,N/A
Malformation syndrome,280558,Warsaw breakage syndrome,Cases/families,N/A
Malformation syndrome,280558,Warsaw breakage syndrome,Point prevalence,N/A
Malformation syndrome,3216,Conductive deafness-malformed external ear syndrome,Cases/families,N/A
Malformation syndrome,3216,Conductive deafness-malformed external ear syndrome,Point prevalence,N/A
Malformation syndrome,3218,Deafness-epiphyseal dysplasia-short stature syndrome,Cases/families,N/A
Malformation syndrome,3218,Deafness-epiphyseal dysplasia-short stature syndrome,Point prevalence,N/A
Malformation syndrome,647,Nijmegen breakage syndrome,Prevalence at birth,N/A
Malformation syndrome,647,Nijmegen breakage syndrome,Point prevalence,N/A
Malformation syndrome,647,Nijmegen breakage syndrome,Point prevalence,N/A
Malformation syndrome,647,Nijmegen breakage syndrome,Point prevalence,N/A
Malformation syndrome,647,Nijmegen breakage syndrome,Point prevalence,N/A
Malformation syndrome,647,Nijmegen breakage syndrome,Point prevalence,N/A
Malformation syndrome,647,Nijmegen breakage syndrome,Point prevalence,N/A
Malformation syndrome,647,Nijmegen breakage syndrome,Point prevalence,N/A
Disease,280062,Calciphylaxis,Point prevalence,N/A
Clinical syndrome,279947,Postorgasmic illness syndrome,Point prevalence,N/A
Clinical syndrome,279947,Postorgasmic illness syndrome,Cases/families,N/A
Disease,1267,Botulism,Annual incidence,N/A
Disease,1267,Botulism,Point prevalence,N/A
Disease,1267,Botulism,Annual incidence,N/A
Disease,1267,Botulism,Annual incidence,N/A
Disease,1267,Botulism,Annual incidence,N/A
Disease,1267,Botulism,Annual incidence,N/A
Disease,1267,Botulism,Annual incidence,N/A
Disease,1267,Botulism,Annual incidence,N/A
Disease,1267,Botulism,Annual incidence,N/A
Disease,1267,Botulism,Annual incidence,N/A
Disease,1267,Botulism,Annual incidence,N/A
Disease,1267,Botulism,Annual incidence,N/A
Disease,1267,Botulism,Annual incidence,N/A
Disease,1267,Botulism,Annual incidence,N/A
Disease,1267,Botulism,Annual incidence,N/A
Disease,1267,Botulism,Annual incidence,N/A
Disease,1267,Botulism,Annual incidence,N/A
Disease,1267,Botulism,Annual incidence,N/A
Disease,1267,Botulism,Annual incidence,N/A
Disease,1267,Botulism,Annual incidence,N/A
Disease,1267,Botulism,Annual incidence,N/A
Disease,1267,Botulism,Annual incidence,N/A
Disease,1267,Botulism,Annual incidence,N/A
Disease,1267,Botulism,Annual incidence,N/A
Disease,1267,Botulism,Annual incidence,N/A
Disease,2897,Pityriasis rubra pilaris,Cases/families,N/A
Disease,2897,Pityriasis rubra pilaris,Point prevalence,N/A
Malformation syndrome,3163,SHORT syndrome,Cases/families,N/A
Malformation syndrome,3163,SHORT syndrome,Point prevalence,N/A
Malformation syndrome,1479,Atrial septal defect-atrioventricular conduction defects syndrome,Cases/families,N/A
Malformation syndrome,1479,Atrial septal defect-atrioventricular conduction defects syndrome,Point prevalence,N/A
Disease,280071,ALG11-CDG,Cases/families,N/A
Disease,280071,ALG11-CDG,Point prevalence,N/A
Malformation syndrome,3157,Septo-optic dysplasia spectrum,Prevalence at birth,N/A
Malformation syndrome,3157,Septo-optic dysplasia spectrum,Point prevalence,N/A
Disease,2070,Eosinophilic gastroenteritis,Cases/families,N/A
Disease,2070,Eosinophilic gastroenteritis,Point prevalence,N/A
Disease,2070,Eosinophilic gastroenteritis,Point prevalence,N/A
Disease,183707,Infantile LAD-like disease due to RAC2 deficiency,Cases/families,N/A
Disease,183707,Infantile LAD-like disease due to RAC2 deficiency,Point prevalence,N/A
Disease,2314,Autosomal dominant hyper-IgE syndrome due to STAT3 deficiency,Annual incidence,N/A
Disease,2314,Autosomal dominant hyper-IgE syndrome due to STAT3 deficiency,Point prevalence,N/A
Malformation syndrome,3177,Spinocerebellar degeneration-corneal dystrophy syndrome,Cases/families,N/A
Malformation syndrome,3177,Spinocerebellar degeneration-corneal dystrophy syndrome,Point prevalence,N/A
Clinical subtype,280205,Laryngotracheoesophageal cleft type 0,Point prevalence,N/A
Disease,3175,X-linked spasticity-intellectual disability-epilepsy syndrome,Cases/families,N/A
Disease,3175,X-linked spasticity-intellectual disability-epilepsy syndrome,Point prevalence,N/A
Clinical subtype,280195,Septopreoptic holoprosencephaly,Point prevalence,N/A
Malformation syndrome,3172,Eyebrow duplication-syndactyly syndrome,Cases/families,N/A
Malformation syndrome,3172,Eyebrow duplication-syndactyly syndrome,Point prevalence,N/A
Biological anomaly,280183,Methylmalonic aciduria due to transcobalamin receptor defect,Cases/families,N/A
Biological anomaly,280183,Methylmalonic aciduria due to transcobalamin receptor defect,Point prevalence,N/A
Clinical subtype,280282,Pelizaeus-Merzbacher-like disease due to GJC2 mutation,Point prevalence,N/A
Disease,280270,Pelizaeus-Merzbacher-like disease,Point prevalence,N/A
Disease,183675,Recurrent infections associated with rare immunoglobulin isotypes deficiency,Point prevalence,N/A
Malformation syndrome,2177,Hydranencephaly,Prevalence at birth,N/A
Malformation syndrome,2177,Hydranencephaly,Point prevalence,N/A
Malformation syndrome,2177,Hydranencephaly,Prevalence at birth,N/A
Malformation syndrome,2177,Hydranencephaly,Prevalence at birth,N/A
Malformation syndrome,3258,Cenani-Lenz syndrome,Cases/families,N/A
Malformation syndrome,3258,Cenani-Lenz syndrome,Point prevalence,N/A
Disease,276575,Autosomal dominant hyperinsulinism due to SUR1 deficiency,Point prevalence,N/A
Malformation syndrome,3262,Dobrow syndrome,Cases/families,N/A
Malformation syndrome,3262,Dobrow syndrome,Point prevalence,N/A
Disease,276598,Diazoxide-resistant focal hyperinsulinism due to SUR1 deficiency,Point prevalence,N/A
Disease,276608,Non-insulinoma pancreatogenous hypoglycemia syndrome,Point prevalence,N/A
Morphological anomaly,3265,Isolated humero-radial synostosis,Cases/families,N/A
Morphological anomaly,3265,Isolated humero-radial synostosis,Point prevalence,N/A
Disease,276603,Diazoxide-resistant focal hyperinsulinism due to Kir6.2 deficiency,Point prevalence,N/A
Morphological anomaly,3266,Isolated humero-radio-ulnar synostosis,Cases/families,N/A
Morphological anomaly,3266,Isolated humero-radio-ulnar synostosis,Point prevalence,N/A
Disease,276621,Sporadic pheochromocytoma/secreting paraganglioma,Point prevalence,N/A
Disease,183713,OBSOLETE:Bacterial susceptibility due to TLR signaling pathway deficiency,Cases/families,N/A
Disease,183713,OBSOLETE:Bacterial susceptibility due to TLR signaling pathway deficiency,Point prevalence,N/A
Disease,2380,Legg-Calv-Perthes disease,Point prevalence,N/A
Malformation syndrome,276630,Symptomatic form of Coffin-Lowry syndrome in female carriers,Point prevalence,N/A
Malformation syndrome,3270,Radioulnar synostosis-developmental delay-hypotonia syndrome,Cases/families,N/A
Malformation syndrome,3270,Radioulnar synostosis-developmental delay-hypotonia syndrome,Point prevalence,N/A
Malformation syndrome,3275,Spondylocarpotarsal synostosis,Cases/families,N/A
Malformation syndrome,3275,Spondylocarpotarsal synostosis,Point prevalence,N/A
Disease,425,Apolipoprotein A-I deficiency,Cases/families,N/A
Disease,425,Apolipoprotein A-I deficiency,Point prevalence,N/A
Disease,425,Apolipoprotein A-I deficiency,Point prevalence,N/A
Malformation syndrome,3291,Teebi-Shaltout syndrome,Cases/families,N/A
Malformation syndrome,3291,Teebi-Shaltout syndrome,Point prevalence,N/A
Malformation syndrome,3293,Telecanthus-hypertelorism-strabismus-pes cavus syndrome,Cases/families,N/A
Malformation syndrome,3293,Telecanthus-hypertelorism-strabismus-pes cavus syndrome,Point prevalence,N/A
Malformation syndrome,3292,Tel Hashomer camptodactyly syndrome,Point prevalence,N/A
Clinical syndrome,279882,Spasmus nutans,Point prevalence,N/A
Malformation syndrome,3294,Extensor tendons of finger anomalies,Cases/families,N/A
Malformation syndrome,3294,Extensor tendons of finger anomalies,Point prevalence,N/A
Clinical subtype,279888,Acute endophthalmitis,Point prevalence,N/A
Clinical subtype,279891,Chronic endophthalmitis,Point prevalence,N/A
Disease,897,Waardenburg-Shah syndrome,Cases/families,N/A
Disease,897,Waardenburg-Shah syndrome,Point prevalence,N/A
Malformation syndrome,3301,Tetraamelia-multiple malformations syndrome,Point prevalence,N/A
Malformation syndrome,3301,Tetraamelia-multiple malformations syndrome,Cases/families,N/A
Disease,279897,Primary oculocerebral lymphoma,Point prevalence,N/A
Disease,279904,Primary intraocular lymphoma,Point prevalence,N/A
Malformation syndrome,3027,Caudal regression syndrome,Point prevalence,N/A
Malformation syndrome,3027,Caudal regression syndrome,Prevalence at birth,N/A
Malformation syndrome,3027,Caudal regression syndrome,Prevalence at birth,N/A
Malformation syndrome,3312,Thalidomide embryopathy,Point prevalence,N/A
Disease,279914,Intermediate uveitis,Point prevalence,N/A
Disease,643,Giant axonal neuropathy,Cases/families,N/A
Disease,643,Giant axonal neuropathy,Point prevalence,N/A
Disease,276193,Spinocerebellar ataxia type 35,Cases/families,N/A
Disease,276193,Spinocerebellar ataxia type 35,Point prevalence,N/A
Disease,276183,Spinocerebellar ataxia type 32,Cases/families,N/A
Disease,276183,Spinocerebellar ataxia type 32,Point prevalence,N/A
Disease,2828,Young-onset Parkinson disease,Point prevalence,N/A
Disease,2828,Young-onset Parkinson disease,Point prevalence,N/A
Clinical subtype,276238,Machado-Joseph disease type 1,Point prevalence,N/A
Disease,276234,Non-syndromic male infertility due to sperm motility disorder,Point prevalence,N/A
Malformation syndrome,638,Neurofibromatosis-Noonan syndrome,Point prevalence,N/A
Clinical group,3231,Deafness-onychodystrophy syndrome,Cases/families,N/A
Clinical group,3231,Deafness-onychodystrophy syndrome,Point prevalence,N/A
Disease,526,Liddle syndrome,Cases/families,N/A
Disease,526,Liddle syndrome,Point prevalence,N/A
Clinical subtype,276241,Machado-Joseph disease type 2,Point prevalence,N/A
Disease,427,Familial hypoaldosteronism,Point prevalence,N/A
Disease,215,Congenital stationary night blindness,Point prevalence,N/A
Malformation syndrome,3232,Deafness-ear malformation-facial palsy syndrome,Cases/families,N/A
Malformation syndrome,3232,Deafness-ear malformation-facial palsy syndrome,Point prevalence,N/A
Malformation syndrome,3233,Cochleosaccular degeneration-cataract syndrome,Cases/families,N/A
Malformation syndrome,3233,Cochleosaccular degeneration-cataract syndrome,Point prevalence,N/A
Disease,180,Choroideremia,Point prevalence,N/A
Malformation syndrome,276280,Hemihyperplasia-multiple lipomatosis syndrome,Cases/families,N/A
Malformation syndrome,276280,Hemihyperplasia-multiple lipomatosis syndrome,Point prevalence,N/A
Disease,276399,Familial multinodular goiter,Point prevalence,N/A
Malformation syndrome,3239,Deafness-vitiligo-achalasia syndrome,Cases/families,N/A
Malformation syndrome,3239,Deafness-vitiligo-achalasia syndrome,Point prevalence,N/A
Category,183518,Hereditary ataxia,Point prevalence,N/A
Malformation syndrome,3237,Multiple synostoses syndrome,Cases/families,N/A
Malformation syndrome,3237,Multiple synostoses syndrome,Point prevalence,N/A
Disease,403,Familial hyperaldosteronism type I,Point prevalence,N/A
Malformation syndrome,276413,10q22.3q23.3 microdeletion syndrome,Point prevalence,N/A
Disease,653,Multiple endocrine neoplasia type 2,Point prevalence,N/A
Disease,653,Multiple endocrine neoplasia type 2,Point prevalence,N/A
Disease,276405,Hyperbiliverdinemia,Cases/families,N/A
Disease,276405,Hyperbiliverdinemia,Point prevalence,N/A
Disease,157,Carnitine palmitoyltransferase II deficiency,Cases/families,N/A
Disease,157,Carnitine palmitoyltransferase II deficiency,Point prevalence,N/A
Disease,157,Carnitine palmitoyltransferase II deficiency,Prevalence at birth,N/A
Disease,157,Carnitine palmitoyltransferase II deficiency,Point prevalence,N/A
Malformation syndrome,847,X-linked alpha-thalassemia-intellectual disability syndrome,Cases/families,N/A
Malformation syndrome,847,X-linked alpha-thalassemia-intellectual disability syndrome,Point prevalence,N/A
Malformation syndrome,3255,Filippi syndrome,Cases/families,N/A
Malformation syndrome,3255,Filippi syndrome,Point prevalence,N/A
Category,183435,Inherited ichthyosis,Point prevalence,N/A
Malformation syndrome,2268,ICF syndrome,Cases/families,N/A
Malformation syndrome,2268,ICF syndrome,Point prevalence,N/A
Malformation syndrome,3253,Cleft lip/palate-ectodermal dysplasia syndrome,Point prevalence,N/A
Malformation syndrome,3253,Cleft lip/palate-ectodermal dysplasia syndrome,Cases/families,N/A
Malformation syndrome,392,Holt-Oram syndrome,Prevalence at birth,N/A
Malformation syndrome,392,Holt-Oram syndrome,Prevalence at birth,N/A
Malformation syndrome,392,Holt-Oram syndrome,Point prevalence,N/A
Disease,3325,Heparin-induced thrombocytopenia,Point prevalence,N/A
Malformation syndrome,243,"46,XX gonadal dysgenesis",Point prevalence,N/A
Malformation syndrome,243,"46,XX gonadal dysgenesis",Prevalence at birth,N/A
Category,183422,Polymalformative genetic syndrome with increased risk of developing cancer,Point prevalence,N/A
Disease,136,Cerebral autosomal dominant arteriopathy-subcortical infarcts-leukoencephalopathy,Point prevalence,N/A
Disease,136,Cerebral autosomal dominant arteriopathy-subcortical infarcts-leukoencephalopathy,Point prevalence,N/A
Disease,136,Cerebral autosomal dominant arteriopathy-subcortical infarcts-leukoencephalopathy,Point prevalence,N/A
Category,182114,Rare urogenital tumor,Annual incidence,N/A
Category,182114,Rare urogenital tumor,Annual incidence,N/A
Morphological anomaly,48,Congenital bilateral absence of vas deferens,Point prevalence,N/A
Disease,424,Familial hyperthyroidism due to mutations in TSH receptor,Point prevalence,N/A
Disease,424,Familial hyperthyroidism due to mutations in TSH receptor,Cases/families,N/A
Disease,325,Congenital factor II deficiency,Point prevalence,N/A
Clinical subtype,343,Hyperimmunoglobulinemia D with periodic fever,Cases/families,N/A
Clinical subtype,343,Hyperimmunoglobulinemia D with periodic fever,Point prevalence,N/A
Disease,572,Immunodeficiency by defective expression of MHC class II,Cases/families,N/A
Disease,572,Immunodeficiency by defective expression of MHC class II,Point prevalence,N/A
Disease,1930,Herpes simplex virus encephalitis,Annual incidence,N/A
Disease,1930,Herpes simplex virus encephalitis,Annual incidence,N/A
Disease,1930,Herpes simplex virus encephalitis,Annual incidence,N/A
Disease,1930,Herpes simplex virus encephalitis,Point prevalence,N/A
Disease,158,Systemic primary carnitine deficiency,Prevalence at birth,N/A
Disease,158,Systemic primary carnitine deficiency,Prevalence at birth,N/A
Disease,158,Systemic primary carnitine deficiency,Prevalence at birth,N/A
Disease,158,Systemic primary carnitine deficiency,Prevalence at birth,N/A
Disease,158,Systemic primary carnitine deficiency,Point prevalence,N/A
Disease,158,Systemic primary carnitine deficiency,Annual incidence,N/A
Disease,158,Systemic primary carnitine deficiency,Point prevalence,N/A
Disease,2056,Essential fructosuria,Point prevalence,N/A
Clinical subtype,206436,Infantile Krabbe disease,Annual incidence,N/A
Clinical subtype,206436,Infantile Krabbe disease,Point prevalence,N/A
Disease,1344,Atrial standstill,Point prevalence,N/A
Clinical group,206428,Hypoxanthine-guanine phosphoribosyltransferase deficiency,Point prevalence,N/A
Malformation syndrome,3103,Roberts syndrome,Cases/families,N/A
Malformation syndrome,3103,Roberts syndrome,Point prevalence,N/A
Disease,832,Succinyl-CoA:3-oxoacid CoA transferase deficiency,Cases/families,N/A
Disease,832,Succinyl-CoA:3-oxoacid CoA transferase deficiency,Point prevalence,N/A
Disease,6,3-methylcrotonyl-CoA carboxylase deficiency,Prevalence at birth,N/A
Disease,6,3-methylcrotonyl-CoA carboxylase deficiency,Prevalence at birth,N/A
Disease,6,3-methylcrotonyl-CoA carboxylase deficiency,Prevalence at birth,N/A
Disease,6,3-methylcrotonyl-CoA carboxylase deficiency,Prevalence at birth,N/A
Disease,6,3-methylcrotonyl-CoA carboxylase deficiency,Point prevalence,N/A
Disease,6,3-methylcrotonyl-CoA carboxylase deficiency,Point prevalence,N/A
Malformation syndrome,888,Van der Woude syndrome,Point prevalence,N/A
Malformation syndrome,888,Van der Woude syndrome,Prevalence at birth,N/A
Malformation syndrome,888,Van der Woude syndrome,Point prevalence,N/A
Malformation syndrome,888,Van der Woude syndrome,Point prevalence,N/A
Malformation syndrome,888,Van der Woude syndrome,Prevalence at birth,N/A
Malformation syndrome,888,Van der Woude syndrome,Point prevalence,N/A
Malformation syndrome,888,Van der Woude syndrome,Prevalence at birth,N/A
Malformation syndrome,888,Van der Woude syndrome,Point prevalence,N/A
Malformation syndrome,888,Van der Woude syndrome,Point prevalence,N/A
Malformation syndrome,888,Van der Woude syndrome,Prevalence at birth,N/A
Malformation syndrome,2831,"Rhizomelic dysplasia, Patterson-Lowry type",Cases/families,N/A
Malformation syndrome,2831,"Rhizomelic dysplasia, Patterson-Lowry type",Point prevalence,N/A
Malformation syndrome,1129,Arachnodactyly-abnormal ossification-intellectual disability syndrome,Cases/families,N/A
Malformation syndrome,1129,Arachnodactyly-abnormal ossification-intellectual disability syndrome,Point prevalence,N/A
Disease,548,Leprosy,Point prevalence,N/A
Disease,548,Leprosy,Annual incidence,N/A
Malformation syndrome,1383,Cataract-deafness-hypogonadism syndrome,Cases/families,N/A
Malformation syndrome,1383,Cataract-deafness-hypogonadism syndrome,Point prevalence,N/A
Disease,206538,Malignant non-dysgerminomatous germ cell tumor of ovary,Point prevalence,N/A
Disease,206554,Fukutin-related limb-girdle muscular dystrophy R13,Cases/families,N/A
Disease,206554,Fukutin-related limb-girdle muscular dystrophy R13,Point prevalence,N/A
Malformation syndrome,1524,Craniomicromelic syndrome,Point prevalence,N/A
Disease,206549,Anoctamin-5-related limb-girdle muscular dystrophy R12,Point prevalence,N/A
Disease,569,Familial or sporadic hemiplegic migraine,Point prevalence,N/A
Disease,569,Familial or sporadic hemiplegic migraine,Point prevalence,N/A
Disease,206569,Immune-mediated necrotizing myopathy,Cases/families,N/A
Disease,206569,Immune-mediated necrotizing myopathy,Point prevalence,N/A
Disease,206580,Autosomal recessive lower motor neuron disease with childhood onset,Cases/families,N/A
Disease,206580,Autosomal recessive lower motor neuron disease with childhood onset,Point prevalence,N/A
Malformation syndrome,3439,Von Voss-Cherstvoy syndrome,Cases/families,N/A
Malformation syndrome,3439,Von Voss-Cherstvoy syndrome,Point prevalence,N/A
Disease,1217,Spinal atrophy-ophthalmoplegia-pyramidal syndrome,Cases/families,N/A
Disease,1217,Spinal atrophy-ophthalmoplegia-pyramidal syndrome,Point prevalence,N/A
Malformation syndrome,2680,Hypomyelination neuropathy-arthrogryposis syndrome,Cases/families,N/A
Malformation syndrome,2680,Hypomyelination neuropathy-arthrogryposis syndrome,Point prevalence,N/A
Morphological anomaly,1681,Diprosopus,Cases/families,N/A
Morphological anomaly,1681,Diprosopus,Point prevalence,N/A
Morphological anomaly,1681,Diprosopus,Prevalence at birth,N/A
Malformation syndrome,1655,Mllerian derivatives-lymphangiectasia-polydactyly syndrome,Cases/families,N/A
Malformation syndrome,1655,Mllerian derivatives-lymphangiectasia-polydactyly syndrome,Point prevalence,N/A
Disease,633,Laron syndrome,Point prevalence,N/A
Disease,633,Laron syndrome,Point prevalence,N/A
Clinical subtype,478,Kallmann syndrome,Point prevalence,N/A
Clinical subtype,478,Kallmann syndrome,Annual incidence,N/A
Clinical subtype,478,Kallmann syndrome,Annual incidence,N/A
Clinical subtype,478,Kallmann syndrome,Annual incidence,N/A
Malformation syndrome,240,Lri-Weill dyschondrosteosis,Point prevalence,N/A
Malformation syndrome,2311,Autosomal recessive spondylocostal dysostosis,Point prevalence,N/A
Disease,358,Gitelman syndrome,Point prevalence,N/A
Malformation syndrome,242,"46,XY complete gonadal dysgenesis",Point prevalence,N/A
Malformation syndrome,242,"46,XY complete gonadal dysgenesis",Prevalence at birth,N/A
Malformation syndrome,2052,Fraser syndrome,Prevalence at birth,N/A
Malformation syndrome,2052,Fraser syndrome,Point prevalence,N/A
Malformation syndrome,2052,Fraser syndrome,Prevalence at birth,N/A
Malformation syndrome,1354,Heart defects-limb shortening syndrome,Cases/families,N/A
Malformation syndrome,1354,Heart defects-limb shortening syndrome,Point prevalence,N/A
Disease,28,Vitamin B12-responsive methylmalonic acidemia,Cases/families,N/A
Disease,28,Vitamin B12-responsive methylmalonic acidemia,Point prevalence,N/A
Clinical group,557,Non-syndromic anorectal malformation,Prevalence at birth,N/A
Clinical group,557,Non-syndromic anorectal malformation,Prevalence at birth,N/A
Clinical group,557,Non-syndromic anorectal malformation,Prevalence at birth,N/A
Clinical group,557,Non-syndromic anorectal malformation,Prevalence at birth,N/A
Clinical group,557,Non-syndromic anorectal malformation,Prevalence at birth,N/A
Clinical group,557,Non-syndromic anorectal malformation,Prevalence at birth,N/A
Clinical group,557,Non-syndromic anorectal malformation,Prevalence at birth,N/A
Clinical group,557,Non-syndromic anorectal malformation,Prevalence at birth,N/A
Clinical group,557,Non-syndromic anorectal malformation,Prevalence at birth,N/A
Clinical group,557,Non-syndromic anorectal malformation,Prevalence at birth,N/A
Clinical group,557,Non-syndromic anorectal malformation,Prevalence at birth,N/A
Clinical group,557,Non-syndromic anorectal malformation,Prevalence at birth,N/A
Clinical group,557,Non-syndromic anorectal malformation,Prevalence at birth,N/A
Clinical group,557,Non-syndromic anorectal malformation,Prevalence at birth,N/A
Clinical group,557,Non-syndromic anorectal malformation,Prevalence at birth,N/A
Clinical group,557,Non-syndromic anorectal malformation,Prevalence at birth,N/A
Clinical group,557,Non-syndromic anorectal malformation,Prevalence at birth,N/A
Clinical group,557,Non-syndromic anorectal malformation,Prevalence at birth,N/A
Clinical group,557,Non-syndromic anorectal malformation,Prevalence at birth,N/A
Clinical group,557,Non-syndromic anorectal malformation,Prevalence at birth,N/A
Clinical group,557,Non-syndromic anorectal malformation,Point prevalence,N/A
Disease,111,Barth syndrome,Point prevalence,N/A
Disease,111,Barth syndrome,Prevalence at birth,N/A
Disease,111,Barth syndrome,Prevalence at birth,N/A
Disease,111,Barth syndrome,Prevalence at birth,N/A
Malformation syndrome,10,"48,XXYY syndrome",Prevalence at birth,N/A
Malformation syndrome,10,"48,XXYY syndrome",Point prevalence,N/A
Malformation syndrome,1308,C syndrome,Point prevalence,N/A
Disease,150,Nasopharyngeal carcinoma,Annual incidence,N/A
Disease,150,Nasopharyngeal carcinoma,Point prevalence,N/A
Disease,150,Nasopharyngeal carcinoma,Point prevalence,N/A
Disease,150,Nasopharyngeal carcinoma,Annual incidence,N/A
Disease,150,Nasopharyngeal carcinoma,Annual incidence,N/A
Disease,150,Nasopharyngeal carcinoma,Annual incidence,N/A
Disease,150,Nasopharyngeal carcinoma,Annual incidence,N/A
Disease,150,Nasopharyngeal carcinoma,Annual incidence,N/A
Disease,150,Nasopharyngeal carcinoma,Annual incidence,N/A
Disease,150,Nasopharyngeal carcinoma,Annual incidence,N/A
Disease,150,Nasopharyngeal carcinoma,Annual incidence,N/A
Disease,150,Nasopharyngeal carcinoma,Annual incidence,N/A
Disease,150,Nasopharyngeal carcinoma,Annual incidence,N/A
Disease,150,Nasopharyngeal carcinoma,Annual incidence,N/A
Disease,150,Nasopharyngeal carcinoma,Annual incidence,N/A
Disease,150,Nasopharyngeal carcinoma,Annual incidence,N/A
Disease,150,Nasopharyngeal carcinoma,Annual incidence,N/A
Disease,150,Nasopharyngeal carcinoma,Annual incidence,N/A
Disease,150,Nasopharyngeal carcinoma,Annual incidence,N/A
Disease,150,Nasopharyngeal carcinoma,Annual incidence,N/A
Disease,150,Nasopharyngeal carcinoma,Annual incidence,N/A
Disease,150,Nasopharyngeal carcinoma,Annual incidence,N/A
Disease,150,Nasopharyngeal carcinoma,Annual incidence,N/A
Disease,150,Nasopharyngeal carcinoma,Annual incidence,N/A
Disease,150,Nasopharyngeal carcinoma,Annual incidence,N/A
Disease,150,Nasopharyngeal carcinoma,Annual incidence,N/A
Disease,150,Nasopharyngeal carcinoma,Annual incidence,N/A
Malformation syndrome,3207,White matter hypoplasia-corpus callosum agenesis-intellectual disability syndrome,Cases/families,N/A
Malformation syndrome,3207,White matter hypoplasia-corpus callosum agenesis-intellectual disability syndrome,Point prevalence,N/A
Malformation syndrome,2058,Fryns-Smeets-Thiry syndrome,Cases/families,N/A
Malformation syndrome,2058,Fryns-Smeets-Thiry syndrome,Point prevalence,N/A
Malformation syndrome,2538,Microgastria-limb reduction defect syndrome,Cases/families,N/A
Malformation syndrome,2538,Microgastria-limb reduction defect syndrome,Point prevalence,N/A
Malformation syndrome,1192,Atherosclerosis-deafness-diabetes-epilepsy-nephropathy syndrome,Cases/families,N/A
Malformation syndrome,1192,Atherosclerosis-deafness-diabetes-epilepsy-nephropathy syndrome,Point prevalence,N/A
Malformation syndrome,1437,Ring chromosome 1 syndrome,Cases/families,N/A
Malformation syndrome,1437,Ring chromosome 1 syndrome,Point prevalence,N/A
Malformation syndrome,2015,Cleft palate-short stature-vertebral anomalies syndrome,Cases/families,N/A
Malformation syndrome,2015,Cleft palate-short stature-vertebral anomalies syndrome,Point prevalence,N/A
Malformation syndrome,1447,Ring chromosome 4 syndrome,Cases/families,N/A
Malformation syndrome,1447,Ring chromosome 4 syndrome,Point prevalence,N/A
Malformation syndrome,2898,X-linked intellectual disability-plagiocephaly syndrome,Cases/families,N/A
Malformation syndrome,2898,X-linked intellectual disability-plagiocephaly syndrome,Point prevalence,N/A
Malformation syndrome,1439,Ring chromosome 12 syndrome,Cases/families,N/A
Malformation syndrome,1439,Ring chromosome 12 syndrome,Point prevalence,N/A
Malformation syndrome,1423,Lethal recessive chondrodysplasia,Cases/families,N/A
Malformation syndrome,1423,Lethal recessive chondrodysplasia,Point prevalence,N/A
Malformation syndrome,3306,Inverted duplicated chromosome 15 syndrome,Prevalence at birth,N/A
Malformation syndrome,3306,Inverted duplicated chromosome 15 syndrome,Point prevalence,N/A
Malformation syndrome,3375,Trisomy X syndrome,Point prevalence,N/A
Malformation syndrome,3310,Tetrasomy 9p syndrome,Cases/families,N/A
Malformation syndrome,3310,Tetrasomy 9p syndrome,Point prevalence,N/A
Disease,3000,Familial peripheral male-limited precocious puberty,Point prevalence,N/A
Malformation syndrome,1101,Anophthalmia-megalocornea-cardiopathy-skeletal anomalies syndrome,Cases/families,N/A
Malformation syndrome,1101,Anophthalmia-megalocornea-cardiopathy-skeletal anomalies syndrome,Point prevalence,N/A
Malformation syndrome,1708,Mosaic trisomy 16 syndrome,Point prevalence,N/A
Malformation syndrome,1708,Mosaic trisomy 16 syndrome,Cases/families,N/A
Clinical group,208650,NLRP3-associated autoinflammatory disease,Point prevalence,N/A
Malformation syndrome,3376,Triploidy syndrome,Prevalence at birth,N/A
Malformation syndrome,3376,Triploidy syndrome,Point prevalence,N/A
Disease,208513,Spinocerebellar ataxia type 29,Cases/families,N/A
Disease,208513,Spinocerebellar ataxia type 29,Point prevalence,N/A
Malformation syndrome,1698,Mosaic trisomy 12 syndrome,Point prevalence,N/A
Malformation syndrome,3051,Nicolaides-Baraitser syndrome,Cases/families,N/A
Malformation syndrome,3051,Nicolaides-Baraitser syndrome,Point prevalence,N/A
Malformation syndrome,916,Aase-Smith syndrome,Cases/families,N/A
Malformation syndrome,916,Aase-Smith syndrome,Point prevalence,N/A
Malformation syndrome,1768,Familial caudal dysgenesis,Point prevalence,N/A
Malformation syndrome,1768,Familial caudal dysgenesis,Cases/families,N/A
Malformation syndrome,1445,Ring chromosome 21 syndrome,Point prevalence,N/A
Malformation syndrome,7,3C syndrome,Cases/families,N/A
Malformation syndrome,7,3C syndrome,Point prevalence,N/A
Morphological anomaly,931,Isolated acheiropodia,Point prevalence,N/A
Morphological anomaly,931,Isolated acheiropodia,Prevalence at birth,N/A
Morphological anomaly,931,Isolated acheiropodia,Point prevalence,N/A
Malformation syndrome,1541,"Craniosynostosis, Boston type",Cases/families,N/A
Malformation syndrome,1541,"Craniosynostosis, Boston type",Point prevalence,N/A
Disease,2297,Insulin-resistance syndrome type A,Point prevalence,N/A
Disease,209335,Autosomal dominant adult-onset proximal spinal muscular atrophy,Point prevalence,N/A
Malformation syndrome,921,Abruzzo-Erickson syndrome,Cases/families,N/A
Malformation syndrome,921,Abruzzo-Erickson syndrome,Point prevalence,N/A
Malformation syndrome,3167,Siegler-Brewer-Carey syndrome,Cases/families,N/A
Malformation syndrome,3167,Siegler-Brewer-Carey syndrome,Point prevalence,N/A
Malformation syndrome,1277,Brachydactyly-mesomelia-intellectual disability-heart defects syndrome,Cases/families,N/A
Malformation syndrome,1277,Brachydactyly-mesomelia-intellectual disability-heart defects syndrome,Point prevalence,N/A
Malformation syndrome,2547,Microphthalmia-microtia-fetal akinesia syndrome,Point prevalence,N/A
Malformation syndrome,2547,Microphthalmia-microtia-fetal akinesia syndrome,Cases/families,N/A
Malformation syndrome,1778,Facial dysmorphism-shawl scrotum-joint laxity syndrome,Cases/families,N/A
Malformation syndrome,1778,Facial dysmorphism-shawl scrotum-joint laxity syndrome,Point prevalence,N/A
Malformation syndrome,3074,Intellectual disability-short stature-hypertelorism syndrome,Cases/families,N/A
Malformation syndrome,3074,Intellectual disability-short stature-hypertelorism syndrome,Point prevalence,N/A
Malformation syndrome,210110,Intermediate osteopetrosis,Point prevalence,N/A
Malformation syndrome,3405,Umbilical cord ulceration-intestinal atresia syndrome,Cases/families,N/A
Malformation syndrome,3405,Umbilical cord ulceration-intestinal atresia syndrome,Point prevalence,N/A
Disease,210115,Sterile multifocal osteomyelitis with periostitis and pustulosis,Cases/families,N/A
Disease,210115,Sterile multifocal osteomyelitis with periostitis and pustulosis,Point prevalence,N/A
Disease,1884,Ectopia lentis-chorioretinal dystrophy-myopia syndrome,Cases/families,N/A
Disease,1884,Ectopia lentis-chorioretinal dystrophy-myopia syndrome,Point prevalence,N/A
Disease,939,3-hydroxyisobutyric aciduria,Cases/families,N/A
Disease,939,3-hydroxyisobutyric aciduria,Point prevalence,N/A
Disease,209989,Non-papillary transitional cell carcinoma of the bladder,Point prevalence,N/A
Disease,935,Short-limb skeletal dysplasia with severe combined immunodeficiency,Cases/families,N/A
Disease,935,Short-limb skeletal dysplasia with severe combined immunodeficiency,Point prevalence,N/A
Disease,210133,Leukonychia totalis-acanthosis-nigricans-like lesions-abnormal hair syndrome,Cases/families,N/A
Disease,210133,Leukonychia totalis-acanthosis-nigricans-like lesions-abnormal hair syndrome,Point prevalence,N/A
Disease,37,Acrodermatitis enteropathica,Prevalence at birth,N/A
Disease,37,Acrodermatitis enteropathica,Point prevalence,N/A
Disease,37,Acrodermatitis enteropathica,Point prevalence,N/A
Disease,210122,Congenital alveolar capillary dysplasia,Prevalence at birth,N/A
Disease,210122,Congenital alveolar capillary dysplasia,Cases/families,N/A
Disease,210122,Congenital alveolar capillary dysplasia,Point prevalence,N/A
Malformation syndrome,949,Acrocraniofacial dysostosis,Cases/families,N/A
Malformation syndrome,949,Acrocraniofacial dysostosis,Point prevalence,N/A
Malformation syndrome,2254,Pontocerebellar hypoplasia type 1,Cases/families,N/A
Malformation syndrome,2254,Pontocerebellar hypoplasia type 1,Point prevalence,N/A
Malformation syndrome,957,Acropectorovertebral dysplasia,Cases/families,N/A
Malformation syndrome,957,Acropectorovertebral dysplasia,Point prevalence,N/A
Disease,209964,Solitary rectal ulcer syndrome,Annual incidence,N/A
Disease,209964,Solitary rectal ulcer syndrome,Point prevalence,N/A
Malformation syndrome,955,Hajdu-Cheney syndrome,Cases/families,N/A
Malformation syndrome,955,Hajdu-Cheney syndrome,Point prevalence,N/A
Disease,209956,Idiopathic uveal effusion syndrome,Point prevalence,N/A
Malformation syndrome,1713,17p11.2 microduplication syndrome,Cases/families,N/A
Malformation syndrome,1713,17p11.2 microduplication syndrome,Point prevalence,N/A
Disease,209967,Episodic ataxia type 6,Cases/families,N/A
Disease,209967,Episodic ataxia type 6,Point prevalence,N/A
Malformation syndrome,1742,Trisomy 5p syndrome,Cases/families,N/A
Malformation syndrome,1742,Trisomy 5p syndrome,Point prevalence,N/A
Disease,2795,Fowler urethral sphincter dysfunction syndrome,Cases/families,N/A
Disease,2795,Fowler urethral sphincter dysfunction syndrome,Point prevalence,N/A
Malformation syndrome,1752,Trisomy 8q syndrome,Cases/families,N/A
Malformation syndrome,1752,Trisomy 8q syndrome,Point prevalence,N/A
Disease,209905,Brain-lung-thyroid syndrome,Cases/families,N/A
Disease,209905,Brain-lung-thyroid syndrome,Point prevalence,N/A
Disease,1878,TRIM32-related limb-girdle muscular dystrophy R8,Point prevalence,N/A
Disease,2666,Adult familial nephronophthisis-spastic quadriparesia syndrome,Cases/families,N/A
Disease,2666,Adult familial nephronophthisis-spastic quadriparesia syndrome,Point prevalence,N/A
Malformation syndrome,1948,Epilepsy-microcephaly-skeletal dysplasia syndrome,Cases/families,N/A
Malformation syndrome,1948,Epilepsy-microcephaly-skeletal dysplasia syndrome,Point prevalence,N/A
Disease,209932,Cone dystrophy with supernormal rod response,Cases/families,N/A
Disease,209932,Cone dystrophy with supernormal rod response,Point prevalence,N/A
Disease,209919,Idiopathic copper-associated cirrhosis,Point prevalence,N/A
Disease,381,Griscelli syndrome,Cases/families,N/A
Disease,381,Griscelli syndrome,Point prevalence,N/A
Malformation syndrome,2519,Microcephaly-seizures-intellectual disability-heart disease syndrome,Cases/families,N/A
Malformation syndrome,2519,Microcephaly-seizures-intellectual disability-heart disease syndrome,Point prevalence,N/A
Disease,156,Carnitine palmitoyl transferase 1A deficiency,Cases/families,N/A
Disease,156,Carnitine palmitoyl transferase 1A deficiency,Point prevalence,N/A
Disease,156,Carnitine palmitoyl transferase 1A deficiency,Prevalence at birth,N/A
Disease,156,Carnitine palmitoyl transferase 1A deficiency,Prevalence at birth,N/A
Disease,209867,Autosomal dominant rhegmatogenous retinal detachment,Cases/families,N/A
Disease,209867,Autosomal dominant rhegmatogenous retinal detachment,Point prevalence,N/A
Disease,2598,Mitochondrial myopathy and sideroblastic anemia,Cases/families,N/A
Disease,2598,Mitochondrial myopathy and sideroblastic anemia,Point prevalence,N/A
Disease,3286,Catecholaminergic polymorphic ventricular tachycardia,Point prevalence,N/A
Clinical syndrome,210272,Mal de dbarquement,Point prevalence,N/A
Morphological anomaly,1053,Vein of Galen aneurysmal malformation,Point prevalence,N/A
Disease,210159,Adult hepatocellular carcinoma,Annual incidence,N/A
Disease,1040,Metaphyseal anadysplasia,Cases/families,N/A
Disease,1040,Metaphyseal anadysplasia,Point prevalence,N/A
Malformation syndrome,1041,Hydrops fetalis,Prevalence at birth,N/A
Malformation syndrome,1041,Hydrops fetalis,Prevalence at birth,N/A
Malformation syndrome,1041,Hydrops fetalis,Prevalence at birth,N/A
Malformation syndrome,1041,Hydrops fetalis,Point prevalence,N/A
Disease,3240,Early-onset progressive leukoencephalopathy-central nervous system calcification-deafness-visual impairment syndrome,Cases/families,N/A
Disease,3240,Early-onset progressive leukoencephalopathy-central nervous system calcification-deafness-visual impairment syndrome,Point prevalence,N/A
Disease,210141,Inherited congenital spastic tetraplegia,Cases/families,N/A
Disease,210141,Inherited congenital spastic tetraplegia,Point prevalence,N/A
Malformation syndrome,1126,Aprosencephaly cerebellar dysgenesis,Cases/families,N/A
Malformation syndrome,1126,Aprosencephaly cerebellar dysgenesis,Point prevalence,N/A
Disease,1546,Cryptococcosis,Annual incidence,N/A
Disease,1546,Cryptococcosis,Point prevalence,N/A
Malformation syndrome,1121,Radial deficiency-tibial hypoplasia syndrome,Point prevalence,N/A
Disease,210584,Spindle cell hemangioma,Annual incidence,N/A
Disease,210584,Spindle cell hemangioma,Point prevalence,N/A
Malformation syndrome,1122,Ulnar hypoplasia-split foot syndrome,Point prevalence,N/A
Malformation syndrome,1122,Ulnar hypoplasia-split foot syndrome,Cases/families,N/A
Disease,1116,Aplasia cutis congenita-intestinal lymphangiectasia syndrome,Cases/families,N/A
Disease,1116,Aplasia cutis congenita-intestinal lymphangiectasia syndrome,Point prevalence,N/A
Malformation syndrome,1118,Fibular aplasia-ectrodactyly syndrome,Cases/families,N/A
Malformation syndrome,1118,Fibular aplasia-ectrodactyly syndrome,Point prevalence,N/A
Category,599,Distal myopathy,Point prevalence,N/A
Disease,3392,Tularemia,Annual incidence,N/A
Disease,3392,Tularemia,Annual incidence,N/A
Disease,3392,Tularemia,Annual incidence,N/A
Disease,3392,Tularemia,Annual incidence,N/A
Disease,3392,Tularemia,Annual incidence,N/A
Disease,3392,Tularemia,Annual incidence,N/A
Disease,3392,Tularemia,Annual incidence,N/A
Disease,3392,Tularemia,Annual incidence,N/A
Disease,3392,Tularemia,Annual incidence,N/A
Disease,3392,Tularemia,Annual incidence,N/A
Disease,3392,Tularemia,Annual incidence,N/A
Disease,3392,Tularemia,Annual incidence,N/A
Disease,3392,Tularemia,Annual incidence,N/A
Disease,3392,Tularemia,Annual incidence,N/A
Disease,3392,Tularemia,Annual incidence,N/A
Disease,3392,Tularemia,Annual incidence,N/A
Disease,3392,Tularemia,Annual incidence,N/A
Disease,3392,Tularemia,Annual incidence,N/A
Disease,3392,Tularemia,Annual incidence,N/A
Disease,3392,Tularemia,Annual incidence,N/A
Disease,3392,Tularemia,Annual incidence,N/A
Disease,3392,Tularemia,Annual incidence,N/A
Disease,3392,Tularemia,Annual incidence,N/A
Disease,3392,Tularemia,Point prevalence,N/A
Disease,3392,Tularemia,Annual incidence,N/A
Disease,3392,Tularemia,Annual incidence,N/A
Malformation syndrome,1094,Anonychia-microcephaly syndrome,Cases/families,N/A
Malformation syndrome,1094,Anonychia-microcephaly syndrome,Point prevalence,N/A
Disease,2737,Onchocerciasis,Point prevalence,N/A
Disease,2737,Onchocerciasis,Point prevalence,N/A
Malformation syndrome,990,Agnathia-holoprosencephaly-situs inversus syndrome,Point prevalence,N/A
Disease,3343,Toxocariasis,Annual incidence,N/A
Disease,3343,Toxocariasis,Point prevalence,N/A
Malformation syndrome,994,Fetal akinesia deformation sequence,Prevalence at birth,N/A
Malformation syndrome,994,Fetal akinesia deformation sequence,Point prevalence,N/A
Category,2034,Filariasis,Point prevalence,N/A
Category,2034,Filariasis,Point prevalence,N/A
Morphological anomaly,981,Internal carotid absence,Cases/families,N/A
Morphological anomaly,981,Internal carotid absence,Point prevalence,N/A
Disease,211017,Spinocerebellar ataxia type 30,Cases/families,N/A
Disease,211017,Spinocerebellar ataxia type 30,Point prevalence,N/A
Disease,977,Adrenomyodystrophy,Cases/families,N/A
Disease,977,Adrenomyodystrophy,Point prevalence,N/A
Disease,656,Hereditary steroid-resistant nephrotic syndrome,Point prevalence,N/A
Disease,970,Hereditary sensory and autonomic neuropathy type 2,Cases/families,N/A
Disease,970,Hereditary sensory and autonomic neuropathy type 2,Point prevalence,N/A
Category,2415,Rare lymphatic malformation,Point prevalence,N/A
Malformation syndrome,40,"Acromesomelic dysplasia, Maroteaux type",Cases/families,N/A
Malformation syndrome,40,"Acromesomelic dysplasia, Maroteaux type",Point prevalence,N/A
Disease,2591,Infantile myofibromatosis,Prevalence at birth,N/A
Disease,2591,Infantile myofibromatosis,Point prevalence,N/A
Disease,35,Propionic acidemia,Prevalence at birth,N/A
Disease,35,Propionic acidemia,Annual incidence,N/A
Disease,35,Propionic acidemia,Point prevalence,N/A
Disease,35,Propionic acidemia,Prevalence at birth,N/A
Disease,35,Propionic acidemia,Prevalence at birth,N/A
Disease,35,Propionic acidemia,Prevalence at birth,N/A
Disease,35,Propionic acidemia,Prevalence at birth,N/A
Disease,35,Propionic acidemia,Prevalence at birth,N/A
Disease,35,Propionic acidemia,Point prevalence,N/A
Malformation syndrome,968,"Acromesomelic dysplasia, Hunter-Thompson type",Cases/families,N/A
Malformation syndrome,968,"Acromesomelic dysplasia, Hunter-Thompson type",Point prevalence,N/A
Disease,139411,Carney triad,Point prevalence,N/A
Disease,139411,Carney triad,Cases/families,N/A
Disease,2968,Leukocyte adhesion deficiency,Cases/families,N/A
Disease,2968,Leukocyte adhesion deficiency,Point prevalence,N/A
Disease,2968,Leukocyte adhesion deficiency,Point prevalence,N/A
Malformation syndrome,1028,Amelo-onycho-hypohidrotic syndrome,Cases/families,N/A
Malformation syndrome,1028,Amelo-onycho-hypohidrotic syndrome,Point prevalence,N/A
Disease,139417,Acute transverse myelitis,Annual incidence,N/A
Disease,139417,Acute transverse myelitis,Point prevalence,N/A
Disease,139417,Acute transverse myelitis,Annual incidence,N/A
Disease,5,Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency,Prevalence at birth,N/A
Disease,5,Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency,Prevalence at birth,N/A
Disease,5,Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency,Prevalence at birth,N/A
Disease,5,Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency,Prevalence at birth,N/A
Disease,5,Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency,Prevalence at birth,N/A
Disease,5,Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency,Prevalence at birth,N/A
Disease,5,Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency,Prevalence at birth,N/A
Disease,5,Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency,Point prevalence,N/A
Disease,5,Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency,Point prevalence,N/A
Disease,5,Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency,Prevalence at birth,N/A
Disease,5,Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency,Prevalence at birth,N/A
Disease,5,Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency,Prevalence at birth,N/A
Disease,139426,Perioral myoclonia with absences,Cases/families,N/A
Disease,139426,Perioral myoclonia with absences,Point prevalence,N/A
Disease,139431,Epilepsy with eyelid myoclonia,Point prevalence,N/A
Disease,25,Glutaryl-CoA dehydrogenase deficiency,Point prevalence,N/A
Disease,25,Glutaryl-CoA dehydrogenase deficiency,Point prevalence,N/A
Disease,25,Glutaryl-CoA dehydrogenase deficiency,Prevalence at birth,N/A
Disease,25,Glutaryl-CoA dehydrogenase deficiency,Prevalence at birth,N/A
Disease,25,Glutaryl-CoA dehydrogenase deficiency,Prevalence at birth,N/A
Disease,25,Glutaryl-CoA dehydrogenase deficiency,Prevalence at birth,N/A
Disease,25,Glutaryl-CoA dehydrogenase deficiency,Point prevalence,N/A
Disease,25,Glutaryl-CoA dehydrogenase deficiency,Prevalence at birth,N/A
Disease,25,Glutaryl-CoA dehydrogenase deficiency,Prevalence at birth,N/A
Disease,25,Glutaryl-CoA dehydrogenase deficiency,Prevalence at birth,N/A
Disease,64,Alstrm syndrome,Point prevalence,N/A
Disease,64,Alstrm syndrome,Cases/families,N/A
Malformation syndrome,1246,Brachydactyly-nystagmus-cerebellar ataxia syndrome,Cases/families,N/A
Malformation syndrome,1246,Brachydactyly-nystagmus-cerebellar ataxia syndrome,Point prevalence,N/A
Clinical subtype,139396,X-linked cerebral adrenoleukodystrophy,Point prevalence,N/A
Disease,139402,Drug reaction with eosinophilia and systemic symptoms,Point prevalence,N/A
Disease,139406,Encephalopathy due to prosaposin deficiency,Cases/families,N/A
Disease,139406,Encephalopathy due to prosaposin deficiency,Point prevalence,N/A
Disease,1008,Alopecia-epilepsy-pyorrhea-intellectual disability syndrome,Cases/families,N/A
Disease,1008,Alopecia-epilepsy-pyorrhea-intellectual disability syndrome,Point prevalence,N/A
Malformation syndrome,818,Smith-Lemli-Opitz syndrome,Prevalence at birth,N/A
Malformation syndrome,818,Smith-Lemli-Opitz syndrome,Prevalence at birth,N/A
Malformation syndrome,818,Smith-Lemli-Opitz syndrome,Prevalence at birth,N/A
Malformation syndrome,818,Smith-Lemli-Opitz syndrome,Prevalence at birth,N/A
Malformation syndrome,818,Smith-Lemli-Opitz syndrome,Prevalence at birth,N/A
Malformation syndrome,818,Smith-Lemli-Opitz syndrome,Point prevalence,N/A
Malformation syndrome,818,Smith-Lemli-Opitz syndrome,Prevalence at birth,N/A
Malformation syndrome,818,Smith-Lemli-Opitz syndrome,Annual incidence,N/A
Disease,1014,Alopecia-intellectual disability-hypergonadotropic hypogonadism syndrome,Cases/families,N/A
Disease,1014,Alopecia-intellectual disability-hypergonadotropic hypogonadism syndrome,Point prevalence,N/A
Malformation syndrome,1001,2q37 microdeletion syndrome,Cases/families,N/A
Malformation syndrome,1001,2q37 microdeletion syndrome,Point prevalence,N/A
Disease,59,Allan-Herndon-Dudley syndrome,Cases/families,N/A
Disease,59,Allan-Herndon-Dudley syndrome,Point prevalence,N/A
Disease,59,Allan-Herndon-Dudley syndrome,Point prevalence,N/A
Disease,213504,Adenocarcinoma of ovary,Annual incidence,N/A
Disease,213504,Adenocarcinoma of ovary,Annual incidence,N/A
Disease,213504,Adenocarcinoma of ovary,Annual incidence,N/A
Disease,213504,Adenocarcinoma of ovary,Annual incidence,N/A
Disease,213504,Adenocarcinoma of ovary,Annual incidence,N/A
Disease,213504,Adenocarcinoma of ovary,Annual incidence,N/A
Disease,213504,Adenocarcinoma of ovary,Annual incidence,N/A
Disease,213504,Adenocarcinoma of ovary,Annual incidence,N/A
Disease,213504,Adenocarcinoma of ovary,Annual incidence,N/A
Disease,213504,Adenocarcinoma of ovary,Annual incidence,N/A
Disease,213504,Adenocarcinoma of ovary,Annual incidence,N/A
Disease,213504,Adenocarcinoma of ovary,Annual incidence,N/A
Disease,213504,Adenocarcinoma of ovary,Annual incidence,N/A
Disease,213504,Adenocarcinoma of ovary,Annual incidence,N/A
Disease,213504,Adenocarcinoma of ovary,Annual incidence,N/A
Disease,213504,Adenocarcinoma of ovary,Annual incidence,N/A
Disease,213504,Adenocarcinoma of ovary,Annual incidence,N/A
Disease,213504,Adenocarcinoma of ovary,Annual incidence,N/A
Disease,213504,Adenocarcinoma of ovary,Annual incidence,N/A
Disease,213504,Adenocarcinoma of ovary,Annual incidence,N/A
Disease,213504,Adenocarcinoma of ovary,Annual incidence,N/A
Disease,213504,Adenocarcinoma of ovary,Annual incidence,N/A
Disease,213504,Adenocarcinoma of ovary,Annual incidence,N/A
Disease,213504,Adenocarcinoma of ovary,Annual incidence,N/A
Malformation syndrome,127,Borjeson-Forssman-Lehmann syndrome,Cases/families,N/A
Malformation syndrome,127,Borjeson-Forssman-Lehmann syndrome,Point prevalence,N/A
Malformation syndrome,1264,Tricho-retino-dento-digital syndrome,Cases/families,N/A
Malformation syndrome,1264,Tricho-retino-dento-digital syndrome,Point prevalence,N/A
Malformation syndrome,1262,Bk syndrome,Cases/families,N/A
Malformation syndrome,1262,Bk syndrome,Point prevalence,N/A
Disease,1263,Boomerang dysplasia,Cases/families,N/A
Disease,1263,Boomerang dysplasia,Point prevalence,N/A
Disease,42,Medium chain acyl-CoA dehydrogenase deficiency,Prevalence at birth,N/A
Disease,42,Medium chain acyl-CoA dehydrogenase deficiency,Prevalence at birth,N/A
Disease,42,Medium chain acyl-CoA dehydrogenase deficiency,Prevalence at birth,N/A
Disease,42,Medium chain acyl-CoA dehydrogenase deficiency,Prevalence at birth,N/A
Disease,42,Medium chain acyl-CoA dehydrogenase deficiency,Prevalence at birth,N/A
Disease,42,Medium chain acyl-CoA dehydrogenase deficiency,Prevalence at birth,N/A
Disease,42,Medium chain acyl-CoA dehydrogenase deficiency,Prevalence at birth,N/A
Disease,42,Medium chain acyl-CoA dehydrogenase deficiency,Prevalence at birth,N/A
Disease,42,Medium chain acyl-CoA dehydrogenase deficiency,Prevalence at birth,N/A
Disease,42,Medium chain acyl-CoA dehydrogenase deficiency,Prevalence at birth,N/A
Disease,42,Medium chain acyl-CoA dehydrogenase deficiency,Prevalence at birth,N/A
Disease,42,Medium chain acyl-CoA dehydrogenase deficiency,Prevalence at birth,N/A
Disease,42,Medium chain acyl-CoA dehydrogenase deficiency,Prevalence at birth,N/A
Disease,42,Medium chain acyl-CoA dehydrogenase deficiency,Point prevalence,N/A
Disease,42,Medium chain acyl-CoA dehydrogenase deficiency,Prevalence at birth,N/A
Disease,42,Medium chain acyl-CoA dehydrogenase deficiency,Prevalence at birth,N/A
Disease,42,Medium chain acyl-CoA dehydrogenase deficiency,Prevalence at birth,N/A
Disease,42,Medium chain acyl-CoA dehydrogenase deficiency,Prevalence at birth,N/A
Disease,42,Medium chain acyl-CoA dehydrogenase deficiency,Prevalence at birth,N/A
Malformation syndrome,1231,Barber-Say syndrome,Cases/families,N/A
Malformation syndrome,1231,Barber-Say syndrome,Point prevalence,N/A
Malformation syndrome,1229,Congenital intrauterine infection-like syndrome,Cases/families,N/A
Malformation syndrome,1229,Congenital intrauterine infection-like syndrome,Point prevalence,N/A
Malformation syndrome,109,Bannayan-Riley-Ruvalcaba syndrome,Point prevalence,N/A
Malformation syndrome,1228,Banki syndrome,Cases/families,N/A
Malformation syndrome,1228,Banki syndrome,Point prevalence,N/A
Malformation syndrome,1241,Bencze syndrome,Cases/families,N/A
Malformation syndrome,1241,Bencze syndrome,Point prevalence,N/A
Malformation syndrome,1237,Beemer-Ertbruggen syndrome,Cases/families,N/A
Malformation syndrome,1237,Beemer-Ertbruggen syndrome,Point prevalence,N/A
Disease,2066,Gamma-aminobutyric acid transaminase deficiency,Cases/families,N/A
Disease,2066,Gamma-aminobutyric acid transaminase deficiency,Point prevalence,N/A
Disease,213531,Metaplastic carcinoma of the breast,Annual incidence,N/A
Disease,213531,Metaplastic carcinoma of the breast,Annual incidence,N/A
Disease,213531,Metaplastic carcinoma of the breast,Annual incidence,N/A
Disease,213531,Metaplastic carcinoma of the breast,Annual incidence,N/A
Disease,213531,Metaplastic carcinoma of the breast,Annual incidence,N/A
Disease,213531,Metaplastic carcinoma of the breast,Annual incidence,N/A
Disease,213531,Metaplastic carcinoma of the breast,Annual incidence,N/A
Disease,213531,Metaplastic carcinoma of the breast,Annual incidence,N/A
Disease,213531,Metaplastic carcinoma of the breast,Annual incidence,N/A
Disease,213531,Metaplastic carcinoma of the breast,Annual incidence,N/A
Disease,213531,Metaplastic carcinoma of the breast,Annual incidence,N/A
Disease,213531,Metaplastic carcinoma of the breast,Annual incidence,N/A
Disease,213531,Metaplastic carcinoma of the breast,Annual incidence,N/A
Disease,213531,Metaplastic carcinoma of the breast,Annual incidence,N/A
Disease,213531,Metaplastic carcinoma of the breast,Annual incidence,N/A
Disease,213531,Metaplastic carcinoma of the breast,Annual incidence,N/A
Disease,213531,Metaplastic carcinoma of the breast,Annual incidence,N/A
Disease,213531,Metaplastic carcinoma of the breast,Annual incidence,N/A
Disease,213531,Metaplastic carcinoma of the breast,Annual incidence,N/A
Disease,213531,Metaplastic carcinoma of the breast,Annual incidence,N/A
Disease,213531,Metaplastic carcinoma of the breast,Annual incidence,N/A
Disease,213531,Metaplastic carcinoma of the breast,Annual incidence,N/A
Disease,213531,Metaplastic carcinoma of the breast,Annual incidence,N/A
Disease,213531,Metaplastic carcinoma of the breast,Annual incidence,N/A
Disease,213528,Rare adenocarcinoma of the breast,Annual incidence,N/A
Disease,213528,Rare adenocarcinoma of the breast,Annual incidence,N/A
Disease,213528,Rare adenocarcinoma of the breast,Annual incidence,N/A
Disease,213528,Rare adenocarcinoma of the breast,Annual incidence,N/A
Disease,213528,Rare adenocarcinoma of the breast,Annual incidence,N/A
Disease,213528,Rare adenocarcinoma of the breast,Annual incidence,N/A
Disease,213528,Rare adenocarcinoma of the breast,Annual incidence,N/A
Disease,213528,Rare adenocarcinoma of the breast,Annual incidence,N/A
Disease,213528,Rare adenocarcinoma of the breast,Annual incidence,N/A
Disease,213528,Rare adenocarcinoma of the breast,Annual incidence,N/A
Disease,213528,Rare adenocarcinoma of the breast,Annual incidence,N/A
Disease,213528,Rare adenocarcinoma of the breast,Annual incidence,N/A
Disease,213528,Rare adenocarcinoma of the breast,Annual incidence,N/A
Disease,213528,Rare adenocarcinoma of the breast,Annual incidence,N/A
Disease,213528,Rare adenocarcinoma of the breast,Annual incidence,N/A
Disease,213528,Rare adenocarcinoma of the breast,Annual incidence,N/A
Disease,213528,Rare adenocarcinoma of the breast,Annual incidence,N/A
Disease,213528,Rare adenocarcinoma of the breast,Annual incidence,N/A
Disease,213528,Rare adenocarcinoma of the breast,Annual incidence,N/A
Disease,213528,Rare adenocarcinoma of the breast,Annual incidence,N/A
Disease,213528,Rare adenocarcinoma of the breast,Annual incidence,N/A
Disease,213528,Rare adenocarcinoma of the breast,Annual incidence,N/A
Disease,213528,Rare adenocarcinoma of the breast,Annual incidence,N/A
Disease,213528,Rare adenocarcinoma of the breast,Annual incidence,N/A
Clinical group,1293,Brachyolmia,Point prevalence,N/A
Clinical group,1293,Brachyolmia,Cases/families,N/A
Morphological anomaly,860,Congenitally uncorrected transposition of the great arteries,Prevalence at birth,N/A
Morphological anomaly,860,Congenitally uncorrected transposition of the great arteries,Point prevalence,N/A
Clinical subtype,137639,Hypomyelinating leukodystrophy-ataxia-hypodontia-hypomyelination syndrome,Cases/families,N/A
Clinical subtype,137639,Hypomyelinating leukodystrophy-ataxia-hypodontia-hypomyelination syndrome,Point prevalence,N/A
Particular clinical situation in a disease or syndrome,137577,Neonatal hypoxic and ischemic brain injury,Point prevalence,N/A
Disease,137583,Vulvar intraepithelial neoplasia,Point prevalence,N/A
Malformation syndrome,1276,Brachydactyly-arterial hypertension syndrome,Cases/families,N/A
Malformation syndrome,1276,Brachydactyly-arterial hypertension syndrome,Point prevalence,N/A
Malformation syndrome,1275,Brachydactyly-elbow wrist dysplasia syndrome,Cases/families,N/A
Malformation syndrome,1275,Brachydactyly-elbow wrist dysplasia syndrome,Point prevalence,N/A
Malformation syndrome,1270,Bowen-Conradi syndrome,Cases/families,N/A
Malformation syndrome,1270,Bowen-Conradi syndrome,Point prevalence,N/A
Malformation syndrome,1270,Bowen-Conradi syndrome,Prevalence at birth,N/A
Malformation syndrome,137605,Legius syndrome,Prevalence at birth,N/A
Malformation syndrome,137605,Legius syndrome,Point prevalence,N/A
Disease,137596,Neurotrophic keratopathy,Point prevalence,N/A
Disease,137596,Neurotrophic keratopathy,Point prevalence,N/A
Morphological anomaly,3400,Aorto-ventricular tunnel,Cases/families,N/A
Morphological anomaly,3400,Aorto-ventricular tunnel,Point prevalence,N/A
Disease,137599,Herpes simplex virus stromal keratitis,Point prevalence,N/A
Disease,137599,Herpes simplex virus stromal keratitis,Annual incidence,N/A
Morphological anomaly,1166,Congenital unilateral hypoplasia of depressor anguli oris,Point prevalence,N/A
Disease,1168,Ataxia-oculomotor apraxia type 1,Point prevalence,N/A
Disease,1160,Chylous ascites,Point prevalence,N/A
Disease,137817,Arachnoiditis,Point prevalence,N/A
Malformation syndrome,1174,Cerebellar ataxia-ectodermal dysplasia syndrome,Point prevalence,N/A
Disease,137839,Lemierre syndrome,Annual incidence,N/A
Disease,137839,Lemierre syndrome,Annual incidence,N/A
Disease,137839,Lemierre syndrome,Point prevalence,N/A
Disease,137834,Frank-Ter Haar syndrome,Cases/families,N/A
Disease,137834,Frank-Ter Haar syndrome,Point prevalence,N/A
Disease,137831,X-linked intellectual disability-cerebellar hypoplasia syndrome,Cases/families,N/A
Disease,137831,X-linked intellectual disability-cerebellar hypoplasia syndrome,Point prevalence,N/A
Disease,1170,Autosomal recessive cerebelloparenchymal disorder type 3,Point prevalence,N/A
Disease,213746,Transitional cell carcinoma of the corpus uteri,Annual incidence,N/A
Disease,1175,X-linked progressive cerebellar ataxia,Point prevalence,N/A
Disease,1180,Ataxia-hypogonadism-choroidal dystrophy syndrome,Point prevalence,N/A
Disease,1179,Benign paroxysmal tonic upgaze of childhood with ataxia,Cases/families,N/A
Disease,1179,Benign paroxysmal tonic upgaze of childhood with ataxia,Point prevalence,N/A
Disease,1173,Cerebellar ataxia-hypogonadism syndrome,Point prevalence,N/A
Disease,137867,Madras motor neuron disease,Cases/families,N/A
Disease,137867,Madras motor neuron disease,Point prevalence,N/A
Disease,137681,Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1,Cases/families,N/A
Disease,137681,Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1,Point prevalence,N/A
Malformation syndrome,2849,Perlman syndrome,Cases/families,N/A
Malformation syndrome,2849,Perlman syndrome,Point prevalence,N/A
Disease,213772,Adenocarcinoma of the cervix uteri,Annual incidence,N/A
Disease,213772,Adenocarcinoma of the cervix uteri,Annual incidence,N/A
Disease,213772,Adenocarcinoma of the cervix uteri,Annual incidence,N/A
Disease,213772,Adenocarcinoma of the cervix uteri,Annual incidence,N/A
Disease,213772,Adenocarcinoma of the cervix uteri,Annual incidence,N/A
Disease,213772,Adenocarcinoma of the cervix uteri,Annual incidence,N/A
Disease,213772,Adenocarcinoma of the cervix uteri,Annual incidence,N/A
Disease,213772,Adenocarcinoma of the cervix uteri,Annual incidence,N/A
Disease,213772,Adenocarcinoma of the cervix uteri,Annual incidence,N/A
Disease,213772,Adenocarcinoma of the cervix uteri,Annual incidence,N/A
Disease,213772,Adenocarcinoma of the cervix uteri,Annual incidence,N/A
Disease,213772,Adenocarcinoma of the cervix uteri,Annual incidence,N/A
Disease,213772,Adenocarcinoma of the cervix uteri,Annual incidence,N/A
Disease,213772,Adenocarcinoma of the cervix uteri,Annual incidence,N/A
Disease,213772,Adenocarcinoma of the cervix uteri,Annual incidence,N/A
Disease,213772,Adenocarcinoma of the cervix uteri,Annual incidence,N/A
Disease,213772,Adenocarcinoma of the cervix uteri,Annual incidence,N/A
Disease,213772,Adenocarcinoma of the cervix uteri,Annual incidence,N/A
Disease,213772,Adenocarcinoma of the cervix uteri,Annual incidence,N/A
Disease,213772,Adenocarcinoma of the cervix uteri,Annual incidence,N/A
Disease,213772,Adenocarcinoma of the cervix uteri,Annual incidence,N/A
Disease,213772,Adenocarcinoma of the cervix uteri,Annual incidence,N/A
Disease,213772,Adenocarcinoma of the cervix uteri,Annual incidence,N/A
Disease,213772,Adenocarcinoma of the cervix uteri,Annual incidence,N/A
Malformation syndrome,1144,Arthrogryposis-like hand anomaly-sensorineural deafness syndrome,Cases/families,N/A
Malformation syndrome,1144,Arthrogryposis-like hand anomaly-sensorineural deafness syndrome,Point prevalence,N/A
Disease,137686,Asherman syndrome,Point prevalence,N/A
Disease,213767,Squamous cell carcinoma of the cervix uteri,Annual incidence,N/A
Disease,213767,Squamous cell carcinoma of the cervix uteri,Annual incidence,N/A
Disease,213767,Squamous cell carcinoma of the cervix uteri,Annual incidence,N/A
Disease,213767,Squamous cell carcinoma of the cervix uteri,Annual incidence,N/A
Disease,213767,Squamous cell carcinoma of the cervix uteri,Annual incidence,N/A
Disease,213767,Squamous cell carcinoma of the cervix uteri,Annual incidence,N/A
Disease,213767,Squamous cell carcinoma of the cervix uteri,Annual incidence,N/A
Disease,213767,Squamous cell carcinoma of the cervix uteri,Annual incidence,N/A
Disease,213767,Squamous cell carcinoma of the cervix uteri,Annual incidence,N/A
Disease,213767,Squamous cell carcinoma of the cervix uteri,Annual incidence,N/A
Disease,213767,Squamous cell carcinoma of the cervix uteri,Annual incidence,N/A
Disease,213767,Squamous cell carcinoma of the cervix uteri,Annual incidence,N/A
Disease,213767,Squamous cell carcinoma of the cervix uteri,Annual incidence,N/A
Disease,213767,Squamous cell carcinoma of the cervix uteri,Annual incidence,N/A
Disease,213767,Squamous cell carcinoma of the cervix uteri,Annual incidence,N/A
Disease,213767,Squamous cell carcinoma of the cervix uteri,Annual incidence,N/A
Disease,213767,Squamous cell carcinoma of the cervix uteri,Annual incidence,N/A
Disease,213767,Squamous cell carcinoma of the cervix uteri,Annual incidence,N/A
Disease,213767,Squamous cell carcinoma of the cervix uteri,Annual incidence,N/A
Disease,213767,Squamous cell carcinoma of the cervix uteri,Annual incidence,N/A
Disease,213767,Squamous cell carcinoma of the cervix uteri,Annual incidence,N/A
Disease,213767,Squamous cell carcinoma of the cervix uteri,Annual incidence,N/A
Disease,213767,Squamous cell carcinoma of the cervix uteri,Annual incidence,N/A
Disease,213767,Squamous cell carcinoma of the cervix uteri,Annual incidence,N/A
Disease,213792,Adenosarcoma of the cervix uteri,Annual incidence,N/A
Disease,213787,Carcinosarcoma of the cervix uteri,Annual incidence,N/A
Disease,1215,Autosomal dominant optic atrophy plus syndrome,Point prevalence,N/A
Disease,747,Autoimmune pulmonary alveolar proteinosis,Annual incidence,N/A
Disease,747,Autoimmune pulmonary alveolar proteinosis,Point prevalence,N/A
Disease,747,Autoimmune pulmonary alveolar proteinosis,Point prevalence,N/A
Disease,747,Autoimmune pulmonary alveolar proteinosis,Point prevalence,N/A
Malformation syndrome,1225,Baller-Gerold syndrome,Cases/families,N/A
Malformation syndrome,1225,Baller-Gerold syndrome,Point prevalence,N/A
Disease,2953,Musculocontractural Ehlers-Danlos syndrome,Cases/families,N/A
Disease,2953,Musculocontractural Ehlers-Danlos syndrome,Point prevalence,N/A
Malformation syndrome,1227,Bangstad syndrome,Cases/families,N/A
Malformation syndrome,1227,Bangstad syndrome,Point prevalence,N/A
Malformation syndrome,782,Axenfeld-Rieger syndrome,Point prevalence,N/A
Disease,1182,Spastic ataxia with congenital miosis,Cases/families,N/A
Disease,1182,Spastic ataxia with congenital miosis,Point prevalence,N/A
Malformation syndrome,3259,Syndactyly-polydactyly-ear lobe syndrome,Cases/families,N/A
Malformation syndrome,3259,Syndactyly-polydactyly-ear lobe syndrome,Point prevalence,N/A
Disease,1186,Infantile-onset spinocerebellar ataxia,Cases/families,N/A
Disease,1186,Infantile-onset spinocerebellar ataxia,Point prevalence,N/A
Disease,1185,Spinocerebellar ataxia-dysmorphism syndrome,Cases/families,N/A
Disease,1185,Spinocerebellar ataxia-dysmorphism syndrome,Point prevalence,N/A
Category,216675,Transposition of the great arteries,Prevalence at birth,N/A
Category,216675,Transposition of the great arteries,Prevalence at birth,N/A
Category,216675,Transposition of the great arteries,Prevalence at birth,N/A
Category,216675,Transposition of the great arteries,Prevalence at birth,N/A
Category,216675,Transposition of the great arteries,Prevalence at birth,N/A
Category,216675,Transposition of the great arteries,Prevalence at birth,N/A
Category,216675,Transposition of the great arteries,Prevalence at birth,N/A
Category,216675,Transposition of the great arteries,Prevalence at birth,N/A
Category,216675,Transposition of the great arteries,Prevalence at birth,N/A
Category,216675,Transposition of the great arteries,Prevalence at birth,N/A
Category,216675,Transposition of the great arteries,Prevalence at birth,N/A
Category,216675,Transposition of the great arteries,Prevalence at birth,N/A
Category,216675,Transposition of the great arteries,Prevalence at birth,N/A
Category,216675,Transposition of the great arteries,Prevalence at birth,N/A
Category,216675,Transposition of the great arteries,Prevalence at birth,N/A
Category,216675,Transposition of the great arteries,Prevalence at birth,N/A
Category,216675,Transposition of the great arteries,Prevalence at birth,N/A
Category,216675,Transposition of the great arteries,Point prevalence,N/A
Disease,137908,Hypotonia with lactic acidemia and hyperammonemia,Cases/families,N/A
Disease,137908,Hypotonia with lactic acidemia and hyperammonemia,Point prevalence,N/A
Morphological anomaly,137914,Choanal atresia,Prevalence at birth,N/A
Morphological anomaly,137914,Choanal atresia,Point prevalence,N/A
Morphological anomaly,137914,Choanal atresia,Prevalence at birth,N/A
Morphological anomaly,137914,Choanal atresia,Prevalence at birth,N/A
Morphological anomaly,137914,Choanal atresia,Prevalence at birth,N/A
Morphological anomaly,137914,Choanal atresia,Prevalence at birth,N/A
Morphological anomaly,137914,Choanal atresia,Prevalence at birth,N/A
Morphological anomaly,137914,Choanal atresia,Prevalence at birth,N/A
Morphological anomaly,137914,Choanal atresia,Prevalence at birth,N/A
Morphological anomaly,137914,Choanal atresia,Prevalence at birth,N/A
Morphological anomaly,137914,Choanal atresia,Prevalence at birth,N/A
Morphological anomaly,137914,Choanal atresia,Prevalence at birth,N/A
Morphological anomaly,137914,Choanal atresia,Prevalence at birth,N/A
Morphological anomaly,137914,Choanal atresia,Prevalence at birth,N/A
Morphological anomaly,137914,Choanal atresia,Prevalence at birth,N/A
Morphological anomaly,137914,Choanal atresia,Prevalence at birth,N/A
Morphological anomaly,137914,Choanal atresia,Prevalence at birth,N/A
Malformation syndrome,1193,Atkin-Flaitz syndrome,Cases/families,N/A
Malformation syndrome,1193,Atkin-Flaitz syndrome,Point prevalence,N/A
Clinical subtype,137917,"Choanal atresia, unilateral",Point prevalence,N/A
Clinical subtype,137917,"Choanal atresia, unilateral",Prevalence at birth,N/A
Malformation syndrome,1200,Burn-McKeown syndrome,Cases/families,N/A
Malformation syndrome,1200,Burn-McKeown syndrome,Point prevalence,N/A
Clinical subtype,137920,"Choanal atresia, bilateral",Point prevalence,N/A
Morphological anomaly,1198,Colonic atresia,Prevalence at birth,N/A
Morphological anomaly,1198,Colonic atresia,Point prevalence,N/A
Morphological anomaly,1198,Colonic atresia,Prevalence at birth,N/A
Morphological anomaly,1198,Colonic atresia,Prevalence at birth,N/A
Morphological anomaly,1203,Duodenal atresia,Prevalence at birth,N/A
Morphological anomaly,1203,Duodenal atresia,Point prevalence,N/A
Morphological anomaly,1203,Duodenal atresia,Prevalence at birth,N/A
Morphological anomaly,1203,Duodenal atresia,Point prevalence,N/A
Morphological anomaly,1203,Duodenal atresia,Prevalence at birth,N/A
Morphological anomaly,1203,Duodenal atresia,Point prevalence,N/A
Morphological anomaly,1203,Duodenal atresia,Prevalence at birth,N/A
Morphological anomaly,1203,Duodenal atresia,Point prevalence,N/A
Morphological anomaly,1203,Duodenal atresia,Prevalence at birth,N/A
Morphological anomaly,1203,Duodenal atresia,Point prevalence,N/A
Morphological anomaly,1203,Duodenal atresia,Prevalence at birth,N/A
Morphological anomaly,1203,Duodenal atresia,Point prevalence,N/A
Morphological anomaly,1203,Duodenal atresia,Prevalence at birth,N/A
Morphological anomaly,1203,Duodenal atresia,Point prevalence,N/A
Morphological anomaly,1203,Duodenal atresia,Prevalence at birth,N/A
Morphological anomaly,1203,Duodenal atresia,Point prevalence,N/A
Morphological anomaly,1203,Duodenal atresia,Prevalence at birth,N/A
Morphological anomaly,1203,Duodenal atresia,Point prevalence,N/A
Morphological anomaly,1203,Duodenal atresia,Prevalence at birth,N/A
Morphological anomaly,1203,Duodenal atresia,Point prevalence,N/A
Morphological anomaly,1203,Duodenal atresia,Prevalence at birth,N/A
Morphological anomaly,1203,Duodenal atresia,Point prevalence,N/A
Morphological anomaly,1203,Duodenal atresia,Prevalence at birth,N/A
Morphological anomaly,1203,Duodenal atresia,Point prevalence,N/A
Morphological anomaly,1203,Duodenal atresia,Prevalence at birth,N/A
Morphological anomaly,1203,Duodenal atresia,Point prevalence,N/A
Morphological anomaly,1203,Duodenal atresia,Prevalence at birth,N/A
Morphological anomaly,1203,Duodenal atresia,Point prevalence,N/A
Morphological anomaly,1208,Pulmonary atresia-intact ventricular septum syndrome,Prevalence at birth,N/A
Morphological anomaly,1208,Pulmonary atresia-intact ventricular septum syndrome,Prevalence at birth,N/A
Morphological anomaly,1208,Pulmonary atresia-intact ventricular septum syndrome,Point prevalence,N/A
Morphological anomaly,1208,Pulmonary atresia-intact ventricular septum syndrome,Point prevalence,N/A
Malformation syndrome,1449,Ring chromosome 7 syndrome,Cases/families,N/A
Malformation syndrome,1449,Ring chromosome 7 syndrome,Point prevalence,N/A
Malformation syndrome,1453,Cleidorhizomelic syndrome,Cases/families,N/A
Malformation syndrome,1453,Cleidorhizomelic syndrome,Point prevalence,N/A
Malformation syndrome,1440,Ring chromosome 14 syndrome,Cases/families,N/A
Malformation syndrome,1440,Ring chromosome 14 syndrome,Point prevalence,N/A
Malformation syndrome,1443,Ring chromosome 19 syndrome,Cases/families,N/A
Malformation syndrome,1443,Ring chromosome 19 syndrome,Point prevalence,N/A
Morphological anomaly,141258,Tessier number 4 facial cleft,Cases/families,N/A
Morphological anomaly,141258,Tessier number 4 facial cleft,Point prevalence,N/A
Malformation syndrome,1458,CODAS syndrome,Cases/families,N/A
Malformation syndrome,1458,CODAS syndrome,Point prevalence,N/A
Clinical group,141253,Oblique facial cleft,Prevalence at birth,N/A
Clinical group,141253,Oblique facial cleft,Point prevalence,N/A
Clinical group,141253,Oblique facial cleft,Point prevalence,N/A
Disease,1454,Joubert syndrome with hepatic defect,Cases/families,N/A
Disease,1454,Joubert syndrome with hepatic defect,Point prevalence,N/A
Disease,190,Coats disease,Annual incidence,N/A
Disease,190,Coats disease,Point prevalence,N/A
Disease,1426,Greenberg dysplasia,Cases/families,N/A
Disease,1426,Greenberg dysplasia,Point prevalence,N/A
Disease,141184,Rapidly involuting congenital hemangioma,Point prevalence,N/A
Disease,1427,Autosomal recessive otospondylomegaepiphyseal dysplasia,Cases/families,N/A
Disease,1427,Autosomal recessive otospondylomegaepiphyseal dysplasia,Point prevalence,N/A
Malformation syndrome,1435,Xq21 microdeletion syndrome,Cases/families,N/A
Malformation syndrome,1435,Xq21 microdeletion syndrome,Point prevalence,N/A
Malformation syndrome,1436,X-linked skeletal dysplasia-intellectual disability syndrome,Cases/families,N/A
Malformation syndrome,1436,X-linked skeletal dysplasia-intellectual disability syndrome,Point prevalence,N/A
Malformation syndrome,1433,Choroidal atrophy-alopecia syndrome,Cases/families,N/A
Malformation syndrome,1433,Choroidal atrophy-alopecia syndrome,Point prevalence,N/A
Malformation syndrome,1484,Contractures-ectodermal dysplasia-cleft lip/palate syndrome,Cases/families,N/A
Malformation syndrome,1484,Contractures-ectodermal dysplasia-cleft lip/palate syndrome,Point prevalence,N/A
Disease,141333,Biemond syndrome type 2,Point prevalence,N/A
Malformation syndrome,1490,Corneal dystrophy-perceptive deafness syndrome,Cases/families,N/A
Malformation syndrome,1490,Corneal dystrophy-perceptive deafness syndrome,Point prevalence,N/A
Malformation syndrome,1487,Cooks syndrome,Cases/families,N/A
Malformation syndrome,1487,Cooks syndrome,Point prevalence,N/A
Malformation syndrome,1486,Lethal congenital contracture syndrome type 1,Point prevalence,N/A
Malformation syndrome,1486,Lethal congenital contracture syndrome type 1,Prevalence at birth,N/A
Clinical subtype,1466,COFS syndrome,Cases/families,N/A
Clinical subtype,1466,COFS syndrome,Point prevalence,N/A
Malformation syndrome,1471,Coloboma of macula-brachydactyly type B syndrome,Cases/families,N/A
Malformation syndrome,1471,Coloboma of macula-brachydactyly type B syndrome,Point prevalence,N/A
Morphological anomaly,141291,Cleft lip and alveolus,Point prevalence,N/A
Malformation syndrome,141091,Polyrrhinia,Point prevalence,N/A
Morphological anomaly,141083,Nasolacrimal duct cyst,Prevalence at birth,N/A
Morphological anomaly,141083,Nasolacrimal duct cyst,Point prevalence,N/A
Disease,1410,Uncombable hair syndrome,Point prevalence,N/A
Malformation syndrome,141099,Proboscis lateralis,Point prevalence,N/A
Malformation syndrome,141096,Supernumerary nostril,Cases/families,N/A
Malformation syndrome,141096,Supernumerary nostril,Point prevalence,N/A
Malformation syndrome,1412,Tarsal-carpal coalition syndrome,Cases/families,N/A
Malformation syndrome,1412,Tarsal-carpal coalition syndrome,Point prevalence,N/A
Disease,1416,Familial calcium pyrophosphate deposition,Cases/families,N/A
Disease,1416,Familial calcium pyrophosphate deposition,Point prevalence,N/A
Malformation syndrome,1394,Cerebrofaciothoracic dysplasia,Cases/families,N/A
Malformation syndrome,1394,Cerebrofaciothoracic dysplasia,Point prevalence,N/A
Malformation syndrome,1397,Hydrocephaly-cerebellar agenesis syndrome,Point prevalence,N/A
Malformation syndrome,1397,Hydrocephaly-cerebellar agenesis syndrome,Cases/families,N/A
Morphological anomaly,1398,Isolated cerebellar agenesis,Point prevalence,N/A
Malformation syndrome,1399,Richards-Rundle syndrome,Point prevalence,N/A
Clinical subtype,141077,Epignathus,Point prevalence,N/A
Clinical subtype,141077,Epignathus,Prevalence at birth,N/A
Malformation syndrome,1401,CHAND syndrome,Point prevalence,N/A
Morphological anomaly,141152,Isolated congenital hypoglossia/aglossia,Point prevalence,N/A
Disease,174,"Metaphyseal chondrodysplasia, Schmid type",Point prevalence,N/A
Malformation syndrome,141163,Glossopalatine ankylosis,Cases/families,N/A
Malformation syndrome,141163,Glossopalatine ankylosis,Point prevalence,N/A
Malformation syndrome,1425,Desbuquois syndrome,Cases/families,N/A
Malformation syndrome,1425,Desbuquois syndrome,Point prevalence,N/A
Disease,141179,Non-involuting congenital hemangioma,Point prevalence,N/A
Morphological anomaly,141127,Congenital tracheal stenosis,Point prevalence,N/A
Morphological anomaly,141127,Congenital tracheal stenosis,Prevalence at birth,N/A
Malformation syndrome,141132,Oculo-auriculo-vertebral spectrum,Prevalence at birth,N/A
Malformation syndrome,141132,Oculo-auriculo-vertebral spectrum,Point prevalence,N/A
Malformation syndrome,141132,Oculo-auriculo-vertebral spectrum,Point prevalence,N/A
Malformation syndrome,141132,Oculo-auriculo-vertebral spectrum,Prevalence at birth,N/A
Malformation syndrome,141132,Oculo-auriculo-vertebral spectrum,Prevalence at birth,N/A
Malformation syndrome,141145,Hemifacial hyperplasia,Point prevalence,N/A
Malformation syndrome,141145,Hemifacial hyperplasia,Prevalence at birth,N/A
Malformation syndrome,141148,Hemifacial myohyperplasia,Cases/families,N/A
Malformation syndrome,141148,Hemifacial myohyperplasia,Point prevalence,N/A
Disease,156728,"Spondyloepimetaphyseal dysplasia, matrilin-3 type",Cases/families,N/A
Disease,156728,"Spondyloepimetaphyseal dysplasia, matrilin-3 type",Point prevalence,N/A
Malformation syndrome,1375,Cataract-hypertrichosis-intellectual disability syndrome,Point prevalence,N/A
Disease,163,Hereditary hyperferritinemia-cataract syndrome,Cases/families,N/A
Disease,163,Hereditary hyperferritinemia-cataract syndrome,Point prevalence,N/A
Malformation syndrome,1373,Cataract-aberrant oral frenula-growth delay syndrome,Cases/families,N/A
Malformation syndrome,1373,Cataract-aberrant oral frenula-growth delay syndrome,Point prevalence,N/A
Disease,1368,Cataract-ataxia-deafness syndrome,Cases/families,N/A
Disease,1368,Cataract-ataxia-deafness syndrome,Point prevalence,N/A
Disease,1366,Autosomal recessive palmoplantar keratoderma and congenital alopecia,Cases/families,N/A
Disease,1366,Autosomal recessive palmoplantar keratoderma and congenital alopecia,Point prevalence,N/A
Biological anomaly,1361,Carnosinase deficiency,Cases/families,N/A
Biological anomaly,1361,Carnosinase deficiency,Point prevalence,N/A
Biological anomaly,1361,Carnosinase deficiency,Prevalence at birth,N/A
Malformation syndrome,1393,Cerebrocostomandibular syndrome,Cases/families,N/A
Malformation syndrome,1393,Cerebrocostomandibular syndrome,Point prevalence,N/A
Disease,157826,Congenital epulis,Point prevalence,N/A
Malformation syndrome,1390,Night blindness-skeletal anomalies-dysmorphism syndrome,Cases/families,N/A
Malformation syndrome,1390,Night blindness-skeletal anomalies-dysmorphism syndrome,Point prevalence,N/A
Disease,157820,Cold-induced sweating syndrome,Cases/families,N/A
Disease,157820,Cold-induced sweating syndrome,Point prevalence,N/A
Malformation syndrome,1389,Cortical blindness-intellectual disability-polydactyly syndrome,Cases/families,N/A
Malformation syndrome,1389,Cortical blindness-intellectual disability-polydactyly syndrome,Point prevalence,N/A
Disease,157798,Serrated polyposis syndrome,Annual incidence,N/A
Disease,157798,Serrated polyposis syndrome,Point prevalence,N/A
Malformation syndrome,1388,Catel-Manzke syndrome,Cases/families,N/A
Malformation syndrome,1388,Catel-Manzke syndrome,Point prevalence,N/A
Morphological anomaly,157801,Mesoaxial synostotic syndactyly with phalangeal reduction,Cases/families,N/A
Morphological anomaly,157801,Mesoaxial synostotic syndactyly with phalangeal reduction,Point prevalence,N/A
Malformation syndrome,1387,Cataract-intellectual disability-hypogonadism syndrome,Cases/families,N/A
Malformation syndrome,1387,Cataract-intellectual disability-hypogonadism syndrome,Point prevalence,N/A
Disease,157791,Epithelioid hemangioendothelioma,Point prevalence,N/A
Malformation syndrome,1381,Cataract-intellectual disability-anal atresia-urinary defects syndrome,Cases/families,N/A
Malformation syndrome,1381,Cataract-intellectual disability-anal atresia-urinary defects syndrome,Point prevalence,N/A
Malformation syndrome,1380,Cataract-nephropathy-encephalopathy syndrome,Cases/families,N/A
Malformation syndrome,1380,Cataract-nephropathy-encephalopathy syndrome,Point prevalence,N/A
Malformation syndrome,1377,Cataract-microcornea syndrome,Cases/families,N/A
Malformation syndrome,1377,Cataract-microcornea syndrome,Point prevalence,N/A
Disease,157215,Hereditary hypophosphatemic rickets with hypercalciuria,Point prevalence,N/A
Malformation syndrome,1325,Camptodactyly-taurinuria syndrome,Cases/families,N/A
Malformation syndrome,1325,Camptodactyly-taurinuria syndrome,Point prevalence,N/A
Malformation syndrome,1326,"Camptodactyly syndrome, Guadalajara type 2",Cases/families,N/A
Malformation syndrome,1326,"Camptodactyly syndrome, Guadalajara type 2",Point prevalence,N/A
Malformation syndrome,1327,"Camptodactyly syndrome, Guadalajara type 1",Cases/families,N/A
Malformation syndrome,1327,"Camptodactyly syndrome, Guadalajara type 1",Point prevalence,N/A
Malformation syndrome,1328,Camurati-Engelmann disease,Cases/families,N/A
Malformation syndrome,1328,Camurati-Engelmann disease,Point prevalence,N/A
Malformation syndrome,1323,Camptodactyly-joint contractures-facial skeletal defects syndrome,Cases/families,N/A
Malformation syndrome,1323,Camptodactyly-joint contractures-facial skeletal defects syndrome,Point prevalence,N/A
Clinical group,156152,Anti-neutrophil cytoplasmic antibody-associated vasculitis,Point prevalence,N/A
Clinical group,156152,Anti-neutrophil cytoplasmic antibody-associated vasculitis,Point prevalence,N/A
Clinical group,156152,Anti-neutrophil cytoplasmic antibody-associated vasculitis,Annual incidence,N/A
Clinical group,156152,Anti-neutrophil cytoplasmic antibody-associated vasculitis,Point prevalence,N/A
Disease,1314,Symmetrical thalamic calcifications,Cases/families,N/A
Disease,1314,Symmetrical thalamic calcifications,Point prevalence,N/A
Malformation syndrome,1318,"Campomelia, Cumming type",Cases/families,N/A
Malformation syndrome,1318,"Campomelia, Cumming type",Point prevalence,N/A
Malformation syndrome,1319,Camptobrachydactyly,Cases/families,N/A
Malformation syndrome,1319,Camptobrachydactyly,Point prevalence,N/A
Malformation syndrome,1305,Feingold syndrome,Cases/families,N/A
Malformation syndrome,1305,Feingold syndrome,Point prevalence,N/A
Malformation syndrome,1307,Distal limb deficiencies-micrognathia syndrome,Cases/families,N/A
Malformation syndrome,1307,Distal limb deficiencies-micrognathia syndrome,Point prevalence,N/A
Disease,1313,Infantile choroidocerebral calcification syndrome,Cases/families,N/A
Disease,1313,Infantile choroidocerebral calcification syndrome,Point prevalence,N/A
Malformation syndrome,1350,Heart-hand syndrome type 2,Cases/families,N/A
Malformation syndrome,1350,Heart-hand syndrome type 2,Point prevalence,N/A
Malformation syndrome,1355,Congenital heart defect-round face-developmental delay syndrome,Cases/families,N/A
Malformation syndrome,1355,Congenital heart defect-round face-developmental delay syndrome,Point prevalence,N/A
Malformation syndrome,1352,Atrioventricular defect-blepharophimosis-radial and anal defect syndrome,Cases/families,N/A
Malformation syndrome,1352,Atrioventricular defect-blepharophimosis-radial and anal defect syndrome,Point prevalence,N/A
Disease,1345,Cardiomyopathy-cataract-hip spine disease syndrome,Cases/families,N/A
Disease,1345,Cardiomyopathy-cataract-hip spine disease syndrome,Point prevalence,N/A
Malformation syndrome,1338,Heart defect-tongue hamartoma-polysyndactyly syndrome,Cases/families,N/A
Malformation syndrome,1338,Heart defect-tongue hamartoma-polysyndactyly syndrome,Point prevalence,N/A
Malformation syndrome,1340,Cardiofaciocutaneous syndrome,Point prevalence,N/A
Malformation syndrome,1340,Cardiofaciocutaneous syndrome,Cases/families,N/A
Malformation syndrome,1340,Cardiofaciocutaneous syndrome,Point prevalence,N/A
Malformation syndrome,2856,Persistent Mllerian duct syndrome,Point prevalence,N/A
Disease,1336,Hyperkeratosis-hyperpigmentation syndrome,Cases/families,N/A
Disease,1336,Hyperkeratosis-hyperpigmentation syndrome,Point prevalence,N/A
Malformation syndrome,1335,Pentalogy of Cantrell,Prevalence at birth,N/A
Malformation syndrome,1335,Pentalogy of Cantrell,Point prevalence,N/A
Malformation syndrome,1335,Pentalogy of Cantrell,Prevalence at birth,N/A
Malformation syndrome,1682,Arterial dissection-lentiginosis syndrome,Cases/families,N/A
Malformation syndrome,1682,Arterial dissection-lentiginosis syndrome,Point prevalence,N/A
Malformation syndrome,1757,Fibular dimelia-diplopodia syndrome,Cases/families,N/A
Malformation syndrome,1757,Fibular dimelia-diplopodia syndrome,Point prevalence,N/A
Malformation syndrome,1756,Caudal duplication,Point prevalence,N/A
Disease,1766,Dysequilibrium syndrome,Point prevalence,N/A
Disease,1766,Dysequilibrium syndrome,Cases/families,N/A
Malformation syndrome,1777,Temtamy syndrome,Cases/families,N/A
Malformation syndrome,1777,Temtamy syndrome,Point prevalence,N/A
Malformation syndrome,1780,Thakker-Donnai syndrome,Cases/families,N/A
Malformation syndrome,1780,Thakker-Donnai syndrome,Point prevalence,N/A
Malformation syndrome,1772,"45,X/46,XY mixed gonadal dysgenesis",Point prevalence,N/A
Malformation syndrome,1784,Acrofrontofacionasal dysostosis,Cases/families,N/A
Malformation syndrome,1784,Acrofrontofacionasal dysostosis,Point prevalence,N/A
Malformation syndrome,1782,Dysosteosclerosis,Cases/families,N/A
Malformation syndrome,1782,Dysosteosclerosis,Point prevalence,N/A
Malformation syndrome,1790,Hypomandibular faciocranial dysostosis,Cases/families,N/A
Malformation syndrome,1790,Hypomandibular faciocranial dysostosis,Point prevalence,N/A
Malformation syndrome,1786,"Acrofacial dysostosis, Catania type",Cases/families,N/A
Malformation syndrome,1786,"Acrofacial dysostosis, Catania type",Point prevalence,N/A
Malformation syndrome,1788,"Acrofacial dysostosis, Rodrguez type",Cases/families,N/A
Malformation syndrome,1788,"Acrofacial dysostosis, Rodrguez type",Point prevalence,N/A
Disease,859,Transcobalamin deficiency,Cases/families,N/A
Disease,859,Transcobalamin deficiency,Point prevalence,N/A
Disease,139441,Hypomyelination with atrophy of basal ganglia and cerebellum,Cases/families,N/A
Disease,139441,Hypomyelination with atrophy of basal ganglia and cerebellum,Point prevalence,N/A
Disease,3196,Steroid dehydrogenase deficiency-dental anomalies syndrome,Cases/families,N/A
Disease,3196,Steroid dehydrogenase deficiency-dental anomalies syndrome,Point prevalence,N/A
Disease,139444,Leukoencephalopathy with bilateral anterior temporal lobe cysts,Cases/families,N/A
Disease,139444,Leukoencephalopathy with bilateral anterior temporal lobe cysts,Point prevalence,N/A
Disease,139447,Progressive cavitating leukoencephalopathy,Cases/families,N/A
Disease,139447,Progressive cavitating leukoencephalopathy,Point prevalence,N/A
Malformation syndrome,1573,Hypotrichosis with juvenile macular degeneration,Cases/families,N/A
Malformation syndrome,1573,Hypotrichosis with juvenile macular degeneration,Point prevalence,N/A
Disease,726,Alpers-Huttenlocher syndrome,Prevalence at birth,N/A
Disease,726,Alpers-Huttenlocher syndrome,Point prevalence,N/A
Malformation syndrome,139450,Microtia-eye coloboma-imperforation of the nasolacrimal duct syndrome,Cases/families,N/A
Malformation syndrome,139450,Microtia-eye coloboma-imperforation of the nasolacrimal duct syndrome,Point prevalence,N/A
Disease,139455,Autosomal recessive bestrophinopathy,Cases/families,N/A
Disease,139455,Autosomal recessive bestrophinopathy,Point prevalence,N/A
Malformation syndrome,1574,Retinal degeneration-nanophthalmos-glaucoma syndrome,Cases/families,N/A
Malformation syndrome,1574,Retinal degeneration-nanophthalmos-glaucoma syndrome,Point prevalence,N/A
Malformation syndrome,139466,SERKAL syndrome,Cases/families,N/A
Malformation syndrome,139466,SERKAL syndrome,Point prevalence,N/A
Malformation syndrome,1596,Distal deletion 15q syndrome,Cases/families,N/A
Malformation syndrome,1596,Distal deletion 15q syndrome,Point prevalence,N/A
Malformation syndrome,139471,Microphthalmia with brain and digit anomalies,Cases/families,N/A
Malformation syndrome,139471,Microphthalmia with brain and digit anomalies,Point prevalence,N/A
Malformation syndrome,139474,17q11.2 microduplication syndrome,Cases/families,N/A
Malformation syndrome,139474,17q11.2 microduplication syndrome,Point prevalence,N/A
Etiological subtype,1617,Developmental delay-language impairment-dopa responsive dystonia-parkinsonism syndrome due to 2q24 microdeletion,Cases/families,N/A
Etiological subtype,1617,Developmental delay-language impairment-dopa responsive dystonia-parkinsonism syndrome due to 2q24 microdeletion,Point prevalence,N/A
Malformation syndrome,1606,1p36 deletion syndrome,Prevalence at birth,N/A
Malformation syndrome,1606,1p36 deletion syndrome,Point prevalence,N/A
Disease,139480,Autosomal recessive spastic paraplegia type 39,Cases/families,N/A
Disease,139480,Autosomal recessive spastic paraplegia type 39,Point prevalence,N/A
Malformation syndrome,1647,Oculocerebrocutaneous syndrome,Cases/families,N/A
Malformation syndrome,1647,Oculocerebrocutaneous syndrome,Point prevalence,N/A
Disease,139485,Autosomal recessive ataxia due to ubiquinone deficiency,Cases/families,N/A
Disease,139485,Autosomal recessive ataxia due to ubiquinone deficiency,Point prevalence,N/A
Disease,1653,Dentin dysplasia,Point prevalence,N/A
Disease,139515,Charcot-Marie-Tooth disease type 4J,Cases/families,N/A
Disease,139515,Charcot-Marie-Tooth disease type 4J,Point prevalence,N/A
Disease,139512,Neuropathy with hearing impairment,Cases/families,N/A
Disease,139512,Neuropathy with hearing impairment,Point prevalence,N/A
Malformation syndrome,1657,"Dermatoosteolysis, Kirghizian type",Cases/families,N/A
Malformation syndrome,1657,"Dermatoosteolysis, Kirghizian type",Point prevalence,N/A
Disease,139525,Distal hereditary motor neuropathy type 2,Point prevalence,N/A
Disease,139525,Distal hereditary motor neuropathy type 2,Cases/families,N/A
Disease,1658,Absence of fingerprints-congenital milia syndrome,Cases/families,N/A
Disease,1658,Absence of fingerprints-congenital milia syndrome,Point prevalence,N/A
Disease,1659,Dermatoleukodystrophy,Cases/families,N/A
Disease,1659,Dermatoleukodystrophy,Point prevalence,N/A
Disease,139547,Distal spinal muscular atrophy type 3,Cases/families,N/A
Disease,139547,Distal spinal muscular atrophy type 3,Point prevalence,N/A
Malformation syndrome,1660,Dermoodontodysplasia,Cases/families,N/A
Malformation syndrome,1660,Dermoodontodysplasia,Point prevalence,N/A
Disease,139557,X-linked distal spinal muscular atrophy type 3,Cases/families,N/A
Disease,139557,X-linked distal spinal muscular atrophy type 3,Point prevalence,N/A
Disease,1661,X-linked corneal dermoid,Cases/families,N/A
Disease,1661,X-linked corneal dermoid,Point prevalence,N/A
Disease,1662,Restrictive dermopathy,Cases/families,N/A
Disease,1662,Restrictive dermopathy,Point prevalence,N/A
Disease,139552,"Distal hereditary motor neuropathy, Jerash type",Cases/families,N/A
Disease,139552,"Distal hereditary motor neuropathy, Jerash type",Point prevalence,N/A
Disease,139573,Hereditary sensory and autonomic neuropathy with deafness and global delay,Cases/families,N/A
Disease,139573,Hereditary sensory and autonomic neuropathy with deafness and global delay,Point prevalence,N/A
Disease,139564,Hereditary sensory and autonomic neuropathy type 1B,Cases/families,N/A
Disease,139564,Hereditary sensory and autonomic neuropathy type 1B,Point prevalence,N/A
Disease,139583,X-linked hereditary sensory and autonomic neuropathy with deafness,Cases/families,N/A
Disease,139583,X-linked hereditary sensory and autonomic neuropathy with deafness,Point prevalence,N/A
Disease,1667,Wolcott-Rallison syndrome,Cases/families,N/A
Disease,1667,Wolcott-Rallison syndrome,Point prevalence,N/A
Disease,139578,Mutilating hereditary sensory neuropathy with spastic paraplegia,Cases/families,N/A
Disease,139578,Mutilating hereditary sensory neuropathy with spastic paraplegia,Point prevalence,N/A
Morphological anomaly,1671,Split cord malformation type I,Point prevalence,N/A
Malformation syndrome,140917,Stapes ankylosis with broad thumbs and toes,Cases/families,N/A
Malformation syndrome,140917,Stapes ankylosis with broad thumbs and toes,Point prevalence,N/A
Malformation syndrome,1548,Cryptorchidism-arachnodactyly-intellectual disability syndrome,Cases/families,N/A
Malformation syndrome,1548,Cryptorchidism-arachnodactyly-intellectual disability syndrome,Point prevalence,N/A
Malformation syndrome,1547,Cryptomicrotia-brachydactyly-excess fingertip arch syndrome,Cases/families,N/A
Malformation syndrome,1547,Cryptomicrotia-brachydactyly-excess fingertip arch syndrome,Point prevalence,N/A
Disease,140922,Titin-related limb-girdle muscular dystrophy R10,Cases/families,N/A
Disease,140922,Titin-related limb-girdle muscular dystrophy R10,Point prevalence,N/A
Malformation syndrome,1545,Crisponi syndrome,Cases/families,N/A
Malformation syndrome,1545,Crisponi syndrome,Point prevalence,N/A
Malformation syndrome,1540,Jackson-Weiss syndrome,Point prevalence,N/A
Malformation syndrome,1540,Jackson-Weiss syndrome,Cases/families,N/A
Category,140874,Joubert syndrome and related disorders,Prevalence at birth,N/A
Category,140874,Joubert syndrome and related disorders,Prevalence at birth,N/A
Category,140874,Joubert syndrome and related disorders,Prevalence at birth,N/A
Category,140874,Joubert syndrome and related disorders,Point prevalence,N/A
Category,140874,Joubert syndrome and related disorders,Point prevalence,N/A
Disease,140896,Severe acute respiratory syndrome,Point prevalence,N/A
Disease,140896,Severe acute respiratory syndrome,Annual incidence,N/A
Malformation syndrome,1532,Gmez-Lpez-Hernndez syndrome,Cases/families,N/A
Malformation syndrome,1532,Gmez-Lpez-Hernndez syndrome,Point prevalence,N/A
Malformation syndrome,140952,Syndactyly-telecanthus-anogenital and renal malformations syndrome,Cases/families,N/A
Malformation syndrome,140952,Syndactyly-telecanthus-anogenital and renal malformations syndrome,Point prevalence,N/A
Disease,140957,Autosomal dominant macrothrombocytopenia,Cases/families,N/A
Disease,140957,Autosomal dominant macrothrombocytopenia,Point prevalence,N/A
Malformation syndrome,140944,CLOVES syndrome,Cases/families,N/A
Malformation syndrome,140944,CLOVES syndrome,Point prevalence,N/A
Particular clinical situation in a disease or syndrome,140949,Low-flow priapism,Point prevalence,N/A
Malformation syndrome,1555,Cutis gyrata-acanthosis nigricans-craniosynostosis syndrome,Cases/families,N/A
Malformation syndrome,1555,Cutis gyrata-acanthosis nigricans-craniosynostosis syndrome,Point prevalence,N/A
Malformation syndrome,140936,Lelis syndrome,Cases/families,N/A
Malformation syndrome,140936,Lelis syndrome,Point prevalence,N/A
Disease,140941,Short stature due to primary acid-labile subunit deficiency,Point prevalence,N/A
Malformation syndrome,1553,Curry-Jones syndrome,Cases/families,N/A
Malformation syndrome,1553,Curry-Jones syndrome,Point prevalence,N/A
Disease,140927,Self-limited neonatal-infantile epilepsy,Cases/families,N/A
Disease,140927,Self-limited neonatal-infantile epilepsy,Point prevalence,N/A
Disease,140933,Linear atrophoderma of Moulin,Cases/families,N/A
Disease,140933,Linear atrophoderma of Moulin,Point prevalence,N/A
Disease,140989,Primary angiitis of the central nervous system,Annual incidence,N/A
Disease,140989,Primary angiitis of the central nervous system,Point prevalence,N/A
Malformation syndrome,1566,Dandy-Walker malformation-postaxial polydactyly syndrome,Cases/families,N/A
Malformation syndrome,1566,Dandy-Walker malformation-postaxial polydactyly syndrome,Point prevalence,N/A
Disease,140976,RHYNS syndrome,Cases/families,N/A
Disease,140976,RHYNS syndrome,Point prevalence,N/A
Malformation syndrome,1563,Dahlberg-Borer-Newcomer syndrome,Cases/families,N/A
Malformation syndrome,1563,Dahlberg-Borer-Newcomer syndrome,Point prevalence,N/A
Disease,140969,Saldino-Mainzer syndrome,Cases/families,N/A
Disease,140969,Saldino-Mainzer syndrome,Point prevalence,N/A
Disease,140966,"Palmoplantar keratoderma, Nagashima type",Cases/families,N/A
Disease,140966,"Palmoplantar keratoderma, Nagashima type",Point prevalence,N/A
Malformation syndrome,140963,Bilateral microtia-deafness-cleft palate syndrome,Cases/families,N/A
Malformation syndrome,140963,Bilateral microtia-deafness-cleft palate syndrome,Point prevalence,N/A
Disease,382,Guanidinoacetate methyltransferase deficiency,Cases/families,N/A
Disease,382,Guanidinoacetate methyltransferase deficiency,Point prevalence,N/A
Disease,742,Prolidase deficiency,Cases/families,N/A
Disease,742,Prolidase deficiency,Point prevalence,N/A
Disease,742,Prolidase deficiency,Prevalence at birth,N/A
Disease,1979,Lipodystrophy due to peptidic growth factors deficiency,Cases/families,N/A
Disease,1979,Lipodystrophy due to peptidic growth factors deficiency,Point prevalence,N/A
Malformation syndrome,1571,Knobloch syndrome,Cases/families,N/A
Malformation syndrome,1571,Knobloch syndrome,Point prevalence,N/A
Malformation syndrome,141007,Orofaciodigital syndrome type 9,Cases/families,N/A
Malformation syndrome,141007,Orofaciodigital syndrome type 9,Point prevalence,N/A
Disease,1551,Familial benign copper deficiency,Cases/families,N/A
Disease,1551,Familial benign copper deficiency,Point prevalence,N/A
Malformation syndrome,1568,X-linked intellectual disability-Dandy-Walker malformation-basal ganglia disease-seizures syndrome,Cases/families,N/A
Malformation syndrome,1568,X-linked intellectual disability-Dandy-Walker malformation-basal ganglia disease-seizures syndrome,Point prevalence,N/A
Malformation syndrome,141000,Orofaciodigital syndrome type 11,Point prevalence,N/A
Clinical subtype,1497,X-linked complicated corpus callosum dysgenesis,Cases/families,N/A
Clinical subtype,1497,X-linked complicated corpus callosum dysgenesis,Point prevalence,N/A
Malformation syndrome,1493,Vici syndrome,Cases/families,N/A
Malformation syndrome,1493,Vici syndrome,Point prevalence,N/A
Disease,140286,Secondary hypoparathyroidism due to impaired parathormon secretion,Point prevalence,N/A
Disease,140286,Secondary hypoparathyroidism due to impaired parathormon secretion,Annual incidence,N/A
Disease,140286,Secondary hypoparathyroidism due to impaired parathormon secretion,Annual incidence,N/A
Disease,140286,Secondary hypoparathyroidism due to impaired parathormon secretion,Annual incidence,N/A
Malformation syndrome,1495,Intellectual disability-hypoplastic corpus callosum-preauricular tag syndrome,Cases/families,N/A
Malformation syndrome,1495,Intellectual disability-hypoplastic corpus callosum-preauricular tag syndrome,Point prevalence,N/A
Disease,1509,Coxopodopatellar syndrome,Cases/families,N/A
Disease,1509,Coxopodopatellar syndrome,Point prevalence,N/A
Malformation syndrome,1512,Crane-Heise syndrome,Cases/families,N/A
Malformation syndrome,1512,Crane-Heise syndrome,Point prevalence,N/A
Malformation syndrome,1506,Thin ribs-tubular bones-dysmorphism syndrome,Cases/families,N/A
Malformation syndrome,1506,Thin ribs-tubular bones-dysmorphism syndrome,Point prevalence,N/A
Malformation syndrome,1508,Coxoauricular syndrome,Cases/families,N/A
Malformation syndrome,1508,Coxoauricular syndrome,Point prevalence,N/A
Clinical subtype,1507,Autosomal recessive Robinow syndrome,Cases/families,N/A
Clinical subtype,1507,Autosomal recessive Robinow syndrome,Point prevalence,N/A
Malformation syndrome,1517,Cant syndrome,Cases/families,N/A
Malformation syndrome,1517,Cant syndrome,Point prevalence,N/A
Malformation syndrome,1519,SPECC1L-related hypertelorism syndrome,Cases/families,N/A
Malformation syndrome,1519,SPECC1L-related hypertelorism syndrome,Point prevalence,N/A
Malformation syndrome,1520,Craniofrontonasal dysplasia,Point prevalence,N/A
Malformation syndrome,1513,Craniodiaphyseal dysplasia,Cases/families,N/A
Malformation syndrome,1513,Craniodiaphyseal dysplasia,Point prevalence,N/A
Malformation syndrome,1514,Craniodigital-intellectual disability syndrome,Cases/families,N/A
Malformation syndrome,1514,Craniodigital-intellectual disability syndrome,Point prevalence,N/A
Disease,140481,Autosomal dominant slowed nerve conduction velocity,Cases/families,N/A
Disease,140481,Autosomal dominant slowed nerve conduction velocity,Point prevalence,N/A
Malformation syndrome,1515,Cranioectodermal dysplasia,Cases/families,N/A
Malformation syndrome,1515,Cranioectodermal dysplasia,Point prevalence,N/A
Malformation syndrome,1516,Non-syndromic bilambdoid and sagittal craniosynostosis,Cases/families,N/A
Malformation syndrome,1516,Non-syndromic bilambdoid and sagittal craniosynostosis,Prevalence at birth,N/A
Malformation syndrome,1516,Non-syndromic bilambdoid and sagittal craniosynostosis,Point prevalence,N/A
Malformation syndrome,1516,Non-syndromic bilambdoid and sagittal craniosynostosis,Prevalence at birth,N/A
Malformation syndrome,1527,"Craniosynostosis, Philadelphia type",Cases/families,N/A
Malformation syndrome,1527,"Craniosynostosis, Philadelphia type",Point prevalence,N/A
Malformation syndrome,1528,Craniotelencephalic dysplasia,Cases/families,N/A
Malformation syndrome,1528,Craniotelencephalic dysplasia,Point prevalence,N/A
Malformation syndrome,1529,Craniofacial-deafness-hand syndrome,Cases/families,N/A
Malformation syndrome,1529,Craniofacial-deafness-hand syndrome,Point prevalence,N/A
Malformation syndrome,1521,Craniofrontonasal dysplasia-Poland anomaly syndrome,Cases/families,N/A
Malformation syndrome,1521,Craniofrontonasal dysplasia-Poland anomaly syndrome,Point prevalence,N/A
Malformation syndrome,1522,Craniometaphyseal dysplasia,Cases/families,N/A
Malformation syndrome,1522,Craniometaphyseal dysplasia,Point prevalence,N/A
Malformation syndrome,1525,Cranio-osteoarthropathy,Cases/families,N/A
Malformation syndrome,1525,Cranio-osteoarthropathy,Point prevalence,N/A
Malformation syndrome,1969,Facial dysmorphism-anorexia-cachexia-eye and skin anomalies syndrome,Cases/families,N/A
Malformation syndrome,1969,Facial dysmorphism-anorexia-cachexia-eye and skin anomalies syndrome,Point prevalence,N/A
Malformation syndrome,1968,Flat face-microstomia-ear anomaly syndrome,Cases/families,N/A
Malformation syndrome,1968,Flat face-microstomia-ear anomaly syndrome,Point prevalence,N/A
Malformation syndrome,1970,Facial dysmorphism-macrocephaly-myopia-Dandy-Walker malformation syndrome,Cases/families,N/A
Malformation syndrome,1970,Facial dysmorphism-macrocephaly-myopia-Dandy-Walker malformation syndrome,Point prevalence,N/A
Malformation syndrome,1973,Faciocardiorenal syndrome,Cases/families,N/A
Malformation syndrome,1973,Faciocardiorenal syndrome,Point prevalence,N/A
Malformation syndrome,1972,Lethal faciocardiomelic dysplasia,Cases/families,N/A
Malformation syndrome,1972,Lethal faciocardiomelic dysplasia,Point prevalence,N/A
Malformation syndrome,1974,Autosomal recessive faciodigitogenital syndrome,Cases/families,N/A
Malformation syndrome,1974,Autosomal recessive faciodigitogenital syndrome,Point prevalence,N/A
Malformation syndrome,1962,Exostoses-anetodermia-brachydactyly type E syndrome,Cases/families,N/A
Malformation syndrome,1962,Exostoses-anetodermia-brachydactyly type E syndrome,Point prevalence,N/A
Malformation syndrome,1964,Extrasystoles-short stature-hyperpigmentation-microcephaly syndrome,Cases/families,N/A
Malformation syndrome,1964,Extrasystoles-short stature-hyperpigmentation-microcephaly syndrome,Point prevalence,N/A
Malformation syndrome,1822,Dysplasia epiphysealis hemimelica,Annual incidence,N/A
Malformation syndrome,1822,Dysplasia epiphysealis hemimelica,Point prevalence,N/A
Disease,1824,Lowry-Wood syndrome,Cases/families,N/A
Disease,1824,Lowry-Wood syndrome,Point prevalence,N/A
Malformation syndrome,1952,Epiphyseal stippling-osteoclastic hyperplasia syndrome,Cases/families,N/A
Malformation syndrome,1952,Epiphyseal stippling-osteoclastic hyperplasia syndrome,Point prevalence,N/A
Disease,1954,Congenital lethal erythroderma,Cases/families,N/A
Disease,1954,Congenital lethal erythroderma,Point prevalence,N/A
Disease,1955,Spinocerebellar ataxia type 34,Point prevalence,N/A
Disease,1955,Spinocerebellar ataxia type 34,Cases/families,N/A
Malformation syndrome,1926,Diabetic embryopathy,Point prevalence,N/A
Malformation syndrome,2209,Maternal phenylketonuria,Point prevalence,N/A
Malformation syndrome,2209,Maternal phenylketonuria,Annual incidence,N/A
Malformation syndrome,1927,Emery-Nelson syndrome,Cases/families,N/A
Malformation syndrome,1927,Emery-Nelson syndrome,Point prevalence,N/A
Malformation syndrome,1937,Eng-Strom syndrome,Point prevalence,N/A
Malformation syndrome,1937,Eng-Strom syndrome,Cases/families,N/A
Malformation syndrome,1920,Toluene embryopathy,Point prevalence,N/A
Malformation syndrome,1919,Phenobarbital embryopathy,Point prevalence,N/A
Malformation syndrome,1917,Fetal methylmercury syndrome,Point prevalence,N/A
Malformation syndrome,1923,Methimazole embryofetopathy,Cases/families,N/A
Malformation syndrome,1923,Methimazole embryofetopathy,Point prevalence,N/A
Malformation syndrome,1912,Fetal hydantoin syndrome,Point prevalence,N/A
Malformation syndrome,1918,Fetal minoxidil syndrome,Point prevalence,N/A
Malformation syndrome,1911,Cocaine embryofetopathy,Point prevalence,N/A
Malformation syndrome,1910,Fetal iodine syndrome,Point prevalence,N/A
Malformation syndrome,1916,Diethylstilbestrol syndrome,Point prevalence,N/A
Disease,294,Fetal cytomegalovirus syndrome,Point prevalence,N/A
Malformation syndrome,1914,Vitamin K antagonist embryofetopathy,Point prevalence,N/A
Malformation syndrome,1913,Fetal trimethadione syndrome,Point prevalence,N/A
Malformation syndrome,1896,EEC syndrome,Prevalence at birth,N/A
Malformation syndrome,1896,EEC syndrome,Point prevalence,N/A
Malformation syndrome,1897,EEM syndrome,Cases/families,N/A
Malformation syndrome,1897,EEM syndrome,Point prevalence,N/A
Malformation syndrome,1908,Aminopterin/methotrexate embryofetopathy,Cases/families,N/A
Malformation syndrome,1908,Aminopterin/methotrexate embryofetopathy,Point prevalence,N/A
Malformation syndrome,1909,Indomethacin embryofetopathy,Point prevalence,N/A
Malformation syndrome,1906,Fetal valproate spectrum disorder,Point prevalence,N/A
Malformation syndrome,1906,Fetal valproate spectrum disorder,Prevalence at birth,N/A
Malformation syndrome,1906,Fetal valproate spectrum disorder,Prevalence at birth,N/A
Malformation syndrome,1906,Fetal valproate spectrum disorder,Prevalence at birth,N/A
Malformation syndrome,1906,Fetal valproate spectrum disorder,Prevalence at birth,N/A
Malformation syndrome,1906,Fetal valproate spectrum disorder,Prevalence at birth,N/A
Malformation syndrome,1906,Fetal valproate spectrum disorder,Prevalence at birth,N/A
Malformation syndrome,1906,Fetal valproate spectrum disorder,Prevalence at birth,N/A
Malformation syndrome,1895,Edinburgh malformation syndrome,Cases/families,N/A
Malformation syndrome,1895,Edinburgh malformation syndrome,Point prevalence,N/A
Malformation syndrome,1891,Intellectual disability-spasticity-ectrodactyly syndrome,Cases/families,N/A
Malformation syndrome,1891,Intellectual disability-spasticity-ectrodactyly syndrome,Point prevalence,N/A
Malformation syndrome,1892,Ectrodactyly-polydactyly syndrome,Cases/families,N/A
Malformation syndrome,1892,Ectrodactyly-polydactyly syndrome,Point prevalence,N/A
Malformation syndrome,1816,Leukomelanoderma-infantilism-intellectual disability-hypodontia-hypotrichosis syndrome,Cases/families,N/A
Malformation syndrome,1816,Leukomelanoderma-infantilism-intellectual disability-hypodontia-hypotrichosis syndrome,Point prevalence,N/A
Clinical subtype,1807,Focal facial dermal dysplasia type III,Point prevalence,N/A
Clinical subtype,1807,Focal facial dermal dysplasia type III,Cases/families,N/A
Malformation syndrome,1818,"Ectodermal dysplasia, trichoodontoonychial type",Cases/families,N/A
Malformation syndrome,1818,"Ectodermal dysplasia, trichoodontoonychial type",Point prevalence,N/A
Malformation syndrome,1883,Ectodermal dysplasia-sensorineural deafness syndrome,Point prevalence,N/A
Malformation syndrome,1883,Ectodermal dysplasia-sensorineural deafness syndrome,Cases/families,N/A
Malformation syndrome,1882,Hypohidrotic ectodermal dysplasia-hypothyroidism-ciliary dyskinesia syndrome,Cases/families,N/A
Malformation syndrome,1882,Hypohidrotic ectodermal dysplasia-hypothyroidism-ciliary dyskinesia syndrome,Point prevalence,N/A
Disease,1875,Congenital muscular dystrophy-infantile cataract-hypogonadism syndrome,Point prevalence,N/A
Disease,1875,Congenital muscular dystrophy-infantile cataract-hypogonadism syndrome,Cases/families,N/A
Malformation syndrome,1873,Jalili syndrome,Point prevalence,N/A
Malformation syndrome,1873,Jalili syndrome,Cases/families,N/A
Malformation syndrome,1873,Jalili syndrome,Point prevalence,N/A
Malformation syndrome,1879,Melorheostosis with osteopoikilosis,Cases/families,N/A
Malformation syndrome,1879,Melorheostosis with osteopoikilosis,Point prevalence,N/A
Disease,1867,"Hereditary bullous dystrophy, macular type",Cases/families,N/A
Disease,1867,"Hereditary bullous dystrophy, macular type",Point prevalence,N/A
Disease,1872,Cone rod dystrophy,Point prevalence,N/A
Disease,1871,Progressive cone dystrophy,Point prevalence,N/A
Clinical subtype,1860,Thanatophoric dysplasia type 1,Point prevalence,N/A
Malformation syndrome,1861,Thoracic dysplasia-hydrocephalus syndrome,Cases/families,N/A
Malformation syndrome,1861,Thoracic dysplasia-hydrocephalus syndrome,Point prevalence,N/A
Disease,1865,"Dyssegmental dysplasia, Silverman-Handmaker type",Point prevalence,N/A
Malformation syndrome,1858,Skeletal dysplasia-epilepsy-short stature syndrome,Cases/families,N/A
Malformation syndrome,1858,Skeletal dysplasia-epilepsy-short stature syndrome,Point prevalence,N/A
Clinical group,254,Spondylometaphyseal dysplasia,Prevalence at birth,N/A
Clinical group,254,Spondylometaphyseal dysplasia,Point prevalence,N/A
Disease,1852,X-linked retinal dysplasia,Cases/families,N/A
Disease,1852,X-linked retinal dysplasia,Point prevalence,N/A
Malformation syndrome,1842,"Bone dysplasia, lethal Holmgren type",Cases/families,N/A
Malformation syndrome,1842,"Bone dysplasia, lethal Holmgren type",Point prevalence,N/A
Malformation syndrome,1839,Hereditary mucoepithelial dysplasia,Point prevalence,N/A
Disease,1837,"Metaphyseal chondrodysplasia, Rosenberg type",Cases/families,N/A
Disease,1837,"Metaphyseal chondrodysplasia, Rosenberg type",Point prevalence,N/A
Malformation syndrome,1836,"Mesomelic dysplasia, Kantaputra type",Cases/families,N/A
Malformation syndrome,1836,"Mesomelic dysplasia, Kantaputra type",Point prevalence,N/A
Malformation syndrome,1834,Axial mesodermal dysplasia spectrum,Point prevalence,N/A
Disease,1830,Schimke immuno-osseous dysplasia,Cases/families,N/A
Disease,1830,Schimke immuno-osseous dysplasia,Point prevalence,N/A
Malformation syndrome,1825,Epiphyseal dysplasia-hearing loss-dysmorphism syndrome,Cases/families,N/A
Malformation syndrome,1825,Epiphyseal dysplasia-hearing loss-dysmorphism syndrome,Point prevalence,N/A
Clinical group,251,Multiple epiphyseal dysplasia,Point prevalence,N/A
Malformation syndrome,1811,Odontomicronychial dysplasia,Cases/families,N/A
Malformation syndrome,1811,Odontomicronychial dysplasia,Point prevalence,N/A
Malformation syndrome,1812,Ectodermal dysplasia-intellectual disability-central nervous system malformation syndrome,Point prevalence,N/A
Malformation syndrome,1808,"Hidrotic ectodermal dysplasia, Christianson-Fourie type",Cases/families,N/A
Malformation syndrome,1808,"Hidrotic ectodermal dysplasia, Christianson-Fourie type",Point prevalence,N/A
Malformation syndrome,1809,"Hidrotic ectodermal dysplasia, Halal type",Cases/families,N/A
Malformation syndrome,1809,"Hidrotic ectodermal dysplasia, Halal type",Point prevalence,N/A
Malformation syndrome,1806,Ectodermal dysplasia-blindness syndrome,Cases/families,N/A
Malformation syndrome,1806,Ectodermal dysplasia-blindness syndrome,Point prevalence,N/A
Malformation syndrome,1802,Ghosal hematodiaphyseal dysplasia,Point prevalence,N/A
Disease,1803,Thoracomelic dysplasia,Cases/families,N/A
Disease,1803,Thoracomelic dysplasia,Point prevalence,N/A
Malformation syndrome,1798,Craniofacial dysostosis-diaphyseal hyperplasia syndrome,Point prevalence,N/A
Clinical syndrome,1799,Familial developmental dysphasia,Cases/families,N/A
Clinical syndrome,1799,Familial developmental dysphasia,Point prevalence,N/A
Malformation syndrome,1794,Oculomaxillofacial dysostosis,Cases/families,N/A
Malformation syndrome,1794,Oculomaxillofacial dysostosis,Point prevalence,N/A
Clinical group,2130,Non-syndromic hemimelia,Point prevalence,N/A
Malformation syndrome,2136,Hennekam syndrome,Cases/families,N/A
Malformation syndrome,2136,Hennekam syndrome,Point prevalence,N/A
Malformation syndrome,2138,"46,XX ovotesticular difference of sex development",Cases/families,N/A
Malformation syndrome,2138,"46,XX ovotesticular difference of sex development",Prevalence at birth,N/A
Malformation syndrome,2138,"46,XX ovotesticular difference of sex development",Point prevalence,N/A
Malformation syndrome,2139,Hernndez-Aguirre Negrete syndrome,Point prevalence,N/A
Malformation syndrome,2141,Diaphragmatic defect-limb deficiency-skull defect syndrome,Cases/families,N/A
Malformation syndrome,2141,Diaphragmatic defect-limb deficiency-skull defect syndrome,Point prevalence,N/A
Malformation syndrome,2143,Donnai-Barrow syndrome,Cases/families,N/A
Malformation syndrome,2143,Donnai-Barrow syndrome,Point prevalence,N/A
Malformation syndrome,2145,"Craniosynostosis, Herrmann-Opitz type",Cases/families,N/A
Malformation syndrome,2145,"Craniosynostosis, Herrmann-Opitz type",Point prevalence,N/A
Morphological anomaly,2149,Nodular neuronal heterotopia,Point prevalence,N/A
Disease,2148,Lissencephaly type 1 due to doublecortin gene mutation,Point prevalence,N/A
Particular clinical situation in a disease or syndrome,158048,Hemophagocytic syndrome associated with an infection,Point prevalence,N/A
Particular clinical situation in a disease or syndrome,158057,Acquired hemophagocytic lymphohistiocytosis associated with malignant disease,Point prevalence,N/A
Malformation syndrome,2108,Hallermann-Streiff syndrome,Cases/families,N/A
Malformation syndrome,2108,Hallermann-Streiff syndrome,Point prevalence,N/A
Malformation syndrome,2108,Hallermann-Streiff syndrome,Prevalence at birth,N/A
Clinical syndrome,158061,Macrophage activation syndrome,Point prevalence,N/A
Malformation syndrome,2107,Hall-Riggs syndrome,Cases/families,N/A
Malformation syndrome,2107,Hall-Riggs syndrome,Point prevalence,N/A
Malformation syndrome,2110,Hallux varus-preaxial polysyndactyly syndrome,Cases/families,N/A
Malformation syndrome,2110,Hallux varus-preaxial polysyndactyly syndrome,Point prevalence,N/A
Malformation syndrome,2109,Hallermann-Streiff-like syndrome,Cases/families,N/A
Malformation syndrome,2109,Hallermann-Streiff-like syndrome,Point prevalence,N/A
Disease,2111,Cystic hamartoma of lung and kidney,Cases/families,N/A
Disease,2111,Cystic hamartoma of lung and kidney,Point prevalence,N/A
Clinical group,158266,Huntington disease-like syndrome,Point prevalence,N/A
Malformation syndrome,2115,Harrod syndrome,Cases/families,N/A
Malformation syndrome,2115,Harrod syndrome,Point prevalence,N/A
Disease,2114,"Hip dysplasia, Beukes type",Point prevalence,N/A
Malformation syndrome,2994,Short stature-craniofacial anomalies-genital hypoplasia syndrome,Cases/families,N/A
Malformation syndrome,2994,Short stature-craniofacial anomalies-genital hypoplasia syndrome,Point prevalence,N/A
Malformation syndrome,2117,Hartsfield syndrome,Cases/families,N/A
Malformation syndrome,2117,Hartsfield syndrome,Point prevalence,N/A
Malformation syndrome,2119,HEC syndrome,Cases/families,N/A
Malformation syndrome,2119,HEC syndrome,Point prevalence,N/A
Malformation syndrome,2123,Multifocal infantile hemangioma with extracutenous involvement,Cases/families,N/A
Malformation syndrome,2123,Multifocal infantile hemangioma with extracutenous involvement,Point prevalence,N/A
Disease,157997,Benign cephalic histiocytosis,Point prevalence,N/A
Malformation syndrome,2090,GMS syndrome,Cases/families,N/A
Malformation syndrome,2090,GMS syndrome,Point prevalence,N/A
Disease,157991,Generalized eruptive histiocytosis,Point prevalence,N/A
Malformation syndrome,2091,Multinodular goiter-cystic kidney-polydactyly syndrome,Cases/families,N/A
Malformation syndrome,2091,Multinodular goiter-cystic kidney-polydactyly syndrome,Point prevalence,N/A
Malformation syndrome,376,Gordon syndrome,Point prevalence,N/A
Malformation syndrome,2092,Focal dermal hypoplasia,Cases/families,N/A
Malformation syndrome,2092,Focal dermal hypoplasia,Point prevalence,N/A
Disease,158000,Juvenile xanthogranuloma,Annual incidence,N/A
Disease,158000,Juvenile xanthogranuloma,Point prevalence,N/A
Malformation syndrome,2098,"Acromesomelic dysplasia, Grebe type",Point prevalence,N/A
Disease,158025,Hereditary progressive mucinous histiocytosis,Cases/families,N/A
Disease,158025,Hereditary progressive mucinous histiocytosis,Point prevalence,N/A
Malformation syndrome,380,Greig cephalopolysyndactyly syndrome,Prevalence at birth,N/A
Malformation syndrome,380,Greig cephalopolysyndactyly syndrome,Point prevalence,N/A
Malformation syndrome,2095,Gorlin-Chaudhry-Moss syndrome,Cases/families,N/A
Malformation syndrome,2095,Gorlin-Chaudhry-Moss syndrome,Point prevalence,N/A
Disease,158014,Rosa-Dorfman disease,Cases/families,N/A
Disease,158014,Rosa-Dorfman disease,Point prevalence,N/A
Malformation syndrome,2097,Grant syndrome,Cases/families,N/A
Malformation syndrome,2097,Grant syndrome,Point prevalence,N/A
Malformation syndrome,2101,Grubben-de Cock-Borghgraef syndrome,Cases/families,N/A
Malformation syndrome,2101,Grubben-de Cock-Borghgraef syndrome,Point prevalence,N/A
Malformation syndrome,2104,Dysmorphism-pectus carinatum-joint laxity syndrome,Cases/families,N/A
Malformation syndrome,2104,Dysmorphism-pectus carinatum-joint laxity syndrome,Point prevalence,N/A
Category,158032,Hemophagocytic syndrome,Point prevalence,N/A
Category,158032,Hemophagocytic syndrome,Annual incidence,N/A
Disease,158029,Sea-blue histiocytosis,Cases/families,N/A
Disease,158029,Sea-blue histiocytosis,Point prevalence,N/A
Disease,2069,Gastrocutaneous syndrome,Cases/families,N/A
Disease,2069,Gastrocutaneous syndrome,Point prevalence,N/A
Disease,157846,Neuroferritinopathy,Cases/families,N/A
Disease,157846,Neuroferritinopathy,Point prevalence,N/A
Malformation syndrome,157832,Craniorhiny,Cases/families,N/A
Malformation syndrome,157832,Craniorhiny,Point prevalence,N/A
Malformation syndrome,2067,GAPO syndrome,Cases/families,N/A
Malformation syndrome,2067,GAPO syndrome,Point prevalence,N/A
Disease,157835,Paroxysmal hemicrania,Point prevalence,N/A
Malformation syndrome,2065,Galloway-Mowat syndrome,Cases/families,N/A
Malformation syndrome,2065,Galloway-Mowat syndrome,Point prevalence,N/A
Malformation syndrome,2075,Genitopalatocardiac syndrome,Cases/families,N/A
Malformation syndrome,2075,Genitopalatocardiac syndrome,Point prevalence,N/A
Malformation syndrome,2074,Gemignani syndrome,Cases/families,N/A
Malformation syndrome,2074,Gemignani syndrome,Point prevalence,N/A
Disease,157850,Pantothenate kinase-associated neurodegeneration,Point prevalence,N/A
Clinical subtype,2072,Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome,Cases/families,N/A
Clinical subtype,2072,Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome,Point prevalence,N/A
Disease,157954,ANE syndrome,Cases/families,N/A
Disease,157954,ANE syndrome,Point prevalence,N/A
Malformation syndrome,157962,"Oculoauricular syndrome, Schorderet type",Cases/families,N/A
Malformation syndrome,157962,"Oculoauricular syndrome, Schorderet type",Point prevalence,N/A
Disease,157946,Huntington disease-like 3,Point prevalence,N/A
Malformation syndrome,2078,Geroderma osteodysplastica,Cases/families,N/A
Malformation syndrome,2078,Geroderma osteodysplastica,Point prevalence,N/A
Malformation syndrome,2077,German syndrome,Cases/families,N/A
Malformation syndrome,2077,German syndrome,Point prevalence,N/A
Disease,157973,Congenital muscular dystrophy due to LMNA mutation,Cases/families,N/A
Disease,157973,Congenital muscular dystrophy due to LMNA mutation,Point prevalence,N/A
Disease,2085,Glaucoma-sleep apnea syndrome,Cases/families,N/A
Disease,2085,Glaucoma-sleep apnea syndrome,Point prevalence,N/A
Malformation syndrome,2084,Glaucoma-ectopia lentis-microspherophakia-stiff joints-short stature syndrome,Cases/families,N/A
Malformation syndrome,2084,Glaucoma-ectopia lentis-microspherophakia-stiff joints-short stature syndrome,Point prevalence,N/A
Clinical subtype,157965,SLC39A13-related spondylodysplastic Ehlers-Danlos syndrome,Cases/families,N/A
Clinical subtype,157965,SLC39A13-related spondylodysplastic Ehlers-Danlos syndrome,Point prevalence,N/A
Malformation syndrome,2083,Prominent glabella-microcephaly-hypogenitalism syndrome,Cases/families,N/A
Malformation syndrome,2083,Prominent glabella-microcephaly-hypogenitalism syndrome,Point prevalence,N/A
Malformation syndrome,1791,Frontofacionasal dysplasia,Cases/families,N/A
Malformation syndrome,1791,Frontofacionasal dysplasia,Point prevalence,N/A
Disease,1826,Frontometaphyseal dysplasia,Cases/families,N/A
Disease,1826,Frontometaphyseal dysplasia,Point prevalence,N/A
Disease,2047,Flynn-Aird syndrome,Cases/families,N/A
Disease,2047,Flynn-Aird syndrome,Point prevalence,N/A
Malformation syndrome,2048,Foix-Chavany-Marie syndrome,Cases/families,N/A
Malformation syndrome,2048,Foix-Chavany-Marie syndrome,Point prevalence,N/A
Malformation syndrome,2050,Cole-Carpenter syndrome,Cases/families,N/A
Malformation syndrome,2050,Cole-Carpenter syndrome,Point prevalence,N/A
Malformation syndrome,2063,Splenogonadal fusion-limb defects-micrognathia syndrome,Cases/families,N/A
Malformation syndrome,2063,Splenogonadal fusion-limb defects-micrognathia syndrome,Point prevalence,N/A
Malformation syndrome,2064,Posterior fusion of lumbosacral vertebrae-blepharoptosis syndrome,Cases/families,N/A
Malformation syndrome,2064,Posterior fusion of lumbosacral vertebrae-blepharoptosis syndrome,Point prevalence,N/A
Clinical group,250,Frontonasal dysplasia,Point prevalence,N/A
Clinical group,250,Frontonasal dysplasia,Prevalence at birth,N/A
Malformation syndrome,2057,Blepharophimosis-ptosis-esotropia-syndactyly-short stature syndrome,Cases/families,N/A
Malformation syndrome,2057,Blepharophimosis-ptosis-esotropia-syndactyly-short stature syndrome,Point prevalence,N/A
Malformation syndrome,2059,Fryns syndrome,Prevalence at birth,N/A
Malformation syndrome,2059,Fryns syndrome,Point prevalence,N/A
Malformation syndrome,2059,Fryns syndrome,Prevalence at birth,N/A
Malformation syndrome,2026,Gingival fibromatosis-hypertrichosis syndrome,Point prevalence,N/A
Malformation syndrome,2025,Gingival fibromatosis-facial dysmorphism syndrome,Cases/families,N/A
Malformation syndrome,2025,Gingival fibromatosis-facial dysmorphism syndrome,Point prevalence,N/A
Clinical subtype,2028,Juvenile hyaline fibromatosis,Cases/families,N/A
Clinical subtype,2028,Juvenile hyaline fibromatosis,Point prevalence,N/A
Malformation syndrome,2027,Gingival fibromatosis-progressive deafness syndrome,Cases/families,N/A
Malformation syndrome,2027,Gingival fibromatosis-progressive deafness syndrome,Point prevalence,N/A
Disease,2021,Fibrochondrogenesis,Cases/families,N/A
Disease,2021,Fibrochondrogenesis,Point prevalence,N/A
Malformation syndrome,2019,Femur-fibula-ulna complex,Prevalence at birth,N/A
Malformation syndrome,2019,Femur-fibula-ulna complex,Point prevalence,N/A
Malformation syndrome,2024,Hereditary gingival fibromatosis,Point prevalence,N/A
Disease,2022,Endocardial fibroelastosis,Point prevalence,N/A
Malformation syndrome,2824,Paraplegia-intellectual disability-hyperkeratosis syndrome,Cases/families,N/A
Malformation syndrome,2824,Paraplegia-intellectual disability-hyperkeratosis syndrome,Point prevalence,N/A
Disease,2045,FLOTCH syndrome,Cases/families,N/A
Disease,2045,FLOTCH syndrome,Point prevalence,N/A
Malformation syndrome,2044,Floating-Harbor syndrome,Point prevalence,N/A
Malformation syndrome,2031,Hepatic fibrosis-renal cysts-intellectual disability syndrome,Cases/families,N/A
Malformation syndrome,2031,Hepatic fibrosis-renal cysts-intellectual disability syndrome,Point prevalence,N/A
Malformation syndrome,2036,Scalp-ear-nipple syndrome,Cases/families,N/A
Malformation syndrome,2036,Scalp-ear-nipple syndrome,Point prevalence,N/A
Morphological anomaly,2006,Median cleft lip/mandible,Cases/families,N/A
Morphological anomaly,2006,Median cleft lip/mandible,Point prevalence,N/A
Malformation syndrome,2007,Alar cartilages hypoplasia-coloboma-telecanthus syndrome,Cases/families,N/A
Malformation syndrome,2007,Alar cartilages hypoplasia-coloboma-telecanthus syndrome,Point prevalence,N/A
Malformation syndrome,2003,Cleft lip/palate-deafness-sacral lipoma syndrome,Cases/families,N/A
Malformation syndrome,2003,Cleft lip/palate-deafness-sacral lipoma syndrome,Point prevalence,N/A
Disease,158687,Lethal acantholytic erosive disorder,Cases/families,N/A
Disease,158687,Lethal acantholytic erosive disorder,Point prevalence,N/A
Disease,158684,Epidermolysis bullosa simplex with pyloric atresia,Point prevalence,N/A
Morphological anomaly,2004,Laryngotracheoesophageal cleft,Prevalence at birth,N/A
Morphological anomaly,2004,Laryngotracheoesophageal cleft,Point prevalence,N/A
Malformation syndrome,2001,Cleft lip/palate-intestinal malrotation-cardiopathy syndrome,Cases/families,N/A
Malformation syndrome,2001,Cleft lip/palate-intestinal malrotation-cardiopathy syndrome,Point prevalence,N/A
Disease,158681,Epidermolysis bullosa simplex with circinate migratory erythema,Point prevalence,N/A
Clinical subtype,158676,"Localized dystrophic epidermolysis bullosa, nails only",Point prevalence,N/A
Clinical subtype,158676,"Localized dystrophic epidermolysis bullosa, nails only",Cases/families,N/A
Clinical subtype,158673,"Localized dystrophic epidermolysis bullosa, acral form",Cases/families,N/A
Clinical subtype,158673,"Localized dystrophic epidermolysis bullosa, acral form",Point prevalence,N/A
Disease,158668,Ectodermal dysplasia-skin fragility syndrome,Point prevalence,N/A
Malformation syndrome,2016,Cleft palate-lateral synechia syndrome,Cases/families,N/A
Malformation syndrome,2016,Cleft palate-lateral synechia syndrome,Point prevalence,N/A
Morphological anomaly,2017,Sternal cleft,Prevalence at birth,N/A
Morphological anomaly,2017,Sternal cleft,Point prevalence,N/A
Malformation syndrome,2013,Cleft palate-large ears-small head syndrome,Cases/families,N/A
Malformation syndrome,2013,Cleft palate-large ears-small head syndrome,Point prevalence,N/A
Malformation syndrome,2010,Cleft palate-stapes fixation-oligodontia syndrome,Cases/families,N/A
Malformation syndrome,2010,Cleft palate-stapes fixation-oligodontia syndrome,Point prevalence,N/A
Disease,158775,Smoldering systemic mastocytosis,Point prevalence,N/A
Malformation syndrome,2008,Acrocardiofacial syndrome,Cases/families,N/A
Malformation syndrome,2008,Acrocardiofacial syndrome,Point prevalence,N/A
Malformation syndrome,1986,Gollop-Wolfgang complex,Cases/families,N/A
Malformation syndrome,1986,Gollop-Wolfgang complex,Point prevalence,N/A
Disease,1980,Bilateral striopallidodentate calcinosis,Cases/families,N/A
Disease,1980,Bilateral striopallidodentate calcinosis,Point prevalence,N/A
Malformation syndrome,1997,Blepharo-cheilo-odontic syndrome,Cases/families,N/A
Malformation syndrome,1997,Blepharo-cheilo-odontic syndrome,Point prevalence,N/A
Malformation syndrome,1995,Cleft lip-retinopathy syndrome,Cases/families,N/A
Malformation syndrome,1995,Cleft lip-retinopathy syndrome,Point prevalence,N/A
Malformation syndrome,1993,Pai syndrome,Cases/families,N/A
Malformation syndrome,1993,Pai syndrome,Point prevalence,N/A
Malformation syndrome,1988,Femoral-facial syndrome,Cases/families,N/A
Malformation syndrome,1988,Femoral-facial syndrome,Point prevalence,N/A
Disease,2348,"Familial partial lipodystrophy, Dunnigan type",Point prevalence,N/A
Clinical subtype,247775,Mayer-Rokitansky-Kster-Hauser syndrome type 1,Point prevalence,N/A
Malformation syndrome,2351,Kousseff syndrome,Cases/families,N/A
Malformation syndrome,2351,Kousseff syndrome,Point prevalence,N/A
Malformation syndrome,247768,Mllerian aplasia and hyperandrogenism,Point prevalence,N/A
Malformation syndrome,2353,Schilbach-Rott syndrome,Cases/families,N/A
Malformation syndrome,2353,Schilbach-Rott syndrome,Point prevalence,N/A
Disease,247790,FTH1-related iron overload,Cases/families,N/A
Disease,247790,FTH1-related iron overload,Point prevalence,N/A
Disease,247794,Juvenile cataract-microcornea-renal glucosuria syndrome,Cases/families,N/A
Disease,247794,Juvenile cataract-microcornea-renal glucosuria syndrome,Point prevalence,N/A
Disease,247815,Autosomal recessive ataxia due to PEX10 deficiency,Cases/families,N/A
Disease,247815,Autosomal recessive ataxia due to PEX10 deficiency,Point prevalence,N/A
Malformation syndrome,2363,Lacrimoauriculodentodigital syndrome,Cases/families,N/A
Malformation syndrome,2363,Lacrimoauriculodentodigital syndrome,Point prevalence,N/A
Disease,247691,Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations,Point prevalence,N/A
Disease,2340,Keratosis follicularis spinulosa decalvans,Point prevalence,N/A
Clinical subtype,247685,Odontohypophosphatasia,Point prevalence,N/A
Disease,2342,Haim-Munk syndrome,Cases/families,N/A
Disease,2342,Haim-Munk syndrome,Point prevalence,N/A
Clinical subtype,247709,Multiple endocrine neoplasia type 2B,Point prevalence,N/A
Disease,485,Kniest dysplasia,Point prevalence,N/A
Disease,247762,Lipoblastoma,Point prevalence,N/A
Malformation syndrome,2347,Lethal Kniest-like dysplasia,Cases/families,N/A
Malformation syndrome,2347,Lethal Kniest-like dysplasia,Point prevalence,N/A
Disease,247585,Citrullinemia type II,Point prevalence,N/A
Malformation syndrome,2333,Kenny-Caffey syndrome,Cases/families,N/A
Malformation syndrome,2333,Kenny-Caffey syndrome,Point prevalence,N/A
Disease,247598,Neonatal intrahepatic cholestasis due to citrin deficiency,Point prevalence,N/A
Malformation syndrome,2332,KBG syndrome,Cases/families,N/A
Malformation syndrome,2332,KBG syndrome,Point prevalence,N/A
Disease,247604,Juvenile primary lateral sclerosis,Cases/families,N/A
Disease,247604,Juvenile primary lateral sclerosis,Point prevalence,N/A
Clinical subtype,247623,Perinatal lethal hypophosphatasia,Point prevalence,N/A
Clinical subtype,247638,Prenatal benign hypophosphatasia,Point prevalence,N/A
Disease,2337,"Diffuse palmoplantar keratoderma, Bothnian type",Point prevalence,N/A
Clinical subtype,247651,Infantile hypophosphatasia,Point prevalence,N/A
Clinical subtype,247667,Childhood-onset hypophosphatasia,Point prevalence,N/A
Malformation syndrome,2339,Keratosis follicularis-dwarfism-cerebral atrophy syndrome,Cases/families,N/A
Malformation syndrome,2339,Keratosis follicularis-dwarfism-cerebral atrophy syndrome,Point prevalence,N/A
Clinical subtype,247676,Adult hypophosphatasia,Point prevalence,N/A
Disease,494,Keratoderma hereditarium mutilans,Cases/families,N/A
Disease,494,Keratoderma hereditarium mutilans,Point prevalence,N/A
Malformation syndrome,2322,Kabuki syndrome,Prevalence at birth,N/A
Malformation syndrome,2322,Kabuki syndrome,Prevalence at birth,N/A
Malformation syndrome,2322,Kabuki syndrome,Point prevalence,N/A
Malformation syndrome,2322,Kabuki syndrome,Prevalence at birth,N/A
Disease,247378,Autosomal recessive secondary polycythemia not associated with VHL gene,Point prevalence,N/A
Malformation syndrome,2321,Jung syndrome,Cases/families,N/A
Malformation syndrome,2321,Jung syndrome,Point prevalence,N/A
Malformation syndrome,2324,Osteopenia-intellectual disability-sparse hair syndrome,Cases/families,N/A
Malformation syndrome,2324,Osteopenia-intellectual disability-sparse hair syndrome,Point prevalence,N/A
Disease,247511,Autosomal dominant secondary polycythemia,Point prevalence,N/A
Malformation syndrome,2323,Sanjad-Sakati syndrome,Point prevalence,N/A
Disease,247522,Primary ciliary dyskinesia-retinitis pigmentosa syndrome,Cases/families,N/A
Disease,247522,Primary ciliary dyskinesia-retinitis pigmentosa syndrome,Point prevalence,N/A
Disease,247525,Citrullinemia type I,Point prevalence,N/A
Disease,247525,Citrullinemia type I,Prevalence at birth,N/A
Disease,247525,Citrullinemia type I,Prevalence at birth,N/A
Disease,247525,Citrullinemia type I,Prevalence at birth,N/A
Disease,247525,Citrullinemia type I,Prevalence at birth,N/A
Malformation syndrome,2325,Epidermolysis bullosa simplex with anodontia/hypodontia,Point prevalence,N/A
Malformation syndrome,2325,Epidermolysis bullosa simplex with anodontia/hypodontia,Cases/families,N/A
Malformation syndrome,2329,Karsch-Neugebauer syndrome,Cases/families,N/A
Malformation syndrome,2329,Karsch-Neugebauer syndrome,Point prevalence,N/A
Category,247582,Citrin deficiency,Point prevalence,N/A
Malformation syndrome,2328,Kapur-Toriello syndrome,Cases/families,N/A
Malformation syndrome,2328,Kapur-Toriello syndrome,Point prevalence,N/A
Malformation syndrome,2408,Lowe-Kohn-Cohen syndrome,Cases/families,N/A
Malformation syndrome,2408,Lowe-Kohn-Cohen syndrome,Point prevalence,N/A
Malformation syndrome,2409,Lowry-MacLean syndrome,Cases/families,N/A
Malformation syndrome,2409,Lowry-MacLean syndrome,Point prevalence,N/A
Malformation syndrome,2405,Thickened earlobes-conductive deafness syndrome,Cases/families,N/A
Malformation syndrome,2405,Thickened earlobes-conductive deafness syndrome,Point prevalence,N/A
Disease,2407,Laryngo-onycho-cutaneous syndrome,Cases/families,N/A
Disease,2407,Laryngo-onycho-cutaneous syndrome,Point prevalence,N/A
Malformation syndrome,2412,Dislocation of the hip-dysmorphism syndrome,Cases/families,N/A
Malformation syndrome,2412,Dislocation of the hip-dysmorphism syndrome,Point prevalence,N/A
Disease,2575,Cystic fibrosis-gastritis-megaloblastic anemia syndrome,Cases/families,N/A
Disease,2575,Cystic fibrosis-gastritis-megaloblastic anemia syndrome,Point prevalence,N/A
Malformation syndrome,2410,Hypergonadotropic hypogonadism-cataract syndrome,Cases/families,N/A
Malformation syndrome,2410,Hypergonadotropic hypogonadism-cataract syndrome,Point prevalence,N/A
Malformation syndrome,2399,Nasopalpebral lipoma-coloboma syndrome,Cases/families,N/A
Malformation syndrome,2399,Nasopalpebral lipoma-coloboma syndrome,Point prevalence,N/A
Disease,2400,Peripheral motor neuropathy-dysautonomia syndrome,Cases/families,N/A
Disease,2400,Peripheral motor neuropathy-dysautonomia syndrome,Point prevalence,N/A
Disease,2396,Encephalocraniocutaneous lipomatosis,Cases/families,N/A
Disease,2396,Encephalocraniocutaneous lipomatosis,Point prevalence,N/A
Disease,2388,Choreoacanthocytosis,Point prevalence,N/A
Disease,248111,Juvenile Huntington disease,Annual incidence,N/A
Disease,248111,Juvenile Huntington disease,Point prevalence,N/A
Disease,2386,Leukoencephalopathy-palmoplantar keratoderma syndrome,Cases/families,N/A
Disease,2386,Leukoencephalopathy-palmoplantar keratoderma syndrome,Point prevalence,N/A
Clinical group,248095,Primary hypertrophic osteoarthropathy,Point prevalence,N/A
Disease,2379,Early-onset parkinsonism-intellectual disability syndrome,Cases/families,N/A
Disease,2379,Early-onset parkinsonism-intellectual disability syndrome,Point prevalence,N/A
Malformation syndrome,2391,Congenitally short costocoracoid ligament,Cases/families,N/A
Malformation syndrome,2391,Congenitally short costocoracoid ligament,Point prevalence,N/A
Disease,2390,Lichtenstein syndrome,Cases/families,N/A
Disease,2390,Lichtenstein syndrome,Point prevalence,N/A
Disease,247834,Occult macular dystrophy,Point prevalence,N/A
Malformation syndrome,2371,Lethal Larsen-like syndrome,Cases/families,N/A
Malformation syndrome,2371,Lethal Larsen-like syndrome,Point prevalence,N/A
Malformation syndrome,2369,Limb body wall complex,Prevalence at birth,N/A
Malformation syndrome,2369,Limb body wall complex,Point prevalence,N/A
Malformation syndrome,2369,Limb body wall complex,Prevalence at birth,N/A
Malformation syndrome,247820,Ectodermal dysplasia-pili torti-cutaneous syndactyly syndrome,Cases/families,N/A
Malformation syndrome,247820,Ectodermal dysplasia-pili torti-cutaneous syndactyly syndrome,Point prevalence,N/A
Malformation syndrome,247827,Ectodermal dysplasia-hyperhidrosis-cutaneous syndactyly syndrome,Cases/families,N/A
Malformation syndrome,247827,Ectodermal dysplasia-hyperhidrosis-cutaneous syndactyly syndrome,Point prevalence,N/A
Malformation syndrome,2378,Laurin-Sandrow syndrome,Cases/families,N/A
Malformation syndrome,2378,Laurin-Sandrow syndrome,Point prevalence,N/A
Disease,247868,NLRP12-associated hereditary periodic fever syndrome,Cases/families,N/A
Disease,247868,NLRP12-associated hereditary periodic fever syndrome,Point prevalence,N/A
Malformation syndrome,2375,Laryngeal abductor paralysis-intellectual disability syndrome,Cases/families,N/A
Malformation syndrome,2375,Laryngeal abductor paralysis-intellectual disability syndrome,Point prevalence,N/A
Malformation syndrome,2457,Mandibuloacral dysplasia,Cases/families,N/A
Malformation syndrome,2457,Mandibuloacral dysplasia,Point prevalence,N/A
Malformation syndrome,2451,Mucocutaneous venous malformations,Point prevalence,N/A
Malformation syndrome,2439,Patterson-Stevenson-Fontaine syndrome,Cases/families,N/A
Malformation syndrome,2439,Patterson-Stevenson-Fontaine syndrome,Point prevalence,N/A
Disease,244305,Dominant hypophosphatemia with nephrolithiasis or osteoporosis,Cases/families,N/A
Disease,244305,Dominant hypophosphatemia with nephrolithiasis or osteoporosis,Point prevalence,N/A
Malformation syndrome,244283,Biliary atresia with splenic malformation syndrome,Point prevalence,N/A
Malformation syndrome,2440,Isolated split hand-split foot malformation,Prevalence at birth,N/A
Malformation syndrome,2440,Isolated split hand-split foot malformation,Prevalence at birth,N/A
Malformation syndrome,2440,Isolated split hand-split foot malformation,Prevalence at birth,N/A
Malformation syndrome,2440,Isolated split hand-split foot malformation,Prevalence at birth,N/A
Malformation syndrome,2440,Isolated split hand-split foot malformation,Prevalence at birth,N/A
Malformation syndrome,2440,Isolated split hand-split foot malformation,Point prevalence,N/A
Disease,244310,RFT1-CDG,Cases/families,N/A
Disease,244310,RFT1-CDG,Point prevalence,N/A
Disease,244242,HELLP syndrome,Point prevalence,N/A
Disease,296,Ollier disease,Point prevalence,N/A
Malformation syndrome,2437,Czeizel-Losonci syndrome,Cases/families,N/A
Malformation syndrome,2437,Czeizel-Losonci syndrome,Point prevalence,N/A
Particular clinical situation in a disease or syndrome,244275,De novo thrombotic microangiopathy after kidney transplantation,Point prevalence,N/A
Disease,243343,Dimethylglycine dehydrogenase deficiency,Cases/families,N/A
Disease,243343,Dimethylglycine dehydrogenase deficiency,Point prevalence,N/A
Disease,2435,Hypo- and hypermelanotic cutaneous macules-retarded growth-intellectual disability syndrome,Cases/families,N/A
Disease,2435,Hypo- and hypermelanotic cutaneous macules-retarded growth-intellectual disability syndrome,Point prevalence,N/A
Malformation syndrome,2429,Macrocephaly-spastic paraplegia-dysmorphism syndrome,Point prevalence,N/A
Malformation syndrome,2432,Macrosomia-microphthalmia-cleft palate syndrome,Cases/families,N/A
Malformation syndrome,2432,Macrosomia-microphthalmia-cleft palate syndrome,Point prevalence,N/A
Malformation syndrome,2489,Upper limb defect-eye and ear abnormalities syndrome,Cases/families,N/A
Malformation syndrome,2489,Upper limb defect-eye and ear abnormalities syndrome,Point prevalence,N/A
Disease,247353,Generalized pustular psoriasis,Point prevalence,N/A
Disease,247353,Generalized pustular psoriasis,Point prevalence,N/A
Disease,247262,Hyperphosphatasia-intellectual disability syndrome,Cases/families,N/A
Disease,247262,Hyperphosphatasia-intellectual disability syndrome,Point prevalence,N/A
Malformation syndrome,2487,Lower limb malformation-hypospadias syndrome,Cases/families,N/A
Malformation syndrome,2487,Lower limb malformation-hypospadias syndrome,Point prevalence,N/A
Disease,247257,Inhalational anthrax,Point prevalence,N/A
Disease,247245,Superficial siderosis,Cases/families,N/A
Disease,247245,Superficial siderosis,Point prevalence,N/A
Malformation syndrome,2485,Melorheostosis,Point prevalence,N/A
Disease,247234,Sporadic adult-onset ataxia of unknown etiology,Point prevalence,N/A
Disease,247234,Sporadic adult-onset ataxia of unknown etiology,Point prevalence,N/A
Disease,247234,Sporadic adult-onset ataxia of unknown etiology,Point prevalence,N/A
Malformation syndrome,2483,Melkersson-Rosenthal syndrome,Point prevalence,N/A
Disease,247203,Collecting duct carcinoma,Annual incidence,N/A
Malformation syndrome,2484,Melnick-Needles syndrome,Cases/families,N/A
Malformation syndrome,2484,Melnick-Needles syndrome,Point prevalence,N/A
Disease,247198,Progressive cerebello-cerebral atrophy,Cases/families,N/A
Disease,247198,Progressive cerebello-cerebral atrophy,Point prevalence,N/A
Disease,2481,Neurocutaneous melanocytosis,Point prevalence,N/A
Malformation syndrome,2482,Melhem-Fahl syndrome,Cases/families,N/A
Malformation syndrome,2482,Melhem-Fahl syndrome,Point prevalence,N/A
Disease,247165,Infantile mercury poisoning,Point prevalence,N/A
Malformation syndrome,2475,White forelock with malformations,Point prevalence,N/A
Malformation syndrome,2475,White forelock with malformations,Cases/families,N/A
Malformation syndrome,2476,Dysraphism-cleft lip/palate-limb reduction defects syndrome,Cases/families,N/A
Malformation syndrome,2476,Dysraphism-cleft lip/palate-limb reduction defects syndrome,Point prevalence,N/A
Malformation syndrome,2473,McKusick-Kaufman syndrome,Point prevalence,N/A
Malformation syndrome,2473,McKusick-Kaufman syndrome,Cases/families,N/A
Malformation syndrome,2473,McKusick-Kaufman syndrome,Prevalence at birth,N/A
Malformation syndrome,2471,McDonough syndrome,Cases/families,N/A
Malformation syndrome,2471,McDonough syndrome,Point prevalence,N/A
Malformation syndrome,2470,Matthew-Wood syndrome,Cases/families,N/A
Malformation syndrome,2470,Matthew-Wood syndrome,Point prevalence,N/A
Malformation syndrome,561,Marshall-Smith syndrome,Cases/families,N/A
Malformation syndrome,561,Marshall-Smith syndrome,Point prevalence,N/A
Malformation syndrome,2464,"Marfanoid syndrome, De Silva type",Cases/families,N/A
Malformation syndrome,2464,"Marfanoid syndrome, De Silva type",Point prevalence,N/A
Disease,559,Marinesco-Sjgren syndrome,Cases/families,N/A
Disease,559,Marinesco-Sjgren syndrome,Point prevalence,N/A
Malformation syndrome,2463,Marfanoid habitus-autosomal recessive intellectual disability syndrome,Cases/families,N/A
Malformation syndrome,2463,Marfanoid habitus-autosomal recessive intellectual disability syndrome,Point prevalence,N/A
Malformation syndrome,2462,Shprintzen-Goldberg syndrome,Cases/families,N/A
Malformation syndrome,2462,Shprintzen-Goldberg syndrome,Point prevalence,N/A
Malformation syndrome,2461,Marden-Walker syndrome,Cases/families,N/A
Malformation syndrome,2461,Marden-Walker syndrome,Point prevalence,N/A
Malformation syndrome,2461,Marden-Walker syndrome,Prevalence at birth,N/A
Disease,251630,Anaplastic oligodendroglioma,Annual incidence,N/A
Disease,251630,Anaplastic oligodendroglioma,Annual incidence,N/A
Malformation syndrome,2172,Microcephaly-glomerulonephritis-marfanoid habitus syndrome,Cases/families,N/A
Malformation syndrome,2172,Microcephaly-glomerulonephritis-marfanoid habitus syndrome,Point prevalence,N/A
Disease,251636,Ependymoma,Annual incidence,N/A
Disease,251636,Ependymoma,Point prevalence,N/A
Disease,251639,Subependymoma,Annual incidence,N/A
Clinical subtype,2176,Infantile systemic hyalinosis,Point prevalence,N/A
Disease,251643,Myxopapillary ependymoma,Annual incidence,N/A
Disease,251643,Myxopapillary ependymoma,Point prevalence,N/A
Disease,251646,Anaplastic ependymoma,Annual incidence,N/A
Clinical group,251651,Oligoastrocytic tumor,Annual incidence,N/A
Clinical group,251651,Oligoastrocytic tumor,Annual incidence,N/A
Malformation syndrome,2181,Hydrocephaly-tall stature-joint laxity syndrome,Cases/families,N/A
Malformation syndrome,2181,Hydrocephaly-tall stature-joint laxity syndrome,Point prevalence,N/A
Malformation syndrome,2180,Hydrocephalus-costovertebral dysplasia-Sprengel anomaly syndrome,Cases/families,N/A
Malformation syndrome,2180,Hydrocephalus-costovertebral dysplasia-Sprengel anomaly syndrome,Point prevalence,N/A
Malformation syndrome,2186,Hydrocephalus-blue sclerae-nephropathy syndrome,Cases/families,N/A
Malformation syndrome,2186,Hydrocephalus-blue sclerae-nephropathy syndrome,Point prevalence,N/A
Disease,251671,Angiocentric glioma,Cases/families,N/A
Disease,251671,Angiocentric glioma,Point prevalence,N/A
Malformation syndrome,2189,Hydrolethalus,Prevalence at birth,N/A
Malformation syndrome,2189,Hydrolethalus,Point prevalence,N/A
Malformation syndrome,2189,Hydrolethalus,Point prevalence,N/A
Disease,251679,Astroblastoma,Annual incidence,N/A
Disease,312,Autosomal dominant epidermolytic ichthyosis,Point prevalence,N/A
Disease,312,Autosomal dominant epidermolytic ichthyosis,Point prevalence,N/A
Disease,312,Autosomal dominant epidermolytic ichthyosis,Point prevalence,N/A
Disease,312,Autosomal dominant epidermolytic ichthyosis,Point prevalence,N/A
Disease,312,Autosomal dominant epidermolytic ichthyosis,Point prevalence,N/A
Clinical subtype,2196,Primary hypomagnesemia with hypercalciuria and nephrocalcinosis with severe ocular involvement,Cases/families,N/A
Clinical subtype,2196,Primary hypomagnesemia with hypercalciuria and nephrocalcinosis with severe ocular involvement,Point prevalence,N/A
Category,251852,Embryonal tumor of neuroepithelial tissue,Annual incidence,N/A
Histopathological subtype,251576,Gliosarcoma,Annual incidence,N/A
Malformation syndrome,2150,Hirschsprung disease-type D brachydactyly syndrome,Cases/families,N/A
Malformation syndrome,2150,Hirschsprung disease-type D brachydactyly syndrome,Point prevalence,N/A
Disease,251582,Gliomatosis cerebri,Annual incidence,N/A
Histopathological subtype,251579,Giant cell glioblastoma,Annual incidence,N/A
Malformation syndrome,2152,Mowat-Wilson syndrome,Point prevalence,N/A
Malformation syndrome,2152,Mowat-Wilson syndrome,Prevalence at birth,N/A
Malformation syndrome,2153,Hirschsprung disease-nail hypoplasia-dysmorphism syndrome,Cases/families,N/A
Malformation syndrome,2153,Hirschsprung disease-nail hypoplasia-dysmorphism syndrome,Point prevalence,N/A
Disease,251589,Anaplastic astrocytoma,Annual incidence,N/A
Histopathological subtype,251598,Protoplasmic astrocytoma,Annual incidence,N/A
Malformation syndrome,2155,Hirschsprung disease-deafness-polydactyly syndrome,Cases/families,N/A
Malformation syndrome,2155,Hirschsprung disease-deafness-polydactyly syndrome,Point prevalence,N/A
Disease,251595,Diffuse astrocytoma,Annual incidence,N/A
Disease,2158,Histidinuria-renal tubular defect syndrome,Cases/families,N/A
Disease,2158,Histidinuria-renal tubular defect syndrome,Point prevalence,N/A
Disease,251612,Pilocytic astrocytoma,Annual incidence,N/A
Malformation syndrome,2163,Holoprosencephaly-craniosynostosis syndrome,Cases/families,N/A
Malformation syndrome,2163,Holoprosencephaly-craniosynostosis syndrome,Point prevalence,N/A
Disease,251607,Pleomorphic xanthoastrocytoma,Annual incidence,N/A
Malformation syndrome,2165,Holoprosencephaly-caudal dysgenesis syndrome,Prevalence at birth,N/A
Malformation syndrome,2165,Holoprosencephaly-caudal dysgenesis syndrome,Point prevalence,N/A
Malformation syndrome,2166,Holoprosencephaly-postaxial polydactyly syndrome,Point prevalence,N/A
Disease,251627,Oligodendroglioma,Annual incidence,N/A
Malformation syndrome,2167,Holzgreve syndrome,Cases/families,N/A
Malformation syndrome,2167,Holzgreve syndrome,Point prevalence,N/A
Clinical subtype,2169,Methylcobalamin deficiency type cblE,Cases/families,N/A
Clinical subtype,2169,Methylcobalamin deficiency type cblE,Point prevalence,N/A
Disease,2222,Hypertrichosis lanuginosa congenita,Cases/families,N/A
Disease,2222,Hypertrichosis lanuginosa congenita,Point prevalence,N/A
Malformation syndrome,2220,Hypertrichosis cubiti,Cases/families,N/A
Malformation syndrome,2220,Hypertrichosis cubiti,Point prevalence,N/A
Malformation syndrome,1051,Ramos-Arroyo syndrome,Cases/families,N/A
Malformation syndrome,1051,Ramos-Arroyo syndrome,Point prevalence,N/A
Malformation syndrome,2228,Hypodontia-dysplasia of nails syndrome,Point prevalence,N/A
Disease,2224,Hypertryptophanemia,Cases/families,N/A
Disease,2224,Hypertryptophanemia,Point prevalence,N/A
Disease,2232,Primary hypergonadotropic hypogonadism-partial alopecia syndrome,Cases/families,N/A
Disease,2232,Primary hypergonadotropic hypogonadism-partial alopecia syndrome,Point prevalence,N/A
Disease,2230,Hypogonadotropic hypogonadism-frontoparietal alopecia syndrome,Cases/families,N/A
Disease,2230,Hypogonadotropic hypogonadism-frontoparietal alopecia syndrome,Point prevalence,N/A
Malformation syndrome,2229,Dilated cardiomyopathy-hypergonadotropic hypogonadism syndrome,Cases/families,N/A
Malformation syndrome,2229,Dilated cardiomyopathy-hypergonadotropic hypogonadism syndrome,Point prevalence,N/A
Disease,2238,Familial isolated hypoparathyroidism,Cases/families,N/A
Disease,2238,Familial isolated hypoparathyroidism,Point prevalence,N/A
Malformation syndrome,2237,Hypoparathyroidism-sensorineural deafness-renal disease syndrome,Point prevalence,N/A
Malformation syndrome,2237,Hypoparathyroidism-sensorineural deafness-renal disease syndrome,Cases/families,N/A
Disease,2235,Hypogonadotropic hypogonadism-retinitis pigmentosa syndrome,Cases/families,N/A
Disease,2235,Hypogonadotropic hypogonadism-retinitis pigmentosa syndrome,Point prevalence,N/A
Malformation syndrome,2234,Male hypergonadotropic hypogonadism-intellectual disability-skeletal anomalies syndrome,Cases/families,N/A
Malformation syndrome,2234,Male hypergonadotropic hypogonadism-intellectual disability-skeletal anomalies syndrome,Point prevalence,N/A
Histopathological subtype,251863,Desmoplastic/nodular medulloblastoma,Annual incidence,N/A
Disease,2198,Palmoplantar keratoderma-esophageal carcinoma syndrome,Cases/families,N/A
Disease,2198,Palmoplantar keratoderma-esophageal carcinoma syndrome,Point prevalence,N/A
Malformation syndrome,2206,Ankylosing vertebral hyperostosis with tylosis,Cases/families,N/A
Malformation syndrome,2206,Ankylosing vertebral hyperostosis with tylosis,Point prevalence,N/A
Disease,2201,Palmoplantar keratoderma-spastic paralysis syndrome,Cases/families,N/A
Disease,2201,Palmoplantar keratoderma-spastic paralysis syndrome,Point prevalence,N/A
Disease,2202,Palmoplantar keratoderma-deafness syndrome,Cases/families,N/A
Disease,2202,Palmoplantar keratoderma-deafness syndrome,Point prevalence,N/A
Clinical group,251870,Central nervous system embryonal tumor,Annual incidence,N/A
Disease,251899,Choroid plexus carcinoma,Annual incidence,N/A
Disease,251899,Choroid plexus carcinoma,Point prevalence,N/A
Disease,251899,Choroid plexus carcinoma,Lifetime Prevalence,N/A
Malformation syndrome,2213,Hypertelorism-microtia-facial clefting syndrome,Cases/families,N/A
Malformation syndrome,2213,Hypertelorism-microtia-facial clefting syndrome,Point prevalence,N/A
Clinical group,251896,Choroid plexus tumor,Annual incidence,N/A
Malformation syndrome,2211,Hypertelorism-hypospadias-polysyndactyly syndrome,Cases/families,N/A
Malformation syndrome,2211,Hypertelorism-hypospadias-polysyndactyly syndrome,Point prevalence,N/A
Disease,2218,Cervical hypertrichosis-peripheral neuropathy syndrome,Cases/families,N/A
Disease,2218,Cervical hypertrichosis-peripheral neuropathy syndrome,Point prevalence,N/A
Disease,251909,Pineoblastoma,Annual incidence,N/A
Malformation syndrome,2215,Multiple pterygium-malignant hyperthermia syndrome,Cases/families,N/A
Malformation syndrome,2215,Multiple pterygium-malignant hyperthermia syndrome,Point prevalence,N/A
Malformation syndrome,251019,2q32q33 microdeletion syndrome,Cases/families,N/A
Malformation syndrome,251019,2q32q33 microdeletion syndrome,Point prevalence,N/A
Disease,2266,"Hypotrichosis-intellectual disability, Lopes type",Cases/families,N/A
Disease,2266,"Hypotrichosis-intellectual disability, Lopes type",Point prevalence,N/A
Etiological subtype,251028,SATB2-associated syndrome due to a chromosomal rearrangement,Cases/families,N/A
Etiological subtype,251028,SATB2-associated syndrome due to a chromosomal rearrangement,Point prevalence,N/A
Disease,2269,Ichthyosis-alopecia-eclabion-ectropion-intellectual disability syndrome,Cases/families,N/A
Disease,2269,Ichthyosis-alopecia-eclabion-ectropion-intellectual disability syndrome,Point prevalence,N/A
Malformation syndrome,251038,3q29 microduplication syndrome,Point prevalence,N/A
Malformation syndrome,250999,1q41q42 microdeletion syndrome,Point prevalence,N/A
Malformation syndrome,2261,"Hypospadias-intellectual disability, Goldblatt type syndrome",Cases/families,N/A
Malformation syndrome,2261,"Hypospadias-intellectual disability, Goldblatt type syndrome",Point prevalence,N/A
Malformation syndrome,251004,Paternal uniparental disomy of chromosome 1 syndrome,Point prevalence,N/A
Malformation syndrome,251009,Maternal uniparental disomy of chromosome 1 syndrome,Point prevalence,N/A
Malformation syndrome,672,Pallister-Hall syndrome,Cases/families,N/A
Malformation syndrome,672,Pallister-Hall syndrome,Point prevalence,N/A
Malformation syndrome,251014,2q31.1 microdeletion syndrome,Point prevalence,N/A
Disease,455,Superficial epidermolytic ichthyosis,Cases/families,N/A
Disease,455,Superficial epidermolytic ichthyosis,Point prevalence,N/A
Malformation syndrome,251061,7q31 microdeletion syndrome,Cases/families,N/A
Malformation syndrome,251061,7q31 microdeletion syndrome,Point prevalence,N/A
Malformation syndrome,251066,8p11.2 deletion syndrome,Cases/families,N/A
Malformation syndrome,251066,8p11.2 deletion syndrome,Point prevalence,N/A
Malformation syndrome,2272,Ichthyosis-oral and digital anomalies syndrome,Cases/families,N/A
Malformation syndrome,2272,Ichthyosis-oral and digital anomalies syndrome,Point prevalence,N/A
Malformation syndrome,251071,8p23.1 microdeletion syndrome,Point prevalence,N/A
Disease,2274,Ichthyosis-hepatosplenomegaly-cerebellar degeneration syndrome,Cases/families,N/A
Disease,2274,Ichthyosis-hepatosplenomegaly-cerebellar degeneration syndrome,Point prevalence,N/A
Malformation syndrome,251076,8p23.1 duplication syndrome,Point prevalence,N/A
Disease,2273,Ichthyosis follicularis-alopecia-photophobia syndrome,Cases/families,N/A
Disease,2273,Ichthyosis follicularis-alopecia-photophobia syndrome,Point prevalence,N/A
Malformation syndrome,251043,Ring chromosome 5 syndrome,Point prevalence,N/A
Clinical group,165,Neutral lipid storage disease,Point prevalence,N/A
Clinical group,165,Neutral lipid storage disease,Cases/families,N/A
Disease,139,CHILD syndrome,Cases/families,N/A
Disease,139,CHILD syndrome,Point prevalence,N/A
Malformation syndrome,251046,6p22 microdeletion syndrome,Cases/families,N/A
Malformation syndrome,251046,6p22 microdeletion syndrome,Point prevalence,N/A
Disease,457,Harlequin ichthyosis,Point prevalence,N/A
Disease,457,Harlequin ichthyosis,Cases/families,N/A
Disease,2271,Congenital ichthyosis-microcephalus-tetraplegia syndrome,Point prevalence,N/A
Disease,2271,Congenital ichthyosis-microcephalus-tetraplegia syndrome,Cases/families,N/A
Malformation syndrome,251056,6q25.2q25.3 microdeletion syndrome,Cases/families,N/A
Malformation syndrome,251056,6q25.2q25.3 microdeletion syndrome,Point prevalence,N/A
Malformation syndrome,2246,Cerebellar hypoplasia-tapetoretinal degeneration syndrome,Cases/families,N/A
Malformation syndrome,2246,Cerebellar hypoplasia-tapetoretinal degeneration syndrome,Point prevalence,N/A
Malformation syndrome,2249,Ulna hypoplasia-intellectual disability syndrome,Cases/families,N/A
Malformation syndrome,2249,Ulna hypoplasia-intellectual disability syndrome,Point prevalence,N/A
Clinical subtype,2239,Familial isolated hypoparathyroidism due to agenesis of parathyroid gland,Cases/families,N/A
Clinical subtype,2239,Familial isolated hypoparathyroidism due to agenesis of parathyroid gland,Point prevalence,N/A
Malformation syndrome,2241,Megacystis-microcolon-intestinal hypoperistalsis syndrome,Cases/families,N/A
Malformation syndrome,2241,Megacystis-microcolon-intestinal hypoperistalsis syndrome,Point prevalence,N/A
Clinical subtype,250984,Autosomal recessive Stickler syndrome,Cases/families,N/A
Clinical subtype,250984,Autosomal recessive Stickler syndrome,Point prevalence,N/A
Malformation syndrome,2256,Fibulo-ulnar hypoplasia-renal anomalies syndrome,Cases/families,N/A
Malformation syndrome,2256,Fibulo-ulnar hypoplasia-renal anomalies syndrome,Point prevalence,N/A
Disease,250977,AICA-ribosiduria,Cases/families,N/A
Disease,250977,AICA-ribosiduria,Point prevalence,N/A
Malformation syndrome,250994,1q21.1 microduplication syndrome,Cases/families,N/A
Malformation syndrome,250994,1q21.1 microduplication syndrome,Point prevalence,N/A
Malformation syndrome,250989,1q21.1 microdeletion syndrome,Point prevalence,N/A
Disease,2250,Hyposmia-nasal and ocular hypoplasia-hypogonadotropic hypogonadism syndrome,Cases/families,N/A
Disease,2250,Hyposmia-nasal and ocular hypoplasia-hypogonadotropic hypogonadism syndrome,Point prevalence,N/A
Morphological anomaly,250923,Isolated aniridia,Annual incidence,N/A
Morphological anomaly,250923,Isolated aniridia,Point prevalence,N/A
Morphological anomaly,250923,Isolated aniridia,Point prevalence,N/A
Morphological anomaly,250923,Isolated aniridia,Point prevalence,N/A
Malformation syndrome,2251,Thumb deformity-alopecia-pigmentation anomaly syndrome,Cases/families,N/A
Malformation syndrome,2251,Thumb deformity-alopecia-pigmentation anomaly syndrome,Point prevalence,N/A
Malformation syndrome,2252,Radial hypoplasia-triphalangeal thumbs-hypospadias-maxillary diastema syndrome,Cases/families,N/A
Malformation syndrome,2252,Radial hypoplasia-triphalangeal thumbs-hypospadias-maxillary diastema syndrome,Point prevalence,N/A
Malformation syndrome,250972,Polymicrogyria with optic nerve hypoplasia,Cases/families,N/A
Malformation syndrome,250972,Polymicrogyria with optic nerve hypoplasia,Point prevalence,N/A
Disease,2255,Pancreatic hypoplasia-diabetes-congenital heart disease syndrome,Cases/families,N/A
Disease,2255,Pancreatic hypoplasia-diabetes-congenital heart disease syndrome,Point prevalence,N/A
Disease,251380,Hereditary persistence of fetal hemoglobin-sickle cell disease syndrome,Prevalence at birth,N/A
Disease,251380,Hereditary persistence of fetal hemoglobin-sickle cell disease syndrome,Point prevalence,N/A
Malformation syndrome,2306,Isotretinoin-like syndrome,Cases/families,N/A
Malformation syndrome,2306,Isotretinoin-like syndrome,Point prevalence,N/A
Malformation syndrome,251383,CK syndrome,Cases/families,N/A
Malformation syndrome,251383,CK syndrome,Point prevalence,N/A
Malformation syndrome,2305,Isotretinoin syndrome,Point prevalence,N/A
Disease,251370,Sickle cell-hemoglobin D disease syndrome,Point prevalence,N/A
Disease,251375,Sickle cell-hemoglobin E disease syndrome,Point prevalence,N/A
Disease,251359,Sickle cell-beta-thalassemia disease syndrome,Point prevalence,N/A
Disease,251365,Sickle cell-hemoglobin C disease syndrome,Point prevalence,N/A
Disease,2295,Familial articular hypermobility syndrome,Point prevalence,N/A
Malformation syndrome,2319,Juberg-Hayward syndrome,Cases/families,N/A
Malformation syndrome,2319,Juberg-Hayward syndrome,Point prevalence,N/A
Disease,251523,Hyperzincemia and hypercalprotectinemia,Cases/families,N/A
Disease,251523,Hyperzincemia and hypercalprotectinemia,Point prevalence,N/A
Malformation syndrome,2316,Johnson neuroectodermal syndrome,Point prevalence,N/A
Malformation syndrome,2315,Johanson-Blizzard syndrome,Prevalence at birth,N/A
Malformation syndrome,2315,Johanson-Blizzard syndrome,Point prevalence,N/A
Malformation syndrome,251510,"46,XY partial gonadal dysgenesis",Point prevalence,N/A
Malformation syndrome,251515,Distal arthrogryposis type 10,Cases/families,N/A
Malformation syndrome,251515,Distal arthrogryposis type 10,Point prevalence,N/A
Malformation syndrome,2310,Absence deformity of leg-cataract syndrome,Cases/families,N/A
Malformation syndrome,2310,Absence deformity of leg-cataract syndrome,Point prevalence,N/A
Disease,2309,Pachyonychia congenita,Cases/families,N/A
Disease,2309,Pachyonychia congenita,Point prevalence,N/A
Disease,251393,Localized junctional epidermolysis bullosa,Cases/families,N/A
Disease,251393,Localized junctional epidermolysis bullosa,Point prevalence,N/A
Malformation syndrome,2307,IVIC syndrome,Cases/families,N/A
Malformation syndrome,2307,IVIC syndrome,Point prevalence,N/A
Disease,251295,Pigmented paravenous retinochoroidal atrophy,Cases/families,N/A
Disease,251295,Pigmented paravenous retinochoroidal atrophy,Point prevalence,N/A
Malformation syndrome,251290,Parietal foramina with clavicular hypoplasia,Cases/families,N/A
Malformation syndrome,251290,Parietal foramina with clavicular hypoplasia,Point prevalence,N/A
Malformation syndrome,2282,Dysmorphism-short stature-deafness-difference of sex development syndrome,Cases/families,N/A
Malformation syndrome,2282,Dysmorphism-short stature-deafness-difference of sex development syndrome,Point prevalence,N/A
Disease,251287,Benign concentric annular macular dystrophy,Cases/families,N/A
Disease,251287,Benign concentric annular macular dystrophy,Point prevalence,N/A
Disease,251282,Autosomal dominant spastic ataxia type 1,Point prevalence,N/A
Disease,251282,Autosomal dominant spastic ataxia type 1,Cases/families,N/A
Disease,251279,Microphthalmia-retinitis pigmentosa-foveoschisis-optic disc drusen syndrome,Cases/families,N/A
Disease,251279,Microphthalmia-retinitis pigmentosa-foveoschisis-optic disc drusen syndrome,Point prevalence,N/A
Disease,251274,Familial hyperaldosteronism type III,Cases/families,N/A
Disease,251274,Familial hyperaldosteronism type III,Point prevalence,N/A
Malformation syndrome,2278,Ichthyosis-intellectual disability-dwarfism-renal impairment syndrome,Cases/families,N/A
Malformation syndrome,2278,Ichthyosis-intellectual disability-dwarfism-renal impairment syndrome,Point prevalence,N/A
Disease,251262,Familial osteochondritis dissecans,Point prevalence,N/A
Disease,251347,Ataxia-telangiectasia-like disorder,Point prevalence,N/A
Disease,2289,Neuronal intranuclear inclusion disease,Point prevalence,N/A
Disease,2290,Microvillus inclusion disease,Point prevalence,N/A
Disease,2290,Microvillus inclusion disease,Cases/families,N/A
Disease,2290,Microvillus inclusion disease,Point prevalence,N/A
Morphological anomaly,2285,Primary basilar invagination,Point prevalence,N/A
Disease,251307,Idiopathic recurrent pericarditis,Point prevalence,N/A
Disease,251304,Infantile onset panniculitis with uveitis and systemic granulomatosis,Cases/families,N/A
Disease,251304,Infantile onset panniculitis with uveitis and systemic granulomatosis,Point prevalence,N/A
Malformation syndrome,2674,Cyprus facial-neuromusculoskeletal syndrome,Cases/families,N/A
Malformation syndrome,2674,Cyprus facial-neuromusculoskeletal syndrome,Point prevalence,N/A
Malformation syndrome,2673,Neurofaciodigitorenal syndrome,Cases/families,N/A
Malformation syndrome,2673,Neurofaciodigitorenal syndrome,Point prevalence,N/A
Malformation syndrome,2672,Neuhauser-Eichner-Opitz syndrome,Cases/families,N/A
Malformation syndrome,2672,Neuhauser-Eichner-Opitz syndrome,Point prevalence,N/A
Malformation syndrome,2678,Familial isolated caf-au-lait macules,Point prevalence,N/A
Malformation syndrome,2668,Nephropathy-deafness-hyperparathyroidism syndrome,Cases/families,N/A
Malformation syndrome,2668,Nephropathy-deafness-hyperparathyroidism syndrome,Point prevalence,N/A
Malformation syndrome,2663,Nathalie syndrome,Cases/families,N/A
Malformation syndrome,2663,Nathalie syndrome,Point prevalence,N/A
Malformation syndrome,2662,Keipert syndrome,Cases/families,N/A
Malformation syndrome,2662,Keipert syndrome,Point prevalence,N/A
Malformation syndrome,2671,Neu-Laxova syndrome,Cases/families,N/A
Malformation syndrome,2671,Neu-Laxova syndrome,Point prevalence,N/A
Malformation syndrome,1475,Renal coloboma syndrome,Cases/families,N/A
Malformation syndrome,1475,Renal coloboma syndrome,Point prevalence,N/A
Malformation syndrome,2670,Pierson syndrome,Cases/families,N/A
Malformation syndrome,2670,Pierson syndrome,Point prevalence,N/A
Malformation syndrome,2669,Nephrosis-deafness-urinary tract-digital malformations syndrome,Cases/families,N/A
Malformation syndrome,2669,Nephrosis-deafness-urinary tract-digital malformations syndrome,Point prevalence,N/A
Disease,254930,Combined oxidative phosphorylation defect type 7,Cases/families,N/A
Disease,254930,Combined oxidative phosphorylation defect type 7,Point prevalence,N/A
Disease,254925,Combined oxidative phosphorylation defect type 4,Cases/families,N/A
Disease,254925,Combined oxidative phosphorylation defect type 4,Point prevalence,N/A
Malformation syndrome,2697,Arthrogryposis-renal dysfunction-cholestasis syndrome,Cases/families,N/A
Malformation syndrome,2697,Arthrogryposis-renal dysfunction-cholestasis syndrome,Point prevalence,N/A
Disease,254920,Combined oxidative phosphorylation defect type 2,Cases/families,N/A
Disease,254920,Combined oxidative phosphorylation defect type 2,Point prevalence,N/A
Malformation syndrome,2695,Bifid nose,Point prevalence,N/A
Clinical subtype,255182,Pyruvate dehydrogenase E3-binding protein deficiency,Point prevalence,N/A
Malformation syndrome,2701,Noonan syndrome-like disorder with loose anagen hair,Cases/families,N/A
Malformation syndrome,2701,Noonan syndrome-like disorder with loose anagen hair,Point prevalence,N/A
Clinical subtype,255138,Pyruvate dehydrogenase E1-beta deficiency,Point prevalence,N/A
Disease,255132,Adult-onset autosomal recessive sideroblastic anemia,Point prevalence,N/A
Disease,255132,Adult-onset autosomal recessive sideroblastic anemia,Cases/families,N/A
Disease,2698,Knuckle pads-leukonychia-sensorineural deafness-palmoplantar hyperkeratosis syndrome,Point prevalence,N/A
Malformation syndrome,2699,Median nodule of the upper lip,Cases/families,N/A
Malformation syndrome,2699,Median nodule of the upper lip,Point prevalence,N/A
Disease,254875,"Mitochondrial DNA depletion syndrome, myopathic form",Cases/families,N/A
Disease,254875,"Mitochondrial DNA depletion syndrome, myopathic form",Point prevalence,N/A
Disease,2690,Neutropenia-monocytopenia-deafness syndrome,Cases/families,N/A
Disease,2690,Neutropenia-monocytopenia-deafness syndrome,Point prevalence,N/A
Disease,254898,Deafness-encephaloneuropathy-obesity-valvulopathy syndrome,Cases/families,N/A
Disease,254898,Deafness-encephaloneuropathy-obesity-valvulopathy syndrome,Point prevalence,N/A
Malformation syndrome,2712,Oculofaciocardiodental syndrome,Point prevalence,N/A
Malformation syndrome,2714,Oculo-palato-cerebral syndrome,Cases/families,N/A
Malformation syndrome,2714,Oculo-palato-cerebral syndrome,Point prevalence,N/A
Malformation syndrome,2713,Oculoosteocutaneous syndrome,Cases/families,N/A
Malformation syndrome,2713,Oculoosteocutaneous syndrome,Point prevalence,N/A
Malformation syndrome,2715,Severe oculo-renal-cerebellar syndrome,Cases/families,N/A
Malformation syndrome,2715,Severe oculo-renal-cerebellar syndrome,Point prevalence,N/A
Malformation syndrome,2718,Oculotrichodysplasia,Cases/families,N/A
Malformation syndrome,2718,Oculotrichodysplasia,Point prevalence,N/A
Malformation syndrome,2717,Oculotrichoanal syndrome,Cases/families,N/A
Malformation syndrome,2717,Oculotrichoanal syndrome,Point prevalence,N/A
Malformation syndrome,2704,Urofacial syndrome,Cases/families,N/A
Malformation syndrome,2704,Urofacial syndrome,Point prevalence,N/A
Malformation syndrome,2703,Port-wine nevi-mega cisterna magna-hydrocephalus syndrome,Cases/families,N/A
Malformation syndrome,2703,Port-wine nevi-mega cisterna magna-hydrocephalus syndrome,Point prevalence,N/A
Disease,255210,Mitochondrial DNA-associated Leigh syndrome,Prevalence at birth,N/A
Disease,255210,Mitochondrial DNA-associated Leigh syndrome,Point prevalence,N/A
Disease,255229,Navajo neurohepatopathy,Cases/families,N/A
Disease,255229,Navajo neurohepatopathy,Point prevalence,N/A
Malformation syndrome,2707,"Oculocerebrofacial syndrome, Kaufman type",Cases/families,N/A
Malformation syndrome,2707,"Oculocerebrofacial syndrome, Kaufman type",Point prevalence,N/A
Disease,255235,"Mitochondrial DNA depletion syndrome, encephalomyopathic form with renal tubulopathy",Cases/families,N/A
Disease,255235,"Mitochondrial DNA depletion syndrome, encephalomyopathic form with renal tubulopathy",Point prevalence,N/A
Malformation syndrome,2710,Oculodentodigital dysplasia,Cases/families,N/A
Malformation syndrome,2710,Oculodentodigital dysplasia,Point prevalence,N/A
Malformation syndrome,2709,"Oculodental syndrome, Rutherfurd type",Cases/families,N/A
Malformation syndrome,2709,"Oculodental syndrome, Rutherfurd type",Point prevalence,N/A
Malformation syndrome,2728,"Blepharophimosis-intellectual disability syndrome, Ohdo type",Cases/families,N/A
Malformation syndrome,2728,"Blepharophimosis-intellectual disability syndrome, Ohdo type",Point prevalence,N/A
Malformation syndrome,2730,Postaxial tetramelic oligodactyly,Cases/families,N/A
Malformation syndrome,2730,Postaxial tetramelic oligodactyly,Point prevalence,N/A
Malformation syndrome,2732,Olivopontocerebellar atrophy-deafness syndrome,Point prevalence,N/A
Malformation syndrome,2733,Omodysplasia,Point prevalence,N/A
Malformation syndrome,2733,Omodysplasia,Cases/families,N/A
Malformation syndrome,2719,"Oculocerebral hypopigmentation syndrome, Cross type",Cases/families,N/A
Malformation syndrome,2719,"Oculocerebral hypopigmentation syndrome, Cross type",Point prevalence,N/A
Malformation syndrome,2720,"Oculocerebral hypopigmentation syndrome, Preus type",Cases/families,N/A
Malformation syndrome,2720,"Oculocerebral hypopigmentation syndrome, Preus type",Point prevalence,N/A
Disease,2721,Odonto-onycho-dermal dysplasia,Cases/families,N/A
Disease,2721,Odonto-onycho-dermal dysplasia,Point prevalence,N/A
Malformation syndrome,2722,Odonto-onycho dysplasia-alopecia syndrome,Cases/families,N/A
Malformation syndrome,2722,Odonto-onycho dysplasia-alopecia syndrome,Point prevalence,N/A
Malformation syndrome,2723,Odontotrichomelic syndrome,Cases/families,N/A
Malformation syndrome,2723,Odontotrichomelic syndrome,Point prevalence,N/A
Malformation syndrome,2724,Odontomatosis-aortae esophagus stenosis syndrome,Cases/families,N/A
Malformation syndrome,2724,Odontomatosis-aortae esophagus stenosis syndrome,Point prevalence,N/A
Malformation syndrome,2755,Orofaciodigital syndrome type 8,Cases/families,N/A
Malformation syndrome,2755,Orofaciodigital syndrome type 8,Point prevalence,N/A
Malformation syndrome,2754,Orofaciodigital syndrome type 6,Cases/families,N/A
Malformation syndrome,2754,Orofaciodigital syndrome type 6,Point prevalence,N/A
Disease,252164,Benign schwannoma,Point prevalence,N/A
Malformation syndrome,2753,Orofaciodigital syndrome type 4,Cases/families,N/A
Malformation syndrome,2753,Orofaciodigital syndrome type 4,Point prevalence,N/A
Malformation syndrome,2751,Orofaciodigital syndrome type 2,Cases/families,N/A
Malformation syndrome,2751,Orofaciodigital syndrome type 2,Point prevalence,N/A
Malformation syndrome,2750,Orofaciodigital syndrome type 1,Prevalence at birth,N/A
Malformation syndrome,2750,Orofaciodigital syndrome type 1,Prevalence at birth,N/A
Malformation syndrome,2750,Orofaciodigital syndrome type 1,Point prevalence,N/A
Category,252057,Tumor of cranial and spinal nerves,Annual incidence,N/A
Malformation syndrome,2743,Ophthalmoplegia-intellectual disability-lingua scrotalis syndrome,Cases/families,N/A
Malformation syndrome,2743,Ophthalmoplegia-intellectual disability-lingua scrotalis syndrome,Point prevalence,N/A
Malformation syndrome,2741,Ophthalmomandibulomelic dysplasia,Cases/families,N/A
Malformation syndrome,2741,Ophthalmomandibulomelic dysplasia,Point prevalence,N/A
Category,252028,Primary melanocytic tumor of central nervous system,Annual incidence,N/A
Disease,661,Congenital central hypoventilation syndrome,Prevalence at birth,N/A
Disease,661,Congenital central hypoventilation syndrome,Point prevalence,N/A
Malformation syndrome,2736,Lethal omphalocele-cleft palate syndrome,Cases/families,N/A
Malformation syndrome,2736,Lethal omphalocele-cleft palate syndrome,Point prevalence,N/A
Category,254367,Rare lichen planus,Point prevalence,N/A
Malformation syndrome,2776,Autosomal recessive distal osteolysis syndrome,Point prevalence,N/A
Malformation syndrome,2777,Osteomesopyknosis,Cases/families,N/A
Malformation syndrome,2777,Osteomesopyknosis,Point prevalence,N/A
Disease,254361,Plectin-related limb-girdle muscular dystrophy R17,Cases/families,N/A
Disease,254361,Plectin-related limb-girdle muscular dystrophy R17,Point prevalence,N/A
Malformation syndrome,2774,Multicentric carpo-tarsal osteolysis with or without nephropathy,Point prevalence,N/A
Malformation syndrome,254351,Distal 7q11.23 microdeletion syndrome,Cases/families,N/A
Malformation syndrome,254351,Distal 7q11.23 microdeletion syndrome,Point prevalence,N/A
Malformation syndrome,2769,"Familial osteodysplasia, Anderson type",Point prevalence,N/A
Malformation syndrome,2769,"Familial osteodysplasia, Anderson type",Cases/families,N/A
Malformation syndrome,254346,19p13.12 microdeletion syndrome,Cases/families,N/A
Malformation syndrome,254346,19p13.12 microdeletion syndrome,Point prevalence,N/A
Malformation syndrome,2770,Nasu-Hakola disease,Point prevalence,N/A
Malformation syndrome,2770,Nasu-Hakola disease,Point prevalence,N/A
Disease,254343,Autosomal recessive spastic ataxia-optic atrophy-dysarthria syndrome,Cases/families,N/A
Disease,254343,Autosomal recessive spastic ataxia-optic atrophy-dysarthria syndrome,Point prevalence,N/A
Malformation syndrome,2767,Carpotarsal osteochondromatosis,Point prevalence,N/A
Disease,254334,Autosomal recessive intermediate Charcot-Marie-Tooth disease type B,Cases/families,N/A
Disease,254334,Autosomal recessive intermediate Charcot-Marie-Tooth disease type B,Point prevalence,N/A
Malformation syndrome,2768,Blount disease,Point prevalence,N/A
Histopathological subtype,252212,Malignant triton tumor,Cases/families,N/A
Histopathological subtype,252212,Malignant triton tumor,Point prevalence,N/A
Malformation syndrome,2763,Osteocraniostenosis,Cases/families,N/A
Malformation syndrome,2763,Osteocraniostenosis,Point prevalence,N/A
Malformation syndrome,2759,Imperforate oropharynx-costovertebral anomalies syndrome,Cases/families,N/A
Malformation syndrome,2759,Imperforate oropharynx-costovertebral anomalies syndrome,Point prevalence,N/A
Malformation syndrome,2760,OSLAM syndrome,Cases/families,N/A
Malformation syndrome,2760,OSLAM syndrome,Point prevalence,N/A
Clinical subtype,252175,Vestibular schwannoma,Annual incidence,N/A
Clinical subtype,252175,Vestibular schwannoma,Annual incidence,N/A
Clinical subtype,252175,Vestibular schwannoma,Annual incidence,N/A
Clinical subtype,252175,Vestibular schwannoma,Annual incidence,N/A
Malformation syndrome,254516,Temple syndrome,Cases/families,N/A
Malformation syndrome,254516,Temple syndrome,Point prevalence,N/A
Malformation syndrome,2793,Otoonychoperoneal syndrome,Cases/families,N/A
Malformation syndrome,2793,Otoonychoperoneal syndrome,Point prevalence,N/A
Malformation syndrome,254519,Kagami-Ogata syndrome,Cases/families,N/A
Malformation syndrome,254519,Kagami-Ogata syndrome,Point prevalence,N/A
Etiological subtype,254525,Temple syndrome due to paternal 14q32.2 microdeletion,Cases/families,N/A
Etiological subtype,254525,Temple syndrome due to paternal 14q32.2 microdeletion,Point prevalence,N/A
Malformation syndrome,2798,Pachygyria-intellectual disability-epilepsy syndrome,Cases/families,N/A
Malformation syndrome,2798,Pachygyria-intellectual disability-epilepsy syndrome,Point prevalence,N/A
Malformation syndrome,2796,Pachydermoperiostosis,Cases/families,N/A
Malformation syndrome,2796,Pachydermoperiostosis,Point prevalence,N/A
Etiological subtype,254528,Kagami-Ogata syndrome due to maternal 14q32.2 microdeletion,Cases/families,N/A
Etiological subtype,254528,Kagami-Ogata syndrome due to maternal 14q32.2 microdeletion,Point prevalence,N/A
Disease,254478,Lichen planus pemphigoides,Cases/families,N/A
Disease,254478,Lichen planus pemphigoides,Point prevalence,N/A
Malformation syndrome,2789,Lateral meningocele syndrome,Cases/families,N/A
Malformation syndrome,2789,Lateral meningocele syndrome,Point prevalence,N/A
Disease,2788,Osteoporosis-pseudoglioma syndrome,Point prevalence,N/A
Disease,254492,Frontal fibrosing alopecia,Point prevalence,N/A
Malformation syndrome,2791,Otodental syndrome,Cases/families,N/A
Malformation syndrome,2791,Otodental syndrome,Point prevalence,N/A
Clinical subtype,254504,Inhalational botulism,Cases/families,N/A
Clinical subtype,254504,Inhalational botulism,Point prevalence,N/A
Malformation syndrome,2790,"Endosteal hyperostosis, Worth type",Cases/families,N/A
Malformation syndrome,2790,"Endosteal hyperostosis, Worth type",Point prevalence,N/A
Clinical subtype,254509,Iatrogenic botulism,Cases/families,N/A
Clinical subtype,254509,Iatrogenic botulism,Point prevalence,N/A
Disease,254411,Annular atrophic lichen planus,Cases/families,N/A
Disease,254411,Annular atrophic lichen planus,Point prevalence,N/A
Disease,254424,Annular lichen planus,Point prevalence,N/A
Malformation syndrome,2783,Autosomal dominant osteopetrosis type 1,Cases/families,N/A
Malformation syndrome,2783,Autosomal dominant osteopetrosis type 1,Point prevalence,N/A
Disease,254449,Atrophic lichen planus,Point prevalence,N/A
Malformation syndrome,2786,Osteoporosis-oculocutaneous hypopigmentation syndrome,Point prevalence,N/A
Malformation syndrome,2786,Osteoporosis-oculocutaneous hypopigmentation syndrome,Cases/families,N/A
Disease,254463,Lichen planus pigmentosus,Point prevalence,N/A
Malformation syndrome,2780,Osteopathia striata-cranial sclerosis syndrome,Cases/families,N/A
Malformation syndrome,2780,Osteopathia striata-cranial sclerosis syndrome,Point prevalence,N/A
Malformation syndrome,2779,Osteopathia striata-pigmentary dermopathy-white forelock syndrome,Cases/families,N/A
Malformation syndrome,2779,Osteopathia striata-pigmentary dermopathy-white forelock syndrome,Point prevalence,N/A
Disease,254379,Linear lichen planus,Point prevalence,N/A
Disease,254395,Actinic lichen planus,Point prevalence,N/A
Malformation syndrome,667,Autosomal recessive malignant osteopetrosis,Prevalence at birth,N/A
Malformation syndrome,667,Autosomal recessive malignant osteopetrosis,Point prevalence,N/A
Malformation syndrome,2815,Spastic paraparesis-deafness syndrome,Cases/families,N/A
Malformation syndrome,2815,Spastic paraparesis-deafness syndrome,Point prevalence,N/A
Disease,2818,Spastic paraplegia-glaucoma-intellectual disability syndrome,Cases/families,N/A
Disease,2818,Spastic paraplegia-glaucoma-intellectual disability syndrome,Point prevalence,N/A
Malformation syndrome,2808,Laryngeal abductor paralysis,Cases/families,N/A
Malformation syndrome,2808,Laryngeal abductor paralysis,Point prevalence,N/A
Disease,2812,Parana hard skin syndrome,Cases/families,N/A
Disease,2812,Parana hard skin syndrome,Point prevalence,N/A
Morphological anomaly,2805,Partial pancreatic agenesis,Cases/families,N/A
Morphological anomaly,2805,Partial pancreatic agenesis,Point prevalence,N/A
Disease,254698,Epithelioid trophoblastic tumor,Point prevalence,N/A
Disease,254698,Epithelioid trophoblastic tumor,Annual incidence,N/A
Disease,254698,Epithelioid trophoblastic tumor,Lifetime Prevalence,N/A
Clinical subtype,254693,Partial hydatidiform mole,Point prevalence,N/A
Morphological anomaly,675,Annular pancreas,Prevalence at birth,N/A
Morphological anomaly,675,Annular pancreas,Prevalence at birth,N/A
Morphological anomaly,675,Annular pancreas,Prevalence at birth,N/A
Morphological anomaly,675,Annular pancreas,Prevalence at birth,N/A
Morphological anomaly,675,Annular pancreas,Prevalence at birth,N/A
Morphological anomaly,675,Annular pancreas,Prevalence at birth,N/A
Morphological anomaly,675,Annular pancreas,Prevalence at birth,N/A
Morphological anomaly,675,Annular pancreas,Prevalence at birth,N/A
Morphological anomaly,675,Annular pancreas,Prevalence at birth,N/A
Morphological anomaly,675,Annular pancreas,Prevalence at birth,N/A
Morphological anomaly,675,Annular pancreas,Prevalence at birth,N/A
Morphological anomaly,675,Annular pancreas,Prevalence at birth,N/A
Morphological anomaly,675,Annular pancreas,Prevalence at birth,N/A
Morphological anomaly,675,Annular pancreas,Prevalence at birth,N/A
Morphological anomaly,675,Annular pancreas,Prevalence at birth,N/A
Morphological anomaly,675,Annular pancreas,Point prevalence,N/A
Disease,678,Papillon-Lefvre syndrome,Point prevalence,N/A
Biological anomaly,254704,Genetic hyperferritinemia without iron overload,Point prevalence,N/A
Etiological subtype,254534,Kagami-Ogata syndrome due to maternal 14q32.2 hypermethylation,Cases/families,N/A
Etiological subtype,254534,Kagami-Ogata syndrome due to maternal 14q32.2 hypermethylation,Point prevalence,N/A
Disease,2802,X-linked sideroblastic anemia and spinocerebellar ataxia,Cases/families,N/A
Disease,2802,X-linked sideroblastic anemia and spinocerebellar ataxia,Point prevalence,N/A
Etiological subtype,254531,Temple syndrome due to paternal 14q32.2 hypomethylation,Cases/families,N/A
Etiological subtype,254531,Temple syndrome due to paternal 14q32.2 hypomethylation,Point prevalence,N/A
Clinical subtype,254688,Complete hydatidiform mole,Point prevalence,N/A
Malformation syndrome,2804,W syndrome,Cases/families,N/A
Malformation syndrome,2804,W syndrome,Point prevalence,N/A
Malformation syndrome,2491,Mllerian duct anomalies-limb anomalies syndrome,Cases/families,N/A
Malformation syndrome,2491,Mllerian duct anomalies-limb anomalies syndrome,Point prevalence,N/A
Malformation syndrome,2492,FATCO syndrome,Cases/families,N/A
Malformation syndrome,2492,FATCO syndrome,Point prevalence,N/A
Malformation syndrome,2499,Metachondromatosis,Cases/families,N/A
Malformation syndrome,2499,Metachondromatosis,Point prevalence,N/A
Malformation syndrome,2496,Mesomelia-synostoses syndrome,Cases/families,N/A
Malformation syndrome,2496,Mesomelia-synostoses syndrome,Point prevalence,N/A
Malformation syndrome,2497,"Upper limb mesomelic dysplasia, type Fryns",Cases/families,N/A
Malformation syndrome,2497,"Upper limb mesomelic dysplasia, type Fryns",Point prevalence,N/A
Malformation syndrome,2502,Metaphyseal dysostosis-intellectual disability-conductive deafness syndrome,Cases/families,N/A
Malformation syndrome,2502,Metaphyseal dysostosis-intellectual disability-conductive deafness syndrome,Point prevalence,N/A
Disease,2501,"Metaphyseal chondrodysplasia, Spahr type",Cases/families,N/A
Disease,2501,"Metaphyseal chondrodysplasia, Spahr type",Point prevalence,N/A
Malformation syndrome,2504,Metaphyseal dysplasia-maxillary hypoplasia-brachydacty syndrome,Cases/families,N/A
Malformation syndrome,2504,Metaphyseal dysplasia-maxillary hypoplasia-brachydacty syndrome,Point prevalence,N/A
Malformation syndrome,2511,Microbrachycephaly-ptosis-cleft lip syndrome,Cases/families,N/A
Malformation syndrome,2511,Microbrachycephaly-ptosis-cleft lip syndrome,Point prevalence,N/A
Malformation syndrome,2510,Micro syndrome,Cases/families,N/A
Malformation syndrome,2510,Micro syndrome,Point prevalence,N/A
Malformation syndrome,2508,Corpus callosum agenesis-abnormal genitalia syndrome,Point prevalence,N/A
Malformation syndrome,2516,Microcephaly-cardiac defect-lung malsegmentation syndrome,Cases/families,N/A
Malformation syndrome,2516,Microcephaly-cardiac defect-lung malsegmentation syndrome,Point prevalence,N/A
Malformation syndrome,2515,Microcephaly-cardiomyopathy syndrome,Cases/families,N/A
Malformation syndrome,2515,Microcephaly-cardiomyopathy syndrome,Point prevalence,N/A
Malformation syndrome,2513,Microcephaly-albinism-digital anomalies syndrome,Cases/families,N/A
Malformation syndrome,2513,Microcephaly-albinism-digital anomalies syndrome,Point prevalence,N/A
Malformation syndrome,2521,Microcephaly-cleft palate-abnormal retinal pigmentation syndrome,Cases/families,N/A
Malformation syndrome,2521,Microcephaly-cleft palate-abnormal retinal pigmentation syndrome,Point prevalence,N/A
Malformation syndrome,2524,Pontocerebellar hypoplasia type 2,Cases/families,N/A
Malformation syndrome,2524,Pontocerebellar hypoplasia type 2,Point prevalence,N/A
Malformation syndrome,2523,Microcephaly-brain defect-spasticity-hypernatremia syndrome,Cases/families,N/A
Malformation syndrome,2523,Microcephaly-brain defect-spasticity-hypernatremia syndrome,Point prevalence,N/A
Malformation syndrome,2522,Microcephaly-cervical spine fusion anomalies syndrome,Cases/families,N/A
Malformation syndrome,2522,Microcephaly-cervical spine fusion anomalies syndrome,Point prevalence,N/A
Malformation syndrome,2526,Microcephaly-lymphedema-chorioretinopathy syndrome,Cases/families,N/A
Malformation syndrome,2526,Microcephaly-lymphedema-chorioretinopathy syndrome,Point prevalence,N/A
Malformation syndrome,2528,"Microcephaly-microcornea syndrome, Seemanova type",Cases/families,N/A
Malformation syndrome,2528,"Microcephaly-microcornea syndrome, Seemanova type",Point prevalence,N/A
Malformation syndrome,2533,Microcephaly-deafness-intellectual disability syndrome,Cases/families,N/A
Malformation syndrome,2533,Microcephaly-deafness-intellectual disability syndrome,Point prevalence,N/A
Malformation syndrome,2536,Microcornea-glaucoma-absent frontal sinuses syndrome,Cases/families,N/A
Malformation syndrome,2536,Microcornea-glaucoma-absent frontal sinuses syndrome,Point prevalence,N/A
Malformation syndrome,2551,Microspherophakia-metaphyseal dysplasia syndrome,Point prevalence,N/A
Malformation syndrome,2554,Ear-patella-short stature syndrome,Cases/families,N/A
Malformation syndrome,2554,Ear-patella-short stature syndrome,Point prevalence,N/A
Malformation syndrome,2556,Microphthalmia with linear skin defects syndrome,Cases/families,N/A
Malformation syndrome,2556,Microphthalmia with linear skin defects syndrome,Point prevalence,N/A
Malformation syndrome,2558,Mikati-Najjar-Sahli syndrome,Cases/families,N/A
Malformation syndrome,2558,Mikati-Najjar-Sahli syndrome,Point prevalence,N/A
Malformation syndrome,2557,Mietens syndrome,Cases/families,N/A
Malformation syndrome,2557,Mietens syndrome,Point prevalence,N/A
Malformation syndrome,2561,Pyramidal molars-abnormal upper lip syndrome,Cases/families,N/A
Malformation syndrome,2561,Pyramidal molars-abnormal upper lip syndrome,Point prevalence,N/A
Malformation syndrome,2560,Moebius syndrome-axonal neuropathy-hypogonadotropic hypogonadism syndrome,Cases/families,N/A
Malformation syndrome,2560,Moebius syndrome-axonal neuropathy-hypogonadotropic hypogonadism syndrome,Point prevalence,N/A
Malformation syndrome,2564,Tetramelic monodactyly,Point prevalence,N/A
Malformation syndrome,2563,MOMO syndrome,Cases/families,N/A
Malformation syndrome,2563,MOMO syndrome,Point prevalence,N/A
Malformation syndrome,2565,Mononen-Karnes-Senac syndrome,Cases/families,N/A
Malformation syndrome,2565,Mononen-Karnes-Senac syndrome,Point prevalence,N/A
Malformation syndrome,2574,Moynahan syndrome,Cases/families,N/A
Malformation syndrome,2574,Moynahan syndrome,Point prevalence,N/A
Disease,575,Muckle-Wells syndrome,Cases/families,N/A
Disease,575,Muckle-Wells syndrome,Point prevalence,N/A
Disease,2572,Spastic ataxia-corneal dystrophy syndrome,Cases/families,N/A
Disease,2572,Spastic ataxia-corneal dystrophy syndrome,Point prevalence,N/A
Disease,2573,Moyamoya disease,Annual incidence,N/A
Disease,2573,Moyamoya disease,Point prevalence,N/A
Disease,2573,Moyamoya disease,Annual incidence,N/A
Disease,2573,Moyamoya disease,Point prevalence,N/A
Disease,2573,Moyamoya disease,Annual incidence,N/A
Disease,2573,Moyamoya disease,Point prevalence,N/A
Disease,2573,Moyamoya disease,Annual incidence,N/A
Disease,2573,Moyamoya disease,Point prevalence,N/A
Disease,2573,Moyamoya disease,Annual incidence,N/A
Disease,2573,Moyamoya disease,Point prevalence,N/A
Malformation syndrome,2570,Lethal intrauterine growth restriction-cortical malformation-congenital contractures syndrome,Cases/families,N/A
Malformation syndrome,2570,Lethal intrauterine growth restriction-cortical malformation-congenital contractures syndrome,Point prevalence,N/A
Disease,2571,X-linked immunoneurologic disorder,Cases/families,N/A
Disease,2571,X-linked immunoneurologic disorder,Point prevalence,N/A
Malformation syndrome,261183,15q11.2 microdeletion syndrome,Cases/families,N/A
Malformation syndrome,261183,15q11.2 microdeletion syndrome,Point prevalence,N/A
Clinical subtype,261144,FOXG1 syndrome due to 14q12 microdeletion,Cases/families,N/A
Clinical subtype,261144,FOXG1 syndrome due to 14q12 microdeletion,Point prevalence,N/A
Malformation syndrome,261120,14q11.2 microdeletion syndrome,Cases/families,N/A
Malformation syndrome,261120,14q11.2 microdeletion syndrome,Point prevalence,N/A
Clinical subtype,2578,Mayer-Rokitansky-Kster-Hauser syndrome type 2,Prevalence at birth,N/A
Clinical subtype,2578,Mayer-Rokitansky-Kster-Hauser syndrome type 2,Point prevalence,N/A
Disease,2579,Muscular atrophy-ataxia-retinitis pigmentosa-diabetes mellitus syndrome,Cases/families,N/A
Disease,2579,Muscular atrophy-ataxia-retinitis pigmentosa-diabetes mellitus syndrome,Point prevalence,N/A
Malformation syndrome,261102,Distal 7q11.23 microduplication syndrome,Cases/families,N/A
Malformation syndrome,261102,Distal 7q11.23 microduplication syndrome,Point prevalence,N/A
Malformation syndrome,2576,Mulibrey nanism,Cases/families,N/A
Malformation syndrome,2576,Mulibrey nanism,Point prevalence,N/A
Malformation syndrome,2576,Mulibrey nanism,Annual incidence,N/A
Malformation syndrome,261236,16p13.11 microdeletion syndrome,Prevalence at birth,N/A
Malformation syndrome,261236,16p13.11 microdeletion syndrome,Point prevalence,N/A
Malformation syndrome,261243,16p13.11 microduplication syndrome,Cases/families,N/A
Malformation syndrome,261243,16p13.11 microduplication syndrome,Point prevalence,N/A
Malformation syndrome,2608,N syndrome,Cases/families,N/A
Malformation syndrome,2608,N syndrome,Point prevalence,N/A
Malformation syndrome,261222,Distal 16p11.2 microdeletion syndrome,Point prevalence,N/A
Disease,1359,Carney complex,Cases/families,N/A
Disease,1359,Carney complex,Point prevalence,N/A
Malformation syndrome,261229,14q11.2 microduplication syndrome,Cases/families,N/A
Malformation syndrome,261229,14q11.2 microduplication syndrome,Point prevalence,N/A
Disease,2590,Spinal muscular atrophy-progressive myoclonic epilepsy syndrome,Cases/families,N/A
Disease,2590,Spinal muscular atrophy-progressive myoclonic epilepsy syndrome,Point prevalence,N/A
Malformation syndrome,261204,16p11.2p12.2 microduplication syndrome,Point prevalence,N/A
Malformation syndrome,261204,16p11.2p12.2 microduplication syndrome,Cases/families,N/A
Malformation syndrome,261211,16p11.2p12.2 microdeletion syndrome,Cases/families,N/A
Malformation syndrome,261211,16p11.2p12.2 microdeletion syndrome,Point prevalence,N/A
Malformation syndrome,2589,Myoclonus-cerebellar ataxia-deafness syndrome,Cases/families,N/A
Malformation syndrome,2589,Myoclonus-cerebellar ataxia-deafness syndrome,Point prevalence,N/A
Clinical subtype,261190,Cleft palate-congenital heart defect-intellectual disability syndrome due to 15q14 microdeletion,Cases/families,N/A
Clinical subtype,261190,Cleft palate-congenital heart defect-intellectual disability syndrome due to 15q14 microdeletion,Point prevalence,N/A
Malformation syndrome,2588,Myhre syndrome,Point prevalence,N/A
Malformation syndrome,261197,Proximal 16p11.2 microdeletion syndrome,Point prevalence,N/A
Malformation syndrome,261197,Proximal 16p11.2 microdeletion syndrome,Point prevalence,N/A
Malformation syndrome,261295,20p12.3 microdeletion syndrome,Cases/families,N/A
Malformation syndrome,261295,20p12.3 microdeletion syndrome,Point prevalence,N/A
Malformation syndrome,261304,Paternal 20q13.2q13.3 microdeletion syndrome,Cases/families,N/A
Malformation syndrome,261304,Paternal 20q13.2q13.3 microdeletion syndrome,Point prevalence,N/A
Malformation syndrome,261279,17q23.1q23.2 microdeletion syndrome,Cases/families,N/A
Malformation syndrome,261279,17q23.1q23.2 microdeletion syndrome,Point prevalence,N/A
Malformation syndrome,261290,Trisomy 17p syndrome,Point prevalence,N/A
Malformation syndrome,2617,"Microcephalic primordial dwarfism, Montreal type",Cases/families,N/A
Malformation syndrome,2617,"Microcephalic primordial dwarfism, Montreal type",Point prevalence,N/A
Malformation syndrome,261265,17q12 microdeletion syndrome,Point prevalence,N/A
Malformation syndrome,261265,17q12 microdeletion syndrome,Point prevalence,N/A
Malformation syndrome,261265,17q12 microdeletion syndrome,Cases/families,N/A
Malformation syndrome,261272,17q12 microduplication syndrome,Cases/families,N/A
Malformation syndrome,261272,17q12 microduplication syndrome,Point prevalence,N/A
Malformation syndrome,261272,17q12 microduplication syndrome,Point prevalence,N/A
Malformation syndrome,2616,3M syndrome,Cases/families,N/A
Malformation syndrome,2616,3M syndrome,Point prevalence,N/A
Malformation syndrome,261250,16q24.3 microdeletion syndrome,Cases/families,N/A
Malformation syndrome,261250,16q24.3 microdeletion syndrome,Point prevalence,N/A
Disease,2613,Nail-patella-like renal disease,Cases/families,N/A
Disease,2613,Nail-patella-like renal disease,Point prevalence,N/A
Malformation syndrome,261257,Distal 17p13.3 microdeletion syndrome,Cases/families,N/A
Malformation syndrome,261257,Distal 17p13.3 microdeletion syndrome,Point prevalence,N/A
Malformation syndrome,261344,Trisomy 1q syndrome,Cases/families,N/A
Malformation syndrome,261344,Trisomy 1q syndrome,Point prevalence,N/A
Malformation syndrome,261337,Distal 22q11.2 microduplication syndrome,Point prevalence,N/A
Disease,261476,Xp21 deletion syndrome,Point prevalence,N/A
Disease,261476,Xp21 deletion syndrome,Cases/families,N/A
Malformation syndrome,261349,2p15p16.1 microdeletion syndrome,Cases/families,N/A
Malformation syndrome,261349,2p15p16.1 microdeletion syndrome,Point prevalence,N/A
Malformation syndrome,261318,Trisomy 20p syndrome,Point prevalence,N/A
Malformation syndrome,261311,20q13.33 microdeletion syndrome,Point prevalence,N/A
Malformation syndrome,2623,Geleophysic dysplasia,Cases/families,N/A
Malformation syndrome,2623,Geleophysic dysplasia,Point prevalence,N/A
Malformation syndrome,261330,Distal 22q11.2 microdeletion syndrome,Point prevalence,N/A
Malformation syndrome,261323,21q22.11q22.12 microdeletion syndrome,Cases/families,N/A
Malformation syndrome,261323,21q22.11q22.12 microdeletion syndrome,Point prevalence,N/A
Malformation syndrome,261524,Paternal uniparental disomy of chromosome X syndrome,Point prevalence,N/A
Malformation syndrome,261519,Maternal uniparental disomy of chromosome X syndrome,Point prevalence,N/A
Malformation syndrome,261534,"49,XXXYY syndrome",Cases/families,N/A
Malformation syndrome,261534,"49,XXXYY syndrome",Point prevalence,N/A
Malformation syndrome,261529,Ring chromosome Y syndrome,Point prevalence,N/A
Malformation syndrome,2631,Mesomelic dwarfism-cleft palate-camptodactyly syndrome,Cases/families,N/A
Malformation syndrome,2631,Mesomelic dwarfism-cleft palate-camptodactyly syndrome,Point prevalence,N/A
Malformation syndrome,261494,Kleefstra syndrome,Cases/families,N/A
Malformation syndrome,261494,Kleefstra syndrome,Point prevalence,N/A
Malformation syndrome,261483,Xq27.3q28 duplication syndrome,Cases/families,N/A
Malformation syndrome,261483,Xq27.3q28 duplication syndrome,Point prevalence,N/A
Malformation syndrome,2632,Langer mesomelic dysplasia,Cases/families,N/A
Malformation syndrome,2632,Langer mesomelic dysplasia,Point prevalence,N/A
Malformation syndrome,261501,Atypical Norrie disease due to Xp11.3 microdeletion,Point prevalence,N/A
Malformation syndrome,2634,"Mesomelic dwarfism, Reinhardt-Pfeiffer type",Point prevalence,N/A
Malformation syndrome,2645,Osteoglosphonic dysplasia,Cases/families,N/A
Malformation syndrome,2645,Osteoglosphonic dysplasia,Point prevalence,N/A
Etiological subtype,261600,Alagille syndrome due to 20p12 microdeletion,Point prevalence,N/A
Malformation syndrome,2643,"Microcephalic primordial dwarfism, Toriello type",Cases/families,N/A
Malformation syndrome,2643,"Microcephalic primordial dwarfism, Toriello type",Point prevalence,N/A
Malformation syndrome,2636,Microcephalic osteodysplastic primordial dwarfism types I and III,Cases/families,N/A
Malformation syndrome,2636,Microcephalic osteodysplastic primordial dwarfism types I and III,Point prevalence,N/A
Malformation syndrome,2658,Lenz-Majewski hyperostotic dwarfism,Cases/families,N/A
Malformation syndrome,2658,Lenz-Majewski hyperostotic dwarfism,Point prevalence,N/A
Etiological subtype,261638,Okihiro syndrome due to 20q13 microdeletion,Point prevalence,N/A
Etiological subtype,261652,Kleefstra syndrome due to a point mutation,Cases/families,N/A
Etiological subtype,261652,Kleefstra syndrome due to a point mutation,Point prevalence,N/A
Malformation syndrome,264200,14q22q23 microdeletion syndrome,Cases/families,N/A
Malformation syndrome,264200,14q22q23 microdeletion syndrome,Point prevalence,N/A
Disease,3057,Monoamine oxidase A deficiency,Point prevalence,N/A
Malformation syndrome,3055,X-linked intellectual disability-hypogonadism-ichthyosis-obesity-short stature syndrome,Cases/families,N/A
Malformation syndrome,3055,X-linked intellectual disability-hypogonadism-ichthyosis-obesity-short stature syndrome,Point prevalence,N/A
Disease,3052,X-linked intellectual disability-seizures-psoriasis syndrome,Cases/families,N/A
Disease,3052,X-linked intellectual disability-seizures-psoriasis syndrome,Point prevalence,N/A
Malformation syndrome,3047,"Blepharophimosis-intellectual disability syndrome, SBBYS type",Cases/families,N/A
Malformation syndrome,3047,"Blepharophimosis-intellectual disability syndrome, SBBYS type",Point prevalence,N/A
Malformation syndrome,3044,Intellectual disability-dysmorphism-hypogonadism-diabetes mellitus syndrome,Cases/families,N/A
Malformation syndrome,3044,Intellectual disability-dysmorphism-hypogonadism-diabetes mellitus syndrome,Point prevalence,N/A
Malformation syndrome,3042,Intellectual disability-cataracts-calcified pinnae-myopathy syndrome,Cases/families,N/A
Malformation syndrome,3042,Intellectual disability-cataracts-calcified pinnae-myopathy syndrome,Point prevalence,N/A
Malformation syndrome,3041,Intellectual disability-balding-patella luxation-acromicria syndrome,Cases/families,N/A
Malformation syndrome,3041,Intellectual disability-balding-patella luxation-acromicria syndrome,Point prevalence,N/A
Malformation syndrome,3038,Delayed speech-facial asymmetry-strabismus-ear lobe creases syndrome,Cases/families,N/A
Malformation syndrome,3038,Delayed speech-facial asymmetry-strabismus-ear lobe creases syndrome,Point prevalence,N/A
Disease,263665,NK-cell enteropathy,Cases/families,N/A
Disease,263665,NK-cell enteropathy,Point prevalence,N/A
Malformation syndrome,3035,Growth delay-hydrocephaly-lung hypoplasia syndrome,Cases/families,N/A
Malformation syndrome,3035,Growth delay-hydrocephaly-lung hypoplasia syndrome,Point prevalence,N/A
Disease,263662,Familial multiple meningioma,Point prevalence,N/A
Malformation syndrome,3034,Delayed membranous cranial ossification,Cases/families,N/A
Malformation syndrome,3034,Delayed membranous cranial ossification,Point prevalence,N/A
Clinical subtype,263548,Peeling skin syndrome type A,Cases/families,N/A
Clinical subtype,263548,Peeling skin syndrome type A,Point prevalence,N/A
Malformation syndrome,3033,Renal tubular dysgenesis,Point prevalence,N/A
Malformation syndrome,3033,Renal tubular dysgenesis,Prevalence at birth,N/A
Clinical subtype,263553,Peeling skin syndrome type B,Cases/families,N/A
Clinical subtype,263553,Peeling skin syndrome type B,Point prevalence,N/A
Malformation syndrome,3032,NPHP3-related Meckel-like syndrome,Cases/families,N/A
Malformation syndrome,3032,NPHP3-related Meckel-like syndrome,Point prevalence,N/A
Disease,263534,Acral peeling skin syndrome,Cases/families,N/A
Disease,263534,Acral peeling skin syndrome,Point prevalence,N/A
Disease,263543,Generalized peeling skin syndrome,Point prevalence,N/A
Disease,263516,Progressive myoclonic epilepsy type 3,Cases/families,N/A
Disease,263516,Progressive myoclonic epilepsy type 3,Point prevalence,N/A
Disease,263524,Acute necrotizing encephalopathy of childhood,Point prevalence,N/A
Disease,263501,COG4-CDG,Cases/families,N/A
Disease,263501,COG4-CDG,Point prevalence,N/A
Malformation syndrome,3026,Radial ray hypoplasia-choanal atresia syndrome,Point prevalence,N/A
Malformation syndrome,3026,Radial ray hypoplasia-choanal atresia syndrome,Cases/families,N/A
Disease,263508,COG1-CDG,Cases/families,N/A
Disease,263508,COG1-CDG,Point prevalence,N/A
Disease,263482,"Spondyloepimetaphyseal dysplasia, Maroteaux type",Cases/families,N/A
Disease,263482,"Spondyloepimetaphyseal dysplasia, Maroteaux type",Point prevalence,N/A
Malformation syndrome,3021,RAPADILINO syndrome,Cases/families,N/A
Malformation syndrome,3021,RAPADILINO syndrome,Point prevalence,N/A
Disease,263479,Fuchs heterochromic iridocyclitis,Annual incidence,N/A
Disease,263479,Fuchs heterochromic iridocyclitis,Point prevalence,N/A
Disease,263479,Fuchs heterochromic iridocyclitis,Point prevalence,N/A
Disease,263494,DPM3-CDG,Cases/families,N/A
Disease,263494,DPM3-CDG,Point prevalence,N/A
Malformation syndrome,3023,External auditory canal atresia-vertical talus-hypertelorism syndrome,Cases/families,N/A
Malformation syndrome,3023,External auditory canal atresia-vertical talus-hypertelorism syndrome,Point prevalence,N/A
Disease,263487,COG5-CDG,Cases/families,N/A
Disease,263487,COG5-CDG,Point prevalence,N/A
Disease,263458,Hyperinsulinism due to INSR deficiency,Cases/families,N/A
Disease,263458,Hyperinsulinism due to INSR deficiency,Point prevalence,N/A
Disease,263455,Congenital hyperinsulinism due to HNF4A deficiency,Point prevalence,N/A
Malformation syndrome,1832,Osteosclerotic bone dysplasia,Cases/families,N/A
Malformation syndrome,1832,Osteosclerotic bone dysplasia,Point prevalence,N/A
Malformation syndrome,3018,Retinal ischemic syndrome-digestive tract small vessel hyalinosis-diffuse cerebral calcifications syndrome,Cases/families,N/A
Malformation syndrome,3018,Retinal ischemic syndrome-digestive tract small vessel hyalinosis-diffuse cerebral calcifications syndrome,Point prevalence,N/A
Malformation syndrome,3019,Ramon syndrome,Cases/families,N/A
Malformation syndrome,3019,Ramon syndrome,Point prevalence,N/A
Disease,263463,CHST3-related skeletal dysplasia,Cases/families,N/A
Disease,263463,CHST3-related skeletal dysplasia,Point prevalence,N/A
Disease,263432,Nevus of Ito,Point prevalence,N/A
Disease,263432,Nevus of Ito,Point prevalence,N/A
Disease,263425,Nevus of Ota,Point prevalence,N/A
Malformation syndrome,3015,Radio-renal syndrome,Cases/families,N/A
Malformation syndrome,3015,Radio-renal syndrome,Point prevalence,N/A
Clinical group,263440,Neuroacanthocytosis,Point prevalence,N/A
Disease,263435,Congenital smooth muscle hamartoma,Prevalence at birth,N/A
Disease,263435,Congenital smooth muscle hamartoma,Point prevalence,N/A
Malformation syndrome,3016,Absent radius-anogenital anomalies syndrome,Cases/families,N/A
Malformation syndrome,3016,Absent radius-anogenital anomalies syndrome,Point prevalence,N/A
Disease,263410,Infantile spasms-psychomotor retardation-progressive brain atrophy-basal ganglia disease syndrome,Cases/families,N/A
Disease,263410,Infantile spasms-psychomotor retardation-progressive brain atrophy-basal ganglia disease syndrome,Point prevalence,N/A
Disease,3010,Qazi-Markouizos syndrome,Cases/families,N/A
Disease,3010,Qazi-Markouizos syndrome,Point prevalence,N/A
Disease,3011,Spastic tetraplegia-retinitis pigmentosa-intellectual disability syndrome,Cases/families,N/A
Disease,3011,Spastic tetraplegia-retinitis pigmentosa-intellectual disability syndrome,Point prevalence,N/A
Malformation syndrome,769,Rabson-Mendenhall syndrome,Point prevalence,N/A
Disease,263413,Angiosarcoma,Annual incidence,N/A
Disease,263413,Angiosarcoma,Lifetime Prevalence,N/A
Disease,263413,Angiosarcoma,Point prevalence,N/A
Malformation syndrome,3003,Pyknoachondrogenesis,Cases/families,N/A
Malformation syndrome,3003,Pyknoachondrogenesis,Point prevalence,N/A
Histopathological subtype,263335,Moderately-differentiated thymic neuroendocrine carcinoma,Point prevalence,N/A
Histopathological subtype,263339,Poorly differentiated thymic neuroendocrine carcinoma,Point prevalence,N/A
Disease,3005,Pyle disease,Cases/families,N/A
Disease,3005,Pyle disease,Point prevalence,N/A
Disease,263347,MRCS syndrome,Cases/families,N/A
Disease,263347,MRCS syndrome,Point prevalence,N/A
Particular clinical situation in a disease or syndrome,263352,Postcardiotomy right ventricular failure,Point prevalence,N/A
Malformation syndrome,3004,Mirror polydactyly-vertebral segmentation-limbs defects syndrome,Prevalence at birth,N/A
Malformation syndrome,3004,Mirror polydactyly-vertebral segmentation-limbs defects syndrome,Point prevalence,N/A
Histopathological subtype,263310,Thymoma type A,Annual incidence,N/A
Histopathological subtype,263310,Thymoma type A,Point prevalence,N/A
Malformation syndrome,2997,Ptosis-vocal cord paralysis syndrome,Cases/families,N/A
Malformation syndrome,2997,Ptosis-vocal cord paralysis syndrome,Point prevalence,N/A
Histopathological subtype,263317,Thymoma type B,Annual incidence,N/A
Histopathological subtype,263317,Thymoma type B,Point prevalence,N/A
Histopathological subtype,263324,Thymoma type AB,Annual incidence,N/A
Histopathological subtype,263324,Thymoma type AB,Point prevalence,N/A
Malformation syndrome,2999,Ptosis-strabismus-ectopic pupils syndrome,Cases/families,N/A
Malformation syndrome,2999,Ptosis-strabismus-ectopic pupils syndrome,Point prevalence,N/A
Histopathological subtype,263331,Well-differentiated thymic neuroendocrine carcinoma,Point prevalence,N/A
Malformation syndrome,2990,Autosomal recessive multiple pterygium syndrome,Point prevalence,N/A
Malformation syndrome,2990,Autosomal recessive multiple pterygium syndrome,Cases/families,N/A
Disease,263297,Glycogen storage disease with severe cardiomyopathy due to glycogenin deficiency,Cases/families,N/A
Disease,263297,Glycogen storage disease with severe cardiomyopathy due to glycogenin deficiency,Point prevalence,N/A
Malformation syndrome,2987,Antecubital pterygium syndrome,Cases/families,N/A
Malformation syndrome,2987,Antecubital pterygium syndrome,Point prevalence,N/A
Malformation syndrome,2985,Pseudoprogeria syndrome,Cases/families,N/A
Malformation syndrome,2985,Pseudoprogeria syndrome,Point prevalence,N/A
Malformation syndrome,2988,Pterygium colli-intellectual disability-digital anomalies syndrome,Cases/families,N/A
Malformation syndrome,2988,Pterygium colli-intellectual disability-digital anomalies syndrome,Point prevalence,N/A
Malformation syndrome,3138,Ulnar-mammary syndrome,Cases/families,N/A
Malformation syndrome,3138,Ulnar-mammary syndrome,Point prevalence,N/A
Disease,3145,Arginine vasopressin resistance-intracranial calcification-short stature-facial dysmorphism syndrome,Cases/families,N/A
Disease,3145,Arginine vasopressin resistance-intracranial calcification-short stature-facial dysmorphism syndrome,Point prevalence,N/A
Disease,3143,Autoimmune polyendocrinopathy type 2,Point prevalence,N/A
Malformation syndrome,3144,Schneckenbecken dysplasia,Point prevalence,N/A
Malformation syndrome,3132,Say-Barber-Miller syndrome,Cases/families,N/A
Malformation syndrome,3132,Say-Barber-Miller syndrome,Point prevalence,N/A
Disease,3130,Satoyoshi syndrome,Cases/families,N/A
Disease,3130,Satoyoshi syndrome,Point prevalence,N/A
Malformation syndrome,798,Schinzel-Giedion syndrome,Point prevalence,N/A
Malformation syndrome,798,Schinzel-Giedion syndrome,Prevalence at birth,N/A
Malformation syndrome,798,Schinzel-Giedion syndrome,Cases/families,N/A
Category,262941,Partial duplication of the long arm of chromosome 14 syndrome,Cases/families,N/A
Category,262941,Partial duplication of the long arm of chromosome 14 syndrome,Point prevalence,N/A
Malformation syndrome,3134,SCARF syndrome,Cases/families,N/A
Malformation syndrome,3134,SCARF syndrome,Point prevalence,N/A
Malformation syndrome,3121,Ruvalcaba syndrome,Point prevalence,N/A
Disease,2909,Rothmund-Thomson syndrome,Cases/families,N/A
Disease,2909,Rothmund-Thomson syndrome,Point prevalence,N/A
Disease,3110,Rombo syndrome,Point prevalence,N/A
Malformation syndrome,3101,Richieri Costa-da Silva syndrome,Cases/families,N/A
Malformation syndrome,3101,Richieri Costa-da Silva syndrome,Point prevalence,N/A
Malformation syndrome,3102,Richieri Costa-Pereira syndrome,Cases/families,N/A
Malformation syndrome,3102,Richieri Costa-Pereira syndrome,Point prevalence,N/A
Malformation syndrome,3104,Robin sequence-oligodactyly syndrome,Cases/families,N/A
Malformation syndrome,3104,Robin sequence-oligodactyly syndrome,Point prevalence,N/A
Clinical subtype,3107,Autosomal dominant Robinow syndrome,Cases/families,N/A
Clinical subtype,3107,Autosomal dominant Robinow syndrome,Point prevalence,N/A
Malformation syndrome,3109,Mayer-Rokitansky-Kster-Hauser syndrome,Prevalence at birth,N/A
Malformation syndrome,3109,Mayer-Rokitansky-Kster-Hauser syndrome,Point prevalence,N/A
Disease,3086,Autosomal dominant vitreoretinochoroidopathy,Cases/families,N/A
Disease,3086,Autosomal dominant vitreoretinochoroidopathy,Point prevalence,N/A
Malformation syndrome,3088,Revesz syndrome,Cases/families,N/A
Malformation syndrome,3088,Revesz syndrome,Point prevalence,N/A
Malformation syndrome,3097,Meacham syndrome,Cases/families,N/A
Malformation syndrome,3097,Meacham syndrome,Point prevalence,N/A
Malformation syndrome,3098,"Rhizomelic syndrome, Urbach type",Cases/families,N/A
Malformation syndrome,3098,"Rhizomelic syndrome, Urbach type",Point prevalence,N/A
Malformation syndrome,3078,"Severe X-linked intellectual disability, Gustavson type",Cases/families,N/A
Malformation syndrome,3078,"Severe X-linked intellectual disability, Gustavson type",Point prevalence,N/A
Malformation syndrome,3077,X-linked intellectual disability-psychosis-macroorchidism syndrome,Cases/families,N/A
Malformation syndrome,3077,X-linked intellectual disability-psychosis-macroorchidism syndrome,Point prevalence,N/A
Malformation syndrome,3080,"Intellectual disability, Wolff type",Cases/families,N/A
Malformation syndrome,3080,"Intellectual disability, Wolff type",Point prevalence,N/A
Malformation syndrome,3079,"Intellectual disability, Buenos-Aires type",Cases/families,N/A
Malformation syndrome,3079,"Intellectual disability, Buenos-Aires type",Point prevalence,N/A
Disease,3063,"X-linked intellectual disability, Snyder type",Cases/families,N/A
Disease,3063,"X-linked intellectual disability, Snyder type",Point prevalence,N/A
Disease,3068,Intellectual disability-myopathy-short stature-endocrine defect syndrome,Cases/families,N/A
Disease,3068,Intellectual disability-myopathy-short stature-endocrine defect syndrome,Point prevalence,N/A
Category,268843,"Malformation of the neurenteric canal, spinal cord and column",Point prevalence,N/A
Malformation syndrome,2886,TARP syndrome,Cases/families,N/A
Malformation syndrome,2886,TARP syndrome,Point prevalence,N/A
Morphological anomaly,268861,Primary tethered cord syndrome,Point prevalence,N/A
Malformation syndrome,2885,Piebald trait-neurologic defects syndrome,Cases/families,N/A
Malformation syndrome,2885,Piebald trait-neurologic defects syndrome,Point prevalence,N/A
Disease,2884,Piebaldism,Point prevalence,N/A
Disease,2881,Cutaneous photosensitivity-lethal colitis syndrome,Cases/families,N/A
Disease,2881,Cutaneous photosensitivity-lethal colitis syndrome,Point prevalence,N/A
Malformation syndrome,2879,"Phocomelia, Schinzel type",Point prevalence,N/A
Clinical subtype,268826,Parietal encephalocele,Point prevalence,N/A
Clinical subtype,268829,Basal encephalocele,Point prevalence,N/A
Clinical subtype,268920,Isolated megalencephaly,Point prevalence,N/A
Morphological anomaly,268882,Arnold-Chiari malformation type I,Point prevalence,N/A
Malformation syndrome,2892,Pilodental dysplasia-refractive errors syndrome,Cases/families,N/A
Malformation syndrome,2892,Pilodental dysplasia-refractive errors syndrome,Point prevalence,N/A
Malformation syndrome,2891,Pili torti-developmental delay-neurological abnormalities syndrome,Cases/families,N/A
Malformation syndrome,2891,Pili torti-developmental delay-neurological abnormalities syndrome,Point prevalence,N/A
Disease,2889,Pili torti,Point prevalence,N/A
Malformation syndrome,2890,Pili torti-onychodysplasia syndrome,Cases/families,N/A
Malformation syndrome,2890,Pili torti-onychodysplasia syndrome,Point prevalence,N/A
Morphological anomaly,268865,Neurenteric cyst,Point prevalence,N/A
Malformation syndrome,2888,Pierre Robin syndrome-faciodigital anomaly syndrome,Cases/families,N/A
Malformation syndrome,2888,Pierre Robin syndrome-faciodigital anomaly syndrome,Point prevalence,N/A
Morphological anomaly,268868,Isolated amyelia,Point prevalence,N/A
Malformation syndrome,2865,Short stature-webbed neck-heart disease syndrome,Cases/families,N/A
Malformation syndrome,2865,Short stature-webbed neck-heart disease syndrome,Point prevalence,N/A
Malformation syndrome,2866,Short stature-deafness-neutrophil dysfunction-dysmorphism syndrome,Cases/families,N/A
Malformation syndrome,2866,Short stature-deafness-neutrophil dysfunction-dysmorphism syndrome,Point prevalence,N/A
Malformation syndrome,2863,Short stature-wormian bones-dextrocardia syndrome,Cases/families,N/A
Malformation syndrome,2863,Short stature-wormian bones-dextrocardia syndrome,Point prevalence,N/A
Clinical group,268744,Spinal dysraphism with a posterior meningocele,Prevalence at birth,N/A
Clinical group,268744,Spinal dysraphism with a posterior meningocele,Point prevalence,N/A
Clinical subtype,268823,Occipital encephalocele,Point prevalence,N/A
Malformation syndrome,2876,PHAVER syndrome,Cases/families,N/A
Malformation syndrome,2876,PHAVER syndrome,Point prevalence,N/A
Morphological anomaly,268820,Cranial meningocele,Point prevalence,N/A
Clinical group,268817,Cephalocele,Point prevalence,N/A
Malformation syndrome,2874,Phakomatosis pigmentokeratotica,Point prevalence,N/A
Malformation syndrome,2874,Phakomatosis pigmentokeratotica,Cases/families,N/A
Clinical group,268813,Myelocystocele,Point prevalence,N/A
Morphological anomaly,268810,Isolated posterior meningocele,Point prevalence,N/A
Malformation syndrome,2871,Pfeiffer-Palm-Teller syndrome,Cases/families,N/A
Malformation syndrome,2871,Pfeiffer-Palm-Teller syndrome,Point prevalence,N/A
Malformation syndrome,2872,"Cardiocranial syndrome, Pfeiffer type",Cases/families,N/A
Malformation syndrome,2872,"Cardiocranial syndrome, Pfeiffer type",Point prevalence,N/A
Malformation syndrome,2867,"Short stature, Brussels type",Cases/families,N/A
Malformation syndrome,2867,"Short stature, Brussels type",Point prevalence,N/A
Malformation syndrome,2868,Short stature-valvular heart disease-characteristic facies syndrome,Cases/families,N/A
Malformation syndrome,2868,Short stature-valvular heart disease-characteristic facies syndrome,Point prevalence,N/A
Category,2846,Congenital pericardium anomaly,Point prevalence,N/A
Morphological anomaly,2842,Penoscrotal transposition,Point prevalence,N/A
Disease,2848,Camptodactyly-arthropathy-coxa-vara-pericarditis syndrome,Cases/families,N/A
Disease,2848,Camptodactyly-arthropathy-coxa-vara-pericarditis syndrome,Point prevalence,N/A
Malformation syndrome,2847,Pericardial and diaphragmatic defect,Cases/families,N/A
Malformation syndrome,2847,Pericardial and diaphragmatic defect,Point prevalence,N/A
Category,268357,Neural tube closure defect,Point prevalence,N/A
Malformation syndrome,2838,Renal caliceal diverticuli-deafness syndrome,Cases/families,N/A
Malformation syndrome,2838,Renal caliceal diverticuli-deafness syndrome,Point prevalence,N/A
Disease,268322,Hereditary thrombocytopenia with normal platelets,Point prevalence,N/A
Malformation syndrome,2840,Pelvic dysplasia-arthrogryposis of lower limbs syndrome,Cases/families,N/A
Malformation syndrome,2840,Pelvic dysplasia-arthrogryposis of lower limbs syndrome,Point prevalence,N/A
Malformation syndrome,2839,Pelvis-shoulder dysplasia,Cases/families,N/A
Malformation syndrome,2839,Pelvis-shoulder dysplasia,Point prevalence,N/A
Disease,2855,Perrault syndrome,Cases/families,N/A
Disease,2855,Perrault syndrome,Point prevalence,N/A
Malformation syndrome,2854,Fuhrmann syndrome,Cases/families,N/A
Malformation syndrome,2854,Fuhrmann syndrome,Point prevalence,N/A
Morphological anomaly,708,Peters anomaly,Cases/families,N/A
Morphological anomaly,708,Peters anomaly,Point prevalence,N/A
Clinical subtype,268363,Open iniencephaly,Point prevalence,N/A
Clinical subtype,268366,Closed iniencephaly,Point prevalence,N/A
Disease,2850,Alopecia-intellectual disability syndrome,Point prevalence,N/A
Disease,2850,Alopecia-intellectual disability syndrome,Cases/families,N/A
Clinical group,268369,Open spinal dysraphism,Prevalence at birth,N/A
Clinical group,268369,Open spinal dysraphism,Point prevalence,N/A
Clinical group,268369,Open spinal dysraphism,Prevalence at birth,N/A
Clinical group,268369,Open spinal dysraphism,Prevalence at birth,N/A
Clinical group,268369,Open spinal dysraphism,Prevalence at birth,N/A
Clinical group,268369,Open spinal dysraphism,Point prevalence,N/A
Disease,268114,RAS-associated autoimmune leukoproliferative disease,Point prevalence,N/A
Disease,268114,RAS-associated autoimmune leukoproliferative disease,Cases/families,N/A
Malformation syndrome,2825,PARC syndrome,Cases/families,N/A
Malformation syndrome,2825,PARC syndrome,Point prevalence,N/A
Disease,2826,Spastic paraplegia-precocious puberty syndrome,Cases/families,N/A
Disease,2826,Spastic paraplegia-precocious puberty syndrome,Point prevalence,N/A
Disease,268139,Intraocular medulloepithelioma,Point prevalence,N/A
Disease,268129,Spheroid body myopathy,Point prevalence,N/A
Malformation syndrome,2819,Spastic paraplegia-facial-cutaneous lesions syndrome,Cases/families,N/A
Malformation syndrome,2819,Spastic paraplegia-facial-cutaneous lesions syndrome,Point prevalence,N/A
Clinical syndrome,2820,Spastic paraplegia-nephritis-deafness syndrome,Cases/families,N/A
Clinical syndrome,2820,Spastic paraplegia-nephritis-deafness syndrome,Point prevalence,N/A
Disease,2821,Spastic paraplegia-neuropathy-poikiloderma syndrome,Cases/families,N/A
Disease,2821,Spastic paraplegia-neuropathy-poikiloderma syndrome,Point prevalence,N/A
Disease,2822,Autosomal recessive spastic paraplegia type 11,Point prevalence,N/A
Malformation syndrome,2835,Pectus excavatum-macrocephaly-dysplastic nails syndrome,Cases/families,N/A
Malformation syndrome,2835,Pectus excavatum-macrocephaly-dysplastic nails syndrome,Point prevalence,N/A
Etiological subtype,268261,DYRK1A-related intellectual disability syndrome due to 21q22.13q22.2 microdeletion,Cases/families,N/A
Etiological subtype,268261,DYRK1A-related intellectual disability syndrome due to 21q22.13q22.2 microdeletion,Point prevalence,N/A
Disease,2836,PEHO syndrome,Point prevalence,N/A
Malformation syndrome,268249,Mycophenolate mofetil embryopathy,Cases/families,N/A
Malformation syndrome,268249,Mycophenolate mofetil embryopathy,Point prevalence,N/A
Morphological anomaly,216694,Congenitally corrected transposition of the great arteries,Prevalence at birth,N/A
Morphological anomaly,216694,Congenitally corrected transposition of the great arteries,Point prevalence,N/A
Clinical subtype,216718,Isolated congenitally uncorrected transposition of the great arteries,Point prevalence,N/A
Clinical subtype,216729,Congenitally uncorrected transposition of the great arteries with cardiac malformation,Point prevalence,N/A
Malformation syndrome,3411,Double uterus-hemivagina-renal agenesis syndrome,Cases/families,N/A
Malformation syndrome,3411,Double uterus-hemivagina-renal agenesis syndrome,Point prevalence,N/A
Disease,882,Tyrosinemia type 1,Prevalence at birth,N/A
Disease,882,Tyrosinemia type 1,Prevalence at birth,N/A
Disease,882,Tyrosinemia type 1,Prevalence at birth,N/A
Disease,882,Tyrosinemia type 1,Prevalence at birth,N/A
Disease,882,Tyrosinemia type 1,Prevalence at birth,N/A
Disease,882,Tyrosinemia type 1,Prevalence at birth,N/A
Disease,882,Tyrosinemia type 1,Point prevalence,N/A
Clinical subtype,216796,Osteogenesis imperfecta type 1,Point prevalence,N/A
Clinical subtype,216796,Osteogenesis imperfecta type 1,Prevalence at birth,N/A
Disease,903,Von Willebrand disease,Point prevalence,N/A
Clinical subtype,216804,Osteogenesis imperfecta type 2,Point prevalence,N/A
Clinical subtype,216812,Osteogenesis imperfecta type 3,Point prevalence,N/A
Clinical subtype,216812,Osteogenesis imperfecta type 3,Prevalence at birth,N/A
Clinical subtype,216820,Osteogenesis imperfecta type 4,Point prevalence,N/A
Clinical subtype,216820,Osteogenesis imperfecta type 4,Prevalence at birth,N/A
Clinical subtype,216828,Osteogenesis imperfecta type 5,Cases/families,N/A
Clinical subtype,216828,Osteogenesis imperfecta type 5,Point prevalence,N/A
Malformation syndrome,3474,CHIME syndrome,Cases/families,N/A
Malformation syndrome,3474,CHIME syndrome,Point prevalence,N/A
Malformation syndrome,1441,Ring chromosome 17 syndrome,Cases/families,N/A
Malformation syndrome,1441,Ring chromosome 17 syndrome,Point prevalence,N/A
Clinical subtype,216978,"Niemann-Pick disease type C, late infantile neurologic onset",Point prevalence,N/A
Disease,361,Familial glucocorticoid deficiency,Point prevalence,N/A
Disease,361,Familial glucocorticoid deficiency,Point prevalence,N/A
Clinical subtype,216975,"Niemann-Pick disease type C, severe early infantile neurologic onset",Point prevalence,N/A
Malformation syndrome,1787,"Acrofacial dysostosis, Palagonia type",Cases/families,N/A
Malformation syndrome,1787,"Acrofacial dysostosis, Palagonia type",Point prevalence,N/A
Clinical subtype,216981,"Niemann-Pick disease type C, juvenile neurologic onset",Point prevalence,N/A
Malformation syndrome,217008,Bockenheimer syndrome,Cases/families,N/A
Malformation syndrome,217008,Bockenheimer syndrome,Point prevalence,N/A
Malformation syndrome,217017,Zechi-Ceide syndrome,Cases/families,N/A
Malformation syndrome,217017,Zechi-Ceide syndrome,Point prevalence,N/A
Disease,217012,Spinocerebellar ataxia type 31,Cases/families,N/A
Disease,217012,Spinocerebellar ataxia type 31,Point prevalence,N/A
Disease,2088,Fanconi-Bickel syndrome,Cases/families,N/A
Disease,2088,Fanconi-Bickel syndrome,Point prevalence,N/A
Disease,2088,Fanconi-Bickel syndrome,Prevalence at birth,N/A
Disease,2088,Fanconi-Bickel syndrome,Prevalence at birth,N/A
Malformation syndrome,217026,"Microcephaly-facio-cardio-skeletal syndrome, Hadziselimovic type",Cases/families,N/A
Malformation syndrome,217026,"Microcephaly-facio-cardio-skeletal syndrome, Hadziselimovic type",Point prevalence,N/A
Malformation syndrome,217266,BNAR syndrome,Cases/families,N/A
Malformation syndrome,217266,BNAR syndrome,Point prevalence,N/A
Disease,179,Birdshot chorioretinopathy,Point prevalence,N/A
Disease,179,Birdshot chorioretinopathy,Point prevalence,N/A
Disease,217260,Progressive multifocal leukoencephalopathy,Point prevalence,N/A
Disease,217260,Progressive multifocal leukoencephalopathy,Annual incidence,N/A
Disease,217260,Progressive multifocal leukoencephalopathy,Annual incidence,N/A
Disease,292,Congenital enterovirus infection,Point prevalence,N/A
Disease,217253,NMDA receptor encephalitis,Point prevalence,N/A
Disease,767,Polyarteritis nodosa,Point prevalence,N/A
Disease,767,Polyarteritis nodosa,Point prevalence,N/A
Disease,767,Polyarteritis nodosa,Annual incidence,N/A
Disease,767,Polyarteritis nodosa,Point prevalence,N/A
Disease,767,Polyarteritis nodosa,Annual incidence,N/A
Disease,767,Polyarteritis nodosa,Annual incidence,N/A
Disease,767,Polyarteritis nodosa,Point prevalence,N/A
Disease,767,Polyarteritis nodosa,Annual incidence,N/A
Disease,767,Polyarteritis nodosa,Annual incidence,N/A
Disease,2584,Classic mycosis fungoides,Annual incidence,N/A
Disease,2584,Classic mycosis fungoides,Point prevalence,N/A
Clinical subtype,217093,"Mucopolysaccharidosis type 2, attenuated form",Point prevalence,N/A
Disease,3162,Szary syndrome,Annual incidence,N/A
Disease,3162,Szary syndrome,Annual incidence,N/A
Disease,3162,Szary syndrome,Point prevalence,N/A
Clinical subtype,217085,"Mucopolysaccharidosis type 2, severe form",Prevalence at birth,N/A
Clinical subtype,217085,"Mucopolysaccharidosis type 2, severe form",Point prevalence,N/A
Particular clinical situation in a disease or syndrome,217080,Pulmonary fungal infections in patients deemed at risk,Point prevalence,N/A
Category,217074,Rare carcinoma of pancreas,Annual incidence,N/A
Category,217074,Rare carcinoma of pancreas,Lifetime Prevalence,N/A
Category,217074,Rare carcinoma of pancreas,Point prevalence,N/A
Category,217074,Rare carcinoma of pancreas,Annual incidence,N/A
Category,217074,Rare carcinoma of pancreas,Point prevalence,N/A
Particular clinical situation in a disease or syndrome,2330,Kasabach-Merritt phenomenon,Cases/families,N/A
Particular clinical situation in a disease or syndrome,2330,Kasabach-Merritt phenomenon,Point prevalence,N/A
Clinical group,217071,Renal cell carcinoma,Point prevalence,N/A
Clinical group,217071,Renal cell carcinoma,Annual incidence,N/A
Particular clinical situation in a disease or syndrome,217067,Pouchitis,Point prevalence,N/A
Disease,2700,Noma,Point prevalence,N/A
Particular clinical situation in a disease or syndrome,217064,5-fluorouracil poisoning,Point prevalence,N/A
Disease,1451,CINCA syndrome,Point prevalence,N/A
Morphological anomaly,217059,Isolated nail clubbing,Point prevalence,N/A
Disease,217055,Autosomal recessive intermediate Charcot-Marie-Tooth disease type A,Cases/families,N/A
Disease,217055,Autosomal recessive intermediate Charcot-Marie-Tooth disease type A,Point prevalence,N/A
Disease,556,Malakoplakia,Point prevalence,N/A
Malformation syndrome,217335,RIN2 syndrome,Cases/families,N/A
Malformation syndrome,217335,RIN2 syndrome,Point prevalence,N/A
Malformation syndrome,2745,Opitz GBBB syndrome,Point prevalence,N/A
Malformation syndrome,217340,17q21.31 microduplication syndrome,Point prevalence,N/A
Disease,3260,Idiopathic hypereosinophilic syndrome,Point prevalence,N/A
Clinical subtype,217330,REN-related autosomal dominant tubulointerstitial kidney disease,Cases/families,N/A
Clinical subtype,217330,REN-related autosomal dominant tubulointerstitial kidney disease,Point prevalence,N/A
Disease,2086,Optic pathway glioma,Annual incidence,N/A
Disease,2086,Optic pathway glioma,Point prevalence,N/A
Disease,2566,Chronic Epstein-Barr virus infection syndrome,Point prevalence,N/A
Disease,3385,African trypanosomiasis,Point prevalence,N/A
Disease,1560,Cysticercosis,Point prevalence,N/A
Malformation syndrome,566,Congenital microcoria,Point prevalence,N/A
Category,341,Viral hemorrhagic fever,Point prevalence,N/A
Disease,340,Hemorrhagic fever-renal syndrome,Annual incidence,N/A
Disease,340,Hemorrhagic fever-renal syndrome,Point prevalence,N/A
Disease,340,Hemorrhagic fever-renal syndrome,Annual incidence,N/A
Disease,340,Hemorrhagic fever-renal syndrome,Annual incidence,N/A
Disease,340,Hemorrhagic fever-renal syndrome,Annual incidence,N/A
Disease,340,Hemorrhagic fever-renal syndrome,Annual incidence,N/A
Disease,340,Hemorrhagic fever-renal syndrome,Annual incidence,N/A
Disease,340,Hemorrhagic fever-renal syndrome,Annual incidence,N/A
Disease,340,Hemorrhagic fever-renal syndrome,Annual incidence,N/A
Disease,340,Hemorrhagic fever-renal syndrome,Annual incidence,N/A
Disease,340,Hemorrhagic fever-renal syndrome,Annual incidence,N/A
Disease,340,Hemorrhagic fever-renal syndrome,Annual incidence,N/A
Disease,340,Hemorrhagic fever-renal syndrome,Annual incidence,N/A
Disease,340,Hemorrhagic fever-renal syndrome,Annual incidence,N/A
Disease,340,Hemorrhagic fever-renal syndrome,Annual incidence,N/A
Disease,340,Hemorrhagic fever-renal syndrome,Annual incidence,N/A
Disease,340,Hemorrhagic fever-renal syndrome,Annual incidence,N/A
Disease,340,Hemorrhagic fever-renal syndrome,Annual incidence,N/A
Disease,340,Hemorrhagic fever-renal syndrome,Annual incidence,N/A
Disease,340,Hemorrhagic fever-renal syndrome,Annual incidence,N/A
Disease,2552,Microsporidiosis,Point prevalence,N/A
Disease,1171,Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome,Cases/families,N/A
Disease,1171,Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome,Point prevalence,N/A
Disease,217560,Neuroendocrine cell hyperplasia of infancy,Point prevalence,N/A
Disease,217557,Pulmonary interstitial glycogenosis,Point prevalence,N/A
Morphological anomaly,1686,Cardiac diverticulum,Point prevalence,N/A
Disease,217563,Neonatal acute respiratory distress syndrome,Point prevalence,N/A
Disease,217563,Neonatal acute respiratory distress syndrome,Prevalence at birth,N/A
Disease,217407,Hereditary hypotrichosis with recurrent skin vesicles,Cases/families,N/A
Disease,217407,Hereditary hypotrichosis with recurrent skin vesicles,Point prevalence,N/A
Morphological anomaly,1456,Middle aortic syndrome,Prevalence at birth,N/A
Morphological anomaly,1456,Middle aortic syndrome,Point prevalence,N/A
Morphological anomaly,1457,Aorta coarctation,Prevalence at birth,N/A
Morphological anomaly,1457,Aorta coarctation,Prevalence at birth,N/A
Morphological anomaly,1457,Aorta coarctation,Prevalence at birth,N/A
Morphological anomaly,1457,Aorta coarctation,Prevalence at birth,N/A
Morphological anomaly,1457,Aorta coarctation,Prevalence at birth,N/A
Morphological anomaly,1457,Aorta coarctation,Prevalence at birth,N/A
Morphological anomaly,1457,Aorta coarctation,Prevalence at birth,N/A
Morphological anomaly,1457,Aorta coarctation,Prevalence at birth,N/A
Morphological anomaly,1457,Aorta coarctation,Prevalence at birth,N/A
Morphological anomaly,1457,Aorta coarctation,Prevalence at birth,N/A
Morphological anomaly,1457,Aorta coarctation,Prevalence at birth,N/A
Morphological anomaly,1457,Aorta coarctation,Prevalence at birth,N/A
Morphological anomaly,1457,Aorta coarctation,Prevalence at birth,N/A
Morphological anomaly,1457,Aorta coarctation,Prevalence at birth,N/A
Morphological anomaly,1457,Aorta coarctation,Prevalence at birth,N/A
Morphological anomaly,1457,Aorta coarctation,Prevalence at birth,N/A
Morphological anomaly,1457,Aorta coarctation,Prevalence at birth,N/A
Morphological anomaly,1457,Aorta coarctation,Prevalence at birth,N/A
Morphological anomaly,1457,Aorta coarctation,Prevalence at birth,N/A
Morphological anomaly,1457,Aorta coarctation,Point prevalence,N/A
Disease,217390,Combined immunodeficiency due to DOCK8 deficiency,Cases/families,N/A
Disease,217390,Combined immunodeficiency due to DOCK8 deficiency,Point prevalence,N/A
Category,1132,Aortic arch defects,Point prevalence,N/A
Malformation syndrome,217385,17p13.3 microduplication syndrome,Cases/families,N/A
Malformation syndrome,217385,17p13.3 microduplication syndrome,Point prevalence,N/A
Disease,217399,Congenital insensitivity to pain-hyperhidrosis-absence of cutaneous sensory innervation,Cases/families,N/A
Disease,217399,Congenital insensitivity to pain-hyperhidrosis-absence of cutaneous sensory innervation,Point prevalence,N/A
Disease,217396,Progressive polyneuropathy with bilateral striatal necrosis,Cases/families,N/A
Disease,217396,Progressive polyneuropathy with bilateral striatal necrosis,Point prevalence,N/A
Clinical group,982,Pulmonary valve agenesis,Point prevalence,N/A
Disease,217371,Acute infantile liver failure due to synthesis defect of mtDNA-encoded proteins,Cases/families,N/A
Disease,217371,Acute infantile liver failure due to synthesis defect of mtDNA-encoded proteins,Point prevalence,N/A
Malformation syndrome,217346,19q13.11 microdeletion syndrome,Cases/families,N/A
Malformation syndrome,217346,19q13.11 microdeletion syndrome,Point prevalence,N/A
Morphological anomaly,980,Absence of the pulmonary artery,Annual incidence,N/A
Morphological anomaly,980,Absence of the pulmonary artery,Point prevalence,N/A
Disease,217382,Neurodegenerative syndrome due to cerebral folate transport deficiency,Cases/families,N/A
Disease,217382,Neurodegenerative syndrome due to cerebral folate transport deficiency,Point prevalence,N/A
Morphological anomaly,1054,Aneurysm of sinus of Valsalva,Point prevalence,N/A
Malformation syndrome,217377,Microduplication Xp11.22p11.23 syndrome,Cases/families,N/A
Malformation syndrome,217377,Microduplication Xp11.22p11.23 syndrome,Point prevalence,N/A
Disease,217622,Sensorineural deafness with dilated cardiomyopathy,Cases/families,N/A
Disease,217622,Sensorineural deafness with dilated cardiomyopathy,Point prevalence,N/A
Morphological anomaly,3092,Fixed subaortic stenosis,Point prevalence,N/A
Morphological anomaly,2299,Aortic arch interruption,Prevalence at birth,N/A
Morphological anomaly,2299,Aortic arch interruption,Point prevalence,N/A
Morphological anomaly,3427,Double outlet left ventricle,Prevalence at birth,N/A
Morphological anomaly,3427,Double outlet left ventricle,Point prevalence,N/A
Morphological anomaly,3426,Double outlet right ventricle,Prevalence at birth,N/A
Morphological anomaly,3426,Double outlet right ventricle,Point prevalence,N/A
Morphological anomaly,439,Isolated right ventricular hypoplasia,Point prevalence,N/A
Disease,422,Idiopathic/heritable pulmonary arterial hypertension,Annual incidence,N/A
Disease,422,Idiopathic/heritable pulmonary arterial hypertension,Point prevalence,N/A
Disease,422,Idiopathic/heritable pulmonary arterial hypertension,Annual incidence,N/A
Disease,422,Idiopathic/heritable pulmonary arterial hypertension,Point prevalence,N/A
Disease,422,Idiopathic/heritable pulmonary arterial hypertension,Annual incidence,N/A
Disease,422,Idiopathic/heritable pulmonary arterial hypertension,Point prevalence,N/A
Disease,422,Idiopathic/heritable pulmonary arterial hypertension,Point prevalence,N/A
Morphological anomaly,2038,Pulmonary arteriovenous malformation,Annual incidence,N/A
Morphological anomaly,2038,Pulmonary arteriovenous malformation,Point prevalence,N/A
Morphological anomaly,2041,Coronary arterial fistula,Point prevalence,N/A
Clinical group,282,Frontotemporal dementia,Point prevalence,N/A
Clinical group,282,Frontotemporal dementia,Annual incidence,N/A
Disease,331,Congenital factor XIII deficiency,Annual incidence,N/A
Disease,331,Congenital factor XIII deficiency,Point prevalence,N/A
Disease,159,Carnitine-acylcarnitine translocase deficiency,Cases/families,N/A
Disease,159,Carnitine-acylcarnitine translocase deficiency,Point prevalence,N/A
Category,542,Primary cutaneous lymphoma,Annual incidence,N/A
Category,542,Primary cutaneous lymphoma,Point prevalence,N/A
Disease,707,Plague,Point prevalence,N/A
Disease,707,Plague,Annual incidence,N/A
Disease,335,Congenital fibrinogen deficiency,Point prevalence,N/A
Disease,79,Congenital alpha2-antiplasmin deficiency,Cases/families,N/A
Disease,79,Congenital alpha2-antiplasmin deficiency,Point prevalence,N/A
Disease,217656,Inherited isolated arrhythmogenic cardiomyopathy,Point prevalence,N/A
Disease,1070,Anisakiasis,Annual incidence,N/A
Disease,1070,Anisakiasis,Annual incidence,N/A
Disease,1070,Anisakiasis,Point prevalence,N/A
Disease,1467,Cogan syndrome,Cases/families,N/A
Disease,1467,Cogan syndrome,Point prevalence,N/A
Disease,2157,Histidinemia,Prevalence at birth,N/A
Disease,2157,Histidinemia,Point prevalence,N/A
Disease,2157,Histidinemia,Prevalence at birth,N/A
Disease,2157,Histidinemia,Prevalence at birth,N/A
Disease,3124,Saccharopinuria,Point prevalence,N/A
Clinical subtype,220407,Limited systemic sclerosis,Cases/families,N/A
Clinical subtype,220407,Limited systemic sclerosis,Point prevalence,N/A
Clinical subtype,220386,Semilobar holoprosencephaly,Point prevalence,N/A
Disease,2203,Hyperlysinemia,Point prevalence,N/A
Clinical subtype,220393,Diffuse cutaneous systemic sclerosis,Point prevalence,N/A
Clinical subtype,220393,Diffuse cutaneous systemic sclerosis,Annual incidence,N/A
Disease,332,Congenital intrinsic factor deficiency,Cases/families,N/A
Disease,332,Congenital intrinsic factor deficiency,Point prevalence,N/A
Disease,220448,Macrothrombocytopenia with mitral valve insufficiency,Cases/families,N/A
Disease,220448,Macrothrombocytopenia with mitral valve insufficiency,Point prevalence,N/A
Disease,220436,Quebec platelet disorder,Point prevalence,N/A
Disease,220436,Quebec platelet disorder,Point prevalence,N/A
Disease,2195,Dicarboxylic aminoaciduria,Point prevalence,N/A
Disease,2195,Dicarboxylic aminoaciduria,Prevalence at birth,N/A
Clinical subtype,2170,Methylcobalamin deficiency type cblG,Cases/families,N/A
Clinical subtype,2170,Methylcobalamin deficiency type cblG,Point prevalence,N/A
Disease,220295,Xeroderma pigmentosum-Cockayne syndrome complex,Cases/families,N/A
Disease,220295,Xeroderma pigmentosum-Cockayne syndrome complex,Point prevalence,N/A
Disease,414,Gyrate atrophy of choroid and retina,Point prevalence,N/A
Disease,414,Gyrate atrophy of choroid and retina,Cases/families,N/A
Disease,414,Gyrate atrophy of choroid and retina,Point prevalence,N/A
Disease,622,Homocystinuria without methylmalonic aciduria,Cases/families,N/A
Disease,622,Homocystinuria without methylmalonic aciduria,Point prevalence,N/A
Disease,927,Hyperammonemia due to N-acetylglutamate synthase deficiency,Point prevalence,N/A
Disease,927,Hyperammonemia due to N-acetylglutamate synthase deficiency,Cases/families,N/A
Disease,2880,Phosphoenolpyruvate carboxykinase deficiency,Cases/families,N/A
Disease,2880,Phosphoenolpyruvate carboxykinase deficiency,Point prevalence,N/A
Disease,941,D-glyceric aciduria,Point prevalence,N/A
Disease,220465,Laron syndrome with immunodeficiency,Cases/families,N/A
Disease,220465,Laron syndrome with immunodeficiency,Point prevalence,N/A
Category,220489,Rare hereditary hemochromatosis,Point prevalence,N/A
Clinical group,19,2-hydroxyglutaric aciduria,Point prevalence,N/A
Disease,2843,Pentosuria,Point prevalence,N/A
Malformation syndrome,220497,Joubert syndrome with renal defect,Point prevalence,N/A
Disease,212,Cystathioninuria,Prevalence at birth,N/A
Disease,212,Cystathioninuria,Point prevalence,N/A
Disease,212,Cystathioninuria,Point prevalence,N/A
Malformation syndrome,220493,Joubert syndrome with ocular defect,Point prevalence,N/A
Disease,470,Lysinuric protein intolerance,Prevalence at birth,N/A
Disease,470,Lysinuric protein intolerance,Prevalence at birth,N/A
Disease,470,Lysinuric protein intolerance,Prevalence at birth,N/A
Disease,470,Lysinuric protein intolerance,Prevalence at birth,N/A
Disease,470,Lysinuric protein intolerance,Point prevalence,N/A
Disease,221074,Marchiafava-Bignami disease,Cases/families,N/A
Disease,221074,Marchiafava-Bignami disease,Point prevalence,N/A
Disease,145,Hereditary breast and/or ovarian cancer syndrome,Point prevalence,N/A
Disease,2965,Prolactinoma,Point prevalence,N/A
Disease,2965,Prolactinoma,Point prevalence,N/A
Disease,2965,Prolactinoma,Point prevalence,N/A
Disease,2965,Prolactinoma,Annual incidence,N/A
Disease,2965,Prolactinoma,Point prevalence,N/A
Disease,221091,Trigeminal neuralgia,Point prevalence,N/A
Disease,221091,Trigeminal neuralgia,Annual incidence,N/A
Disease,221091,Trigeminal neuralgia,Annual incidence,N/A
Disease,538,Lymphangioleiomyomatosis,Annual incidence,N/A
Disease,538,Lymphangioleiomyomatosis,Point prevalence,N/A
Disease,538,Lymphangioleiomyomatosis,Annual incidence,N/A
Disease,538,Lymphangioleiomyomatosis,Point prevalence,N/A
Disease,538,Lymphangioleiomyomatosis,Annual incidence,N/A
Disease,538,Lymphangioleiomyomatosis,Point prevalence,N/A
Disease,538,Lymphangioleiomyomatosis,Point prevalence,N/A
Disease,538,Lymphangioleiomyomatosis,Point prevalence,N/A
Disease,538,Lymphangioleiomyomatosis,Point prevalence,N/A
Disease,538,Lymphangioleiomyomatosis,Point prevalence,N/A
Disease,538,Lymphangioleiomyomatosis,Point prevalence,N/A
Disease,538,Lymphangioleiomyomatosis,Point prevalence,N/A
Disease,538,Lymphangioleiomyomatosis,Point prevalence,N/A
Disease,221098,Glossopharyngeal neuralgia,Point prevalence,N/A
Disease,221098,Glossopharyngeal neuralgia,Annual incidence,N/A
Disease,2942,Postpoliomyelitis syndrome,Point prevalence,N/A
Clinical subtype,1578,Pterin-4 alpha-carbinolamine dehydratase deficiency,Cases/families,N/A
Clinical subtype,1578,Pterin-4 alpha-carbinolamine dehydratase deficiency,Point prevalence,N/A
Disease,3208,Isolated succinate-CoQ reductase deficiency,Cases/families,N/A
Disease,3208,Isolated succinate-CoQ reductase deficiency,Point prevalence,N/A
Clinical subtype,221008,Rothmund-Thomson syndrome type 1,Cases/families,N/A
Clinical subtype,221008,Rothmund-Thomson syndrome type 1,Point prevalence,N/A
Disease,24,Fumaric aciduria,Cases/families,N/A
Disease,24,Fumaric aciduria,Point prevalence,N/A
Clinical subtype,221016,Rothmund-Thomson syndrome type 2,Cases/families,N/A
Clinical subtype,221016,Rothmund-Thomson syndrome type 2,Point prevalence,N/A
Disease,221039,"Hereditary sclerosing poikiloderma, Weary type",Point prevalence,N/A
Disease,221039,"Hereditary sclerosing poikiloderma, Weary type",Cases/families,N/A
Disease,851,Paris-Trousseau thrombocytopenia,Cases/families,N/A
Disease,851,Paris-Trousseau thrombocytopenia,Point prevalence,N/A
Disease,221043,Hereditary fibrosing poikiloderma-tendon contractures-myopathy-pulmonary fibrosis syndrome,Cases/families,N/A
Disease,221043,Hereditary fibrosing poikiloderma-tendon contractures-myopathy-pulmonary fibrosis syndrome,Point prevalence,N/A
Disease,221046,Poikiloderma with neutropenia,Cases/families,N/A
Disease,221046,Poikiloderma with neutropenia,Point prevalence,N/A
Disease,745,Severe hereditary thrombophilia due to congenital protein C deficiency,Prevalence at birth,N/A
Disease,745,Severe hereditary thrombophilia due to congenital protein C deficiency,Point prevalence,N/A
Malformation syndrome,221054,Acrocephalopolydactyly,Cases/families,N/A
Malformation syndrome,221054,Acrocephalopolydactyly,Point prevalence,N/A
Malformation syndrome,221061,Familial cerebral cavernous malformation,Point prevalence,N/A
Disease,849,Glanzmann thrombasthenia,Point prevalence,N/A
Disease,225154,Familial infantile bilateral striatal necrosis,Point prevalence,N/A
Disease,225123,TFR2-related hemochromatosis,Cases/families,N/A
Disease,225123,TFR2-related hemochromatosis,Point prevalence,N/A
Disease,225147,Sporadic infantile bilateral striatal necrosis,Point prevalence,N/A
Clinical group,223727,Bone sarcoma,Annual incidence,N/A
Clinical group,223727,Bone sarcoma,Point prevalence,N/A
Malformation syndrome,221120,Pseudoaminopterin syndrome,Cases/families,N/A
Malformation syndrome,221120,Pseudoaminopterin syndrome,Point prevalence,N/A
Malformation syndrome,221126,Fowler vasculopathy,Cases/families,N/A
Malformation syndrome,221126,Fowler vasculopathy,Point prevalence,N/A
Disease,221139,Combined immunodeficiency with facio-oculo-skeletal anomalies,Cases/families,N/A
Disease,221139,Combined immunodeficiency with facio-oculo-skeletal anomalies,Point prevalence,N/A
Disease,221142,Confetti-like macular atrophy,Cases/families,N/A
Disease,221142,Confetti-like macular atrophy,Point prevalence,N/A
Malformation syndrome,221145,"Cutis laxa with severe pulmonary, gastrointestinal and urinary anomalies",Cases/families,N/A
Malformation syndrome,221145,"Cutis laxa with severe pulmonary, gastrointestinal and urinary anomalies",Point prevalence,N/A
Disease,228003,Severe combined immunodeficiency due to CORO1A deficiency,Cases/families,N/A
Disease,228003,Severe combined immunodeficiency due to CORO1A deficiency,Point prevalence,N/A
Category,3398,Thymic epithelial neoplasm,Annual incidence,N/A
Category,3398,Thymic epithelial neoplasm,Annual incidence,N/A
Category,3398,Thymic epithelial neoplasm,Point prevalence,N/A
Biological anomaly,228000,Idiopathic CD4 lymphocytopenia,Point prevalence,N/A
Category,547,Non-Hodgkin lymphoma,Point prevalence,N/A
Category,547,Non-Hodgkin lymphoma,Annual incidence,N/A
Disease,842,Testicular seminomatous germ cell tumor,Annual incidence,N/A
Disease,842,Testicular seminomatous germ cell tumor,Lifetime Prevalence,N/A
Disease,842,Testicular seminomatous germ cell tumor,Point prevalence,N/A
Disease,227976,"Autosomal recessive optic atrophy, OPA7 type",Point prevalence,N/A
Disease,227976,"Autosomal recessive optic atrophy, OPA7 type",Cases/families,N/A
Disease,876,Yolk sac tumor,Point prevalence,N/A
Disease,876,Yolk sac tumor,Annual incidence,N/A
Disease,227972,Toxic oil syndrome,Point prevalence,N/A
Disease,227972,Toxic oil syndrome,Cases/families,N/A
Disease,227796,Fundus albipunctatus,Point prevalence,N/A
Disease,228123,Coccidioidomycosis,Point prevalence,N/A
Disease,228119,Fusariosis,Point prevalence,N/A
Disease,228116,Hughes-Stovin syndrome,Cases/families,N/A
Disease,228116,Hughes-Stovin syndrome,Point prevalence,N/A
Particular clinical situation in a disease or syndrome,228113,Anal fistula,Point prevalence,N/A
Particular clinical situation in a disease or syndrome,228113,Anal fistula,Point prevalence,N/A
Category,3399,Germ cell tumor,Point prevalence,N/A
Disease,389,Langerhans cell histiocytosis,Point prevalence,N/A
Disease,228012,Progressive sensorineural hearing loss-hypertrophic cardiomyopathy syndrome,Cases/families,N/A
Disease,228012,Progressive sensorineural hearing loss-hypertrophic cardiomyopathy syndrome,Point prevalence,N/A
Disease,616,Medulloblastoma,Annual incidence,N/A
Disease,616,Medulloblastoma,Point prevalence,N/A
Disease,616,Medulloblastoma,Annual incidence,N/A
Clinical group,301,Ependymal tumor,Annual incidence,N/A
Clinical group,301,Ependymal tumor,Point prevalence,N/A
Clinical group,301,Ependymal tumor,Lifetime Prevalence,N/A
Clinical group,301,Ependymal tumor,Annual incidence,N/A
Clinical group,301,Ependymal tumor,Annual incidence,N/A
Clinical group,541,Primary cutaneous CD30+ T-cell lymphoproliferative disease,Annual incidence,N/A
Clinical group,541,Primary cutaneous CD30+ T-cell lymphoproliferative disease,Point prevalence,N/A
Disease,543,Burkitt lymphoma,Annual incidence,N/A
Disease,543,Burkitt lymphoma,Point prevalence,N/A
Disease,543,Burkitt lymphoma,Point prevalence,N/A
Disease,543,Burkitt lymphoma,Point prevalence,N/A
Disease,319,Skeletal Ewing sarcoma,Annual incidence,N/A
Disease,319,Skeletal Ewing sarcoma,Lifetime Prevalence,N/A
Disease,319,Skeletal Ewing sarcoma,Point prevalence,N/A
Disease,668,Osteosarcoma,Annual incidence,N/A
Disease,668,Osteosarcoma,Point prevalence,N/A
Disease,668,Osteosarcoma,Lifetime Prevalence,N/A
Disease,668,Osteosarcoma,Annual incidence,N/A
Clinical subtype,227510,"Multiple system atrophy, cerebellar type",Point prevalence,N/A
Clinical group,94,Astrocytoma,Annual incidence,N/A
Clinical group,94,Astrocytoma,Point prevalence,N/A
Clinical group,94,Astrocytoma,Annual incidence,N/A
Clinical group,94,Astrocytoma,Annual incidence,N/A
Clinical group,94,Astrocytoma,Annual incidence,N/A
Clinical group,94,Astrocytoma,Annual incidence,N/A
Clinical group,94,Astrocytoma,Annual incidence,N/A
Clinical group,94,Astrocytoma,Annual incidence,N/A
Clinical group,94,Astrocytoma,Annual incidence,N/A
Clinical group,94,Astrocytoma,Annual incidence,N/A
Clinical group,94,Astrocytoma,Annual incidence,N/A
Clinical group,94,Astrocytoma,Annual incidence,N/A
Clinical group,94,Astrocytoma,Annual incidence,N/A
Clinical group,94,Astrocytoma,Annual incidence,N/A
Clinical group,94,Astrocytoma,Annual incidence,N/A
Clinical group,94,Astrocytoma,Annual incidence,N/A
Clinical group,94,Astrocytoma,Annual incidence,N/A
Clinical group,94,Astrocytoma,Annual incidence,N/A
Clinical group,94,Astrocytoma,Annual incidence,N/A
Clinical group,94,Astrocytoma,Annual incidence,N/A
Clinical group,94,Astrocytoma,Annual incidence,N/A
Clinical group,94,Astrocytoma,Annual incidence,N/A
Clinical group,94,Astrocytoma,Annual incidence,N/A
Clinical group,94,Astrocytoma,Annual incidence,N/A
Clinical group,94,Astrocytoma,Annual incidence,N/A
Disease,360,Glioblastoma,Annual incidence,N/A
Disease,360,Glioblastoma,Point prevalence,N/A
Disease,360,Glioblastoma,Annual incidence,N/A
Disease,360,Glioblastoma,Annual incidence,N/A
Disease,360,Glioblastoma,Annual incidence,N/A
Disease,360,Glioblastoma,Annual incidence,N/A
Disease,360,Glioblastoma,Annual incidence,N/A
Category,226292,Permanent congenital hypothyroidism,Prevalence at birth,N/A
Category,226292,Permanent congenital hypothyroidism,Point prevalence,N/A
Clinical group,513,Acute lymphoblastic leukemia,Annual incidence,N/A
Clinical group,513,Acute lymphoblastic leukemia,Annual incidence,N/A
Clinical group,513,Acute lymphoblastic leukemia,Annual incidence,N/A
Clinical group,513,Acute lymphoblastic leukemia,Lifetime Prevalence,N/A
Clinical group,513,Acute lymphoblastic leukemia,Point prevalence,N/A
Disease,1957,Esthesioneuroblastoma,Annual incidence,N/A
Disease,1957,Esthesioneuroblastoma,Point prevalence,N/A
Clinical group,226298,Central congenital hypothyroidism,Point prevalence,N/A
Disease,2030,Fibrosarcoma,Annual incidence,N/A
Disease,2030,Fibrosarcoma,Point prevalence,N/A
Disease,2126,Solitary fibrous tumor,Point prevalence,N/A
Clinical group,226295,Primary congenital hypothyroidism,Point prevalence,N/A
Clinical group,226295,Primary congenital hypothyroidism,Prevalence at birth,N/A
Clinical group,226295,Primary congenital hypothyroidism,Prevalence at birth,N/A
Disease,758,Pseudoxanthoma elasticum,Point prevalence,N/A
Disease,419,Hyperprolinemia type 1,Point prevalence,N/A
Disease,1501,Adrenocortical carcinoma,Point prevalence,N/A
Disease,1501,Adrenocortical carcinoma,Annual incidence,N/A
Disease,1501,Adrenocortical carcinoma,Annual incidence,N/A
Disease,1501,Adrenocortical carcinoma,Annual incidence,N/A
Disease,1501,Adrenocortical carcinoma,Annual incidence,N/A
Disease,1501,Adrenocortical carcinoma,Annual incidence,N/A
Disease,1501,Adrenocortical carcinoma,Annual incidence,N/A
Disease,1501,Adrenocortical carcinoma,Annual incidence,N/A
Disease,1501,Adrenocortical carcinoma,Annual incidence,N/A
Disease,1501,Adrenocortical carcinoma,Annual incidence,N/A
Disease,1501,Adrenocortical carcinoma,Annual incidence,N/A
Disease,1501,Adrenocortical carcinoma,Annual incidence,N/A
Disease,1501,Adrenocortical carcinoma,Annual incidence,N/A
Disease,1501,Adrenocortical carcinoma,Annual incidence,N/A
Disease,1501,Adrenocortical carcinoma,Annual incidence,N/A
Disease,1501,Adrenocortical carcinoma,Annual incidence,N/A
Disease,1501,Adrenocortical carcinoma,Annual incidence,N/A
Disease,1501,Adrenocortical carcinoma,Annual incidence,N/A
Disease,1501,Adrenocortical carcinoma,Annual incidence,N/A
Disease,1501,Adrenocortical carcinoma,Annual incidence,N/A
Disease,1501,Adrenocortical carcinoma,Annual incidence,N/A
Disease,1501,Adrenocortical carcinoma,Annual incidence,N/A
Disease,1501,Adrenocortical carcinoma,Annual incidence,N/A
Disease,1501,Adrenocortical carcinoma,Annual incidence,N/A
Disease,1501,Adrenocortical carcinoma,Annual incidence,N/A
Disease,226307,Hypothyroidism due to deficient transcription factors involved in pituitary development or function,Point prevalence,N/A
Disease,3148,Malignant peripheral nerve sheath tumor,Annual incidence,N/A
Disease,3148,Malignant peripheral nerve sheath tumor,Point prevalence,N/A
Disease,3273,Synovial sarcoma,Point prevalence,N/A
Disease,391,Classic Hodgkin lymphoma,Annual incidence,N/A
Disease,391,Classic Hodgkin lymphoma,Annual incidence,N/A
Disease,391,Classic Hodgkin lymphoma,Point prevalence,N/A
Disease,391,Classic Hodgkin lymphoma,Lifetime Prevalence,N/A
Disease,391,Classic Hodgkin lymphoma,Annual incidence,N/A
Disease,391,Classic Hodgkin lymphoma,Annual incidence,N/A
Disease,391,Classic Hodgkin lymphoma,Annual incidence,N/A
Disease,391,Classic Hodgkin lymphoma,Annual incidence,N/A
Disease,391,Classic Hodgkin lymphoma,Annual incidence,N/A
Disease,391,Classic Hodgkin lymphoma,Annual incidence,N/A
Disease,391,Classic Hodgkin lymphoma,Annual incidence,N/A
Disease,391,Classic Hodgkin lymphoma,Annual incidence,N/A
Disease,391,Classic Hodgkin lymphoma,Annual incidence,N/A
Disease,391,Classic Hodgkin lymphoma,Annual incidence,N/A
Disease,391,Classic Hodgkin lymphoma,Annual incidence,N/A
Disease,391,Classic Hodgkin lymphoma,Annual incidence,N/A
Disease,391,Classic Hodgkin lymphoma,Annual incidence,N/A
Disease,391,Classic Hodgkin lymphoma,Annual incidence,N/A
Disease,391,Classic Hodgkin lymphoma,Annual incidence,N/A
Disease,391,Classic Hodgkin lymphoma,Annual incidence,N/A
Disease,391,Classic Hodgkin lymphoma,Annual incidence,N/A
Disease,391,Classic Hodgkin lymphoma,Annual incidence,N/A
Disease,391,Classic Hodgkin lymphoma,Annual incidence,N/A
Disease,391,Classic Hodgkin lymphoma,Annual incidence,N/A
Disease,391,Classic Hodgkin lymphoma,Annual incidence,N/A
Disease,391,Classic Hodgkin lymphoma,Annual incidence,N/A
Disease,391,Classic Hodgkin lymphoma,Annual incidence,N/A
Disease,391,Classic Hodgkin lymphoma,Annual incidence,N/A
Disease,391,Classic Hodgkin lymphoma,Annual incidence,N/A
Disease,391,Classic Hodgkin lymphoma,Annual incidence,N/A
Morphological anomaly,2260,Oligomeganephronia,Point prevalence,N/A
Malformation syndrome,503,Larsen syndrome,Prevalence at birth,N/A
Malformation syndrome,503,Larsen syndrome,Point prevalence,N/A
Malformation syndrome,503,Larsen syndrome,Prevalence at birth,N/A
Malformation syndrome,503,Larsen syndrome,Point prevalence,N/A
Disease,1652,Dent disease,Cases/families,N/A
Disease,1652,Dent disease,Point prevalence,N/A
Clinical group,2542,Isolated microphthalmia-anophthalmia-coloboma,Prevalence at birth,N/A
Clinical group,2542,Isolated microphthalmia-anophthalmia-coloboma,Prevalence at birth,N/A
Clinical group,2542,Isolated microphthalmia-anophthalmia-coloboma,Prevalence at birth,N/A
Clinical group,2542,Isolated microphthalmia-anophthalmia-coloboma,Prevalence at birth,N/A
Clinical group,2542,Isolated microphthalmia-anophthalmia-coloboma,Point prevalence,N/A
Clinical group,3280,Syringomyelia,Point prevalence,N/A
Clinical group,3280,Syringomyelia,Point prevalence,N/A
Clinical group,3280,Syringomyelia,Point prevalence,N/A
Clinical group,3280,Syringomyelia,Point prevalence,N/A
Clinical group,3280,Syringomyelia,Point prevalence,N/A
Disease,2478,Megalencephalic leukoencephalopathy with subcortical cysts,Cases/families,N/A
Disease,2478,Megalencephalic leukoencephalopathy with subcortical cysts,Point prevalence,N/A
Disease,3337,Primary Fanconi renotubular syndrome,Point prevalence,N/A
Disease,223,Arginine vasopressin resistance,Point prevalence,N/A
Disease,223,Arginine vasopressin resistance,Prevalence at birth,N/A
Disease,757,Pseudohypoaldosteronism type 2,Cases/families,N/A
Disease,757,Pseudohypoaldosteronism type 2,Point prevalence,N/A
Disease,228423,GATA2 deficiency spectrum,Cases/families,N/A
Disease,228423,GATA2 deficiency spectrum,Point prevalence,N/A
Disease,521,Chronic myeloid leukemia,Annual incidence,N/A
Disease,521,Chronic myeloid leukemia,Annual incidence,N/A
Disease,521,Chronic myeloid leukemia,Point prevalence,N/A
Disease,521,Chronic myeloid leukemia,Lifetime Prevalence,N/A
Disease,521,Chronic myeloid leukemia,Annual incidence,N/A
Malformation syndrome,228415,5q35 microduplication syndrome,Cases/families,N/A
Malformation syndrome,228415,5q35 microduplication syndrome,Point prevalence,N/A
Disease,132,Hereditary butyrylcholinesterase deficiency,Point prevalence,N/A
Category,1172,Autosomal recessive cerebellar ataxia,Point prevalence,N/A
Category,1172,Autosomal recessive cerebellar ataxia,Point prevalence,N/A
Category,1172,Autosomal recessive cerebellar ataxia,Point prevalence,N/A
Category,1172,Autosomal recessive cerebellar ataxia,Point prevalence,N/A
Category,1172,Autosomal recessive cerebellar ataxia,Point prevalence,N/A
Disease,229717,Isolated agammaglobulinemia,Point prevalence,N/A
Disease,228426,Syndromic multisystem autoimmune disease due to Itch deficiency,Cases/families,N/A
Disease,228426,Syndromic multisystem autoimmune disease due to Itch deficiency,Point prevalence,N/A
Malformation syndrome,2345,Isolated Klippel-Feil syndrome,Point prevalence,N/A
Malformation syndrome,2345,Isolated Klippel-Feil syndrome,Prevalence at birth,N/A
Disease,1333,Familial pancreatic carcinoma,Point prevalence,N/A
Malformation syndrome,228396,Ptosis-upper ocular movement limitation-absence of lacrimal punctum syndrome,Cases/families,N/A
Malformation syndrome,228396,Ptosis-upper ocular movement limitation-absence of lacrimal punctum syndrome,Point prevalence,N/A
Disease,228387,Spondylo-megaepiphyseal-metaphyseal dysplasia,Cases/families,N/A
Disease,228387,Spondylo-megaepiphyseal-metaphyseal dysplasia,Point prevalence,N/A
Malformation syndrome,228390,Frontonasal dysplasia-alopecia-genital anomalies syndrome,Cases/families,N/A
Malformation syndrome,228390,Frontonasal dysplasia-alopecia-genital anomalies syndrome,Point prevalence,N/A
Malformation syndrome,228410,Cardiac anomalies-short stature-joint hypermobility-facial dysmorphism syndrome,Cases/families,N/A
Malformation syndrome,228410,Cardiac anomalies-short stature-joint hypermobility-facial dysmorphism syndrome,Point prevalence,N/A
Malformation syndrome,228399,8q12 microduplication syndrome,Cases/families,N/A
Malformation syndrome,228399,8q12 microduplication syndrome,Point prevalence,N/A
Clinical group,2781,Osteopetrosis and related disorders,Annual incidence,N/A
Clinical group,2781,Osteopetrosis and related disorders,Point prevalence,N/A
Malformation syndrome,228402,2q23.1 microdeletion syndrome,Cases/families,N/A
Malformation syndrome,228402,2q23.1 microdeletion syndrome,Point prevalence,N/A
Etiological subtype,228384,5q14.3 microdeletion syndrome,Cases/families,N/A
Etiological subtype,228384,5q14.3 microdeletion syndrome,Point prevalence,N/A
Disease,228379,Virus-associated trichodysplasia spinulosa,Cases/families,N/A
Disease,228379,Virus-associated trichodysplasia spinulosa,Point prevalence,N/A
Disease,228374,Charcot-Marie-Tooth disease type 2B5,Cases/families,N/A
Disease,228374,Charcot-Marie-Tooth disease type 2B5,Point prevalence,N/A
Clinical subtype,228371,Foodborne botulism,Annual incidence,N/A
Clinical subtype,228371,Foodborne botulism,Point prevalence,N/A
Clinical subtype,228371,Foodborne botulism,Annual incidence,N/A
Clinical subtype,228371,Foodborne botulism,Annual incidence,N/A
Disease,228290,White fibrous papulosis of the neck,Point prevalence,N/A
Disease,228293,Pseudoxanthoma elasticum-like papillary dermal elastolysis,Point prevalence,N/A
Disease,228299,Mid-dermal elastolysis,Point prevalence,N/A
Clinical subtype,228302,"Carnitine palmitoyl transferase II deficiency, myopathic form",Cases/families,N/A
Clinical subtype,228302,"Carnitine palmitoyl transferase II deficiency, myopathic form",Point prevalence,N/A
Clinical subtype,228305,"Carnitine palmitoyl transferase II deficiency, severe infantile form",Cases/families,N/A
Clinical subtype,228305,"Carnitine palmitoyl transferase II deficiency, severe infantile form",Point prevalence,N/A
Clinical subtype,228308,"Carnitine palmitoyl transferase II deficiency, neonatal form",Cases/families,N/A
Clinical subtype,228308,"Carnitine palmitoyl transferase II deficiency, neonatal form",Point prevalence,N/A
Clinical group,228312,"Autoimmune hemolytic anemia, cold type",Point prevalence,N/A
Disease,228240,Elastoderma,Cases/families,N/A
Disease,228240,Elastoderma,Point prevalence,N/A
Disease,135,CACH syndrome,Cases/families,N/A
Disease,135,CACH syndrome,Point prevalence,N/A
Disease,228247,Acquired pseudoxanthoma elasticum,Cases/families,N/A
Disease,228247,Acquired pseudoxanthoma elasticum,Point prevalence,N/A
Disease,228254,Elastoma,Point prevalence,N/A
Disease,228264,Papular elastorrhexis,Point prevalence,N/A
Disease,228272,Primary anetoderma,Point prevalence,N/A
Disease,228277,Familial anetoderma,Cases/families,N/A
Disease,228277,Familial anetoderma,Point prevalence,N/A
Disease,228285,Acquired cutis laxa,Point prevalence,N/A
Malformation syndrome,228190,Patent ductus arteriosus-bicuspid aortic valve-hand anomalies syndrome,Cases/families,N/A
Malformation syndrome,228190,Patent ductus arteriosus-bicuspid aortic valve-hand anomalies syndrome,Point prevalence,N/A
Disease,3203,Overhydrated hereditary stomatocytosis,Cases/families,N/A
Disease,3203,Overhydrated hereditary stomatocytosis,Point prevalence,N/A
Disease,3202,Dehydrated hereditary stomatocytosis,Point prevalence,N/A
Disease,3202,Dehydrated hereditary stomatocytosis,Cases/families,N/A
Disease,228236,Linear focal elastosis,Cases/families,N/A
Disease,228236,Linear focal elastosis,Point prevalence,N/A
Disease,228227,Late-onset focal dermal elastosis,Cases/families,N/A
Disease,228227,Late-onset focal dermal elastosis,Point prevalence,N/A
Disease,228140,"Idiopathic ventricular fibrillation, non Brugada type",Point prevalence,N/A
Clinical subtype,1018,X-linked Alport syndrome-diffuse leiomyomatosis,Point prevalence,N/A
Disease,228165,Bal concentric sclerosis,Point prevalence,N/A
Disease,306,Self-limited infantile epilepsy,Point prevalence,N/A
Disease,228157,Marburg acute multiple sclerosis,Point prevalence,N/A
Disease,328,Congenital factor X deficiency,Point prevalence,N/A
Disease,228174,Autosomal dominant Charcot-Marie-Tooth disease type 2N,Cases/families,N/A
Disease,228174,Autosomal dominant Charcot-Marie-Tooth disease type 2N,Point prevalence,N/A
Disease,228169,Autosomal dominant striatal neurodegeneration,Cases/families,N/A
Disease,228169,Autosomal dominant striatal neurodegeneration,Point prevalence,N/A
Disease,2132,Hemoglobin C disease,Point prevalence,N/A
Disease,2132,Hemoglobin C disease,Prevalence at birth,N/A
Disease,2133,Hemoglobin E disease,Point prevalence,N/A
Disease,228179,Autosomal dominant Charcot-Marie-Tooth disease type 2M,Cases/families,N/A
Disease,228179,Autosomal dominant Charcot-Marie-Tooth disease type 2M,Point prevalence,N/A
Disease,288,Hereditary elliptocytosis,Point prevalence,N/A
Clinical subtype,231531,Hermansky-Pudlak syndrome due to BLOC-1 deficiency,Cases/families,N/A
Clinical subtype,231531,Hermansky-Pudlak syndrome due to BLOC-1 deficiency,Point prevalence,N/A
Clinical subtype,231512,Hermansky-Pudlak syndrome due to BLOC-2 deficiency,Point prevalence,N/A
Morphological anomaly,1320,Idiopathic camptocormia,Point prevalence,N/A
Disease,256,Early-onset generalized limb-onset dystonia,Annual incidence,N/A
Disease,256,Early-onset generalized limb-onset dystonia,Annual incidence,N/A
Disease,256,Early-onset generalized limb-onset dystonia,Point prevalence,N/A
Disease,256,Early-onset generalized limb-onset dystonia,Point prevalence,N/A
Disease,256,Early-onset generalized limb-onset dystonia,Prevalence at birth,N/A
Clinical subtype,231500,Hermansky-Pudlak syndrome due to BLOC-3 deficiency,Point prevalence,N/A
Disease,441,Pure autonomic failure,Point prevalence,N/A
Clinical group,1576,Infantile bilateral striatal necrosis,Point prevalence,N/A
Disease,231445,Paraparetic variant of Guillain-Barr syndrome,Point prevalence,N/A
Disease,231445,Paraparetic variant of Guillain-Barr syndrome,Annual incidence,N/A
Disease,2073,Narcolepsy type 1,Point prevalence,N/A
Disease,2073,Narcolepsy type 1,Annual incidence,N/A
Disease,2073,Narcolepsy type 1,Point prevalence,N/A
Disease,2073,Narcolepsy type 1,Point prevalence,N/A
Disease,2073,Narcolepsy type 1,Point prevalence,N/A
Disease,2073,Narcolepsy type 1,Point prevalence,N/A
Disease,2073,Narcolepsy type 1,Point prevalence,N/A
Disease,231401,Alpha-thalassemia-myelodysplastic syndrome,Cases/families,N/A
Disease,231401,Alpha-thalassemia-myelodysplastic syndrome,Point prevalence,N/A
Category,1866,"Focal, segmental or multifocal dystonia",Annual incidence,N/A
Category,1866,"Focal, segmental or multifocal dystonia",Point prevalence,N/A
Category,1866,"Focal, segmental or multifocal dystonia",Point prevalence,N/A
Category,1866,"Focal, segmental or multifocal dystonia",Point prevalence,N/A
Category,1866,"Focal, segmental or multifocal dystonia",Point prevalence,N/A
Category,1866,"Focal, segmental or multifocal dystonia",Point prevalence,N/A
Category,1866,"Focal, segmental or multifocal dystonia",Point prevalence,N/A
Category,1866,"Focal, segmental or multifocal dystonia",Point prevalence,N/A
Disease,231393,Beta-thalassemia-X-linked thrombocytopenia syndrome,Point prevalence,N/A
Disease,809,Mixed connective tissue disease,Annual incidence,N/A
Disease,809,Mixed connective tissue disease,Point prevalence,N/A
Disease,809,Mixed connective tissue disease,Point prevalence,N/A
Disease,809,Mixed connective tissue disease,Point prevalence,N/A
Disease,809,Mixed connective tissue disease,Annual incidence,N/A
Disease,809,Mixed connective tissue disease,Annual incidence,N/A
Morphological anomaly,1309,Medullary sponge kidney,Point prevalence,N/A
Disease,231249,Hemoglobin E-beta-thalassemia syndrome,Point prevalence,N/A
Disease,231242,Hemoglobin C-beta-thalassemia syndrome,Point prevalence,N/A
Disease,2197,Idiopathic hypercalciuria,Annual incidence,N/A
Disease,2197,Idiopathic hypercalciuria,Point prevalence,N/A
Disease,231237,Delta-beta-thalassemia,Point prevalence,N/A
Clinical subtype,231226,Dominant beta-thalassemia,Point prevalence,N/A
Disease,18,Distal renal tubular acidosis,Point prevalence,N/A
Clinical subtype,231222,Beta-thalassemia intermedia,Point prevalence,N/A
Disease,160,Castleman disease,Point prevalence,N/A
Disease,160,Castleman disease,Annual incidence,N/A
Clinical subtype,231214,Beta-thalassemia major,Point prevalence,N/A
Clinical subtype,231214,Beta-thalassemia major,Prevalence at birth,N/A
Clinical subtype,231214,Beta-thalassemia major,Point prevalence,N/A
Clinical subtype,231214,Beta-thalassemia major,Point prevalence,N/A
Disease,2841,Hailey-Hailey disease,Point prevalence,N/A
Clinical subtype,231183,Usher syndrome type 3,Point prevalence,N/A
Clinical subtype,231183,Usher syndrome type 3,Point prevalence,N/A
Clinical subtype,231183,Usher syndrome type 3,Point prevalence,N/A
Disease,347,Frasier syndrome,Cases/families,N/A
Disease,347,Frasier syndrome,Point prevalence,N/A
Clinical subtype,231178,Usher syndrome type 2,Point prevalence,N/A
Clinical subtype,231178,Usher syndrome type 2,Point prevalence,N/A
Disease,1670,Chronic diarrhea with villous atrophy,Cases/families,N/A
Disease,1670,Chronic diarrhea with villous atrophy,Point prevalence,N/A
Disease,231154,Combined immunodeficiency due to partial RAG1 deficiency,Cases/families,N/A
Disease,231154,Combined immunodeficiency due to partial RAG1 deficiency,Point prevalence,N/A
Disease,231160,Familial cerebral saccular aneurysm,Point prevalence,N/A
Disease,231160,Familial cerebral saccular aneurysm,Annual incidence,N/A
Clinical subtype,231169,Usher syndrome type 1,Point prevalence,N/A
Clinical subtype,231169,Usher syndrome type 1,Point prevalence,N/A
Etiological subtype,231147,Silver-Russell syndrome due to maternal uniparental disomy of chromosome 11,Point prevalence,N/A
Particular clinical situation in a disease or syndrome,231080,High-grade dysplasia in patients with Barrett esophagus,Point prevalence,N/A
Disease,231108,Rhabdoid tumor predisposition syndrome,Cases/families,N/A
Disease,231108,Rhabdoid tumor predisposition syndrome,Point prevalence,N/A
Disease,405,Familial hypocalciuric hypercalcemia,Point prevalence,N/A
Disease,231111,Drug-induced lupus erythematosus,Point prevalence,N/A
Disease,1223,Balantidiasis,Point prevalence,N/A
Disease,231040,Familial generalized lentiginosis,Point prevalence,N/A
Disease,3318,Essential thrombocythemia,Point prevalence,N/A
Disease,3318,Essential thrombocythemia,Annual incidence,N/A
Disease,3318,Essential thrombocythemia,Point prevalence,N/A
Disease,3318,Essential thrombocythemia,Point prevalence,N/A
Disease,3318,Essential thrombocythemia,Annual incidence,N/A
Disease,230857,Ehlers-Danlos/osteogenesis imperfecta syndrome,Point prevalence,N/A
Disease,230851,Cardiac-valvular Ehlers-Danlos syndrome,Cases/families,N/A
Disease,230851,Cardiac-valvular Ehlers-Danlos syndrome,Point prevalence,N/A
Disease,231031,Erythema palmare hereditarium,Point prevalence,N/A
Disease,913,Zollinger-Ellison syndrome,Annual incidence,N/A
Disease,913,Zollinger-Ellison syndrome,Point prevalence,N/A
Disease,913,Zollinger-Ellison syndrome,Annual incidence,N/A
Disease,913,Zollinger-Ellison syndrome,Annual incidence,N/A
Disease,913,Zollinger-Ellison syndrome,Annual incidence,N/A
Disease,913,Zollinger-Ellison syndrome,Annual incidence,N/A
Disease,231013,Congenital trigeminal anesthesia,Point prevalence,N/A
Clinical subtype,230800,Toxin-mediated infectious botulism,Point prevalence,N/A
Disease,82,Hereditary thrombophilia due to congenital antithrombin deficiency,Point prevalence,N/A
Disease,230839,Classical-like Ehlers-Danlos syndrome type 1,Cases/families,N/A
Disease,230839,Classical-like Ehlers-Danlos syndrome type 1,Point prevalence,N/A
Clinical group,519,Acute myeloid leukemia,Annual incidence,N/A
Clinical group,519,Acute myeloid leukemia,Point prevalence,N/A
Clinical group,519,Acute myeloid leukemia,Annual incidence,N/A
Clinical group,519,Acute myeloid leukemia,Lifetime Prevalence,N/A
Clinical group,519,Acute myeloid leukemia,Annual incidence,N/A
Clinical group,519,Acute myeloid leukemia,Annual incidence,N/A
Clinical group,519,Acute myeloid leukemia,Annual incidence,N/A
Clinical group,235936,Familial hyperaldosteronism,Point prevalence,N/A
Malformation syndrome,238446,15q11q13 microduplication syndrome,Point prevalence,N/A
Malformation syndrome,238446,15q11q13 microduplication syndrome,Cases/families,N/A
Disease,238329,Severe X-linked mitochondrial encephalomyopathy,Point prevalence,N/A
Disease,238329,Severe X-linked mitochondrial encephalomyopathy,Cases/families,N/A
Disease,231573,Congenital erosive and vesicular dermatosis,Cases/families,N/A
Disease,231573,Congenital erosive and vesicular dermatosis,Point prevalence,N/A
Disease,231580,Primary unilateral adrenal hyperplasia,Point prevalence,N/A
Disease,231556,Late-onset localized junctional epidermolysis bullosa-intellectual disability syndrome,Cases/families,N/A
Disease,231556,Late-onset localized junctional epidermolysis bullosa-intellectual disability syndrome,Point prevalence,N/A
Disease,231568,Autosomal dominant generalized dystrophic epidermolysis bullosa,Point prevalence,N/A
Category,231637,Rare surgically correctable form of primary aldosteronism,Point prevalence,N/A
Disease,231625,Adrenocortical carcinoma with pure aldosterone hypersecretion,Point prevalence,N/A
Clinical subtype,1900,Kyphoscoliotic Ehlers-Danlos syndrome due to lysyl hydroxylase 1 deficiency,Prevalence at birth,N/A
Clinical subtype,1900,Kyphoscoliotic Ehlers-Danlos syndrome due to lysyl hydroxylase 1 deficiency,Point prevalence,N/A
Disease,286,Vascular Ehlers-Danlos syndrome,Point prevalence,N/A
Disease,285,Hypermobile Ehlers-Danlos syndrome,Point prevalence,N/A
Malformation syndrome,231736,Microcornea-posterior megalolenticonus-persistent fetal vasculature-coloboma syndrome,Cases/families,N/A
Malformation syndrome,231736,Microcornea-posterior megalolenticonus-persistent fetal vasculature-coloboma syndrome,Point prevalence,N/A
Malformation syndrome,231742,Epibulbar lipodermoid-preauricular appendage-polythelia syndrome,Cases/families,N/A
Malformation syndrome,231742,Epibulbar lipodermoid-preauricular appendage-polythelia syndrome,Point prevalence,N/A
Disease,257,Epidermolysis bullosa simplex with muscular dystrophy,Cases/families,N/A
Disease,257,Epidermolysis bullosa simplex with muscular dystrophy,Point prevalence,N/A
Disease,1901,Dermatosparaxis Ehlers-Danlos syndrome,Cases/families,N/A
Disease,1901,Dermatosparaxis Ehlers-Danlos syndrome,Point prevalence,N/A
Malformation syndrome,231720,Non-acquired combined pituitary hormone deficiency-sensorineural hearing loss-spine abnormalities syndrome,Cases/families,N/A
Malformation syndrome,231720,Non-acquired combined pituitary hormone deficiency-sensorineural hearing loss-spine abnormalities syndrome,Point prevalence,N/A
Disease,1899,Arthrochalasia Ehlers-Danlos syndrome,Point prevalence,N/A
Disease,839,"Congenital nephrotic syndrome, Finnish type",Point prevalence,N/A
Disease,839,"Congenital nephrotic syndrome, Finnish type",Prevalence at birth,N/A
Malformation syndrome,531,Miller-Dieker syndrome,Prevalence at birth,N/A
Malformation syndrome,531,Miller-Dieker syndrome,Point prevalence,N/A
Clinical group,3394,Soft tissue sarcoma,Annual incidence,N/A
Clinical group,3394,Soft tissue sarcoma,Point prevalence,N/A
Clinical group,3394,Soft tissue sarcoma,Annual incidence,N/A
Disease,1084,Isolated lissencephaly type 1 without known genetic defects,Point prevalence,N/A
Morphological anomaly,1083,Microlissencephaly,Point prevalence,N/A
Malformation syndrome,452,X-linked lissencephaly with abnormal genitalia,Cases/families,N/A
Malformation syndrome,452,X-linked lissencephaly with abnormal genitalia,Point prevalence,N/A
Malformation syndrome,238750,4q21 microdeletion syndrome,Point prevalence,N/A
Malformation syndrome,238750,4q21 microdeletion syndrome,Cases/families,N/A
Malformation syndrome,238763,Glaucoma secondary to spherophakia/ectopia lentis and megalocornea,Cases/families,N/A
Malformation syndrome,238763,Glaucoma secondary to spherophakia/ectopia lentis and megalocornea,Point prevalence,N/A
Disease,238722,Familial congenital mirror movements,Cases/families,N/A
Disease,238722,Familial congenital mirror movements,Point prevalence,N/A
Malformation syndrome,238744,Mammary-digital-nail syndrome,Cases/families,N/A
Malformation syndrome,238744,Mammary-digital-nail syndrome,Point prevalence,N/A
Malformation syndrome,238769,1q44 microdeletion syndrome,Cases/families,N/A
Malformation syndrome,238769,1q44 microdeletion syndrome,Point prevalence,N/A
Clinical group,238517,Hypotonia-cystinuria type 1 syndrome,Point prevalence,N/A
Disease,238505,Combined immunodeficiency due to CD27 deficiency,Cases/families,N/A
Disease,238505,Combined immunodeficiency due to CD27 deficiency,Point prevalence,N/A
Disease,238468,Hypohidrotic ectodermal dysplasia,Point prevalence,N/A
Disease,238475,Familial hypercholanemia,Cases/families,N/A
Disease,238475,Familial hypercholanemia,Point prevalence,N/A
Disease,238455,Infantile dystonia-parkinsonism,Cases/families,N/A
Disease,238455,Infantile dystonia-parkinsonism,Point prevalence,N/A
Disease,238459,SLC35A1-CDG,Cases/families,N/A
Disease,238459,SLC35A1-CDG,Point prevalence,N/A
Etiological subtype,238578,Familial clubfoot due to 17q23.1q23.2 microduplication,Cases/families,N/A
Etiological subtype,238578,Familial clubfoot due to 17q23.1q23.2 microduplication,Point prevalence,N/A
Disease,238583,Hyperphenylalaninemia due to tetrahydrobiopterin deficiency,Prevalence at birth,N/A
Disease,238583,Hyperphenylalaninemia due to tetrahydrobiopterin deficiency,Point prevalence,N/A
Disease,238583,Hyperphenylalaninemia due to tetrahydrobiopterin deficiency,Point prevalence,N/A
Disease,238557,Chuvash erythrocytosis,Point prevalence,N/A
Disease,238569,Immune dysregulation-inflammatory bowel disease-arthritis-recurrent infections syndrome,Cases/families,N/A
Disease,238569,Immune dysregulation-inflammatory bowel disease-arthritis-recurrent infections syndrome,Point prevalence,N/A
Category,238547,Acquired secondary polycythemia,Point prevalence,N/A
Disease,238523,Atypical hypotonia-cystinuria syndrome,Cases/families,N/A
Disease,238523,Atypical hypotonia-cystinuria syndrome,Point prevalence,N/A
Category,238536,Congenital secondary polycythemia,Point prevalence,N/A
Disease,238624,Idiopathic intracranial hypertension,Point prevalence,N/A
Particular clinical situation in a disease or syndrome,238621,Ileal pouch anal anastomosis related faecal incontinence,Point prevalence,N/A
Disease,238606,Primary orthostatic tremor,Cases/families,N/A
Disease,238606,Primary orthostatic tremor,Point prevalence,N/A
Clinical subtype,238593,IgG4-related mesenteritis,Point prevalence,N/A
Disease,238670,Isolated thyrotropin-releasing hormone deficiency,Point prevalence,N/A
Disease,238666,Isolated congenital hypogonadotropic hypogonadism,Point prevalence,N/A
Disease,238666,Isolated congenital hypogonadotropic hypogonadism,Prevalence at birth,N/A
Clinical subtype,238654,"Congenital primary megaureter, nonrefluxing and unobstructed form",Point prevalence,N/A
Clinical subtype,238650,"Congenital primary megaureter, refluxing form",Point prevalence,N/A
Clinical subtype,238646,"Congenital primary megaureter, obstructed form",Point prevalence,N/A
Clinical subtype,238642,"Primary megaureter, adult-onset form",Point prevalence,N/A
Clinical subtype,240071,Classic progressive supranuclear palsy syndrome,Point prevalence,N/A
Clinical subtype,240112,Progressive supranuclear palsy-progressive non-fluent aphasia syndrome,Cases/families,N/A
Clinical subtype,240112,Progressive supranuclear palsy-progressive non-fluent aphasia syndrome,Point prevalence,N/A
Clinical subtype,240103,Progressive supranuclear palsy-corticobasal syndrome,Point prevalence,N/A
Clinical subtype,240094,Progressive supranuclear palsy-pure akinesia with gait freezing syndrome,Point prevalence,N/A
Clinical subtype,240085,Progressive supranuclear palsy-predominant parkinsonism syndrome,Point prevalence,N/A
Malformation syndrome,240760,Nijmegen breakage syndrome-like disorder,Cases/families,N/A
Malformation syndrome,240760,Nijmegen breakage syndrome-like disorder,Point prevalence,N/A
Disease,331226,Susceptibility to infection due to TYK2 deficiency,Cases/families,N/A
Disease,331226,Susceptibility to infection due to TYK2 deficiency,Point prevalence,N/A
Disease,331235,Selective IgM deficiency,Point prevalence,N/A
Disease,331176,Severe congenital neutropenia due to G6PC3 deficiency,Cases/families,N/A
Disease,331176,Severe congenital neutropenia due to G6PC3 deficiency,Point prevalence,N/A
Disease,331187,Immunodeficiency due to MASP-2 deficiency,Cases/families,N/A
Disease,331187,Immunodeficiency due to MASP-2 deficiency,Point prevalence,N/A
Disease,331190,Immunodeficiency due to ficolin3 deficiency,Cases/families,N/A
Disease,331190,Immunodeficiency due to ficolin3 deficiency,Point prevalence,N/A
Disease,331206,Severe combined immunodeficiency due to complete RAG1/2 deficiency,Point prevalence,N/A
Disease,330064,Chronic actinic dermatitis,Point prevalence,N/A
Disease,330064,Chronic actinic dermatitis,Point prevalence,N/A
Disease,330001,Wild type ATTR amyloidosis,Point prevalence,N/A
Clinical subtype,329977,Classic neuroendocrine tumor of appendix,Annual incidence,N/A
Clinical subtype,329977,Classic neuroendocrine tumor of appendix,Point prevalence,N/A
Clinical subtype,329984,Goblet cell carcinoma,Annual incidence,N/A
Clinical subtype,329984,Goblet cell carcinoma,Point prevalence,N/A
Particular clinical situation in a disease or syndrome,330012,High altitude pulmonary edema,Point prevalence,N/A
Disease,330015,Lead poisoning,Point prevalence,N/A
Disease,330015,Lead poisoning,Point prevalence,N/A
Disease,330032,Hemoglobin Lepore-beta-thalassemia syndrome,Point prevalence,N/A
Disease,330041,Hemoglobin M disease,Point prevalence,N/A
Disease,330021,Mercury poisoning,Point prevalence,N/A
Disease,330029,Hypotrichosis-deafness syndrome,Cases/families,N/A
Disease,330029,Hypotrichosis-deafness syndrome,Point prevalence,N/A
Disease,330058,Hydroa vacciniforme,Point prevalence,N/A
Disease,330058,Hydroa vacciniforme,Point prevalence,N/A
Disease,330061,Actinic prurigo,Point prevalence,N/A
Etiological subtype,330050,DNM1L-related encephalopathy due to mitochondrial and peroxisomal fission defect,Cases/families,N/A
Etiological subtype,330050,DNM1L-related encephalopathy due to mitochondrial and peroxisomal fission defect,Point prevalence,N/A
Disease,330054,Congenital cataract-progressive muscular hypotonia-hearing loss-developmental delay syndrome,Cases/families,N/A
Disease,330054,Congenital cataract-progressive muscular hypotonia-hearing loss-developmental delay syndrome,Point prevalence,N/A
Malformation syndrome,329813,Mosaic genome-wide paternal uniparental disomy syndrome,Cases/families,N/A
Malformation syndrome,329813,Mosaic genome-wide paternal uniparental disomy syndrome,Point prevalence,N/A
Malformation syndrome,329802,5p13 microduplication syndrome,Cases/families,N/A
Malformation syndrome,329802,5p13 microduplication syndrome,Point prevalence,N/A
Disease,329883,Non-hypoproteinemic hypertrophic gastropathy,Cases/families,N/A
Disease,329883,Non-hypoproteinemic hypertrophic gastropathy,Point prevalence,N/A
Disease,329874,Idiopathic giant cell myocarditis,Point prevalence,N/A
Disease,329475,Spastic paraplegia-Paget disease of bone syndrome,Cases/families,N/A
Disease,329475,Spastic paraplegia-Paget disease of bone syndrome,Point prevalence,N/A
Disease,329481,Lipoprotein glomerulopathy,Point prevalence,N/A
Disease,329481,Lipoprotein glomerulopathy,Cases/families,N/A
Disease,329478,Adult-onset distal myopathy due to VCP mutation,Cases/families,N/A
Disease,329478,Adult-onset distal myopathy due to VCP mutation,Point prevalence,N/A
Disease,329942,Transient neonatal multiple acyl-CoA dehydrogenase deficiency,Cases/families,N/A
Disease,329942,Transient neonatal multiple acyl-CoA dehydrogenase deficiency,Point prevalence,N/A
Clinical subtype,329971,Generalized juvenile polyposis/juvenile polyposis coli,Point prevalence,N/A
Disease,329967,Intermittent hydrarthrosis,Point prevalence,N/A
Clinical subtype,329918,C3 glomerulopathy,Annual incidence,N/A
Clinical subtype,329903,Immunoglobulin-mediated membranoproliferative glomerulonephritis,Point prevalence,N/A
Disease,329308,Fatty acid hydroxylase-associated neurodegeneration,Point prevalence,N/A
Disease,329314,Adult-onset multiple mitochondrial DNA deletion syndrome due to DGUOK deficiency,Point prevalence,N/A
Disease,329319,Thrombocythemia with distal limb defects,Cases/families,N/A
Disease,329319,Thrombocythemia with distal limb defects,Point prevalence,N/A
Disease,329324,Inverse Klippel-Trnaunay syndrome,Cases/families,N/A
Disease,329324,Inverse Klippel-Trnaunay syndrome,Point prevalence,N/A
Disease,329284,Beta-propeller protein-associated neurodegeneration,Cases/families,N/A
Disease,329284,Beta-propeller protein-associated neurodegeneration,Point prevalence,N/A
Disease,329457,Distal arthrogryposis type 5D,Cases/families,N/A
Disease,329457,Distal arthrogryposis type 5D,Point prevalence,N/A
Disease,329466,"Autosomal dominant focal dystonia, DYT25 type",Cases/families,N/A
Disease,329466,"Autosomal dominant focal dystonia, DYT25 type",Point prevalence,N/A
Clinical subtype,329469,Acute megakaryoblastic leukemia in children without Down syndrome,Point prevalence,N/A
Malformation syndrome,329329,Autosomal recessive frontotemporal pachygyria,Cases/families,N/A
Malformation syndrome,329329,Autosomal recessive frontotemporal pachygyria,Point prevalence,N/A
Malformation syndrome,329332,Microcephaly-cerebellar hypoplasia-cardiac conduction defect syndrome,Cases/families,N/A
Malformation syndrome,329332,Microcephaly-cerebellar hypoplasia-cardiac conduction defect syndrome,Point prevalence,N/A
Disease,329336,Adult-onset chronic progressive external ophthalmoplegia with mitochondrial myopathy,Point prevalence,N/A
Malformation syndrome,329228,Microcephalic primordial dwarfism due to ZNF335 deficiency,Cases/families,N/A
Malformation syndrome,329228,Microcephalic primordial dwarfism due to ZNF335 deficiency,Point prevalence,N/A
Malformation syndrome,329224,Schuurs-Hoeijmakers syndrome,Cases/families,N/A
Malformation syndrome,329224,Schuurs-Hoeijmakers syndrome,Point prevalence,N/A
Disease,329217,Cerebral sinovenous thrombosis,Annual incidence,N/A
Disease,329217,Cerebral sinovenous thrombosis,Point prevalence,N/A
Disease,329211,Autosomal dominant neovascular inflammatory vitreoretinopathy,Cases/families,N/A
Disease,329211,Autosomal dominant neovascular inflammatory vitreoretinopathy,Point prevalence,N/A
Disease,329195,Developmental delay with autism spectrum disorder and gait instability,Cases/families,N/A
Disease,329195,Developmental delay with autism spectrum disorder and gait instability,Point prevalence,N/A
Disease,329191,Tall stature-long halluces-multiple extra-epiphyses syndrome,Cases/families,N/A
Disease,329191,Tall stature-long halluces-multiple extra-epiphyses syndrome,Point prevalence,N/A
Disease,329178,Congenital muscular dystrophy with intellectual disability and severe epilepsy,Cases/families,N/A
Disease,329178,Congenital muscular dystrophy with intellectual disability and severe epilepsy,Point prevalence,N/A
Disease,329258,Autosomal dominant Charcot-Marie-Tooth disease type 2Q,Cases/families,N/A
Disease,329258,Autosomal dominant Charcot-Marie-Tooth disease type 2Q,Point prevalence,N/A
Etiological subtype,329249,Severe early-onset obesity-insulin resistance syndrome due to SH2B1 deficiency,Cases/families,N/A
Etiological subtype,329249,Severe early-onset obesity-insulin resistance syndrome due to SH2B1 deficiency,Point prevalence,N/A
Disease,329242,Congenital chronic diarrhea with protein-losing enteropathy,Cases/families,N/A
Disease,329242,Congenital chronic diarrhea with protein-losing enteropathy,Point prevalence,N/A
Disease,329235,X-linked central congenital hypothyroidism with late-onset testicular enlargement,Cases/families,N/A
Disease,329235,X-linked central congenital hypothyroidism with late-onset testicular enlargement,Point prevalence,N/A
Disease,329173,Autoinflammatory syndrome with pyogenic bacterial infection and amylopectinosis,Cases/families,N/A
Disease,329173,Autoinflammatory syndrome with pyogenic bacterial infection and amylopectinosis,Point prevalence,N/A
Disease,329,Congenital factor XI deficiency,Point prevalence,N/A
Disease,1243,Best vitelliform macular dystrophy,Prevalence at birth,N/A
Disease,1243,Best vitelliform macular dystrophy,Point prevalence,N/A
Disease,1243,Best vitelliform macular dystrophy,Point prevalence,N/A
Disease,1243,Best vitelliform macular dystrophy,Point prevalence,N/A
Disease,1243,Best vitelliform macular dystrophy,Point prevalence,N/A
Disease,324964,Chronic nonbacterial osteomyelitis/Chronic recurrent multifocal osteomyelitis,Point prevalence,N/A
Disease,324964,Chronic nonbacterial osteomyelitis/Chronic recurrent multifocal osteomyelitis,Annual incidence,N/A
Disease,324972,MAGIC syndrome,Cases/families,N/A
Disease,324972,MAGIC syndrome,Point prevalence,N/A
Disease,324977,Proteasome-associated autoinflammatory syndrome,Point prevalence,N/A
Disease,324977,Proteasome-associated autoinflammatory syndrome,Cases/families,N/A
Clinical subtype,324718,ABetaA21G amyloidosis,Cases/families,N/A
Clinical subtype,324718,ABetaA21G amyloidosis,Point prevalence,N/A
Clinical subtype,324713,"ABeta amyloidosis, Italian type",Cases/families,N/A
Clinical subtype,324713,"ABeta amyloidosis, Italian type",Point prevalence,N/A
Disease,324737,SRD5A3-CDG,Cases/families,N/A
Disease,324737,SRD5A3-CDG,Point prevalence,N/A
Clinical subtype,324723,"ABeta amyloidosis, Arctic type",Cases/families,N/A
Clinical subtype,324723,"ABeta amyloidosis, Arctic type",Point prevalence,N/A
Disease,324648,Invasive non-typhoidal salmonellosis,Point prevalence,N/A
Disease,324636,Autoerythrocyte sensitization syndrome,Cases/families,N/A
Disease,324636,Autoerythrocyte sensitization syndrome,Point prevalence,N/A
Clinical subtype,324708,"ABeta amyloidosis, Iowa type",Cases/families,N/A
Clinical subtype,324708,"ABeta amyloidosis, Iowa type",Point prevalence,N/A
Clinical subtype,324703,ABetaL34V amyloidosis,Cases/families,N/A
Clinical subtype,324703,ABetaL34V amyloidosis,Point prevalence,N/A
Disease,324611,Autosomal dominant Charcot-Marie-Tooth disease type 2 due to KIF5A mutation,Point prevalence,N/A
Disease,324632,Hendra virus infection,Cases/families,N/A
Disease,324632,Hendra virus infection,Point prevalence,N/A
Disease,324625,Chikungunya,Annual incidence,N/A
Disease,324625,Chikungunya,Point prevalence,N/A
Disease,324625,Chikungunya,Annual incidence,N/A
Disease,324625,Chikungunya,Annual incidence,N/A
Disease,324625,Chikungunya,Annual incidence,N/A
Disease,324625,Chikungunya,Annual incidence,N/A
Disease,324625,Chikungunya,Annual incidence,N/A
Disease,324625,Chikungunya,Annual incidence,N/A
Disease,324625,Chikungunya,Annual incidence,N/A
Disease,324625,Chikungunya,Annual incidence,N/A
Disease,324625,Chikungunya,Annual incidence,N/A
Disease,324625,Chikungunya,Annual incidence,N/A
Disease,324625,Chikungunya,Annual incidence,N/A
Disease,324625,Chikungunya,Annual incidence,N/A
Disease,324625,Chikungunya,Annual incidence,N/A
Disease,324625,Chikungunya,Annual incidence,N/A
Disease,324625,Chikungunya,Annual incidence,N/A
Disease,324588,Familial dyskinesia and facial myokymia,Cases/families,N/A
Disease,324588,Familial dyskinesia and facial myokymia,Point prevalence,N/A
Malformation syndrome,324601,X-linked cleft palate and ankyloglossia,Point prevalence,N/A
Disease,324581,Benign Samaritan congenital myopathy,Cases/families,N/A
Disease,324581,Benign Samaritan congenital myopathy,Point prevalence,N/A
Disease,324585,Autosomal dominant intermediate Charcot-Marie-Tooth disease with neuropathic pain,Cases/families,N/A
Disease,324585,Autosomal dominant intermediate Charcot-Marie-Tooth disease with neuropathic pain,Point prevalence,N/A
Malformation syndrome,324569,Pontocerebellar hypoplasia type 8,Cases/families,N/A
Malformation syndrome,324569,Pontocerebellar hypoplasia type 8,Point prevalence,N/A
Disease,324575,Hyperinsulinism due to HNF1A deficiency,Cases/families,N/A
Disease,324575,Hyperinsulinism due to HNF1A deficiency,Point prevalence,N/A
Malformation syndrome,324540,Aphonia-deafness-retinal dystrophy-bifid halluces-intellectual disability syndrome,Cases/families,N/A
Malformation syndrome,324540,Aphonia-deafness-retinal dystrophy-bifid halluces-intellectual disability syndrome,Point prevalence,N/A
Disease,324561,Hypopigmentation-punctate palmoplantar keratoderma syndrome,Cases/families,N/A
Disease,324561,Hypopigmentation-punctate palmoplantar keratoderma syndrome,Point prevalence,N/A
Disease,324530,Autoinflammation-PLCG2-associated antibody deficiency-immune dysregulation,Cases/families,N/A
Disease,324530,Autoinflammation-PLCG2-associated antibody deficiency-immune dysregulation,Point prevalence,N/A
Disease,324535,Combined oxidative phosphorylation defect type 11,Cases/families,N/A
Disease,324535,Combined oxidative phosphorylation defect type 11,Point prevalence,N/A
Disease,324525,Hypertrophic cardiomyopathy with kidney anomalies due to mitochondrial DNA mutation,Cases/families,N/A
Disease,324525,Hypertrophic cardiomyopathy with kidney anomalies due to mitochondrial DNA mutation,Point prevalence,N/A
Disease,324442,Autosomal recessive axonal neuropathy with neuromyotonia,Cases/families,N/A
Disease,324442,Autosomal recessive axonal neuropathy with neuromyotonia,Point prevalence,N/A
Malformation syndrome,324416,Muscular hypertrophy-hepatomegaly-polyhydramnios syndrome,Cases/families,N/A
Malformation syndrome,324416,Muscular hypertrophy-hepatomegaly-polyhydramnios syndrome,Point prevalence,N/A
Disease,324422,ALG13-CDG,Cases/families,N/A
Disease,324422,ALG13-CDG,Point prevalence,N/A
Disease,324410,X-linked intellectual disability-cardiomegaly-congestive heart failure syndrome,Cases/families,N/A
Disease,324410,X-linked intellectual disability-cardiomegaly-congestive heart failure syndrome,Point prevalence,N/A
Disease,324381,Hereditary inclusion body myopathy type 4,Cases/families,N/A
Disease,324381,Hereditary inclusion body myopathy type 4,Point prevalence,N/A
Disease,324364,Mixed sclerosing bone dystrophy with extra-skeletal manifestations,Cases/families,N/A
Disease,324364,Mixed sclerosing bone dystrophy with extra-skeletal manifestations,Point prevalence,N/A
Morphological anomaly,324353,Congenital achiasma,Point prevalence,N/A
Disease,324321,Sinoatrial node dysfunction and deafness,Cases/families,N/A
Disease,324321,Sinoatrial node dysfunction and deafness,Point prevalence,N/A
Malformation syndrome,324313,9p13 microdeletion syndrome,Cases/families,N/A
Malformation syndrome,324313,9p13 microdeletion syndrome,Point prevalence,N/A
Malformation syndrome,324307,Severe lateral tibial bowing-short stature-mild winged scapula-mild facial dysmorphism syndrome,Cases/families,N/A
Malformation syndrome,324307,Severe lateral tibial bowing-short stature-mild winged scapula-mild facial dysmorphism syndrome,Point prevalence,N/A
Disease,324299,Multiple paragangliomas associated with polycythemia,Cases/families,N/A
Disease,324299,Multiple paragangliomas associated with polycythemia,Point prevalence,N/A
Disease,324294,T-cell immunodeficiency with epidermodysplasia verruciformis,Cases/families,N/A
Disease,324294,T-cell immunodeficiency with epidermodysplasia verruciformis,Point prevalence,N/A
Disease,324290,Early-onset Lafora body disease,Cases/families,N/A
Disease,324290,Early-onset Lafora body disease,Point prevalence,N/A
Clinical subtype,324262,Autosomal recessive congenital cerebellar ataxia due to MGLUR1 deficiency,Cases/families,N/A
Clinical subtype,324262,Autosomal recessive congenital cerebellar ataxia due to MGLUR1 deficiency,Point prevalence,N/A
Disease,320360,MT-ATP6-related mitochondrial spastic paraplegia,Cases/families,N/A
Disease,320360,MT-ATP6-related mitochondrial spastic paraplegia,Point prevalence,N/A
Disease,320355,Autosomal dominant spastic paraplegia type 41,Cases/families,N/A
Disease,320355,Autosomal dominant spastic paraplegia type 41,Point prevalence,N/A
Disease,320370,Autosomal recessive spastic paraplegia type 43,Cases/families,N/A
Disease,320370,Autosomal recessive spastic paraplegia type 43,Point prevalence,N/A
Disease,320365,Autosomal dominant spastic paraplegia type 36,Cases/families,N/A
Disease,320365,Autosomal dominant spastic paraplegia type 36,Point prevalence,N/A
Disease,320380,Autosomal recessive spastic paraplegia type 54,Cases/families,N/A
Disease,320380,Autosomal recessive spastic paraplegia type 54,Point prevalence,N/A
Disease,320375,Autosomal recessive spastic paraplegia type 55,Point prevalence,N/A
Disease,320375,Autosomal recessive spastic paraplegia type 55,Cases/families,N/A
Disease,320391,Autosomal recessive spastic paraplegia type 46,Cases/families,N/A
Disease,320391,Autosomal recessive spastic paraplegia type 46,Point prevalence,N/A
Disease,320385,Hereditary sensory and autonomic neuropathy due to TECPR2 mutation,Cases/families,N/A
Disease,320385,Hereditary sensory and autonomic neuropathy due to TECPR2 mutation,Point prevalence,N/A
Disease,320401,Autosomal recessive spastic paraplegia type 44,Cases/families,N/A
Disease,320401,Autosomal recessive spastic paraplegia type 44,Point prevalence,N/A
Disease,320396,Autosomal recessive spastic paraplegia type 45,Cases/families,N/A
Disease,320396,Autosomal recessive spastic paraplegia type 45,Point prevalence,N/A
Disease,320411,Autosomal recessive spastic paraplegia type 56,Cases/families,N/A
Disease,320411,Autosomal recessive spastic paraplegia type 56,Point prevalence,N/A
Disease,320406,Spastic paraplegia-optic atrophy-neuropathy syndrome,Cases/families,N/A
Disease,320406,Spastic paraplegia-optic atrophy-neuropathy syndrome,Point prevalence,N/A
Category,319543,Autosomal dominant mendelian susceptibility to mycobacterial diseases due to a partial deficiency,Point prevalence,N/A
Disease,319547,Mendelian susceptibility to mycobacterial diseases due to complete IFNgammaR2 deficiency,Cases/families,N/A
Disease,319547,Mendelian susceptibility to mycobacterial diseases due to complete IFNgammaR2 deficiency,Point prevalence,N/A
Category,319535,Autosomal recessive mendelian susceptibility to mycobacterial diseases due to a complete deficiency,Point prevalence,N/A
Category,319539,Autosomal recessive mendelian susceptibility to mycobacterial diseases due to a partial deficiency,Point prevalence,N/A
Disease,319519,Combined oxidative phosphorylation defect type 14,Cases/families,N/A
Disease,319519,Combined oxidative phosphorylation defect type 14,Point prevalence,N/A
Disease,319524,Combined oxidative phosphorylation defect type 15,Cases/families,N/A
Disease,319524,Combined oxidative phosphorylation defect type 15,Point prevalence,N/A
Disease,319509,Combined oxidative phosphorylation defect type 9,Cases/families,N/A
Disease,319509,Combined oxidative phosphorylation defect type 9,Point prevalence,N/A
Disease,319514,Combined oxidative phosphorylation defect type 13,Cases/families,N/A
Disease,319514,Combined oxidative phosphorylation defect type 13,Point prevalence,N/A
Disease,319589,Autosomal dominant mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR2 deficiency,Cases/families,N/A
Disease,319589,Autosomal dominant mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR2 deficiency,Point prevalence,N/A
Disease,319595,Mendelian susceptibility to mycobacterial diseases due to partial STAT1 deficiency,Cases/families,N/A
Disease,319595,Mendelian susceptibility to mycobacterial diseases due to partial STAT1 deficiency,Point prevalence,N/A
Disease,319574,Autosomal recessive mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR2 deficiency,Cases/families,N/A
Disease,319574,Autosomal recessive mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR2 deficiency,Point prevalence,N/A
Disease,319581,Autosomal dominant mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR1 deficiency,Cases/families,N/A
Disease,319581,Autosomal dominant mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR1 deficiency,Point prevalence,N/A
Disease,319563,Mendelian susceptibility to mycobacterial diseases due to complete ISG15 deficiency,Cases/families,N/A
Disease,319563,Mendelian susceptibility to mycobacterial diseases due to complete ISG15 deficiency,Point prevalence,N/A
Disease,319569,Autosomal recessive mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR1 deficiency,Cases/families,N/A
Disease,319569,Autosomal recessive mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR1 deficiency,Point prevalence,N/A
Disease,319552,Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency,Cases/families,N/A
Disease,319552,Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency,Point prevalence,N/A
Disease,319558,Mendelian susceptibility to mycobacterial diseases due to complete IL12B deficiency,Cases/families,N/A
Disease,319558,Mendelian susceptibility to mycobacterial diseases due to complete IL12B deficiency,Point prevalence,N/A
Disease,319651,Constitutional megaloblastic anemia with severe neurologic disease,Cases/families,N/A
Disease,319651,Constitutional megaloblastic anemia with severe neurologic disease,Point prevalence,N/A
Disease,319646,PGM1-CDG,Cases/families,N/A
Disease,319646,PGM1-CDG,Point prevalence,N/A
Disease,319640,Retinal macular dystrophy type 2,Cases/families,N/A
Disease,319640,Retinal macular dystrophy type 2,Point prevalence,N/A
Disease,319635,Amyloidosis cutis dyschromia,Cases/families,N/A
Disease,319635,Amyloidosis cutis dyschromia,Point prevalence,N/A
Etiological subtype,319623,X-linked mendelian susceptibility to mycobacterial diseases due to CYBB deficiency,Cases/families,N/A
Etiological subtype,319623,X-linked mendelian susceptibility to mycobacterial diseases due to CYBB deficiency,Point prevalence,N/A
Etiological subtype,319612,X-linked mendelian susceptibility to mycobacterial diseases due to IKBKG deficiency,Cases/families,N/A
Etiological subtype,319612,X-linked mendelian susceptibility to mycobacterial diseases due to IKBKG deficiency,Point prevalence,N/A
Disease,319605,X-linked mendelian susceptibility to mycobacterial diseases,Cases/families,N/A
Disease,319605,X-linked mendelian susceptibility to mycobacterial diseases,Point prevalence,N/A
Disease,319600,Mendelian susceptibility to mycobacterial diseases due to partial IRF8 deficiency,Cases/families,N/A
Disease,319600,Mendelian susceptibility to mycobacterial diseases due to partial IRF8 deficiency,Point prevalence,N/A
Disease,319678,Encephalopathy-hypertrophic cardiomyopathy-renal tubular disease syndrome,Cases/families,N/A
Disease,319678,Encephalopathy-hypertrophic cardiomyopathy-renal tubular disease syndrome,Point prevalence,N/A
Malformation syndrome,319675,"Microcephalic primordial dwarfism, Dauber type",Cases/families,N/A
Malformation syndrome,319675,"Microcephalic primordial dwarfism, Dauber type",Point prevalence,N/A
Malformation syndrome,319671,Alazami syndrome,Cases/families,N/A
Malformation syndrome,319671,Alazami syndrome,Point prevalence,N/A
Disease,319276,Clear cell renal carcinoma,Annual incidence,N/A
Disease,319251,Rift valley fever,Annual incidence,N/A
Disease,319319,Renal medullary carcinoma,Annual incidence,N/A
Disease,319298,Papillary renal cell carcinoma,Annual incidence,N/A
Disease,319303,Chromophobe renal cell carcinoma,Annual incidence,N/A
Disease,319332,Autosomal recessive myogenic arthrogryposis multiplex congenita,Cases/families,N/A
Disease,319332,Autosomal recessive myogenic arthrogryposis multiplex congenita,Point prevalence,N/A
Disease,319340,Carney complex-trismus-pseudocamptodactyly syndrome,Cases/families,N/A
Disease,319340,Carney complex-trismus-pseudocamptodactyly syndrome,Point prevalence,N/A
Disease,319504,Combined oxidative phosphorylation defect type 8,Cases/families,N/A
Disease,319504,Combined oxidative phosphorylation defect type 8,Point prevalence,N/A
Disease,319195,Chondroectodermal dysplasia with night blindness,Cases/families,N/A
Disease,319195,Chondroectodermal dysplasia with night blindness,Point prevalence,N/A
Disease,319199,Autosomal recessive spastic paraplegia type 53,Cases/families,N/A
Disease,319199,Autosomal recessive spastic paraplegia type 53,Point prevalence,N/A
Disease,319218,Ebola hemorrhagic fever,Cases/families,N/A
Disease,319218,Ebola hemorrhagic fever,Annual incidence,N/A
Disease,319218,Ebola hemorrhagic fever,Point prevalence,N/A
Disease,319160,Congenital myopathy with internal nuclei and atypical cores,Cases/families,N/A
Disease,319160,Congenital myopathy with internal nuclei and atypical cores,Point prevalence,N/A
Malformation syndrome,319171,Distal 17p13.1 microdeletion syndrome,Cases/families,N/A
Malformation syndrome,319171,Distal 17p13.1 microdeletion syndrome,Point prevalence,N/A
Disease,319189,Familial cortical myoclonus,Cases/families,N/A
Disease,319189,Familial cortical myoclonus,Point prevalence,N/A
Malformation syndrome,319182,Wiedemann-Steiner syndrome,Cases/families,N/A
Malformation syndrome,319182,Wiedemann-Steiner syndrome,Point prevalence,N/A
Clinical subtype,317428,Combined immunodeficiency due to ORAI1 deficiency,Cases/families,N/A
Clinical subtype,317428,Combined immunodeficiency due to ORAI1 deficiency,Point prevalence,N/A
Disease,317425,Severe combined immunodeficiency due to DNA-PKcs deficiency,Cases/families,N/A
Disease,317425,Severe combined immunodeficiency due to DNA-PKcs deficiency,Point prevalence,N/A
Clinical subtype,317430,Combined immunodeficiency due to STIM1 deficiency,Point prevalence,N/A
Disease,317473,Pancytopenia due to IKZF1 mutations,Cases/families,N/A
Disease,317473,Pancytopenia due to IKZF1 mutations,Point prevalence,N/A
Disease,317476,XMEN,Cases/families,N/A
Disease,317476,XMEN,Point prevalence,N/A
Clinical subtype,315311,"Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, simple virilizing form",Point prevalence,N/A
Clinical subtype,315306,"Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, salt wasting form",Prevalence at birth,N/A
Clinical subtype,315306,"Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, salt wasting form",Point prevalence,N/A
Malformation syndrome,314993,Cataract-congenital heart disease-neural tube defect syndrome,Cases/families,N/A
Malformation syndrome,314993,Cataract-congenital heart disease-neural tube defect syndrome,Point prevalence,N/A
Disease,314978,X-linked non progressive cerebellar ataxia,Cases/families,N/A
Disease,314978,X-linked non progressive cerebellar ataxia,Point prevalence,N/A
Clinical subtype,314970,Lymphocytic hypereosinophilic syndrome,Point prevalence,N/A
Disease,314962,Secondary hypereosinophilic syndrome,Point prevalence,N/A
Disease,314950,Primary hypereosinophilic syndrome,Point prevalence,N/A
Clinical subtype,314918,Mild Canavan disease,Point prevalence,N/A
Clinical subtype,314911,Severe Canavan disease,Point prevalence,N/A
Clinical subtype,314701,Primary systemic amyloidosis,Point prevalence,N/A
Malformation syndrome,314679,Cerebrofacioarticular syndrome,Cases/families,N/A
Malformation syndrome,314679,Cerebrofacioarticular syndrome,Point prevalence,N/A
Disease,314667,TMEM165-CDG,Cases/families,N/A
Disease,314667,TMEM165-CDG,Point prevalence,N/A
Disease,314689,Combined immunodeficiency due to STK4 deficiency,Cases/families,N/A
Disease,314689,Combined immunodeficiency due to STK4 deficiency,Point prevalence,N/A
Disease,314684,Primary bone lymphoma,Point prevalence,N/A
Disease,314652,Variant ABeta2M amyloidosis,Cases/families,N/A
Disease,314652,Variant ABeta2M amyloidosis,Point prevalence,N/A
Disease,314647,Non-progressive cerebellar ataxia with intellectual disability,Cases/families,N/A
Disease,314647,Non-progressive cerebellar ataxia with intellectual disability,Point prevalence,N/A
Disease,314662,Segmental progressive overgrowth syndrome with fibroadipose hyperplasia,Cases/families,N/A
Disease,314662,Segmental progressive overgrowth syndrome with fibroadipose hyperplasia,Point prevalence,N/A
Etiological subtype,314655,Severe neonatal hypotonia-seizures-encephalopathy syndrome due to 5q31.3 microdeletion,Cases/families,N/A
Etiological subtype,314655,Severe neonatal hypotonia-seizures-encephalopathy syndrome due to 5q31.3 microdeletion,Point prevalence,N/A
Morphological anomaly,314621,Duplication of the pituitary gland,Cases/families,N/A
Morphological anomaly,314621,Duplication of the pituitary gland,Point prevalence,N/A
Disease,314637,Mitochondrial hypertrophic cardiomyopathy with lactic acidosis due to MTO1 deficiency,Cases/families,N/A
Disease,314637,Mitochondrial hypertrophic cardiomyopathy with lactic acidosis due to MTO1 deficiency,Point prevalence,N/A
Disease,314632,CLN12 disease,Cases/families,N/A
Disease,314632,CLN12 disease,Point prevalence,N/A
Disease,314802,Short stature due to partial GHR deficiency,Point prevalence,N/A
Disease,314811,Short stature due to GHSR deficiency,Cases/families,N/A
Disease,314811,Short stature due to GHSR deficiency,Point prevalence,N/A
Clinical subtype,314889,Autosomal dominant proximal renal tubular acidosis,Cases/families,N/A
Clinical subtype,314889,Autosomal dominant proximal renal tubular acidosis,Point prevalence,N/A
Disease,314777,Familial isolated pituitary adenoma,Cases/families,N/A
Disease,314777,Familial isolated pituitary adenoma,Point prevalence,N/A
Disease,314795,SHOX-related short stature,Point prevalence,N/A
Disease,314718,Lethal arteriopathy syndrome due to fibulin-4 deficiency,Cases/families,N/A
Disease,314718,Lethal arteriopathy syndrome due to fibulin-4 deficiency,Point prevalence,N/A
Clinical subtype,314721,Atypical dentin dysplasia due to SMOC2 deficiency,Cases/families,N/A
Clinical subtype,314721,Atypical dentin dysplasia due to SMOC2 deficiency,Point prevalence,N/A
Disease,370127,Medich giant platelet syndrome,Cases/families,N/A
Disease,370127,Medich giant platelet syndrome,Point prevalence,N/A
Disease,370103,"Primary dystonia, DYT17 type",Cases/families,N/A
Disease,370103,"Primary dystonia, DYT17 type",Point prevalence,N/A
Disease,370097,Oculocutaneous albinism type 6,Cases/families,N/A
Disease,370097,Oculocutaneous albinism type 6,Point prevalence,N/A
Disease,370091,Oculocutaneous albinism type 5,Cases/families,N/A
Disease,370091,Oculocutaneous albinism type 5,Point prevalence,N/A
Disease,370348,Peripheral primitive neuroectodermal tumor,Point prevalence,N/A
Disease,370334,Extraskeletal Ewing sarcoma,Annual incidence,N/A
Disease,370334,Extraskeletal Ewing sarcoma,Annual incidence,N/A
Disease,370334,Extraskeletal Ewing sarcoma,Annual incidence,N/A
Disease,370334,Extraskeletal Ewing sarcoma,Annual incidence,N/A
Disease,370334,Extraskeletal Ewing sarcoma,Annual incidence,N/A
Disease,370334,Extraskeletal Ewing sarcoma,Annual incidence,N/A
Disease,370334,Extraskeletal Ewing sarcoma,Annual incidence,N/A
Disease,370334,Extraskeletal Ewing sarcoma,Annual incidence,N/A
Disease,370334,Extraskeletal Ewing sarcoma,Annual incidence,N/A
Disease,370334,Extraskeletal Ewing sarcoma,Annual incidence,N/A
Disease,370334,Extraskeletal Ewing sarcoma,Annual incidence,N/A
Disease,370334,Extraskeletal Ewing sarcoma,Annual incidence,N/A
Disease,370334,Extraskeletal Ewing sarcoma,Annual incidence,N/A
Disease,370334,Extraskeletal Ewing sarcoma,Annual incidence,N/A
Disease,370334,Extraskeletal Ewing sarcoma,Annual incidence,N/A
Disease,370334,Extraskeletal Ewing sarcoma,Annual incidence,N/A
Disease,370334,Extraskeletal Ewing sarcoma,Annual incidence,N/A
Disease,370334,Extraskeletal Ewing sarcoma,Annual incidence,N/A
Disease,370334,Extraskeletal Ewing sarcoma,Annual incidence,N/A
Disease,370334,Extraskeletal Ewing sarcoma,Annual incidence,N/A
Disease,370334,Extraskeletal Ewing sarcoma,Annual incidence,N/A
Disease,370334,Extraskeletal Ewing sarcoma,Annual incidence,N/A
Disease,370131,White platelet syndrome,Cases/families,N/A
Disease,370131,White platelet syndrome,Point prevalence,N/A
Disease,370046,Didymosis aplasticosebacea,Cases/families,N/A
Disease,370046,Didymosis aplasticosebacea,Point prevalence,N/A
Clinical subtype,370034,Familial syringomyelia,Point prevalence,N/A
Disease,370039,Angora hair nevus,Cases/families,N/A
Disease,370039,Angora hair nevus,Point prevalence,N/A
Disease,370022,Ataxia-intellectual disability-oculomotor apraxia-cerebellar cysts syndrome,Cases/families,N/A
Disease,370022,Ataxia-intellectual disability-oculomotor apraxia-cerebellar cysts syndrome,Point prevalence,N/A
Disease,370026,Acute myeloid leukemia with t(8;16)(p11;p13) translocation,Point prevalence,N/A
Disease,370015,"Spondyloepimetaphyseal dysplasia, Isidor-Toutain type",Cases/families,N/A
Disease,370015,"Spondyloepimetaphyseal dysplasia, Isidor-Toutain type",Point prevalence,N/A
Disease,370088,Acute infantile liver failure-multisystemic involvement syndrome,Cases/families,N/A
Disease,370088,Acute infantile liver failure-multisystemic involvement syndrome,Point prevalence,N/A
Malformation syndrome,370076,Fetal carbamazepine syndrome,Point prevalence,N/A
Disease,370052,SCALP syndrome,Cases/families,N/A
Disease,370052,SCALP syndrome,Point prevalence,N/A
Disease,371007,Congenital muscular dystrophy with hyperlaxity,Cases/families,N/A
Disease,371007,Congenital muscular dystrophy with hyperlaxity,Point prevalence,N/A
Disease,370997,Muscle-eye-brain disease with bilateral multicystic leucodystrophy,Cases/families,N/A
Disease,370997,Muscle-eye-brain disease with bilateral multicystic leucodystrophy,Point prevalence,N/A
Disease,370921,STT3A-CDG,Cases/families,N/A
Disease,370921,STT3A-CDG,Point prevalence,N/A
Disease,370924,STT3B-CDG,Cases/families,N/A
Disease,370924,STT3B-CDG,Point prevalence,N/A
Disease,370927,SSR4-CDG,Cases/families,N/A
Disease,370927,SSR4-CDG,Point prevalence,N/A
Disease,370930,XYLT1-CDG,Cases/families,N/A
Disease,370930,XYLT1-CDG,Point prevalence,N/A
Disease,370968,Congenital muscular dystrophy with intellectual disability,Point prevalence,N/A
Disease,370968,Congenital muscular dystrophy with intellectual disability,Annual incidence,N/A
Disease,370980,Congenital muscular dystrophy without intellectual disability,Point prevalence,N/A
Disease,370980,Congenital muscular dystrophy without intellectual disability,Annual incidence,N/A
Disease,370943,Autism spectrum disorder-epilepsy-arthrogryposis syndrome,Cases/families,N/A
Disease,370943,Autism spectrum disorder-epilepsy-arthrogryposis syndrome,Point prevalence,N/A
Disease,369929,Primary hyperaldosteronism-seizures-neurological abnormalities syndrome,Cases/families,N/A
Disease,369929,Primary hyperaldosteronism-seizures-neurological abnormalities syndrome,Point prevalence,N/A
Malformation syndrome,369920,Pontocerebellar hypoplasia type 9,Cases/families,N/A
Malformation syndrome,369920,Pontocerebellar hypoplasia type 9,Point prevalence,N/A
Disease,369942,CADDS,Cases/families,N/A
Disease,369942,CADDS,Point prevalence,N/A
Malformation syndrome,369939,Severe motor and intellectual disabilities-sensorineural deafness-dystonia syndrome,Cases/families,N/A
Malformation syndrome,369939,Severe motor and intellectual disabilities-sensorineural deafness-dystonia syndrome,Point prevalence,N/A
Clinical subtype,369955,"Methylmalonic acidemia with homocystinuria, type cblJ",Cases/families,N/A
Clinical subtype,369955,"Methylmalonic acidemia with homocystinuria, type cblJ",Point prevalence,N/A
Disease,369950,Intellectual disability-seizures-macrocephaly-obesity syndrome,Cases/families,N/A
Disease,369950,Intellectual disability-seizures-macrocephaly-obesity syndrome,Point prevalence,N/A
Disease,369970,Microcornea-myopic chorioretinal atrophy-telecanthus syndrome,Cases/families,N/A
Disease,369970,Microcornea-myopic chorioretinal atrophy-telecanthus syndrome,Point prevalence,N/A
Clinical subtype,369962,"Methylmalonic acidemia with homocystinuria, type cblX",Cases/families,N/A
Clinical subtype,369962,"Methylmalonic acidemia with homocystinuria, type cblX",Point prevalence,N/A
Malformation syndrome,369979,Finger hyperphalangy-toe anomalies-severe pectus excavatum syndrome,Cases/families,N/A
Malformation syndrome,369979,Finger hyperphalangy-toe anomalies-severe pectus excavatum syndrome,Point prevalence,N/A
Disease,369992,Severe dermatitis-multiple allergies-metabolic wasting syndrome,Cases/families,N/A
Disease,369992,Severe dermatitis-multiple allergies-metabolic wasting syndrome,Point prevalence,N/A
Disease,370002,Focal palmoplantar keratoderma with joint keratoses,Point prevalence,N/A
Disease,369999,Diffuse palmoplantar keratoderma with painful fissures,Point prevalence,N/A
Malformation syndrome,370010,Intellectual disability-facial dysmorphism-hand anomalies syndrome,Cases/families,N/A
Malformation syndrome,370010,Intellectual disability-facial dysmorphism-hand anomalies syndrome,Point prevalence,N/A
Malformation syndrome,369837,Intellectual disability-seizures-hypophosphatasia-ophthalmic-skeletal anomalies syndrome,Cases/families,N/A
Malformation syndrome,369837,Intellectual disability-seizures-hypophosphatasia-ophthalmic-skeletal anomalies syndrome,Point prevalence,N/A
Disease,369840,TRAPPC11-related limb-girdle muscular dystrophy R18,Cases/families,N/A
Disease,369840,TRAPPC11-related limb-girdle muscular dystrophy R18,Point prevalence,N/A
Disease,369847,Intellectual disability-hyperkinetic movement-truncal ataxia syndrome,Cases/families,N/A
Disease,369847,Intellectual disability-hyperkinetic movement-truncal ataxia syndrome,Point prevalence,N/A
Disease,369852,Congenital neutropenia-myelofibrosis-nephromegaly syndrome,Cases/families,N/A
Disease,369852,Congenital neutropenia-myelofibrosis-nephromegaly syndrome,Point prevalence,N/A
Disease,369861,Congenital sideroblastic anemia-B-cell immunodeficiency-periodic fever-developmental delay syndrome,Cases/families,N/A
Disease,369861,Congenital sideroblastic anemia-B-cell immunodeficiency-periodic fever-developmental delay syndrome,Point prevalence,N/A
Disease,369867,Autosomal recessive intermediate Charcot-Marie-Tooth disease type C,Cases/families,N/A
Disease,369867,Autosomal recessive intermediate Charcot-Marie-Tooth disease type C,Point prevalence,N/A
Etiological subtype,369873,Obesity due to SIM1 deficiency,Point prevalence,N/A
Malformation syndrome,369881,2p21 microdeletion syndrome without cystinuria,Cases/families,N/A
Malformation syndrome,369881,2p21 microdeletion syndrome without cystinuria,Point prevalence,N/A
Clinical group,369886,Homozygous 2p21 microdeletion syndrome,Point prevalence,N/A
Malformation syndrome,369891,Developmental delay-facial dysmorphism syndrome due to MED13L deficiency,Cases/families,N/A
Malformation syndrome,369891,Developmental delay-facial dysmorphism syndrome due to MED13L deficiency,Point prevalence,N/A
Disease,369897,"Mitochondrial DNA depletion syndrome, encephalomyopathic form with variable craniofacial anomalies",Cases/families,N/A
Disease,369897,"Mitochondrial DNA depletion syndrome, encephalomyopathic form with variable craniofacial anomalies",Point prevalence,N/A
Disease,369913,Combined oxidative phosphorylation defect type 17,Cases/families,N/A
Disease,369913,Combined oxidative phosphorylation defect type 17,Point prevalence,N/A
Disease,364055,Severe early-childhood-onset retinal dystrophy,Point prevalence,N/A
Disease,364028,X-linked intellectual disability due to GRIA3 mutations,Cases/families,N/A
Disease,364028,X-linked intellectual disability due to GRIA3 mutations,Point prevalence,N/A
Disease,364033,Systemic Epstein-Barr virus-positive T-cell lymphoproliferative disease of childhood,Point prevalence,N/A
Disease,772,Infantile Refsum disease,Point prevalence,N/A
Disease,1194,TMEM70-related mitochondrial encephalo-cardio-myopathy,Point prevalence,N/A
Clinical subtype,363999,Non-immune hydrops fetalis,Prevalence at birth,N/A
Clinical subtype,363999,Non-immune hydrops fetalis,Point prevalence,N/A
Clinical subtype,363999,Non-immune hydrops fetalis,Point prevalence,N/A
Morphological anomaly,1048,Isolated anencephaly/exencephaly,Prevalence at birth,N/A
Morphological anomaly,1048,Isolated anencephaly/exencephaly,Point prevalence,N/A
Morphological anomaly,1048,Isolated anencephaly/exencephaly,Prevalence at birth,N/A
Morphological anomaly,1048,Isolated anencephaly/exencephaly,Prevalence at birth,N/A
Morphological anomaly,1048,Isolated anencephaly/exencephaly,Prevalence at birth,N/A
Morphological anomaly,1048,Isolated anencephaly/exencephaly,Prevalence at birth,N/A
Morphological anomaly,1048,Isolated anencephaly/exencephaly,Prevalence at birth,N/A
Clinical subtype,364013,Immune hydrops fetalis,Point prevalence,N/A
Clinical subtype,364013,Immune hydrops fetalis,Prevalence at birth,N/A
Category,823,Spina bifida and other spinal dysraphisms,Prevalence at birth,N/A
Category,823,Spina bifida and other spinal dysraphisms,Point prevalence,N/A
Category,823,Spina bifida and other spinal dysraphisms,Point prevalence,N/A
Category,823,Spina bifida and other spinal dysraphisms,Prevalence at birth,N/A
Category,823,Spina bifida and other spinal dysraphisms,Prevalence at birth,N/A
Category,823,Spina bifida and other spinal dysraphisms,Prevalence at birth,N/A
Category,823,Spina bifida and other spinal dysraphisms,Prevalence at birth,N/A
Category,823,Spina bifida and other spinal dysraphisms,Prevalence at birth,N/A
Category,823,Spina bifida and other spinal dysraphisms,Prevalence at birth,N/A
Category,823,Spina bifida and other spinal dysraphisms,Prevalence at birth,N/A
Category,823,Spina bifida and other spinal dysraphisms,Prevalence at birth,N/A
Category,823,Spina bifida and other spinal dysraphisms,Prevalence at birth,N/A
Category,823,Spina bifida and other spinal dysraphisms,Prevalence at birth,N/A
Category,823,Spina bifida and other spinal dysraphisms,Prevalence at birth,N/A
Category,823,Spina bifida and other spinal dysraphisms,Prevalence at birth,N/A
Category,823,Spina bifida and other spinal dysraphisms,Prevalence at birth,N/A
Category,823,Spina bifida and other spinal dysraphisms,Prevalence at birth,N/A
Category,823,Spina bifida and other spinal dysraphisms,Prevalence at birth,N/A
Category,823,Spina bifida and other spinal dysraphisms,Prevalence at birth,N/A
Category,823,Spina bifida and other spinal dysraphisms,Prevalence at birth,N/A
Category,823,Spina bifida and other spinal dysraphisms,Prevalence at birth,N/A
Category,823,Spina bifida and other spinal dysraphisms,Prevalence at birth,N/A
Disease,363992,Ichthyosis-short stature-brachydactyly-microspherophakia syndrome,Cases/families,N/A
Disease,363992,Ichthyosis-short stature-brachydactyly-microspherophakia syndrome,Point prevalence,N/A
Disease,363976,Giant cell tumor of bone,Annual incidence,N/A
Disease,363976,Giant cell tumor of bone,Point prevalence,N/A
Disease,363981,Charcot-Marie-Tooth disease type 4B3,Cases/families,N/A
Disease,363981,Charcot-Marie-Tooth disease type 4B3,Point prevalence,N/A
Disease,363969,Autosomal recessive cerebral atrophy,Cases/families,N/A
Disease,363969,Autosomal recessive cerebral atrophy,Point prevalence,N/A
Etiological subtype,363965,Koolen-De Vries syndrome due to a point mutation,Cases/families,N/A
Etiological subtype,363965,Koolen-De Vries syndrome due to a point mutation,Point prevalence,N/A
Etiological subtype,363958,17q21.31 microdeletion syndrome,Point prevalence,N/A
Disease,363746,Balint syndrome,Point prevalence,N/A
Disease,363741,Colobomatous microphthalmia-obesity-hypogenitalism-intellectual disability syndrome,Point prevalence,N/A
Disease,363727,X-linked dyserythropoietic anemia with abnormal platelets and neutropenia,Cases/families,N/A
Disease,363727,X-linked dyserythropoietic anemia with abnormal platelets and neutropenia,Point prevalence,N/A
Clinical subtype,363722,Alexander disease type II,Point prevalence,N/A
Clinical subtype,363717,Alexander disease type I,Point prevalence,N/A
Disease,363710,Spinocerebellar ataxia type 37,Cases/families,N/A
Disease,363710,Spinocerebellar ataxia type 37,Point prevalence,N/A
Disease,363705,Craniofaciofrontodigital syndrome,Cases/families,N/A
Disease,363705,Craniofaciofrontodigital syndrome,Point prevalence,N/A
Disease,363694,Hyperuricemia-pulmonary hypertension-renal failure-alkalosis syndrome,Cases/families,N/A
Disease,363694,Hyperuricemia-pulmonary hypertension-renal failure-alkalosis syndrome,Point prevalence,N/A
Disease,363686,Severe intellectual disability-poor language-strabismus-grimacing face-long fingers syndrome,Cases/families,N/A
Disease,363686,Severe intellectual disability-poor language-strabismus-grimacing face-long fingers syndrome,Point prevalence,N/A
Malformation syndrome,363680,2p13.2 microdeletion syndrome,Cases/families,N/A
Malformation syndrome,363680,2p13.2 microdeletion syndrome,Point prevalence,N/A
Disease,363677,Childhood-onset autosomal recessive myopathy with external ophthalmoplegia,Cases/families,N/A
Disease,363677,Childhood-onset autosomal recessive myopathy with external ophthalmoplegia,Point prevalence,N/A
Malformation syndrome,364577,Intellectual disability-brachydactyly-Pierre Robin syndrome,Cases/families,N/A
Malformation syndrome,364577,Intellectual disability-brachydactyly-Pierre Robin syndrome,Point prevalence,N/A
Morphological anomaly,364198,Bipartite talus,Cases/families,N/A
Morphological anomaly,364198,Bipartite talus,Point prevalence,N/A
Malformation syndrome,363417,Temtamy preaxial brachydactyly syndrome,Cases/families,N/A
Malformation syndrome,363417,Temtamy preaxial brachydactyly syndrome,Point prevalence,N/A
Disease,363409,Fetal akinesia-cerebral and retinal hemorrhage syndrome,Cases/families,N/A
Disease,363409,Fetal akinesia-cerebral and retinal hemorrhage syndrome,Point prevalence,N/A
Disease,363412,Hypomyelination with brain stem and spinal cord involvement and leg spasticity,Cases/families,N/A
Disease,363412,Hypomyelination with brain stem and spinal cord involvement and leg spasticity,Point prevalence,N/A
Disease,363429,Autosomal recessive cerebellar ataxia-pyramidal signs-nystagmus-oculomotor apraxia syndrome,Cases/families,N/A
Disease,363429,Autosomal recessive cerebellar ataxia-pyramidal signs-nystagmus-oculomotor apraxia syndrome,Point prevalence,N/A
Clinical subtype,363432,Autosomal recessive congenital cerebellar ataxia due to GRID2 deficiency,Cases/families,N/A
Clinical subtype,363432,Autosomal recessive congenital cerebellar ataxia due to GRID2 deficiency,Point prevalence,N/A
Disease,363424,Multiple mitochondrial dysfunctions syndrome type 3,Cases/families,N/A
Disease,363424,Multiple mitochondrial dysfunctions syndrome type 3,Point prevalence,N/A
Disease,363396,High myopia-sensorineural deafness syndrome,Cases/families,N/A
Disease,363396,High myopia-sensorineural deafness syndrome,Point prevalence,N/A
Disease,363400,Severe neurodegenerative syndrome with lipodystrophy,Cases/families,N/A
Disease,363400,Severe neurodegenerative syndrome with lipodystrophy,Point prevalence,N/A
Category,363203,Ring chromosome syndrome,Prevalence at birth,N/A
Disease,363618,LMNA-related cardiocutaneous progeria syndrome,Cases/families,N/A
Disease,363618,LMNA-related cardiocutaneous progeria syndrome,Point prevalence,N/A
Disease,363623,GMPPB-related limb-girdle muscular dystrophy R19,Cases/families,N/A
Disease,363623,GMPPB-related limb-girdle muscular dystrophy R19,Point prevalence,N/A
Disease,363649,Mandibular hypoplasia-deafness-progeroid features-lipodystrophy syndrome,Cases/families,N/A
Disease,363649,Mandibular hypoplasia-deafness-progeroid features-lipodystrophy syndrome,Point prevalence,N/A
Disease,363654,X-linked parkinsonism-spasticity syndrome,Cases/families,N/A
Disease,363654,X-linked parkinsonism-spasticity syndrome,Point prevalence,N/A
Malformation syndrome,363659,20q11.2 microduplication syndrome,Point prevalence,N/A
Disease,363665,Acroosteolysis-keloid-like lesions-premature aging syndrome,Cases/families,N/A
Disease,363665,Acroosteolysis-keloid-like lesions-premature aging syndrome,Point prevalence,N/A
Disease,363540,Leukoencephalopathy with mild cerebellar ataxia and white matter edema,Cases/families,N/A
Disease,363540,Leukoencephalopathy with mild cerebellar ataxia and white matter edema,Point prevalence,N/A
Disease,363549,Acute encephalopathy with biphasic seizures and late reduced diffusion,Cases/families,N/A
Disease,363549,Acute encephalopathy with biphasic seizures and late reduced diffusion,Point prevalence,N/A
Disease,363558,New-onset refractory status epilepticus,Point prevalence,N/A
Clinical group,363567,Acute encephalopathy with inflammation-mediated status epilepticus,Point prevalence,N/A
Category,363579,Extragonadal germ cell tumor,Annual incidence,N/A
Disease,363611,CTCF-related neurodevelopmental disorder,Cases/families,N/A
Disease,363611,CTCF-related neurodevelopmental disorder,Point prevalence,N/A
Disease,363494,Non-seminomatous germ cell tumor of testis,Annual incidence,N/A
Disease,363494,Non-seminomatous germ cell tumor of testis,Lifetime Prevalence,N/A
Disease,363523,Hypohidrosis-enamel hypoplasia-palmoplantar keratoderma-intellectual disability syndrome,Cases/families,N/A
Disease,363523,Hypohidrosis-enamel hypoplasia-palmoplantar keratoderma-intellectual disability syndrome,Point prevalence,N/A
Disease,363534,"Mitochondrial DNA depletion syndrome, hepatocerebrorenal form",Cases/families,N/A
Disease,363534,"Mitochondrial DNA depletion syndrome, hepatocerebrorenal form",Point prevalence,N/A
Disease,363528,Intellectual disability-strabismus syndrome,Cases/families,N/A
Disease,363528,Intellectual disability-strabismus syndrome,Point prevalence,N/A
Malformation syndrome,363444,THOC6-related developmental delay-microcephaly-facial dysmorphism syndrome,Cases/families,N/A
Malformation syndrome,363444,THOC6-related developmental delay-microcephaly-facial dysmorphism syndrome,Point prevalence,N/A
Etiological subtype,363454,BICD2-related autosomal dominant childhood-onset proximal spinal muscular atrophy,Cases/families,N/A
Etiological subtype,363454,BICD2-related autosomal dominant childhood-onset proximal spinal muscular atrophy,Point prevalence,N/A
Disease,363447,Autosomal dominant childhood-onset proximal spinal muscular atrophy,Point prevalence,N/A
Disease,363447,Autosomal dominant childhood-onset proximal spinal muscular atrophy,Cases/families,N/A
Disease,363478,Paratesticular adenocarcinoma,Lifetime Prevalence,N/A
Disease,363478,Paratesticular adenocarcinoma,Point prevalence,N/A
Disease,363478,Paratesticular adenocarcinoma,Annual incidence,N/A
Disease,363478,Paratesticular adenocarcinoma,Annual incidence,N/A
Disease,363478,Paratesticular adenocarcinoma,Annual incidence,N/A
Disease,363478,Paratesticular adenocarcinoma,Annual incidence,N/A
Disease,363478,Paratesticular adenocarcinoma,Annual incidence,N/A
Disease,363478,Paratesticular adenocarcinoma,Annual incidence,N/A
Disease,363478,Paratesticular adenocarcinoma,Annual incidence,N/A
Disease,363478,Paratesticular adenocarcinoma,Annual incidence,N/A
Disease,363478,Paratesticular adenocarcinoma,Annual incidence,N/A
Disease,363478,Paratesticular adenocarcinoma,Annual incidence,N/A
Disease,363478,Paratesticular adenocarcinoma,Annual incidence,N/A
Disease,363478,Paratesticular adenocarcinoma,Annual incidence,N/A
Category,363472,Tumor of testis and paratestis,Annual incidence,N/A
Category,363472,Tumor of testis and paratestis,Lifetime Prevalence,N/A
Category,363472,Tumor of testis and paratestis,Point prevalence,N/A
Disease,363489,Sex cord-stromal tumor of testis,Annual incidence,N/A
Disease,363489,Sex cord-stromal tumor of testis,Lifetime Prevalence,N/A
Disease,363489,Sex cord-stromal tumor of testis,Annual incidence,N/A
Disease,363489,Sex cord-stromal tumor of testis,Annual incidence,N/A
Disease,363489,Sex cord-stromal tumor of testis,Annual incidence,N/A
Disease,363489,Sex cord-stromal tumor of testis,Annual incidence,N/A
Disease,363489,Sex cord-stromal tumor of testis,Annual incidence,N/A
Disease,363489,Sex cord-stromal tumor of testis,Annual incidence,N/A
Disease,363489,Sex cord-stromal tumor of testis,Annual incidence,N/A
Disease,363489,Sex cord-stromal tumor of testis,Annual incidence,N/A
Disease,363489,Sex cord-stromal tumor of testis,Annual incidence,N/A
Disease,363489,Sex cord-stromal tumor of testis,Annual incidence,N/A
Disease,363489,Sex cord-stromal tumor of testis,Annual incidence,N/A
Disease,363489,Sex cord-stromal tumor of testis,Annual incidence,N/A
Disease,363489,Sex cord-stromal tumor of testis,Annual incidence,N/A
Disease,363489,Sex cord-stromal tumor of testis,Annual incidence,N/A
Disease,363489,Sex cord-stromal tumor of testis,Annual incidence,N/A
Disease,363489,Sex cord-stromal tumor of testis,Annual incidence,N/A
Disease,363489,Sex cord-stromal tumor of testis,Annual incidence,N/A
Disease,363489,Sex cord-stromal tumor of testis,Annual incidence,N/A
Disease,363489,Sex cord-stromal tumor of testis,Annual incidence,N/A
Disease,363489,Sex cord-stromal tumor of testis,Annual incidence,N/A
Disease,363489,Sex cord-stromal tumor of testis,Annual incidence,N/A
Disease,363483,Testicular teratoma,Lifetime Prevalence,N/A
Disease,363483,Testicular teratoma,Point prevalence,N/A
Malformation syndrome,357175,Short ulna-dysmorphism-hypotonia-intellectual disability syndrome,Cases/families,N/A
Malformation syndrome,357175,Short ulna-dysmorphism-hypotonia-intellectual disability syndrome,Point prevalence,N/A
Disease,357329,Combined immunodeficiency due to IL21R deficiency,Cases/families,N/A
Disease,357329,Combined immunodeficiency due to IL21R deficiency,Point prevalence,N/A
Malformation syndrome,357332,Syndactyly-camptodactyly and clinodactyly of fifth fingers-bifid toes syndrome,Cases/families,N/A
Malformation syndrome,357332,Syndactyly-camptodactyly and clinodactyly of fifth fingers-bifid toes syndrome,Point prevalence,N/A
Disease,357237,Combined immunodeficiency due to CARD11 deficiency,Cases/families,N/A
Disease,357237,Combined immunodeficiency due to CARD11 deficiency,Point prevalence,N/A
Clinical group,357502,Idiopathic nephrotic syndrome,Point prevalence,N/A
Disease,356978,"D,L-2-hydroxyglutaric aciduria",Cases/families,N/A
Disease,356978,"D,L-2-hydroxyglutaric aciduria",Point prevalence,N/A
Malformation syndrome,356947,3q26q27 microdeletion syndrome,Cases/families,N/A
Malformation syndrome,356947,3q26q27 microdeletion syndrome,Point prevalence,N/A
Disease,356961,SLC35A2-CDG,Cases/families,N/A
Disease,356961,SLC35A2-CDG,Point prevalence,N/A
Disease,357008,Hemolytic uremic syndrome with DGKE deficiency,Cases/families,N/A
Disease,357008,Hemolytic uremic syndrome with DGKE deficiency,Point prevalence,N/A
Malformation syndrome,357001,19p13.13 microdeletion syndrome,Cases/families,N/A
Malformation syndrome,357001,19p13.13 microdeletion syndrome,Point prevalence,N/A
Disease,356996,ANK3-related intellectual disability-sleep disturbance syndrome,Cases/families,N/A
Disease,356996,ANK3-related intellectual disability-sleep disturbance syndrome,Point prevalence,N/A
Disease,357043,Amyotrophic lateral sclerosis type 4,Cases/families,N/A
Disease,357043,Amyotrophic lateral sclerosis type 4,Point prevalence,N/A
Clinical subtype,357034,Non-hereditary retinoblastoma,Annual incidence,N/A
Clinical subtype,357034,Non-hereditary retinoblastoma,Point prevalence,N/A
Clinical subtype,357027,Hereditary retinoblastoma,Point prevalence,N/A
Disease,357158,Mandibulofacial dysostosis-macroblepharon-macrostomia syndrome,Cases/families,N/A
Disease,357158,Mandibulofacial dysostosis-macroblepharon-macrostomia syndrome,Point prevalence,N/A
Disease,357154,Oral submucous fibrosis,Point prevalence,N/A
Disease,352654,Early-onset progressive neurodegeneration-blindness-ataxia-spasticity syndrome,Cases/families,N/A
Disease,352654,Early-onset progressive neurodegeneration-blindness-ataxia-spasticity syndrome,Point prevalence,N/A
Disease,352662,Corneal intraepithelial dyskeratosis-palmoplantar hyperkeratosis-laryngeal dyskeratosis syndrome,Cases/families,N/A
Disease,352662,Corneal intraepithelial dyskeratosis-palmoplantar hyperkeratosis-laryngeal dyskeratosis syndrome,Point prevalence,N/A
Disease,352657,Hereditary benign intraepithelial dyskeratosis,Point prevalence,N/A
Disease,352641,Autosomal recessive cerebellar ataxia with late-onset spasticity,Cases/families,N/A
Disease,352641,Autosomal recessive cerebellar ataxia with late-onset spasticity,Point prevalence,N/A
Disease,352636,Phalangeal microgeodic syndrome,Cases/families,N/A
Disease,352636,Phalangeal microgeodic syndrome,Point prevalence,N/A
Disease,352649,Brain dopamine-serotonin vesicular transport disease,Cases/families,N/A
Disease,352649,Brain dopamine-serotonin vesicular transport disease,Point prevalence,N/A
Disease,352596,Progressive myoclonic epilepsy with dystonia,Cases/families,N/A
Disease,352596,Progressive myoclonic epilepsy with dystonia,Point prevalence,N/A
Disease,352629,16q24.1 microdeletion syndrome,Cases/families,N/A
Disease,352629,16q24.1 microdeletion syndrome,Point prevalence,N/A
Disease,352577,Bainbridge-Ropers syndrome,Cases/families,N/A
Disease,352577,Bainbridge-Ropers syndrome,Point prevalence,N/A
Disease,352587,Focal epilepsy-intellectual disability-cerebro-cerebellar malformation,Cases/families,N/A
Disease,352587,Focal epilepsy-intellectual disability-cerebro-cerebellar malformation,Point prevalence,N/A
Disease,352582,Familial infantile myoclonic epilepsy,Cases/families,N/A
Disease,352582,Familial infantile myoclonic epilepsy,Point prevalence,N/A
Disease,352731,Oculocutaneous albinism type 1,Point prevalence,N/A
Clinical subtype,352734,Minimal pigment oculocutaneous albinism type 1,Cases/families,N/A
Clinical subtype,352734,Minimal pigment oculocutaneous albinism type 1,Point prevalence,N/A
Clinical subtype,352737,Temperature-sensitive oculocutaneous albinism type 1,Cases/families,N/A
Clinical subtype,352737,Temperature-sensitive oculocutaneous albinism type 1,Point prevalence,N/A
Disease,352712,Facial dysmorphism-immunodeficiency-livedo-short stature syndrome,Cases/families,N/A
Disease,352712,Facial dysmorphism-immunodeficiency-livedo-short stature syndrome,Point prevalence,N/A
Disease,352718,Progressive retinal dystrophy due to retinol transport defect,Cases/families,N/A
Disease,352718,Progressive retinal dystrophy due to retinol transport defect,Point prevalence,N/A
Disease,352723,Attenuated Chdiak-Higashi syndrome,Cases/families,N/A
Disease,352723,Attenuated Chdiak-Higashi syndrome,Point prevalence,N/A
Etiological subtype,352665,Neurodevelopmental disorder-craniofacial dysmorphism-cardiac defect-skeletal anomalies syndrome due to 9q21.3 microdeletion,Cases/families,N/A
Etiological subtype,352665,Neurodevelopmental disorder-craniofacial dysmorphism-cardiac defect-skeletal anomalies syndrome due to 9q21.3 microdeletion,Point prevalence,N/A
Disease,352670,Autosomal dominant intermediate Charcot-Marie-Tooth disease type F,Cases/families,N/A
Disease,352670,Autosomal dominant intermediate Charcot-Marie-Tooth disease type F,Point prevalence,N/A
Disease,352675,X-linked Charcot-Marie-Tooth disease type 6,Cases/families,N/A
Disease,352675,X-linked Charcot-Marie-Tooth disease type 6,Point prevalence,N/A
Disease,352682,Cobblestone lissencephaly without muscular or ocular involvement,Cases/families,N/A
Disease,352682,Cobblestone lissencephaly without muscular or ocular involvement,Point prevalence,N/A
Disease,353253,Burning mouth syndrome,Point prevalence,N/A
Disease,353253,Burning mouth syndrome,Point prevalence,N/A
Disease,353220,Familial primary localized cutaneous amyloidosis,Point prevalence,N/A
Disease,352763,Scleredema,Point prevalence,N/A
Disease,352745,Oculocutaneous albinism type 7,Cases/families,N/A
Disease,352745,Oculocutaneous albinism type 7,Point prevalence,N/A
Morphological anomaly,353334,Congenital retinal arteriovenous communication,Point prevalence,N/A
Clinical subtype,353320,"Pyruvate carboxylase deficiency, benign type",Cases/families,N/A
Clinical subtype,353320,"Pyruvate carboxylase deficiency, benign type",Point prevalence,N/A
Etiological subtype,353327,Congenital myasthenic syndromes with glycosylation defect,Point prevalence,N/A
Clinical subtype,353308,"Pyruvate carboxylase deficiency, infantile type",Point prevalence,N/A
Clinical subtype,353314,"Pyruvate carboxylase deficiency, severe neonatal type",Point prevalence,N/A
Disease,353298,Roifman syndrome,Cases/families,N/A
Disease,353298,Roifman syndrome,Point prevalence,N/A
Etiological subtype,353284,Rubinstein-Taybi syndrome due to EP300 haploinsufficiency,Cases/families,N/A
Etiological subtype,353284,Rubinstein-Taybi syndrome due to EP300 haploinsufficiency,Point prevalence,N/A
Disease,352403,Spectrin-associated autosomal recessive cerebellar ataxia,Cases/families,N/A
Disease,352403,Spectrin-associated autosomal recessive cerebellar ataxia,Point prevalence,N/A
Disease,352333,Congenital ichthyosis-intellectual disability-spastic quadriplegia syndrome,Cases/families,N/A
Disease,352333,Congenital ichthyosis-intellectual disability-spastic quadriplegia syndrome,Point prevalence,N/A
Disease,352328,MEGDEL syndrome,Cases/families,N/A
Disease,352328,MEGDEL syndrome,Point prevalence,N/A
Disease,352447,Progressive external ophthalmoplegia-myopathy-emaciation syndrome,Cases/families,N/A
Disease,352447,Progressive external ophthalmoplegia-myopathy-emaciation syndrome,Point prevalence,N/A
Disease,352530,Intellectual disability-obesity-brain malformations-facial dysmorphism syndrome,Cases/families,N/A
Disease,352530,Intellectual disability-obesity-brain malformations-facial dysmorphism syndrome,Point prevalence,N/A
Disease,352563,Infantile hypertrophic cardiomyopathy due to MRPL44 deficiency,Cases/families,N/A
Disease,352563,Infantile hypertrophic cardiomyopathy due to MRPL44 deficiency,Point prevalence,N/A
Disease,352540,Oncogenic osteomalacia,Cases/families,N/A
Disease,352540,Oncogenic osteomalacia,Point prevalence,N/A
Disease,352479,ISPD-related limb-girdle muscular dystrophy R20,Cases/families,N/A
Disease,352479,ISPD-related limb-girdle muscular dystrophy R20,Point prevalence,N/A
Disease,352470,DNA2-related mitochondrial DNA deletion syndrome,Cases/families,N/A
Disease,352470,DNA2-related mitochondrial DNA deletion syndrome,Point prevalence,N/A
Disease,352490,Autism spectrum disorder due to AUTS2 deficiency,Cases/families,N/A
Disease,352490,Autism spectrum disorder due to AUTS2 deficiency,Point prevalence,N/A
Clinical syndrome,294422,Chronic intestinal failure,Prevalence at birth,N/A
Clinical syndrome,294422,Chronic intestinal failure,Point prevalence,N/A
Disease,293987,Rapid-onset childhood obesity-hypothalamic dysfunction-hypoventilation-autonomic dysregulation syndrome,Cases/families,N/A
Disease,293987,Rapid-onset childhood obesity-hypothalamic dysfunction-hypoventilation-autonomic dysregulation syndrome,Point prevalence,N/A
Malformation syndrome,294016,Microcephaly-capillary malformation syndrome,Cases/families,N/A
Malformation syndrome,294016,Microcephaly-capillary malformation syndrome,Point prevalence,N/A
Disease,294023,Neonatal inflammatory skin and bowel disease,Cases/families,N/A
Disease,294023,Neonatal inflammatory skin and bowel disease,Point prevalence,N/A
Malformation syndrome,294026,Syndactyly-nystagmus syndrome due to 2q31.1 microduplication,Cases/families,N/A
Malformation syndrome,294026,Syndactyly-nystagmus syndrome due to 2q31.1 microduplication,Point prevalence,N/A
Disease,293964,Hypoinsulinemic hypoglycemia and body hemihypertrophy,Cases/families,N/A
Disease,293964,Hypoinsulinemic hypoglycemia and body hemihypertrophy,Point prevalence,N/A
Malformation syndrome,293967,Hypogonadotropic hypogonadism-severe microcephaly-sensorineural hearing loss-dysmorphism syndrome,Cases/families,N/A
Malformation syndrome,293967,Hypogonadotropic hypogonadism-severe microcephaly-sensorineural hearing loss-dysmorphism syndrome,Point prevalence,N/A
Disease,293978,Deficiency in anterior pituitary function-variable immunodeficiency syndrome,Cases/families,N/A
Disease,293978,Deficiency in anterior pituitary function-variable immunodeficiency syndrome,Point prevalence,N/A
Malformation syndrome,293958,Hypertelorism-preauricular sinus-punctual pits-deafness syndrome,Cases/families,N/A
Malformation syndrome,293958,Hypertelorism-preauricular sinus-punctual pits-deafness syndrome,Point prevalence,N/A
Disease,293955,Childhood encephalopathy due to thiamine pyrophosphokinase deficiency,Cases/families,N/A
Disease,293955,Childhood encephalopathy due to thiamine pyrophosphokinase deficiency,Point prevalence,N/A
Malformation syndrome,293948,1p21.3 microdeletion syndrome,Cases/families,N/A
Malformation syndrome,293948,1p21.3 microdeletion syndrome,Point prevalence,N/A
Malformation syndrome,293939,Distal Xq28 microduplication syndrome,Cases/families,N/A
Malformation syndrome,293939,Distal Xq28 microduplication syndrome,Point prevalence,N/A
Disease,293936,EDICT syndrome,Cases/families,N/A
Disease,293936,EDICT syndrome,Point prevalence,N/A
Malformation syndrome,293925,Lethal occipital encephalocele-skeletal dysplasia syndrome,Cases/families,N/A
Malformation syndrome,293925,Lethal occipital encephalocele-skeletal dysplasia syndrome,Point prevalence,N/A
Malformation syndrome,293864,Hypoplastic pancreas-intestinal atresia-hypoplastic gallbladder syndrome,Cases/families,N/A
Malformation syndrome,293864,Hypoplastic pancreas-intestinal atresia-hypoplastic gallbladder syndrome,Point prevalence,N/A
Malformation syndrome,293843,3MC syndrome,Cases/families,N/A
Malformation syndrome,293843,3MC syndrome,Point prevalence,N/A
Disease,293822,MITF-related melanoma and renal cell carcinoma predisposition syndrome,Cases/families,N/A
Disease,293822,MITF-related melanoma and renal cell carcinoma predisposition syndrome,Point prevalence,N/A
Disease,293825,Congenital dyserythropoietic anemia type IV,Cases/families,N/A
Disease,293825,Congenital dyserythropoietic anemia type IV,Point prevalence,N/A
Disease,293812,Fixed drug eruption,Point prevalence,N/A
Disease,293807,Ketamine-induced biliary dilatation,Cases/families,N/A
Disease,293807,Ketamine-induced biliary dilatation,Point prevalence,N/A
Malformation syndrome,293725,"Blepharophimosis-intellectual disability syndrome, Verloes type",Point prevalence,N/A
Clinical group,293642,Blepharophimosis-intellectual disability syndrome,Cases/families,N/A
Clinical group,293642,Blepharophimosis-intellectual disability syndrome,Point prevalence,N/A
Malformation syndrome,293707,"Blepharophimosis-intellectual disability syndrome, MKB type",Point prevalence,N/A
Morphological anomaly,294975,Isolated absence of upper arm and forearm with hand present,Prevalence at birth,N/A
Morphological anomaly,294975,Isolated absence of upper arm and forearm with hand present,Point prevalence,N/A
Clinical group,294963,Popliteal pterygium syndrome,Prevalence at birth,N/A
Morphological anomaly,294971,Isolated tetra-amelia,Point prevalence,N/A
Clinical subtype,289863,Atypical glycine encephalopathy,Cases/families,N/A
Clinical subtype,289863,Atypical glycine encephalopathy,Point prevalence,N/A
Particular clinical situation in a disease or syndrome,289877,Transient hyperammonemia of the newborn,Point prevalence,N/A
Clinical subtype,289916,Vitamin B12-unresponsive methylmalonic acidemia type mut0,Point prevalence,N/A
Disease,289661,Epstein-Barr virus-positive diffuse large B-cell lymphoma,Annual incidence,N/A
Disease,289661,Epstein-Barr virus-positive diffuse large B-cell lymphoma,Point prevalence,N/A
Clinical subtype,289857,Neonatal glycine encephalopathy,Point prevalence,N/A
Clinical subtype,289860,Infantile glycine encephalopathy,Point prevalence,N/A
Disease,289560,Mitochondrial membrane protein-associated neurodegeneration,Point prevalence,N/A
Malformation syndrome,289553,Dysmorphism-conductive hearing loss-heart defect syndrome,Point prevalence,N/A
Disease,289548,Inherited isolated adrenal insufficiency due to partial CYP11A1 deficiency,Point prevalence,N/A
Disease,289539,BAP1-related tumor predisposition syndrome,Point prevalence,N/A
Disease,289601,Hereditary arterial and articular multiple calcification syndrome,Point prevalence,N/A
Disease,289601,Hereditary arterial and articular multiple calcification syndrome,Cases/families,N/A
Disease,289596,Juvenile nasopharyngeal angiofibroma,Point prevalence,N/A
Disease,289596,Juvenile nasopharyngeal angiofibroma,Annual incidence,N/A
Disease,289586,Exfoliative ichthyosis,Point prevalence,N/A
Clinical group,293355,Methylmalonic acidemia without homocystinuria,Point prevalence,N/A
Clinical group,293355,Methylmalonic acidemia without homocystinuria,Point prevalence,N/A
Disease,293375,Grayson-Wilbrandt corneal dystrophy,Cases/families,N/A
Disease,293375,Grayson-Wilbrandt corneal dystrophy,Point prevalence,N/A
Disease,293381,Epithelial recurrent erosion dystrophy,Cases/families,N/A
Disease,293381,Epithelial recurrent erosion dystrophy,Point prevalence,N/A
Disease,293462,Pre-Descemet corneal dystrophy,Cases/families,N/A
Disease,293462,Pre-Descemet corneal dystrophy,Point prevalence,N/A
Disease,293603,Congenital hereditary endothelial dystrophy type II,Point prevalence,N/A
Disease,293621,X-linked endothelial corneal dystrophy,Cases/families,N/A
Disease,293621,X-linked endothelial corneal dystrophy,Point prevalence,N/A
Disease,811,Shwachman-Diamond syndrome,Prevalence at birth,N/A
Disease,811,Shwachman-Diamond syndrome,Prevalence at birth,N/A
Disease,811,Shwachman-Diamond syndrome,Prevalence at birth,N/A
Disease,811,Shwachman-Diamond syndrome,Prevalence at birth,N/A
Disease,811,Shwachman-Diamond syndrome,Prevalence at birth,N/A
Disease,811,Shwachman-Diamond syndrome,Prevalence at birth,N/A
Disease,811,Shwachman-Diamond syndrome,Point prevalence,N/A
Disease,293168,Infantile-onset ascending hereditary spastic paralysis,Cases/families,N/A
Disease,293168,Infantile-onset ascending hereditary spastic paralysis,Point prevalence,N/A
Disease,293165,Skin fragility-woolly hair-palmoplantar keratoderma syndrome,Cases/families,N/A
Disease,293165,Skin fragility-woolly hair-palmoplantar keratoderma syndrome,Point prevalence,N/A
Clinical subtype,428,Autosomal dominant hypocalcemia,Point prevalence,N/A
Clinical subtype,428,Autosomal dominant hypocalcemia,Point prevalence,N/A
Clinical subtype,428,Autosomal dominant hypocalcemia,Point prevalence,N/A
Disease,293181,Epilepsy of infancy with migrating focal seizures,Cases/families,N/A
Disease,293181,Epilepsy of infancy with migrating focal seizures,Point prevalence,N/A
Disease,293181,Epilepsy of infancy with migrating focal seizures,Point prevalence,N/A
Disease,293181,Epilepsy of infancy with migrating focal seizures,Prevalence at birth,N/A
Disease,2298,Insulin-resistance syndrome type B,Point prevalence,N/A
Clinical group,2207,Familial primary hyperparathyroidism,Point prevalence,N/A
Disease,293173,Acute generalized exanthematous pustulosis,Annual incidence,N/A
Disease,293173,Acute generalized exanthematous pustulosis,Annual incidence,N/A
Disease,293173,Acute generalized exanthematous pustulosis,Point prevalence,N/A
Clinical subtype,293199,Pleomorphic rhabdomyosarcoma,Annual incidence,N/A
Clinical subtype,293199,Pleomorphic rhabdomyosarcoma,Point prevalence,N/A
Malformation syndrome,393,"46,XX testicular difference of sex development",Point prevalence,N/A
Disease,293202,Epithelioid sarcoma,Annual incidence,N/A
Disease,293202,Epithelioid sarcoma,Point prevalence,N/A
Disease,293202,Epithelioid sarcoma,Annual incidence,N/A
Clinical subtype,293284,Tetrahydrobiopterin-responsive hyperphenylalaninemia/phenylketonuria,Point prevalence,N/A
Disease,293208,Celiac artery compression syndrome,Point prevalence,N/A
Disease,2459,Mansonelliasis,Point prevalence,N/A
Disease,2459,Mansonelliasis,Point prevalence,N/A
Disease,2404,Loiasis,Point prevalence,N/A
Disease,2404,Loiasis,Point prevalence,N/A
Clinical subtype,2394,Pyruvate dehydrogenase E3 deficiency,Cases/families,N/A
Clinical subtype,2394,Pyruvate dehydrogenase E3 deficiency,Point prevalence,N/A
Morphological anomaly,2356,Arachnoid cyst,Point prevalence,N/A
Disease,829,Adult-onset Still disease,Annual incidence,N/A
Disease,829,Adult-onset Still disease,Annual incidence,N/A
Disease,829,Adult-onset Still disease,Point prevalence,N/A
Disease,829,Adult-onset Still disease,Annual incidence,N/A
Disease,829,Adult-onset Still disease,Point prevalence,N/A
Disease,829,Adult-onset Still disease,Point prevalence,N/A
Disease,829,Adult-onset Still disease,Annual incidence,N/A
Disease,829,Adult-onset Still disease,Point prevalence,N/A
Disease,1929,Rasmussen subacute encephalitis,Cases/families,N/A
Disease,1929,Rasmussen subacute encephalitis,Point prevalence,N/A
Disease,1183,Opsoclonus-myoclonus syndrome,Annual incidence,N/A
Disease,1183,Opsoclonus-myoclonus syndrome,Point prevalence,N/A
Disease,1183,Opsoclonus-myoclonus syndrome,Annual incidence,N/A
Disease,2688,Adult idiopathic neutropenia,Annual incidence,N/A
Disease,2688,Adult idiopathic neutropenia,Point prevalence,N/A
Disease,2686,Cyclic neutropenia,Point prevalence,N/A
Disease,890,Hepatic veno-occlusive disease,Point prevalence,N/A
Clinical group,176,Non-rhizomelic chondrodysplasia punctata,Point prevalence,N/A
Disease,231,Dracunculiasis,Point prevalence,N/A
Disease,231,Dracunculiasis,Point prevalence,N/A
Disease,2035,Lymphatic filariasis,Point prevalence,N/A
Disease,2035,Lymphatic filariasis,Point prevalence,N/A
Disease,284448,CLIPPERS,Cases/families,N/A
Disease,284448,CLIPPERS,Point prevalence,N/A
Disease,284454,Acute zonal occult outer retinopathy,Cases/families,N/A
Disease,284454,Acute zonal occult outer retinopathy,Point prevalence,N/A
Disease,284460,Acute annular outer retinopathy,Cases/families,N/A
Disease,284460,Acute annular outer retinopathy,Point prevalence,N/A
Etiological subtype,284417,"Phosphoserine aminotransferase deficiency, infantile/juvenile form",Point prevalence,N/A
Clinical subtype,284426,Glycogen storage disease due to lactate dehydrogenase M-subunit deficiency,Point prevalence,N/A
Clinical subtype,284435,Glycogen storage disease due to lactate dehydrogenase H-subunit deficiency,Point prevalence,N/A
Disease,284984,Aneurysm-osteoarthritis syndrome,Cases/families,N/A
Disease,284984,Aneurysm-osteoarthritis syndrome,Point prevalence,N/A
Disease,284979,Neonatal Marfan syndrome,Point prevalence,N/A
Malformation syndrome,289365,Familial vesicoureteral reflux,Point prevalence,N/A
Disease,289347,Infective dermatitis associated with HTLV-1,Point prevalence,N/A
Disease,289356,Primary non-gestational choriocarcinoma of ovary,Point prevalence,N/A
Disease,289377,Early-onset myopathy with fatal cardiomyopathy,Point prevalence,N/A
Disease,289380,Myosclerosis,Point prevalence,N/A
Disease,289290,Hypermethioninemia encephalopathy due to adenosine kinase deficiency,Point prevalence,N/A
Disease,289266,Early-onset epileptic encephalopathy and intellectual disability due to GRIN2A mutation,Point prevalence,N/A
Disease,289326,Tropical spastic paraparesis,Point prevalence,N/A
Disease,289307,Developmental delay due to methylmalonate semialdehyde dehydrogenase deficiency,Point prevalence,N/A
Disease,289504,Combined malonic and methylmalonic acidemia,Annual incidence,N/A
Disease,289504,Combined malonic and methylmalonic acidemia,Point prevalence,N/A
Malformation syndrome,289499,Congenital cataract microcornea with corneal opacity,Point prevalence,N/A
Disease,289494,4H leukodystrophy,Point prevalence,N/A
Disease,289494,4H leukodystrophy,Cases/families,N/A
Malformation syndrome,289522,Microtriplication 11q24.1 syndrome,Cases/families,N/A
Malformation syndrome,289522,Microtriplication 11q24.1 syndrome,Point prevalence,N/A
Malformation syndrome,289513,12q15q21.1 microdeletion syndrome,Cases/families,N/A
Malformation syndrome,289513,12q15q21.1 microdeletion syndrome,Point prevalence,N/A
Disease,289465,Isolated congenital adermatoglyphia,Point prevalence,N/A
Disease,289390,Primary Sjgren syndrome,Point prevalence,N/A
Disease,289390,Primary Sjgren syndrome,Point prevalence,N/A
Disease,289390,Primary Sjgren syndrome,Point prevalence,N/A
Disease,289390,Primary Sjgren syndrome,Point prevalence,N/A
Disease,289390,Primary Sjgren syndrome,Point prevalence,N/A
Disease,289390,Primary Sjgren syndrome,Annual incidence,N/A
Disease,289390,Primary Sjgren syndrome,Point prevalence,N/A
Disease,289390,Primary Sjgren syndrome,Point prevalence,N/A
Disease,289390,Primary Sjgren syndrome,Point prevalence,N/A
Disease,289390,Primary Sjgren syndrome,Point prevalence,N/A
Disease,289390,Primary Sjgren syndrome,Annual incidence,N/A
Disease,289390,Primary Sjgren syndrome,Annual incidence,N/A
Disease,289390,Primary Sjgren syndrome,Annual incidence,N/A
Disease,289390,Primary Sjgren syndrome,Annual incidence,N/A
Particular clinical situation in a disease or syndrome,289385,Malignancy diagnosed during pregnancy,Point prevalence,N/A
Disease,289483,Intellectual disability-alacrima-achalasia syndrome,Point prevalence,N/A
Disease,289478,PASH syndrome,Point prevalence,N/A
Disease,289478,PASH syndrome,Cases/families,N/A
Disease,289176,Autosomal recessive hypophosphatemic rickets,Point prevalence,N/A
Disease,289157,Hypocalcemic vitamin D-dependent rickets,Point prevalence,N/A
Disease,280921,Idiopathic panuveitis,Point prevalence,N/A
Disease,280921,Idiopathic panuveitis,Annual incidence,N/A
Disease,280921,Idiopathic panuveitis,Point prevalence,N/A
Disease,280921,Idiopathic panuveitis,Annual incidence,N/A
Category,280898,Panuveitis,Point prevalence,N/A
Category,280892,Posterior uveitis,Point prevalence,N/A
Category,280886,Anterior uveitis,Point prevalence,N/A
Category,280886,Anterior uveitis,Point prevalence,N/A
Clinical group,281103,Keratinopathic ichthyosis,Point prevalence,N/A
Clinical group,281097,Autosomal recessive congenital ichthyosis,Annual incidence,N/A
Clinical group,281097,Autosomal recessive congenital ichthyosis,Point prevalence,N/A
Clinical group,281097,Autosomal recessive congenital ichthyosis,Point prevalence,N/A
Clinical group,281097,Autosomal recessive congenital ichthyosis,Annual incidence,N/A
Disease,281090,Syndromic recessive X-linked ichthyosis,Point prevalence,N/A
Category,281085,Inherited ichthyosis syndromic form,Point prevalence,N/A
Category,281082,Inherited non-syndromic ichthyosis,Point prevalence,N/A
Disease,281190,Congenital reticular ichthyosiform erythroderma,Cases/families,N/A
Disease,281190,Congenital reticular ichthyosiform erythroderma,Point prevalence,N/A
Disease,281201,Keratosis linearis-ichthyosis congenita-sclerosing keratoderma syndrome,Point prevalence,N/A
Disease,281139,Annular epidermolytic ichthyosis,Cases/families,N/A
Disease,281139,Annular epidermolytic ichthyosis,Point prevalence,N/A
Disease,281122,Self-improving collodion baby,Cases/families,N/A
Disease,281122,Self-improving collodion baby,Point prevalence,N/A
Disease,281127,Acral self-healing collodion baby,Cases/families,N/A
Disease,281127,Acral self-healing collodion baby,Point prevalence,N/A
Disease,280628,Familial progressive hyper- and hypopigmentation,Cases/families,N/A
Disease,280628,Familial progressive hyper- and hypopigmentation,Point prevalence,N/A
Malformation syndrome,280633,Multiple congenital anomalies-hypotonia-seizures syndrome,Cases/families,N/A
Malformation syndrome,280633,Multiple congenital anomalies-hypotonia-seizures syndrome,Point prevalence,N/A
Disease,280615,Hemoglobinopathy Toms River,Cases/families,N/A
Disease,280615,Hemoglobinopathy Toms River,Point prevalence,N/A
Disease,280598,Hereditary sensorimotor neuropathy with hyperelastic skin,Cases/families,N/A
Disease,280598,Hereditary sensorimotor neuropathy with hyperelastic skin,Point prevalence,N/A
Disease,280620,Progressive myoclonic epilepsy type 6,Cases/families,N/A
Disease,280620,Progressive myoclonic epilepsy type 6,Point prevalence,N/A
Disease,280671,Megaconial congenital muscular dystrophy,Cases/families,N/A
Disease,280671,Megaconial congenital muscular dystrophy,Point prevalence,N/A
Malformation syndrome,280640,Occipital pachygyria and polymicrogyria,Cases/families,N/A
Malformation syndrome,280640,Occipital pachygyria and polymicrogyria,Point prevalence,N/A
Disease,280654,Autosomal recessive nail dysplasia,Cases/families,N/A
Disease,280654,Autosomal recessive nail dysplasia,Point prevalence,N/A
Disease,280779,Cutaneous collagenous vasculopathy,Cases/families,N/A
Disease,280779,Cutaneous collagenous vasculopathy,Point prevalence,N/A
Clinical subtype,280785,Bullous diffuse cutaneous mastocytosis,Cases/families,N/A
Clinical subtype,280785,Bullous diffuse cutaneous mastocytosis,Point prevalence,N/A
Clinical subtype,280794,Pseudoxanthomatous diffuse cutaneous mastocytosis,Cases/families,N/A
Clinical subtype,280794,Pseudoxanthomatous diffuse cutaneous mastocytosis,Point prevalence,N/A
Disease,280679,Moyamoya angiopathy-short stature-facial dysmorphism-hypergonadotropic hypogonadism syndrome,Cases/families,N/A
Disease,280679,Moyamoya angiopathy-short stature-facial dysmorphism-hypergonadotropic hypogonadism syndrome,Point prevalence,N/A
Disease,280763,Severe intellectual disability and progressive spastic paraplegia,Cases/families,N/A
Disease,280763,Severe intellectual disability and progressive spastic paraplegia,Point prevalence,N/A
Disease,280774,Generalized essential telangiectasia,Point prevalence,N/A
Malformation syndrome,284149,Craniosynostosis-dental anomalies,Point prevalence,N/A
Malformation syndrome,284139,"Larsen-like syndrome, B3GAT3 type",Cases/families,N/A
Malformation syndrome,284139,"Larsen-like syndrome, B3GAT3 type",Point prevalence,N/A
Malformation syndrome,284180,Xp22.13p22.2 duplication syndrome,Point prevalence,N/A
Clinical subtype,284169,Facial dysmorphism-developmental delay-behavioral abnormalities syndrome due to 10p11.21p12.31 microdeletion,Point prevalence,N/A
Clinical subtype,284169,Facial dysmorphism-developmental delay-behavioral abnormalities syndrome due to 10p11.21p12.31 microdeletion,Cases/families,N/A
Malformation syndrome,284160,8q21.11 microdeletion syndrome,Cases/families,N/A
Malformation syndrome,284160,8q21.11 microdeletion syndrome,Point prevalence,N/A
Malformation syndrome,284247,Familial retinal arterial macroaneurysm,Point prevalence,N/A
Disease,284232,Autosomal dominant Charcot-Marie-Tooth disease type 2O,Point prevalence,N/A
Clinical syndrome,284227,TEMPI syndrome,Cases/families,N/A
Clinical syndrome,284227,TEMPI syndrome,Point prevalence,N/A
Disease,284271,Autosomal recessive cerebellar ataxia-psychomotor delay syndrome,Point prevalence,N/A
Clinical group,284264,IgG4-related disease,Point prevalence,N/A
Disease,284324,Childhood-onset autosomal recessive slowly progressive spinocerebellar ataxia,Point prevalence,N/A
Disease,284282,Autosomal recessive cerebellar ataxia-epilepsy-intellectual disability syndrome due to WWOX deficiency,Point prevalence,N/A
Disease,284289,Adult-onset autosomal recessive cerebellar ataxia,Point prevalence,N/A
Disease,284289,Adult-onset autosomal recessive cerebellar ataxia,Cases/families,N/A
Disease,284343,DICER1 tumor-predisposition syndrome,Annual incidence,N/A
Disease,284332,Infantile-onset autosomal recessive nonprogressive cerebellar ataxia,Point prevalence,N/A
Malformation syndrome,284339,Pontocerebellar hypoplasia type 7,Cases/families,N/A
Malformation syndrome,284339,Pontocerebellar hypoplasia type 7,Point prevalence,N/A
Clinical syndrome,284388,Reversible cerebral vasoconstriction syndrome,Point prevalence,N/A
Disease,284395,Well-differentiated fetal adenocarcinoma of the lung,Point prevalence,N/A
Disease,284400,Small cell carcinoma of the bladder,Annual incidence,N/A
Disease,284400,Small cell carcinoma of the bladder,Point prevalence,N/A
Disease,284400,Small cell carcinoma of the bladder,Annual incidence,N/A
Disease,282166,Inherited Creutzfeldt-Jakob disease,Point prevalence,N/A
Disease,309854,Cirrhosis-dystonia-polycythemia-hypermanganesemia syndrome,Cases/families,N/A
Disease,309854,Cirrhosis-dystonia-polycythemia-hypermanganesemia syndrome,Point prevalence,N/A
Disease,314029,High bone mass osteogenesis imperfecta,Cases/families,N/A
Disease,314029,High bone mass osteogenesis imperfecta,Point prevalence,N/A
Disease,314022,Gastric adenocarcinoma and proximal polyposis of the stomach,Cases/families,N/A
Disease,314022,Gastric adenocarcinoma and proximal polyposis of the stomach,Point prevalence,N/A
Disease,314017,Idiopathic linear interstitial keratitis,Point prevalence,N/A
Malformation syndrome,314002,Contractures-webbed neck-micrognathia-hypoplastic nipples syndrome,Cases/families,N/A
Malformation syndrome,314002,Contractures-webbed neck-micrognathia-hypoplastic nipples syndrome,Point prevalence,N/A
Malformation syndrome,313947,2q23.1 microduplication syndrome,Cases/families,N/A
Malformation syndrome,313947,2q23.1 microduplication syndrome,Point prevalence,N/A
Disease,313936,PENS syndrome,Cases/families,N/A
Disease,313936,PENS syndrome,Point prevalence,N/A
Disease,313920,Epstein-Barr virus-associated gastric carcinoma,Annual incidence,N/A
Disease,313920,Epstein-Barr virus-associated gastric carcinoma,Point prevalence,N/A
Morphological anomaly,313906,Congenital pancreatic cyst,Cases/families,N/A
Morphological anomaly,313906,Congenital pancreatic cyst,Point prevalence,N/A
Clinical subtype,313892,Developmental and speech delay due to SOX5 deficiency,Cases/families,N/A
Clinical subtype,313892,Developmental and speech delay due to SOX5 deficiency,Point prevalence,N/A
Clinical subtype,313884,12p12.1 microdeletion syndrome,Cases/families,N/A
Clinical subtype,313884,12p12.1 microdeletion syndrome,Point prevalence,N/A
Disease,313855,FGFR2-related bent bone dysplasia,Cases/families,N/A
Disease,313855,FGFR2-related bent bone dysplasia,Point prevalence,N/A
Disease,313850,Infantile cerebellar-retinal degeneration,Cases/families,N/A
Disease,313850,Infantile cerebellar-retinal degeneration,Point prevalence,N/A
Disease,313846,Familial cutaneous telangiectasia and oropharyngeal cancer predisposition syndrome,Cases/families,N/A
Disease,313846,Familial cutaneous telangiectasia and oropharyngeal cancer predisposition syndrome,Point prevalence,N/A
Disease,313838,Coats plus syndrome,Point prevalence,N/A
Disease,313800,Retinal dystrophy-optic nerve edema-splenomegaly-anhidrosis-migraine headache syndrome,Cases/families,N/A
Disease,313800,Retinal dystrophy-optic nerve edema-splenomegaly-anhidrosis-migraine headache syndrome,Point prevalence,N/A
Disease,313808,Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia,Cases/families,N/A
Disease,313808,Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia,Point prevalence,N/A
Malformation syndrome,313781,20p13 microdeletion syndrome,Cases/families,N/A
Malformation syndrome,313781,20p13 microdeletion syndrome,Point prevalence,N/A
Malformation syndrome,313795,Jawad syndrome,Cases/families,N/A
Malformation syndrome,313795,Jawad syndrome,Point prevalence,N/A
Disease,313772,Early-onset spastic ataxia-myoclonic epilepsy-neuropathy syndrome,Cases/families,N/A
Disease,313772,Early-onset spastic ataxia-myoclonic epilepsy-neuropathy syndrome,Point prevalence,N/A
Disease,314603,Autosomal recessive spastic ataxia with leukoencephalopathy,Cases/families,N/A
Disease,314603,Autosomal recessive spastic ataxia with leukoencephalopathy,Point prevalence,N/A
Malformation syndrome,314597,Chudley-McCullough syndrome,Cases/families,N/A
Malformation syndrome,314597,Chudley-McCullough syndrome,Point prevalence,N/A
Particular clinical situation in a disease or syndrome,314613,Growing teratoma syndrome,Point prevalence,N/A
Malformation syndrome,314575,Intellectual disability-hypotonia-brachycephaly-pyloric stenosis-cryptorchidism syndrome,Cases/families,N/A
Malformation syndrome,314575,Intellectual disability-hypotonia-brachycephaly-pyloric stenosis-cryptorchidism syndrome,Point prevalence,N/A
Disease,314572,Autosomal recessive leukoencephalopathy-ischemic stroke-retinitis pigmentosa syndrome,Cases/families,N/A
Disease,314572,Autosomal recessive leukoencephalopathy-ischemic stroke-retinitis pigmentosa syndrome,Point prevalence,N/A
Etiological subtype,314588,Distal triplication 15q syndrome,Cases/families,N/A
Etiological subtype,314588,Distal triplication 15q syndrome,Point prevalence,N/A
Malformation syndrome,314585,15q overgrowth syndrome,Cases/families,N/A
Malformation syndrome,314585,15q overgrowth syndrome,Point prevalence,N/A
Disease,314485,Young adult-onset distal hereditary motor neuropathy,Cases/families,N/A
Disease,314485,Young adult-onset distal hereditary motor neuropathy,Point prevalence,N/A
Disease,314566,Primary progressive apraxia of speech,Cases/families,N/A
Disease,314566,Primary progressive apraxia of speech,Point prevalence,N/A
Malformation syndrome,314555,Facial dysmorphism-ocular anomalies-osteopenia-intellectual disability-dental anomalies syndrome,Cases/families,N/A
Malformation syndrome,314555,Facial dysmorphism-ocular anomalies-osteopenia-intellectual disability-dental anomalies syndrome,Point prevalence,N/A
Clinical syndrome,314466,Atypical Meigs syndrome,Cases/families,N/A
Clinical syndrome,314466,Atypical Meigs syndrome,Point prevalence,N/A
Clinical syndrome,314459,Pseudo-Meigs syndrome,Point prevalence,N/A
Disease,314478,Ovarian fibrothecoma,Point prevalence,N/A
Disease,314473,Ovarian fibroma,Point prevalence,N/A
Disease,314422,Ameloblastic carcinoma,Cases/families,N/A
Disease,314422,Ameloblastic carcinoma,Point prevalence,N/A
Malformation syndrome,314432,Spigelian hernia-cryptorchidism syndrome,Cases/families,N/A
Malformation syndrome,314432,Spigelian hernia-cryptorchidism syndrome,Point prevalence,N/A
Clinical syndrome,314451,Meigs syndrome,Point prevalence,N/A
Disease,314394,Short stature-onychodysplasia-facial dysmorphism-hypotrichosis syndrome,Cases/families,N/A
Disease,314394,Short stature-onychodysplasia-facial dysmorphism-hypotrichosis syndrome,Point prevalence,N/A
Disease,314399,Autosomal dominant aplasia and myelodysplasia,Cases/families,N/A
Disease,314399,Autosomal dominant aplasia and myelodysplasia,Point prevalence,N/A
Disease,314404,Autosomal dominant cerebellar ataxia-deafness-narcolepsy syndrome,Cases/families,N/A
Disease,314404,Autosomal dominant cerebellar ataxia-deafness-narcolepsy syndrome,Point prevalence,N/A
Disease,314419,Ameloblastoma,Point prevalence,N/A
Disease,314373,Chronic infantile diarrhea due to guanylate cyclase 2C overactivity,Cases/families,N/A
Disease,314373,Chronic infantile diarrhea due to guanylate cyclase 2C overactivity,Point prevalence,N/A
Disease,314376,Intestinal obstruction in the newborn due to guanylate cyclase 2C deficiency,Cases/families,N/A
Disease,314376,Intestinal obstruction in the newborn due to guanylate cyclase 2C deficiency,Point prevalence,N/A
Disease,314381,Hereditary sensory and autonomic neuropathy type 6,Cases/families,N/A
Disease,314381,Hereditary sensory and autonomic neuropathy type 6,Point prevalence,N/A
Malformation syndrome,314389,Xq12-q13.3 duplication syndrome,Cases/families,N/A
Malformation syndrome,314389,Xq12-q13.3 duplication syndrome,Point prevalence,N/A
Malformation syndrome,314034,7p22.1 microduplication syndrome,Point prevalence,N/A
Malformation syndrome,314034,7p22.1 microduplication syndrome,Cases/families,N/A
Malformation syndrome,314041,Marfanoid habitus-inguinal hernia-advanced bone age syndrome,Cases/families,N/A
Malformation syndrome,314041,Marfanoid habitus-inguinal hernia-advanced bone age syndrome,Point prevalence,N/A
Disease,314051,Leukoencephalopathy-thalamus and brainstem anomalies-high lactate syndrome,Cases/families,N/A
Disease,314051,Leukoencephalopathy-thalamus and brainstem anomalies-high lactate syndrome,Point prevalence,N/A
Disease,306674,Kufor-Rakeb syndrome,Cases/families,N/A
Disease,306674,Kufor-Rakeb syndrome,Point prevalence,N/A
Disease,306669,Hemiparkinsonism-hemiatrophy syndrome,Point prevalence,N/A
Disease,306669,Hemiparkinsonism-hemiatrophy syndrome,Cases/families,N/A
Disease,306741,Hemidystonia-hemiatrophy syndrome,Cases/families,N/A
Disease,306741,Hemidystonia-hemiatrophy syndrome,Point prevalence,N/A
Disease,306734,"Primary dystonia, DYT21 type",Cases/families,N/A
Disease,306734,"Primary dystonia, DYT21 type",Point prevalence,N/A
Particular clinical situation in a disease or syndrome,306731,Sydenham chorea,Point prevalence,N/A
Clinical group,308166,Erythrokeratoderma variabilis progressiva,Point prevalence,N/A
Etiological subtype,308386,Sulfite oxidase deficiency due to molybdenum cofactor deficiency type A,Point prevalence,N/A
Disease,308410,Autism-epilepsy syndrome due to branched chain ketoacid dehydrogenase kinase deficiency,Cases/families,N/A
Disease,308410,Autism-epilepsy syndrome due to branched chain ketoacid dehydrogenase kinase deficiency,Point prevalence,N/A
Disease,308425,Methylmalonic acidemia due to methylmalonyl-CoA epimerase deficiency,Cases/families,N/A
Disease,308425,Methylmalonic acidemia due to methylmalonyl-CoA epimerase deficiency,Point prevalence,N/A
Disease,307766,Curly hair-acral keratoderma-caries syndrome,Cases/families,N/A
Disease,307766,Curly hair-acral keratoderma-caries syndrome,Point prevalence,N/A
Disease,307936,Hypotrichosis-osteolysis-periodontitis-palmoplantar keratoderma syndrome,Point prevalence,N/A
Disease,307936,Hypotrichosis-osteolysis-periodontitis-palmoplantar keratoderma syndrome,Cases/families,N/A
Disease,309111,Combined pancreatic lipase-colipase deficiency,Cases/families,N/A
Disease,309111,Combined pancreatic lipase-colipase deficiency,Point prevalence,N/A
Disease,309031,Pancreatic triacylglycerol lipase deficiency,Point prevalence,N/A
Disease,309031,Pancreatic triacylglycerol lipase deficiency,Annual incidence,N/A
Disease,309108,Pancreatic colipase deficiency,Cases/families,N/A
Disease,309108,Pancreatic colipase deficiency,Point prevalence,N/A
Disease,309025,Mevalonate kinase deficiency,Cases/families,N/A
Disease,309025,Mevalonate kinase deficiency,Point prevalence,N/A
Etiological subtype,309015,Familial lipoprotein lipase deficiency,Point prevalence,N/A
Etiological subtype,309015,Familial lipoprotein lipase deficiency,Point prevalence,N/A
Etiological subtype,309020,Familial apolipoprotein C-II deficiency,Cases/families,N/A
Etiological subtype,309020,Familial apolipoprotein C-II deficiency,Point prevalence,N/A
Disease,178,Chordoma,Annual incidence,N/A
Malformation syndrome,2637,Microcephalic osteodysplastic primordial dwarfism type II,Cases/families,N/A
Malformation syndrome,2637,Microcephalic osteodysplastic primordial dwarfism type II,Point prevalence,N/A
Disease,592,Macrophagic myofasciitis,Point prevalence,N/A
Clinical subtype,308552,"Glycogen storage disease due to acid maltase deficiency, infantile onset",Prevalence at birth,N/A
Clinical subtype,308552,"Glycogen storage disease due to acid maltase deficiency, infantile onset",Prevalence at birth,N/A
Clinical subtype,308552,"Glycogen storage disease due to acid maltase deficiency, infantile onset",Point prevalence,N/A
Clinical subtype,309271,"Metachromatic leukodystrophy, adult form",Prevalence at birth,N/A
Clinical subtype,309271,"Metachromatic leukodystrophy, adult form",Point prevalence,N/A
Disease,309246,"GM2 gangliosidosis, AB variant",Cases/families,N/A
Disease,309246,"GM2 gangliosidosis, AB variant",Point prevalence,N/A
Clinical subtype,309256,"Metachromatic leukodystrophy, late infantile form",Prevalence at birth,N/A
Clinical subtype,309256,"Metachromatic leukodystrophy, late infantile form",Point prevalence,N/A
Clinical subtype,309263,"Metachromatic leukodystrophy, juvenile form",Prevalence at birth,N/A
Clinical subtype,309263,"Metachromatic leukodystrophy, juvenile form",Point prevalence,N/A
Clinical subtype,309324,"Free sialic acid storage disease, infantile form",Point prevalence,N/A
Clinical subtype,309324,"Free sialic acid storage disease, infantile form",Prevalence at birth,N/A
Clinical subtype,309334,Salla disease,Point prevalence,N/A
Clinical subtype,309334,Salla disease,Prevalence at birth,N/A
Clinical group,309294,Sialidosis,Prevalence at birth,N/A
Clinical group,309294,Sialidosis,Prevalence at birth,N/A
Clinical group,309294,Sialidosis,Point prevalence,N/A
Clinical group,309294,Sialidosis,Prevalence at birth,N/A
Clinical group,309294,Sialidosis,Prevalence at birth,N/A
Clinical group,309294,Sialidosis,Prevalence at birth,N/A
Clinical subtype,309297,Mucopolysaccharidosis type 4A,Point prevalence,N/A
Clinical subtype,309297,Mucopolysaccharidosis type 4A,Point prevalence,N/A
Clinical subtype,309297,Mucopolysaccharidosis type 4A,Prevalence at birth,N/A
Clinical subtype,309297,Mucopolysaccharidosis type 4A,Point prevalence,N/A
Clinical subtype,309297,Mucopolysaccharidosis type 4A,Prevalence at birth,N/A
Clinical subtype,309297,Mucopolysaccharidosis type 4A,Point prevalence,N/A
Clinical subtype,309297,Mucopolysaccharidosis type 4A,Prevalence at birth,N/A
Clinical subtype,309297,Mucopolysaccharidosis type 4A,Point prevalence,N/A
Clinical subtype,309297,Mucopolysaccharidosis type 4A,Prevalence at birth,N/A
Clinical subtype,309297,Mucopolysaccharidosis type 4A,Prevalence at birth,N/A
Clinical subtype,309297,Mucopolysaccharidosis type 4A,Point prevalence,N/A
Clinical subtype,309297,Mucopolysaccharidosis type 4A,Prevalence at birth,N/A
Clinical subtype,309297,Mucopolysaccharidosis type 4A,Point prevalence,N/A
Clinical subtype,309310,Mucopolysaccharidosis type 4B,Point prevalence,N/A
Clinical subtype,309310,Mucopolysaccharidosis type 4B,Prevalence at birth,N/A
Disease,309147,Hyper-beta-alaninemia,Cases/families,N/A
Disease,309147,Hyper-beta-alaninemia,Point prevalence,N/A
Clinical group,309152,GM2 gangliosidosis,Prevalence at birth,N/A
Clinical group,309152,GM2 gangliosidosis,Point prevalence,N/A
Disease,300547,Autosomal recessive infantile hypercalcemia,Cases/families,N/A
Disease,300547,Autosomal recessive infantile hypercalcemia,Point prevalence,N/A
Disease,300552,Follicular cholangitis and pancreatitis,Cases/families,N/A
Disease,300552,Follicular cholangitis and pancreatitis,Point prevalence,N/A
Disease,300557,Carcinoma of the ampulla of Vater,Annual incidence,N/A
Disease,300557,Carcinoma of the ampulla of Vater,Point prevalence,N/A
Disease,300557,Carcinoma of the ampulla of Vater,Annual incidence,N/A
Disease,300564,Combined pulmonary fibrosis-emphysema syndrome,Point prevalence,N/A
Disease,300570,Cortical dysgenesis with pontocerebellar hypoplasia due to TUBB3 mutation,Cases/families,N/A
Disease,300570,Cortical dysgenesis with pontocerebellar hypoplasia due to TUBB3 mutation,Point prevalence,N/A
Malformation syndrome,300573,Polymicrogyria due to TUBB2B mutation,Cases/families,N/A
Malformation syndrome,300573,Polymicrogyria due to TUBB2B mutation,Point prevalence,N/A
Disease,300576,Oligodontia-cancer predisposition syndrome,Cases/families,N/A
Disease,300576,Oligodontia-cancer predisposition syndrome,Point prevalence,N/A
Malformation syndrome,300496,Multiple congenital anomalies-hypotonia-seizures syndrome type 2,Cases/families,N/A
Malformation syndrome,300496,Multiple congenital anomalies-hypotonia-seizures syndrome type 2,Point prevalence,N/A
Malformation syndrome,300501,Painful orbital and systemic neurofibromas-marfanoid habitus syndrome,Cases/families,N/A
Malformation syndrome,300501,Painful orbital and systemic neurofibromas-marfanoid habitus syndrome,Point prevalence,N/A
Disease,300504,Onychocytic matricoma,Cases/families,N/A
Disease,300504,Onychocytic matricoma,Point prevalence,N/A
Disease,300512,Onychomatricoma,Cases/families,N/A
Disease,300512,Onychomatricoma,Point prevalence,N/A
Etiological subtype,300525,Pseudohypoaldosteronism type 2D,Cases/families,N/A
Etiological subtype,300525,Pseudohypoaldosteronism type 2D,Point prevalence,N/A
Etiological subtype,300530,Pseudohypoaldosteronism type 2E,Cases/families,N/A
Etiological subtype,300530,Pseudohypoaldosteronism type 2E,Point prevalence,N/A
Disease,300536,DDOST-CDG,Cases/families,N/A
Disease,300536,DDOST-CDG,Point prevalence,N/A
Disease,300865,Primary cutaneous anaplastic large cell lymphoma,Point prevalence,N/A
Disease,300857,T-cell/histiocyte rich large B cell lymphoma,Annual incidence,N/A
Disease,300878,Hairy cell leukemia variant,Annual incidence,N/A
Disease,300878,Hairy cell leukemia variant,Point prevalence,N/A
Histopathological subtype,300895,ALK-positive anaplastic large cell lymphoma,Point prevalence,N/A
Disease,300605,Juvenile amyotrophic lateral sclerosis,Point prevalence,N/A
Category,300755,Laminopathy with striated muscle involvement,Point prevalence,N/A
Disease,300751,Familial dilated cardiomyopathy with conduction defect due to LMNA mutation,Point prevalence,N/A
Category,300763,Laminopathy with lipodystrophy,Point prevalence,N/A
Category,300758,Laminopathy with peripheral neuropathy,Point prevalence,N/A
Category,300842,Indolent B-cell non-Hodgkin lymphoma,Point prevalence,N/A
Category,300766,Laminopathy with premature aging,Point prevalence,N/A
Histopathological subtype,300903,ALK-negative anaplastic large cell lymphoma,Point prevalence,N/A
Clinical group,300912,Marginal zone lymphoma,Annual incidence,N/A
Clinical group,300912,Marginal zone lymphoma,Point prevalence,N/A
Clinical group,300912,Marginal zone lymphoma,Annual incidence,N/A
Disease,306431,Adult-onset immunodeficiency with anti-interferon-gamma autoantibodies,Point prevalence,N/A
Disease,306550,FADD-related immunodeficiency,Cases/families,N/A
Disease,306550,FADD-related immunodeficiency,Point prevalence,N/A
Disease,306553,Myospherulosis,Point prevalence,N/A
Malformation syndrome,306542,Frontonasal dysplasia-severe microphthalmia-severe facial clefting syndrome,Cases/families,N/A
Malformation syndrome,306542,Frontonasal dysplasia-severe microphthalmia-severe facial clefting syndrome,Point prevalence,N/A
Malformation syndrome,306547,Porencephaly-microcephaly-bilateral congenital cataract syndrome,Cases/families,N/A
Malformation syndrome,306547,Porencephaly-microcephaly-bilateral congenital cataract syndrome,Point prevalence,N/A
Morphological anomaly,306530,Congenital hereditary facial paralysis-variable hearing loss syndrome,Cases/families,N/A
Morphological anomaly,306530,Congenital hereditary facial paralysis-variable hearing loss syndrome,Point prevalence,N/A
Morphological anomaly,306527,Isolated hereditary congenital facial paralysis,Cases/families,N/A
Morphological anomaly,306527,Isolated hereditary congenital facial paralysis,Point prevalence,N/A
Disease,306516,Primary hypomagnesemia with hypercalciuria and nephrocalcinosis,Cases/families,N/A
Disease,306516,Primary hypomagnesemia with hypercalciuria and nephrocalcinosis,Point prevalence,N/A
Disease,306511,Autosomal recessive spastic paraplegia type 48,Cases/families,N/A
Disease,306511,Autosomal recessive spastic paraplegia type 48,Point prevalence,N/A
Clinical group,306498,PTEN hamartoma tumor syndrome,Point prevalence,N/A
Disease,306504,Interstitial lung disease-nephrotic syndrome-epidermolysis bullosa syndrome,Cases/families,N/A
Disease,306504,Interstitial lung disease-nephrotic syndrome-epidermolysis bullosa syndrome,Point prevalence,N/A
Particular clinical situation in a disease or syndrome,306644,Complication after organ transplantation,Point prevalence,N/A
Disease,306577,Hereditary sodium channelopathy-related small fibers neuropathy,Cases/families,N/A
Disease,306577,Hereditary sodium channelopathy-related small fibers neuropathy,Point prevalence,N/A
Disease,306558,Primary microcephaly-epilepsy-permanent neonatal diabetes syndrome,Cases/families,N/A
Disease,306558,Primary microcephaly-epilepsy-permanent neonatal diabetes syndrome,Point prevalence,N/A
Category,298644,Disorder of thiamine metabolism and transport,Point prevalence,N/A
Clinical subtype,300179,Kyphoscoliotic Ehlers-Danlos syndrome due to FKBP22 deficiency,Cases/families,N/A
Clinical subtype,300179,Kyphoscoliotic Ehlers-Danlos syndrome due to FKBP22 deficiency,Point prevalence,N/A
Disease,300319,Charcot-Marie-Tooth disease type 2P,Cases/families,N/A
Disease,300319,Charcot-Marie-Tooth disease type 2P,Point prevalence,N/A
Disease,300324,Persistent polyclonal B-cell lymphocytosis,Cases/families,N/A
Disease,300324,Persistent polyclonal B-cell lymphocytosis,Point prevalence,N/A
Disease,300313,Congenital cataract-hearing loss-severe developmental delay syndrome,Cases/families,N/A
Disease,300313,Congenital cataract-hearing loss-severe developmental delay syndrome,Point prevalence,N/A
Disease,300298,Severe congenital hypochromic anemia with ringed sideroblasts,Cases/families,N/A
Disease,300298,Severe congenital hypochromic anemia with ringed sideroblasts,Point prevalence,N/A
Malformation syndrome,300305,11p15.4 microduplication syndrome,Cases/families,N/A
Malformation syndrome,300305,11p15.4 microduplication syndrome,Point prevalence,N/A
Disease,300284,Connective tissue disorder due to lysyl hydroxylase-3 deficiency,Point prevalence,N/A
Disease,300284,Connective tissue disorder due to lysyl hydroxylase-3 deficiency,Cases/families,N/A
Disease,300293,Transient infantile hypertriglyceridemia and hepatosteatosis,Cases/families,N/A
Disease,300293,Transient infantile hypertriglyceridemia and hepatosteatosis,Point prevalence,N/A
Disease,300385,Pituitary carcinoma,Annual incidence,N/A
Disease,300385,Pituitary carcinoma,Lifetime Prevalence,N/A
Disease,300385,Pituitary carcinoma,Point prevalence,N/A
Disease,300385,Pituitary carcinoma,Annual incidence,N/A
Disease,300385,Pituitary carcinoma,Annual incidence,N/A
Disease,300385,Pituitary carcinoma,Annual incidence,N/A
Disease,300385,Pituitary carcinoma,Annual incidence,N/A
Disease,300385,Pituitary carcinoma,Annual incidence,N/A
Disease,300385,Pituitary carcinoma,Annual incidence,N/A
Disease,300385,Pituitary carcinoma,Annual incidence,N/A
Disease,300385,Pituitary carcinoma,Annual incidence,N/A
Disease,300385,Pituitary carcinoma,Annual incidence,N/A
Disease,300385,Pituitary carcinoma,Annual incidence,N/A
Disease,300385,Pituitary carcinoma,Annual incidence,N/A
Disease,300385,Pituitary carcinoma,Annual incidence,N/A
Disease,300385,Pituitary carcinoma,Annual incidence,N/A
Disease,300385,Pituitary carcinoma,Annual incidence,N/A
Disease,300385,Pituitary carcinoma,Annual incidence,N/A
Disease,300385,Pituitary carcinoma,Annual incidence,N/A
Disease,300385,Pituitary carcinoma,Annual incidence,N/A
Disease,300385,Pituitary carcinoma,Annual incidence,N/A
Disease,300385,Pituitary carcinoma,Annual incidence,N/A
Disease,300385,Pituitary carcinoma,Annual incidence,N/A
Disease,300385,Pituitary carcinoma,Annual incidence,N/A
Disease,300385,Pituitary carcinoma,Annual incidence,N/A
Disease,300385,Pituitary carcinoma,Annual incidence,N/A
Particular clinical situation in a disease or syndrome,300493,Sagliker syndrome,Cases/families,N/A
Particular clinical situation in a disease or syndrome,300493,Sagliker syndrome,Point prevalence,N/A
Disease,300373,X-linked acrogigantism,Cases/families,N/A
Disease,300373,X-linked acrogigantism,Point prevalence,N/A
Disease,300382,Progeroid and marfanoid aspect-lipodystrophy syndrome,Cases/families,N/A
Disease,300382,Progeroid and marfanoid aspect-lipodystrophy syndrome,Point prevalence,N/A
Disease,300345,Autosomal systemic lupus erythematosus,Cases/families,N/A
Disease,300345,Autosomal systemic lupus erythematosus,Point prevalence,N/A
Disease,300359,PLCG2-associated antibody deficiency and immune dysregulation,Cases/families,N/A
Disease,300359,PLCG2-associated antibody deficiency and immune dysregulation,Point prevalence,N/A
Disease,300333,Nephrotic syndrome-epidermolysis bullosa-sensorineural deafness syndrome,Cases/families,N/A
Disease,300333,Nephrotic syndrome-epidermolysis bullosa-sensorineural deafness syndrome,Point prevalence,N/A
Disease,464724,Fever-associated acute infantile liver failure syndrome,Cases/families,N/A
Disease,464724,Fever-associated acute infantile liver failure syndrome,Point prevalence,N/A
Malformation syndrome,464738,Basel-Vanagaite-Smirin-Yosef syndrome,Cases/families,N/A
Malformation syndrome,464738,Basel-Vanagaite-Smirin-Yosef syndrome,Point prevalence,N/A
Morphological anomaly,464760,Familial cavitary optic disc anomaly,Point prevalence,N/A
Morphological anomaly,464760,Familial cavitary optic disc anomaly,Cases/families,N/A
Disease,464756,Familial gastric type 1 neuroendocrine tumor,Cases/families,N/A
Disease,464756,Familial gastric type 1 neuroendocrine tumor,Point prevalence,N/A
Disease,465508,Symptomatic form of HFE-related hemochromatosis,Point prevalence,N/A
Disease,464282,Spastic paraplegia-severe developmental delay-epilepsy syndrome,Cases/families,N/A
Disease,464282,Spastic paraplegia-severe developmental delay-epilepsy syndrome,Point prevalence,N/A
Malformation syndrome,464288,Short stature-brachydactyly-obesity-global developmental delay syndrome,Cases/families,N/A
Malformation syndrome,464288,Short stature-brachydactyly-obesity-global developmental delay syndrome,Point prevalence,N/A
Malformation syndrome,464306,DYRK1A-related intellectual disability syndrome,Cases/families,N/A
Malformation syndrome,464306,DYRK1A-related intellectual disability syndrome,Point prevalence,N/A
Disease,464329,Kaposiform lymphangiomatosis,Point prevalence,N/A
Disease,464321,Multifocal lymphangioendotheliomatosis-thrombocytopenia syndrome,Point prevalence,N/A
Disease,464318,Verrucous hemangioma,Point prevalence,N/A
Etiological subtype,464311,Intellectual disability syndrome due to a DYRK1A point mutation,Cases/families,N/A
Etiological subtype,464311,Intellectual disability syndrome due to a DYRK1A point mutation,Point prevalence,N/A
Malformation syndrome,464366,NEK9-related lethal skeletal dysplasia,Cases/families,N/A
Malformation syndrome,464366,NEK9-related lethal skeletal dysplasia,Point prevalence,N/A
Disease,464359,Benign metanephric tumor,Point prevalence,N/A
Disease,464343,Catastrophic antiphospholipid syndrome,Point prevalence,N/A
Disease,464336,BENTA disease,Cases/families,N/A
Disease,464336,BENTA disease,Point prevalence,N/A
Disease,464453,Acquired methemoglobinemia,Cases/families,N/A
Disease,464453,Acquired methemoglobinemia,Point prevalence,N/A
Disease,464443,COG6-CGD,Cases/families,N/A
Disease,464443,COG6-CGD,Point prevalence,N/A
Disease,464440,"Primary dystonia, DYT27 type",Cases/families,N/A
Disease,464440,"Primary dystonia, DYT27 type",Point prevalence,N/A
Disease,464370,Neonatal alloimmune neutropenia,Prevalence at birth,N/A
Disease,464370,Neonatal alloimmune neutropenia,Point prevalence,N/A
Particular clinical situation in a disease or syndrome,464458,Paracetamol poisoning,Annual incidence,N/A
Particular clinical situation in a disease or syndrome,464458,Paracetamol poisoning,Point prevalence,N/A
Disease,639,Polyneuropathy associated with IgM monoclonal gammopathy with anti-MAG,Point prevalence,N/A
Disease,662,Lymphedema with yellow nails,Cases/families,N/A
Disease,662,Lymphedema with yellow nails,Point prevalence,N/A
Clinical subtype,537,Toxic epidermal necrolysis,Point prevalence,N/A
Disease,793,SAPHO syndrome,Point prevalence,N/A
Malformation syndrome,456298,1p35.2 microdeletion syndrome,Cases/families,N/A
Malformation syndrome,456298,1p35.2 microdeletion syndrome,Point prevalence,N/A
Disease,456328,X-linked myotubular myopathy-abnormal genitalia syndrome,Cases/families,N/A
Disease,456328,X-linked myotubular myopathy-abnormal genitalia syndrome,Point prevalence,N/A
Disease,456312,Infantile multisystem neurologic-endocrine-pancreatic disease,Cases/families,N/A
Disease,456312,Infantile multisystem neurologic-endocrine-pancreatic disease,Point prevalence,N/A
Disease,456318,Hereditary sensory neuropathy-deafness-dementia syndrome,Cases/families,N/A
Disease,456318,Hereditary sensory neuropathy-deafness-dementia syndrome,Point prevalence,N/A
Particular clinical situation in a disease or syndrome,454831,Acute radiation syndrome,Point prevalence,N/A
Disease,454836,Avian influenza,Cases/families,N/A
Disease,454836,Avian influenza,Point prevalence,N/A
Disease,454836,Avian influenza,Point prevalence,N/A
Disease,454887,Corticobasal syndrome,Point prevalence,N/A
Disease,454723,Endometrioid carcinoma of ovary,Annual incidence,N/A
Disease,454723,Endometrioid carcinoma of ovary,Annual incidence,N/A
Disease,454718,Holmes-Adie syndrome,Annual incidence,N/A
Disease,454718,Holmes-Adie syndrome,Point prevalence,N/A
Disease,454714,Plasma cell leukemia,Annual incidence,N/A
Histopathological subtype,454821,OBSOLETE: Pleomorphic salivary gland adenoma,Annual incidence,N/A
Morphological anomaly,454750,Isolated tracheoesophageal fistula,Prevalence at birth,N/A
Morphological anomaly,454750,Isolated tracheoesophageal fistula,Prevalence at birth,N/A
Morphological anomaly,454750,Isolated tracheoesophageal fistula,Point prevalence,N/A
Morphological anomaly,454750,Isolated tracheoesophageal fistula,Point prevalence,N/A
Disease,454745,Kuru,Cases/families,N/A
Disease,454745,Kuru,Point prevalence,N/A
Disease,453533,Polyendocrine-polyneuropathy syndrome,Cases/families,N/A
Disease,453533,Polyendocrine-polyneuropathy syndrome,Point prevalence,N/A
Disease,453521,Autosomal recessive cerebellar ataxia due to CWF19L1 deficiency,Cases/families,N/A
Disease,453521,Autosomal recessive cerebellar ataxia due to CWF19L1 deficiency,Point prevalence,N/A
Disease,454710,Anti-p200 pemphigoid,Cases/families,N/A
Disease,454710,Anti-p200 pemphigoid,Point prevalence,N/A
Clinical group,454700,Acquired Creutzfeldt-Jakob disease,Point prevalence,N/A
Disease,451602,Primary cutaneous plasmacytosis,Point prevalence,N/A
Disease,451607,Cutaneous pseudolymphoma,Point prevalence,N/A
Disease,451607,Cutaneous pseudolymphoma,Cases/families,N/A
Morphological anomaly,451612,Familial congenital nasolacrimal duct obstruction,Cases/families,N/A
Morphological anomaly,451612,Familial congenital nasolacrimal duct obstruction,Point prevalence,N/A
Malformation syndrome,453499,Neurodevelopmental disorder-craniofacial dysmorphism-cardiac defect-skeletal anomalies syndrome,Cases/families,N/A
Malformation syndrome,453499,Neurodevelopmental disorder-craniofacial dysmorphism-cardiac defect-skeletal anomalies syndrome,Point prevalence,N/A
Etiological subtype,453504,Neurodevelopmental disorder-craniofacial dysmorphism-cardiac defect-skeletal anomalies syndrome due to a point mutation,Cases/families,N/A
Etiological subtype,453504,Neurodevelopmental disorder-craniofacial dysmorphism-cardiac defect-skeletal anomalies syndrome due to a point mutation,Point prevalence,N/A
Disease,453510,Congenital insensitivity to pain with severe intellectual disability,Cases/families,N/A
Disease,453510,Congenital insensitivity to pain with severe intellectual disability,Point prevalence,N/A
Clinical syndrome,450322,Polyclonal hyperviscosity syndrome,Point prevalence,N/A
Disease,449566,Eosinophilic angiocentric fibrosis,Cases/families,N/A
Disease,449566,Eosinophilic angiocentric fibrosis,Point prevalence,N/A
Clinical subtype,449563,IgG4-related ophthalmic disease,Point prevalence,N/A
Disease,449291,Symptomatic form of fragile X syndrome in female carriers,Point prevalence,N/A
Clinical subtype,449400,IgG4-related aortitis,Point prevalence,N/A
Clinical subtype,449395,IgG4-related kidney disease,Point prevalence,N/A
Clinical subtype,449432,IgG4-related submandibular gland disease,Point prevalence,N/A
Clinical subtype,449427,IgG4-related pachymeningitis,Point prevalence,N/A
Disease,449280,Scedosporiosis,Annual incidence,N/A
Disease,449280,Scedosporiosis,Point prevalence,N/A
Disease,449285,Snakebite envenomation,Point prevalence,N/A
Particular clinical situation in a disease or syndrome,449266,Pleural empyema,Point prevalence,N/A
Disease,448264,Isolated focal non-epidermolytic palmoplantar keratoderma,Cases/families,N/A
Disease,448264,Isolated focal non-epidermolytic palmoplantar keratoderma,Point prevalence,N/A
Disease,448251,Progressive autosomal recessive ataxia-deafness syndrome,Point prevalence,N/A
Disease,448251,Progressive autosomal recessive ataxia-deafness syndrome,Cases/families,N/A
Morphological anomaly,448270,Ectopia cordis,Prevalence at birth,N/A
Morphological anomaly,448270,Ectopia cordis,Point prevalence,N/A
Malformation syndrome,448267,Regressive spondylometaphyseal dysplasia,Cases/families,N/A
Malformation syndrome,448267,Regressive spondylometaphyseal dysplasia,Point prevalence,N/A
Disease,448010,CAD-CDG,Cases/families,N/A
Disease,448010,CAD-CDG,Point prevalence,N/A
Disease,447997,Spastic tetraplegia-thin corpus callosum-progressive postnatal microcephaly syndrome,Cases/families,N/A
Disease,447997,Spastic tetraplegia-thin corpus callosum-progressive postnatal microcephaly syndrome,Point prevalence,N/A
Malformation syndrome,448242,Autosomal recessive brachyolmia,Point prevalence,N/A
Malformation syndrome,448242,Autosomal recessive brachyolmia,Cases/families,N/A
Disease,448237,Zika virus disease,Point prevalence,N/A
Disease,448237,Zika virus disease,Annual incidence,N/A
Disease,447977,Progressive scapulohumeroperoneal distal myopathy,Cases/families,N/A
Disease,447977,Progressive scapulohumeroperoneal distal myopathy,Point prevalence,N/A
Malformation syndrome,447974,Klippel-Feil anomaly-myopathy-facial dysmorphism syndrome,Cases/families,N/A
Malformation syndrome,447974,Klippel-Feil anomaly-myopathy-facial dysmorphism syndrome,Point prevalence,N/A
Malformation syndrome,447980,19p13.3 microduplication syndrome,Cases/families,N/A
Malformation syndrome,447980,19p13.3 microduplication syndrome,Point prevalence,N/A
Disease,447954,Combined oxidative phosphorylation defect type 25,Cases/families,N/A
Disease,447954,Combined oxidative phosphorylation defect type 25,Point prevalence,N/A
Disease,447964,Autosomal dominant Charcot-Marie-Tooth disease type 2V,Cases/families,N/A
Disease,447964,Autosomal dominant Charcot-Marie-Tooth disease type 2V,Point prevalence,N/A
Disease,447961,Pigmentation defects-palmoplantar keratoderma-skin carcinoma syndrome,Cases/families,N/A
Disease,447961,Pigmentation defects-palmoplantar keratoderma-skin carcinoma syndrome,Point prevalence,N/A
Disease,459033,Ataxia-oculomotor apraxia type 4,Cases/families,N/A
Disease,459033,Ataxia-oculomotor apraxia type 4,Point prevalence,N/A
Disease,459051,"Spondyloepiphyseal dysplasia, Stanescu type",Cases/families,N/A
Disease,459051,"Spondyloepiphyseal dysplasia, Stanescu type",Point prevalence,N/A
Malformation syndrome,459061,Craniofacial dysplasia-short stature-ectodermal anomalies-intellectual disability syndrome,Cases/families,N/A
Malformation syndrome,459061,Craniofacial dysplasia-short stature-ectodermal anomalies-intellectual disability syndrome,Point prevalence,N/A
Disease,459056,Autosomal recessive spastic paraplegia type 75,Cases/families,N/A
Disease,459056,Autosomal recessive spastic paraplegia type 75,Point prevalence,N/A
Malformation syndrome,459074,Corpus callosum agenesis-macrocephaly-hypertelorism syndrome,Cases/families,N/A
Malformation syndrome,459074,Corpus callosum agenesis-macrocephaly-hypertelorism syndrome,Point prevalence,N/A
Malformation syndrome,459070,X-linked intellectual disability-cerebellar hypoplasia-spondylo-epiphyseal dysplasia syndrome,Cases/families,N/A
Malformation syndrome,459070,X-linked intellectual disability-cerebellar hypoplasia-spondylo-epiphyseal dysplasia syndrome,Point prevalence,N/A
Disease,458718,Idiopathic spontaneous coronary artery dissection,Point prevalence,N/A
Disease,458758,Composite hemangioendothelioma,Cases/families,N/A
Disease,458758,Composite hemangioendothelioma,Point prevalence,N/A
Disease,458763,Retiform hemangioendothelioma,Cases/families,N/A
Disease,458763,Retiform hemangioendothelioma,Point prevalence,N/A
Disease,458768,Papillary intralymphatic angioendothelioma,Cases/families,N/A
Disease,458768,Papillary intralymphatic angioendothelioma,Point prevalence,N/A
Disease,458798,Spinocerebellar ataxia type 41,Cases/families,N/A
Disease,458798,Spinocerebellar ataxia type 41,Point prevalence,N/A
Disease,458803,Spinocerebellar ataxia type 42,Cases/families,N/A
Disease,458803,Spinocerebellar ataxia type 42,Point prevalence,N/A
Malformation syndrome,457485,Macrocephaly-intellectual disability-neurodevelopmental disorder-small thorax syndrome,Cases/families,N/A
Malformation syndrome,457485,Macrocephaly-intellectual disability-neurodevelopmental disorder-small thorax syndrome,Point prevalence,N/A
Disease,457265,Progressive myoclonic epilepsy type 9,Cases/families,N/A
Disease,457265,Progressive myoclonic epilepsy type 9,Point prevalence,N/A
Malformation syndrome,457279,Intellectual disability-macrocephaly-hypotonia-behavioral abnormalities syndrome,Cases/families,N/A
Malformation syndrome,457279,Intellectual disability-macrocephaly-hypotonia-behavioral abnormalities syndrome,Point prevalence,N/A
Disease,457260,X-linked intellectual disability-hypotonia-movement disorder syndrome,Cases/families,N/A
Disease,457260,X-linked intellectual disability-hypotonia-movement disorder syndrome,Point prevalence,N/A
Malformation syndrome,457240,X-linked intellectual disability-short stature-overweight syndrome,Cases/families,N/A
Malformation syndrome,457240,X-linked intellectual disability-short stature-overweight syndrome,Point prevalence,N/A
Malformation syndrome,457395,Progressive spondyloepimetaphyseal dysplasia-short stature-short fourth metatarsals-intellectual disability syndrome,Cases/families,N/A
Malformation syndrome,457395,Progressive spondyloepimetaphyseal dysplasia-short stature-short fourth metatarsals-intellectual disability syndrome,Point prevalence,N/A
Disease,457406,Multiple mitochondrial dysfunctions syndrome type 4,Cases/families,N/A
Disease,457406,Multiple mitochondrial dysfunctions syndrome type 4,Point prevalence,N/A
Disease,457375,ITPA-related lethal infantile neurological disorder with cataract and cardiac involvement,Cases/families,N/A
Disease,457375,ITPA-related lethal infantile neurological disorder with cataract and cardiac involvement,Point prevalence,N/A
Malformation syndrome,457378,Complex lethal osteochondrodysplasia,Cases/families,N/A
Malformation syndrome,457378,Complex lethal osteochondrodysplasia,Point prevalence,N/A
Malformation syndrome,457359,Megalencephaly-severe kyphoscoliosis-overgrowth syndrome,Cases/families,N/A
Malformation syndrome,457359,Megalencephaly-severe kyphoscoliosis-overgrowth syndrome,Point prevalence,N/A
Malformation syndrome,457365,Intellectual disability-muscle weakness-short stature-facial dysmorphism syndrome,Cases/families,N/A
Malformation syndrome,457365,Intellectual disability-muscle weakness-short stature-facial dysmorphism syndrome,Point prevalence,N/A
Malformation syndrome,457284,Microcephaly-corpus callosum hypoplasia-intellectual disability-facial dysmorphism syndrome,Cases/families,N/A
Malformation syndrome,457284,Microcephaly-corpus callosum hypoplasia-intellectual disability-facial dysmorphism syndrome,Point prevalence,N/A
Malformation syndrome,457351,Microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome,Cases/families,N/A
Malformation syndrome,457351,Microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome,Point prevalence,N/A
Disease,457185,Neonatal encephalomyopathy-cardiomyopathy-respiratory distress syndrome,Cases/families,N/A
Disease,457185,Neonatal encephalomyopathy-cardiomyopathy-respiratory distress syndrome,Point prevalence,N/A
Morphological anomaly,457083,Isolated splenogonadal fusion,Cases/families,N/A
Morphological anomaly,457083,Isolated splenogonadal fusion,Point prevalence,N/A
Disease,457077,TAFRO syndrome,Cases/families,N/A
Disease,457077,TAFRO syndrome,Point prevalence,N/A
Disease,457095,Actinomycosis,Point prevalence,N/A
Disease,457223,Syndromic sensorineural deafness due to combined oxidative phosphorylation defect,Cases/families,N/A
Disease,457223,Syndromic sensorineural deafness due to combined oxidative phosphorylation defect,Point prevalence,N/A
Disease,457212,Progressive essential tremor-speech impairment-facial dysmorphism-intellectual disability-abnormal behavior syndrome,Cases/families,N/A
Disease,457212,Progressive essential tremor-speech impairment-facial dysmorphism-intellectual disability-abnormal behavior syndrome,Point prevalence,N/A
Malformation syndrome,457193,KAT6-related intellectual disability-craniofacial anomalies-cardiac defects syndrome,Cases/families,N/A
Malformation syndrome,457193,KAT6-related intellectual disability-craniofacial anomalies-cardiac defects syndrome,Point prevalence,N/A
Disease,457205,Infantile-onset axonal motor and sensory neuropathy-optic atrophy-neurodegenerative syndrome,Cases/families,N/A
Disease,457205,Infantile-onset axonal motor and sensory neuropathy-optic atrophy-neurodegenerative syndrome,Point prevalence,N/A
Disease,456369,Polyglucosan body myopathy type 2,Cases/families,N/A
Disease,456369,Polyglucosan body myopathy type 2,Point prevalence,N/A
Disease,457050,Autosomal dominant mitochondrial myopathy with exercise intolerance,Cases/families,N/A
Disease,457050,Autosomal dominant mitochondrial myopathy with exercise intolerance,Point prevalence,N/A
Disease,317,Erythrokeratodermia variabilis,Cases/families,N/A
Disease,317,Erythrokeratodermia variabilis,Point prevalence,N/A
Clinical subtype,629,Short stature due to growth hormone qualitative anomaly,Cases/families,N/A
Clinical subtype,629,Short stature due to growth hormone qualitative anomaly,Point prevalence,N/A
Etiological subtype,248,Autosomal recessive hypohidrotic ectodermal dysplasia,Point prevalence,N/A
Etiological subtype,1810,Autosomal dominant hypohidrotic ectodermal dysplasia,Cases/families,N/A
Etiological subtype,1810,Autosomal dominant hypohidrotic ectodermal dysplasia,Point prevalence,N/A
Disease,3437,Vogt-Koyanagi-Harada disease,Point prevalence,N/A
Disease,3437,Vogt-Koyanagi-Harada disease,Annual incidence,N/A
Disease,2032,Idiopathic pulmonary fibrosis,Point prevalence,N/A
Disease,2032,Idiopathic pulmonary fibrosis,Annual incidence,N/A
Disease,2032,Idiopathic pulmonary fibrosis,Point prevalence,N/A
Disease,2032,Idiopathic pulmonary fibrosis,Annual incidence,N/A
Disease,2032,Idiopathic pulmonary fibrosis,Point prevalence,N/A
Disease,2032,Idiopathic pulmonary fibrosis,Annual incidence,N/A
Disease,2032,Idiopathic pulmonary fibrosis,Point prevalence,N/A
Disease,2032,Idiopathic pulmonary fibrosis,Annual incidence,N/A
Disease,2032,Idiopathic pulmonary fibrosis,Point prevalence,N/A
Disease,2032,Idiopathic pulmonary fibrosis,Annual incidence,N/A
Disease,2032,Idiopathic pulmonary fibrosis,Point prevalence,N/A
Disease,2032,Idiopathic pulmonary fibrosis,Point prevalence,N/A
Disease,2032,Idiopathic pulmonary fibrosis,Annual incidence,N/A
Disease,2032,Idiopathic pulmonary fibrosis,Point prevalence,N/A
Disease,2032,Idiopathic pulmonary fibrosis,Annual incidence,N/A
Disease,2032,Idiopathic pulmonary fibrosis,Point prevalence,N/A
Disease,2032,Idiopathic pulmonary fibrosis,Annual incidence,N/A
Clinical group,1303,Bronchiolitis obliterans,Point prevalence,N/A
Disease,3348,Tracheobronchopathia osteochondroplastica,Point prevalence,N/A
Disease,3348,Tracheobronchopathia osteochondroplastica,Cases/families,N/A
Disease,2902,Idiopathic chronic eosinophilic pneumonia,Point prevalence,N/A
Disease,2902,Idiopathic chronic eosinophilic pneumonia,Annual incidence,N/A
Disease,1302,Cryptogenic organizing pneumonia,Point prevalence,N/A
Disease,1302,Cryptogenic organizing pneumonia,Point prevalence,N/A
Disease,1302,Cryptogenic organizing pneumonia,Point prevalence,N/A
Disease,1302,Cryptogenic organizing pneumonia,Annual incidence,N/A
Disease,198,Occipital horn syndrome,Cases/families,N/A
Disease,198,Occipital horn syndrome,Point prevalence,N/A
Disease,891,Familial exudative vitreoretinopathy,Point prevalence,N/A
Disease,466677,Scorpion envenomation,Point prevalence,N/A
Malformation syndrome,466688,Severe intellectual disability-corpus callosum agenesis-facial dysmorphism-cerebellar ataxia syndrome,Cases/families,N/A
Malformation syndrome,466688,Severe intellectual disability-corpus callosum agenesis-facial dysmorphism-cerebellar ataxia syndrome,Point prevalence,N/A
Morphological anomaly,466695,Supratip dysplasia,Cases/families,N/A
Morphological anomaly,466695,Supratip dysplasia,Point prevalence,N/A
Particular clinical situation in a disease or syndrome,466670,Cyanide poisoning,Point prevalence,N/A
Disease,466650,Exercise-induced malignant hyperthermia,Point prevalence,N/A
Disease,466962,SMARCA4-deficient sarcoma of thorax,Cases/families,N/A
Disease,466962,SMARCA4-deficient sarcoma of thorax,Point prevalence,N/A
Clinical subtype,466950,Facial dysmorphism-developmental delay-behavioral abnormalities syndrome due to WAC point mutation,Cases/families,N/A
Clinical subtype,466950,Facial dysmorphism-developmental delay-behavioral abnormalities syndrome due to WAC point mutation,Point prevalence,N/A
Malformation syndrome,466943,WAC-related facial dysmorphism-developmental delay-behavioral abnormalities syndrome,Cases/families,N/A
Malformation syndrome,466943,WAC-related facial dysmorphism-developmental delay-behavioral abnormalities syndrome,Point prevalence,N/A
Disease,466926,Seizures-scoliosis-macrocephaly syndrome,Cases/families,N/A
Disease,466926,Seizures-scoliosis-macrocephaly syndrome,Point prevalence,N/A
Disease,466934,VPS11-related autosomal recessive hypomyelinating leukodystrophy,Cases/families,N/A
Disease,466934,VPS11-related autosomal recessive hypomyelinating leukodystrophy,Point prevalence,N/A
Disease,466921,Childhood-onset progressive contractures-limb-girdle weakness-muscle dystrophy syndrome,Cases/families,N/A
Disease,466921,Childhood-onset progressive contractures-limb-girdle weakness-muscle dystrophy syndrome,Point prevalence,N/A
Disease,466806,Autosomal dominant thrombocytopenia with platelet secretion defect,Cases/families,N/A
Disease,466806,Autosomal dominant thrombocytopenia with platelet secretion defect,Point prevalence,N/A
Disease,466794,Acute infantile liver failure-cerebellar ataxia-peripheral sensory motor neuropathy syndrome,Cases/families,N/A
Disease,466794,Acute infantile liver failure-cerebellar ataxia-peripheral sensory motor neuropathy syndrome,Point prevalence,N/A
Malformation syndrome,466791,Macrocephaly-intellectual disability-left ventricular non compaction syndrome,Cases/families,N/A
Malformation syndrome,466791,Macrocephaly-intellectual disability-left ventricular non compaction syndrome,Point prevalence,N/A
Disease,466784,Neonatal severe cardiopulmonary failure due to mitochondrial methylation defect,Cases/families,N/A
Disease,466784,Neonatal severe cardiopulmonary failure due to mitochondrial methylation defect,Point prevalence,N/A
Disease,466775,Autosomal recessive Charcot-Marie-Tooth disease type 2X,Cases/families,N/A
Disease,466775,Autosomal recessive Charcot-Marie-Tooth disease type 2X,Point prevalence,N/A
Disease,466768,Autosomal dominant Charcot-Marie-Tooth disease type 2Z,Cases/families,N/A
Disease,466768,Autosomal dominant Charcot-Marie-Tooth disease type 2Z,Point prevalence,N/A
Disease,466722,Autosomal recessive spastic paraplegia type 77,Cases/families,N/A
Disease,466722,Autosomal recessive spastic paraplegia type 77,Point prevalence,N/A
Disease,466718,Martinique crinkled retinal pigment epitheliopathy,Cases/families,N/A
Disease,466718,Martinique crinkled retinal pigment epitheliopathy,Point prevalence,N/A
Disease,466703,TMEM199-CDG,Cases/families,N/A
Disease,466703,TMEM199-CDG,Point prevalence,N/A
Malformation syndrome,465824,Fetal encasement syndrome,Cases/families,N/A
Malformation syndrome,465824,Fetal encasement syndrome,Point prevalence,N/A
Disease,466026,Class I glucose-6-phosphate dehydrogenase deficiency,Point prevalence,N/A
Disease,468620,Intellectual disability-epilepsy-extrapyramidal syndrome,Cases/families,N/A
Disease,468620,Intellectual disability-epilepsy-extrapyramidal syndrome,Point prevalence,N/A
Malformation syndrome,468631,Microcephalic cortical malformations-short stature due to RTTN deficiency,Cases/families,N/A
Malformation syndrome,468631,Microcephalic cortical malformations-short stature due to RTTN deficiency,Point prevalence,N/A
Disease,467166,Tubulinopathy-associated dysgyria,Cases/families,N/A
Disease,467166,Tubulinopathy-associated dysgyria,Point prevalence,N/A
Disease,467176,Severe hypotonia-psychomotor developmental delay-strabismus-cardiac septal defect syndrome,Cases/families,N/A
Disease,467176,Severe hypotonia-psychomotor developmental delay-strabismus-cardiac septal defect syndrome,Point prevalence,N/A
Disease,468635,Cryptogenic multifocal ulcerous stenosing enteritis,Cases/families,N/A
Disease,468635,Cryptogenic multifocal ulcerous stenosing enteritis,Point prevalence,N/A
Disease,468641,Chronic enteropathy associated with SLCO2A1 gene,Cases/families,N/A
Disease,468641,Chronic enteropathy associated with SLCO2A1 gene,Point prevalence,N/A
Disease,468661,Autosomal recessive spastic paraplegia type 74,Cases/families,N/A
Disease,468661,Autosomal recessive spastic paraplegia type 74,Point prevalence,N/A
Disease,468666,Isolated generalized anhidrosis with normal sweat glands,Cases/families,N/A
Disease,468666,Isolated generalized anhidrosis with normal sweat glands,Point prevalence,N/A
Disease,468678,White-Sutton syndrome,Point prevalence,N/A
Disease,468684,CCDC115-CDG,Cases/families,N/A
Disease,468684,CCDC115-CDG,Point prevalence,N/A
Disease,468672,Colobomatous macrophthalmia-microcornea syndrome,Cases/families,N/A
Disease,468672,Colobomatous macrophthalmia-microcornea syndrome,Point prevalence,N/A
Disease,468726,Severe primary trimethylaminuria,Point prevalence,N/A
Disease,468699,SLC39A8-CDG,Cases/families,N/A
Disease,468699,SLC39A8-CDG,Point prevalence,N/A
Etiological subtype,468717,Rhizomelic chondrodysplasia punctata type 5,Cases/families,N/A
Etiological subtype,468717,Rhizomelic chondrodysplasia punctata type 5,Point prevalence,N/A
Disease,401785,Autosomal recessive spastic paraplegia type 62,Cases/families,N/A
Disease,401785,Autosomal recessive spastic paraplegia type 62,Point prevalence,N/A
Disease,401780,Autosomal recessive spastic paraplegia type 61,Cases/families,N/A
Disease,401780,Autosomal recessive spastic paraplegia type 61,Point prevalence,N/A
Disease,401800,Autosomal recessive spastic paraplegia type 60,Cases/families,N/A
Disease,401800,Autosomal recessive spastic paraplegia type 60,Point prevalence,N/A
Disease,401795,Autosomal recessive spastic paraplegia type 59,Cases/families,N/A
Disease,401795,Autosomal recessive spastic paraplegia type 59,Point prevalence,N/A
Disease,401768,Proximal myopathy with extrapyramidal signs,Cases/families,N/A
Disease,401768,Proximal myopathy with extrapyramidal signs,Point prevalence,N/A
Disease,401764,Pancytopenia-developmental delay syndrome,Cases/families,N/A
Disease,401764,Pancytopenia-developmental delay syndrome,Point prevalence,N/A
Disease,401777,Optic atrophy-intellectual disability syndrome,Cases/families,N/A
Disease,401777,Optic atrophy-intellectual disability syndrome,Point prevalence,N/A
Disease,401830,Autosomal recessive spastic paraplegia type 69,Cases/families,N/A
Disease,401830,Autosomal recessive spastic paraplegia type 69,Point prevalence,N/A
Disease,401835,Autosomal recessive spastic paraplegia type 70,Cases/families,N/A
Disease,401835,Autosomal recessive spastic paraplegia type 70,Point prevalence,N/A
Disease,401840,Autosomal recessive spastic paraplegia type 71,Cases/families,N/A
Disease,401840,Autosomal recessive spastic paraplegia type 71,Point prevalence,N/A
Disease,401805,Autosomal recessive spastic paraplegia type 63,Cases/families,N/A
Disease,401805,Autosomal recessive spastic paraplegia type 63,Point prevalence,N/A
Disease,401810,Autosomal recessive spastic paraplegia type 64,Cases/families,N/A
Disease,401810,Autosomal recessive spastic paraplegia type 64,Point prevalence,N/A
Disease,401815,Autosomal recessive spastic paraplegia type 66,Cases/families,N/A
Disease,401815,Autosomal recessive spastic paraplegia type 66,Point prevalence,N/A
Disease,401820,Autosomal recessive spastic paraplegia type 67,Cases/families,N/A
Disease,401820,Autosomal recessive spastic paraplegia type 67,Point prevalence,N/A
Disease,401866,Childhood-onset spasticity with hyperglycinemia,Cases/families,N/A
Disease,401866,Childhood-onset spasticity with hyperglycinemia,Point prevalence,N/A
Disease,401869,Multiple mitochondrial dysfunctions syndrome type 1,Cases/families,N/A
Disease,401869,Multiple mitochondrial dysfunctions syndrome type 1,Point prevalence,N/A
Disease,401874,Multiple mitochondrial dysfunctions syndrome type 2,Cases/families,N/A
Disease,401874,Multiple mitochondrial dysfunctions syndrome type 2,Point prevalence,N/A
Disease,401849,Autosomal spastic paraplegia type 72,Cases/families,N/A
Disease,401849,Autosomal spastic paraplegia type 72,Point prevalence,N/A
Disease,401859,Lipoic acid synthetase deficiency,Cases/families,N/A
Disease,401859,Lipoic acid synthetase deficiency,Point prevalence,N/A
Disease,401862,Lipoyl transferase 1 deficiency,Cases/families,N/A
Disease,401862,Lipoyl transferase 1 deficiency,Point prevalence,N/A
Disease,402823,Hepatitis delta,Point prevalence,N/A
Disease,401920,Fibrolamellar hepatocellular carcinoma,Annual incidence,N/A
Disease,401920,Fibrolamellar hepatocellular carcinoma,Annual incidence,N/A
Disease,401920,Fibrolamellar hepatocellular carcinoma,Annual incidence,N/A
Disease,401920,Fibrolamellar hepatocellular carcinoma,Annual incidence,N/A
Disease,401920,Fibrolamellar hepatocellular carcinoma,Annual incidence,N/A
Disease,401920,Fibrolamellar hepatocellular carcinoma,Annual incidence,N/A
Disease,401920,Fibrolamellar hepatocellular carcinoma,Annual incidence,N/A
Disease,401920,Fibrolamellar hepatocellular carcinoma,Annual incidence,N/A
Disease,401920,Fibrolamellar hepatocellular carcinoma,Annual incidence,N/A
Disease,401920,Fibrolamellar hepatocellular carcinoma,Annual incidence,N/A
Disease,401920,Fibrolamellar hepatocellular carcinoma,Annual incidence,N/A
Disease,401920,Fibrolamellar hepatocellular carcinoma,Annual incidence,N/A
Disease,401920,Fibrolamellar hepatocellular carcinoma,Annual incidence,N/A
Disease,401920,Fibrolamellar hepatocellular carcinoma,Annual incidence,N/A
Disease,401920,Fibrolamellar hepatocellular carcinoma,Annual incidence,N/A
Disease,401920,Fibrolamellar hepatocellular carcinoma,Annual incidence,N/A
Disease,401920,Fibrolamellar hepatocellular carcinoma,Annual incidence,N/A
Disease,401920,Fibrolamellar hepatocellular carcinoma,Annual incidence,N/A
Disease,401920,Fibrolamellar hepatocellular carcinoma,Annual incidence,N/A
Disease,401920,Fibrolamellar hepatocellular carcinoma,Annual incidence,N/A
Disease,401920,Fibrolamellar hepatocellular carcinoma,Annual incidence,N/A
Disease,401920,Fibrolamellar hepatocellular carcinoma,Annual incidence,N/A
Clinical subtype,401911,AXIN2-related attenuated familial adenomatous polyposis,Cases/families,N/A
Clinical subtype,401911,AXIN2-related attenuated familial adenomatous polyposis,Point prevalence,N/A
Disease,401901,Huntington disease-like syndrome due to C9ORF72 expansions,Cases/families,N/A
Disease,401901,Huntington disease-like syndrome due to C9ORF72 expansions,Point prevalence,N/A
Malformation syndrome,401942,Familial median cleft of the upper and lower lips,Cases/families,N/A
Malformation syndrome,401942,Familial median cleft of the upper and lower lips,Point prevalence,N/A
Malformation syndrome,401935,14q24.1q24.3 microdeletion syndrome,Cases/families,N/A
Malformation syndrome,401935,14q24.1q24.3 microdeletion syndrome,Point prevalence,N/A
Malformation syndrome,401923,9q31.1q31.3 microdeletion syndrome,Cases/families,N/A
Malformation syndrome,401923,9q31.1q31.3 microdeletion syndrome,Point prevalence,N/A
Malformation syndrome,401959,Partial corpus callosum agenesis-cerebellar vermis hypoplasia with posterior fossa cysts syndrome,Cases/families,N/A
Malformation syndrome,401959,Partial corpus callosum agenesis-cerebellar vermis hypoplasia with posterior fossa cysts syndrome,Point prevalence,N/A
Disease,401953,Episodic ataxia with slurred speech,Cases/families,N/A
Disease,401953,Episodic ataxia with slurred speech,Point prevalence,N/A
Disease,401948,Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency,Cases/families,N/A
Disease,401948,Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency,Point prevalence,N/A
Disease,401945,Moyamoya disease with early-onset achalasia,Cases/families,N/A
Disease,401945,Moyamoya disease with early-onset achalasia,Point prevalence,N/A
Malformation syndrome,401986,1p31p32 microdeletion syndrome,Cases/families,N/A
Malformation syndrome,401986,1p31p32 microdeletion syndrome,Point prevalence,N/A
Malformation syndrome,401979,"Autosomal recessive spondylometaphyseal dysplasia, Mgarban type",Cases/families,N/A
Malformation syndrome,401979,"Autosomal recessive spondylometaphyseal dysplasia, Mgarban type",Point prevalence,N/A
Malformation syndrome,401973,MEND syndrome,Cases/families,N/A
Malformation syndrome,401973,MEND syndrome,Point prevalence,N/A
Disease,401964,Autosomal dominant Charcot-Marie-Tooth disease type 2 with giant axons,Cases/families,N/A
Disease,401964,Autosomal dominant Charcot-Marie-Tooth disease type 2 with giant axons,Point prevalence,N/A
Disease,402003,Autosomal dominant focal non-epidermolytic palmoplantar keratoderma with plantar blistering,Cases/families,N/A
Disease,402003,Autosomal dominant focal non-epidermolytic palmoplantar keratoderma with plantar blistering,Point prevalence,N/A
Disease,401996,Karyomegalic interstitial nephritis,Cases/families,N/A
Disease,401996,Karyomegalic interstitial nephritis,Point prevalence,N/A
Disease,402035,Eosinophilic colitis,Cases/families,N/A
Disease,402035,Eosinophilic colitis,Point prevalence,N/A
Disease,402082,Progressive myoclonic epilepsy type 5,Cases/families,N/A
Disease,402082,Progressive myoclonic epilepsy type 5,Point prevalence,N/A
Malformation syndrome,402364,Infantile cerebral and cerebellar atrophy with postnatal progressive microcephaly,Cases/families,N/A
Malformation syndrome,402364,Infantile cerebral and cerebellar atrophy with postnatal progressive microcephaly,Point prevalence,N/A
Clinical subtype,402041,Autosomal recessive distal renal tubular acidosis,Point prevalence,N/A
Disease,806,Scott syndrome,Cases/families,N/A
Disease,806,Scott syndrome,Point prevalence,N/A
Malformation syndrome,404473,Severe intellectual disability-progressive spastic diplegia syndrome,Cases/families,N/A
Malformation syndrome,404473,Severe intellectual disability-progressive spastic diplegia syndrome,Point prevalence,N/A
Disease,404463,Multisystemic smooth muscle dysfunction syndrome,Cases/families,N/A
Disease,404463,Multisystemic smooth muscle dysfunction syndrome,Point prevalence,N/A
Disease,404466,Female infertility due to zona pellucida defect,Cases/families,N/A
Disease,404466,Female infertility due to zona pellucida defect,Point prevalence,N/A
Malformation syndrome,404451,FBLN1-related developmental delay-central nervous system anomaly-syndactyly syndrome,Cases/families,N/A
Malformation syndrome,404451,FBLN1-related developmental delay-central nervous system anomaly-syndactyly syndrome,Point prevalence,N/A
Disease,404454,Alacrimia-choreoathetosis-liver dysfunction syndrome,Cases/families,N/A
Disease,404454,Alacrimia-choreoathetosis-liver dysfunction syndrome,Point prevalence,N/A
Malformation syndrome,404443,Tatton-Brown-Rahman syndrome,Cases/families,N/A
Malformation syndrome,404443,Tatton-Brown-Rahman syndrome,Point prevalence,N/A
Malformation syndrome,404448,ADNP syndrome,Point prevalence,N/A
Malformation syndrome,404437,Diffuse cerebral and cerebellar atrophy-intractable seizures-progressive microcephaly syndrome,Cases/families,N/A
Malformation syndrome,404437,Diffuse cerebral and cerebellar atrophy-intractable seizures-progressive microcephaly syndrome,Point prevalence,N/A
Malformation syndrome,404440,Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency,Cases/families,N/A
Malformation syndrome,404440,Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency,Point prevalence,N/A
Disease,404560,Familial atypical multiple mole melanoma syndrome,Point prevalence,N/A
Disease,404553,Adenosine deaminase 2 deficiency,Point prevalence,N/A
Disease,404553,Adenosine deaminase 2 deficiency,Cases/families,N/A
Disease,404546,DITRA,Cases/families,N/A
Disease,404546,DITRA,Point prevalence,N/A
Disease,404521,Spinal muscular atrophy with respiratory distress type 2,Cases/families,N/A
Disease,404521,Spinal muscular atrophy with respiratory distress type 2,Point prevalence,N/A
Disease,404507,Chondromyxoid fibroma,Cases/families,N/A
Disease,404507,Chondromyxoid fibroma,Point prevalence,N/A
Disease,404499,Autosomal recessive cerebellar ataxia-epilepsy-intellectual disability syndrome due to RUBCN deficiency,Cases/families,N/A
Disease,404499,Autosomal recessive cerebellar ataxia-epilepsy-intellectual disability syndrome due to RUBCN deficiency,Point prevalence,N/A
Disease,404493,Autosomal recessive cerebellar ataxia-epilepsy-intellectual disability syndrome due to TUD deficiency,Cases/families,N/A
Disease,404493,Autosomal recessive cerebellar ataxia-epilepsy-intellectual disability syndrome due to TUD deficiency,Point prevalence,N/A
Malformation syndrome,404476,Global developmental delay-lung cysts-overgrowth-Wilms tumor syndrome,Cases/families,N/A
Malformation syndrome,404476,Global developmental delay-lung cysts-overgrowth-Wilms tumor syndrome,Point prevalence,N/A
Particular clinical situation in a disease or syndrome,411527,Central retinal vein occlusion,Point prevalence,N/A
Clinical subtype,411536,Mild phosphoribosylpyrophosphate synthetase superactivity,Point prevalence,N/A
Clinical subtype,411543,Severe phosphoribosylpyrophosphate synthetase superactivity,Point prevalence,N/A
Clinical subtype,411543,Severe phosphoribosylpyrophosphate synthetase superactivity,Cases/families,N/A
Disease,411593,Insulin autoimmune syndrome,Cases/families,N/A
Disease,411593,Insulin autoimmune syndrome,Point prevalence,N/A
Disease,411602,Hereditary late-onset Parkinson disease,Point prevalence,N/A
Clinical subtype,411629,Infantile nephropathic cystinosis,Prevalence at birth,N/A
Clinical subtype,411629,Infantile nephropathic cystinosis,Point prevalence,N/A
Malformation syndrome,411493,Pontocerebellar hypoplasia type 10,Cases/families,N/A
Malformation syndrome,411493,Pontocerebellar hypoplasia type 10,Point prevalence,N/A
Disease,411777,Generalized eruptive keratoacanthoma,Cases/families,N/A
Disease,411777,Generalized eruptive keratoacanthoma,Point prevalence,N/A
Disease,411712,Maternal riboflavin deficiency,Cases/families,N/A
Disease,411712,Maternal riboflavin deficiency,Point prevalence,N/A
Disease,411788,Familial isolated trichomegaly,Cases/families,N/A
Disease,411788,Familial isolated trichomegaly,Point prevalence,N/A
Malformation syndrome,411986,Early-onset epileptic encephalopathy-cortical blindness-intellectual disability-facial dysmorphism syndrome,Cases/families,N/A
Malformation syndrome,411986,Early-onset epileptic encephalopathy-cortical blindness-intellectual disability-facial dysmorphism syndrome,Point prevalence,N/A
Malformation syndrome,412035,13q12.3 microdeletion syndrome,Cases/families,N/A
Malformation syndrome,412035,13q12.3 microdeletion syndrome,Point prevalence,N/A
Malformation syndrome,412022,Facial dysmorphism-lens dislocation-anterior segment abnormalities-spontaneous filtering blebs syndrome,Cases/families,N/A
Malformation syndrome,412022,Facial dysmorphism-lens dislocation-anterior segment abnormalities-spontaneous filtering blebs syndrome,Point prevalence,N/A
Clinical subtype,411641,Ocular cystinosis,Point prevalence,N/A
Clinical subtype,411634,Juvenile nephropathic cystinosis,Prevalence at birth,N/A
Clinical subtype,411634,Juvenile nephropathic cystinosis,Point prevalence,N/A
Disease,411696,Proton-pump inhibitor-responsive esophageal eosinophilia,Point prevalence,N/A
Morphological anomaly,411709,Renal agenesis,Prevalence at birth,N/A
Morphological anomaly,411709,Renal agenesis,Point prevalence,N/A
Disease,411703,Pulmonary non-tuberculous mycobacterial infection,Point prevalence,N/A
Disease,371428,Multicentric osteolysis-nodulosis-arthropathy spectrum,Cases/families,N/A
Disease,371428,Multicentric osteolysis-nodulosis-arthropathy spectrum,Point prevalence,N/A
Disease,371364,Hypotonia-speech impairment-severe cognitive delay syndrome,Point prevalence,N/A
Disease,391673,Necrotizing enterocolitis,Point prevalence,N/A
Malformation syndrome,391677,Short stature-optic atrophy-Pelger-Hut anomaly syndrome,Cases/families,N/A
Malformation syndrome,391677,Short stature-optic atrophy-Pelger-Hut anomaly syndrome,Point prevalence,N/A
Malformation syndrome,391474,Frontorhiny,Point prevalence,N/A
Clinical subtype,391504,Transient neonatal myasthenia gravis,Point prevalence,N/A
Clinical subtype,391497,Juvenile myasthenia gravis,Point prevalence,N/A
Clinical subtype,391490,Adult-onset myasthenia gravis,Point prevalence,N/A
Clinical subtype,391490,Adult-onset myasthenia gravis,Annual incidence,N/A
Clinical subtype,391490,Adult-onset myasthenia gravis,Point prevalence,N/A
Clinical subtype,391490,Adult-onset myasthenia gravis,Point prevalence,N/A
Clinical subtype,391490,Adult-onset myasthenia gravis,Point prevalence,N/A
Disease,391487,STAT1-related autoimmune enteropathy and endocrinopathy-susceptibility to chronic infections syndrome,Cases/families,N/A
Disease,391487,STAT1-related autoimmune enteropathy and endocrinopathy-susceptibility to chronic infections syndrome,Point prevalence,N/A
Clinical subtype,391646,Feingold syndrome type 2,Cases/families,N/A
Clinical subtype,391646,Feingold syndrome type 2,Point prevalence,N/A
Clinical subtype,391641,Feingold syndrome type 1,Cases/families,N/A
Clinical subtype,391641,Feingold syndrome type 1,Point prevalence,N/A
Disease,391665,Homozygous familial hypercholesterolemia,Annual incidence,N/A
Disease,391665,Homozygous familial hypercholesterolemia,Point prevalence,N/A
Disease,391665,Homozygous familial hypercholesterolemia,Point prevalence,N/A
Disease,391665,Homozygous familial hypercholesterolemia,Point prevalence,N/A
Disease,391665,Homozygous familial hypercholesterolemia,Point prevalence,N/A
Disease,391665,Homozygous familial hypercholesterolemia,Point prevalence,N/A
Particular clinical situation in a disease or syndrome,391655,Off-periods in Parkinson disease not responding to oral treatment,Point prevalence,N/A
Disease,391343,Fatal post-viral neurodegenerative disorder,Cases/families,N/A
Disease,391343,Fatal post-viral neurodegenerative disorder,Point prevalence,N/A
Disease,391348,Growth and developmental delay-hypotonia-vision impairment-lactic acidosis syndrome,Cases/families,N/A
Disease,391348,Growth and developmental delay-hypotonia-vision impairment-lactic acidosis syndrome,Point prevalence,N/A
Disease,391351,SURF1-related Charcot-Marie-Tooth disease type 4,Cases/families,N/A
Disease,391351,SURF1-related Charcot-Marie-Tooth disease type 4,Point prevalence,N/A
Disease,391366,Growth retardation-mild developmental delay-chronic hepatitis syndrome,Cases/families,N/A
Disease,391366,Growth retardation-mild developmental delay-chronic hepatitis syndrome,Point prevalence,N/A
Malformation syndrome,391372,FOXP1 Syndrome,Cases/families,N/A
Malformation syndrome,391372,FOXP1 Syndrome,Point prevalence,N/A
Disease,391376,Congenital microcephaly-severe encephalopathy-progressive cerebral atrophy syndrome,Cases/families,N/A
Disease,391376,Congenital microcephaly-severe encephalopathy-progressive cerebral atrophy syndrome,Point prevalence,N/A
Disease,391384,Familial episodic pain syndrome,Point prevalence,N/A
Clinical subtype,391389,Familial episodic pain syndrome with predominantly upper body involvement,Cases/families,N/A
Clinical subtype,391389,Familial episodic pain syndrome with predominantly upper body involvement,Point prevalence,N/A
Clinical subtype,391392,Familial episodic pain syndrome with predominantly lower limb involvement,Cases/families,N/A
Clinical subtype,391392,Familial episodic pain syndrome with predominantly lower limb involvement,Point prevalence,N/A
Disease,391397,Hereditary sensory and autonomic neuropathy type 7,Cases/families,N/A
Disease,391397,Hereditary sensory and autonomic neuropathy type 7,Point prevalence,N/A
Disease,391408,Primary microcephaly-mild intellectual disability-young-onset diabetes syndrome,Cases/families,N/A
Disease,391408,Primary microcephaly-mild intellectual disability-young-onset diabetes syndrome,Point prevalence,N/A
Disease,391411,Atypical juvenile parkinsonism,Cases/families,N/A
Disease,391411,Atypical juvenile parkinsonism,Point prevalence,N/A
Disease,391417,HSD10 disease,Cases/families,N/A
Disease,391417,HSD10 disease,Point prevalence,N/A
Clinical subtype,391457,"HSD10 disease, neonatal type",Cases/families,N/A
Clinical subtype,391457,"HSD10 disease, neonatal type",Point prevalence,N/A
Malformation syndrome,391307,Severe intellectual disability-short stature-behavioral abnormalities-facial dysmorphism syndrome,Cases/families,N/A
Malformation syndrome,391307,Severe intellectual disability-short stature-behavioral abnormalities-facial dysmorphism syndrome,Point prevalence,N/A
Disease,391316,Infantile-onset mesial temporal lobe epilepsy with severe cognitive regression,Cases/families,N/A
Disease,391316,Infantile-onset mesial temporal lobe epilepsy with severe cognitive regression,Point prevalence,N/A
Disease,391327,X-linked calvarial hyperostosis,Cases/families,N/A
Disease,391327,X-linked calvarial hyperostosis,Point prevalence,N/A
Etiological subtype,391320,East Texas bleeding disorder,Cases/families,N/A
Etiological subtype,391320,East Texas bleeding disorder,Point prevalence,N/A
Disease,391330,X-linked osteoporosis with fractures,Cases/families,N/A
Disease,391330,X-linked osteoporosis with fractures,Point prevalence,N/A
Disease,398063,Refractory celiac disease,Point prevalence,N/A
Disease,398058,Squamous cell carcinoma of the penis,Annual incidence,N/A
Disease,398058,Squamous cell carcinoma of the penis,Annual incidence,N/A
Disease,398058,Squamous cell carcinoma of the penis,Annual incidence,N/A
Disease,398058,Squamous cell carcinoma of the penis,Annual incidence,N/A
Disease,398058,Squamous cell carcinoma of the penis,Annual incidence,N/A
Disease,398058,Squamous cell carcinoma of the penis,Annual incidence,N/A
Disease,398058,Squamous cell carcinoma of the penis,Annual incidence,N/A
Disease,398058,Squamous cell carcinoma of the penis,Annual incidence,N/A
Disease,398058,Squamous cell carcinoma of the penis,Annual incidence,N/A
Disease,398058,Squamous cell carcinoma of the penis,Annual incidence,N/A
Disease,398058,Squamous cell carcinoma of the penis,Annual incidence,N/A
Disease,398058,Squamous cell carcinoma of the penis,Annual incidence,N/A
Disease,398058,Squamous cell carcinoma of the penis,Annual incidence,N/A
Disease,398058,Squamous cell carcinoma of the penis,Annual incidence,N/A
Disease,398058,Squamous cell carcinoma of the penis,Annual incidence,N/A
Disease,398058,Squamous cell carcinoma of the penis,Annual incidence,N/A
Disease,398058,Squamous cell carcinoma of the penis,Annual incidence,N/A
Disease,398058,Squamous cell carcinoma of the penis,Annual incidence,N/A
Disease,398058,Squamous cell carcinoma of the penis,Annual incidence,N/A
Disease,398058,Squamous cell carcinoma of the penis,Annual incidence,N/A
Disease,398058,Squamous cell carcinoma of the penis,Annual incidence,N/A
Disease,398058,Squamous cell carcinoma of the penis,Annual incidence,N/A
Disease,398058,Squamous cell carcinoma of the penis,Annual incidence,N/A
Disease,398058,Squamous cell carcinoma of the penis,Annual incidence,N/A
Disease,398053,Adenocarcinoma of the penis,Annual incidence,N/A
Disease,398053,Adenocarcinoma of the penis,Annual incidence,N/A
Disease,398053,Adenocarcinoma of the penis,Annual incidence,N/A
Disease,398053,Adenocarcinoma of the penis,Annual incidence,N/A
Disease,398053,Adenocarcinoma of the penis,Annual incidence,N/A
Disease,398053,Adenocarcinoma of the penis,Annual incidence,N/A
Disease,398053,Adenocarcinoma of the penis,Annual incidence,N/A
Disease,398053,Adenocarcinoma of the penis,Annual incidence,N/A
Disease,398053,Adenocarcinoma of the penis,Annual incidence,N/A
Disease,398053,Adenocarcinoma of the penis,Annual incidence,N/A
Disease,398053,Adenocarcinoma of the penis,Annual incidence,N/A
Disease,398053,Adenocarcinoma of the penis,Annual incidence,N/A
Disease,398053,Adenocarcinoma of the penis,Annual incidence,N/A
Disease,398053,Adenocarcinoma of the penis,Annual incidence,N/A
Disease,398053,Adenocarcinoma of the penis,Annual incidence,N/A
Disease,398053,Adenocarcinoma of the penis,Annual incidence,N/A
Disease,398053,Adenocarcinoma of the penis,Annual incidence,N/A
Category,398043,Malignant tumor of penis,Annual incidence,N/A
Category,398043,Malignant tumor of penis,Annual incidence,N/A
Category,398043,Malignant tumor of penis,Annual incidence,N/A
Category,398043,Malignant tumor of penis,Annual incidence,N/A
Category,398043,Malignant tumor of penis,Annual incidence,N/A
Disease,397973,Intellectual disability-obesity-prognathism-eye and skin anomalies syndrome,Cases/families,N/A
Disease,397973,Intellectual disability-obesity-prognathism-eye and skin anomalies syndrome,Point prevalence,N/A
Disease,397968,Charcot-Marie-Tooth disease type 2R,Cases/families,N/A
Disease,397968,Charcot-Marie-Tooth disease type 2R,Point prevalence,N/A
Disease,397964,Combined immunodeficiency due to MALT1 deficiency,Cases/families,N/A
Disease,397964,Combined immunodeficiency due to MALT1 deficiency,Point prevalence,N/A
Disease,397959,TCR-alpha-beta-positive T-cell deficiency,Cases/families,N/A
Disease,397959,TCR-alpha-beta-positive T-cell deficiency,Point prevalence,N/A
Disease,397951,Microcephaly-thin corpus callosum-intellectual disability syndrome,Cases/families,N/A
Disease,397951,Microcephaly-thin corpus callosum-intellectual disability syndrome,Point prevalence,N/A
Disease,397946,Autosomal spastic paraplegia type 58,Cases/families,N/A
Disease,397946,Autosomal spastic paraplegia type 58,Point prevalence,N/A
Disease,397941,MAN1B1-CDG,Cases/families,N/A
Disease,397941,MAN1B1-CDG,Point prevalence,N/A
Disease,397937,Polyglucosan body myopathy type 1,Cases/families,N/A
Disease,397937,Polyglucosan body myopathy type 1,Point prevalence,N/A
Disease,397933,Severe intellectual disability-progressive postnatal microcephaly-midline stereotypic hand movements syndrome,Cases/families,N/A
Disease,397933,Severe intellectual disability-progressive postnatal microcephaly-midline stereotypic hand movements syndrome,Point prevalence,N/A
Malformation syndrome,397927,Sacral agenesis-abnormal ossification of the vertebral bodies-persistent notochordal canal syndrome,Cases/families,N/A
Malformation syndrome,397927,Sacral agenesis-abnormal ossification of the vertebral bodies-persistent notochordal canal syndrome,Point prevalence,N/A
Disease,397922,Ferro-cerebro-cutaneous syndrome,Cases/families,N/A
Disease,397922,Ferro-cerebro-cutaneous syndrome,Point prevalence,N/A
Disease,397787,Combined immunodeficiency due to IKK2 deficiency,Cases/families,N/A
Disease,397787,Combined immunodeficiency due to IKK2 deficiency,Point prevalence,N/A
Disease,397755,Periodic paralysis with transient compartment-like syndrome,Cases/families,N/A
Disease,397755,Periodic paralysis with transient compartment-like syndrome,Point prevalence,N/A
Disease,397758,Retinal dystrophy with inner retinal dysfunction and ganglion cell anomalies,Cases/families,N/A
Disease,397758,Retinal dystrophy with inner retinal dysfunction and ganglion cell anomalies,Point prevalence,N/A
Disease,397744,Peripheral neuropathy-myopathy-hoarseness-hearing loss syndrome,Cases/families,N/A
Disease,397744,Peripheral neuropathy-myopathy-hoarseness-hearing loss syndrome,Point prevalence,N/A
Disease,397750,Periodic paralysis with later-onset distal motor neuropathy,Cases/families,N/A
Disease,397750,Periodic paralysis with later-onset distal motor neuropathy,Point prevalence,N/A
Disease,397725,COASY protein-associated neurodegeneration,Cases/families,N/A
Disease,397725,COASY protein-associated neurodegeneration,Point prevalence,N/A
Disease,397735,Autosomal dominant Charcot-Marie-Tooth disease type 2U,Cases/families,N/A
Disease,397735,Autosomal dominant Charcot-Marie-Tooth disease type 2U,Point prevalence,N/A
Malformation syndrome,397709,Intellectual disability-coarse face-macrocephaly-cerebellar hypotrophy syndrome,Point prevalence,N/A
Malformation syndrome,397709,Intellectual disability-coarse face-macrocephaly-cerebellar hypotrophy syndrome,Cases/families,N/A
Malformation syndrome,397715,Joubert syndrome with Jeune asphyxiating thoracic dystrophy,Cases/families,N/A
Malformation syndrome,397715,Joubert syndrome with Jeune asphyxiating thoracic dystrophy,Point prevalence,N/A
Disease,397692,Hereditary isolated aplastic anemia,Point prevalence,N/A
Disease,397695,3q27.3 microdeletion syndrome,Cases/families,N/A
Disease,397695,3q27.3 microdeletion syndrome,Point prevalence,N/A
Malformation syndrome,397623,Short stature-auditory canal atresia-mandibular hypoplasia-skeletal anomalies syndrome,Cases/families,N/A
Malformation syndrome,397623,Short stature-auditory canal atresia-mandibular hypoplasia-skeletal anomalies syndrome,Point prevalence,N/A
Disease,397685,Familial hyperprolactinemia,Point prevalence,N/A
Etiological subtype,397615,Obesity due to CEP19 deficiency,Cases/families,N/A
Etiological subtype,397615,Obesity due to CEP19 deficiency,Point prevalence,N/A
Disease,397618,Foveal hypoplasia-optic nerve decussation defect-anterior segment dysgenesis syndrome,Cases/families,N/A
Disease,397618,Foveal hypoplasia-optic nerve decussation defect-anterior segment dysgenesis syndrome,Point prevalence,N/A
Disease,397596,Activated PI3K-delta syndrome,Cases/families,N/A
Disease,397596,Activated PI3K-delta syndrome,Point prevalence,N/A
Disease,397593,Severe neonatal lactic acidosis due to NFS1-ISD11 complex deficiency,Cases/families,N/A
Disease,397593,Severe neonatal lactic acidosis due to NFS1-ISD11 complex deficiency,Point prevalence,N/A
Malformation syndrome,397612,Macrocephaly-developmental delay syndrome,Cases/families,N/A
Malformation syndrome,397612,Macrocephaly-developmental delay syndrome,Point prevalence,N/A
Disease,397606,PrP systemic amyloidosis,Point prevalence,N/A
Disease,397606,PrP systemic amyloidosis,Cases/families,N/A
Etiological subtype,397590,Silver-Russell syndrome due to a point mutation,Cases/families,N/A
Etiological subtype,397590,Silver-Russell syndrome due to a point mutation,Point prevalence,N/A
Disease,397587,Deep dermatophytosis,Point prevalence,N/A
Disease,399329,Epiphysiolysis of the hip,Point prevalence,N/A
Disease,399180,Secondary non-traumatic avascular necrosis,Point prevalence,N/A
Disease,399058,Alpha-B crystallin-related late-onset myopathy,Cases/families,N/A
Disease,399058,Alpha-B crystallin-related late-onset myopathy,Point prevalence,N/A
Disease,398987,Malignant teratoma of ovary,Point prevalence,N/A
Disease,398987,Malignant teratoma of ovary,Annual incidence,N/A
Disease,398987,Malignant teratoma of ovary,Annual incidence,N/A
Disease,398987,Malignant teratoma of ovary,Annual incidence,N/A
Disease,398987,Malignant teratoma of ovary,Annual incidence,N/A
Disease,398987,Malignant teratoma of ovary,Annual incidence,N/A
Disease,398987,Malignant teratoma of ovary,Annual incidence,N/A
Disease,398987,Malignant teratoma of ovary,Annual incidence,N/A
Disease,398987,Malignant teratoma of ovary,Annual incidence,N/A
Disease,398987,Malignant teratoma of ovary,Annual incidence,N/A
Disease,398987,Malignant teratoma of ovary,Annual incidence,N/A
Disease,398987,Malignant teratoma of ovary,Annual incidence,N/A
Disease,398987,Malignant teratoma of ovary,Annual incidence,N/A
Disease,398987,Malignant teratoma of ovary,Annual incidence,N/A
Disease,398987,Malignant teratoma of ovary,Annual incidence,N/A
Disease,398987,Malignant teratoma of ovary,Annual incidence,N/A
Disease,398987,Malignant teratoma of ovary,Annual incidence,N/A
Disease,398987,Malignant teratoma of ovary,Annual incidence,N/A
Disease,398987,Malignant teratoma of ovary,Annual incidence,N/A
Disease,398987,Malignant teratoma of ovary,Annual incidence,N/A
Disease,398987,Malignant teratoma of ovary,Annual incidence,N/A
Disease,398987,Malignant teratoma of ovary,Annual incidence,N/A
Disease,398987,Malignant teratoma of ovary,Annual incidence,N/A
Disease,398987,Malignant teratoma of ovary,Annual incidence,N/A
Disease,399086,Finnish upper limb-onset distal myopathy,Point prevalence,N/A
Disease,399086,Finnish upper limb-onset distal myopathy,Cases/families,N/A
Disease,399081,KLHL9-related early-onset distal myopathy,Cases/families,N/A
Disease,399081,KLHL9-related early-onset distal myopathy,Point prevalence,N/A
Disease,399103,Distal nebulin myopathy,Cases/families,N/A
Disease,399103,Distal nebulin myopathy,Point prevalence,N/A
Disease,399096,Distal anoctaminopathy,Cases/families,N/A
Disease,399096,Distal anoctaminopathy,Point prevalence,N/A
Category,398934,Malignant epithelial tumor of ovary,Annual incidence,N/A
Disease,398961,Mucinous adenocarcinoma of ovary,Annual incidence,N/A
Disease,398961,Mucinous adenocarcinoma of ovary,Annual incidence,N/A
Disease,398961,Mucinous adenocarcinoma of ovary,Annual incidence,N/A
Disease,398961,Mucinous adenocarcinoma of ovary,Annual incidence,N/A
Disease,398961,Mucinous adenocarcinoma of ovary,Annual incidence,N/A
Disease,398961,Mucinous adenocarcinoma of ovary,Annual incidence,N/A
Disease,398961,Mucinous adenocarcinoma of ovary,Annual incidence,N/A
Disease,398961,Mucinous adenocarcinoma of ovary,Annual incidence,N/A
Disease,398961,Mucinous adenocarcinoma of ovary,Annual incidence,N/A
Disease,398961,Mucinous adenocarcinoma of ovary,Annual incidence,N/A
Disease,398961,Mucinous adenocarcinoma of ovary,Annual incidence,N/A
Disease,398961,Mucinous adenocarcinoma of ovary,Annual incidence,N/A
Disease,398961,Mucinous adenocarcinoma of ovary,Annual incidence,N/A
Disease,398961,Mucinous adenocarcinoma of ovary,Annual incidence,N/A
Disease,398961,Mucinous adenocarcinoma of ovary,Annual incidence,N/A
Disease,398961,Mucinous adenocarcinoma of ovary,Annual incidence,N/A
Disease,398961,Mucinous adenocarcinoma of ovary,Annual incidence,N/A
Disease,398961,Mucinous adenocarcinoma of ovary,Annual incidence,N/A
Disease,398961,Mucinous adenocarcinoma of ovary,Annual incidence,N/A
Disease,398961,Mucinous adenocarcinoma of ovary,Annual incidence,N/A
Disease,398961,Mucinous adenocarcinoma of ovary,Annual incidence,N/A
Disease,398961,Mucinous adenocarcinoma of ovary,Annual incidence,N/A
Disease,398961,Mucinous adenocarcinoma of ovary,Annual incidence,N/A
Disease,398961,Mucinous adenocarcinoma of ovary,Annual incidence,N/A
Category,398940,Malignant non-epithelial tumor of ovary,Annual incidence,N/A
Disease,398971,Clear cell adenocarcinoma of the ovary,Annual incidence,N/A
Disease,398971,Clear cell adenocarcinoma of the ovary,Annual incidence,N/A
Disease,398971,Clear cell adenocarcinoma of the ovary,Annual incidence,N/A
Disease,398971,Clear cell adenocarcinoma of the ovary,Annual incidence,N/A
Disease,398971,Clear cell adenocarcinoma of the ovary,Annual incidence,N/A
Disease,398971,Clear cell adenocarcinoma of the ovary,Annual incidence,N/A
Disease,398971,Clear cell adenocarcinoma of the ovary,Annual incidence,N/A
Disease,398971,Clear cell adenocarcinoma of the ovary,Annual incidence,N/A
Disease,398971,Clear cell adenocarcinoma of the ovary,Annual incidence,N/A
Disease,398971,Clear cell adenocarcinoma of the ovary,Annual incidence,N/A
Disease,398971,Clear cell adenocarcinoma of the ovary,Annual incidence,N/A
Disease,398971,Clear cell adenocarcinoma of the ovary,Annual incidence,N/A
Disease,398971,Clear cell adenocarcinoma of the ovary,Annual incidence,N/A
Disease,398971,Clear cell adenocarcinoma of the ovary,Annual incidence,N/A
Disease,398971,Clear cell adenocarcinoma of the ovary,Annual incidence,N/A
Disease,398971,Clear cell adenocarcinoma of the ovary,Annual incidence,N/A
Disease,398971,Clear cell adenocarcinoma of the ovary,Annual incidence,N/A
Disease,398971,Clear cell adenocarcinoma of the ovary,Annual incidence,N/A
Disease,398971,Clear cell adenocarcinoma of the ovary,Annual incidence,N/A
Disease,398971,Clear cell adenocarcinoma of the ovary,Annual incidence,N/A
Disease,398971,Clear cell adenocarcinoma of the ovary,Annual incidence,N/A
Disease,398971,Clear cell adenocarcinoma of the ovary,Annual incidence,N/A
Disease,398971,Clear cell adenocarcinoma of the ovary,Annual incidence,N/A
Disease,398971,Clear cell adenocarcinoma of the ovary,Annual incidence,N/A
Disease,398124,Neonatal lupus erythematosus,Prevalence at birth,N/A
Disease,398124,Neonatal lupus erythematosus,Point prevalence,N/A
Disease,398127,Neonatal scleroderma,Cases/families,N/A
Disease,398127,Neonatal scleroderma,Point prevalence,N/A
Disease,398147,Persistent idiopathic facial pain,Point prevalence,N/A
Disease,398147,Persistent idiopathic facial pain,Annual incidence,N/A
Disease,398147,Persistent idiopathic facial pain,Annual incidence,N/A
Disease,398147,Persistent idiopathic facial pain,Lifetime Prevalence,N/A
Malformation syndrome,398156,Oculoauriculofrontonasal syndrome,Cases/families,N/A
Malformation syndrome,398156,Oculoauriculofrontonasal syndrome,Point prevalence,N/A
Malformation syndrome,398166,Focal facial dermal dysplasia,Point prevalence,N/A
Malformation syndrome,398166,Focal facial dermal dysplasia,Cases/families,N/A
Clinical subtype,398173,Focal facial dermal dysplasia type II,Cases/families,N/A
Clinical subtype,398173,Focal facial dermal dysplasia type II,Point prevalence,N/A
Clinical subtype,398189,Focal facial dermal dysplasia type IV,Cases/families,N/A
Clinical subtype,398189,Focal facial dermal dysplasia type IV,Point prevalence,N/A
Disease,398069,Schaaf-Yang syndrome,Cases/families,N/A
Disease,398069,Schaaf-Yang syndrome,Point prevalence,N/A
Clinical group,398073,Prader-Willi-like syndrome,Cases/families,N/A
Clinical group,398073,Prader-Willi-like syndrome,Point prevalence,N/A
Disease,398079,SIM1-related Prader-Willi-like syndrome,Cases/families,N/A
Disease,398079,SIM1-related Prader-Willi-like syndrome,Point prevalence,N/A
Disease,398088,Hereditary cryohydrocytosis with normal stomatin,Cases/families,N/A
Disease,398088,Hereditary cryohydrocytosis with normal stomatin,Point prevalence,N/A
Disease,398097,Neonatal antiphospholipid syndrome,Cases/families,N/A
Disease,398097,Neonatal antiphospholipid syndrome,Point prevalence,N/A
Disease,398109,Neonatal autoimmune hemolytic anemia,Cases/families,N/A
Disease,398109,Neonatal autoimmune hemolytic anemia,Point prevalence,N/A
Disease,398117,Neonatal dermatomyositis,Cases/families,N/A
Disease,398117,Neonatal dermatomyositis,Point prevalence,N/A
Malformation syndrome,435628,Keppen-Lubinsky syndrome,Cases/families,N/A
Malformation syndrome,435628,Keppen-Lubinsky syndrome,Point prevalence,N/A
Disease,435660,LIPE-related familial partial lipodystrophy,Cases/families,N/A
Disease,435660,LIPE-related familial partial lipodystrophy,Point prevalence,N/A
Disease,435651,CIDEC-related familial partial lipodystrophy,Point prevalence,N/A
Disease,435651,CIDEC-related familial partial lipodystrophy,Cases/families,N/A
Malformation syndrome,435638,3p25.3 microdeletion syndrome,Cases/families,N/A
Malformation syndrome,435638,3p25.3 microdeletion syndrome,Point prevalence,N/A
Disease,435804,Short stature-advanced bone age-early-onset osteoarthritis syndrome,Cases/families,N/A
Disease,435804,Short stature-advanced bone age-early-onset osteoarthritis syndrome,Point prevalence,N/A
Malformation syndrome,435845,Lethal neonatal spasticity-epileptic encephalopathy syndrome,Cases/families,N/A
Malformation syndrome,435845,Lethal neonatal spasticity-epileptic encephalopathy syndrome,Point prevalence,N/A
Disease,435930,Colobomatous optic disc-macular atrophy-chorioretinopathy syndrome,Cases/families,N/A
Disease,435930,Colobomatous optic disc-macular atrophy-chorioretinopathy syndrome,Point prevalence,N/A
Disease,435819,Autosomal dominant Charcot-Marie-Tooth disease type 2 due to TFG mutation,Cases/families,N/A
Disease,435819,Autosomal dominant Charcot-Marie-Tooth disease type 2 due to TFG mutation,Point prevalence,N/A
Disease,435953,Progeroid features-hepatocellular carcinoma predisposition syndrome,Cases/families,N/A
Disease,435953,Progeroid features-hepatocellular carcinoma predisposition syndrome,Point prevalence,N/A
Disease,435988,Chronic atrial and intestinal dysrhythmia syndrome,Cases/families,N/A
Disease,435988,Chronic atrial and intestinal dysrhythmia syndrome,Point prevalence,N/A
Disease,435934,COG2-CDG,Cases/families,N/A
Disease,435934,COG2-CDG,Point prevalence,N/A
Malformation syndrome,435938,X-linked microcephaly-growth retardation-prognathism-cryptorchidism syndrome,Cases/families,N/A
Malformation syndrome,435938,X-linked microcephaly-growth retardation-prognathism-cryptorchidism syndrome,Point prevalence,N/A
Malformation syndrome,436141,HIDEA syndrome,Cases/families,N/A
Malformation syndrome,436141,HIDEA syndrome,Point prevalence,N/A
Disease,436144,Intrauterine growth restriction-short stature-early adult-onset diabetes syndrome,Cases/families,N/A
Disease,436144,Intrauterine growth restriction-short stature-early adult-onset diabetes syndrome,Point prevalence,N/A
Disease,435998,Autosomal recessive intermediate Charcot-Marie-Tooth disease type D,Cases/families,N/A
Disease,435998,Autosomal recessive intermediate Charcot-Marie-Tooth disease type D,Point prevalence,N/A
Malformation syndrome,436003,Contractures-developmental delay-Pierre Robin syndrome,Cases/families,N/A
Malformation syndrome,436003,Contractures-developmental delay-Pierre Robin syndrome,Point prevalence,N/A
Disease,436159,Autoimmune lymphoproliferative syndrome due to CTLA4 haploinsuffiency,Cases/families,N/A
Disease,436159,Autoimmune lymphoproliferative syndrome due to CTLA4 haploinsuffiency,Point prevalence,N/A
Disease,436169,Thrombomodulin-related bleeding disorder,Cases/families,N/A
Disease,436169,Thrombomodulin-related bleeding disorder,Point prevalence,N/A
Disease,436166,Periodic fever-infantile enterocolitis-autoinflammatory syndrome,Cases/families,N/A
Disease,436166,Periodic fever-infantile enterocolitis-autoinflammatory syndrome,Point prevalence,N/A
Malformation syndrome,436182,Microcephalic primordial dwarfism-insulin resistance syndrome,Cases/families,N/A
Malformation syndrome,436182,Microcephalic primordial dwarfism-insulin resistance syndrome,Point prevalence,N/A
Disease,436174,Cataract-growth hormone deficiency-sensory neuropathy-sensorineural hearing loss-skeletal dysplasia syndrome,Cases/families,N/A
Disease,436174,Cataract-growth hormone deficiency-sensory neuropathy-sensorineural hearing loss-skeletal dysplasia syndrome,Point prevalence,N/A
Disease,436245,Retinitis pigmentosa-juvenile cataract-short stature-intellectual disability syndrome,Cases/families,N/A
Disease,436245,Retinitis pigmentosa-juvenile cataract-short stature-intellectual disability syndrome,Point prevalence,N/A
Disease,436242,Familial atrial tachyarrhythmia-infra-Hisian cardiac conduction disease,Cases/families,N/A
Disease,436242,Familial atrial tachyarrhythmia-infra-Hisian cardiac conduction disease,Point prevalence,N/A
Disease,436274,Pseudoxanthoma elasticum-like skin manifestations with retinitis pigmentosa,Cases/families,N/A
Disease,436274,Pseudoxanthoma elasticum-like skin manifestations with retinitis pigmentosa,Point prevalence,N/A
Disease,437552,Autosomal recessive primary immunodeficiency with defective spontaneous natural killer cell cytotoxicity,Cases/families,N/A
Disease,437552,Autosomal recessive primary immunodeficiency with defective spontaneous natural killer cell cytotoxicity,Point prevalence,N/A
Disease,438178,Fatty acyl-CoA reductase 1 deficiency,Cases/families,N/A
Disease,438178,Fatty acyl-CoA reductase 1 deficiency,Point prevalence,N/A
Disease,438159,STAT3-related early-onset multisystem autoimmune disease,Cases/families,N/A
Disease,438159,STAT3-related early-onset multisystem autoimmune disease,Point prevalence,N/A
Disease,438134,PCNA-related progressive neurodegenerative photosensitivity syndrome,Cases/families,N/A
Disease,438134,PCNA-related progressive neurodegenerative photosensitivity syndrome,Point prevalence,N/A
Disease,438117,Steel syndrome,Cases/families,N/A
Disease,438117,Steel syndrome,Point prevalence,N/A
Disease,438114,RARS-related autosomal recessive hypomyelinating leukodystrophy,Cases/families,N/A
Disease,438114,RARS-related autosomal recessive hypomyelinating leukodystrophy,Point prevalence,N/A
Disease,438075,Ketoacidosis due to monocarboxylate transporter-1 deficiency,Cases/families,N/A
Disease,438075,Ketoacidosis due to monocarboxylate transporter-1 deficiency,Point prevalence,N/A
Disease,438279,Human infection by orthopoxvirus,Point prevalence,N/A
Disease,438274,GCGR-related hyperglucagonemia,Cases/families,N/A
Disease,438274,GCGR-related hyperglucagonemia,Point prevalence,N/A
Clinical subtype,438266,Progressive encephalomyelitis with rigidity and myoclonus,Point prevalence,N/A
Etiological subtype,438216,PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome due to a point mutation,Cases/families,N/A
Etiological subtype,438216,PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome due to a point mutation,Point prevalence,N/A
Disease,438213,PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome,Cases/families,N/A
Disease,438213,PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome,Point prevalence,N/A
Disease,438207,Severe autosomal recessive macrothrombocytopenia,Cases/families,N/A
Disease,438207,Severe autosomal recessive macrothrombocytopenia,Point prevalence,N/A
Disease,439232,AApoAIV amyloidosis,Cases/families,N/A
Disease,439232,AApoAIV amyloidosis,Point prevalence,N/A
Disease,439212,Early-onset myopathy-areflexia-respiratory distress-dysphagia syndrome,Cases/families,N/A
Disease,439212,Early-onset myopathy-areflexia-respiratory distress-dysphagia syndrome,Point prevalence,N/A
Disease,439218,KCNQ2-related epileptic encephalopathy,Cases/families,N/A
Disease,439218,KCNQ2-related epileptic encephalopathy,Point prevalence,N/A
Particular clinical situation in a disease or syndrome,439196,Zinc-responsive necrolytic acral erythema,Point prevalence,N/A
Clinical syndrome,439167,Placental insufficiency,Point prevalence,N/A
Malformation syndrome,439822,PDE4D haploinsufficiency syndrome,Cases/families,N/A
Malformation syndrome,439822,PDE4D haploinsufficiency syndrome,Point prevalence,N/A
Disease,439254,ITM2B amyloidosis,Cases/families,N/A
Disease,439254,ITM2B amyloidosis,Point prevalence,N/A
Disease,439854,Fatal congenital hypertrophic cardiomyopathy due to glycogen storage disease,Cases/families,N/A
Disease,439854,Fatal congenital hypertrophic cardiomyopathy due to glycogen storage disease,Point prevalence,N/A
Malformation syndrome,439897,Lethal fetal cerebrorenogenitourinary agenesis/hypoplasia syndrome,Cases/families,N/A
Malformation syndrome,439897,Lethal fetal cerebrorenogenitourinary agenesis/hypoplasia syndrome,Point prevalence,N/A
Particular clinical situation in a disease or syndrome,439881,Plastic bronchitis,Point prevalence,N/A
Malformation syndrome,440354,Autosomal dominant myopia-midfacial retrusion-sensorineural hearing loss-rhizomelic dysplasia syndrome,Point prevalence,N/A
Malformation syndrome,440354,Autosomal dominant myopia-midfacial retrusion-sensorineural hearing loss-rhizomelic dysplasia syndrome,Cases/families,N/A
Disease,440713,Isolated sedoheptulokinase deficiency,Cases/families,N/A
Disease,440713,Isolated sedoheptulokinase deficiency,Point prevalence,N/A
Disease,440727,Combined hamartoma of the retina and retinal pigment epithelium,Cases/families,N/A
Disease,440727,Combined hamartoma of the retina and retinal pigment epithelium,Point prevalence,N/A
Biological anomaly,440731,L-ferritin deficiency,Cases/families,N/A
Biological anomaly,440731,L-ferritin deficiency,Point prevalence,N/A
Disease,440706,Ribose-5-P isomerase deficiency,Cases/families,N/A
Disease,440706,Ribose-5-P isomerase deficiency,Point prevalence,N/A
Clinical syndrome,443084,Baroreflex failure,Point prevalence,N/A
Disease,443073,Charcot-Marie-Tooth disease type 2S,Cases/families,N/A
Disease,443073,Charcot-Marie-Tooth disease type 2S,Point prevalence,N/A
Disease,442835,Non-specific early-onset epileptic encephalopathy,Point prevalence,N/A
Disease,442582,AH amyloidosis,Cases/families,N/A
Disease,442582,AH amyloidosis,Point prevalence,N/A
Disease,443197,X-linked erythropoietic protoporphyria,Cases/families,N/A
Disease,443197,X-linked erythropoietic protoporphyria,Point prevalence,N/A
Disease,3008,Pyruvate carboxylase deficiency,Prevalence at birth,N/A
Disease,3008,Pyruvate carboxylase deficiency,Point prevalence,N/A
Clinical subtype,443192,Classic stiff person syndrome,Point prevalence,N/A
Clinical group,595,Centronuclear myopathy,Point prevalence,N/A
Disease,298,Mitochondrial neurogastrointestinal encephalomyopathy,Point prevalence,N/A
Disease,298,Mitochondrial neurogastrointestinal encephalomyopathy,Prevalence at birth,N/A
Disease,298,Mitochondrial neurogastrointestinal encephalomyopathy,Prevalence at birth,N/A
Disease,396,Chronic hiccup,Point prevalence,N/A
Disease,443236,Postural orthostatic tachycardia syndrome due to NET deficiency,Cases/families,N/A
Disease,443236,Postural orthostatic tachycardia syndrome due to NET deficiency,Point prevalence,N/A
Disease,552,MODY,Point prevalence,N/A
Disease,552,MODY,Point prevalence,N/A
Clinical syndrome,854,Non-malignant and non-cirrhotic portal vein thrombosis,Point prevalence,N/A
Clinical syndrome,854,Non-malignant and non-cirrhotic portal vein thrombosis,Annual incidence,N/A
Clinical syndrome,854,Non-malignant and non-cirrhotic portal vein thrombosis,Point prevalence,N/A
Clinical syndrome,854,Non-malignant and non-cirrhotic portal vein thrombosis,Annual incidence,N/A
Clinical syndrome,854,Non-malignant and non-cirrhotic portal vein thrombosis,Annual incidence,N/A
Disease,443098,Hyperostosis cranialis interna,Cases/families,N/A
Disease,443098,Hyperostosis cranialis interna,Point prevalence,N/A
Disease,443087,"46,XY difference of sex development due to testicular 17,20-desmolase deficiency",Cases/families,N/A
Disease,443087,"46,XY difference of sex development due to testicular 17,20-desmolase deficiency",Point prevalence,N/A
Disease,130,Brugada syndrome,Point prevalence,N/A
Disease,130,Brugada syndrome,Point prevalence,N/A
Disease,277,Severe combined immunodeficiency due to adenosine deaminase deficiency,Prevalence at birth,N/A
Disease,277,Severe combined immunodeficiency due to adenosine deaminase deficiency,Point prevalence,N/A
Malformation syndrome,443162,NDE1-related microhydranencephaly,Cases/families,N/A
Malformation syndrome,443162,NDE1-related microhydranencephaly,Point prevalence,N/A
Clinical subtype,443804,Focal stiff limb syndrome,Point prevalence,N/A
Clinical subtype,443804,Focal stiff limb syndrome,Point prevalence,N/A
Disease,443811,PGM3-CDG,Cases/families,N/A
Disease,443811,PGM3-CDG,Point prevalence,N/A
Disease,443950,DNAJB2-related Charcot-Marie-Tooth disease type 2,Cases/families,N/A
Disease,443950,DNAJB2-related Charcot-Marie-Tooth disease type 2,Point prevalence,N/A
Disease,443988,Ventriculomegaly-cystic kidney disease,Cases/families,N/A
Disease,443988,Ventriculomegaly-cystic kidney disease,Point prevalence,N/A
Disease,444092,Autoimmune interstitial lung disease-arthritis syndrome,Cases/families,N/A
Disease,444092,Autoimmune interstitial lung disease-arthritis syndrome,Point prevalence,N/A
Disease,444099,Autosomal dominant spastic paraplegia type 73,Cases/families,N/A
Disease,444099,Autosomal dominant spastic paraplegia type 73,Point prevalence,N/A
Disease,444138,Peeling skin-leukonychia-acral punctate keratoses-cheilitis-knuckle pads syndrome,Cases/families,N/A
Disease,444138,Peeling skin-leukonychia-acral punctate keratoses-cheilitis-knuckle pads syndrome,Point prevalence,N/A
Malformation syndrome,444002,11q22.2q22.3 microdeletion syndrome,Cases/families,N/A
Malformation syndrome,444002,11q22.2q22.3 microdeletion syndrome,Point prevalence,N/A
Malformation syndrome,443995,Mandibulofacial dysostosis with alopecia,Cases/families,N/A
Malformation syndrome,443995,Mandibulofacial dysostosis with alopecia,Point prevalence,N/A
Disease,444048,"46,XX ovarian dysgenesis-short stature syndrome",Cases/families,N/A
Disease,444048,"46,XX ovarian dysgenesis-short stature syndrome",Point prevalence,N/A
Disease,444013,Combined oxidative phosphorylation defect type 23,Cases/families,N/A
Disease,444013,Combined oxidative phosphorylation defect type 23,Point prevalence,N/A
Malformation syndrome,444069,Lethal fetal brain malformation-duodenal atresia-bilateral renal hypoplasia syndrome,Cases/families,N/A
Malformation syndrome,444069,Lethal fetal brain malformation-duodenal atresia-bilateral renal hypoplasia syndrome,Point prevalence,N/A
Malformation syndrome,444051,20q11.2 microdeletion syndrome,Cases/families,N/A
Malformation syndrome,444051,20q11.2 microdeletion syndrome,Point prevalence,N/A
Malformation syndrome,444077,Cognitive impairment-coarse facies-heart defects-obesity-pulmonary involvement-short stature-skeletal dysplasia syndrome,Cases/families,N/A
Malformation syndrome,444077,Cognitive impairment-coarse facies-heart defects-obesity-pulmonary involvement-short stature-skeletal dysplasia syndrome,Point prevalence,N/A
Malformation syndrome,444072,Cerebellar-facial-dental syndrome,Cases/families,N/A
Malformation syndrome,444072,Cerebellar-facial-dental syndrome,Point prevalence,N/A
Disease,444463,Autoimmune hemolytic anemia-autoimmune thrombocytopenia-primary immunodeficiency syndrome due to TPP2 deficiency,Cases/families,N/A
Disease,444463,Autoimmune hemolytic anemia-autoimmune thrombocytopenia-primary immunodeficiency syndrome due to TPP2 deficiency,Point prevalence,N/A
Disease,444490,Familial chylomicronemia syndrome,Annual incidence,N/A
Disease,444490,Familial chylomicronemia syndrome,Point prevalence,N/A
Disease,444458,Combined oxidative phosphorylation defect type 24,Cases/families,N/A
Disease,444458,Combined oxidative phosphorylation defect type 24,Point prevalence,N/A
Disease,445110,Limb-girdle muscular dystrophy due to POMK deficiency,Cases/families,N/A
Disease,445110,Limb-girdle muscular dystrophy due to POMK deficiency,Point prevalence,N/A
Disease,445062,Juvenile-onset diabetes mellitus-central and peripheral neurodegeneration syndrome,Cases/families,N/A
Disease,445062,Juvenile-onset diabetes mellitus-central and peripheral neurodegeneration syndrome,Point prevalence,N/A
Disease,445038,3-methylglutaconic aciduria-neonatal cataract-neurologic involvement-congenital neutropenia syndrome,Cases/families,N/A
Disease,445038,3-methylglutaconic aciduria-neonatal cataract-neurologic involvement-congenital neutropenia syndrome,Point prevalence,N/A
Disease,445018,Combined immunodeficiency due to LRBA deficiency,Cases/families,N/A
Disease,445018,Combined immunodeficiency due to LRBA deficiency,Point prevalence,N/A
Disease,447731,NIK deficiency,Cases/families,N/A
Disease,447731,NIK deficiency,Point prevalence,N/A
Disease,447737,Combined immunodeficiency due to DOCK2 deficiency,Cases/families,N/A
Disease,447737,Combined immunodeficiency due to DOCK2 deficiency,Point prevalence,N/A
Clinical syndrome,447881,Idiopathic dropped head syndrome,Point prevalence,N/A
Clinical subtype,447896,Tremor-ataxia-central hypomyelination syndrome,Cases/families,N/A
Clinical subtype,447896,Tremor-ataxia-central hypomyelination syndrome,Point prevalence,N/A
Clinical subtype,447893,Hypomyelination-cerebellar atrophy-hypoplasia of the corpus callosum syndrome,Cases/families,N/A
Clinical subtype,447893,Hypomyelination-cerebellar atrophy-hypoplasia of the corpus callosum syndrome,Point prevalence,N/A
Clinical syndrome,447788,Cerebral visual impairment,Point prevalence,N/A
Biological anomaly,447795,Lipoyl transferase 2 deficiency,Point prevalence,N/A
Disease,447784,Mitochondrial pyruvate carrier deficiency,Cases/families,N/A
Disease,447784,Mitochondrial pyruvate carrier deficiency,Point prevalence,N/A
Disease,447757,Autosomal dominant spastic paraplegia type 9B,Cases/families,N/A
Disease,447757,Autosomal dominant spastic paraplegia type 9B,Point prevalence,N/A
Disease,447753,Autosomal dominant spastic paraplegia type 9A,Cases/families,N/A
Disease,447753,Autosomal dominant spastic paraplegia type 9A,Point prevalence,N/A
Disease,447760,Autosomal recessive spastic paraplegia type 9B,Cases/families,N/A
Disease,447760,Autosomal recessive spastic paraplegia type 9B,Point prevalence,N/A
Disease,412066,PRKAR1B-related neurodegenerative dementia with intermediate filaments,Cases/families,N/A
Disease,412066,PRKAR1B-related neurodegenerative dementia with intermediate filaments,Point prevalence,N/A
Disease,412057,Autosomal recessive cerebellar ataxia due to STUB1 deficiency,Cases/families,N/A
Disease,412057,Autosomal recessive cerebellar ataxia due to STUB1 deficiency,Point prevalence,N/A
Disease,412181,Epidermolysis bullosa simplex due to BP230 deficiency,Cases/families,N/A
Disease,412181,Epidermolysis bullosa simplex due to BP230 deficiency,Point prevalence,N/A
Malformation syndrome,412069,AHDC1-related intellectual disability-obstructive sleep apnea-mild dysmorphism syndrome,Cases/families,N/A
Malformation syndrome,412069,AHDC1-related intellectual disability-obstructive sleep apnea-mild dysmorphism syndrome,Point prevalence,N/A
Disease,412189,Epidermolysis bullosa simplex due to exophilin 5 deficiency,Cases/families,N/A
Disease,412189,Epidermolysis bullosa simplex due to exophilin 5 deficiency,Point prevalence,N/A
Disease,412217,Dystonia-aphonia syndrome,Cases/families,N/A
Disease,412217,Dystonia-aphonia syndrome,Point prevalence,N/A
Disease,418959,Squamous cell carcinoma of the stomach,Point prevalence,N/A
Disease,418959,Squamous cell carcinoma of the stomach,Annual incidence,N/A
Disease,418959,Squamous cell carcinoma of the stomach,Annual incidence,N/A
Disease,418959,Squamous cell carcinoma of the stomach,Annual incidence,N/A
Disease,418959,Squamous cell carcinoma of the stomach,Annual incidence,N/A
Disease,418959,Squamous cell carcinoma of the stomach,Annual incidence,N/A
Disease,418959,Squamous cell carcinoma of the stomach,Annual incidence,N/A
Disease,418959,Squamous cell carcinoma of the stomach,Annual incidence,N/A
Disease,418959,Squamous cell carcinoma of the stomach,Annual incidence,N/A
Disease,418959,Squamous cell carcinoma of the stomach,Annual incidence,N/A
Disease,418959,Squamous cell carcinoma of the stomach,Annual incidence,N/A
Disease,418959,Squamous cell carcinoma of the stomach,Annual incidence,N/A
Disease,418959,Squamous cell carcinoma of the stomach,Annual incidence,N/A
Disease,418959,Squamous cell carcinoma of the stomach,Annual incidence,N/A
Disease,418959,Squamous cell carcinoma of the stomach,Annual incidence,N/A
Disease,418959,Squamous cell carcinoma of the stomach,Annual incidence,N/A
Disease,418959,Squamous cell carcinoma of the stomach,Annual incidence,N/A
Disease,418959,Squamous cell carcinoma of the stomach,Annual incidence,N/A
Disease,418959,Squamous cell carcinoma of the stomach,Annual incidence,N/A
Disease,418959,Squamous cell carcinoma of the stomach,Annual incidence,N/A
Disease,418959,Squamous cell carcinoma of the stomach,Annual incidence,N/A
Disease,418959,Squamous cell carcinoma of the stomach,Annual incidence,N/A
Disease,418959,Squamous cell carcinoma of the stomach,Annual incidence,N/A
Disease,418959,Squamous cell carcinoma of the stomach,Annual incidence,N/A
Disease,418959,Squamous cell carcinoma of the stomach,Annual incidence,N/A
Disease,418959,Squamous cell carcinoma of the stomach,Annual incidence,N/A
Disease,418945,"Carcinoma of esophagus, salivary gland type",Annual incidence,N/A
Disease,418945,"Carcinoma of esophagus, salivary gland type",Annual incidence,N/A
Disease,418945,"Carcinoma of esophagus, salivary gland type",Annual incidence,N/A
Disease,418945,"Carcinoma of esophagus, salivary gland type",Annual incidence,N/A
Disease,418945,"Carcinoma of esophagus, salivary gland type",Annual incidence,N/A
Disease,418945,"Carcinoma of esophagus, salivary gland type",Annual incidence,N/A
Disease,418945,"Carcinoma of esophagus, salivary gland type",Annual incidence,N/A
Disease,418945,"Carcinoma of esophagus, salivary gland type",Annual incidence,N/A
Disease,418945,"Carcinoma of esophagus, salivary gland type",Annual incidence,N/A
Disease,418945,"Carcinoma of esophagus, salivary gland type",Annual incidence,N/A
Disease,418945,"Carcinoma of esophagus, salivary gland type",Annual incidence,N/A
Disease,418945,"Carcinoma of esophagus, salivary gland type",Annual incidence,N/A
Disease,418945,"Carcinoma of esophagus, salivary gland type",Annual incidence,N/A
Disease,418945,"Carcinoma of esophagus, salivary gland type",Annual incidence,N/A
Disease,418945,"Carcinoma of esophagus, salivary gland type",Annual incidence,N/A
Disease,418945,"Carcinoma of esophagus, salivary gland type",Annual incidence,N/A
Disease,418945,"Carcinoma of esophagus, salivary gland type",Annual incidence,N/A
Disease,418945,"Carcinoma of esophagus, salivary gland type",Annual incidence,N/A
Disease,418951,Undifferentiated carcinoma of esophagus,Annual incidence,N/A
Disease,418951,Undifferentiated carcinoma of esophagus,Annual incidence,N/A
Disease,418951,Undifferentiated carcinoma of esophagus,Annual incidence,N/A
Disease,418951,Undifferentiated carcinoma of esophagus,Annual incidence,N/A
Disease,418951,Undifferentiated carcinoma of esophagus,Annual incidence,N/A
Disease,418951,Undifferentiated carcinoma of esophagus,Annual incidence,N/A
Disease,418951,Undifferentiated carcinoma of esophagus,Annual incidence,N/A
Disease,418951,Undifferentiated carcinoma of esophagus,Annual incidence,N/A
Disease,418951,Undifferentiated carcinoma of esophagus,Annual incidence,N/A
Disease,418951,Undifferentiated carcinoma of esophagus,Annual incidence,N/A
Disease,418951,Undifferentiated carcinoma of esophagus,Annual incidence,N/A
Disease,418951,Undifferentiated carcinoma of esophagus,Annual incidence,N/A
Disease,418951,Undifferentiated carcinoma of esophagus,Annual incidence,N/A
Disease,418951,Undifferentiated carcinoma of esophagus,Annual incidence,N/A
Disease,418951,Undifferentiated carcinoma of esophagus,Annual incidence,N/A
Disease,418951,Undifferentiated carcinoma of esophagus,Annual incidence,N/A
Disease,418951,Undifferentiated carcinoma of esophagus,Annual incidence,N/A
Disease,418951,Undifferentiated carcinoma of esophagus,Annual incidence,N/A
Disease,418951,Undifferentiated carcinoma of esophagus,Annual incidence,N/A
Disease,418951,Undifferentiated carcinoma of esophagus,Annual incidence,N/A
Disease,418951,Undifferentiated carcinoma of esophagus,Annual incidence,N/A
Disease,418951,Undifferentiated carcinoma of esophagus,Annual incidence,N/A
Disease,418951,Undifferentiated carcinoma of esophagus,Annual incidence,N/A
Disease,418951,Undifferentiated carcinoma of esophagus,Annual incidence,N/A
Malformation syndrome,420179,Malan overgrowth syndrome,Cases/families,N/A
Malformation syndrome,420179,Malan overgrowth syndrome,Point prevalence,N/A
Clinical group,415286,Bilirubin encephalopathy,Point prevalence,N/A
Disease,420789,Autoimmune encephalopathy with parasomnia and obstructive sleep apnea,Cases/families,N/A
Disease,420789,Autoimmune encephalopathy with parasomnia and obstructive sleep apnea,Point prevalence,N/A
Malformation syndrome,420794,Cono-spondylar dysplasia,Cases/families,N/A
Malformation syndrome,420794,Cono-spondylar dysplasia,Point prevalence,N/A
Disease,420702,Autosomal recessive severe congenital neutropenia due to CSF3R deficiency,Cases/families,N/A
Disease,420702,Autosomal recessive severe congenital neutropenia due to CSF3R deficiency,Point prevalence,N/A
Disease,420728,Combined oxidative phosphorylation defect type 20,Cases/families,N/A
Disease,420728,Combined oxidative phosphorylation defect type 20,Point prevalence,N/A
Disease,420733,Combined oxidative phosphorylation defect type 21,Cases/families,N/A
Disease,420733,Combined oxidative phosphorylation defect type 21,Point prevalence,N/A
Malformation syndrome,420741,RIDDLE syndrome,Cases/families,N/A
Malformation syndrome,420741,RIDDLE syndrome,Point prevalence,N/A
Disease,420492,"Adult-onset cervical dystonia, DYT23 type",Cases/families,N/A
Disease,420492,"Adult-onset cervical dystonia, DYT23 type",Point prevalence,N/A
Clinical syndrome,420402,Semicircular canal dehiscence syndrome,Point prevalence,N/A
Clinical subtype,420429,"Glycogen storage disease due to acid maltase deficiency, late-onset",Prevalence at birth,N/A
Malformation syndrome,420584,Postaxial polydactyly-anterior pituitary anomalies-facial dysmorphism syndrome,Cases/families,N/A
Malformation syndrome,420584,Postaxial polydactyly-anterior pituitary anomalies-facial dysmorphism syndrome,Point prevalence,N/A
Disease,420699,Autosomal recessive severe congenital neutropenia due to CXCR2 deficiency,Cases/families,N/A
Disease,420699,Autosomal recessive severe congenital neutropenia due to CXCR2 deficiency,Point prevalence,N/A
Disease,420686,Woolly hair-palmoplantar keratoderma syndrome,Cases/families,N/A
Disease,420686,Woolly hair-palmoplantar keratoderma syndrome,Point prevalence,N/A
Disease,420561,Temple-Baraitser syndrome,Cases/families,N/A
Disease,420561,Temple-Baraitser syndrome,Point prevalence,N/A
Disease,420573,Severe combined immunodeficiency due to CTPS1 deficiency,Cases/families,N/A
Disease,420573,Severe combined immunodeficiency due to CTPS1 deficiency,Point prevalence,N/A
Disease,420566,Bleeding disorder due to CalDAG-GEFI deficiency,Cases/families,N/A
Disease,420566,Bleeding disorder due to CalDAG-GEFI deficiency,Point prevalence,N/A
Clinical subtype,423461,Mucolipidosis type III alpha/beta,Point prevalence,N/A
Clinical subtype,423470,Mucolipidosis type III gamma,Point prevalence,N/A
Disease,423454,Nail and teeth abnormalities-marginal palmoplantar keratoderma-oral hyperpigmentation syndrome,Cases/families,N/A
Disease,423454,Nail and teeth abnormalities-marginal palmoplantar keratoderma-oral hyperpigmentation syndrome,Point prevalence,N/A
Disease,423384,Severe congenital neutropenia due to JAGN1 deficiency,Cases/families,N/A
Disease,423384,Severe congenital neutropenia due to JAGN1 deficiency,Point prevalence,N/A
Disease,423296,Spinocerebellar ataxia type 38,Cases/families,N/A
Disease,423296,Spinocerebellar ataxia type 38,Point prevalence,N/A
Malformation syndrome,423306,Microcephaly-short stature-intellectual disability-facial dysmorphism syndrome,Cases/families,N/A
Malformation syndrome,423306,Microcephaly-short stature-intellectual disability-facial dysmorphism syndrome,Point prevalence,N/A
Disease,423479,X-linked intellectual disability-limb spasticity-retinal dystrophy-arginine vasopressin deficiency,Cases/families,N/A
Disease,423479,X-linked intellectual disability-limb spasticity-retinal dystrophy-arginine vasopressin deficiency,Point prevalence,N/A
Disease,422526,Hereditary clear cell renal cell carcinoma,Point prevalence,N/A
Disease,423275,Spinocerebellar ataxia type 40,Cases/families,N/A
Disease,423275,Spinocerebellar ataxia type 40,Point prevalence,N/A
Disease,424065,Solid pseudopapillary carcinoma of pancreas,Annual incidence,N/A
Disease,424065,Solid pseudopapillary carcinoma of pancreas,Annual incidence,N/A
Disease,424065,Solid pseudopapillary carcinoma of pancreas,Annual incidence,N/A
Disease,424065,Solid pseudopapillary carcinoma of pancreas,Annual incidence,N/A
Disease,424065,Solid pseudopapillary carcinoma of pancreas,Annual incidence,N/A
Disease,424065,Solid pseudopapillary carcinoma of pancreas,Annual incidence,N/A
Disease,424065,Solid pseudopapillary carcinoma of pancreas,Annual incidence,N/A
Disease,424065,Solid pseudopapillary carcinoma of pancreas,Annual incidence,N/A
Disease,424065,Solid pseudopapillary carcinoma of pancreas,Annual incidence,N/A
Disease,424065,Solid pseudopapillary carcinoma of pancreas,Annual incidence,N/A
Disease,424065,Solid pseudopapillary carcinoma of pancreas,Annual incidence,N/A
Disease,424065,Solid pseudopapillary carcinoma of pancreas,Annual incidence,N/A
Disease,424058,Intraductal papillary mucinous carcinoma of pancreas,Annual incidence,N/A
Disease,424058,Intraductal papillary mucinous carcinoma of pancreas,Annual incidence,N/A
Disease,424058,Intraductal papillary mucinous carcinoma of pancreas,Annual incidence,N/A
Disease,424058,Intraductal papillary mucinous carcinoma of pancreas,Annual incidence,N/A
Disease,424058,Intraductal papillary mucinous carcinoma of pancreas,Annual incidence,N/A
Disease,424058,Intraductal papillary mucinous carcinoma of pancreas,Annual incidence,N/A
Disease,424058,Intraductal papillary mucinous carcinoma of pancreas,Annual incidence,N/A
Disease,424058,Intraductal papillary mucinous carcinoma of pancreas,Annual incidence,N/A
Disease,424058,Intraductal papillary mucinous carcinoma of pancreas,Annual incidence,N/A
Disease,424058,Intraductal papillary mucinous carcinoma of pancreas,Annual incidence,N/A
Disease,424058,Intraductal papillary mucinous carcinoma of pancreas,Annual incidence,N/A
Disease,424058,Intraductal papillary mucinous carcinoma of pancreas,Annual incidence,N/A
Disease,424058,Intraductal papillary mucinous carcinoma of pancreas,Annual incidence,N/A
Disease,424080,Undifferentiated carcinoma with osteoclast-like giant cells of pancreas,Annual incidence,N/A
Disease,424080,Undifferentiated carcinoma with osteoclast-like giant cells of pancreas,Annual incidence,N/A
Disease,424080,Undifferentiated carcinoma with osteoclast-like giant cells of pancreas,Annual incidence,N/A
Disease,424080,Undifferentiated carcinoma with osteoclast-like giant cells of pancreas,Annual incidence,N/A
Disease,424080,Undifferentiated carcinoma with osteoclast-like giant cells of pancreas,Annual incidence,N/A
Disease,424080,Undifferentiated carcinoma with osteoclast-like giant cells of pancreas,Annual incidence,N/A
Disease,424080,Undifferentiated carcinoma with osteoclast-like giant cells of pancreas,Annual incidence,N/A
Disease,424080,Undifferentiated carcinoma with osteoclast-like giant cells of pancreas,Annual incidence,N/A
Disease,424080,Undifferentiated carcinoma with osteoclast-like giant cells of pancreas,Annual incidence,N/A
Disease,424073,Serous cystadenocarcinoma of pancreas,Annual incidence,N/A
Disease,424073,Serous cystadenocarcinoma of pancreas,Annual incidence,N/A
Disease,424073,Serous cystadenocarcinoma of pancreas,Annual incidence,N/A
Disease,424073,Serous cystadenocarcinoma of pancreas,Annual incidence,N/A
Disease,424107,Congenital myopathy with myasthenic-like onset,Cases/families,N/A
Disease,424107,Congenital myopathy with myasthenic-like onset,Point prevalence,N/A
Malformation syndrome,424099,Colobomatous microphthalmia-rhizomelic dysplasia syndrome,Cases/families,N/A
Malformation syndrome,424099,Colobomatous microphthalmia-rhizomelic dysplasia syndrome,Point prevalence,N/A
Disease,424261,TOR1AIP1-related limb-girdle muscular dystrophy,Cases/families,N/A
Disease,424261,TOR1AIP1-related limb-girdle muscular dystrophy,Point prevalence,N/A
Disease,424016,Adenocarcinoma of the anal canal,Annual incidence,N/A
Disease,424016,Adenocarcinoma of the anal canal,Annual incidence,N/A
Disease,424016,Adenocarcinoma of the anal canal,Annual incidence,N/A
Disease,424016,Adenocarcinoma of the anal canal,Annual incidence,N/A
Disease,424016,Adenocarcinoma of the anal canal,Annual incidence,N/A
Disease,424016,Adenocarcinoma of the anal canal,Annual incidence,N/A
Disease,424016,Adenocarcinoma of the anal canal,Annual incidence,N/A
Disease,424016,Adenocarcinoma of the anal canal,Annual incidence,N/A
Disease,424016,Adenocarcinoma of the anal canal,Annual incidence,N/A
Disease,424016,Adenocarcinoma of the anal canal,Annual incidence,N/A
Disease,424016,Adenocarcinoma of the anal canal,Annual incidence,N/A
Disease,424016,Adenocarcinoma of the anal canal,Annual incidence,N/A
Disease,424016,Adenocarcinoma of the anal canal,Annual incidence,N/A
Disease,424016,Adenocarcinoma of the anal canal,Annual incidence,N/A
Disease,424016,Adenocarcinoma of the anal canal,Annual incidence,N/A
Disease,424016,Adenocarcinoma of the anal canal,Annual incidence,N/A
Disease,424016,Adenocarcinoma of the anal canal,Annual incidence,N/A
Disease,424016,Adenocarcinoma of the anal canal,Annual incidence,N/A
Disease,424016,Adenocarcinoma of the anal canal,Annual incidence,N/A
Disease,424016,Adenocarcinoma of the anal canal,Annual incidence,N/A
Disease,424016,Adenocarcinoma of the anal canal,Annual incidence,N/A
Disease,424016,Adenocarcinoma of the anal canal,Annual incidence,N/A
Disease,424016,Adenocarcinoma of the anal canal,Annual incidence,N/A
Disease,424027,Progressive myoclonic epilepsy type 8,Cases/families,N/A
Disease,424027,Progressive myoclonic epilepsy type 8,Point prevalence,N/A
Disease,424019,Squamous cell carcinoma of the anal canal,Annual incidence,N/A
Disease,424019,Squamous cell carcinoma of the anal canal,Annual incidence,N/A
Disease,424019,Squamous cell carcinoma of the anal canal,Annual incidence,N/A
Disease,424019,Squamous cell carcinoma of the anal canal,Annual incidence,N/A
Disease,424019,Squamous cell carcinoma of the anal canal,Annual incidence,N/A
Disease,424019,Squamous cell carcinoma of the anal canal,Annual incidence,N/A
Disease,424019,Squamous cell carcinoma of the anal canal,Annual incidence,N/A
Disease,424019,Squamous cell carcinoma of the anal canal,Annual incidence,N/A
Disease,424019,Squamous cell carcinoma of the anal canal,Annual incidence,N/A
Disease,424019,Squamous cell carcinoma of the anal canal,Annual incidence,N/A
Disease,424019,Squamous cell carcinoma of the anal canal,Annual incidence,N/A
Disease,424019,Squamous cell carcinoma of the anal canal,Annual incidence,N/A
Disease,424019,Squamous cell carcinoma of the anal canal,Annual incidence,N/A
Disease,424019,Squamous cell carcinoma of the anal canal,Annual incidence,N/A
Disease,424019,Squamous cell carcinoma of the anal canal,Annual incidence,N/A
Disease,424019,Squamous cell carcinoma of the anal canal,Annual incidence,N/A
Disease,424019,Squamous cell carcinoma of the anal canal,Annual incidence,N/A
Disease,424019,Squamous cell carcinoma of the anal canal,Annual incidence,N/A
Disease,424019,Squamous cell carcinoma of the anal canal,Annual incidence,N/A
Disease,424019,Squamous cell carcinoma of the anal canal,Annual incidence,N/A
Disease,424019,Squamous cell carcinoma of the anal canal,Annual incidence,N/A
Disease,424019,Squamous cell carcinoma of the anal canal,Annual incidence,N/A
Disease,424019,Squamous cell carcinoma of the anal canal,Annual incidence,N/A
Disease,424039,Squamous cell carcinoma of pancreas,Annual incidence,N/A
Disease,424039,Squamous cell carcinoma of pancreas,Annual incidence,N/A
Disease,424039,Squamous cell carcinoma of pancreas,Annual incidence,N/A
Disease,424039,Squamous cell carcinoma of pancreas,Annual incidence,N/A
Disease,424039,Squamous cell carcinoma of pancreas,Annual incidence,N/A
Disease,424039,Squamous cell carcinoma of pancreas,Annual incidence,N/A
Disease,424039,Squamous cell carcinoma of pancreas,Annual incidence,N/A
Disease,424039,Squamous cell carcinoma of pancreas,Annual incidence,N/A
Disease,424039,Squamous cell carcinoma of pancreas,Annual incidence,N/A
Disease,424039,Squamous cell carcinoma of pancreas,Annual incidence,N/A
Disease,424039,Squamous cell carcinoma of pancreas,Annual incidence,N/A
Disease,424039,Squamous cell carcinoma of pancreas,Annual incidence,N/A
Disease,424039,Squamous cell carcinoma of pancreas,Annual incidence,N/A
Disease,424039,Squamous cell carcinoma of pancreas,Annual incidence,N/A
Disease,424039,Squamous cell carcinoma of pancreas,Annual incidence,N/A
Disease,424039,Squamous cell carcinoma of pancreas,Annual incidence,N/A
Disease,424039,Squamous cell carcinoma of pancreas,Annual incidence,N/A
Disease,424039,Squamous cell carcinoma of pancreas,Annual incidence,N/A
Disease,424039,Squamous cell carcinoma of pancreas,Annual incidence,N/A
Disease,424039,Squamous cell carcinoma of pancreas,Annual incidence,N/A
Disease,424039,Squamous cell carcinoma of pancreas,Annual incidence,N/A
Disease,424039,Squamous cell carcinoma of pancreas,Annual incidence,N/A
Disease,424053,Mucinous cystadenocarcinoma of the pancreas,Annual incidence,N/A
Disease,424053,Mucinous cystadenocarcinoma of the pancreas,Point prevalence,N/A
Disease,424053,Mucinous cystadenocarcinoma of the pancreas,Annual incidence,N/A
Disease,424053,Mucinous cystadenocarcinoma of the pancreas,Annual incidence,N/A
Disease,424053,Mucinous cystadenocarcinoma of the pancreas,Annual incidence,N/A
Disease,424053,Mucinous cystadenocarcinoma of the pancreas,Annual incidence,N/A
Disease,424053,Mucinous cystadenocarcinoma of the pancreas,Annual incidence,N/A
Disease,424053,Mucinous cystadenocarcinoma of the pancreas,Annual incidence,N/A
Disease,424053,Mucinous cystadenocarcinoma of the pancreas,Annual incidence,N/A
Disease,424053,Mucinous cystadenocarcinoma of the pancreas,Annual incidence,N/A
Disease,424053,Mucinous cystadenocarcinoma of the pancreas,Annual incidence,N/A
Disease,424053,Mucinous cystadenocarcinoma of the pancreas,Annual incidence,N/A
Disease,424053,Mucinous cystadenocarcinoma of the pancreas,Annual incidence,N/A
Disease,424053,Mucinous cystadenocarcinoma of the pancreas,Annual incidence,N/A
Disease,424046,Acinar cell carcinoma of pancreas,Annual incidence,N/A
Disease,424046,Acinar cell carcinoma of pancreas,Annual incidence,N/A
Disease,424046,Acinar cell carcinoma of pancreas,Annual incidence,N/A
Disease,424046,Acinar cell carcinoma of pancreas,Annual incidence,N/A
Disease,424046,Acinar cell carcinoma of pancreas,Annual incidence,N/A
Disease,424046,Acinar cell carcinoma of pancreas,Annual incidence,N/A
Disease,424046,Acinar cell carcinoma of pancreas,Annual incidence,N/A
Disease,424046,Acinar cell carcinoma of pancreas,Annual incidence,N/A
Disease,424046,Acinar cell carcinoma of pancreas,Annual incidence,N/A
Disease,424046,Acinar cell carcinoma of pancreas,Annual incidence,N/A
Disease,424046,Acinar cell carcinoma of pancreas,Annual incidence,N/A
Disease,424046,Acinar cell carcinoma of pancreas,Annual incidence,N/A
Disease,424046,Acinar cell carcinoma of pancreas,Annual incidence,N/A
Disease,424046,Acinar cell carcinoma of pancreas,Annual incidence,N/A
Disease,424046,Acinar cell carcinoma of pancreas,Annual incidence,N/A
Disease,424046,Acinar cell carcinoma of pancreas,Annual incidence,N/A
Disease,424046,Acinar cell carcinoma of pancreas,Annual incidence,N/A
Disease,424046,Acinar cell carcinoma of pancreas,Annual incidence,N/A
Disease,424046,Acinar cell carcinoma of pancreas,Annual incidence,N/A
Disease,424046,Acinar cell carcinoma of pancreas,Annual incidence,N/A
Disease,424046,Acinar cell carcinoma of pancreas,Annual incidence,N/A
Disease,423968,Squamous cell carcinoma of the small intestine,Annual incidence,N/A
Disease,423968,Squamous cell carcinoma of the small intestine,Annual incidence,N/A
Disease,423968,Squamous cell carcinoma of the small intestine,Annual incidence,N/A
Disease,423968,Squamous cell carcinoma of the small intestine,Annual incidence,N/A
Disease,423968,Squamous cell carcinoma of the small intestine,Annual incidence,N/A
Disease,423968,Squamous cell carcinoma of the small intestine,Annual incidence,N/A
Disease,423968,Squamous cell carcinoma of the small intestine,Annual incidence,N/A
Disease,423968,Squamous cell carcinoma of the small intestine,Annual incidence,N/A
Disease,423968,Squamous cell carcinoma of the small intestine,Annual incidence,N/A
Disease,423968,Squamous cell carcinoma of the small intestine,Annual incidence,N/A
Disease,423968,Squamous cell carcinoma of the small intestine,Annual incidence,N/A
Disease,423968,Squamous cell carcinoma of the small intestine,Annual incidence,N/A
Disease,423968,Squamous cell carcinoma of the small intestine,Annual incidence,N/A
Disease,423968,Squamous cell carcinoma of the small intestine,Annual incidence,N/A
Disease,423968,Squamous cell carcinoma of the small intestine,Annual incidence,N/A
Disease,423968,Squamous cell carcinoma of the small intestine,Annual incidence,N/A
Disease,423968,Squamous cell carcinoma of the small intestine,Annual incidence,N/A
Disease,423968,Squamous cell carcinoma of the small intestine,Annual incidence,N/A
Disease,423968,Squamous cell carcinoma of the small intestine,Annual incidence,N/A
Disease,423968,Squamous cell carcinoma of the small intestine,Annual incidence,N/A
Disease,423994,Squamous cell carcinoma of the colon,Annual incidence,N/A
Disease,423994,Squamous cell carcinoma of the colon,Annual incidence,N/A
Disease,423994,Squamous cell carcinoma of the colon,Annual incidence,N/A
Disease,423994,Squamous cell carcinoma of the colon,Annual incidence,N/A
Disease,423994,Squamous cell carcinoma of the colon,Annual incidence,N/A
Disease,423994,Squamous cell carcinoma of the colon,Annual incidence,N/A
Disease,423994,Squamous cell carcinoma of the colon,Annual incidence,N/A
Disease,423994,Squamous cell carcinoma of the colon,Annual incidence,N/A
Disease,423994,Squamous cell carcinoma of the colon,Annual incidence,N/A
Disease,423994,Squamous cell carcinoma of the colon,Annual incidence,N/A
Disease,423994,Squamous cell carcinoma of the colon,Annual incidence,N/A
Disease,423994,Squamous cell carcinoma of the colon,Annual incidence,N/A
Disease,423994,Squamous cell carcinoma of the colon,Annual incidence,N/A
Disease,423994,Squamous cell carcinoma of the colon,Annual incidence,N/A
Disease,423994,Squamous cell carcinoma of the colon,Annual incidence,N/A
Disease,423994,Squamous cell carcinoma of the colon,Annual incidence,N/A
Disease,423994,Squamous cell carcinoma of the colon,Annual incidence,N/A
Disease,423994,Squamous cell carcinoma of the colon,Annual incidence,N/A
Disease,423994,Squamous cell carcinoma of the colon,Annual incidence,N/A
Disease,423994,Squamous cell carcinoma of the colon,Annual incidence,N/A
Disease,423994,Squamous cell carcinoma of the colon,Annual incidence,N/A
Disease,423994,Squamous cell carcinoma of the colon,Annual incidence,N/A
Disease,424002,Squamous cell carcinoma of the rectum,Annual incidence,N/A
Disease,424002,Squamous cell carcinoma of the rectum,Annual incidence,N/A
Disease,424002,Squamous cell carcinoma of the rectum,Annual incidence,N/A
Disease,424002,Squamous cell carcinoma of the rectum,Annual incidence,N/A
Disease,424002,Squamous cell carcinoma of the rectum,Annual incidence,N/A
Disease,424002,Squamous cell carcinoma of the rectum,Annual incidence,N/A
Disease,424002,Squamous cell carcinoma of the rectum,Annual incidence,N/A
Disease,424002,Squamous cell carcinoma of the rectum,Annual incidence,N/A
Disease,424002,Squamous cell carcinoma of the rectum,Annual incidence,N/A
Disease,424002,Squamous cell carcinoma of the rectum,Annual incidence,N/A
Disease,424002,Squamous cell carcinoma of the rectum,Annual incidence,N/A
Disease,424002,Squamous cell carcinoma of the rectum,Annual incidence,N/A
Disease,424002,Squamous cell carcinoma of the rectum,Annual incidence,N/A
Disease,424002,Squamous cell carcinoma of the rectum,Annual incidence,N/A
Disease,424002,Squamous cell carcinoma of the rectum,Annual incidence,N/A
Disease,424002,Squamous cell carcinoma of the rectum,Annual incidence,N/A
Disease,424002,Squamous cell carcinoma of the rectum,Annual incidence,N/A
Disease,424002,Squamous cell carcinoma of the rectum,Annual incidence,N/A
Disease,424002,Squamous cell carcinoma of the rectum,Annual incidence,N/A
Disease,424002,Squamous cell carcinoma of the rectum,Annual incidence,N/A
Disease,424002,Squamous cell carcinoma of the rectum,Annual incidence,N/A
Disease,424002,Squamous cell carcinoma of the rectum,Annual incidence,N/A
Disease,424002,Squamous cell carcinoma of the rectum,Annual incidence,N/A
Disease,423786,Undifferentiated carcinoma of stomach,Annual incidence,N/A
Disease,423786,Undifferentiated carcinoma of stomach,Annual incidence,N/A
Disease,423786,Undifferentiated carcinoma of stomach,Annual incidence,N/A
Disease,423786,Undifferentiated carcinoma of stomach,Annual incidence,N/A
Disease,423786,Undifferentiated carcinoma of stomach,Annual incidence,N/A
Disease,423786,Undifferentiated carcinoma of stomach,Annual incidence,N/A
Disease,423786,Undifferentiated carcinoma of stomach,Annual incidence,N/A
Disease,423786,Undifferentiated carcinoma of stomach,Annual incidence,N/A
Disease,423786,Undifferentiated carcinoma of stomach,Annual incidence,N/A
Disease,423786,Undifferentiated carcinoma of stomach,Annual incidence,N/A
Disease,423786,Undifferentiated carcinoma of stomach,Annual incidence,N/A
Disease,423786,Undifferentiated carcinoma of stomach,Annual incidence,N/A
Disease,423786,Undifferentiated carcinoma of stomach,Annual incidence,N/A
Disease,423786,Undifferentiated carcinoma of stomach,Annual incidence,N/A
Disease,423786,Undifferentiated carcinoma of stomach,Annual incidence,N/A
Disease,423786,Undifferentiated carcinoma of stomach,Annual incidence,N/A
Disease,423786,Undifferentiated carcinoma of stomach,Annual incidence,N/A
Disease,423786,Undifferentiated carcinoma of stomach,Annual incidence,N/A
Disease,423786,Undifferentiated carcinoma of stomach,Annual incidence,N/A
Disease,423786,Undifferentiated carcinoma of stomach,Annual incidence,N/A
Disease,423786,Undifferentiated carcinoma of stomach,Annual incidence,N/A
Disease,423786,Undifferentiated carcinoma of stomach,Annual incidence,N/A
Disease,423786,Undifferentiated carcinoma of stomach,Annual incidence,N/A
Disease,423786,Undifferentiated carcinoma of stomach,Annual incidence,N/A
Disease,423786,Undifferentiated carcinoma of stomach,Annual incidence,N/A
Disease,423894,Microcephaly-complex motor and sensory axonal neuropathy syndrome,Cases/families,N/A
Disease,423894,Microcephaly-complex motor and sensory axonal neuropathy syndrome,Point prevalence,N/A
Malformation syndrome,431140,X-linked colobomatous microphthalmia-microcephaly-intellectual disability-short stature syndrome,Cases/families,N/A
Malformation syndrome,431140,X-linked colobomatous microphthalmia-microcephaly-intellectual disability-short stature syndrome,Point prevalence,N/A
Disease,425120,STING-associated vasculopathy with onset in infancy,Point prevalence,N/A
Disease,425120,STING-associated vasculopathy with onset in infancy,Cases/families,N/A
Disease,424943,Adenocarcinoma of the liver and intrahepatic biliary tract,Annual incidence,N/A
Disease,424943,Adenocarcinoma of the liver and intrahepatic biliary tract,Annual incidence,N/A
Disease,424943,Adenocarcinoma of the liver and intrahepatic biliary tract,Annual incidence,N/A
Disease,424943,Adenocarcinoma of the liver and intrahepatic biliary tract,Annual incidence,N/A
Disease,424943,Adenocarcinoma of the liver and intrahepatic biliary tract,Annual incidence,N/A
Disease,424943,Adenocarcinoma of the liver and intrahepatic biliary tract,Annual incidence,N/A
Disease,424943,Adenocarcinoma of the liver and intrahepatic biliary tract,Annual incidence,N/A
Disease,424943,Adenocarcinoma of the liver and intrahepatic biliary tract,Annual incidence,N/A
Disease,424943,Adenocarcinoma of the liver and intrahepatic biliary tract,Annual incidence,N/A
Disease,424943,Adenocarcinoma of the liver and intrahepatic biliary tract,Annual incidence,N/A
Disease,424943,Adenocarcinoma of the liver and intrahepatic biliary tract,Annual incidence,N/A
Disease,424943,Adenocarcinoma of the liver and intrahepatic biliary tract,Annual incidence,N/A
Disease,424943,Adenocarcinoma of the liver and intrahepatic biliary tract,Annual incidence,N/A
Disease,424943,Adenocarcinoma of the liver and intrahepatic biliary tract,Annual incidence,N/A
Disease,424943,Adenocarcinoma of the liver and intrahepatic biliary tract,Annual incidence,N/A
Disease,424943,Adenocarcinoma of the liver and intrahepatic biliary tract,Annual incidence,N/A
Disease,424943,Adenocarcinoma of the liver and intrahepatic biliary tract,Annual incidence,N/A
Disease,424943,Adenocarcinoma of the liver and intrahepatic biliary tract,Annual incidence,N/A
Disease,424943,Adenocarcinoma of the liver and intrahepatic biliary tract,Annual incidence,N/A
Disease,424943,Adenocarcinoma of the liver and intrahepatic biliary tract,Annual incidence,N/A
Disease,424943,Adenocarcinoma of the liver and intrahepatic biliary tract,Annual incidence,N/A
Disease,424943,Adenocarcinoma of the liver and intrahepatic biliary tract,Annual incidence,N/A
Disease,424943,Adenocarcinoma of the liver and intrahepatic biliary tract,Annual incidence,N/A
Disease,424970,Undifferentiated carcinoma of liver and intrahepatic biliary tract,Annual incidence,N/A
Disease,424970,Undifferentiated carcinoma of liver and intrahepatic biliary tract,Annual incidence,N/A
Disease,424970,Undifferentiated carcinoma of liver and intrahepatic biliary tract,Annual incidence,N/A
Disease,424970,Undifferentiated carcinoma of liver and intrahepatic biliary tract,Annual incidence,N/A
Disease,424970,Undifferentiated carcinoma of liver and intrahepatic biliary tract,Annual incidence,N/A
Disease,424970,Undifferentiated carcinoma of liver and intrahepatic biliary tract,Annual incidence,N/A
Disease,424970,Undifferentiated carcinoma of liver and intrahepatic biliary tract,Annual incidence,N/A
Disease,424970,Undifferentiated carcinoma of liver and intrahepatic biliary tract,Annual incidence,N/A
Disease,424970,Undifferentiated carcinoma of liver and intrahepatic biliary tract,Annual incidence,N/A
Disease,424970,Undifferentiated carcinoma of liver and intrahepatic biliary tract,Annual incidence,N/A
Disease,424970,Undifferentiated carcinoma of liver and intrahepatic biliary tract,Annual incidence,N/A
Disease,424970,Undifferentiated carcinoma of liver and intrahepatic biliary tract,Annual incidence,N/A
Disease,424970,Undifferentiated carcinoma of liver and intrahepatic biliary tract,Annual incidence,N/A
Disease,424970,Undifferentiated carcinoma of liver and intrahepatic biliary tract,Annual incidence,N/A
Disease,424970,Undifferentiated carcinoma of liver and intrahepatic biliary tract,Annual incidence,N/A
Disease,424970,Undifferentiated carcinoma of liver and intrahepatic biliary tract,Annual incidence,N/A
Disease,424970,Undifferentiated carcinoma of liver and intrahepatic biliary tract,Annual incidence,N/A
Disease,424970,Undifferentiated carcinoma of liver and intrahepatic biliary tract,Annual incidence,N/A
Disease,424970,Undifferentiated carcinoma of liver and intrahepatic biliary tract,Annual incidence,N/A
Disease,424991,Adenocarcinoma of the gallbladder and extrahepatic biliary tract,Annual incidence,N/A
Disease,424996,Squamous cell carcinoma of gallbladder and extrahepatic biliary tract,Annual incidence,N/A
Disease,424996,Squamous cell carcinoma of gallbladder and extrahepatic biliary tract,Annual incidence,N/A
Disease,424996,Squamous cell carcinoma of gallbladder and extrahepatic biliary tract,Annual incidence,N/A
Disease,424996,Squamous cell carcinoma of gallbladder and extrahepatic biliary tract,Annual incidence,N/A
Disease,424996,Squamous cell carcinoma of gallbladder and extrahepatic biliary tract,Annual incidence,N/A
Disease,424996,Squamous cell carcinoma of gallbladder and extrahepatic biliary tract,Annual incidence,N/A
Disease,424996,Squamous cell carcinoma of gallbladder and extrahepatic biliary tract,Annual incidence,N/A
Disease,424996,Squamous cell carcinoma of gallbladder and extrahepatic biliary tract,Annual incidence,N/A
Disease,424996,Squamous cell carcinoma of gallbladder and extrahepatic biliary tract,Annual incidence,N/A
Disease,424996,Squamous cell carcinoma of gallbladder and extrahepatic biliary tract,Annual incidence,N/A
Disease,424996,Squamous cell carcinoma of gallbladder and extrahepatic biliary tract,Annual incidence,N/A
Disease,424996,Squamous cell carcinoma of gallbladder and extrahepatic biliary tract,Annual incidence,N/A
Disease,424996,Squamous cell carcinoma of gallbladder and extrahepatic biliary tract,Annual incidence,N/A
Disease,424996,Squamous cell carcinoma of gallbladder and extrahepatic biliary tract,Annual incidence,N/A
Disease,424996,Squamous cell carcinoma of gallbladder and extrahepatic biliary tract,Annual incidence,N/A
Disease,424996,Squamous cell carcinoma of gallbladder and extrahepatic biliary tract,Annual incidence,N/A
Disease,424996,Squamous cell carcinoma of gallbladder and extrahepatic biliary tract,Annual incidence,N/A
Disease,424996,Squamous cell carcinoma of gallbladder and extrahepatic biliary tract,Annual incidence,N/A
Disease,424996,Squamous cell carcinoma of gallbladder and extrahepatic biliary tract,Annual incidence,N/A
Disease,424996,Squamous cell carcinoma of gallbladder and extrahepatic biliary tract,Annual incidence,N/A
Disease,424996,Squamous cell carcinoma of gallbladder and extrahepatic biliary tract,Annual incidence,N/A
Disease,424996,Squamous cell carcinoma of gallbladder and extrahepatic biliary tract,Annual incidence,N/A
Disease,424996,Squamous cell carcinoma of gallbladder and extrahepatic biliary tract,Annual incidence,N/A
Disease,424975,Squamous cell carcinoma of liver and intrahepatic biliary tract,Annual incidence,N/A
Disease,424975,Squamous cell carcinoma of liver and intrahepatic biliary tract,Annual incidence,N/A
Disease,424975,Squamous cell carcinoma of liver and intrahepatic biliary tract,Annual incidence,N/A
Disease,424975,Squamous cell carcinoma of liver and intrahepatic biliary tract,Annual incidence,N/A
Disease,424975,Squamous cell carcinoma of liver and intrahepatic biliary tract,Annual incidence,N/A
Disease,424975,Squamous cell carcinoma of liver and intrahepatic biliary tract,Annual incidence,N/A
Disease,424975,Squamous cell carcinoma of liver and intrahepatic biliary tract,Annual incidence,N/A
Disease,424975,Squamous cell carcinoma of liver and intrahepatic biliary tract,Annual incidence,N/A
Disease,424975,Squamous cell carcinoma of liver and intrahepatic biliary tract,Annual incidence,N/A
Disease,424975,Squamous cell carcinoma of liver and intrahepatic biliary tract,Annual incidence,N/A
Disease,424975,Squamous cell carcinoma of liver and intrahepatic biliary tract,Annual incidence,N/A
Disease,424975,Squamous cell carcinoma of liver and intrahepatic biliary tract,Annual incidence,N/A
Disease,424975,Squamous cell carcinoma of liver and intrahepatic biliary tract,Annual incidence,N/A
Disease,424975,Squamous cell carcinoma of liver and intrahepatic biliary tract,Annual incidence,N/A
Disease,424975,Squamous cell carcinoma of liver and intrahepatic biliary tract,Annual incidence,N/A
Disease,424975,Squamous cell carcinoma of liver and intrahepatic biliary tract,Annual incidence,N/A
Disease,424975,Squamous cell carcinoma of liver and intrahepatic biliary tract,Annual incidence,N/A
Disease,424975,Squamous cell carcinoma of liver and intrahepatic biliary tract,Annual incidence,N/A
Disease,424982,Biliary cystadenocarcinoma,Annual incidence,N/A
Disease,424982,Biliary cystadenocarcinoma,Annual incidence,N/A
Disease,424982,Biliary cystadenocarcinoma,Annual incidence,N/A
Disease,424982,Biliary cystadenocarcinoma,Annual incidence,N/A
Disease,424982,Biliary cystadenocarcinoma,Annual incidence,N/A
Disease,424982,Biliary cystadenocarcinoma,Annual incidence,N/A
Disease,424982,Biliary cystadenocarcinoma,Annual incidence,N/A
Disease,424982,Biliary cystadenocarcinoma,Annual incidence,N/A
Disease,424982,Biliary cystadenocarcinoma,Annual incidence,N/A
Disease,424982,Biliary cystadenocarcinoma,Annual incidence,N/A
Disease,424982,Biliary cystadenocarcinoma,Annual incidence,N/A
Disease,424982,Biliary cystadenocarcinoma,Annual incidence,N/A
Disease,424982,Biliary cystadenocarcinoma,Annual incidence,N/A
Disease,424982,Biliary cystadenocarcinoma,Annual incidence,N/A
Disease,424982,Biliary cystadenocarcinoma,Annual incidence,N/A
Disease,431361,Progressive encephalopathy with leukodystrophy due to DECR deficiency,Cases/families,N/A
Disease,431361,Progressive encephalopathy with leukodystrophy due to DECR deficiency,Point prevalence,N/A
Category,431353,Pulmonary veno-occlusive disease and/or pulmonary capillary haemangiomatosis,Annual incidence,N/A
Morphological anomaly,431341,Patent urachus,Prevalence at birth,N/A
Morphological anomaly,431341,Patent urachus,Point prevalence,N/A
Morphological anomaly,431344,Urachal sinus,Point prevalence,N/A
Disease,431272,X-linked scapuloperoneal muscular dystrophy,Cases/families,N/A
Disease,431272,X-linked scapuloperoneal muscular dystrophy,Point prevalence,N/A
Disease,431329,Autosomal recessive spastic paraplegia type 57,Cases/families,N/A
Disease,431329,Autosomal recessive spastic paraplegia type 57,Point prevalence,N/A
Disease,431255,Scapuloperoneal spinal muscular atrophy,Cases/families,N/A
Disease,431255,Scapuloperoneal spinal muscular atrophy,Point prevalence,N/A
Disease,431149,Combined immunodeficiency due to OX40 deficiency,Cases/families,N/A
Disease,431149,Combined immunodeficiency due to OX40 deficiency,Point prevalence,N/A
Disease,431166,Primary immunodeficiency with post-measles-mumps-rubella vaccine viral infection,Cases/families,N/A
Disease,431166,Primary immunodeficiency with post-measles-mumps-rubella vaccine viral infection,Point prevalence,N/A
Disease,435438,Progressive myoclonic epilepsy type 7,Cases/families,N/A
Disease,435438,Progressive myoclonic epilepsy type 7,Point prevalence,N/A
Disease,435387,Autosomal dominant Charcot-Marie-Tooth disease type 2Y,Cases/families,N/A
Disease,435387,Autosomal dominant Charcot-Marie-Tooth disease type 2Y,Point prevalence,N/A
Disease,435329,Familial ossifying fibroma,Point prevalence,N/A
Malformation syndrome,434179,Orofaciodigital syndrome type 14,Cases/families,N/A
Malformation syndrome,434179,Orofaciodigital syndrome type 14,Point prevalence,N/A
Disease,504476,Cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome,Point prevalence,N/A
Disease,504476,Cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome,Cases/families,N/A
Disease,504523,Severe combined immunodeficiency due to LAT deficiency,Cases/families,N/A
Disease,504523,Severe combined immunodeficiency due to LAT deficiency,Point prevalence,N/A
Disease,504530,Combined immunodeficiency due to Moesin deficiency,Cases/families,N/A
Disease,504530,Combined immunodeficiency due to Moesin deficiency,Point prevalence,N/A
Disease,26793,Very long chain acyl-CoA dehydrogenase deficiency,Point prevalence,N/A
Disease,26793,Very long chain acyl-CoA dehydrogenase deficiency,Prevalence at birth,N/A
Disease,26793,Very long chain acyl-CoA dehydrogenase deficiency,Prevalence at birth,N/A
Disease,26793,Very long chain acyl-CoA dehydrogenase deficiency,Point prevalence,N/A
Disease,26793,Very long chain acyl-CoA dehydrogenase deficiency,Prevalence at birth,N/A
Disease,26793,Very long chain acyl-CoA dehydrogenase deficiency,Prevalence at birth,N/A
Disease,26793,Very long chain acyl-CoA dehydrogenase deficiency,Prevalence at birth,N/A
Disease,29072,Hereditary pheochromocytoma-paraganglioma,Annual incidence,N/A
Disease,29072,Hereditary pheochromocytoma-paraganglioma,Point prevalence,N/A
Disease,28378,Tyrosinemia type 2,Cases/families,N/A
Disease,28378,Tyrosinemia type 2,Point prevalence,N/A
Disease,29207,Reactive arthritis,Point prevalence,N/A
Disease,29073,Multiple myeloma,Prevalence at birth,N/A
Disease,29073,Multiple myeloma,Annual incidence,N/A
Disease,29073,Multiple myeloma,Point prevalence,N/A
Disease,29073,Multiple myeloma,Annual incidence,N/A
Disease,29073,Multiple myeloma,Annual incidence,N/A
Disease,29073,Multiple myeloma,Annual incidence,N/A
Disease,29073,Multiple myeloma,Annual incidence,N/A
Disease,29073,Multiple myeloma,Annual incidence,N/A
Disease,29073,Multiple myeloma,Annual incidence,N/A
Disease,29822,Spontaneous periodic hypothermia,Cases/families,N/A
Disease,29822,Spontaneous periodic hypothermia,Point prevalence,N/A
Morphological anomaly,30391,Isolated biliary atresia,Point prevalence,N/A
Morphological anomaly,30391,Isolated biliary atresia,Prevalence at birth,N/A
Morphological anomaly,30391,Isolated biliary atresia,Point prevalence,N/A
Morphological anomaly,30391,Isolated biliary atresia,Prevalence at birth,N/A
Morphological anomaly,30391,Isolated biliary atresia,Prevalence at birth,N/A
Morphological anomaly,30391,Isolated biliary atresia,Prevalence at birth,N/A
Morphological anomaly,30391,Isolated biliary atresia,Prevalence at birth,N/A
Morphological anomaly,30391,Isolated biliary atresia,Prevalence at birth,N/A
Morphological anomaly,30391,Isolated biliary atresia,Prevalence at birth,N/A
Morphological anomaly,30391,Isolated biliary atresia,Prevalence at birth,N/A
Morphological anomaly,30391,Isolated biliary atresia,Prevalence at birth,N/A
Morphological anomaly,30391,Isolated biliary atresia,Prevalence at birth,N/A
Morphological anomaly,30391,Isolated biliary atresia,Prevalence at birth,N/A
Morphological anomaly,30391,Isolated biliary atresia,Prevalence at birth,N/A
Morphological anomaly,30391,Isolated biliary atresia,Prevalence at birth,N/A
Morphological anomaly,30391,Isolated biliary atresia,Prevalence at birth,N/A
Morphological anomaly,30391,Isolated biliary atresia,Prevalence at birth,N/A
Morphological anomaly,30391,Isolated biliary atresia,Prevalence at birth,N/A
Disease,320,Apparent mineralocorticoid excess,Point prevalence,N/A
Disease,724,Idiopathic acute eosinophilic pneumonia,Cases/families,N/A
Disease,724,Idiopathic acute eosinophilic pneumonia,Point prevalence,N/A
Disease,230,Dopamine beta-hydroxylase deficiency,Cases/families,N/A
Disease,230,Dopamine beta-hydroxylase deficiency,Point prevalence,N/A
Disease,725,Developmental and epileptic encephalopathy with spike-wave activation in sleep,Point prevalence,N/A
Disease,590,Congenital myasthenic syndrome,Point prevalence,N/A
Disease,590,Congenital myasthenic syndrome,Point prevalence,N/A
Disease,404,Familial hyperaldosteronism type II,Point prevalence,N/A
Disease,756,Pseudohypoaldosteronism type 1,Prevalence at birth,N/A
Disease,756,Pseudohypoaldosteronism type 1,Point prevalence,N/A
Malformation syndrome,162,Congenital cataract-anterior segment dysgenesis syndrome,Cases/families,N/A
Malformation syndrome,162,Congenital cataract-anterior segment dysgenesis syndrome,Point prevalence,N/A
Clinical group,544,Diffuse large B-cell lymphoma,Point prevalence,N/A
Clinical group,544,Diffuse large B-cell lymphoma,Annual incidence,N/A
Clinical group,544,Diffuse large B-cell lymphoma,Annual incidence,N/A
Clinical group,544,Diffuse large B-cell lymphoma,Annual incidence,N/A
Clinical group,544,Diffuse large B-cell lymphoma,Annual incidence,N/A
Clinical group,544,Diffuse large B-cell lymphoma,Annual incidence,N/A
Clinical group,544,Diffuse large B-cell lymphoma,Annual incidence,N/A
Clinical group,544,Diffuse large B-cell lymphoma,Annual incidence,N/A
Clinical group,544,Diffuse large B-cell lymphoma,Annual incidence,N/A
Clinical group,544,Diffuse large B-cell lymphoma,Annual incidence,N/A
Clinical group,544,Diffuse large B-cell lymphoma,Annual incidence,N/A
Clinical group,544,Diffuse large B-cell lymphoma,Annual incidence,N/A
Clinical group,544,Diffuse large B-cell lymphoma,Annual incidence,N/A
Clinical group,544,Diffuse large B-cell lymphoma,Annual incidence,N/A
Clinical group,544,Diffuse large B-cell lymphoma,Annual incidence,N/A
Clinical group,544,Diffuse large B-cell lymphoma,Annual incidence,N/A
Clinical group,544,Diffuse large B-cell lymphoma,Annual incidence,N/A
Clinical group,544,Diffuse large B-cell lymphoma,Annual incidence,N/A
Clinical group,544,Diffuse large B-cell lymphoma,Annual incidence,N/A
Clinical group,544,Diffuse large B-cell lymphoma,Annual incidence,N/A
Clinical group,544,Diffuse large B-cell lymphoma,Annual incidence,N/A
Clinical group,544,Diffuse large B-cell lymphoma,Annual incidence,N/A
Clinical group,544,Diffuse large B-cell lymphoma,Annual incidence,N/A
Clinical group,544,Diffuse large B-cell lymphoma,Annual incidence,N/A
Clinical group,544,Diffuse large B-cell lymphoma,Annual incidence,N/A
Clinical group,544,Diffuse large B-cell lymphoma,Annual incidence,N/A
Disease,545,Follicular lymphoma,Point prevalence,N/A
Disease,545,Follicular lymphoma,Annual incidence,N/A
Disease,545,Follicular lymphoma,Annual incidence,N/A
Disease,545,Follicular lymphoma,Annual incidence,N/A
Disease,545,Follicular lymphoma,Annual incidence,N/A
Disease,545,Follicular lymphoma,Annual incidence,N/A
Disease,545,Follicular lymphoma,Annual incidence,N/A
Disease,545,Follicular lymphoma,Annual incidence,N/A
Disease,545,Follicular lymphoma,Annual incidence,N/A
Disease,545,Follicular lymphoma,Annual incidence,N/A
Disease,545,Follicular lymphoma,Annual incidence,N/A
Disease,545,Follicular lymphoma,Annual incidence,N/A
Disease,545,Follicular lymphoma,Annual incidence,N/A
Disease,545,Follicular lymphoma,Annual incidence,N/A
Disease,545,Follicular lymphoma,Annual incidence,N/A
Disease,545,Follicular lymphoma,Annual incidence,N/A
Disease,545,Follicular lymphoma,Annual incidence,N/A
Disease,545,Follicular lymphoma,Annual incidence,N/A
Disease,545,Follicular lymphoma,Annual incidence,N/A
Disease,545,Follicular lymphoma,Annual incidence,N/A
Disease,545,Follicular lymphoma,Annual incidence,N/A
Disease,545,Follicular lymphoma,Annual incidence,N/A
Disease,545,Follicular lymphoma,Annual incidence,N/A
Disease,545,Follicular lymphoma,Annual incidence,N/A
Disease,545,Follicular lymphoma,Annual incidence,N/A
Disease,545,Follicular lymphoma,Annual incidence,N/A
Disease,88,Idiopathic aplastic anemia,Point prevalence,N/A
Disease,88,Idiopathic aplastic anemia,Annual incidence,N/A
Disease,102,Multiple system atrophy,Point prevalence,N/A
Disease,102,Multiple system atrophy,Point prevalence,N/A
Disease,102,Multiple system atrophy,Annual incidence,N/A
Disease,102,Multiple system atrophy,Annual incidence,N/A
Disease,102,Multiple system atrophy,Point prevalence,N/A
Disease,102,Multiple system atrophy,Annual incidence,N/A
Disease,102,Multiple system atrophy,Point prevalence,N/A
Disease,102,Multiple system atrophy,Annual incidence,N/A
Disease,102,Multiple system atrophy,Point prevalence,N/A
Disease,102,Multiple system atrophy,Annual incidence,N/A
Disease,102,Multiple system atrophy,Point prevalence,N/A
Disease,102,Multiple system atrophy,Point prevalence,N/A
Disease,102,Multiple system atrophy,Point prevalence,N/A
Disease,824,Primary myelofibrosis,Annual incidence,N/A
Disease,824,Primary myelofibrosis,Point prevalence,N/A
Clinical group,748,Mendelian susceptibility to mycobacterial diseases,Point prevalence,N/A
Disease,729,Polycythemia vera,Annual incidence,N/A
Disease,729,Polycythemia vera,Point prevalence,N/A
Disease,729,Polycythemia vera,Point prevalence,N/A
Disease,25980,X-linked myopathy with excessive autophagy,Cases/families,N/A
Disease,25980,X-linked myopathy with excessive autophagy,Point prevalence,N/A
Disease,26137,Juvenile temporal arteritis,Cases/families,N/A
Disease,26137,Juvenile temporal arteritis,Point prevalence,N/A
Disease,26106,Hereditary diffuse gastric cancer,Annual incidence,N/A
Disease,26106,Hereditary diffuse gastric cancer,Point prevalence,N/A
Particular clinical situation in a disease or syndrome,505395,Ventilator-induced diaphragmatic dysfunction,Point prevalence,N/A
Disease,25968,Self-limited childhood occipital epilepsy,Point prevalence,N/A
Disease,26790,Pseudomyxoma peritonei,Annual incidence,N/A
Disease,26790,Pseudomyxoma peritonei,Annual incidence,N/A
Disease,26790,Pseudomyxoma peritonei,Point prevalence,N/A
Disease,26790,Pseudomyxoma peritonei,Point prevalence,N/A
Disease,26792,Short chain acyl-CoA dehydrogenase deficiency,Point prevalence,N/A
Disease,26792,Short chain acyl-CoA dehydrogenase deficiency,Prevalence at birth,N/A
Disease,26791,Multiple acyl-CoA dehydrogenase deficiency,Prevalence at birth,N/A
Disease,26791,Multiple acyl-CoA dehydrogenase deficiency,Point prevalence,N/A
Disease,26791,Multiple acyl-CoA dehydrogenase deficiency,Prevalence at birth,N/A
Disease,26791,Multiple acyl-CoA dehydrogenase deficiency,Prevalence at birth,N/A
Morphological anomaly,49,Penile agenesis,Cases/families,N/A
Morphological anomaly,49,Penile agenesis,Point prevalence,N/A
Morphological anomaly,227,Diphallia,Prevalence at birth,N/A
Morphological anomaly,227,Diphallia,Point prevalence,N/A
Morphological anomaly,674,Accessory pancreas,Point prevalence,N/A
Disease,266,Autosomal dominant limb-girdle muscular dystrophy type 1A,Cases/families,N/A
Disease,266,Autosomal dominant limb-girdle muscular dystrophy type 1A,Point prevalence,N/A
Disease,353,Gamma-sarcoglycan-related limb-girdle muscular dystrophy R5,Point prevalence,N/A
Disease,353,Gamma-sarcoglycan-related limb-girdle muscular dystrophy R5,Point prevalence,N/A
Disease,353,Gamma-sarcoglycan-related limb-girdle muscular dystrophy R5,Annual incidence,N/A
Disease,219,Delta-sarcoglycan-related limb-girdle muscular dystrophy R6,Point prevalence,N/A
Disease,641,Multifocal motor neuropathy,Point prevalence,N/A
Disease,641,Multifocal motor neuropathy,Point prevalence,N/A
Disease,119,Beta-sarcoglycan-related limb-girdle muscular dystrophy R4,Point prevalence,N/A
Disease,119,Beta-sarcoglycan-related limb-girdle muscular dystrophy R4,Point prevalence,N/A
Disease,603,"Distal myopathy, Welander type",Point prevalence,N/A
Disease,603,"Distal myopathy, Welander type",Point prevalence,N/A
Disease,505227,Combined immunodeficiency due to GINS1 deficiency,Cases/families,N/A
Disease,505227,Combined immunodeficiency due to GINS1 deficiency,Point prevalence,N/A
Malformation syndrome,505237,Early-onset seizures-distal limb anomalies-facial dysmorphism-global developmental delay syndrome,Cases/families,N/A
Malformation syndrome,505237,Early-onset seizures-distal limb anomalies-facial dysmorphism-global developmental delay syndrome,Point prevalence,N/A
Malformation syndrome,588,Muscle-eye-brain disease,Point prevalence,N/A
Disease,899,Walker-Warburg syndrome,Point prevalence,N/A
Disease,899,Walker-Warburg syndrome,Prevalence at birth,N/A
Disease,899,Walker-Warburg syndrome,Point prevalence,N/A
Disease,899,Walker-Warburg syndrome,Prevalence at birth,N/A
Disease,505216,3-methylglutaconic aciduria type 9,Cases/families,N/A
Disease,505216,3-methylglutaconic aciduria type 9,Point prevalence,N/A
Malformation syndrome,272,"Congenital muscular dystrophy, Fukuyama type",Prevalence at birth,N/A
Malformation syndrome,272,"Congenital muscular dystrophy, Fukuyama type",Point prevalence,N/A
Disease,505208,3-methylglutaconic aciduria type 8,Cases/families,N/A
Disease,505208,3-methylglutaconic aciduria type 8,Point prevalence,N/A
Disease,268,Dysferlin-related limb-girdle muscular dystrophy R2,Point prevalence,N/A
Disease,268,Dysferlin-related limb-girdle muscular dystrophy R2,Point prevalence,N/A
Clinical group,263,Limb-girdle muscular dystrophy,Point prevalence,N/A
Clinical group,263,Limb-girdle muscular dystrophy,Point prevalence,N/A
Clinical group,263,Limb-girdle muscular dystrophy,Point prevalence,N/A
Clinical group,263,Limb-girdle muscular dystrophy,Point prevalence,N/A
Clinical group,263,Limb-girdle muscular dystrophy,Point prevalence,N/A
Clinical group,263,Limb-girdle muscular dystrophy,Lifetime Prevalence,N/A
Clinical group,263,Limb-girdle muscular dystrophy,Point prevalence,N/A
Clinical group,263,Limb-girdle muscular dystrophy,Point prevalence,N/A
Disease,600,Vocal cord and pharyngeal distal myopathy,Point prevalence,N/A
Malformation syndrome,505248,Mucopolysaccharidosis-like syndrome with congenital heart defects and hematopoietic disorders,Cases/families,N/A
Malformation syndrome,505248,Mucopolysaccharidosis-like syndrome with congenital heart defects and hematopoietic disorders,Point prevalence,N/A
Disease,609,Tibial muscular dystrophy,Point prevalence,N/A
Disease,609,Tibial muscular dystrophy,Point prevalence,N/A
Disease,602,GNE myopathy,Point prevalence,N/A
Disease,602,GNE myopathy,Point prevalence,N/A
Disease,505242,Psychomotor regression-oculomotor apraxia-movement disorder-nephropathy syndrome,Cases/families,N/A
Disease,505242,Psychomotor regression-oculomotor apraxia-movement disorder-nephropathy syndrome,Point prevalence,N/A
Malformation syndrome,508093,MEPAN syndrome,Cases/families,N/A
Malformation syndrome,508093,MEPAN syndrome,Point prevalence,N/A
Disease,508533,Skeletal dysplasia-T-cell immunodeficiency-developmental delay syndrome,Cases/families,N/A
Disease,508533,Skeletal dysplasia-T-cell immunodeficiency-developmental delay syndrome,Point prevalence,N/A
Disease,508542,Congenital progressive bone marrow failure-B-cell immunodeficiency-skeletal dysplasia syndrome,Cases/families,N/A
Disease,508542,Congenital progressive bone marrow failure-B-cell immunodeficiency-skeletal dysplasia syndrome,Point prevalence,N/A
Disease,508512,Intrauterine growth restriction-congenital multiple caf-au-lait macules-increased sister chromatid exchange syndrome,Cases/families,N/A
Disease,508512,Intrauterine growth restriction-congenital multiple caf-au-lait macules-increased sister chromatid exchange syndrome,Point prevalence,N/A
Disease,508529,Intermediate epidermolysis bullosa simplex with cardiomyopathy,Cases/families,N/A
Disease,508529,Intermediate epidermolysis bullosa simplex with cardiomyopathy,Point prevalence,N/A
Disease,508523,Hyperphenylalaninemia due to DNAJC12 deficiency,Cases/families,N/A
Disease,508523,Hyperphenylalaninemia due to DNAJC12 deficiency,Point prevalence,N/A
Malformation syndrome,508488,8q24.3 microdeletion syndrome,Cases/families,N/A
Malformation syndrome,508488,8q24.3 microdeletion syndrome,Point prevalence,N/A
Malformation syndrome,508476,Cleft lip and palate-craniofacial dysmorphism-congenital heart defect-hearing loss syndrome,Cases/families,N/A
Malformation syndrome,508476,Cleft lip and palate-craniofacial dysmorphism-congenital heart defect-hearing loss syndrome,Point prevalence,N/A
Malformation syndrome,508501,Oral-facial-digital syndrome with short stature and brachymesophalangy,Cases/families,N/A
Malformation syndrome,508501,Oral-facial-digital syndrome with short stature and brachymesophalangy,Point prevalence,N/A
Malformation syndrome,508498,Intellectual disability-cardiac anomalies-short stature-joint laxity syndrome,Cases/families,N/A
Malformation syndrome,508498,Intellectual disability-cardiac anomalies-short stature-joint laxity syndrome,Point prevalence,N/A
Disease,505652,CDKL5-deficiency disorder,Point prevalence,N/A
Disease,505652,CDKL5-deficiency disorder,Prevalence at birth,N/A
Disease,505652,CDKL5-deficiency disorder,Prevalence at birth,N/A
Disease,505652,CDKL5-deficiency disorder,Prevalence at birth,N/A
Malformation syndrome,506307,Stromme syndrome,Cases/families,N/A
Malformation syndrome,506307,Stromme syndrome,Point prevalence,N/A
Malformation syndrome,506358,Gabriele-de Vries syndrome,Cases/families,N/A
Malformation syndrome,506358,Gabriele-de Vries syndrome,Point prevalence,N/A
Disease,506353,Autosomal recessive complex spastic paraplegia due to Kennedy pathway dysfunction,Cases/families,N/A
Disease,506353,Autosomal recessive complex spastic paraplegia due to Kennedy pathway dysfunction,Point prevalence,N/A
Disease,495274,Charcot-Marie-Tooth disease type 2T,Cases/families,N/A
Disease,495274,Charcot-Marie-Tooth disease type 2T,Point prevalence,N/A
Disease,495844,C11ORF73-related autosomal recessive hypomyelinating leukodystrophy,Cases/families,N/A
Disease,495844,C11ORF73-related autosomal recessive hypomyelinating leukodystrophy,Point prevalence,N/A
Malformation syndrome,495818,9q33.3q34.11 microdeletion syndrome,Cases/families,N/A
Malformation syndrome,495818,9q33.3q34.11 microdeletion syndrome,Point prevalence,N/A
Morphological anomaly,495879,Congenital agenesis of the scrotum,Cases/families,N/A
Morphological anomaly,495879,Congenital agenesis of the scrotum,Point prevalence,N/A
Malformation syndrome,495875,Congenital labioscrotal agenesis-cerebellar malformation-corneal dystrophy-facial dysmorphism syndrome,Cases/families,N/A
Malformation syndrome,495875,Congenital labioscrotal agenesis-cerebellar malformation-corneal dystrophy-facial dysmorphism syndrome,Point prevalence,N/A
Disease,495930,Familial monosomy 7 syndrome,Cases/families,N/A
Disease,495930,Familial monosomy 7 syndrome,Point prevalence,N/A
Malformation syndrome,496641,Early-onset progressive diffuse brain atrophy-microcephaly-muscle weakness-optic atrophy syndrome,Cases/families,N/A
Malformation syndrome,496641,Early-onset progressive diffuse brain atrophy-microcephaly-muscle weakness-optic atrophy syndrome,Point prevalence,N/A
Disease,496686,Kyphosis-lateral tongue atrophy-myofibrillar myopathy syndrome,Point prevalence,N/A
Disease,496686,Kyphosis-lateral tongue atrophy-myofibrillar myopathy syndrome,Cases/families,N/A
Disease,496689,Kyphoscoliosis-lateral tongue atrophy-hereditary spastic paraplegia syndrome,Point prevalence,N/A
Disease,496689,Kyphoscoliosis-lateral tongue atrophy-hereditary spastic paraplegia syndrome,Cases/families,N/A
Malformation syndrome,496693,Omphalocele-diaphragmatic hernia-cardiovascular anomalies-radial ray defect syndrome,Cases/families,N/A
Malformation syndrome,496693,Omphalocele-diaphragmatic hernia-cardiovascular anomalies-radial ray defect syndrome,Point prevalence,N/A
Malformation syndrome,496751,EVEN-plus syndrome,Cases/families,N/A
Malformation syndrome,496751,EVEN-plus syndrome,Point prevalence,N/A
Disease,496756,Early-onset progressive encephalopathy-spastic ataxia-distal spinal muscular atrophy syndrome,Cases/families,N/A
Disease,496756,Early-onset progressive encephalopathy-spastic ataxia-distal spinal muscular atrophy syndrome,Point prevalence,N/A
Disease,496790,Ocular anomalies-axonal neuropathy-developmental delay syndrome,Cases/families,N/A
Disease,496790,Ocular anomalies-axonal neuropathy-developmental delay syndrome,Point prevalence,N/A
Disease,494433,MIRAGE syndrome,Cases/families,N/A
Disease,494433,MIRAGE syndrome,Point prevalence,N/A
Malformation syndrome,494439,Retinitis pigmentosa-hearing loss-premature aging-short stature-facial dysmorphism syndrome,Cases/families,N/A
Malformation syndrome,494439,Retinitis pigmentosa-hearing loss-premature aging-short stature-facial dysmorphism syndrome,Point prevalence,N/A
Morphological anomaly,494424,Extracranial carotid artery aneurysm,Point prevalence,N/A
Disease,494428,Idiopathic pleuroparenchymal fibroelastosis,Point prevalence,N/A
Disease,494428,Idiopathic pleuroparenchymal fibroelastosis,Cases/families,N/A
Disease,494444,DIAPH1-related sensorineural hearing loss-thrombocytopenia syndrome,Cases/families,N/A
Disease,494444,DIAPH1-related sensorineural hearing loss-thrombocytopenia syndrome,Point prevalence,N/A
Malformation syndrome,494344,RERE-related neurodevelopmental syndrome,Cases/families,N/A
Malformation syndrome,494344,RERE-related neurodevelopmental syndrome,Point prevalence,N/A
Disease,494547,Squamous cell carcinoma of the hypopharynx,Annual incidence,N/A
Disease,494541,Childhood-onset benign chorea with striatal involvement,Cases/families,N/A
Disease,494541,Childhood-onset benign chorea with striatal involvement,Point prevalence,N/A
Disease,494526,Infantile-onset generalized dyskinesia with orofacial involvement,Cases/families,N/A
Disease,494526,Infantile-onset generalized dyskinesia with orofacial involvement,Point prevalence,N/A
Disease,494550,Squamous cell carcinoma of the larynx,Annual incidence,N/A
Disease,500180,Childhood-onset motor and cognitive regression syndrome with extrapyramidal movement disorder,Cases/families,N/A
Disease,500180,Childhood-onset motor and cognitive regression syndrome with extrapyramidal movement disorder,Point prevalence,N/A
Malformation syndrome,500188,X-linked external auditory canal atresia-dilated internal auditory canal-facial dysmorphism syndrome,Cases/families,N/A
Malformation syndrome,500188,X-linked external auditory canal atresia-dilated internal auditory canal-facial dysmorphism syndrome,Point prevalence,N/A
Disease,68,Amoebiasis due to free-living amoebae,Point prevalence,N/A
Disease,781,Q fever,Annual incidence,N/A
Disease,781,Q fever,Annual incidence,N/A
Disease,781,Q fever,Point prevalence,N/A
Disease,781,Q fever,Annual incidence,N/A
Disease,781,Q fever,Annual incidence,N/A
Disease,781,Q fever,Annual incidence,N/A
Disease,781,Q fever,Annual incidence,N/A
Disease,781,Q fever,Annual incidence,N/A
Disease,781,Q fever,Annual incidence,N/A
Disease,781,Q fever,Annual incidence,N/A
Disease,781,Q fever,Annual incidence,N/A
Disease,781,Q fever,Annual incidence,N/A
Disease,781,Q fever,Annual incidence,N/A
Disease,781,Q fever,Annual incidence,N/A
Disease,781,Q fever,Annual incidence,N/A
Disease,781,Q fever,Annual incidence,N/A
Disease,781,Q fever,Annual incidence,N/A
Disease,781,Q fever,Annual incidence,N/A
Disease,781,Q fever,Annual incidence,N/A
Disease,781,Q fever,Annual incidence,N/A
Disease,781,Q fever,Annual incidence,N/A
Disease,781,Q fever,Annual incidence,N/A
Disease,781,Q fever,Annual incidence,N/A
Disease,781,Q fever,Annual incidence,N/A
Malformation syndrome,500150,Brain malformations-musculoskeletal abnormalities-facial dysmorphism-intellectual disability syndrome,Cases/families,N/A
Malformation syndrome,500150,Brain malformations-musculoskeletal abnormalities-facial dysmorphism-intellectual disability syndrome,Point prevalence,N/A
Malformation syndrome,500159,Microcephaly-corpus callosum and cerebellar vermis hypoplasia-facial dysmorphism-intellectual disability syndrom,Cases/families,N/A
Malformation syndrome,500159,Microcephaly-corpus callosum and cerebellar vermis hypoplasia-facial dysmorphism-intellectual disability syndrom,Point prevalence,N/A
Malformation syndrome,500163,Witteveen-Kolk syndrome,Cases/families,N/A
Malformation syndrome,500163,Witteveen-Kolk syndrome,Point prevalence,N/A
Disease,302,Inherited epidermodysplasia verruciformis,Cases/families,N/A
Disease,302,Inherited epidermodysplasia verruciformis,Point prevalence,N/A
Disease,297,Tick-borne encephalitis,Point prevalence,N/A
Disease,182,Chromomycosis,Point prevalence,N/A
Disease,128,Diphyllobothriasis,Annual incidence,N/A
Disease,128,Diphyllobothriasis,Point prevalence,N/A
Disease,210,Cyclosporiasis,Point prevalence,N/A
Disease,76,Strongyloidiasis,Point prevalence,N/A
Disease,76,Strongyloidiasis,Annual incidence,N/A
Disease,74,Angiostrongyliasis,Point prevalence,N/A
Disease,108,Babesiosis,Point prevalence,N/A
Disease,78,Ankylostomiasis,Point prevalence,N/A
Malformation syndrome,500135,Multinucleated neurons-anhydramnios-renal dysplasia-cerebellar hypoplasia-hydranencephaly syndrome,Cases/families,N/A
Malformation syndrome,500135,Multinucleated neurons-anhydramnios-renal dysplasia-cerebellar hypoplasia-hydranencephaly syndrome,Point prevalence,N/A
Malformation syndrome,500144,Early-onset progressive encephalopathy-hearing loss-pons hypoplasia-brain atrophy syndrome,Cases/families,N/A
Malformation syndrome,500144,Early-onset progressive encephalopathy-hearing loss-pons hypoplasia-brain atrophy syndrome,Point prevalence,N/A
Etiological subtype,500055,Hao-Fountain syndrome due to 16p13.2 microdeletion,Cases/families,N/A
Etiological subtype,500055,Hao-Fountain syndrome due to 16p13.2 microdeletion,Point prevalence,N/A
Malformation syndrome,500095,Tall stature-intellectual disability-renal anomalies syndrome,Cases/families,N/A
Malformation syndrome,500095,Tall stature-intellectual disability-renal anomalies syndrome,Point prevalence,N/A
Disease,500062,Infantile-onset periodic fever-panniculitis-dermatosis syndrome,Cases/families,N/A
Disease,500062,Infantile-onset periodic fever-panniculitis-dermatosis syndrome,Point prevalence,N/A
Disease,129,Pseudopelade of Brocq,Point prevalence,N/A
Disease,123,Bjrnstad syndrome,Cases/families,N/A
Disease,123,Bjrnstad syndrome,Point prevalence,N/A
Disease,898,Wagner disease,Cases/families,N/A
Disease,898,Wagner disease,Point prevalence,N/A
Disease,500478,Squamous cell carcinoma of the oropharynx,Annual incidence,N/A
Disease,518,Acute megakaryoblastic leukemia,Point prevalence,N/A
Disease,518,Acute megakaryoblastic leukemia,Annual incidence,N/A
Disease,318,Acute erythroid leukemia,Annual incidence,N/A
Disease,318,Acute erythroid leukemia,Point prevalence,N/A
Disease,514,Acute monoblastic/monocytic leukemia,Annual incidence,N/A
Disease,514,Acute monoblastic/monocytic leukemia,Point prevalence,N/A
Disease,517,Acute myelomonocytic leukemia,Point prevalence,N/A
Disease,517,Acute myelomonocytic leukemia,Annual incidence,N/A
Disease,505,Graham Little-Piccardi-Lassueur syndrome,Point prevalence,N/A
Disease,346,Quinquaud folliculitis decalvans,Point prevalence,N/A
Disease,222,Erosive pustular dermatosis of the scalp,Point prevalence,N/A
Disease,202,Crandall syndrome,Point prevalence,N/A
Disease,170,Woolly hair,Point prevalence,N/A
Malformation syndrome,500548,Osteosclerotic metaphyseal dysplasia,Cases/families,N/A
Malformation syndrome,500548,Osteosclerotic metaphyseal dysplasia,Point prevalence,N/A
Disease,169,Ringed hair disease,Point prevalence,N/A
Disease,500533,Polyhydramnios-megalencephaly-symptomatic epilepsy syndrome,Cases/families,N/A
Disease,500533,Polyhydramnios-megalencephaly-symptomatic epilepsy syndrome,Point prevalence,N/A
Disease,168,Loose anagen syndrome,Point prevalence,N/A
Disease,500545,Severe neurodevelopmental disorder with feeding difficulties-stereotypic hand movement-bilateral cataract,Cases/families,N/A
Disease,500545,Severe neurodevelopmental disorder with feeding difficulties-stereotypic hand movement-bilateral cataract,Point prevalence,N/A
Disease,345,Dissecting cellulitis of the scalp,Point prevalence,N/A
Disease,591,Furuncular myiasis,Point prevalence,N/A
Disease,723,Pneumocystosis,Point prevalence,N/A
Disease,472,Isosporiasis,Point prevalence,N/A
Disease,401,Hymenolepiasis,Point prevalence,N/A
Disease,400,Cystic echinococcosis,Annual incidence,N/A
Disease,400,Cystic echinococcosis,Point prevalence,N/A
Disease,500464,Squamous cell carcinoma of the nasal cavity and paranasal sinuses,Annual incidence,N/A
Disease,520,Acute promyelocytic leukemia,Annual incidence,N/A
Disease,520,Acute promyelocytic leukemia,Annual incidence,N/A
Disease,520,Acute promyelocytic leukemia,Annual incidence,N/A
Disease,520,Acute promyelocytic leukemia,Point prevalence,N/A
Category,450,Heterotaxia,Prevalence at birth,N/A
Category,450,Heterotaxia,Point prevalence,N/A
Disease,529,Roch-Leri mesosomatous lipomatosis,Point prevalence,N/A
Category,224,Neonatal diabetes mellitus,Prevalence at birth,N/A
Category,224,Neonatal diabetes mellitus,Prevalence at birth,N/A
Category,224,Neonatal diabetes mellitus,Prevalence at birth,N/A
Category,224,Neonatal diabetes mellitus,Annual incidence,N/A
Category,224,Neonatal diabetes mellitus,Point prevalence,N/A
Disease,826,Sporotrichosis,Point prevalence,N/A
Disease,826,Sporotrichosis,Point prevalence,N/A
Disease,826,Sporotrichosis,Annual incidence,N/A
Disease,879,Tungiasis,Point prevalence,N/A
Disease,502363,Squamous cell carcinoma of the oral cavity,Annual incidence,N/A
Disease,502366,Squamous cell carcinoma of the lip,Annual incidence,N/A
Disease,502423,Mitochondrial myopathy-cerebellar ataxia-pigmentary retinopathy syndrome,Cases/families,N/A
Disease,502423,Mitochondrial myopathy-cerebellar ataxia-pigmentary retinopathy syndrome,Point prevalence,N/A
Malformation syndrome,502430,Weiss-Kruszka Syndrome,Cases/families,N/A
Malformation syndrome,502430,Weiss-Kruszka Syndrome,Point prevalence,N/A
Malformation syndrome,502434,STAG1-related intellectual disability-facial dysmorphism-gastroesophageal reflux syndrome,Cases/families,N/A
Malformation syndrome,502434,STAG1-related intellectual disability-facial dysmorphism-gastroesophageal reflux syndrome,Point prevalence,N/A
Malformation syndrome,502437,4q25 proximal deletion syndrome,Cases/families,N/A
Malformation syndrome,502437,4q25 proximal deletion syndrome,Point prevalence,N/A
Disease,502444,Alkaline ceramidase 3 deficiency,Cases/families,N/A
Disease,502444,Alkaline ceramidase 3 deficiency,Point prevalence,N/A
Disease,91,Aromatase deficiency,Cases/families,N/A
Disease,91,Aromatase deficiency,Point prevalence,N/A
Disease,785,Estrogen resistance syndrome,Cases/families,N/A
Disease,785,Estrogen resistance syndrome,Point prevalence,N/A
Disease,873,Desmoid tumor,Annual incidence,N/A
Disease,873,Desmoid tumor,Annual incidence,N/A
Disease,873,Desmoid tumor,Point prevalence,N/A
Clinical subtype,679,Malignant atrophic papulosis,Cases/families,N/A
Clinical subtype,679,Malignant atrophic papulosis,Point prevalence,N/A
Disease,901,Wells syndrome,Cases/families,N/A
Disease,901,Wells syndrome,Point prevalence,N/A
Disease,703,Bullous pemphigoid,Annual incidence,N/A
Disease,703,Bullous pemphigoid,Annual incidence,N/A
Disease,703,Bullous pemphigoid,Annual incidence,N/A
Disease,703,Bullous pemphigoid,Annual incidence,N/A
Disease,703,Bullous pemphigoid,Point prevalence,N/A
Disease,703,Bullous pemphigoid,Point prevalence,N/A
Disease,841,Sebocystomatosis,Point prevalence,N/A
Clinical group,817,Peeling skin syndrome,Point prevalence,N/A
Clinical subtype,867,Familial multiple trichoepithelioma,Point prevalence,N/A
Disease,735,Porokeratosis of Mibelli,Point prevalence,N/A
Disease,497906,Childhood-onset basal ganglia degeneration syndrome,Cases/families,N/A
Disease,497906,Childhood-onset basal ganglia degeneration syndrome,Point prevalence,N/A
Disease,659,Mutilating palmoplantar keratoderma with periorificial keratotic plaques,Cases/families,N/A
Disease,659,Mutilating palmoplantar keratoderma with periorificial keratotic plaques,Point prevalence,N/A
Disease,737,Porokeratosis plantaris palmaris et disseminata,Point prevalence,N/A
Clinical group,497623,C12ORF65-related combined oxidative phosphorylation defect,Point prevalence,N/A
Clinical group,497623,C12ORF65-related combined oxidative phosphorylation defect,Cases/families,N/A
Disease,523,Hereditary leiomyomatosis and renal cell cancer,Cases/families,N/A
Disease,523,Hereditary leiomyomatosis and renal cell cancer,Point prevalence,N/A
Disease,497757,MME-related autosomal dominant Charcot Marie Tooth disease type 2,Cases/families,N/A
Disease,497757,MME-related autosomal dominant Charcot Marie Tooth disease type 2,Point prevalence,N/A
Disease,497764,Spinocerebellar ataxia type 43,Cases/families,N/A
Disease,497764,Spinocerebellar ataxia type 43,Point prevalence,N/A
Malformation syndrome,530,Lipoid proteinosis,Cases/families,N/A
Malformation syndrome,530,Lipoid proteinosis,Point prevalence,N/A
Disease,497188,Diffuse intrinsic pontine glioma,Annual incidence,N/A
Disease,454,Acquired ichthyosis,Point prevalence,N/A
Morphological anomaly,617,Congenital primary megaureter,Point prevalence,N/A
Morphological anomaly,488,Urachal cyst,Point prevalence,N/A
Morphological anomaly,105,Atresia of urethra,Prevalence at birth,N/A
Morphological anomaly,105,Atresia of urethra,Point prevalence,N/A
Morphological anomaly,237,Duplication of urethra,Cases/families,N/A
Morphological anomaly,237,Duplication of urethra,Point prevalence,N/A
Disease,721,Gray platelet syndrome,Cases/families,N/A
Disease,721,Gray platelet syndrome,Point prevalence,N/A
Disease,722,Hypoplasminogenemia,Point prevalence,N/A
Disease,853,Fetal and neonatal alloimmune thrombocytopenia,Point prevalence,N/A
Disease,853,Fetal and neonatal alloimmune thrombocytopenia,Prevalence at birth,N/A
Disease,498359,Aquagenic palmoplantar keratoderma,Point prevalence,N/A
Disease,465,Congenital plasminogen activator inhibitor type 1 deficiency,Point prevalence,N/A
Clinical group,310,Reflex epilepsy,Point prevalence,N/A
Disease,498251,Menstrual cycle-dependent periodic fever,Cases/families,N/A
Disease,498251,Menstrual cycle-dependent periodic fever,Point prevalence,N/A
Disease,1332,Medullary thyroid carcinoma,Point prevalence,N/A
Disease,1332,Medullary thyroid carcinoma,Annual incidence,N/A
Disease,1332,Medullary thyroid carcinoma,Annual incidence,N/A
Category,877,Neuroendocrine neoplasm,Annual incidence,N/A
Category,877,Neuroendocrine neoplasm,Annual incidence,N/A
Category,877,Neuroendocrine neoplasm,Annual incidence,N/A
Category,877,Neuroendocrine neoplasm,Point prevalence,N/A
Category,877,Neuroendocrine neoplasm,Point prevalence,N/A
Malformation syndrome,73,Gorham-Stout disease,Cases/families,N/A
Malformation syndrome,73,Gorham-Stout disease,Point prevalence,N/A
Disease,498228,Phyllodes tumor of the prostate,Cases/families,N/A
Disease,728,Relapsing polychondritis,Annual incidence,N/A
Disease,728,Relapsing polychondritis,Annual incidence,N/A
Disease,728,Relapsing polychondritis,Point prevalence,N/A
Disease,728,Relapsing polychondritis,Annual incidence,N/A
Disease,728,Relapsing polychondritis,Point prevalence,N/A
Category,467,Non-acquired combined pituitary hormone deficiency,Prevalence at birth,N/A
Category,467,Non-acquired combined pituitary hormone deficiency,Point prevalence,N/A
Disease,142,Anaplastic thyroid carcinoma,Annual incidence,N/A
Disease,142,Anaplastic thyroid carcinoma,Point prevalence,N/A
Disease,143,Parathyroid carcinoma,Annual incidence,N/A
Disease,143,Parathyroid carcinoma,Point prevalence,N/A
Disease,143,Parathyroid carcinoma,Lifetime Prevalence,N/A
Disease,143,Parathyroid carcinoma,Annual incidence,N/A
Disease,143,Parathyroid carcinoma,Annual incidence,N/A
Disease,143,Parathyroid carcinoma,Annual incidence,N/A
Disease,143,Parathyroid carcinoma,Annual incidence,N/A
Disease,143,Parathyroid carcinoma,Annual incidence,N/A
Disease,143,Parathyroid carcinoma,Annual incidence,N/A
Disease,143,Parathyroid carcinoma,Annual incidence,N/A
Disease,143,Parathyroid carcinoma,Annual incidence,N/A
Disease,143,Parathyroid carcinoma,Annual incidence,N/A
Disease,143,Parathyroid carcinoma,Annual incidence,N/A
Disease,143,Parathyroid carcinoma,Annual incidence,N/A
Disease,143,Parathyroid carcinoma,Annual incidence,N/A
Disease,143,Parathyroid carcinoma,Annual incidence,N/A
Disease,143,Parathyroid carcinoma,Annual incidence,N/A
Disease,143,Parathyroid carcinoma,Annual incidence,N/A
Disease,143,Parathyroid carcinoma,Annual incidence,N/A
Disease,143,Parathyroid carcinoma,Annual incidence,N/A
Disease,143,Parathyroid carcinoma,Annual incidence,N/A
Disease,143,Parathyroid carcinoma,Annual incidence,N/A
Disease,143,Parathyroid carcinoma,Annual incidence,N/A
Disease,143,Parathyroid carcinoma,Annual incidence,N/A
Disease,143,Parathyroid carcinoma,Annual incidence,N/A
Disease,143,Parathyroid carcinoma,Annual incidence,N/A
Disease,143,Parathyroid carcinoma,Annual incidence,N/A
Disease,786,Generalized glucocorticoid resistance syndrome,Point prevalence,N/A
Morphological anomaly,1461,Criss-cross heart,Prevalence at birth,N/A
Morphological anomaly,1461,Criss-cross heart,Point prevalence,N/A
Disease,875,Primary pediatric heart tumor,Point prevalence,N/A
Disease,615,Familial atrial myxoma,Cases/families,N/A
Disease,615,Familial atrial myxoma,Point prevalence,N/A
Disease,874,Primary adult heart tumor,Point prevalence,N/A
Disease,499009,Congenital syphilis,Point prevalence,N/A
Disease,499009,Congenital syphilis,Point prevalence,N/A
Disease,499009,Congenital syphilis,Prevalence at birth,N/A
Disease,499009,Congenital syphilis,Prevalence at birth,N/A
Disease,499009,Congenital syphilis,Prevalence at birth,N/A
Disease,499009,Congenital syphilis,Prevalence at birth,N/A
Disease,499009,Congenital syphilis,Prevalence at birth,N/A
Disease,499009,Congenital syphilis,Prevalence at birth,N/A
Disease,499009,Congenital syphilis,Prevalence at birth,N/A
Disease,499009,Congenital syphilis,Prevalence at birth,N/A
Disease,499009,Congenital syphilis,Prevalence at birth,N/A
Disease,499009,Congenital syphilis,Prevalence at birth,N/A
Disease,499009,Congenital syphilis,Prevalence at birth,N/A
Disease,499009,Congenital syphilis,Prevalence at birth,N/A
Disease,499009,Congenital syphilis,Prevalence at birth,N/A
Disease,499009,Congenital syphilis,Prevalence at birth,N/A
Disease,499009,Congenital syphilis,Prevalence at birth,N/A
Morphological anomaly,1330,Partial atrioventricular septal defect,Prevalence at birth,N/A
Morphological anomaly,1330,Partial atrioventricular septal defect,Point prevalence,N/A
Morphological anomaly,1677,Familial idiopathic dilatation of the right atrium,Point prevalence,N/A
Malformation syndrome,498497,Short rib-polydactyly syndrome type 5,Cases/families,N/A
Malformation syndrome,498497,Short rib-polydactyly syndrome type 5,Point prevalence,N/A
Disease,720,Pili bifurcati,Point prevalence,N/A
Clinical group,671,Primary cutis verticis gyrata,Point prevalence,N/A
Disease,864,Trichofolliculoma,Point prevalence,N/A
Morphological anomaly,498602,Sugarman brachydactyly,Cases/families,N/A
Morphological anomaly,498602,Sugarman brachydactyly,Point prevalence,N/A
Clinical group,247,Inherited arrhythmogenic cardiomyopathy,Point prevalence,N/A
Clinical group,247,Inherited arrhythmogenic cardiomyopathy,Point prevalence,N/A
Disease,498693,MYBPC1-related autosomal recessive non-lethal arthrogryposis multiplex congenita syndrome,Cases/families,N/A
Disease,498693,MYBPC1-related autosomal recessive non-lethal arthrogryposis multiplex congenita syndrome,Point prevalence,N/A
Disease,444,Marie Unna hereditary hypotrichosis,Point prevalence,N/A
Disease,2221,Acquired hypertrichosis lanuginosa,Cases/families,N/A
Disease,2221,Acquired hypertrichosis lanuginosa,Point prevalence,N/A
Disease,498474,Hyaline fibromatosis syndrome,Cases/families,N/A
Disease,498474,Hyaline fibromatosis syndrome,Point prevalence,N/A
Disease,499,Kerion celsi,Point prevalence,N/A
Malformation syndrome,498485,Overgrowth-metaphyseal undermodeling-spondylar dysplasia syndrome,Cases/families,N/A
Malformation syndrome,498485,Overgrowth-metaphyseal undermodeling-spondylar dysplasia syndrome,Point prevalence,N/A
Disease,573,Monilethrix,Point prevalence,N/A
Malformation syndrome,498488,Overgrowth syndrome with 2q37 translocation,Cases/families,N/A
Malformation syndrome,498488,Overgrowth syndrome with 2q37 translocation,Point prevalence,N/A
Disease,525,Lichen planopilaris,Cases/families,N/A
Disease,525,Lichen planopilaris,Point prevalence,N/A
Disease,700,Alopecia totalis,Point prevalence,N/A
Disease,840,Syringocystadenoma papilliferum,Cases/families,N/A
Disease,840,Syringocystadenoma papilliferum,Point prevalence,N/A
Disease,315,Erythrokeratoderma ''en cocardes'',Point prevalence,N/A
Disease,409,Hyperkeratosis lenticularis perstans,Point prevalence,N/A
Disease,41,Dyschromatosis symmetrica hereditaria,Cases/families,N/A
Disease,41,Dyschromatosis symmetrica hereditaria,Point prevalence,N/A
Disease,41,Dyschromatosis symmetrica hereditaria,Point prevalence,N/A
Malformation syndrome,122,Birt-Hogg-Dub syndrome,Point prevalence,N/A
Disease,38,Acrokeratoelastoidosis of Costa,Point prevalence,N/A
Disease,39,Acromelanosis,Cases/families,N/A
Disease,39,Acromelanosis,Point prevalence,N/A
Disease,316,Progressive symmetric erythrokeratodermia,Point prevalence,N/A
Clinical group,658,Non-histaminic angioedema,Point prevalence,N/A
Disease,3282,Multifocal atrial tachycardia,Prevalence at birth,N/A
Disease,3282,Multifocal atrial tachycardia,Point prevalence,N/A
Disease,188,Systemic capillary leak syndrome,Cases/families,N/A
Disease,188,Systemic capillary leak syndrome,Point prevalence,N/A
Clinical group,303,Dystrophic epidermolysis bullosa,Point prevalence,N/A
Clinical group,303,Dystrophic epidermolysis bullosa,Point prevalence,N/A
Clinical group,303,Dystrophic epidermolysis bullosa,Point prevalence,N/A
Clinical group,303,Dystrophic epidermolysis bullosa,Point prevalence,N/A
Clinical group,303,Dystrophic epidermolysis bullosa,Point prevalence,N/A
Clinical group,303,Dystrophic epidermolysis bullosa,Point prevalence,N/A
Clinical group,303,Dystrophic epidermolysis bullosa,Annual incidence,N/A
Clinical group,305,Junctional epidermolysis bullosa,Point prevalence,N/A
Clinical group,305,Junctional epidermolysis bullosa,Point prevalence,N/A
Clinical group,305,Junctional epidermolysis bullosa,Point prevalence,N/A
Clinical group,305,Junctional epidermolysis bullosa,Point prevalence,N/A
Clinical group,305,Junctional epidermolysis bullosa,Point prevalence,N/A
Clinical group,305,Junctional epidermolysis bullosa,Prevalence at birth,N/A
Clinical group,305,Junctional epidermolysis bullosa,Point prevalence,N/A
Clinical group,305,Junctional epidermolysis bullosa,Point prevalence,N/A
Clinical group,305,Junctional epidermolysis bullosa,Prevalence at birth,N/A
Clinical group,305,Junctional epidermolysis bullosa,Point prevalence,N/A
Clinical group,305,Junctional epidermolysis bullosa,Point prevalence,N/A
Clinical group,305,Junctional epidermolysis bullosa,Annual incidence,N/A
Clinical group,305,Junctional epidermolysis bullosa,Point prevalence,N/A
Disease,3406,Ulerythema ophryogenesis,Point prevalence,N/A
Disease,2908,Kindler epidermolysis bullosa,Cases/families,N/A
Disease,2908,Kindler epidermolysis bullosa,Point prevalence,N/A
Disease,81,Antisynthetase syndrome,Point prevalence,N/A
Disease,563,Peripartum cardiomyopathy,Prevalence at birth,N/A
Disease,563,Peripartum cardiomyopathy,Prevalence at birth,N/A
Disease,563,Peripartum cardiomyopathy,Prevalence at birth,N/A
Disease,563,Peripartum cardiomyopathy,Prevalence at birth,N/A
Disease,563,Peripartum cardiomyopathy,Prevalence at birth,N/A
Disease,563,Peripartum cardiomyopathy,Prevalence at birth,N/A
Disease,563,Peripartum cardiomyopathy,Point prevalence,N/A
Disease,764,Pyomyositis,Point prevalence,N/A
Disease,779,Reynolds syndrome,Point prevalence,N/A
Disease,838,Susac syndrome,Cases/families,N/A
Disease,838,Susac syndrome,Point prevalence,N/A
Disease,889,Cutaneous small vessel vasculitis,Point prevalence,N/A
Disease,889,Cutaneous small vessel vasculitis,Point prevalence,N/A
Disease,482,Kimura disease,Cases/families,N/A
Disease,482,Kimura disease,Point prevalence,N/A
Disease,486811,Prenatal-onset spinal muscular atrophy with congenital bone fractures,Point prevalence,N/A
Disease,486811,Prenatal-onset spinal muscular atrophy with congenital bone fractures,Cases/families,N/A
Disease,486815,Congenital muscular dystrophy-respiratory failure-skin abnormalities-joint hyperlaxity syndrome,Cases/families,N/A
Disease,486815,Congenital muscular dystrophy-respiratory failure-skin abnormalities-joint hyperlaxity syndrome,Point prevalence,N/A
Disease,485418,EMILIN-1-related connective tissue disease,Cases/families,N/A
Disease,485418,EMILIN-1-related connective tissue disease,Point prevalence,N/A
Etiological subtype,485421,MFF-related encephalopathy due to mitochondrial and peroxisomal fission defect,Cases/families,N/A
Etiological subtype,485421,MFF-related encephalopathy due to mitochondrial and peroxisomal fission defect,Point prevalence,N/A
Malformation syndrome,485405,16p12.1p12.3 triplication syndrome,Cases/families,N/A
Malformation syndrome,485405,16p12.1p12.3 triplication syndrome,Point prevalence,N/A
Disease,485350,CLCN4-related X-linked intellectual disability syndrome,Point prevalence,N/A
Disease,485350,CLCN4-related X-linked intellectual disability syndrome,Cases/families,N/A
Malformation syndrome,485358,Propylthiouracil embryofetopathy,Point prevalence,N/A
Malformation syndrome,482606,X-linked keloid scarring-reduced joint mobility-increased optic cup-to-disc ratio syndrome,Cases/families,N/A
Malformation syndrome,482606,X-linked keloid scarring-reduced joint mobility-increased optic cup-to-disc ratio syndrome,Point prevalence,N/A
Disease,482601,Adenylosuccinate synthetase-like 1-related distal myopathy,Cases/families,N/A
Disease,482601,Adenylosuccinate synthetase-like 1-related distal myopathy,Point prevalence,N/A
Particular clinical situation in a disease or syndrome,31828,Digitalis poisoning,Point prevalence,N/A
Disease,480864,Recurrent metabolic encephalomyopathic crises-rhabdomyolysis-cardiac arrhythmia-intellectual disability syndrome,Cases/families,N/A
Disease,480864,Recurrent metabolic encephalomyopathic crises-rhabdomyolysis-cardiac arrhythmia-intellectual disability syndrome,Point prevalence,N/A
Disease,31837,Pulmonary venoocclusive disease,Annual incidence,N/A
Disease,31837,Pulmonary venoocclusive disease,Annual incidence,N/A
Disease,31837,Pulmonary venoocclusive disease,Point prevalence,N/A
Malformation syndrome,480907,X-linked intellectual disability-global development delay-facial dysmorphism-sacral caudal remnant syndrome,Cases/families,N/A
Malformation syndrome,480907,X-linked intellectual disability-global development delay-facial dysmorphism-sacral caudal remnant syndrome,Point prevalence,N/A
Disease,480898,Global developmental delay-visual anomalies-progressive cerebellar atrophy-truncal hypotonia syndrome,Cases/families,N/A
Disease,480898,Global developmental delay-visual anomalies-progressive cerebellar atrophy-truncal hypotonia syndrome,Point prevalence,N/A
Malformation syndrome,480880,X-linked female restricted facial dysmorphism-short stature-choanal atresia-intellectual disability,Cases/families,N/A
Malformation syndrome,480880,X-linked female restricted facial dysmorphism-short stature-choanal atresia-intellectual disability,Point prevalence,N/A
Disease,31740,Hypersensitivity pneumonitis,Point prevalence,N/A
Disease,480556,Isolated neonatal sclerosing cholangitis,Cases/families,N/A
Disease,480556,Isolated neonatal sclerosing cholangitis,Point prevalence,N/A
Disease,31709,Infantile convulsions and choreoathetosis,Point prevalence,N/A
Disease,31826,Ethylene glycol poisoning,Point prevalence,N/A
Disease,480851,Hereditary thrombocytopenia with early-onset myelofibrosis,Cases/families,N/A
Disease,480851,Hereditary thrombocytopenia with early-onset myelofibrosis,Point prevalence,N/A
Disease,31827,Paraquat poisoning,Point prevalence,N/A
Particular clinical situation in a disease or syndrome,31824,Colchicine poisoning,Point prevalence,N/A
Disease,480682,POGLUT1-related limb-girdle muscular dystrophy R21,Cases/families,N/A
Disease,480682,POGLUT1-related limb-girdle muscular dystrophy R21,Point prevalence,N/A
Disease,31825,Methanol poisoning,Point prevalence,N/A
Disease,481665,USP18 deficiency,Cases/families,N/A
Disease,481665,USP18 deficiency,Point prevalence,N/A
Disease,482077,HTRA1-related autosomal dominant cerebral small vessel disease,Cases/families,N/A
Disease,482077,HTRA1-related autosomal dominant cerebral small vessel disease,Point prevalence,N/A
Malformation syndrome,481152,PYCR2-related microcephaly-progressive leukoencephalopathy,Cases/families,N/A
Malformation syndrome,481152,PYCR2-related microcephaly-progressive leukoencephalopathy,Point prevalence,N/A
Disease,481662,Familial Chilblain lupus,Cases/families,N/A
Disease,481662,Familial Chilblain lupus,Point prevalence,N/A
Clinical subtype,480476,Progressive familial intrahepatic cholestasis type 5,Cases/families,N/A
Clinical subtype,480476,Progressive familial intrahepatic cholestasis type 5,Point prevalence,N/A
Clinical subtype,480491,MYO5B-related progressive familial intrahepatic cholestasis,Cases/families,N/A
Clinical subtype,480491,MYO5B-related progressive familial intrahepatic cholestasis,Point prevalence,N/A
Clinical subtype,480483,Progressive familial intrahepatic cholestasis type 4,Cases/families,N/A
Clinical subtype,480483,Progressive familial intrahepatic cholestasis type 4,Point prevalence,N/A
Malformation syndrome,480528,Lethal hydranencephaly-diaphragmatic hernia syndrome,Point prevalence,N/A
Malformation syndrome,480528,Lethal hydranencephaly-diaphragmatic hernia syndrome,Cases/families,N/A
Clinical subtype,480536,MSH3-related attenuated familial adenomatous polyposis,Cases/families,N/A
Clinical subtype,480536,MSH3-related attenuated familial adenomatous polyposis,Point prevalence,N/A
Malformation syndrome,480520,Caroli syndrome,Point prevalence,N/A
Malformation syndrome,477814,Progressive microcephaly-seizures-cortical blindness-developmental delay syndrome,Cases/families,N/A
Malformation syndrome,477814,Progressive microcephaly-seizures-cortical blindness-developmental delay syndrome,Point prevalence,N/A
Disease,477781,Primary condylar hyperplasia,Point prevalence,N/A
Disease,477787,Cytosolic phospholipase-A2 alpha deficiency associated bleeding disorder,Cases/families,N/A
Disease,477787,Cytosolic phospholipase-A2 alpha deficiency associated bleeding disorder,Point prevalence,N/A
Disease,478029,Combined oxidative phosphorylation defect type 29,Cases/families,N/A
Disease,478029,Combined oxidative phosphorylation defect type 29,Point prevalence,N/A
Disease,478042,Combined oxidative phosphorylation defect type 30,Cases/families,N/A
Disease,478042,Combined oxidative phosphorylation defect type 30,Point prevalence,N/A
Malformation syndrome,477993,Palatal anomalies-widely spaced teeth-facial dysmorphism-developmental delay syndrome,Cases/families,N/A
Malformation syndrome,477993,Palatal anomalies-widely spaced teeth-facial dysmorphism-developmental delay syndrome,Point prevalence,N/A
Disease,477857,Mendelian susceptibility to mycobacterial diseases due to complete RORgamma receptor deficiency,Cases/families,N/A
Disease,477857,Mendelian susceptibility to mycobacterial diseases due to complete RORgamma receptor deficiency,Point prevalence,N/A
Malformation syndrome,477817,PMP22-RAI1 contiguous gene duplication syndrome,Cases/families,N/A
Malformation syndrome,477817,PMP22-RAI1 contiguous gene duplication syndrome,Point prevalence,N/A
Malformation syndrome,477831,Kosaki overgrowth syndrome,Cases/families,N/A
Malformation syndrome,477831,Kosaki overgrowth syndrome,Point prevalence,N/A
Disease,478049,Lethal left ventricular non-compaction-seizures-hypotonia-cataract-developmental delay syndrome,Cases/families,N/A
Disease,478049,Lethal left ventricular non-compaction-seizures-hypotonia-cataract-developmental delay syndrome,Point prevalence,N/A
Disease,478664,Hereditary sensory and autonomic neuropathy type 8,Cases/families,N/A
Disease,478664,Hereditary sensory and autonomic neuropathy type 8,Point prevalence,N/A
Disease,477650,Fibroblastic rheumatism,Cases/families,N/A
Disease,477650,Fibroblastic rheumatism,Point prevalence,N/A
Disease,477661,IL21-related infantile inflammatory bowel disease,Cases/families,N/A
Disease,477661,IL21-related infantile inflammatory bowel disease,Point prevalence,N/A
Disease,477684,Combined oxidative phosphorylation defect type 26,Cases/families,N/A
Disease,477684,Combined oxidative phosphorylation defect type 26,Point prevalence,N/A
Disease,477673,Postnatal microcephaly-infantile hypotonia-spastic diplegia-dysarthria-intellectual disability syndrome,Cases/families,N/A
Disease,477673,Postnatal microcephaly-infantile hypotonia-spastic diplegia-dysarthria-intellectual disability syndrome,Point prevalence,N/A
Disease,477749,Pontine autosomal dominant microangiopathy with leukoencephalopathy,Cases/families,N/A
Disease,477749,Pontine autosomal dominant microangiopathy with leukoencephalopathy,Point prevalence,N/A
Disease,477742,Nodular fasciitis,Point prevalence,N/A
Disease,477774,Combined oxidative phosphorylation defect type 27,Cases/families,N/A
Disease,477774,Combined oxidative phosphorylation defect type 27,Point prevalence,N/A
Malformation syndrome,476119,Autosomal dominant preaxial polydactyly-upperback hypertrichosis syndrome,Cases/families,N/A
Malformation syndrome,476119,Autosomal dominant preaxial polydactyly-upperback hypertrichosis syndrome,Point prevalence,N/A
Disease,476113,Combined immunodeficiency due to TFRC deficiency,Cases/families,N/A
Disease,476113,Combined immunodeficiency due to TFRC deficiency,Point prevalence,N/A
Malformation syndrome,476126,Micrognathia-recurrent infections-behavioral abnormalities-mild intellectual disability syndrome,Cases/families,N/A
Malformation syndrome,476126,Micrognathia-recurrent infections-behavioral abnormalities-mild intellectual disability syndrome,Point prevalence,N/A
Disease,476406,Congenital generalized hypercontractile muscle stiffness syndrome,Cases/families,N/A
Disease,476406,Congenital generalized hypercontractile muscle stiffness syndrome,Point prevalence,N/A
Disease,476394,PMP2-related Charcot-Marie-Tooth disease type 1,Cases/families,N/A
Disease,476394,PMP2-related Charcot-Marie-Tooth disease type 1,Point prevalence,N/A
Disease,493342,Vibratory urticaria,Cases/families,N/A
Disease,493342,Vibratory urticaria,Point prevalence,N/A
Malformation syndrome,488642,TELO2-related intellectual disability-neurodevelopmental disorder,Cases/families,N/A
Malformation syndrome,488642,TELO2-related intellectual disability-neurodevelopmental disorder,Point prevalence,N/A
Disease,488647,DDX41-related hematologic malignancy predisposition syndrome,Cases/families,N/A
Disease,488647,DDX41-related hematologic malignancy predisposition syndrome,Point prevalence,N/A
Disease,488650,"Distal myopathy, Tateyama type",Point prevalence,N/A
Disease,488650,"Distal myopathy, Tateyama type",Cases/families,N/A
Malformation syndrome,488618,Transketolase deficiency,Cases/families,N/A
Malformation syndrome,488618,Transketolase deficiency,Point prevalence,N/A
Malformation syndrome,488627,Severe growth deficiency-strabismus-extensive dermal melanocytosis-intellectual disability syndrome,Cases/families,N/A
Malformation syndrome,488627,Severe growth deficiency-strabismus-extensive dermal melanocytosis-intellectual disability syndrome,Point prevalence,N/A
Malformation syndrome,488632,TBCK-related intellectual disability syndrome,Cases/families,N/A
Malformation syndrome,488632,TBCK-related intellectual disability syndrome,Point prevalence,N/A
Disease,488635,Early-onset epilepsy-intellectual disability-brain anomalies syndrome,Cases/families,N/A
Disease,488635,Early-onset epilepsy-intellectual disability-brain anomalies syndrome,Point prevalence,N/A
Disease,488239,Acute macular neuroretinopathy,Cases/families,N/A
Disease,488239,Acute macular neuroretinopathy,Point prevalence,N/A
Malformation syndrome,488232,Split-foot malformation-mesoaxial polydactyly syndrome,Cases/families,N/A
Malformation syndrome,488232,Split-foot malformation-mesoaxial polydactyly syndrome,Point prevalence,N/A
Disease,488333,Autosomal dominant Charcot-Marie-Tooth disease type 2W,Cases/families,N/A
Disease,488333,Autosomal dominant Charcot-Marie-Tooth disease type 2W,Point prevalence,N/A
Disease,488280,14q32 duplication syndrome,Cases/families,N/A
Disease,488280,14q32 duplication syndrome,Point prevalence,N/A
Malformation syndrome,488437,SIX2-related frontonasal dysplasia,Cases/families,N/A
Malformation syndrome,488437,SIX2-related frontonasal dysplasia,Point prevalence,N/A
Malformation syndrome,488434,"Camptodactyly syndrome, Guadalajara type 3",Cases/families,N/A
Malformation syndrome,488434,"Camptodactyly syndrome, Guadalajara type 3",Point prevalence,N/A
Malformation syndrome,488613,Global developmental delay-neuro-ophthalmological abnormalities-seizures-intellectual disability syndrome,Cases/families,N/A
Malformation syndrome,488613,Global developmental delay-neuro-ophthalmological abnormalities-seizures-intellectual disability syndrome,Point prevalence,N/A
Disease,488594,Autosomal recessive spastic paraplegia type 76,Cases/families,N/A
Disease,488594,Autosomal recessive spastic paraplegia type 76,Point prevalence,N/A
Disease,488197,Familial progressive retinal dystrophy-iris coloboma-congenital cataract syndrome,Cases/families,N/A
Disease,488197,Familial progressive retinal dystrophy-iris coloboma-congenital cataract syndrome,Point prevalence,N/A
Malformation syndrome,488168,Microcephaly-congenital cataract-psoriasiform dermatitis syndrome,Cases/families,N/A
Malformation syndrome,488168,Microcephaly-congenital cataract-psoriasiform dermatitis syndrome,Point prevalence,N/A
Disease,488191,Female infertility due to oocyte meiotic arrest,Cases/families,N/A
Disease,488191,Female infertility due to oocyte meiotic arrest,Point prevalence,N/A
Malformation syndrome,487796,Takenouchi-Kosaki syndrome,Cases/families,N/A
Malformation syndrome,487796,Takenouchi-Kosaki syndrome,Point prevalence,N/A
Disease,487814,Autosomal dominant Charcot-Marie-Tooth disease type 2 due to DGAT2 mutation,Cases/families,N/A
Disease,487814,Autosomal dominant Charcot-Marie-Tooth disease type 2 due to DGAT2 mutation,Point prevalence,N/A
Disease,487809,Pediatric collagenous gastritis,Cases/families,N/A
Disease,487809,Pediatric collagenous gastritis,Point prevalence,N/A
Malformation syndrome,487825,Pierpont syndrome,Cases/families,N/A
Malformation syndrome,487825,Pierpont syndrome,Point prevalence,N/A
Disease,31205,Rat-bite fever,Point prevalence,N/A
Disease,31204,Nocardiosis,Point prevalence,N/A
Disease,31202,Melioidosis,Point prevalence,N/A
Disease,31202,Melioidosis,Annual incidence,N/A
Disease,31202,Melioidosis,Annual incidence,N/A
Disease,31150,Tangier disease,Cases/families,N/A
Disease,31150,Tangier disease,Point prevalence,N/A
Clinical subtype,31043,Primary hypomagnesemia with hypercalciuria and nephrocalcinosis without severe ocular involvement,Cases/families,N/A
Clinical subtype,31043,Primary hypomagnesemia with hypercalciuria and nephrocalcinosis without severe ocular involvement,Point prevalence,N/A
Disease,31112,Dermatofibrosarcoma protuberans,Point prevalence,N/A
Disease,30924,Primary hypomagnesemia with secondary hypocalcemia,Cases/families,N/A
Disease,30924,Primary hypomagnesemia with secondary hypocalcemia,Point prevalence,N/A
Clinical subtype,30925,Hereditary arginine vasopressin deficiency,Point prevalence,N/A
Disease,476084,BVES-related limb-girdle muscular dystrophy,Cases/families,N/A
Disease,476084,BVES-related limb-girdle muscular dystrophy,Point prevalence,N/A
Disease,476096,Erythrokeratodermia-cardiomyopathy syndrome,Cases/families,N/A
Disease,476096,Erythrokeratodermia-cardiomyopathy syndrome,Point prevalence,N/A
Disease,476093,Autosomal dominant distal axonal motor neuropathy-myofibrillar myopathy syndrome,Cases/families,N/A
Disease,476093,Autosomal dominant distal axonal motor neuropathy-myofibrillar myopathy syndrome,Point prevalence,N/A
Disease,71278,Congenital brain dysgenesis due to glutamine synthetase deficiency,Cases/families,N/A
Disease,71278,Congenital brain dysgenesis due to glutamine synthetase deficiency,Point prevalence,N/A
Disease,71279,CANOMAD syndrome,Point prevalence,N/A
Disease,71279,CANOMAD syndrome,Cases/families,N/A
Malformation syndrome,71271,Split hand-split foot-deafness syndrome,Cases/families,N/A
Malformation syndrome,71271,Split hand-split foot-deafness syndrome,Point prevalence,N/A
Disease,71272,Sandifer syndrome,Point prevalence,N/A
Disease,71273,Renal nutcracker syndrome,Point prevalence,N/A
Disease,71274,Disseminated peritoneal leiomyomatosis,Cases/families,N/A
Disease,71274,Disseminated peritoneal leiomyomatosis,Point prevalence,N/A
Disease,71275,Rh deficiency syndrome,Point prevalence,N/A
Disease,71276,Silent sinus syndrome,Cases/families,N/A
Disease,71276,Silent sinus syndrome,Point prevalence,N/A
Disease,71277,Classic glucose transporter type 1 deficiency syndrome,Point prevalence,N/A
Disease,71277,Classic glucose transporter type 1 deficiency syndrome,Point prevalence,N/A
Disease,71277,Classic glucose transporter type 1 deficiency syndrome,Point prevalence,N/A
Disease,71277,Classic glucose transporter type 1 deficiency syndrome,Point prevalence,N/A
Disease,71212,Hyperinsulinism due to short chain 3-hydroxylacyl-CoA dehydrogenase deficiency,Cases/families,N/A
Disease,71212,Hyperinsulinism due to short chain 3-hydroxylacyl-CoA dehydrogenase deficiency,Point prevalence,N/A
Disease,71211,Neuromyelitis optica spectrum disorder,Annual incidence,N/A
Disease,71211,Neuromyelitis optica spectrum disorder,Annual incidence,N/A
Disease,71211,Neuromyelitis optica spectrum disorder,Annual incidence,N/A
Disease,71211,Neuromyelitis optica spectrum disorder,Point prevalence,N/A
Disease,71211,Neuromyelitis optica spectrum disorder,Point prevalence,N/A
Disease,71211,Neuromyelitis optica spectrum disorder,Annual incidence,N/A
Disease,71211,Neuromyelitis optica spectrum disorder,Point prevalence,N/A
Disease,71211,Neuromyelitis optica spectrum disorder,Annual incidence,N/A
Disease,71211,Neuromyelitis optica spectrum disorder,Annual incidence,N/A
Disease,71211,Neuromyelitis optica spectrum disorder,Point prevalence,N/A
Disease,71211,Neuromyelitis optica spectrum disorder,Annual incidence,N/A
Disease,71211,Neuromyelitis optica spectrum disorder,Point prevalence,N/A
Disease,71211,Neuromyelitis optica spectrum disorder,Annual incidence,N/A
Disease,71211,Neuromyelitis optica spectrum disorder,Point prevalence,N/A
Disease,71211,Neuromyelitis optica spectrum disorder,Annual incidence,N/A
Disease,71211,Neuromyelitis optica spectrum disorder,Point prevalence,N/A
Disease,71211,Neuromyelitis optica spectrum disorder,Annual incidence,N/A
Disease,71211,Neuromyelitis optica spectrum disorder,Point prevalence,N/A
Disease,71211,Neuromyelitis optica spectrum disorder,Annual incidence,N/A
Disease,71211,Neuromyelitis optica spectrum disorder,Point prevalence,N/A
Disease,71211,Neuromyelitis optica spectrum disorder,Annual incidence,N/A
Disease,71211,Neuromyelitis optica spectrum disorder,Annual incidence,N/A
Disease,71211,Neuromyelitis optica spectrum disorder,Point prevalence,N/A
Disease,71211,Neuromyelitis optica spectrum disorder,Point prevalence,N/A
Disease,71211,Neuromyelitis optica spectrum disorder,Annual incidence,N/A
Disease,71211,Neuromyelitis optica spectrum disorder,Point prevalence,N/A
Disease,71211,Neuromyelitis optica spectrum disorder,Point prevalence,N/A
Disease,71211,Neuromyelitis optica spectrum disorder,Annual incidence,N/A
Disease,71211,Neuromyelitis optica spectrum disorder,Point prevalence,N/A
Disease,71211,Neuromyelitis optica spectrum disorder,Point prevalence,N/A
Disease,71211,Neuromyelitis optica spectrum disorder,Annual incidence,N/A
Malformation syndrome,71267,Dentinogenesis imperfecta-short stature-hearing loss-intellectual disability syndrome,Cases/families,N/A
Malformation syndrome,71267,Dentinogenesis imperfecta-short stature-hearing loss-intellectual disability syndrome,Point prevalence,N/A
Disease,71213,Retinal capillary malformation,Point prevalence,N/A
Category,71198,Rare pulmonary hypertension,Point prevalence,N/A
Disease,558411,Idiopathic gastroparesis,Point prevalence,N/A
Disease,70591,Chronic thromboembolic pulmonary hypertension,Point prevalence,N/A
Disease,70591,Chronic thromboembolic pulmonary hypertension,Annual incidence,N/A
Disease,70591,Chronic thromboembolic pulmonary hypertension,Annual incidence,N/A
Disease,70591,Chronic thromboembolic pulmonary hypertension,Annual incidence,N/A
Disease,70592,Transient predisposition to invasive pyogenic bacterial infection,Cases/families,N/A
Disease,70592,Transient predisposition to invasive pyogenic bacterial infection,Point prevalence,N/A
Malformation syndrome,70589,Bronchopulmonary dysplasia,Point prevalence,N/A
Disease,70595,Sensory ataxic neuropathy-dysarthria-ophthalmoparesis syndrome,Point prevalence,N/A
Disease,70596,Congenital Epstein-Barr virus infection,Point prevalence,N/A
Disease,70593,Immunodeficiency due to selective anti-polysaccharide antibody deficiency,Point prevalence,N/A
Disease,70594,Dopa-responsive dystonia due to sepiapterin reductase deficiency,Cases/families,N/A
Disease,70594,Dopa-responsive dystonia due to sepiapterin reductase deficiency,Point prevalence,N/A
Disease,70578,Adult acute respiratory distress syndrome,Annual incidence,N/A
Disease,70578,Adult acute respiratory distress syndrome,Point prevalence,N/A
Disease,70578,Adult acute respiratory distress syndrome,Annual incidence,N/A
Disease,70578,Adult acute respiratory distress syndrome,Annual incidence,N/A
Disease,70578,Adult acute respiratory distress syndrome,Annual incidence,N/A
Disease,70578,Adult acute respiratory distress syndrome,Annual incidence,N/A
Disease,70578,Adult acute respiratory distress syndrome,Annual incidence,N/A
Disease,70578,Adult acute respiratory distress syndrome,Point prevalence,N/A
Disease,70573,Small cell lung cancer,Point prevalence,N/A
Disease,70568,Post-transplant lymphoproliferative disease,Point prevalence,N/A
Disease,70588,Meconium aspiration syndrome,Point prevalence,N/A
Disease,70472,"Congenital lactic acidosis, Saguenay-Lac-Saint-Jean type",Point prevalence,N/A
Disease,70567,Cholangiocarcinoma,Annual incidence,N/A
Disease,70567,Cholangiocarcinoma,Point prevalence,N/A
Disease,70567,Cholangiocarcinoma,Annual incidence,N/A
Disease,70567,Cholangiocarcinoma,Annual incidence,N/A
Disease,70567,Cholangiocarcinoma,Annual incidence,N/A
Disease,70567,Cholangiocarcinoma,Annual incidence,N/A
Disease,70567,Cholangiocarcinoma,Annual incidence,N/A
Disease,70567,Cholangiocarcinoma,Point prevalence,N/A
Clinical group,70482,Carcinoma of esophagus,Annual incidence,N/A
Clinical group,70482,Carcinoma of esophagus,Point prevalence,N/A
Clinical group,70482,Carcinoma of esophagus,Annual incidence,N/A
Clinical group,70482,Carcinoma of esophagus,Lifetime Prevalence,N/A
Clinical group,70482,Carcinoma of esophagus,Annual incidence,N/A
Clinical group,70482,Carcinoma of esophagus,Point prevalence,N/A
Clinical group,70482,Carcinoma of esophagus,Annual incidence,N/A
Clinical group,70482,Carcinoma of esophagus,Annual incidence,N/A
Clinical group,70482,Carcinoma of esophagus,Annual incidence,N/A
Clinical group,70482,Carcinoma of esophagus,Annual incidence,N/A
Clinical group,70482,Carcinoma of esophagus,Annual incidence,N/A
Clinical group,70482,Carcinoma of esophagus,Annual incidence,N/A
Clinical group,70482,Carcinoma of esophagus,Annual incidence,N/A
Clinical group,70482,Carcinoma of esophagus,Annual incidence,N/A
Clinical group,70482,Carcinoma of esophagus,Annual incidence,N/A
Clinical group,70482,Carcinoma of esophagus,Point prevalence,N/A
Clinical group,70482,Carcinoma of esophagus,Annual incidence,N/A
Clinical group,70482,Carcinoma of esophagus,Annual incidence,N/A
Clinical group,70482,Carcinoma of esophagus,Annual incidence,N/A
Clinical group,70482,Carcinoma of esophagus,Annual incidence,N/A
Clinical group,70482,Carcinoma of esophagus,Annual incidence,N/A
Clinical group,70482,Carcinoma of esophagus,Annual incidence,N/A
Clinical group,70482,Carcinoma of esophagus,Annual incidence,N/A
Clinical group,70482,Carcinoma of esophagus,Annual incidence,N/A
Clinical group,70482,Carcinoma of esophagus,Annual incidence,N/A
Clinical group,70482,Carcinoma of esophagus,Annual incidence,N/A
Clinical group,70482,Carcinoma of esophagus,Annual incidence,N/A
Clinical group,70482,Carcinoma of esophagus,Annual incidence,N/A
Clinical group,70482,Carcinoma of esophagus,Annual incidence,N/A
Clinical group,70482,Carcinoma of esophagus,Annual incidence,N/A
Clinical group,70482,Carcinoma of esophagus,Annual incidence,N/A
Clinical group,70482,Carcinoma of esophagus,Annual incidence,N/A
Clinical group,70482,Carcinoma of esophagus,Annual incidence,N/A
Clinical group,70482,Carcinoma of esophagus,Annual incidence,N/A
Clinical group,70482,Carcinoma of esophagus,Annual incidence,N/A
Clinical group,70482,Carcinoma of esophagus,Annual incidence,N/A
Clinical group,70482,Carcinoma of esophagus,Annual incidence,N/A
Clinical group,70482,Carcinoma of esophagus,Annual incidence,N/A
Disease,70476,Vernal keratoconjunctivitis,Point prevalence,N/A
Disease,70476,Vernal keratoconjunctivitis,Point prevalence,N/A
Disease,70476,Vernal keratoconjunctivitis,Point prevalence,N/A
Disease,70476,Vernal keratoconjunctivitis,Point prevalence,N/A
Disease,70476,Vernal keratoconjunctivitis,Point prevalence,N/A
Disease,70476,Vernal keratoconjunctivitis,Point prevalence,N/A
Disease,70476,Vernal keratoconjunctivitis,Point prevalence,N/A
Disease,70475,Radiation proctitis,Point prevalence,N/A
Disease,69744,Circumscribed palmoplantar hypokeratosis,Cases/families,N/A
Disease,69744,Circumscribed palmoplantar hypokeratosis,Point prevalence,N/A
Disease,69745,Warty dyskeratoma,Point prevalence,N/A
Disease,69735,Hypotrichosis-lymphedema-telangiectasia-renal defect syndrome,Cases/families,N/A
Disease,69735,Hypotrichosis-lymphedema-telangiectasia-renal defect syndrome,Point prevalence,N/A
Disease,69736,Bilateral acute depigmentation of the iris,Cases/families,N/A
Disease,69736,Bilateral acute depigmentation of the iris,Point prevalence,N/A
Malformation syndrome,69737,Bosley-Salih-Alorainy syndrome,Cases/families,N/A
Malformation syndrome,69737,Bosley-Salih-Alorainy syndrome,Point prevalence,N/A
Disease,69739,Athabaskan brainstem dysgenesis syndrome,Cases/families,N/A
Disease,69739,Athabaskan brainstem dysgenesis syndrome,Point prevalence,N/A
Disease,69663,Low phospholipid-associated cholelithiasis,Point prevalence,N/A
Disease,69665,Intrahepatic cholestasis of pregnancy,Point prevalence,N/A
Disease,69723,Tyrosinemia type 3,Cases/families,N/A
Disease,69723,Tyrosinemia type 3,Point prevalence,N/A
Disease,69126,PAPA syndrome,Cases/families,N/A
Disease,69126,PAPA syndrome,Point prevalence,N/A
Disease,69087,Naegeli-Franceschetti-Jadassohn syndrome,Point prevalence,N/A
Malformation syndrome,69125,Anonychia with flexural pigmentation,Cases/families,N/A
Malformation syndrome,69125,Anonychia with flexural pigmentation,Point prevalence,N/A
Disease,69088,Anhidrotic ectodermal dysplasia-immunodeficiency-osteopetrosis-lymphedema syndrome,Cases/families,N/A
Disease,69088,Anhidrotic ectodermal dysplasia-immunodeficiency-osteopetrosis-lymphedema syndrome,Point prevalence,N/A
Malformation syndrome,69083,"Ectodermal dysplasia with natal teeth, Turnpenny type",Point prevalence,N/A
Malformation syndrome,69083,"Ectodermal dysplasia with natal teeth, Turnpenny type",Cases/families,N/A
Malformation syndrome,69082,Odonto-tricho-ungual-digito-palmar syndrome,Cases/families,N/A
Malformation syndrome,69082,Odonto-tricho-ungual-digito-palmar syndrome,Point prevalence,N/A
Malformation syndrome,69085,Limb-mammary syndrome,Cases/families,N/A
Malformation syndrome,69085,Limb-mammary syndrome,Point prevalence,N/A
Malformation syndrome,69084,Pure hair and nail ectodermal dysplasia,Cases/families,N/A
Malformation syndrome,69084,Pure hair and nail ectodermal dysplasia,Point prevalence,N/A
Disease,69077,Rhabdoid tumor,Cases/families,N/A
Disease,69077,Rhabdoid tumor,Annual incidence,N/A
Disease,69077,Rhabdoid tumor,Point prevalence,N/A
Disease,69076,Familial renal glucosuria,Point prevalence,N/A
Disease,69078,Liposarcoma,Annual incidence,N/A
Disease,69078,Liposarcoma,Annual incidence,N/A
Disease,69078,Liposarcoma,Point prevalence,N/A
Clinical syndrome,69061,Idiopathic steroid-sensitive nephrotic syndrome,Point prevalence,N/A
Disease,69063,Congenital membranous nephropathy due to fetomaternal anti-neutral endopeptidase alloimmunization,Cases/families,N/A
Disease,69063,Congenital membranous nephropathy due to fetomaternal anti-neutral endopeptidase alloimmunization,Point prevalence,N/A
Disease,67048,3-methylglutaconic aciduria type 4,Point prevalence,N/A
Category,69028,Dysostosis with brachydactyly,Point prevalence,N/A
Disease,67046,3-methylglutaconic aciduria type 1,Cases/families,N/A
Disease,67046,3-methylglutaconic aciduria type 1,Point prevalence,N/A
Disease,67047,3-methylglutaconic aciduria type 3,Point prevalence,N/A
Disease,67044,Thrombocytopenia with congenital dyserythropoietic anemia,Cases/families,N/A
Disease,67044,Thrombocytopenia with congenital dyserythropoietic anemia,Point prevalence,N/A
Clinical subtype,67045,X-linked intellectual disability with isolated growth hormone deficiency,Cases/families,N/A
Clinical subtype,67045,X-linked intellectual disability with isolated growth hormone deficiency,Point prevalence,N/A
Disease,67042,Late-onset retinal degeneration,Point prevalence,N/A
Disease,67043,Amoebic keratitis,Point prevalence,N/A
Disease,67039,Segmental odontomaxillary dysplasia,Cases/families,N/A
Disease,67039,Segmental odontomaxillary dysplasia,Point prevalence,N/A
Disease,67041,Hyaluronidase deficiency,Point prevalence,N/A
Disease,67038,B-cell chronic lymphocytic leukemia,Point prevalence,N/A
Disease,67038,B-cell chronic lymphocytic leukemia,Annual incidence,N/A
Disease,67036,Autosomal dominant optic atrophy and cataract,Cases/families,N/A
Disease,67036,Autosomal dominant optic atrophy and cataract,Point prevalence,N/A
Clinical group,66646,Cutaneous mastocytosis,Point prevalence,N/A
Malformation syndrome,66637,Diaphanospondylodysostosis,Cases/families,N/A
Malformation syndrome,66637,Diaphanospondylodysostosis,Point prevalence,N/A
Disease,66634,Dilated cardiomyopathy with ataxia,Point prevalence,N/A
Disease,66633,Sensorineural hearing loss-early graying-essential tremor syndrome,Cases/families,N/A
Disease,66633,Sensorineural hearing loss-early graying-essential tremor syndrome,Point prevalence,N/A
Disease,66631,CEDNIK syndrome,Cases/families,N/A
Disease,66631,CEDNIK syndrome,Point prevalence,N/A
Disease,66630,Congenital pseudoarthrosis of the clavicle,Cases/families,N/A
Disease,66630,Congenital pseudoarthrosis of the clavicle,Point prevalence,N/A
Malformation syndrome,66629,Goldberg-Shprintzen megacolon syndrome,Cases/families,N/A
Malformation syndrome,66629,Goldberg-Shprintzen megacolon syndrome,Point prevalence,N/A
Etiological subtype,66628,Obesity due to congenital leptin deficiency,Cases/families,N/A
Etiological subtype,66628,Obesity due to congenital leptin deficiency,Point prevalence,N/A
Disease,66627,Tenosynovial giant cell tumor,Point prevalence,N/A
Malformation syndrome,66625,Cerebrooculonasal syndrome,Cases/families,N/A
Malformation syndrome,66625,Cerebrooculonasal syndrome,Point prevalence,N/A
Disease,66624,PANDAS,Point prevalence,N/A
Disease,66529,Tako-Tsubo cardiomyopathy,Point prevalence,N/A
Disease,66529,Tako-Tsubo cardiomyopathy,Annual incidence,N/A
Disease,66518,Short fifth metacarpals-insulin resistance syndrome,Cases/families,N/A
Disease,66518,Short fifth metacarpals-insulin resistance syndrome,Point prevalence,N/A
Malformation syndrome,65283,Timothy syndrome,Cases/families,N/A
Malformation syndrome,65283,Timothy syndrome,Point prevalence,N/A
Disease,65282,Carvajal syndrome,Cases/families,N/A
Disease,65282,Carvajal syndrome,Point prevalence,N/A
Disease,562639,Primary biliary cholangitis/primary sclerosing cholangitis and autoimmune hepatitis overlap syndrome,Point prevalence,N/A
Disease,65285,Lhermitte-Duclos disease,Cases/families,N/A
Disease,65285,Lhermitte-Duclos disease,Point prevalence,N/A
Disease,65287,Beta-ureidopropionase deficiency,Cases/families,N/A
Disease,65287,Beta-ureidopropionase deficiency,Point prevalence,N/A
Malformation syndrome,65286,3q29 microdeletion syndrome,Point prevalence,N/A
Morphological anomaly,65681,Vaginal atresia,Point prevalence,N/A
Malformation syndrome,65288,Permanent neonatal diabetes mellitus-pancreatic and cerebellar agenesis syndrome,Cases/families,N/A
Malformation syndrome,65288,Permanent neonatal diabetes mellitus-pancreatic and cerebellar agenesis syndrome,Point prevalence,N/A
Disease,65683,Isolated focal cortical dysplasia,Point prevalence,N/A
Disease,65682,Benign recurrent intrahepatic cholestasis,Point prevalence,N/A
Malformation syndrome,65720,Arthrogryposis-severe scoliosis syndrome,Cases/families,N/A
Malformation syndrome,65720,Arthrogryposis-severe scoliosis syndrome,Point prevalence,N/A
Disease,65684,Monomelic amyotrophy,Point prevalence,N/A
Disease,65748,Multiple self-healing squamous epithelioma,Point prevalence,N/A
Disease,65748,Multiple self-healing squamous epithelioma,Cases/families,N/A
Malformation syndrome,65743,Autosomal dominant multiple pterygium syndrome,Cases/families,N/A
Malformation syndrome,65743,Autosomal dominant multiple pterygium syndrome,Point prevalence,N/A
Malformation syndrome,65759,Carpenter syndrome,Cases/families,N/A
Malformation syndrome,65759,Carpenter syndrome,Point prevalence,N/A
Clinical group,65753,Charcot-Marie-Tooth disease type 1,Point prevalence,N/A
Clinical subtype,64744,IgG4-related thyroid disease,Annual incidence,N/A
Clinical subtype,64744,IgG4-related thyroid disease,Point prevalence,N/A
Disease,64745,Pruritic urticarial papules and plaques of pregnancy,Point prevalence,N/A
Clinical group,64746,Autosomal dominant Charcot-Marie-Tooth disease type 2,Point prevalence,N/A
Clinical group,64747,X-linked Charcot-Marie-Tooth disease,Point prevalence,N/A
Disease,64748,Dejerine-Sottas syndrome,Point prevalence,N/A
Clinical group,64749,Charcot-Marie-Tooth disease type 4,Point prevalence,N/A
Disease,562509,Heme oxygenase-1 deficiency,Cases/families,N/A
Disease,562509,Heme oxygenase-1 deficiency,Point prevalence,N/A
Disease,64752,Hereditary sensory and autonomic neuropathy type 5,Point prevalence,N/A
Disease,64752,Hereditary sensory and autonomic neuropathy type 5,Point prevalence,N/A
Disease,64753,Spinocerebellar ataxia with axonal neuropathy type 2,Point prevalence,N/A
Disease,64754,Nevus comedonicus syndrome,Point prevalence,N/A
Malformation syndrome,562528,Congenital limbs-face contractures-hypotonia-developmental delay syndrome,Cases/families,N/A
Malformation syndrome,562528,Congenital limbs-face contractures-hypotonia-developmental delay syndrome,Point prevalence,N/A
Disease,64755,Becker nevus syndrome,Point prevalence,N/A
Malformation syndrome,562559,Anterior maxillary protrusion-strabismus-intellectual disability syndrome,Cases/families,N/A
Malformation syndrome,562559,Anterior maxillary protrusion-strabismus-intellectual disability syndrome,Point prevalence,N/A
Malformation syndrome,562569,TMEM94-associated congenital heart defect-facial dysmorphism-developmental delay syndrome,Cases/families,N/A
Malformation syndrome,562569,TMEM94-associated congenital heart defect-facial dysmorphism-developmental delay syndrome,Point prevalence,N/A
Malformation syndrome,64542,"Acrofacial dysostosis, Kennedy-Teebi type",Cases/families,N/A
Malformation syndrome,64542,"Acrofacial dysostosis, Kennedy-Teebi type",Point prevalence,N/A
Disease,64280,Childhood absence epilepsy,Annual incidence,N/A
Disease,64280,Childhood absence epilepsy,Point prevalence,N/A
Disease,64720,Leiomyosarcoma,Annual incidence,N/A
Disease,64720,Leiomyosarcoma,Point prevalence,N/A
Disease,64739,Ovarian hyperstimulation syndrome,Point prevalence,N/A
Disease,64734,Iridocorneal endothelial syndrome,Point prevalence,N/A
Histopathological subtype,64743,Hepatoportal sclerosis,Point prevalence,N/A
Disease,64742,Pleuropulmonary blastoma,Prevalence at birth,N/A
Disease,64742,Pleuropulmonary blastoma,Point prevalence,N/A
Disease,64741,Pulmonary blastoma,Cases/families,N/A
Disease,64741,Pulmonary blastoma,Point prevalence,N/A
Disease,64741,Pulmonary blastoma,Annual incidence,N/A
Disease,64741,Pulmonary blastoma,Annual incidence,N/A
Disease,64741,Pulmonary blastoma,Annual incidence,N/A
Disease,64741,Pulmonary blastoma,Annual incidence,N/A
Disease,64741,Pulmonary blastoma,Annual incidence,N/A
Disease,64741,Pulmonary blastoma,Annual incidence,N/A
Morphological anomaly,63259,Iniencephaly,Prevalence at birth,N/A
Morphological anomaly,63259,Iniencephaly,Point prevalence,N/A
Malformation syndrome,63442,Angel-shaped phalango-epiphyseal dysplasia,Cases/families,N/A
Malformation syndrome,63442,Angel-shaped phalango-epiphyseal dysplasia,Point prevalence,N/A
Disease,63273,Distal myopathy with posterior leg and anterior hand involvement,Cases/families,N/A
Disease,63273,Distal myopathy with posterior leg and anterior hand involvement,Point prevalence,N/A
Disease,63275,Pemphigoid gestationis,Annual incidence,N/A
Disease,63275,Pemphigoid gestationis,Annual incidence,N/A
Disease,63275,Pemphigoid gestationis,Annual incidence,N/A
Disease,63275,Pemphigoid gestationis,Point prevalence,N/A
Category,63454,Pattern dystrophy,Point prevalence,N/A
Disease,63455,Paraneoplastic pemphigus,Point prevalence,N/A
Category,63443,Rare epithelial tumor of stomach,Annual incidence,N/A
Category,63443,Rare epithelial tumor of stomach,Lifetime Prevalence,N/A
Category,63443,Rare epithelial tumor of stomach,Annual incidence,N/A
Category,63443,Rare epithelial tumor of stomach,Point prevalence,N/A
Category,63443,Rare epithelial tumor of stomach,Annual incidence,N/A
Category,63443,Rare epithelial tumor of stomach,Point prevalence,N/A
Category,63443,Rare epithelial tumor of stomach,Point prevalence,N/A
Malformation syndrome,63446,Acrocapitofemoral dysplasia,Point prevalence,N/A
Malformation syndrome,63862,Schisis association,Point prevalence,N/A
Malformation syndrome,60040,Megalencephaly-capillary malformation-polymicrogyria syndrome,Cases/families,N/A
Malformation syndrome,60040,Megalencephaly-capillary malformation-polymicrogyria syndrome,Point prevalence,N/A
Disease,60039,Pudendal nerve entrapment syndrome,Point prevalence,N/A
Disease,60039,Pudendal nerve entrapment syndrome,Point prevalence,N/A
Disease,60041,Congenital heart block,Prevalence at birth,N/A
Disease,60041,Congenital heart block,Point prevalence,N/A
Disease,60032,Recurrent respiratory papillomatosis,Point prevalence,N/A
Disease,60032,Recurrent respiratory papillomatosis,Annual incidence,N/A
Disease,60032,Recurrent respiratory papillomatosis,Annual incidence,N/A
Disease,60032,Recurrent respiratory papillomatosis,Annual incidence,N/A
Disease,60032,Recurrent respiratory papillomatosis,Point prevalence,N/A
Disease,60032,Recurrent respiratory papillomatosis,Point prevalence,N/A
Disease,60033,Idiopathic bronchiectasis,Annual incidence,N/A
Disease,60033,Idiopathic bronchiectasis,Prevalence at birth,N/A
Disease,59303,Neonatal ichthyosis-sclerosing cholangitis syndrome,Cases/families,N/A
Disease,59303,Neonatal ichthyosis-sclerosing cholangitis syndrome,Point prevalence,N/A
Clinical group,59305,Gestational trophoblastic neoplasm,Point prevalence,N/A
Clinical group,59305,Gestational trophoblastic neoplasm,Annual incidence,N/A
Disease,59306,McLeod neuroacanthocytosis syndrome,Cases/families,N/A
Disease,59306,McLeod neuroacanthocytosis syndrome,Point prevalence,N/A
Disease,59298,Schilder disease,Point prevalence,N/A
Malformation syndrome,60015,Enlarged parietal foramina,Point prevalence,N/A
Malformation syndrome,60015,Enlarged parietal foramina,Point prevalence,N/A
Disease,564003,Osteochondrosis of the metatarsal bone,Point prevalence,N/A
Disease,60025,Pulmonary alveolar microlithiasis,Point prevalence,N/A
Disease,563991,Osteochondrosis of the tarsal bone,Point prevalence,N/A
Disease,60026,Pulmonary nodular lymphoid hyperplasia,Point prevalence,N/A
Disease,564178,Primary hypomagnesemia-refractory seizures-intellectual disability syndrome,Point prevalence,N/A
Disease,564178,Primary hypomagnesemia-refractory seizures-intellectual disability syndrome,Cases/families,N/A
Malformation syndrome,60030,Loeys-Dietz syndrome,Cases/families,N/A
Malformation syndrome,60030,Loeys-Dietz syndrome,Point prevalence,N/A
Malformation syndrome,59315,Rhombencephalosynapsis,Cases/families,N/A
Malformation syndrome,59315,Rhombencephalosynapsis,Point prevalence,N/A
Disease,60014,Argyria,Point prevalence,N/A
Disease,57196,Medial condensing osteitis of the clavicle,Cases/families,N/A
Disease,57196,Medial condensing osteitis of the clavicle,Point prevalence,N/A
Clinical subtype,563690,Furuncular myiasis due to Cordylobia rodhaini,Point prevalence,N/A
Disease,57145,SUNCT syndrome,Point prevalence,N/A
Disease,57145,SUNCT syndrome,Point prevalence,N/A
Clinical subtype,563684,Furuncular myiasis due to Dermatobia hominis,Point prevalence,N/A
Clinical subtype,563687,Furuncular myiasis due to Cordylobia anthropophaga,Point prevalence,N/A
Category,56970,Human prion disease,Annual incidence,N/A
Category,56970,Human prion disease,Point prevalence,N/A
Disease,56425,Cold agglutinin disease,Point prevalence,N/A
Disease,59181,Sorsby pseudoinflammatory fundus dystrophy,Point prevalence,N/A
Disease,59135,Laing distal myopathy,Point prevalence,N/A
Disease,58017,Classic hairy cell leukemia,Annual incidence,N/A
Disease,58017,Classic hairy cell leukemia,Lifetime Prevalence,N/A
Disease,58017,Classic hairy cell leukemia,Annual incidence,N/A
Disease,58017,Classic hairy cell leukemia,Annual incidence,N/A
Disease,58017,Classic hairy cell leukemia,Annual incidence,N/A
Disease,58017,Classic hairy cell leukemia,Annual incidence,N/A
Disease,58017,Classic hairy cell leukemia,Annual incidence,N/A
Disease,58017,Classic hairy cell leukemia,Annual incidence,N/A
Disease,58017,Classic hairy cell leukemia,Point prevalence,N/A
Malformation syndrome,57782,Mazabraud syndrome,Cases/families,N/A
Malformation syndrome,57782,Mazabraud syndrome,Point prevalence,N/A
Disease,55595,TNP03-related limb-girdle muscular dystrophy D2,Cases/families,N/A
Disease,55595,TNP03-related limb-girdle muscular dystrophy D2,Point prevalence,N/A
Disease,55596,HNRNPDL-related limb-girdle muscular dystrophy D3,Cases/families,N/A
Disease,55596,HNRNPDL-related limb-girdle muscular dystrophy D3,Point prevalence,N/A
Disease,54595,Craniopharyngioma,Annual incidence,N/A
Disease,54595,Craniopharyngioma,Point prevalence,N/A
Disease,54595,Craniopharyngioma,Annual incidence,N/A
Disease,54595,Craniopharyngioma,Annual incidence,N/A
Disease,54368,Sarcocystosis,Point prevalence,N/A
Disease,54370,Primary membranoproliferative glomerulonephritis,Point prevalence,N/A
Disease,54272,Hepatocellular adenoma,Point prevalence,N/A
Malformation syndrome,56304,Atelosteogenesis type II,Cases/families,N/A
Malformation syndrome,56304,Atelosteogenesis type II,Point prevalence,N/A
Malformation syndrome,56305,Atelosteogenesis type III,Cases/families,N/A
Malformation syndrome,56305,Atelosteogenesis type III,Point prevalence,N/A
Clinical group,56044,Carcinoma of gallbladder and extrahepatic biliary tract,Annual incidence,N/A
Clinical group,56044,Carcinoma of gallbladder and extrahepatic biliary tract,Annual incidence,N/A
Clinical group,56044,Carcinoma of gallbladder and extrahepatic biliary tract,Annual incidence,N/A
Clinical group,56044,Carcinoma of gallbladder and extrahepatic biliary tract,Annual incidence,N/A
Clinical group,56044,Carcinoma of gallbladder and extrahepatic biliary tract,Annual incidence,N/A
Clinical group,56044,Carcinoma of gallbladder and extrahepatic biliary tract,Point prevalence,N/A
Clinical group,56044,Carcinoma of gallbladder and extrahepatic biliary tract,Annual incidence,N/A
Disease,55880,Chondrosarcoma,Annual incidence,N/A
Disease,55880,Chondrosarcoma,Point prevalence,N/A
Disease,55880,Chondrosarcoma,Lifetime Prevalence,N/A
Disease,55881,Adamantinoma,Annual incidence,N/A
Disease,55881,Adamantinoma,Point prevalence,N/A
Disease,55881,Adamantinoma,Lifetime Prevalence,N/A
Disease,55654,Hypotrichosis simplex,Cases/families,N/A
Disease,55654,Hypotrichosis simplex,Point prevalence,N/A
Malformation syndrome,565858,Craniosynostosis-microretrognathia-severe intellectual disability syndrome,Cases/families,N/A
Malformation syndrome,565858,Craniosynostosis-microretrognathia-severe intellectual disability syndrome,Point prevalence,N/A
Disease,565788,Infantile inflammatory bowel disease with neurological involvement,Cases/families,N/A
Disease,565788,Infantile inflammatory bowel disease with neurological involvement,Point prevalence,N/A
Category,79213,Mucopolysaccharidosis,Prevalence at birth,N/A
Category,79213,Mucopolysaccharidosis,Prevalence at birth,N/A
Category,79213,Mucopolysaccharidosis,Prevalence at birth,N/A
Category,79213,Mucopolysaccharidosis,Prevalence at birth,N/A
Category,79213,Mucopolysaccharidosis,Prevalence at birth,N/A
Category,79213,Mucopolysaccharidosis,Prevalence at birth,N/A
Category,79213,Mucopolysaccharidosis,Prevalence at birth,N/A
Category,79213,Mucopolysaccharidosis,Prevalence at birth,N/A
Category,79213,Mucopolysaccharidosis,Prevalence at birth,N/A
Category,79213,Mucopolysaccharidosis,Prevalence at birth,N/A
Category,79213,Mucopolysaccharidosis,Prevalence at birth,N/A
Category,79213,Mucopolysaccharidosis,Prevalence at birth,N/A
Category,79213,Mucopolysaccharidosis,Prevalence at birth,N/A
Category,79213,Mucopolysaccharidosis,Prevalence at birth,N/A
Category,79213,Mucopolysaccharidosis,Prevalence at birth,N/A
Category,79213,Mucopolysaccharidosis,Prevalence at birth,N/A
Category,79213,Mucopolysaccharidosis,Prevalence at birth,N/A
Category,79213,Mucopolysaccharidosis,Prevalence at birth,N/A
Category,79213,Mucopolysaccharidosis,Prevalence at birth,N/A
Category,79213,Mucopolysaccharidosis,Prevalence at birth,N/A
Category,79213,Mucopolysaccharidosis,Point prevalence,N/A
Category,79213,Mucopolysaccharidosis,Point prevalence,N/A
Disease,565899,POMGNT2-related limb-girdle muscular dystrophy R24,Cases/families,N/A
Disease,565899,POMGNT2-related limb-girdle muscular dystrophy R24,Point prevalence,N/A
Disease,565909,Calpain-3-related limb-girdle muscular dystrophy D4,Point prevalence,N/A
Disease,565909,Calpain-3-related limb-girdle muscular dystrophy D4,Cases/families,N/A
Disease,79233,Hypoxanthine guanine phosphoribosyltransferase partial deficiency,Point prevalence,N/A
Disease,79230,HJV or HAMP-related hemochromatosis,Cases/families,N/A
Disease,79230,HJV or HAMP-related hemochromatosis,Point prevalence,N/A
Disease,79237,Galactokinase deficiency,Point prevalence,N/A
Disease,566067,CEBPE-associated autoinflammation-immunodeficiency-neutrophil dysfunction syndrome,Cases/families,N/A
Disease,566067,CEBPE-associated autoinflammation-immunodeficiency-neutrophil dysfunction syndrome,Point prevalence,N/A
Clinical subtype,79234,Crigler-Najjar syndrome type 1,Point prevalence,N/A
Clinical subtype,79235,Crigler-Najjar syndrome type 2,Point prevalence,N/A
Clinical group,79189,Peroxisome biogenesis disorder,Prevalence at birth,N/A
Clinical group,79189,Peroxisome biogenesis disorder,Point prevalence,N/A
Clinical group,79189,Peroxisome biogenesis disorder,Prevalence at birth,N/A
Clinical group,79189,Peroxisome biogenesis disorder,Point prevalence,N/A
Clinical group,79189,Peroxisome biogenesis disorder,Point prevalence,N/A
Disease,565624,Combined oxidative phosphorylation defect type 39,Cases/families,N/A
Disease,565624,Combined oxidative phosphorylation defect type 39,Point prevalence,N/A
Disease,565612,Primary triglyceride deposit cardiomyovasculopathy,Cases/families,N/A
Disease,565612,Primary triglyceride deposit cardiomyovasculopathy,Point prevalence,N/A
Category,79201,Glycogen storage disease,Point prevalence,N/A
Disease,565782,Methotrexate toxicity,Point prevalence,N/A
Disease,79157,2-methylbutyryl-CoA dehydrogenase deficiency,Cases/families,N/A
Disease,79157,2-methylbutyryl-CoA dehydrogenase deficiency,Point prevalence,N/A
Disease,79156,Seizures-intellectual disability due to hydroxylysinuria syndrome,Cases/families,N/A
Disease,79156,Seizures-intellectual disability due to hydroxylysinuria syndrome,Point prevalence,N/A
Disease,79155,Hydroxykynureninuria,Cases/families,N/A
Disease,79155,Hydroxykynureninuria,Point prevalence,N/A
Disease,79154,2-aminoadipic 2-oxoadipic aciduria,Cases/families,N/A
Disease,79154,2-aminoadipic 2-oxoadipic aciduria,Point prevalence,N/A
Disease,79153,Idiopathic trachyonychia,Point prevalence,N/A
Disease,79152,Disseminated superficial actinic porokeratosis,Point prevalence,N/A
Disease,79151,Acrokeratosis verruciformis of Hopf,Point prevalence,N/A
Disease,79149,Dermochondrocorneal dystrophy,Point prevalence,N/A
Disease,79149,Dermochondrocorneal dystrophy,Cases/families,N/A
Disease,79148,Elastosis perforans serpiginosa,Point prevalence,N/A
Disease,79147,Familial reactive perforating collagenosis,Point prevalence,N/A
Disease,79147,Familial reactive perforating collagenosis,Cases/families,N/A
Disease,79145,Dowling-Degos disease,Point prevalence,N/A
Disease,79144,Isolated congenital onychodysplasia,Point prevalence,N/A
Disease,79143,Isolated congenital anonychia,Cases/families,N/A
Disease,79143,Isolated congenital anonychia,Point prevalence,N/A
Clinical group,79172,Creatine deficiency syndrome,Point prevalence,N/A
Category,79168,Disorder of bile acid synthesis,Point prevalence,N/A
Category,79158,Cerebral organic aciduria,Point prevalence,N/A
Disease,79159,Isobutyryl-CoA dehydrogenase deficiency,Point prevalence,N/A
Malformation syndrome,79107,Developmental malformations-deafness-dystonia syndrome,Cases/families,N/A
Malformation syndrome,79107,Developmental malformations-deafness-dystonia syndrome,Point prevalence,N/A
Disease,566231,Resistance to thyroid hormone due to a mutation in thyroid hormone receptor alpha,Cases/families,N/A
Disease,566231,Resistance to thyroid hormone due to a mutation in thyroid hormone receptor alpha,Point prevalence,N/A
Malformation syndrome,79106,Eiken syndrome,Cases/families,N/A
Malformation syndrome,79106,Eiken syndrome,Point prevalence,N/A
Disease,566243,Resistance to thyroid hormone due to a mutation in thyroid hormone receptor beta,Point prevalence,N/A
Disease,566243,Resistance to thyroid hormone due to a mutation in thyroid hormone receptor beta,Point prevalence,N/A
Disease,566243,Resistance to thyroid hormone due to a mutation in thyroid hormone receptor beta,Prevalence at birth,N/A
Disease,566243,Resistance to thyroid hormone due to a mutation in thyroid hormone receptor beta,Prevalence at birth,N/A
Disease,79118,Neonatal diabetes-congenital hypothyroidism-congenital glaucoma-hepatic fibrosis-polycystic kidneys syndrome,Cases/families,N/A
Disease,79118,Neonatal diabetes-congenital hypothyroidism-congenital glaucoma-hepatic fibrosis-polycystic kidneys syndrome,Point prevalence,N/A
Malformation syndrome,79113,Mandibulofacial dysostosis-microcephaly syndrome,Cases/families,N/A
Malformation syndrome,79113,Mandibulofacial dysostosis-microcephaly syndrome,Point prevalence,N/A
Disease,79102,Thyrotoxic periodic paralysis,Point prevalence,N/A
Disease,79105,Myxofibrosarcoma,Point prevalence,N/A
Disease,79099,Interstitial granulomatous dermatitis with arthritis,Cases/families,N/A
Disease,79099,Interstitial granulomatous dermatitis with arthritis,Point prevalence,N/A
Disease,79098,Sympathetic ophthalmia,Annual incidence,N/A
Disease,79098,Sympathetic ophthalmia,Point prevalence,N/A
Disease,79101,Hyperprolinemia type 2,Point prevalence,N/A
Disease,566192,Congenital autosomal recessive small-platelet thrombocytopenia,Cases/families,N/A
Disease,566192,Congenital autosomal recessive small-platelet thrombocytopenia,Point prevalence,N/A
Disease,79100,Atrophoderma vermiculata,Point prevalence,N/A
Disease,79095,Congenital bile acid synthesis defect type 4,Cases/families,N/A
Disease,79095,Congenital bile acid synthesis defect type 4,Point prevalence,N/A
Malformation syndrome,79094,Grange syndrome,Cases/families,N/A
Malformation syndrome,79094,Grange syndrome,Point prevalence,N/A
Disease,566175,Complement hyperactivation-angiopathic thrombosis-protein-losing enteropathy syndrome,Point prevalence,N/A
Disease,79097,Folinic acid-responsive seizures,Point prevalence,N/A
Disease,79096,Pyridoxal phosphate-responsive seizures,Point prevalence,N/A
Disease,79096,Pyridoxal phosphate-responsive seizures,Point prevalence,N/A
Disease,79138,Bickerstaff brainstem encephalitis,Point prevalence,N/A
Disease,79139,Japanese encephalitis,Annual incidence,N/A
Disease,79139,Japanese encephalitis,Point prevalence,N/A
Disease,79140,Cutaneous neuroendocrine carcinoma,Annual incidence,N/A
Disease,79140,Cutaneous neuroendocrine carcinoma,Point prevalence,N/A
Disease,79140,Cutaneous neuroendocrine carcinoma,Annual incidence,N/A
Disease,79140,Cutaneous neuroendocrine carcinoma,Lifetime Prevalence,N/A
Disease,79140,Cutaneous neuroendocrine carcinoma,Annual incidence,N/A
Disease,79140,Cutaneous neuroendocrine carcinoma,Annual incidence,N/A
Disease,79140,Cutaneous neuroendocrine carcinoma,Annual incidence,N/A
Disease,79140,Cutaneous neuroendocrine carcinoma,Annual incidence,N/A
Disease,79140,Cutaneous neuroendocrine carcinoma,Annual incidence,N/A
Disease,79140,Cutaneous neuroendocrine carcinoma,Annual incidence,N/A
Disease,79140,Cutaneous neuroendocrine carcinoma,Annual incidence,N/A
Disease,79140,Cutaneous neuroendocrine carcinoma,Annual incidence,N/A
Disease,79141,Hereditary painful callosities,Cases/families,N/A
Disease,79141,Hereditary painful callosities,Point prevalence,N/A
Disease,79134,DEND syndrome,Cases/families,N/A
Disease,79134,DEND syndrome,Point prevalence,N/A
Disease,79135,Episodic ataxia type 3,Cases/families,N/A
Disease,79135,Episodic ataxia type 3,Point prevalence,N/A
Disease,79136,Episodic ataxia type 4,Cases/families,N/A
Disease,79136,Episodic ataxia type 4,Point prevalence,N/A
Disease,79137,Generalized epilepsy-paroxysmal dyskinesia syndrome,Point prevalence,N/A
Malformation syndrome,79129,Trichodysplasia-amelogenesis imperfecta syndrome,Cases/families,N/A
Malformation syndrome,79129,Trichodysplasia-amelogenesis imperfecta syndrome,Point prevalence,N/A
Clinical subtype,79133,Focal facial dermal dysplasia type I,Cases/families,N/A
Clinical subtype,79133,Focal facial dermal dysplasia type I,Point prevalence,N/A
Disease,79124,Hepatic veno-occlusive disease-immunodeficiency syndrome,Cases/families,N/A
Disease,79124,Hepatic veno-occlusive disease-immunodeficiency syndrome,Point prevalence,N/A
Disease,79126,Acute interstitial pneumonia,Point prevalence,N/A
Disease,79127,Respiratory bronchiolitis-interstitial lung disease syndrome,Point prevalence,N/A
Disease,79128,Lymphoid interstitial pneumonia,Point prevalence,N/A
Disease,77293,Chronic visceral acid sphingomyelinase deficiency,Prevalence at birth,N/A
Disease,77293,Chronic visceral acid sphingomyelinase deficiency,Point prevalence,N/A
Clinical subtype,77295,Odontoleukodystrophy,Cases/families,N/A
Clinical subtype,77295,Odontoleukodystrophy,Point prevalence,N/A
Clinical subtype,77261,Gaucher disease type 3,Point prevalence,N/A
Disease,77292,Infantile neurovisceral acid sphingomyelinase deficiency,Prevalence at birth,N/A
Disease,77292,Infantile neurovisceral acid sphingomyelinase deficiency,Point prevalence,N/A
Malformation syndrome,77298,Anophthalmia/microphthalmia-esophageal atresia syndrome,Cases/families,N/A
Malformation syndrome,77298,Anophthalmia/microphthalmia-esophageal atresia syndrome,Point prevalence,N/A
Malformation syndrome,77299,Microphthalmia-brain atrophy syndrome,Cases/families,N/A
Malformation syndrome,77299,Microphthalmia-brain atrophy syndrome,Point prevalence,N/A
Malformation syndrome,77296,Morgagni-Stewart-Morel syndrome,Point prevalence,N/A
Disease,77297,Majeed syndrome,Cases/families,N/A
Disease,77297,Majeed syndrome,Point prevalence,N/A
Disease,567502,B-cell immunodeficiency-limb anomaly-urogenital malformation syndrome,Cases/families,N/A
Disease,567502,B-cell immunodeficiency-limb anomaly-urogenital malformation syndrome,Point prevalence,N/A
Malformation syndrome,77300,Auricular abnormalities-cleft lip with or without cleft palate-ocular abnormalities syndrome,Cases/families,N/A
Malformation syndrome,77300,Auricular abnormalities-cleft lip with or without cleft palate-ocular abnormalities syndrome,Point prevalence,N/A
Malformation syndrome,77301,Monosomy 9q22.3 syndrome,Cases/families,N/A
Malformation syndrome,77301,Monosomy 9q22.3 syndrome,Point prevalence,N/A
Clinical subtype,567550,Idiopathic multidrug-resistant nephrotic syndrome,Point prevalence,N/A
Clinical syndrome,567548,Idiopathic steroid-resistant nephrotic syndrome,Annual incidence,N/A
Clinical syndrome,567548,Idiopathic steroid-resistant nephrotic syndrome,Point prevalence,N/A
Clinical syndrome,567546,Idiopathic steroid-sensitive nephrotic syndrome with secondary steroid resistance,Point prevalence,N/A
Clinical syndrome,567544,Idiopathic non-lupus full-house nephropathy,Point prevalence,N/A
Disease,79083,PPARG-related familial partial lipodystrophy,Cases/families,N/A
Disease,79083,PPARG-related familial partial lipodystrophy,Point prevalence,N/A
Clinical subtype,79078,IgG4-related dacryoadenitis and sialadenitis,Point prevalence,N/A
Clinical subtype,79076,Juvenile polyposis of infancy,Cases/families,N/A
Clinical subtype,79076,Juvenile polyposis of infancy,Point prevalence,N/A
Disease,79087,Acquired partial lipodystrophy,Point prevalence,N/A
Disease,79087,Acquired partial lipodystrophy,Point prevalence,N/A
Disease,79086,Acquired generalized lipodystrophy,Point prevalence,N/A
Disease,79086,Acquired generalized lipodystrophy,Point prevalence,N/A
Disease,79085,AKT2-related familial partial lipodystrophy,Cases/families,N/A
Disease,79085,AKT2-related familial partial lipodystrophy,Point prevalence,N/A
Disease,79084,"Familial partial lipodystrophy, Kbberling type",Cases/families,N/A
Disease,79084,"Familial partial lipodystrophy, Kbberling type",Point prevalence,N/A
Particular clinical situation in a disease or syndrome,567983,Parenteral nutrition-associated cholestasis,Point prevalence,N/A
Malformation syndrome,79093,Foix-Alajouanine syndrome,Point prevalence,N/A
Disease,79091,Hereditary inclusion body myopathy-joint contractures-ophthalmoplegia syndrome,Cases/families,N/A
Disease,79091,Hereditary inclusion body myopathy-joint contractures-ophthalmoplegia syndrome,Point prevalence,N/A
Clinical group,79088,Localized lipodystrophy,Point prevalence,N/A
Disease,75327,North Carolina macular dystrophy,Cases/families,N/A
Disease,75327,North Carolina macular dystrophy,Point prevalence,N/A
Disease,75373,Progressive bifocal chorioretinal atrophy,Cases/families,N/A
Disease,75373,Progressive bifocal chorioretinal atrophy,Point prevalence,N/A
Disease,75374,Bradyopsia,Cases/families,N/A
Disease,75374,Bradyopsia,Point prevalence,N/A
Disease,75376,Familial drusen,Point prevalence,N/A
Disease,75377,Central areolar choroidal dystrophy,Point prevalence,N/A
Disease,75377,Central areolar choroidal dystrophy,Point prevalence,N/A
Disease,75378,Oligocone trichromacy,Cases/families,N/A
Disease,75378,Oligocone trichromacy,Point prevalence,N/A
Disease,75381,Cystoid macular dystrophy,Cases/families,N/A
Disease,75381,Cystoid macular dystrophy,Point prevalence,N/A
Malformation syndrome,75382,Oguchi disease,Cases/families,N/A
Malformation syndrome,75382,Oguchi disease,Point prevalence,N/A
Malformation syndrome,75389,Brain malformation-congenital heart disease-postaxial polydactyly syndrome,Cases/families,N/A
Malformation syndrome,75389,Brain malformation-congenital heart disease-postaxial polydactyly syndrome,Point prevalence,N/A
Disease,566841,Liver adenomatosis,Point prevalence,N/A
Disease,75391,Primary immunodeficiency with natural-killer cell deficiency and adrenal insufficiency,Cases/families,N/A
Disease,75391,Primary immunodeficiency with natural-killer cell deficiency and adrenal insufficiency,Point prevalence,N/A
Disease,75392,Periodontal Ehlers-Danlos syndrome,Cases/families,N/A
Disease,75392,Periodontal Ehlers-Danlos syndrome,Point prevalence,N/A
Clinical subtype,75496,B4GALT7-related spondylodysplastic Ehlers-Danlos syndrome,Point prevalence,N/A
Clinical subtype,75496,B4GALT7-related spondylodysplastic Ehlers-Danlos syndrome,Cases/families,N/A
Disease,75497,X-linked Ehlers-Danlos syndrome,Cases/families,N/A
Disease,75497,X-linked Ehlers-Danlos syndrome,Point prevalence,N/A
Malformation syndrome,75508,Angioosteohypotrophic syndrome,Point prevalence,N/A
Disease,75563,X-linked sideroblastic anemia,Cases/families,N/A
Disease,75563,X-linked sideroblastic anemia,Point prevalence,N/A
Disease,566943,Mueller-Weiss syndrome,Cases/families,N/A
Disease,566943,Mueller-Weiss syndrome,Point prevalence,N/A
Disease,75565,Tropical endomyocardial fibrosis,Point prevalence,N/A
Disease,75564,Acquired idiopathic sideroblastic anemia,Point prevalence,N/A
Disease,75564,Acquired idiopathic sideroblastic anemia,Annual incidence,N/A
Clinical syndrome,75567,Primary progressive freezing gait,Point prevalence,N/A
Disease,75566,Loeffler endocarditis,Point prevalence,N/A
Malformation syndrome,75857,6q terminal deletion syndrome,Cases/families,N/A
Malformation syndrome,75857,6q terminal deletion syndrome,Point prevalence,N/A
Disease,75840,Ullrich congenital muscular dystrophy,Point prevalence,N/A
Disease,75840,Ullrich congenital muscular dystrophy,Point prevalence,N/A
Category,77240,Primary lymphedema,Point prevalence,N/A
Disease,75858,MORM syndrome,Point prevalence,N/A
Malformation syndrome,77258,Trichorhinophalangeal syndrome type 1,Cases/families,N/A
Malformation syndrome,77258,Trichorhinophalangeal syndrome type 1,Point prevalence,N/A
Clinical subtype,77260,Gaucher disease type 2,Point prevalence,N/A
Clinical subtype,77259,Gaucher disease type 1,Point prevalence,N/A
Clinical subtype,77259,Gaucher disease type 1,Prevalence at birth,N/A
Disease,73271,Bleeding diathesis due to a collagen receptor defect,Cases/families,N/A
Disease,73271,Bleeding diathesis due to a collagen receptor defect,Point prevalence,N/A
Disease,73263,Zygomycosis,Point prevalence,N/A
Disease,73267,Non-24-hour sleep-wake syndrome,Point prevalence,N/A
Disease,73256,Central neurocytoma,Cases/families,N/A
Disease,73256,Central neurocytoma,Point prevalence,N/A
Disease,73260,Paracoccidioidomycosis,Point prevalence,N/A
Malformation syndrome,73246,Visceral neuropathy-brain anomalies-facial dysmorphism-developmental delay syndrome,Cases/families,N/A
Malformation syndrome,73246,Visceral neuropathy-brain anomalies-facial dysmorphism-developmental delay syndrome,Point prevalence,N/A
Disease,569821,Congenital primary lymphedema of Gordon,Cases/families,N/A
Disease,569821,Congenital primary lymphedema of Gordon,Point prevalence,N/A
Disease,73423,Acute ackee fruit intoxication,Point prevalence,N/A
Disease,569816,CELSR1-related late-onset primary lymphedema,Point prevalence,N/A
Disease,569816,CELSR1-related late-onset primary lymphedema,Cases/families,N/A
Disease,73272,Growth delay due to insulin-like growth factor type 1 deficiency,Cases/families,N/A
Disease,73272,Growth delay due to insulin-like growth factor type 1 deficiency,Point prevalence,N/A
Disease,73273,Growth delay due to insulin-like growth factor I resistance,Point prevalence,N/A
Disease,75326,Familial isolated retinal arteriolar tortuosity,Cases/families,N/A
Disease,75326,Familial isolated retinal arteriolar tortuosity,Point prevalence,N/A
Disease,75325,Osteosclerosis-ichthyosis-premature ovarian failure syndrome,Cases/families,N/A
Disease,75325,Osteosclerosis-ichthyosis-premature ovarian failure syndrome,Point prevalence,N/A
Disease,75249,Familial isolated restrictive cardiomyopathy,Point prevalence,N/A
Clinical subtype,75234,Cholesteryl ester storage disease,Prevalence at birth,N/A
Clinical subtype,75234,Cholesteryl ester storage disease,Point prevalence,N/A
Clinical subtype,75234,Cholesteryl ester storage disease,Point prevalence,N/A
Clinical subtype,75233,Wolman disease,Prevalence at birth,N/A
Clinical subtype,75233,Wolman disease,Point prevalence,N/A
Disease,568065,EPHB4-related lymphatic-related hydrops fetalis,Cases/families,N/A
Disease,568065,EPHB4-related lymphatic-related hydrops fetalis,Point prevalence,N/A
Disease,568062,PIEZO1-related generalized lymphatic dysplasia with non-immune hydrops fetalis,Point prevalence,N/A
Disease,568062,PIEZO1-related generalized lymphatic dysplasia with non-immune hydrops fetalis,Cases/families,N/A
Disease,71493,Familial thrombocytosis,Point prevalence,N/A
Disease,71505,Cancer-associated retinopathy,Point prevalence,N/A
Disease,568056,Warts-immunodeficiency-lymphedema-anogenital dysplasia syndrome,Cases/families,N/A
Disease,568056,Warts-immunodeficiency-lymphedema-anogenital dysplasia syndrome,Point prevalence,N/A
Disease,568051,GJC2-related late-onset primary lymphedema,Point prevalence,N/A
Malformation syndrome,71289,Radio-ulnar synostosis-amegakaryocytic thrombocytopenia syndrome,Cases/families,N/A
Malformation syndrome,71289,Radio-ulnar synostosis-amegakaryocytic thrombocytopenia syndrome,Point prevalence,N/A
Etiological subtype,71526,Obesity due to pro-opiomelanocortin deficiency,Cases/families,N/A
Etiological subtype,71526,Obesity due to pro-opiomelanocortin deficiency,Point prevalence,N/A
Etiological subtype,71528,Obesity due to prohormone convertase I deficiency,Cases/families,N/A
Etiological subtype,71528,Obesity due to prohormone convertase I deficiency,Point prevalence,N/A
Etiological subtype,71529,Obesity due to melanocortin 4 receptor deficiency,Point prevalence,N/A
Etiological subtype,71529,Obesity due to melanocortin 4 receptor deficiency,Point prevalence,N/A
Disease,569164,Angiomatoid fibrous histiocytoma,Point prevalence,N/A
Disease,71517,Rapid-onset dystonia-parkinsonism,Cases/families,N/A
Disease,71517,Rapid-onset dystonia-parkinsonism,Point prevalence,N/A
Disease,71518,Benign paroxysmal torticollis of infancy,Cases/families,N/A
Disease,71518,Benign paroxysmal torticollis of infancy,Point prevalence,N/A
Clinical syndrome,71519,Psychogenic movement disorders,Point prevalence,N/A
Disease,569274,Multiple mitochondrial dysfunctions syndrome type 5,Cases/families,N/A
Disease,569274,Multiple mitochondrial dysfunctions syndrome type 5,Point prevalence,N/A
Disease,569290,Multiple mitochondrial dysfunctions syndrome type 6,Cases/families,N/A
Disease,569290,Multiple mitochondrial dysfunctions syndrome type 6,Point prevalence,N/A
Disease,569248,Microcystic stromal tumor,Point prevalence,N/A
Disease,73229,HANAC syndrome,Cases/families,N/A
Disease,73229,HANAC syndrome,Point prevalence,N/A
Disease,73224,Kidney tubulopathy-dilated cardiomyopathy syndrome,Cases/families,N/A
Disease,73224,Kidney tubulopathy-dilated cardiomyopathy syndrome,Point prevalence,N/A
Malformation syndrome,73245,Spinal muscular atrophy-Dandy-Walker malformation-cataracts syndrome,Cases/families,N/A
Malformation syndrome,73245,Spinal muscular atrophy-Dandy-Walker malformation-cataracts syndrome,Point prevalence,N/A
Disease,73230,Ossification anomalies-psychomotor developmental delay syndrome,Cases/families,N/A
Disease,73230,Ossification anomalies-psychomotor developmental delay syndrome,Point prevalence,N/A
Clinical group,73217,Mllerian aplasia,Point prevalence,N/A
Clinical group,73217,Mllerian aplasia,Prevalence at birth,N/A
Clinical group,73217,Mllerian aplasia,Point prevalence,N/A
Malformation syndrome,73223,Global developmental delay-osteopenia-ectodermal defect syndrome,Cases/families,N/A
Malformation syndrome,73223,Global developmental delay-osteopenia-ectodermal defect syndrome,Point prevalence,N/A
Malformation syndrome,40366,Acitretin/etretinate embryopathy,Cases/families,N/A
Malformation syndrome,40366,Acitretin/etretinate embryopathy,Point prevalence,N/A
Disease,40923,Eales disease,Point prevalence,N/A
Disease,39812,Graft versus host disease,Point prevalence,N/A
Etiological subtype,530849,Familial apolipoprotein A5 deficiency,Point prevalence,N/A
Etiological subtype,530849,Familial apolipoprotein A5 deficiency,Cases/families,N/A
Disease,39041,Omenn syndrome,Cases/families,N/A
Disease,39041,Omenn syndrome,Point prevalence,N/A
Disease,530838,KRT1-related diffuse nonepidermolytic keratoderma,Point prevalence,N/A
Disease,39044,Uveal melanoma,Annual incidence,N/A
Disease,39044,Uveal melanoma,Point prevalence,N/A
Disease,39044,Uveal melanoma,Lifetime Prevalence,N/A
Disease,39044,Uveal melanoma,Annual incidence,N/A
Disease,530792,RELA fusion-positive ependymoma,Point prevalence,N/A
Disease,38874,Dihydropyrimidinuria,Point prevalence,N/A
Malformation syndrome,37748,Schnitzler syndrome,Cases/families,N/A
Malformation syndrome,37748,Schnitzler syndrome,Point prevalence,N/A
Disease,37612,Episodic ataxia type 1,Point prevalence,N/A
Disease,37553,Andersen-Tawil syndrome,Annual incidence,N/A
Disease,37553,Andersen-Tawil syndrome,Point prevalence,N/A
Disease,37553,Andersen-Tawil syndrome,Point prevalence,N/A
Disease,37553,Andersen-Tawil syndrome,Point prevalence,N/A
Disease,37202,Interstitial cystitis,Point prevalence,N/A
Disease,37202,Interstitial cystitis,Point prevalence,N/A
Disease,37202,Interstitial cystitis,Point prevalence,N/A
Disease,37202,Interstitial cystitis,Annual incidence,N/A
Disease,37042,Immune dysregulation-polyendocrinopathy-enteropathy-X-linked syndrome,Cases/families,N/A
Disease,37042,Immune dysregulation-polyendocrinopathy-enteropathy-X-linked syndrome,Point prevalence,N/A
Disease,36913,Autoimmune hypoparathyroidism,Annual incidence,N/A
Disease,36913,Autoimmune hypoparathyroidism,Point prevalence,N/A
Disease,36913,Autoimmune hypoparathyroidism,Annual incidence,N/A
Disease,36913,Autoimmune hypoparathyroidism,Point prevalence,N/A
Disease,36899,Myoclonus-dystonia syndrome,Point prevalence,N/A
Malformation syndrome,531151,9q21.13 microdeletion syndrome,Cases/families,N/A
Malformation syndrome,531151,9q21.13 microdeletion syndrome,Point prevalence,N/A
Disease,530983,Lamb-Shaffer syndrome,Cases/families,N/A
Disease,530983,Lamb-Shaffer syndrome,Point prevalence,N/A
Disease,530995,Mixed phenotype acute leukemia,Point prevalence,N/A
Disease,41751,Bietti crystalline dystrophy,Point prevalence,N/A
Disease,42062,Iminoglycinuria,Prevalence at birth,N/A
Disease,42062,Iminoglycinuria,Point prevalence,N/A
Category,35705,Neurometabolic disorder due to serine deficiency,Cases/families,N/A
Category,35705,Neurometabolic disorder due to serine deficiency,Point prevalence,N/A
Disease,35706,Glutaric acidemia type 3,Point prevalence,N/A
Disease,35704,L-Arginine:glycine amidinotransferase deficiency,Cases/families,N/A
Disease,35704,L-Arginine:glycine amidinotransferase deficiency,Point prevalence,N/A
Disease,35710,Glucose-galactose malabsorption,Point prevalence,N/A
Disease,35710,Glucose-galactose malabsorption,Prevalence at birth,N/A
Morphological anomaly,35737,Morning glory disc anomaly,Point prevalence,N/A
Disease,35708,Aromatic L-amino acid decarboxylase deficiency,Cases/families,N/A
Disease,35708,Aromatic L-amino acid decarboxylase deficiency,Point prevalence,N/A
Disease,35689,Primary lateral sclerosis,Point prevalence,N/A
Disease,35701,3-hydroxy-3-methylglutaryl-CoA synthase deficiency,Cases/families,N/A
Disease,35701,3-hydroxy-3-methylglutaryl-CoA synthase deficiency,Point prevalence,N/A
Category,35698,Mitochondrial DNA depletion syndrome,Point prevalence,N/A
Category,35698,Mitochondrial DNA depletion syndrome,Prevalence at birth,N/A
Category,35698,Mitochondrial DNA depletion syndrome,Prevalence at birth,N/A
Malformation syndrome,35612,Nanophthalmos,Point prevalence,N/A
Disease,35173,X-linked dominant chondrodysplasia punctata,Prevalence at birth,N/A
Disease,35173,X-linked dominant chondrodysplasia punctata,Point prevalence,N/A
Disease,35687,Erdheim-Chester disease,Cases/families,N/A
Disease,35687,Erdheim-Chester disease,Point prevalence,N/A
Etiological subtype,35664,ALDH18A1-related De Barsy syndrome,Cases/families,N/A
Etiological subtype,35664,ALDH18A1-related De Barsy syndrome,Point prevalence,N/A
Clinical group,35656,Coenzyme Q10 deficiency,Point prevalence,N/A
Disease,35107,Desmosterolosis,Cases/families,N/A
Disease,35107,Desmosterolosis,Point prevalence,N/A
Disease,35125,Epidermal nevus syndrome,Cases/families,N/A
Disease,35125,Epidermal nevus syndrome,Point prevalence,N/A
Disease,35122,Congenital sucrase-isomaltase deficiency,Point prevalence,N/A
Disease,35121,Lysosomal acid phosphatase deficiency,Point prevalence,N/A
Disease,36387,Genetic epilepsy with febrile seizure plus,Point prevalence,N/A
Category,36388,Paraneoplastic neurologic syndrome,Point prevalence,N/A
Disease,36397,Adiposis dolorosa,Point prevalence,N/A
Disease,36412,Hypocomplementemic urticarial vasculitis,Point prevalence,N/A
Clinical subtype,36426,Stevens-Johnson syndrome,Annual incidence,N/A
Clinical subtype,36426,Stevens-Johnson syndrome,Point prevalence,N/A
Disease,36355,Bleeding disorder due to P2Y12 defect,Cases/families,N/A
Disease,36355,Bleeding disorder due to P2Y12 defect,Point prevalence,N/A
Disease,36386,Hereditary sensory and autonomic neuropathy type 1,Point prevalence,N/A
Disease,36234,Bacterial toxic-shock syndrome,Point prevalence,N/A
Disease,36236,Staphylococcal scalded skin syndrome,Annual incidence,N/A
Disease,36236,Staphylococcal scalded skin syndrome,Point prevalence,N/A
Disease,36238,Staphylococcal necrotizing pneumonia,Point prevalence,N/A
Disease,36237,Bullous impetigo,Point prevalence,N/A
Disease,36273,Gastric linitis plastica,Point prevalence,N/A
Disease,36258,Buerger disease,Point prevalence,N/A
Disease,36258,Buerger disease,Point prevalence,N/A
Category,35808,Malignant sex cord stromal tumor of ovary,Point prevalence,N/A
Category,35808,Malignant sex cord stromal tumor of ovary,Annual incidence,N/A
Category,35808,Malignant sex cord stromal tumor of ovary,Annual incidence,N/A
Category,35808,Malignant sex cord stromal tumor of ovary,Point prevalence,N/A
Category,35808,Malignant sex cord stromal tumor of ovary,Annual incidence,N/A
Category,35808,Malignant sex cord stromal tumor of ovary,Annual incidence,N/A
Category,35808,Malignant sex cord stromal tumor of ovary,Annual incidence,N/A
Category,35808,Malignant sex cord stromal tumor of ovary,Annual incidence,N/A
Category,35808,Malignant sex cord stromal tumor of ovary,Annual incidence,N/A
Category,35808,Malignant sex cord stromal tumor of ovary,Annual incidence,N/A
Category,35808,Malignant sex cord stromal tumor of ovary,Annual incidence,N/A
Category,35808,Malignant sex cord stromal tumor of ovary,Annual incidence,N/A
Category,35808,Malignant sex cord stromal tumor of ovary,Annual incidence,N/A
Category,35808,Malignant sex cord stromal tumor of ovary,Annual incidence,N/A
Category,35808,Malignant sex cord stromal tumor of ovary,Annual incidence,N/A
Category,35808,Malignant sex cord stromal tumor of ovary,Annual incidence,N/A
Category,35808,Malignant sex cord stromal tumor of ovary,Annual incidence,N/A
Category,35808,Malignant sex cord stromal tumor of ovary,Annual incidence,N/A
Category,35808,Malignant sex cord stromal tumor of ovary,Annual incidence,N/A
Category,35808,Malignant sex cord stromal tumor of ovary,Annual incidence,N/A
Category,35808,Malignant sex cord stromal tumor of ovary,Annual incidence,N/A
Category,35808,Malignant sex cord stromal tumor of ovary,Annual incidence,N/A
Category,35808,Malignant sex cord stromal tumor of ovary,Annual incidence,N/A
Category,35808,Malignant sex cord stromal tumor of ovary,Annual incidence,N/A
Category,35808,Malignant sex cord stromal tumor of ovary,Annual incidence,N/A
Category,35808,Malignant sex cord stromal tumor of ovary,Annual incidence,N/A
Category,35808,Malignant sex cord stromal tumor of ovary,Annual incidence,N/A
Category,35807,Malignant germ cell tumor of ovary,Annual incidence,N/A
Category,35807,Malignant germ cell tumor of ovary,Lifetime Prevalence,N/A
Category,35807,Malignant germ cell tumor of ovary,Annual incidence,N/A
Category,35807,Malignant germ cell tumor of ovary,Point prevalence,N/A
Category,35807,Malignant germ cell tumor of ovary,Annual incidence,N/A
Category,35807,Malignant germ cell tumor of ovary,Annual incidence,N/A
Category,35807,Malignant germ cell tumor of ovary,Annual incidence,N/A
Category,35807,Malignant germ cell tumor of ovary,Annual incidence,N/A
Category,35807,Malignant germ cell tumor of ovary,Annual incidence,N/A
Category,35807,Malignant germ cell tumor of ovary,Annual incidence,N/A
Category,35807,Malignant germ cell tumor of ovary,Annual incidence,N/A
Category,35807,Malignant germ cell tumor of ovary,Annual incidence,N/A
Category,35807,Malignant germ cell tumor of ovary,Annual incidence,N/A
Category,35807,Malignant germ cell tumor of ovary,Annual incidence,N/A
Category,35807,Malignant germ cell tumor of ovary,Annual incidence,N/A
Category,35807,Malignant germ cell tumor of ovary,Annual incidence,N/A
Category,35807,Malignant germ cell tumor of ovary,Annual incidence,N/A
Category,35807,Malignant germ cell tumor of ovary,Annual incidence,N/A
Category,35807,Malignant germ cell tumor of ovary,Annual incidence,N/A
Category,35807,Malignant germ cell tumor of ovary,Annual incidence,N/A
Category,35807,Malignant germ cell tumor of ovary,Annual incidence,N/A
Category,35807,Malignant germ cell tumor of ovary,Annual incidence,N/A
Category,35807,Malignant germ cell tumor of ovary,Annual incidence,N/A
Category,35807,Malignant germ cell tumor of ovary,Annual incidence,N/A
Category,35807,Malignant germ cell tumor of ovary,Annual incidence,N/A
Category,35807,Malignant germ cell tumor of ovary,Annual incidence,N/A
Category,35807,Malignant germ cell tumor of ovary,Annual incidence,N/A
Disease,35878,Hyperinsulinism-hyperammonemia syndrome,Point prevalence,N/A
Disease,35858,Imerslund-Grsbeck syndrome,Point prevalence,N/A
Disease,35858,Imerslund-Grsbeck syndrome,Point prevalence,N/A
Disease,35858,Imerslund-Grsbeck syndrome,Point prevalence,N/A
Disease,35858,Imerslund-Grsbeck syndrome,Point prevalence,N/A
Disease,35909,Combined deficiency of factor V and factor VIII,Point prevalence,N/A
Disease,35909,Combined deficiency of factor V and factor VIII,Point prevalence,N/A
Disease,35889,Acute opioid intoxication,Point prevalence,N/A
Clinical group,36204,Intestinal lymphangiectasia,Point prevalence,N/A
Clinical group,35981,Polymicrogyria,Point prevalence,N/A
Disease,33572,5-oxoprolinase deficiency,Cases/families,N/A
Disease,33572,5-oxoprolinase deficiency,Point prevalence,N/A
Disease,33543,Kleine-Levin syndrome,Point prevalence,N/A
Disease,33543,Kleine-Levin syndrome,Point prevalence,N/A
Disease,33475,Meningococcal meningitis,Point prevalence,N/A
Disease,33475,Meningococcal meningitis,Annual incidence,N/A
Disease,33475,Meningococcal meningitis,Annual incidence,N/A
Disease,33475,Meningococcal meningitis,Annual incidence,N/A
Malformation syndrome,33445,Neuroectodermal melanolysosomal disease,Cases/families,N/A
Malformation syndrome,33445,Neuroectodermal melanolysosomal disease,Point prevalence,N/A
Disease,33408,Bullous lichen planus,Point prevalence,N/A
Etiological subtype,535458,Familial GPIHBP1 deficiency,Cases/families,N/A
Etiological subtype,535458,Familial GPIHBP1 deficiency,Point prevalence,N/A
Disease,33402,Pediatric hepatocellular carcinoma,Point prevalence,N/A
Disease,33402,Pediatric hepatocellular carcinoma,Annual incidence,N/A
Disease,33402,Pediatric hepatocellular carcinoma,Annual incidence,N/A
Disease,34217,Naxos disease,Point prevalence,N/A
Disease,33577,Nodular non-suppurative panniculitis,Point prevalence,N/A
Disease,33574,Glutamate-cysteine ligase deficiency,Cases/families,N/A
Disease,33574,Glutamate-cysteine ligase deficiency,Point prevalence,N/A
Disease,33573,Gamma-glutamyl transpeptidase deficiency,Cases/families,N/A
Disease,33573,Gamma-glutamyl transpeptidase deficiency,Point prevalence,N/A
Clinical subtype,33110,Autosomal agammaglobulinemia,Cases/families,N/A
Clinical subtype,33110,Autosomal agammaglobulinemia,Point prevalence,N/A
Disease,33111,Granulomatous slack skin,Cases/families,N/A
Disease,33111,Granulomatous slack skin,Point prevalence,N/A
Malformation syndrome,33108,Lethal multiple pterygium syndrome,Cases/families,N/A
Malformation syndrome,33108,Lethal multiple pterygium syndrome,Point prevalence,N/A
Disease,33067,"Metaphyseal chondrodysplasia, Jansen type",Cases/families,N/A
Disease,33067,"Metaphyseal chondrodysplasia, Jansen type",Point prevalence,N/A
Disease,33069,Dravet syndrome,Prevalence at birth,N/A
Disease,33069,Dravet syndrome,Point prevalence,N/A
Malformation syndrome,33001,Lymphedema-distichiasis syndrome,Point prevalence,N/A
Disease,33355,Reticular dysgenesis,Annual incidence,N/A
Disease,33355,Reticular dysgenesis,Point prevalence,N/A
Etiological subtype,535453,Familial lipase maturation factor 1 deficiency,Cases/families,N/A
Etiological subtype,535453,Familial lipase maturation factor 1 deficiency,Point prevalence,N/A
Disease,33364,Trichothiodystrophy,Point prevalence,N/A
Disease,33364,Trichothiodystrophy,Cases/families,N/A
Disease,33364,Trichothiodystrophy,Prevalence at birth,N/A
Disease,33276,Kaposi sarcoma,Annual incidence,N/A
Disease,33276,Kaposi sarcoma,Point prevalence,N/A
Disease,33276,Kaposi sarcoma,Lifetime Prevalence,N/A
Disease,33276,Kaposi sarcoma,Annual incidence,N/A
Disease,33276,Kaposi sarcoma,Annual incidence,N/A
Disease,33276,Kaposi sarcoma,Annual incidence,N/A
Disease,33276,Kaposi sarcoma,Annual incidence,N/A
Disease,33276,Kaposi sarcoma,Annual incidence,N/A
Disease,33276,Kaposi sarcoma,Annual incidence,N/A
Disease,33276,Kaposi sarcoma,Annual incidence,N/A
Disease,33276,Kaposi sarcoma,Annual incidence,N/A
Disease,33276,Kaposi sarcoma,Annual incidence,N/A
Disease,33276,Kaposi sarcoma,Annual incidence,N/A
Disease,33276,Kaposi sarcoma,Annual incidence,N/A
Disease,33276,Kaposi sarcoma,Annual incidence,N/A
Disease,33276,Kaposi sarcoma,Annual incidence,N/A
Disease,33276,Kaposi sarcoma,Annual incidence,N/A
Disease,33276,Kaposi sarcoma,Annual incidence,N/A
Disease,33276,Kaposi sarcoma,Annual incidence,N/A
Disease,33276,Kaposi sarcoma,Annual incidence,N/A
Disease,33276,Kaposi sarcoma,Annual incidence,N/A
Disease,33276,Kaposi sarcoma,Annual incidence,N/A
Disease,33276,Kaposi sarcoma,Annual incidence,N/A
Disease,33276,Kaposi sarcoma,Annual incidence,N/A
Disease,33276,Kaposi sarcoma,Annual incidence,N/A
Disease,33276,Kaposi sarcoma,Annual incidence,N/A
Disease,33314,Jessner lymphocytic infiltration of the skin,Point prevalence,N/A
Disease,33208,Idiopathic hypersomnia,Point prevalence,N/A
Disease,33208,Idiopathic hypersomnia,Point prevalence,N/A
Disease,33226,Waldenstrm macroglobulinemia,Annual incidence,N/A
Disease,33226,Waldenstrm macroglobulinemia,Annual incidence,N/A
Disease,33226,Waldenstrm macroglobulinemia,Annual incidence,N/A
Disease,33226,Waldenstrm macroglobulinemia,Annual incidence,N/A
Disease,33226,Waldenstrm macroglobulinemia,Annual incidence,N/A
Disease,33226,Waldenstrm macroglobulinemia,Point prevalence,N/A
Disease,33226,Waldenstrm macroglobulinemia,Point prevalence,N/A
Disease,35069,Infantile neuroaxonal dystrophy,Cases/families,N/A
Disease,35069,Infantile neuroaxonal dystrophy,Point prevalence,N/A
Morphological anomaly,35093,Non-syndromic sagittal craniosynostosis,Point prevalence,N/A
Morphological anomaly,35093,Non-syndromic sagittal craniosynostosis,Prevalence at birth,N/A
Disease,35078,T-B+ severe combined immunodeficiency due to JAK3 deficiency,Point prevalence,N/A
Disease,35062,Severe disseminated cytomegalovirus infection in immunocompetent patients,Point prevalence,N/A
Disease,34520,Congenital muscular dystrophy with integrin alpha-7 deficiency,Point prevalence,N/A
Disease,34514,Telethonin-related limb-girdle muscular dystrophy R7,Cases/families,N/A
Disease,34514,Telethonin-related limb-girdle muscular dystrophy R7,Point prevalence,N/A
Disease,34515,FKRP-related limb-girdle muscular dystrophy R9,Point prevalence,N/A
Disease,34515,FKRP-related limb-girdle muscular dystrophy R9,Point prevalence,N/A
Disease,34515,FKRP-related limb-girdle muscular dystrophy R9,Point prevalence,N/A
Disease,34516,DNAJB6-related limb-girdle muscular dystrophy D1,Cases/families,N/A
Disease,34516,DNAJB6-related limb-girdle muscular dystrophy D1,Point prevalence,N/A
Disease,34587,Danon disease,Cases/families,N/A
Disease,34587,Danon disease,Point prevalence,N/A
Disease,34587,Danon disease,Prevalence at birth,N/A
Disease,34592,Immunodeficiency by defective expression of MHC class I,Cases/families,N/A
Disease,34592,Immunodeficiency by defective expression of MHC class I,Point prevalence,N/A
Disease,34528,Autosomal dominant primary hypomagnesemia with hypocalciuria,Cases/families,N/A
Disease,34528,Autosomal dominant primary hypomagnesemia with hypocalciuria,Point prevalence,N/A
Category,34533,Corneal dystrophy,Point prevalence,N/A
Category,34533,Corneal dystrophy,Point prevalence,N/A
Disease,536516,Myopathic Ehlers-Danlos syndrome,Cases/families,N/A
Disease,536516,Myopathic Ehlers-Danlos syndrome,Point prevalence,N/A
Disease,536471,Spondylodysplastic Ehlers-Danlos syndrome,Point prevalence,N/A
Disease,536471,Spondylodysplastic Ehlers-Danlos syndrome,Cases/families,N/A
Clinical subtype,536467,B3GALT6-related spondylodysplastic Ehlers-Danlos syndrome,Cases/families,N/A
Clinical subtype,536467,B3GALT6-related spondylodysplastic Ehlers-Danlos syndrome,Point prevalence,N/A
Disease,536545,Kyphoscoliotic Ehlers-Danlos syndrome,Point prevalence,N/A
Disease,536532,Classical-like Ehlers-Danlos syndrome type 2,Cases/families,N/A
Disease,536532,Classical-like Ehlers-Danlos syndrome type 2,Point prevalence,N/A
Clinical subtype,537072,PLG-related hereditary angioedema with normal C1Inh,Cases/families,N/A
Clinical subtype,537072,PLG-related hereditary angioedema with normal C1Inh,Point prevalence,N/A
Disease,32960,Tumor necrosis factor receptor 1 associated periodic syndrome,Point prevalence,N/A
Disease,32960,Tumor necrosis factor receptor 1 associated periodic syndrome,Point prevalence,N/A
Disease,52530,Pseudo-von Willebrand disease,Cases/families,N/A
Disease,52530,Pseudo-von Willebrand disease,Point prevalence,N/A
Clinical group,52688,Myelodysplastic syndrome,Annual incidence,N/A
Clinical group,52688,Myelodysplastic syndrome,Lifetime Prevalence,N/A
Clinical group,52688,Myelodysplastic syndrome,Annual incidence,N/A
Clinical group,52688,Myelodysplastic syndrome,Point prevalence,N/A
Clinical group,52688,Myelodysplastic syndrome,Annual incidence,N/A
Clinical group,52688,Myelodysplastic syndrome,Point prevalence,N/A
Clinical group,52688,Myelodysplastic syndrome,Annual incidence,N/A
Clinical group,52688,Myelodysplastic syndrome,Annual incidence,N/A
Clinical group,52688,Myelodysplastic syndrome,Annual incidence,N/A
Clinical group,52688,Myelodysplastic syndrome,Annual incidence,N/A
Clinical group,52688,Myelodysplastic syndrome,Annual incidence,N/A
Clinical group,52688,Myelodysplastic syndrome,Annual incidence,N/A
Clinical group,52688,Myelodysplastic syndrome,Point prevalence,N/A
Clinical group,52688,Myelodysplastic syndrome,Point prevalence,N/A
Clinical group,52688,Myelodysplastic syndrome,Annual incidence,N/A
Clinical group,52688,Myelodysplastic syndrome,Point prevalence,N/A
Clinical group,52688,Myelodysplastic syndrome,Annual incidence,N/A
Disease,538096,Autosomal recessive lethal neonatal axonal sensorimotor polyneuropathy,Point prevalence,N/A
Disease,538096,Autosomal recessive lethal neonatal axonal sensorimotor polyneuropathy,Cases/families,N/A
Disease,52503,X-linked creatine transporter deficiency,Cases/families,N/A
Disease,52503,X-linked creatine transporter deficiency,Point prevalence,N/A
Disease,538101,Congenital axonal neuropathy with encephalopathy,Point prevalence,N/A
Disease,538101,Congenital axonal neuropathy with encephalopathy,Cases/families,N/A
Disease,52430,Inclusion body myopathy with Paget disease of bone and frontotemporal dementia,Cases/families,N/A
Disease,52430,Inclusion body myopathy with Paget disease of bone and frontotemporal dementia,Point prevalence,N/A
Disease,52416,Mantle cell lymphoma,Annual incidence,N/A
Disease,52416,Mantle cell lymphoma,Point prevalence,N/A
Disease,52416,Mantle cell lymphoma,Annual incidence,N/A
Disease,52427,Retinitis punctata albescens,Point prevalence,N/A
Disease,52427,Retinitis punctata albescens,Point prevalence,N/A
Disease,52417,MALT lymphoma,Annual incidence,N/A
Disease,52417,MALT lymphoma,Annual incidence,N/A
Disease,52417,MALT lymphoma,Point prevalence,N/A
Malformation syndrome,52056,Ulnar/fibula ray defect-brachydactyly syndrome,Cases/families,N/A
Malformation syndrome,52056,Ulnar/fibula ray defect-brachydactyly syndrome,Point prevalence,N/A
Malformation syndrome,52055,Corpus callosum agenesis-intellectual disability-coloboma-micrognathia syndrome,Cases/families,N/A
Malformation syndrome,52055,Corpus callosum agenesis-intellectual disability-coloboma-micrognathia syndrome,Point prevalence,N/A
Disease,52368,Mohr-Tranebjaerg syndrome,Cases/families,N/A
Disease,52368,Mohr-Tranebjaerg syndrome,Point prevalence,N/A
Malformation syndrome,53271,Muenke syndrome,Prevalence at birth,N/A
Malformation syndrome,53271,Muenke syndrome,Point prevalence,N/A
Malformation syndrome,53271,Muenke syndrome,Prevalence at birth,N/A
Disease,53296,Familial cutaneous collagenoma,Cases/families,N/A
Disease,53296,Familial cutaneous collagenoma,Point prevalence,N/A
Disease,53347,Brody myopathy,Point prevalence,N/A
Disease,52994,Orbital leiomyoma,Cases/families,N/A
Disease,52994,Orbital leiomyoma,Point prevalence,N/A
Malformation syndrome,53035,Caroli disease,Annual incidence,N/A
Malformation syndrome,53035,Caroli disease,Point prevalence,N/A
Category,52759,Vasculitis,Point prevalence,N/A
Disease,52901,Isolated follicle stimulating hormone deficiency,Point prevalence,N/A
Clinical subtype,538863,Classic pyoderma gangrenosum,Point prevalence,N/A
Clinical subtype,538863,Classic pyoderma gangrenosum,Annual incidence,N/A
Disease,538756,Familial multiple discoid fibromas,Cases/families,N/A
Disease,538756,Familial multiple discoid fibromas,Point prevalence,N/A
Disease,538574,Palmoplantar keratoderma-hereditary motor and sensory neuropathy syndrome,Cases/families,N/A
Disease,538574,Palmoplantar keratoderma-hereditary motor and sensory neuropathy syndrome,Point prevalence,N/A
Disease,53583,Paroxysmal dystonic choreathetosis with episodic ataxia and spasticity,Cases/families,N/A
Disease,53583,Paroxysmal dystonic choreathetosis with episodic ataxia and spasticity,Point prevalence,N/A
Disease,53540,Goldmann-Favre syndrome,Cases/families,N/A
Disease,53540,Goldmann-Favre syndrome,Point prevalence,N/A
Disease,53372,Hereditary geniospasm,Point prevalence,N/A
Disease,53351,X-linked dystonia-parkinsonism,Point prevalence,N/A
Disease,53351,X-linked dystonia-parkinsonism,Point prevalence,N/A
Disease,54247,Posterior cortical atrophy,Point prevalence,N/A
Disease,538934,X-linked lymphoproliferative disease due to XIAP deficiency,Cases/families,N/A
Disease,538934,X-linked lymphoproliferative disease due to XIAP deficiency,Point prevalence,N/A
Disease,54251,Aseptic abscess syndrome,Cases/families,N/A
Disease,54251,Aseptic abscess syndrome,Point prevalence,N/A
Disease,538931,X-linked lymphoproliferative disease due to SAP deficiency,Cases/families,N/A
Disease,538931,X-linked lymphoproliferative disease due to SAP deficiency,Point prevalence,N/A
Disease,54057,Thrombotic thrombocytopenic purpura,Point prevalence,N/A
Disease,54057,Thrombotic thrombocytopenic purpura,Annual incidence,N/A
Disease,54028,Plummer-Vinson syndrome,Cases/families,N/A
Disease,54028,Plummer-Vinson syndrome,Point prevalence,N/A
Malformation syndrome,53719,Wyburn-Mason syndrome,Point prevalence,N/A
Malformation syndrome,53719,Wyburn-Mason syndrome,Cases/families,N/A
Malformation syndrome,53721,Spinal arteriovenous metameric syndrome,Cases/families,N/A
Malformation syndrome,53721,Spinal arteriovenous metameric syndrome,Point prevalence,N/A
Disease,53715,Familial tumoral calcinosis,Point prevalence,N/A
Malformation syndrome,53696,Arthrogryposis-anterior horn cell disease syndrome,Cases/families,N/A
Malformation syndrome,53696,Arthrogryposis-anterior horn cell disease syndrome,Point prevalence,N/A
Clinical subtype,538872,Vegetative pyoderma gangrenosum,Point prevalence,N/A
Clinical subtype,538872,Vegetative pyoderma gangrenosum,Annual incidence,N/A
Malformation syndrome,53697,Gnathodiaphyseal dysplasia,Point prevalence,N/A
Clinical subtype,538869,Bullous pyoderma gangrenosum,Point prevalence,N/A
Clinical subtype,538869,Bullous pyoderma gangrenosum,Annual incidence,N/A
Clinical subtype,538866,Pustular pyoderma gangrenosum,Point prevalence,N/A
Clinical subtype,538866,Pustular pyoderma gangrenosum,Annual incidence,N/A
Disease,53693,GRACILE syndrome,Prevalence at birth,N/A
Disease,53693,GRACILE syndrome,Point prevalence,N/A
Disease,53693,GRACILE syndrome,Point prevalence,N/A
Disease,48818,Aceruloplasminemia,Point prevalence,N/A
Disease,48818,Aceruloplasminemia,Point prevalence,N/A
Clinical subtype,49041,IgG4-related retroperitoneal fibrosis,Annual incidence,N/A
Clinical subtype,49041,IgG4-related retroperitoneal fibrosis,Point prevalence,N/A
Clinical subtype,49041,IgG4-related retroperitoneal fibrosis,Point prevalence,N/A
Disease,48918,Focal myositis,Cases/families,N/A
Disease,48918,Focal myositis,Point prevalence,N/A
Disease,49382,Achromatopsia,Point prevalence,N/A
Disease,49042,Dentinogenesis imperfecta,Point prevalence,N/A
Disease,538958,Combined immunodeficiency due to CD70 deficiency,Cases/families,N/A
Disease,538958,Combined immunodeficiency due to CD70 deficiency,Point prevalence,N/A
Malformation syndrome,48431,Congenital cataracts-facial dysmorphism-neuropathy syndrome,Cases/families,N/A
Malformation syndrome,48431,Congenital cataracts-facial dysmorphism-neuropathy syndrome,Point prevalence,N/A
Disease,538963,Combined immunodeficiency due to ITK deficiency,Cases/families,N/A
Disease,538963,Combined immunodeficiency due to ITK deficiency,Point prevalence,N/A
Disease,48435,Postinfectious vasculitis,Point prevalence,N/A
Disease,48686,Primary effusion lymphoma,Cases/families,N/A
Disease,48686,Primary effusion lymphoma,Point prevalence,N/A
Malformation syndrome,48652,Phelan-McDermid syndrome,Cases/families,N/A
Malformation syndrome,48652,Phelan-McDermid syndrome,Point prevalence,N/A
Malformation syndrome,50809,Talo-patello-scaphoid osteolysis,Cases/families,N/A
Malformation syndrome,50809,Talo-patello-scaphoid osteolysis,Point prevalence,N/A
Malformation syndrome,50810,Microlissencephaly-micromelia syndrome,Cases/families,N/A
Malformation syndrome,50810,Microlissencephaly-micromelia syndrome,Point prevalence,N/A
Disease,50811,Lipodystrophy-intellectual disability-deafness syndrome,Cases/families,N/A
Disease,50811,Lipodystrophy-intellectual disability-deafness syndrome,Point prevalence,N/A
Disease,50812,Zellweger-like syndrome without peroxisomal anomalies,Cases/families,N/A
Disease,50812,Zellweger-like syndrome without peroxisomal anomalies,Point prevalence,N/A
Malformation syndrome,50814,Craniolenticulosutural dysplasia,Cases/families,N/A
Malformation syndrome,50814,Craniolenticulosutural dysplasia,Point prevalence,N/A
Malformation syndrome,50815,Branchiogenic deafness syndrome,Cases/families,N/A
Malformation syndrome,50815,Branchiogenic deafness syndrome,Point prevalence,N/A
Disease,49566,Acquired purpura fulminans,Annual incidence,N/A
Disease,49566,Acquired purpura fulminans,Point prevalence,N/A
Disease,49827,Thiamine-responsive megaloblastic anemia syndrome,Cases/families,N/A
Disease,49827,Thiamine-responsive megaloblastic anemia syndrome,Point prevalence,N/A
Disease,50251,Pleural mesothelioma,Point prevalence,N/A
Disease,50251,Pleural mesothelioma,Annual incidence,N/A
Disease,50251,Pleural mesothelioma,Annual incidence,N/A
Malformation syndrome,50945,Blomstrand lethal chondrodysplasia,Cases/families,N/A
Malformation syndrome,50945,Blomstrand lethal chondrodysplasia,Point prevalence,N/A
Disease,50944,Schpf-Schulz-Passarge syndrome,Cases/families,N/A
Disease,50944,Schpf-Schulz-Passarge syndrome,Point prevalence,N/A
Disease,51083,Familial short QT syndrome,Point prevalence,N/A
Disease,51083,Familial short QT syndrome,Cases/families,N/A
Disease,50839,Cat-scratch disease,Point prevalence,N/A
Disease,50918,Kikuchi-Fujimoto disease,Point prevalence,N/A
Disease,50918,Kikuchi-Fujimoto disease,Cases/families,N/A
Disease,50918,Kikuchi-Fujimoto disease,Annual incidence,N/A
Malformation syndrome,52054,Craniosynostosis-intracranial calcifications syndrome,Cases/families,N/A
Malformation syndrome,52054,Craniosynostosis-intracranial calcifications syndrome,Point prevalence,N/A
Malformation syndrome,52022,Potocki-Shaffer syndrome,Cases/families,N/A
Malformation syndrome,52022,Potocki-Shaffer syndrome,Point prevalence,N/A
Malformation syndrome,52047,Braddock syndrome,Cases/families,N/A
Malformation syndrome,52047,Braddock syndrome,Point prevalence,N/A
Clinical group,51577,Cobblestone lissencephaly,Prevalence at birth,N/A
Clinical group,51577,Cobblestone lissencephaly,Point prevalence,N/A
Disease,51608,Generalized arterial calcification of infancy,Point prevalence,N/A
Disease,51608,Generalized arterial calcification of infancy,Cases/families,N/A
Disease,51188,Ethylmalonic encephalopathy,Cases/families,N/A
Disease,51188,Ethylmalonic encephalopathy,Point prevalence,N/A
Disease,541423,Growth delay-intellectual disability-hepatopathy syndrome,Cases/families,N/A
Disease,541423,Growth delay-intellectual disability-hepatopathy syndrome,Point prevalence,N/A
Disease,51208,Formiminoglutamic aciduria,Point prevalence,N/A
Disease,51636,WHIM syndrome,Cases/families,N/A
Disease,51636,WHIM syndrome,Point prevalence,N/A
Disease,51636,WHIM syndrome,Prevalence at birth,N/A
Disease,51890,Anterior cutaneous nerve entrapment syndrome,Point prevalence,N/A
Disease,51890,Anterior cutaneous nerve entrapment syndrome,Annual incidence,N/A
Disease,542306,GNB5-related intellectual disability-cardiac arrhythmia syndrome,Point prevalence,N/A
Disease,542306,GNB5-related intellectual disability-cardiac arrhythmia syndrome,Cases/families,N/A
Disease,542301,Combined immunodeficiency due to CARMIL2 deficiency,Cases/families,N/A
Disease,542301,Combined immunodeficiency due to CARMIL2 deficiency,Point prevalence,N/A
Disease,542310,Leukoencephalopathy with calcifications and cysts,Cases/families,N/A
Disease,542310,Leukoencephalopathy with calcifications and cysts,Point prevalence,N/A
Disease,42642,PFAPA syndrome,Cases/families,N/A
Disease,42642,PFAPA syndrome,Point prevalence,N/A
Malformation syndrome,42665,Tietz syndrome,Cases/families,N/A
Malformation syndrome,42665,Tietz syndrome,Point prevalence,N/A
Particular clinical situation in a disease or syndrome,542323,CAR T cell therapy-associated cytokine release syndrome,Point prevalence,N/A
Particular clinical situation in a disease or syndrome,43117,Acute tricyclic antidepressant poisoning,Point prevalence,N/A
Disease,542585,Auditory neuropathy-optic atrophy syndrome,Cases/families,N/A
Disease,542585,Auditory neuropathy-optic atrophy syndrome,Point prevalence,N/A
Disease,43116,Serotonin syndrome,Point prevalence,N/A
Disease,542592,Necrobiosis lipoidica,Point prevalence,N/A
Disease,43393,Lambert-Eaton myasthenic syndrome,Annual incidence,N/A
Disease,43393,Lambert-Eaton myasthenic syndrome,Point prevalence,N/A
Disease,43393,Lambert-Eaton myasthenic syndrome,Point prevalence,N/A
Particular clinical situation in a disease or syndrome,43119,Acute poisoning by drugs with membrane-stabilizing effect,Point prevalence,N/A
Clinical syndrome,542643,Livedoid vasculopathy,Annual incidence,N/A
Clinical syndrome,542643,Livedoid vasculopathy,Point prevalence,N/A
Malformation syndrome,42775,PHACE syndrome,Cases/families,N/A
Malformation syndrome,42775,PHACE syndrome,Point prevalence,N/A
Clinical group,42738,Severe congenital neutropenia,Prevalence at birth,N/A
Clinical group,42738,Severe congenital neutropenia,Point prevalence,N/A
Clinical group,42738,Severe congenital neutropenia,Point prevalence,N/A
Clinical group,42738,Severe congenital neutropenia,Prevalence at birth,N/A
Clinical group,42738,Severe congenital neutropenia,Point prevalence,N/A
Clinical group,42738,Severe congenital neutropenia,Point prevalence,N/A
Clinical group,42738,Severe congenital neutropenia,Point prevalence,N/A
Clinical group,42738,Severe congenital neutropenia,Point prevalence,N/A
Disease,43115,Hereditary myopathy with lactic acidosis due to ISCU deficiency,Cases/families,N/A
Disease,43115,Hereditary myopathy with lactic acidosis due to ISCU deficiency,Point prevalence,N/A
Disease,45448,Miyoshi myopathy,Annual incidence,N/A
Disease,45448,Miyoshi myopathy,Point prevalence,N/A
Disease,45448,Miyoshi myopathy,Point prevalence,N/A
Disease,543470,Optic atrophy-ataxia-peripheral neuropathy-global developmental delay syndrome,Cases/families,N/A
Disease,543470,Optic atrophy-ataxia-peripheral neuropathy-global developmental delay syndrome,Point prevalence,N/A
Disease,45453,Incessant infant ventricular tachycardia,Prevalence at birth,N/A
Disease,45453,Incessant infant ventricular tachycardia,Point prevalence,N/A
Disease,45453,Incessant infant ventricular tachycardia,Prevalence at birth,N/A
Disease,45453,Incessant infant ventricular tachycardia,Point prevalence,N/A
Disease,45452,Idiopathic neonatal atrial flutter,Prevalence at birth,N/A
Disease,45452,Idiopathic neonatal atrial flutter,Prevalence at birth,N/A
Disease,45452,Idiopathic neonatal atrial flutter,Point prevalence,N/A
Disease,542657,Isolated hyperchlorhidrosis,Cases/families,N/A
Disease,542657,Isolated hyperchlorhidrosis,Point prevalence,N/A
Disease,44890,Gastrointestinal stromal tumor,Point prevalence,N/A
Disease,44890,Gastrointestinal stromal tumor,Annual incidence,N/A
Disease,44890,Gastrointestinal stromal tumor,Annual incidence,N/A
Disease,44890,Gastrointestinal stromal tumor,Annual incidence,N/A
Disease,44890,Gastrointestinal stromal tumor,Point prevalence,N/A
Disease,44890,Gastrointestinal stromal tumor,Annual incidence,N/A
Disease,44890,Gastrointestinal stromal tumor,Annual incidence,N/A
Disease,44890,Gastrointestinal stromal tumor,Point prevalence,N/A
Disease,45358,Congenital fibrosis of extraocular muscles,Point prevalence,N/A
Disease,45358,Congenital fibrosis of extraocular muscles,Point prevalence,N/A
Disease,46487,Epidermolysis bullosa acquisita,Annual incidence,N/A
Disease,46487,Epidermolysis bullosa acquisita,Annual incidence,N/A
Disease,46487,Epidermolysis bullosa acquisita,Annual incidence,N/A
Disease,46487,Epidermolysis bullosa acquisita,Annual incidence,N/A
Disease,46487,Epidermolysis bullosa acquisita,Point prevalence,N/A
Disease,46487,Epidermolysis bullosa acquisita,Annual incidence,N/A
Disease,46487,Epidermolysis bullosa acquisita,Point prevalence,N/A
Disease,544254,SYNGAP1-related developmental and epileptic encephalopathy,Cases/families,N/A
Disease,544254,SYNGAP1-related developmental and epileptic encephalopathy,Point prevalence,N/A
Disease,46488,Linear IgA dermatosis,Annual incidence,N/A
Disease,46488,Linear IgA dermatosis,Annual incidence,N/A
Disease,46488,Linear IgA dermatosis,Annual incidence,N/A
Disease,46488,Linear IgA dermatosis,Point prevalence,N/A
Disease,46488,Linear IgA dermatosis,Point prevalence,N/A
Disease,46488,Linear IgA dermatosis,Point prevalence,N/A
Clinical group,46485,Superficial pemphigus,Point prevalence,N/A
Disease,46486,Mucous membrane pemphigoid,Annual incidence,N/A
Disease,46486,Mucous membrane pemphigoid,Annual incidence,N/A
Disease,46486,Mucous membrane pemphigoid,Point prevalence,N/A
Disease,46486,Mucous membrane pemphigoid,Point prevalence,N/A
Disease,46348,Paroxysmal extreme pain disorder,Cases/families,N/A
Disease,46348,Paroxysmal extreme pain disorder,Point prevalence,N/A
Clinical group,46484,Oligodendroglial tumor,Annual incidence,N/A
Clinical group,46484,Oligodendroglial tumor,Point prevalence,N/A
Clinical group,46484,Oligodendroglial tumor,Annual incidence,N/A
Disease,46059,Lathosterolosis,Cases/families,N/A
Disease,46059,Lathosterolosis,Point prevalence,N/A
Disease,46135,Primary central nervous system lymphoma,Annual incidence,N/A
Disease,46135,Primary central nervous system lymphoma,Annual incidence,N/A
Morphological anomaly,46724,Cerebral arteriovenous malformation,Point prevalence,N/A
Malformation syndrome,46627,Char syndrome,Cases/families,N/A
Malformation syndrome,46627,Char syndrome,Point prevalence,N/A
Disease,46532,Hereditary persistence of fetal hemoglobin-beta-thalassemia syndrome,Point prevalence,N/A
Histopathological subtype,48372,Nodular regenerative hyperplasia of the liver,Annual incidence,N/A
Histopathological subtype,48372,Nodular regenerative hyperplasia of the liver,Point prevalence,N/A
Histopathological subtype,48372,Nodular regenerative hyperplasia of the liver,Point prevalence,N/A
Clinical subtype,48162,Lewis-Sumner syndrome,Point prevalence,N/A
Clinical subtype,544493,Streptococcus pneumoniae-associated hemolytic uremic syndrome,Point prevalence,N/A
Disease,48104,Pyoderma gangrenosum,Annual incidence,N/A
Disease,48104,Pyoderma gangrenosum,Annual incidence,N/A
Disease,48104,Pyoderma gangrenosum,Point prevalence,N/A
Disease,48104,Pyoderma gangrenosum,Annual incidence,N/A
Disease,48104,Pyoderma gangrenosum,Annual incidence,N/A
Disease,48104,Pyoderma gangrenosum,Annual incidence,N/A
Disease,544503,RNF13-related severe early-onset epileptic encephalopathy,Cases/families,N/A
Disease,544503,RNF13-related severe early-onset epileptic encephalopathy,Point prevalence,N/A
Disease,47612,Felty syndrome,Point prevalence,N/A
Disease,544482,Infection-related hemolytic uremic syndrome,Point prevalence,N/A
Disease,47159,Proximal renal tubular acidosis,Point prevalence,N/A
Disease,544488,Global developmental delay-alopecia-macrocephaly-facial dysmorphism-structural brain anomalies syndrome,Cases/families,N/A
Disease,544488,Global developmental delay-alopecia-macrocephaly-facial dysmorphism-structural brain anomalies syndrome,Point prevalence,N/A
Malformation syndrome,544469,PRUNE1-related neurological syndrome,Cases/families,N/A
Malformation syndrome,544469,PRUNE1-related neurological syndrome,Point prevalence,N/A
Etiological subtype,544472,Atypical hemolytic uremic syndrome with complement gene abnormality,Point prevalence,N/A
Disease,47045,Familial cold urticaria,Annual incidence,N/A
Disease,47045,Familial cold urticaria,Point prevalence,N/A
Disease,544628,Atypical Fanconi syndrome-neonatal hyperinsulinism syndrome,Point prevalence,N/A
Disease,544628,Atypical Fanconi syndrome-neonatal hyperinsulinism syndrome,Cases/families,N/A
Disease,544602,Congenital myopathy with reduced type 2 muscle fibers,Cases/families,N/A
Disease,544602,Congenital myopathy with reduced type 2 muscle fibers,Point prevalence,N/A
Disease,48377,Subcorneal pustular dermatosis,Cases/families,N/A
Disease,48377,Subcorneal pustular dermatosis,Point prevalence,N/A
Clinical subtype,544578,"Congenital primary megaureter, refluxing and obstructed form",Point prevalence,N/A
Disease,555402,NAD(P)HX dehydratase deficiency,Cases/families,N/A
Disease,555402,NAD(P)HX dehydratase deficiency,Point prevalence,N/A
Clinical subtype,555434,Fibrohistiocytic inflammatory pseudotumor of the liver,Point prevalence,N/A
Disease,555407,NAD(P)HX epimerase deficiency,Cases/families,N/A
Disease,555407,NAD(P)HX epimerase deficiency,Point prevalence,N/A
Category,68367,Rare inborn errors of metabolism,Prevalence at birth,N/A
Clinical subtype,555437,Lymphoplasmacytic inflammatory pseudotumor of the liver,Point prevalence,N/A
Morphological anomaly,555874,Congenital tricuspid valve dysplasia,Point prevalence,N/A
Morphological anomaly,555877,FLNA-related X-linked myxomatous valvular dysplasia,Point prevalence,N/A
Disease,555905,IgA pemphigus,Point prevalence,N/A
Clinical subtype,556030,Early-onset familial hypoaldosteronism,Point prevalence,N/A
Clinical subtype,556037,Late-onset familial hypoaldosteronism,Point prevalence,N/A
Disease,556985,Early-onset calcifying leukoencephalopathy-skeletal dysplasia,Point prevalence,N/A
Disease,556985,Early-onset calcifying leukoencephalopathy-skeletal dysplasia,Cases/families,N/A
Disease,556955,Pancreatic agenesis-holoprosencephaly syndrome,Cases/families,N/A
Disease,556955,Pancreatic agenesis-holoprosencephaly syndrome,Point prevalence,N/A
Disease,557064,Neonatal epileptic encephalopathy due to glutaminase deficiency,Cases/families,N/A
Disease,557064,Neonatal epileptic encephalopathy due to glutaminase deficiency,Point prevalence,N/A
Disease,557056,Spastic ataxia-dysarthria due to glutaminase deficiency,Cases/families,N/A
Disease,557056,Spastic ataxia-dysarthria due to glutaminase deficiency,Point prevalence,N/A
Disease,557003,Oculoskeletodental syndrome,Cases/families,N/A
Disease,557003,Oculoskeletodental syndrome,Point prevalence,N/A
Particular clinical situation in a disease or syndrome,90065,Acquired aneurysmal subarachnoid hemorrhage,Point prevalence,N/A
Particular clinical situation in a disease or syndrome,90066,Pneumonia caused by Pseudomonas aeruginosa infection,Point prevalence,N/A
Disease,90068,Cocaine intoxication,Point prevalence,N/A
Category,90061,Non-infectious posterior uveitis,Point prevalence,N/A
Clinical syndrome,90062,Acute liver failure,Point prevalence,N/A
Malformation syndrome,519388,Autosomal recessive anterior segment dysgenesis,Cases/families,N/A
Malformation syndrome,519388,Autosomal recessive anterior segment dysgenesis,Point prevalence,N/A
Particular clinical situation in a disease or syndrome,90064,Acute peripheral arterial occlusion,Point prevalence,N/A
Particular clinical situation in a disease or syndrome,90073,Hepatitis B reinfection following liver transplantation,Point prevalence,N/A
Particular clinical situation in a disease or syndrome,90076,Partial deep dermal and full thickness burns,Point prevalence,N/A
Disease,90069,Systemic monochloroacetate poisoning,Point prevalence,N/A
Disease,90050,Retinopathy of prematurity,Point prevalence,N/A
Disease,90045,Hereditary folate malabsorption,Cases/families,N/A
Disease,90045,Hereditary folate malabsorption,Point prevalence,N/A
Particular clinical situation in a disease or syndrome,90052,Recurrent hepatitis C virus induced liver disease in liver transplant recipients,Point prevalence,N/A
Particular clinical situation in a disease or syndrome,90051,Sepsis in premature infants,Point prevalence,N/A
Disease,90041,Gaisbck syndrome,Point prevalence,N/A
Disease,90039,Hemoglobin D disease,Point prevalence,N/A
Disease,90044,Familial pseudohyperkalemia,Point prevalence,N/A
Disease,90042,Primary familial polycythemia,Point prevalence,N/A
Particular clinical situation in a disease or syndrome,90058,Spinal cord injury,Annual incidence,N/A
Particular clinical situation in a disease or syndrome,90058,Spinal cord injury,Point prevalence,N/A
Clinical syndrome,90060,Diffuse alveolar hemorrhage,Point prevalence,N/A
Particular clinical situation in a disease or syndrome,90059,Sudden sensorineural hearing loss,Point prevalence,N/A
Particular clinical situation in a disease or syndrome,90053,Complications after hematopoietic stem cell transplantation,Point prevalence,N/A
Particular clinical situation in a disease or syndrome,90056,Moderate and severe traumatic brain injury,Point prevalence,N/A
Malformation syndrome,90024,"Deafness with labyrinthine aplasia, microtia, and microdontia",Cases/families,N/A
Malformation syndrome,90024,"Deafness with labyrinthine aplasia, microtia, and microdontia",Point prevalence,N/A
Disease,90023,Primary immunodeficiency syndrome due to P14/LAMTOR2 deficiency,Cases/families,N/A
Disease,90023,Primary immunodeficiency syndrome due to P14/LAMTOR2 deficiency,Point prevalence,N/A
Disease,90003,Inflammatory pseudotumor of the liver,Cases/families,N/A
Disease,90003,Inflammatory pseudotumor of the liver,Point prevalence,N/A
Disease,90037,Drug-induced autoimmune hemolytic anemia,Point prevalence,N/A
Clinical subtype,90038,Shiga toxin-associated hemolytic uremic syndrome,Annual incidence,N/A
Clinical subtype,90038,Shiga toxin-associated hemolytic uremic syndrome,Point prevalence,N/A
Disease,90035,Paroxysmal cold hemoglobinuria,Point prevalence,N/A
Disease,90036,Mixed-type autoimmune hemolytic anemia,Point prevalence,N/A
Disease,90031,Non-spherocytic hemolytic anemia due to hexokinase deficiency,Cases/families,N/A
Disease,90031,Non-spherocytic hemolytic anemia due to hexokinase deficiency,Point prevalence,N/A
Disease,90033,"Autoimmune hemolytic anemia, warm type",Point prevalence,N/A
Disease,90026,Primary erythromelalgia,Annual incidence,N/A
Disease,90026,Primary erythromelalgia,Point prevalence,N/A
Disease,90030,Hemolytic anemia due to glutathione reductase deficiency,Cases/families,N/A
Disease,90030,Hemolytic anemia due to glutathione reductase deficiency,Point prevalence,N/A
Disease,89936,X-linked hypophosphatemia,Point prevalence,N/A
Disease,89936,X-linked hypophosphatemia,Point prevalence,N/A
Disease,89936,X-linked hypophosphatemia,Point prevalence,N/A
Disease,89936,X-linked hypophosphatemia,Annual incidence,N/A
Disease,89936,X-linked hypophosphatemia,Point prevalence,N/A
Clinical subtype,89844,"Lissencephaly syndrome, Norman-Roberts type",Point prevalence,N/A
Disease,89843,Dystrophic epidermolysis bullosa pruriginosa,Cases/families,N/A
Disease,89843,Dystrophic epidermolysis bullosa pruriginosa,Point prevalence,N/A
Disease,89842,"Autosomal recessive generalized dystrophic epidermolysis bullosa, intermediate form",Point prevalence,N/A
Disease,90001,X-linked cone dysfunction syndrome with myopia,Cases/families,N/A
Disease,90001,X-linked cone dysfunction syndrome with myopia,Point prevalence,N/A
Disease,90000,Erythema elevatum diutinum,Point prevalence,N/A
Clinical subtype,89938,Bartter syndrome type 4,Point prevalence,N/A
Disease,89937,Autosomal dominant hypophosphatemic rickets,Cases/families,N/A
Disease,89937,Autosomal dominant hypophosphatemic rickets,Point prevalence,N/A
Disease,90340,Blau syndrome,Prevalence at birth,N/A
Disease,90340,Blau syndrome,Point prevalence,N/A
Disease,90342,Xeroderma pigmentosum variant,Cases/families,N/A
Disease,90342,Xeroderma pigmentosum variant,Point prevalence,N/A
Disease,90348,Autosomal dominant cutis laxa,Cases/families,N/A
Disease,90348,Autosomal dominant cutis laxa,Point prevalence,N/A
Disease,90349,Autosomal recessive cutis laxa type 1,Cases/families,N/A
Disease,90349,Autosomal recessive cutis laxa type 1,Point prevalence,N/A
Clinical group,90350,Autosomal recessive cutis laxa type 2,Cases/families,N/A
Clinical group,90350,Autosomal recessive cutis laxa type 2,Point prevalence,N/A
Disease,90354,Brittle cornea syndrome,Cases/families,N/A
Disease,90354,Brittle cornea syndrome,Point prevalence,N/A
Disease,90362,Primary intestinal lymphangiectasia,Point prevalence,N/A
Disease,90289,Localized scleroderma,Point prevalence,N/A
Disease,90301,Acanthosis nigricans-insulin resistance-muscle cramps-acral enlargement syndrome,Cases/families,N/A
Disease,90301,Acanthosis nigricans-insulin resistance-muscle cramps-acral enlargement syndrome,Point prevalence,N/A
Disease,90291,Systemic sclerosis,Point prevalence,N/A
Disease,90291,Systemic sclerosis,Annual incidence,N/A
Disease,90291,Systemic sclerosis,Point prevalence,N/A
Disease,90291,Systemic sclerosis,Point prevalence,N/A
Disease,90291,Systemic sclerosis,Point prevalence,N/A
Disease,90291,Systemic sclerosis,Annual incidence,N/A
Disease,90291,Systemic sclerosis,Point prevalence,N/A
Disease,90291,Systemic sclerosis,Annual incidence,N/A
Disease,90291,Systemic sclerosis,Point prevalence,N/A
Disease,90291,Systemic sclerosis,Point prevalence,N/A
Disease,90291,Systemic sclerosis,Point prevalence,N/A
Disease,90291,Systemic sclerosis,Annual incidence,N/A
Disease,90291,Systemic sclerosis,Point prevalence,N/A
Disease,90291,Systemic sclerosis,Annual incidence,N/A
Disease,90291,Systemic sclerosis,Point prevalence,N/A
Disease,90291,Systemic sclerosis,Point prevalence,N/A
Disease,90291,Systemic sclerosis,Annual incidence,N/A
Disease,90308,Klippel-Trnaunay syndrome,Annual incidence,N/A
Disease,90308,Klippel-Trnaunay syndrome,Point prevalence,N/A
Disease,90280,Chilblain lupus,Cases/families,N/A
Disease,90280,Chilblain lupus,Point prevalence,N/A
Disease,90281,Discoid lupus erythematosus,Annual incidence,N/A
Disease,90281,Discoid lupus erythematosus,Annual incidence,N/A
Disease,90186,Meige disease,Point prevalence,N/A
Disease,90285,Lupus erythematosus panniculitis,Annual incidence,N/A
Disease,90285,Lupus erythematosus panniculitis,Point prevalence,N/A
Disease,90283,Lupus erythematosus tumidus,Cases/families,N/A
Disease,90283,Lupus erythematosus tumidus,Point prevalence,N/A
Particular clinical situation in a disease or syndrome,90080,Scarring in glaucoma filtration surgical procedures,Point prevalence,N/A
Particular clinical situation in a disease or syndrome,90078,Invasive infections due to vancomycin-resistant enterococci,Point prevalence,N/A
Malformation syndrome,90103,Charcot-Marie-Tooth disease-deafness-intellectual disability syndrome,Cases/families,N/A
Malformation syndrome,90103,Charcot-Marie-Tooth disease-deafness-intellectual disability syndrome,Point prevalence,N/A
Clinical group,514980,ATP13A2-related parkinsonism,Point prevalence,N/A
Particular clinical situation in a disease or syndrome,90081,AIDS wasting syndrome,Point prevalence,N/A
Disease,90117,"Hereditary motor and sensory neuropathy, Okinawa type",Cases/families,N/A
Disease,90117,"Hereditary motor and sensory neuropathy, Okinawa type",Point prevalence,N/A
Clinical group,90114,Autosomal dominant intermediate Charcot-Marie-Tooth disease,Point prevalence,N/A
Clinical group,88673,Hepatocellular carcinoma,Annual incidence,N/A
Clinical group,88673,Hepatocellular carcinoma,Point prevalence,N/A
Clinical group,88673,Hepatocellular carcinoma,Annual incidence,N/A
Clinical group,88673,Hepatocellular carcinoma,Annual incidence,N/A
Clinical group,88673,Hepatocellular carcinoma,Annual incidence,N/A
Clinical group,88673,Hepatocellular carcinoma,Annual incidence,N/A
Clinical group,88673,Hepatocellular carcinoma,Annual incidence,N/A
Clinical group,88673,Hepatocellular carcinoma,Annual incidence,N/A
Clinical group,88673,Hepatocellular carcinoma,Annual incidence,N/A
Clinical group,88673,Hepatocellular carcinoma,Annual incidence,N/A
Clinical group,88673,Hepatocellular carcinoma,Annual incidence,N/A
Clinical group,88673,Hepatocellular carcinoma,Annual incidence,N/A
Clinical group,88673,Hepatocellular carcinoma,Annual incidence,N/A
Clinical group,88673,Hepatocellular carcinoma,Annual incidence,N/A
Clinical group,88673,Hepatocellular carcinoma,Annual incidence,N/A
Clinical group,88673,Hepatocellular carcinoma,Annual incidence,N/A
Clinical group,88673,Hepatocellular carcinoma,Annual incidence,N/A
Clinical group,88673,Hepatocellular carcinoma,Annual incidence,N/A
Clinical group,88673,Hepatocellular carcinoma,Annual incidence,N/A
Clinical group,88673,Hepatocellular carcinoma,Annual incidence,N/A
Clinical group,88673,Hepatocellular carcinoma,Annual incidence,N/A
Clinical group,88673,Hepatocellular carcinoma,Annual incidence,N/A
Clinical group,88673,Hepatocellular carcinoma,Annual incidence,N/A
Clinical group,88673,Hepatocellular carcinoma,Annual incidence,N/A
Clinical group,88673,Hepatocellular carcinoma,Annual incidence,N/A
Clinical group,88673,Hepatocellular carcinoma,Annual incidence,N/A
Clinical group,88673,Hepatocellular carcinoma,Annual incidence,N/A
Clinical group,88673,Hepatocellular carcinoma,Annual incidence,N/A
Clinical group,88673,Hepatocellular carcinoma,Annual incidence,N/A
Clinical group,88673,Hepatocellular carcinoma,Annual incidence,N/A
Clinical group,88673,Hepatocellular carcinoma,Annual incidence,N/A
Clinical group,88673,Hepatocellular carcinoma,Annual incidence,N/A
Clinical group,88673,Hepatocellular carcinoma,Annual incidence,N/A
Clinical group,88673,Hepatocellular carcinoma,Annual incidence,N/A
Disease,88644,"Autosomal recessive ataxia, Beauce type",Cases/families,N/A
Disease,88644,"Autosomal recessive ataxia, Beauce type",Point prevalence,N/A
Disease,88659,Autosomal dominant progressive nephropathy with hypertension,Cases/families,N/A
Disease,88659,Autosomal dominant progressive nephropathy with hypertension,Point prevalence,N/A
Disease,88661,Amelogenesis imperfecta,Point prevalence,N/A
Disease,88661,Amelogenesis imperfecta,Point prevalence,N/A
Disease,88661,Amelogenesis imperfecta,Point prevalence,N/A
Disease,88661,Amelogenesis imperfecta,Point prevalence,N/A
Clinical subtype,88637,Hypomyelination-hypogonadotropic hypogonadism-hypodontia syndrome,Point prevalence,N/A
Disease,88639,Neurodegeneration due to 3-hydroxyisobutyryl-CoA hydrolase deficiency,Cases/families,N/A
Disease,88639,Neurodegeneration due to 3-hydroxyisobutyryl-CoA hydrolase deficiency,Point prevalence,N/A
Disease,88642,Congenital insensitivity to pain-anosmia-neuropathic arthropathy,Cases/families,N/A
Disease,88642,Congenital insensitivity to pain-anosmia-neuropathic arthropathy,Point prevalence,N/A
Disease,88643,Obesity-colitis-hypothyroidism-cardiac hypertrophy-developmental delay syndrome,Cases/families,N/A
Disease,88643,Obesity-colitis-hypothyroidism-cardiac hypertrophy-developmental delay syndrome,Point prevalence,N/A
Disease,88635,Vacuolar myopathy with sarcoplasmic reticulum protein aggregates,Cases/families,N/A
Disease,88635,Vacuolar myopathy with sarcoplasmic reticulum protein aggregates,Point prevalence,N/A
Disease,88621,Ichthyosis-prematurity syndrome,Cases/families,N/A
Disease,88621,Ichthyosis-prematurity syndrome,Point prevalence,N/A
Disease,88628,Posterior column ataxia-retinitis pigmentosa syndrome,Cases/families,N/A
Disease,88628,Posterior column ataxia-retinitis pigmentosa syndrome,Point prevalence,N/A
Disease,88629,Tritanopia,Point prevalence,N/A
Malformation syndrome,88630,Terminal osseous dysplasia-pigmentary defects syndrome,Point prevalence,N/A
Disease,88620,Isolated congenital anosmia,Cases/families,N/A
Disease,88620,Isolated congenital anosmia,Point prevalence,N/A
Disease,88619,Familial acute necrotizing encephalopathy,Cases/families,N/A
Disease,88619,Familial acute necrotizing encephalopathy,Point prevalence,N/A
Disease,88618,S-adenosylhomocysteine hydrolase deficiency,Cases/families,N/A
Disease,88618,S-adenosylhomocysteine hydrolase deficiency,Point prevalence,N/A
Disease,87884,Non-syndromic genetic deafness,Point prevalence,N/A
Disease,87876,Sialidosis type 2,Point prevalence,N/A
Disease,87876,Sialidosis type 2,Prevalence at birth,N/A
Disease,87503,Mal de Meleda,Point prevalence,N/A
Disease,86923,"Hereditary palmoplantar keratoderma, Gamborg-Nielsen type",Point prevalence,N/A
Disease,86920,Dermatopathia pigmentosa reticularis,Cases/families,N/A
Disease,86920,Dermatopathia pigmentosa reticularis,Point prevalence,N/A
Disease,86919,Keratosis palmaris et plantaris-clinodactyly syndrome,Cases/families,N/A
Disease,86919,Keratosis palmaris et plantaris-clinodactyly syndrome,Point prevalence,N/A
Disease,86918,Diffuse palmoplantar keratoderma-acrocyanosis syndrome,Cases/families,N/A
Disease,86918,Diffuse palmoplantar keratoderma-acrocyanosis syndrome,Point prevalence,N/A
Malformation syndrome,86915,Lymphedema-atrial septal defects-facial changes syndrome,Cases/families,N/A
Malformation syndrome,86915,Lymphedema-atrial septal defects-facial changes syndrome,Point prevalence,N/A
Disease,522077,Infantile hypotonia-oculomotor anomalies-hyperkinetic movements-developmental delay syndrome,Cases/families,N/A
Disease,522077,Infantile hypotonia-oculomotor anomalies-hyperkinetic movements-developmental delay syndrome,Point prevalence,N/A
Malformation syndrome,86913,Myoclonic epilepsy in non-progressive encephalopathies,Point prevalence,N/A
Malformation syndrome,86914,Lymphedema-cerebral arteriovenous anomaly-primary pulmonary hypertension syndrome,Cases/families,N/A
Malformation syndrome,86914,Lymphedema-cerebral arteriovenous anomaly-primary pulmonary hypertension syndrome,Point prevalence,N/A
Disease,86909,Myoclonic epilepsy of infancy,Cases/families,N/A
Disease,86909,Myoclonic epilepsy of infancy,Point prevalence,N/A
Disease,521450,LAMA5-related multisystemic syndrome,Cases/families,N/A
Disease,521450,LAMA5-related multisystemic syndrome,Point prevalence,N/A
Malformation syndrome,521445,Microcephaly-facial dysmorphism-ocular anomalies-multiple congenital anomalies syndrome,Cases/families,N/A
Malformation syndrome,521445,Microcephaly-facial dysmorphism-ocular anomalies-multiple congenital anomalies syndrome,Point prevalence,N/A
Malformation syndrome,521438,Congenital vertebral-cardiac-renal anomalies syndrome,Point prevalence,N/A
Malformation syndrome,521438,Congenital vertebral-cardiac-renal anomalies syndrome,Cases/families,N/A
Disease,86900,Interdigitating dendritic cell sarcoma,Annual incidence,N/A
Disease,521432,Congenital cataract-severe neonatal hepatopathy-global developmental delay syndrome,Point prevalence,N/A
Disease,521432,Congenital cataract-severe neonatal hepatopathy-global developmental delay syndrome,Cases/families,N/A
Disease,86902,Follicular dendritic cell sarcoma,Annual incidence,N/A
Malformation syndrome,521426,PLAA-associated neurodevelopmental disorder,Cases/families,N/A
Malformation syndrome,521426,PLAA-associated neurodevelopmental disorder,Point prevalence,N/A
Disease,86896,Histiocytic sarcoma,Annual incidence,N/A
Disease,521414,Autosomal dominant Charcot-Marie-Tooth disease type 2DD,Cases/families,N/A
Disease,521414,Autosomal dominant Charcot-Marie-Tooth disease type 2DD,Point prevalence,N/A
Malformation syndrome,521258,Xq25 microduplication syndrome,Cases/families,N/A
Malformation syndrome,521258,Xq25 microduplication syndrome,Point prevalence,N/A
Disease,521305,Proximal myopathy with focal depletion of mitochondria,Cases/families,N/A
Disease,521305,Proximal myopathy with focal depletion of mitochondria,Point prevalence,N/A
Malformation syndrome,521308,Frontonasal dysplasia-bifid nose-upper limb anomalies syndrome,Cases/families,N/A
Malformation syndrome,521308,Frontonasal dysplasia-bifid nose-upper limb anomalies syndrome,Point prevalence,N/A
Malformation syndrome,521390,Spastic paraplegia-intellectual disability-nystagmus-obesity syndrome,Cases/families,N/A
Malformation syndrome,521390,Spastic paraplegia-intellectual disability-nystagmus-obesity syndrome,Point prevalence,N/A
Disease,521406,Dystonia-parkinsonism-hypermanganesemia syndrome,Cases/families,N/A
Disease,521406,Dystonia-parkinsonism-hypermanganesemia syndrome,Point prevalence,N/A
Disease,89838,Autosomal recessive generalized epidermolysis bullosa simplex,Cases/families,N/A
Disease,89838,Autosomal recessive generalized epidermolysis bullosa simplex,Point prevalence,N/A
Disease,521411,Autosomal recessive axonal Charcot-Marie-Tooth disease due to copper metabolism defect,Cases/families,N/A
Disease,521411,Autosomal recessive axonal Charcot-Marie-Tooth disease due to copper metabolism defect,Point prevalence,N/A
Clinical syndrome,521219,Mirizzi syndrome,Point prevalence,N/A
Clinical subtype,88949,MUC1-related autosomal dominant tubulointerstitial kidney disease,Annual incidence,N/A
Clinical subtype,88949,MUC1-related autosomal dominant tubulointerstitial kidney disease,Point prevalence,N/A
Clinical subtype,88949,MUC1-related autosomal dominant tubulointerstitial kidney disease,Point prevalence,N/A
Clinical subtype,88949,MUC1-related autosomal dominant tubulointerstitial kidney disease,Point prevalence,N/A
Clinical subtype,88950,UMOD-related autosomal dominant tubulointerstitial kidney disease,Point prevalence,N/A
Clinical subtype,88950,UMOD-related autosomal dominant tubulointerstitial kidney disease,Point prevalence,N/A
Clinical subtype,88950,UMOD-related autosomal dominant tubulointerstitial kidney disease,Point prevalence,N/A
Category,88991,Rare congenital non-syndromic heart malformation,Prevalence at birth,N/A
Category,88991,Rare congenital non-syndromic heart malformation,Prevalence at birth,N/A
Disease,88924,Autosomal dominant polycystic kidney disease type 1 with tuberous sclerosis,Cases/families,N/A
Disease,88924,Autosomal dominant polycystic kidney disease type 1 with tuberous sclerosis,Point prevalence,N/A
Clinical subtype,88917,X-linked Alport syndrome,Prevalence at birth,N/A
Clinical subtype,88917,X-linked Alport syndrome,Point prevalence,N/A
Malformation syndrome,93256,Fragile X-associated tremor/ataxia syndrome,Point prevalence,N/A
Malformation syndrome,93256,Fragile X-associated tremor/ataxia syndrome,Lifetime Prevalence,N/A
Malformation syndrome,93256,Fragile X-associated tremor/ataxia syndrome,Point prevalence,N/A
Disease,528105,Hypohidrosis-electrolyte imbalance-lacrimal gland dysfunction-ichthyosis-xerostomia syndrome,Cases/families,N/A
Disease,528105,Hypohidrosis-electrolyte imbalance-lacrimal gland dysfunction-ichthyosis-xerostomia syndrome,Point prevalence,N/A
Disease,528091,Hydrops-lactic acidosis-sideroblastic anemia-multisystemic failure syndrome,Cases/families,N/A
Disease,528091,Hydrops-lactic acidosis-sideroblastic anemia-multisystemic failure syndrome,Point prevalence,N/A
Disease,528084,Non-specific syndromic intellectual disability,Point prevalence,N/A
Malformation syndrome,93262,Crouzon syndrome-acanthosis nigricans syndrome,Prevalence at birth,N/A
Malformation syndrome,93262,Crouzon syndrome-acanthosis nigricans syndrome,Point prevalence,N/A
Clinical subtype,93260,Pfeiffer syndrome type 3,Point prevalence,N/A
Clinical subtype,93259,Pfeiffer syndrome type 2,Point prevalence,N/A
Clinical subtype,93258,Pfeiffer syndrome type 1,Point prevalence,N/A
Malformation syndrome,93271,"Short rib-polydactyly syndrome, Verma-Naumoff type",Prevalence at birth,N/A
Malformation syndrome,93271,"Short rib-polydactyly syndrome, Verma-Naumoff type",Point prevalence,N/A
Malformation syndrome,93269,"Short rib-polydactyly syndrome, Majewski type",Cases/families,N/A
Malformation syndrome,93269,"Short rib-polydactyly syndrome, Majewski type",Point prevalence,N/A
Malformation syndrome,93267,Cloverleaf skull-multiple congenital anomalies syndrome,Cases/families,N/A
Malformation syndrome,93267,Cloverleaf skull-multiple congenital anomalies syndrome,Point prevalence,N/A
Disease,93282,"Spondyloepimetaphyseal dysplasia, PAPSS2 type",Cases/families,N/A
Disease,93282,"Spondyloepimetaphyseal dysplasia, PAPSS2 type",Point prevalence,N/A
Disease,93283,"Spondyloepiphyseal dysplasia, Kimberley type",Cases/families,N/A
Disease,93283,"Spondyloepiphyseal dysplasia, Kimberley type",Point prevalence,N/A
Disease,93279,Mild spondyloepiphyseal dysplasia due to COL2A1 mutation with early-onset osteoarthritis,Cases/families,N/A
Disease,93279,Mild spondyloepiphyseal dysplasia due to COL2A1 mutation with early-onset osteoarthritis,Point prevalence,N/A
Clinical subtype,93274,Thanatophoric dysplasia type 2,Point prevalence,N/A
Morphological anomaly,93108,Renal dysplasia,Point prevalence,N/A
Morphological anomaly,93108,Renal dysplasia,Prevalence at birth,N/A
Disease,527497,NKX6-2-related autosomal recessive hypomyelinating leukodystrophy,Cases/families,N/A
Disease,527497,NKX6-2-related autosomal recessive hypomyelinating leukodystrophy,Point prevalence,N/A
Morphological anomaly,93101,Renal hypoplasia,Point prevalence,N/A
Morphological anomaly,93110,Posterior urethral valve,Point prevalence,N/A
Morphological anomaly,93110,Posterior urethral valve,Prevalence at birth,N/A
Morphological anomaly,93110,Posterior urethral valve,Prevalence at birth,N/A
Morphological anomaly,93109,Congenital megacalycosis,Cases/families,N/A
Morphological anomaly,93109,Congenital megacalycosis,Point prevalence,N/A
Malformation syndrome,527450,Severe myopia-generalized joint laxity-short stature syndrome,Cases/families,N/A
Malformation syndrome,527450,Severe myopia-generalized joint laxity-short stature syndrome,Point prevalence,N/A
Disease,91547,Relapsing fever,Point prevalence,N/A
Clinical subtype,93100,"Renal agenesis, unilateral",Point prevalence,N/A
Clinical subtype,93100,"Renal agenesis, unilateral",Prevalence at birth,N/A
Malformation syndrome,527468,Diaphragmatic hernia-short bowel-asplenia syndrome,Cases/families,N/A
Malformation syndrome,527468,Diaphragmatic hernia-short bowel-asplenia syndrome,Point prevalence,N/A
Disease,92050,Congenital tufting enteropathy,Prevalence at birth,N/A
Disease,92050,Congenital tufting enteropathy,Point prevalence,N/A
Disease,93160,Hypocalcemic vitamin D-resistant rickets,Point prevalence,N/A
Disease,93164,Transient pseudohypoaldosteronism,Cases/families,N/A
Disease,93164,Transient pseudohypoaldosteronism,Point prevalence,N/A
Disease,93114,Autosomal dominant intermediate Charcot-Marie-Tooth disease type E,Cases/families,N/A
Disease,93114,Autosomal dominant intermediate Charcot-Marie-Tooth disease type E,Point prevalence,N/A
Clinical subtype,93111,HNF1B-related autosomal dominant tubulointerstitial kidney disease,Point prevalence,N/A
Disease,93126,Pauci-immune glomerulonephritis,Point prevalence,N/A
Clinical subtype,93172,"Renal dysplasia, unilateral",Point prevalence,N/A
Clinical subtype,93172,"Renal dysplasia, unilateral",Prevalence at birth,N/A
Clinical subtype,93173,"Renal dysplasia, bilateral",Point prevalence,N/A
Morphological anomaly,93322,Isolated tibial hemimelia,Prevalence at birth,N/A
Morphological anomaly,93322,Isolated tibial hemimelia,Point prevalence,N/A
Morphological anomaly,93321,Isolated radial hemimelia,Prevalence at birth,N/A
Morphological anomaly,93321,Isolated radial hemimelia,Point prevalence,N/A
Morphological anomaly,93320,Isolated ulnar hemimelia,Point prevalence,N/A
Morphological anomaly,93323,Isolated fibular hemimelia,Prevalence at birth,N/A
Morphological anomaly,93323,Isolated fibular hemimelia,Point prevalence,N/A
Clinical subtype,93329,Autosomal recessive omodysplasia,Cases/families,N/A
Clinical subtype,93329,Autosomal recessive omodysplasia,Point prevalence,N/A
Morphological anomaly,93335,Postaxial polydactyly type B,Point prevalence,N/A
Morphological anomaly,93335,Postaxial polydactyly type B,Prevalence at birth,N/A
Morphological anomaly,93334,Postaxial polydactyly type A,Point prevalence,N/A
Morphological anomaly,93334,Postaxial polydactyly type A,Prevalence at birth,N/A
Malformation syndrome,93333,Pelviscapular dysplasia,Cases/families,N/A
Malformation syndrome,93333,Pelviscapular dysplasia,Point prevalence,N/A
Morphological anomaly,93337,Polydactyly of an index finger,Point prevalence,N/A
Disease,527276,Encephalopathy due to mitochondrial and peroxisomal fission defect,Cases/families,N/A
Disease,527276,Encephalopathy due to mitochondrial and peroxisomal fission defect,Point prevalence,N/A
Disease,93346,"Spondyloepimetaphyseal dysplasia congenita, Strudwick type",Cases/families,N/A
Disease,93346,"Spondyloepimetaphyseal dysplasia congenita, Strudwick type",Point prevalence,N/A
Disease,93347,Anauxetic dysplasia,Cases/families,N/A
Disease,93347,Anauxetic dysplasia,Point prevalence,N/A
Disease,93356,"Spondyloepimetaphyseal dysplasia, Missouri type",Cases/families,N/A
Disease,93356,"Spondyloepimetaphyseal dysplasia, Missouri type",Point prevalence,N/A
Disease,93351,"Spondyloepimetaphyseal dysplasia, Irapa type",Point prevalence,N/A
Disease,93352,"Spondyloepimetaphyseal dysplasia, Shohat type",Cases/families,N/A
Disease,93352,"Spondyloepimetaphyseal dysplasia, Shohat type",Point prevalence,N/A
Disease,93284,Spondyloepiphyseal dysplasia tarda,Point prevalence,N/A
Clinical subtype,93296,Achondrogenesis type 2,Point prevalence,N/A
Clinical subtype,93298,Achondrogenesis type 1B,Point prevalence,N/A
Clinical subtype,93297,Hypochondrogenesis,Point prevalence,N/A
Clinical subtype,93299,Achondrogenesis type 1A,Point prevalence,N/A
Malformation syndrome,93302,"Brachyolmia, Maroteaux type",Cases/families,N/A
Malformation syndrome,93302,"Brachyolmia, Maroteaux type",Point prevalence,N/A
Disease,93307,Multiple epiphyseal dysplasia type 4,Point prevalence,N/A
Disease,93308,Multiple epiphyseal dysplasia type 1,Point prevalence,N/A
Disease,93311,Multiple epiphyseal dysplasia type 5,Cases/families,N/A
Disease,93311,Multiple epiphyseal dysplasia type 5,Point prevalence,N/A
Disease,93314,"Spondylometaphyseal dysplasia, Kozlowski type",Point prevalence,N/A
Disease,93315,"Spondylometaphyseal dysplasia, 'corner fracture' type",Cases/families,N/A
Disease,93315,"Spondylometaphyseal dysplasia, 'corner fracture' type",Point prevalence,N/A
Disease,93316,"Spondylometaphyseal dysplasia, Schmidt type",Cases/families,N/A
Disease,93316,"Spondylometaphyseal dysplasia, Schmidt type",Point prevalence,N/A
Malformation syndrome,93317,"Spondylometaphyseal dysplasia, Sedaghatian type",Cases/families,N/A
Malformation syndrome,93317,"Spondylometaphyseal dysplasia, Sedaghatian type",Point prevalence,N/A
Malformation syndrome,529962,17q24.2 microdeletion syndrome,Point prevalence,N/A
Malformation syndrome,529962,17q24.2 microdeletion syndrome,Cases/families,N/A
Disease,529864,Secondary erythromelalgia,Point prevalence,N/A
Disease,529864,Secondary erythromelalgia,Annual incidence,N/A
Disease,529852,Combined hepatocellular carcinoma and cholangiocarcinoma,Point prevalence,N/A
Disease,90673,Hypothyroidism due to TSH receptor mutations,Point prevalence,N/A
Disease,90674,Isolated thyroid-stimulating hormone deficiency,Point prevalence,N/A
Particular clinical situation in a disease or syndrome,529831,Letrozole toxicity,Point prevalence,N/A
Clinical syndrome,529808,Chronic bilirubin encephalopathy,Point prevalence,N/A
Clinical syndrome,529808,Chronic bilirubin encephalopathy,Point prevalence,N/A
Clinical syndrome,529808,Chronic bilirubin encephalopathy,Point prevalence,N/A
Clinical syndrome,529808,Chronic bilirubin encephalopathy,Prevalence at birth,N/A
Clinical syndrome,529808,Chronic bilirubin encephalopathy,Prevalence at birth,N/A
Clinical syndrome,529808,Chronic bilirubin encephalopathy,Prevalence at birth,N/A
Disease,90658,Charcot-Marie-Tooth disease type 1E,Point prevalence,N/A
Clinical syndrome,529799,Acute bilirubin encephalopathy,Point prevalence,N/A
Clinical syndrome,529799,Acute bilirubin encephalopathy,Prevalence at birth,N/A
Disease,90791,Congenital adrenal hyperplasia due to 3-beta-hydroxysteroid dehydrogenase deficiency,Cases/families,N/A
Disease,90791,Congenital adrenal hyperplasia due to 3-beta-hydroxysteroid dehydrogenase deficiency,Point prevalence,N/A
Disease,90790,Congenital lipoid adrenal hyperplasia due to STAR deficency,Point prevalence,N/A
Disease,529980,Inflammatory bowel disease-recurrent sinopulmonary infections syndrome,Cases/families,N/A
Disease,529980,Inflammatory bowel disease-recurrent sinopulmonary infections syndrome,Point prevalence,N/A
Disease,529977,Immune dysregulation-inflammatory bowel disease-arthritis-recurrent infections-lymphopenia syndrome,Cases/families,N/A
Disease,529977,Immune dysregulation-inflammatory bowel disease-arthritis-recurrent infections-lymphopenia syndrome,Point prevalence,N/A
Malformation syndrome,529965,Intellectual disability-autism-speech apraxia-craniofacial dysmorphism syndrome,Cases/families,N/A
Malformation syndrome,529965,Intellectual disability-autism-speech apraxia-craniofacial dysmorphism syndrome,Point prevalence,N/A
Clinical subtype,529970,Male infertility due to acephalic spermatozoa,Point prevalence,N/A
Clinical subtype,90400,Scleromyxedema without monoclonal gammopathy,Cases/families,N/A
Clinical subtype,90400,Scleromyxedema without monoclonal gammopathy,Point prevalence,N/A
Etiological subtype,90625,Rare X-linked non-syndromic sensorineural deafness type DFN,Point prevalence,N/A
Etiological subtype,90635,Rare autosomal dominant non-syndromic sensorineural deafness type DFNA,Point prevalence,N/A
Etiological subtype,90636,Rare autosomal recessive non-syndromic sensorineural deafness type DFNB,Point prevalence,N/A
Disease,529468,Monoclonal mast cell activation syndrome,Point prevalence,N/A
Malformation syndrome,529574,Duane retraction syndrome with congenital deafness,Cases/families,N/A
Malformation syndrome,529574,Duane retraction syndrome with congenital deafness,Point prevalence,N/A
Clinical subtype,90398,Localized lichen myxedematosus with mixed features of different subtypes,Cases/families,N/A
Clinical subtype,90398,Localized lichen myxedematosus with mixed features of different subtypes,Point prevalence,N/A
Clinical subtype,90399,Localized lichen myxedematosus with monoclonal gammopathy or systemic symptoms,Cases/families,N/A
Clinical subtype,90399,Localized lichen myxedematosus with monoclonal gammopathy or systemic symptoms,Point prevalence,N/A
Disease,90368,Hypotrichosis simplex of the scalp,Point prevalence,N/A
Clinical subtype,90390,Anonychia-onychodystrophy syndrome,Cases/families,N/A
Clinical subtype,90390,Anonychia-onychodystrophy syndrome,Point prevalence,N/A
Malformation syndrome,90652,Otopalatodigital syndrome type 2,Cases/families,N/A
Malformation syndrome,90652,Otopalatodigital syndrome type 2,Point prevalence,N/A
Malformation syndrome,529665,Neurodevelopmental delay-seizures-ophthalmic anomalies-osteopenia-cerebellar atrophy syndrome,Cases/families,N/A
Malformation syndrome,529665,Neurodevelopmental delay-seizures-ophthalmic anomalies-osteopenia-cerebellar atrophy syndrome,Point prevalence,N/A
Disease,90647,Jervell and Lange-Nielsen syndrome,Point prevalence,N/A
Etiological subtype,90641,Rare mitochondrial non-syndromic sensorineural deafness,Point prevalence,N/A
Disease,91387,Familial thoracic aortic aneurysm and aortic dissection,Cases/families,N/A
Disease,91387,Familial thoracic aortic aneurysm and aortic dissection,Point prevalence,N/A
Morphological anomaly,91396,Isolated cryptophthalmia,Point prevalence,N/A
Morphological anomaly,91396,Isolated cryptophthalmia,Cases/families,N/A
Clinical group,91378,Hereditary angioedema,Point prevalence,N/A
Clinical group,91378,Hereditary angioedema,Point prevalence,N/A
Clinical group,91378,Hereditary angioedema,Point prevalence,N/A
Clinical group,91378,Hereditary angioedema,Point prevalence,N/A
Clinical group,91385,Acquired angioedema,Point prevalence,N/A
Clinical group,91385,Acquired angioedema,Cases/families,N/A
Clinical group,91385,Acquired angioedema,Point prevalence,N/A
Disease,91412,Marcus-Gunn syndrome,Point prevalence,N/A
Morphological anomaly,91397,Isolated ankyloblepharon filiforme adnatum,Point prevalence,N/A
Disease,91411,Congenital ptosis,Point prevalence,N/A
Malformation syndrome,91355,Sheehan syndrome,Annual incidence,N/A
Malformation syndrome,91355,Sheehan syndrome,Point prevalence,N/A
Disease,91359,Chronic pneumonitis of infancy,Point prevalence,N/A
Disease,91496,Snowflake vitreoretinal degeneration,Cases/families,N/A
Disease,91496,Snowflake vitreoretinal degeneration,Point prevalence,N/A
Disease,91495,Persistent hyperplastic primary vitreous,Point prevalence,N/A
Malformation syndrome,91494,Macular coloboma-cleft palate-hallux valgus syndrome,Cases/families,N/A
Malformation syndrome,91494,Macular coloboma-cleft palate-hallux valgus syndrome,Point prevalence,N/A
Disease,91546,Lyme disease,Annual incidence,N/A
Disease,91546,Lyme disease,Annual incidence,N/A
Disease,91546,Lyme disease,Annual incidence,N/A
Disease,91546,Lyme disease,Annual incidence,N/A
Disease,91546,Lyme disease,Annual incidence,N/A
Disease,91546,Lyme disease,Annual incidence,N/A
Disease,91546,Lyme disease,Point prevalence,N/A
Disease,91500,Tubulointerstitial nephritis and uveitis syndrome,Point prevalence,N/A
Disease,91498,Familial congenital palsy of trochlear nerve,Cases/families,N/A
Disease,91498,Familial congenital palsy of trochlear nerve,Point prevalence,N/A
Disease,91481,Ring dermoid of cornea,Cases/families,N/A
Disease,91481,Ring dermoid of cornea,Point prevalence,N/A
Disease,91416,Isolated congenital alacrima,Point prevalence,N/A
Disease,91414,Pilomatrixoma,Point prevalence,N/A
Particular clinical situation in a disease or syndrome,91127,Adenovirus infection in immunocompromised patients,Point prevalence,N/A
Disease,91130,Cardiomyopathy-hypotonia-lactic acidosis syndrome,Cases/families,N/A
Disease,91130,Cardiomyopathy-hypotonia-lactic acidosis syndrome,Point prevalence,N/A
Disease,91131,DK1-CDG,Cases/families,N/A
Disease,91131,DK1-CDG,Point prevalence,N/A
Disease,91132,Ichthyosis-hypotrichosis syndrome,Cases/families,N/A
Disease,91132,Ichthyosis-hypotrichosis syndrome,Point prevalence,N/A
Disease,90793,Congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiency,Point prevalence,N/A
Disease,90794,Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency,Point prevalence,N/A
Disease,90794,Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency,Prevalence at birth,N/A
Disease,90794,Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency,Prevalence at birth,N/A
Disease,90794,Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency,Prevalence at birth,N/A
Disease,90794,Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency,Prevalence at birth,N/A
Disease,90794,Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency,Prevalence at birth,N/A
Disease,90794,Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency,Prevalence at birth,N/A
Disease,90794,Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency,Prevalence at birth,N/A
Disease,90794,Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency,Prevalence at birth,N/A
Disease,90794,Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency,Prevalence at birth,N/A
Disease,90794,Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency,Prevalence at birth,N/A
Disease,90795,Congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency,Prevalence at birth,N/A
Disease,90795,Congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency,Point prevalence,N/A
Disease,90796,"46,XY difference of sex development due to isolated 17,20-lyase deficiency",Cases/families,N/A
Disease,90796,"46,XY difference of sex development due to isolated 17,20-lyase deficiency",Point prevalence,N/A
Disease,90797,Partial androgen insensitivity syndrome,Point prevalence,N/A
Category,90970,Primary lipodystrophy,Point prevalence,N/A
Disease,91347,TSH-secreting pituitary adenoma,Point prevalence,N/A
Disease,91349,Non-functioning pituitary adenoma,Annual incidence,N/A
Disease,91349,Non-functioning pituitary adenoma,Annual incidence,N/A
Disease,91349,Non-functioning pituitary adenoma,Point prevalence,N/A
Disease,91349,Non-functioning pituitary adenoma,Annual incidence,N/A
Disease,91349,Non-functioning pituitary adenoma,Annual incidence,N/A
Disease,91349,Non-functioning pituitary adenoma,Point prevalence,N/A
Disease,91349,Non-functioning pituitary adenoma,Point prevalence,N/A
Disease,91349,Non-functioning pituitary adenoma,Point prevalence,N/A
Disease,91349,Non-functioning pituitary adenoma,Point prevalence,N/A
Disease,91350,Pituitary deficiency due to Rathke cleft cysts,Point prevalence,N/A
Disease,91136,Acquired monoclonal Ig light chain-associated Fanconi syndrome,Cases/families,N/A
Disease,91136,Acquired monoclonal Ig light chain-associated Fanconi syndrome,Point prevalence,N/A
Disease,91135,Body skin hyperlaxity due to vitamin K-dependent coagulation factor deficiency,Cases/families,N/A
Disease,91135,Body skin hyperlaxity due to vitamin K-dependent coagulation factor deficiency,Point prevalence,N/A
Disease,91138,Cryoglobulinemic vasculitis,Point prevalence,N/A
Disease,91138,Cryoglobulinemic vasculitis,Point prevalence,N/A
Clinical group,91137,Immunotactoid or fibrillary glomerulopathy,Point prevalence,N/A
Disease,91139,Simple cryoglobulinemia,Point prevalence,N/A
Disease,79396,"Autosomal dominant generalized epidermolysis bullosa simplex, severe form",Point prevalence,N/A
Disease,79397,Epidermolysis bullosa simplex with mottled pigmentation,Point prevalence,N/A
Disease,79394,Congenital ichthyosiform erythroderma,Point prevalence,N/A
Disease,79394,Congenital ichthyosiform erythroderma,Point prevalence,N/A
Disease,79395,Keratoderma hereditarium mutilans with ichthyosis,Cases/families,N/A
Disease,79395,Keratoderma hereditarium mutilans with ichthyosis,Point prevalence,N/A
Category,79373,Ectodermal dysplasia syndrome,Point prevalence,N/A
Disease,79399,"Autosomal dominant generalized epidermolysis bullosa simplex, intermediate form",Point prevalence,N/A
Disease,79401,PLEC-related intermediate epidermolysis bullosa simplex without extracutaneous involvement,Cases/families,N/A
Disease,79401,PLEC-related intermediate epidermolysis bullosa simplex without extracutaneous involvement,Point prevalence,N/A
Disease,79400,Localized epidermolysis bullosa simplex,Point prevalence,N/A
Disease,79403,Junctional epidermolysis bullosa with pyloric atresia,Cases/families,N/A
Disease,79403,Junctional epidermolysis bullosa with pyloric atresia,Point prevalence,N/A
Disease,79402,Intermediate generalized junctional epidermolysis bullosa,Point prevalence,N/A
Disease,79405,Junctional epidermolysis bullosa inversa,Cases/families,N/A
Disease,79405,Junctional epidermolysis bullosa inversa,Point prevalence,N/A
Disease,79404,Severe generalized junctional epidermolysis bullosa,Prevalence at birth,N/A
Disease,79404,Severe generalized junctional epidermolysis bullosa,Prevalence at birth,N/A
Disease,79404,Severe generalized junctional epidermolysis bullosa,Prevalence at birth,N/A
Disease,79404,Severe generalized junctional epidermolysis bullosa,Prevalence at birth,N/A
Disease,79404,Severe generalized junctional epidermolysis bullosa,Point prevalence,N/A
Disease,79406,Late-onset junctional epidermolysis bullosa,Cases/families,N/A
Disease,79406,Late-onset junctional epidermolysis bullosa,Point prevalence,N/A
Disease,79409,Recessive dystrophic epidermolysis bullosa inversa,Cases/families,N/A
Disease,79409,Recessive dystrophic epidermolysis bullosa inversa,Point prevalence,N/A
Disease,79408,"Autosomal recessive generalized dystrophic epidermolysis bullosa, severe form",Prevalence at birth,N/A
Disease,79408,"Autosomal recessive generalized dystrophic epidermolysis bullosa, severe form",Prevalence at birth,N/A
Disease,79408,"Autosomal recessive generalized dystrophic epidermolysis bullosa, severe form",Point prevalence,N/A
Disease,79408,"Autosomal recessive generalized dystrophic epidermolysis bullosa, severe form",Point prevalence,N/A
Disease,79411,Self-improving dystrophic epidermolysis bullosa,Cases/families,N/A
Disease,79411,Self-improving dystrophic epidermolysis bullosa,Point prevalence,N/A
Clinical subtype,79410,"Localized dystrophic epidermolysis bullosa, pretibial form",Cases/families,N/A
Clinical subtype,79410,"Localized dystrophic epidermolysis bullosa, pretibial form",Point prevalence,N/A
Disease,79452,Milroy disease,Point prevalence,N/A
Disease,79452,Milroy disease,Prevalence at birth,N/A
Malformation syndrome,79447,X-linked lethal multiple pterygium syndrome,Cases/families,N/A
Malformation syndrome,79447,X-linked lethal multiple pterygium syndrome,Point prevalence,N/A
Disease,79456,Diffuse cutaneous mastocytosis,Cases/families,N/A
Disease,79456,Diffuse cutaneous mastocytosis,Point prevalence,N/A
Disease,79457,Maculopapular cutaneous mastocytosis,Point prevalence,N/A
Disease,79455,Cutaneous mastocytoma,Point prevalence,N/A
Disease,79435,Oculocutaneous albinism type 4,Point prevalence,N/A
Clinical subtype,79434,Oculocutaneous albinism type 1B,Point prevalence,N/A
Disease,79433,Oculocutaneous albinism type 3,Point prevalence,N/A
Disease,79433,Oculocutaneous albinism type 3,Point prevalence,N/A
Disease,79432,Oculocutaneous albinism type 2,Point prevalence,N/A
Disease,79432,Oculocutaneous albinism type 2,Point prevalence,N/A
Disease,79432,Oculocutaneous albinism type 2,Point prevalence,N/A
Disease,79432,Oculocutaneous albinism type 2,Point prevalence,N/A
Disease,79432,Oculocutaneous albinism type 2,Point prevalence,N/A
Clinical subtype,79431,Oculocutaneous albinism type 1A,Point prevalence,N/A
Disease,79430,Hermansky-Pudlak syndrome,Point prevalence,N/A
Disease,79430,Hermansky-Pudlak syndrome,Point prevalence,N/A
Disease,79445,Pseudopseudohypoparathyroidism,Point prevalence,N/A
Disease,79444,Pseudohypoparathyroidism type 1C,Point prevalence,N/A
Disease,79443,Pseudohypoparathyroidism type 1A,Point prevalence,N/A
Clinical subtype,79478,Griscelli syndrome type 3,Cases/families,N/A
Clinical subtype,79478,Griscelli syndrome type 3,Point prevalence,N/A
Disease,79479,Pemphigus vegetans,Point prevalence,N/A
Disease,79481,Pemphigus foliaceus,Point prevalence,N/A
Disease,79493,Brooke-Spiegler syndrome,Cases/families,N/A
Disease,79493,Brooke-Spiegler syndrome,Point prevalence,N/A
Clinical subtype,79477,Griscelli syndrome type 2,Cases/families,N/A
Clinical subtype,79477,Griscelli syndrome type 2,Point prevalence,N/A
Clinical subtype,79476,Griscelli syndrome type 1,Cases/families,N/A
Clinical subtype,79476,Griscelli syndrome type 1,Point prevalence,N/A
Disease,79473,Variegate porphyria,Annual incidence,N/A
Disease,79473,Variegate porphyria,Point prevalence,N/A
Disease,79473,Variegate porphyria,Annual incidence,N/A
Disease,79473,Variegate porphyria,Point prevalence,N/A
Disease,79473,Variegate porphyria,Annual incidence,N/A
Disease,79473,Variegate porphyria,Point prevalence,N/A
Disease,79473,Variegate porphyria,Annual incidence,N/A
Disease,79473,Variegate porphyria,Point prevalence,N/A
Disease,79473,Variegate porphyria,Annual incidence,N/A
Disease,79473,Variegate porphyria,Point prevalence,N/A
Disease,79473,Variegate porphyria,Point prevalence,N/A
Disease,79473,Variegate porphyria,Annual incidence,N/A
Disease,79473,Variegate porphyria,Annual incidence,N/A
Disease,79473,Variegate porphyria,Point prevalence,N/A
Disease,79473,Variegate porphyria,Annual incidence,N/A
Disease,79473,Variegate porphyria,Point prevalence,N/A
Disease,79473,Variegate porphyria,Annual incidence,N/A
Disease,79473,Variegate porphyria,Point prevalence,N/A
Disease,79473,Variegate porphyria,Annual incidence,N/A
Disease,79473,Variegate porphyria,Point prevalence,N/A
Disease,79473,Variegate porphyria,Annual incidence,N/A
Disease,79473,Variegate porphyria,Point prevalence,N/A
Etiological subtype,79269,Sanfilippo syndrome type A,Point prevalence,N/A
Etiological subtype,79269,Sanfilippo syndrome type A,Prevalence at birth,N/A
Etiological subtype,79269,Sanfilippo syndrome type A,Prevalence at birth,N/A
Etiological subtype,79269,Sanfilippo syndrome type A,Prevalence at birth,N/A
Etiological subtype,79269,Sanfilippo syndrome type A,Prevalence at birth,N/A
Etiological subtype,79269,Sanfilippo syndrome type A,Prevalence at birth,N/A
Etiological subtype,79269,Sanfilippo syndrome type A,Prevalence at birth,N/A
Etiological subtype,79269,Sanfilippo syndrome type A,Point prevalence,N/A
Etiological subtype,79269,Sanfilippo syndrome type A,Prevalence at birth,N/A
Clinical subtype,79257,GM1 gangliosidosis type 3,Cases/families,N/A
Clinical subtype,79257,GM1 gangliosidosis type 3,Point prevalence,N/A
Clinical subtype,79256,GM1 gangliosidosis type 2,Cases/families,N/A
Clinical subtype,79256,GM1 gangliosidosis type 2,Point prevalence,N/A
Clinical subtype,79255,GM1 gangliosidosis type 1,Cases/families,N/A
Clinical subtype,79255,GM1 gangliosidosis type 1,Point prevalence,N/A
Clinical subtype,79254,Classic phenylketonuria,Point prevalence,N/A
Clinical subtype,79254,Classic phenylketonuria,Point prevalence,N/A
Clinical subtype,79254,Classic phenylketonuria,Prevalence at birth,N/A
Clinical subtype,79254,Classic phenylketonuria,Prevalence at birth,N/A
Clinical subtype,79259,Glycogen storage disease due to glucose-6-phosphatase deficiency type Ib,Cases/families,N/A
Clinical subtype,79259,Glycogen storage disease due to glucose-6-phosphatase deficiency type Ib,Point prevalence,N/A
Clinical subtype,79259,Glycogen storage disease due to glucose-6-phosphatase deficiency type Ib,Prevalence at birth,N/A
Clinical subtype,79259,Glycogen storage disease due to glucose-6-phosphatase deficiency type Ib,Prevalence at birth,N/A
Clinical subtype,79258,Glycogen storage disease due to glucose-6-phosphatase deficiency type Ia,Prevalence at birth,N/A
Clinical subtype,79258,Glycogen storage disease due to glucose-6-phosphatase deficiency type Ia,Prevalence at birth,N/A
Clinical subtype,79258,Glycogen storage disease due to glucose-6-phosphatase deficiency type Ia,Point prevalence,N/A
Clinical subtype,79258,Glycogen storage disease due to glucose-6-phosphatase deficiency type Ia,Prevalence at birth,N/A
Clinical subtype,79246,Pyruvate dehydrogenase phosphatase deficiency,Point prevalence,N/A
Clinical subtype,79253,Mild phenylketonuria,Point prevalence,N/A
Disease,79240,Glycogen storage disease due to liver and muscle phosphorylase kinase deficiency,Point prevalence,N/A
Disease,79241,Biotinidase deficiency,Prevalence at birth,N/A
Disease,79241,Biotinidase deficiency,Point prevalence,N/A
Disease,79241,Biotinidase deficiency,Prevalence at birth,N/A
Disease,79241,Biotinidase deficiency,Prevalence at birth,N/A
Disease,79241,Biotinidase deficiency,Point prevalence,N/A
Disease,79241,Biotinidase deficiency,Prevalence at birth,N/A
Disease,79241,Biotinidase deficiency,Prevalence at birth,N/A
Disease,79241,Biotinidase deficiency,Point prevalence,N/A
Disease,79241,Biotinidase deficiency,Prevalence at birth,N/A
Disease,79241,Biotinidase deficiency,Prevalence at birth,N/A
Disease,79241,Biotinidase deficiency,Prevalence at birth,N/A
Disease,79241,Biotinidase deficiency,Point prevalence,N/A
Disease,79241,Biotinidase deficiency,Prevalence at birth,N/A
Disease,79238,Galactose epimerase deficiency,Point prevalence,N/A
Disease,79239,Classic galactosemia,Annual incidence,N/A
Disease,79239,Classic galactosemia,Prevalence at birth,N/A
Disease,79239,Classic galactosemia,Prevalence at birth,N/A
Disease,79239,Classic galactosemia,Prevalence at birth,N/A
Disease,79239,Classic galactosemia,Prevalence at birth,N/A
Disease,79239,Classic galactosemia,Prevalence at birth,N/A
Disease,79239,Classic galactosemia,Prevalence at birth,N/A
Disease,79239,Classic galactosemia,Point prevalence,N/A
Clinical subtype,79244,Pyruvate dehydrogenase E2 deficiency,Point prevalence,N/A
Disease,79242,Holocarboxylase synthetase deficiency,Prevalence at birth,N/A
Disease,79242,Holocarboxylase synthetase deficiency,Point prevalence,N/A
Clinical subtype,79243,Pyruvate dehydrogenase E1-alpha deficiency,Point prevalence,N/A
Clinical group,79298,Diazoxide-resistant focal hyperinsulinism,Point prevalence,N/A
Disease,79301,Congenital bile acid synthesis defect type 1,Point prevalence,N/A
Clinical subtype,79293,Familial LCAT deficiency,Cases/families,N/A
Clinical subtype,79293,Familial LCAT deficiency,Point prevalence,N/A
Clinical subtype,79292,Fish-eye disease,Cases/families,N/A
Clinical subtype,79292,Fish-eye disease,Point prevalence,N/A
Disease,79278,Autosomal erythropoietic protoporphyria,Annual incidence,N/A
Disease,79278,Autosomal erythropoietic protoporphyria,Point prevalence,N/A
Disease,79278,Autosomal erythropoietic protoporphyria,Annual incidence,N/A
Disease,79278,Autosomal erythropoietic protoporphyria,Point prevalence,N/A
Disease,79278,Autosomal erythropoietic protoporphyria,Annual incidence,N/A
Disease,79278,Autosomal erythropoietic protoporphyria,Point prevalence,N/A
Disease,79278,Autosomal erythropoietic protoporphyria,Annual incidence,N/A
Disease,79278,Autosomal erythropoietic protoporphyria,Point prevalence,N/A
Disease,79278,Autosomal erythropoietic protoporphyria,Annual incidence,N/A
Disease,79278,Autosomal erythropoietic protoporphyria,Point prevalence,N/A
Disease,79278,Autosomal erythropoietic protoporphyria,Annual incidence,N/A
Disease,79278,Autosomal erythropoietic protoporphyria,Point prevalence,N/A
Disease,79278,Autosomal erythropoietic protoporphyria,Annual incidence,N/A
Disease,79278,Autosomal erythropoietic protoporphyria,Point prevalence,N/A
Disease,79278,Autosomal erythropoietic protoporphyria,Annual incidence,N/A
Disease,79278,Autosomal erythropoietic protoporphyria,Point prevalence,N/A
Disease,79278,Autosomal erythropoietic protoporphyria,Annual incidence,N/A
Disease,79278,Autosomal erythropoietic protoporphyria,Point prevalence,N/A
Disease,79278,Autosomal erythropoietic protoporphyria,Annual incidence,N/A
Disease,79278,Autosomal erythropoietic protoporphyria,Point prevalence,N/A
Disease,79278,Autosomal erythropoietic protoporphyria,Point prevalence,N/A
Disease,79278,Autosomal erythropoietic protoporphyria,Point prevalence,N/A
Clinical subtype,79279,Alpha-N-acetylgalactosaminidase deficiency type 1,Cases/families,N/A
Clinical subtype,79279,Alpha-N-acetylgalactosaminidase deficiency type 1,Point prevalence,N/A
Clinical subtype,79280,Alpha-N-acetylgalactosaminidase deficiency type 2,Cases/families,N/A
Clinical subtype,79280,Alpha-N-acetylgalactosaminidase deficiency type 2,Point prevalence,N/A
Clinical subtype,79281,Alpha-N-acetylgalactosaminidase deficiency type 3,Cases/families,N/A
Clinical subtype,79281,Alpha-N-acetylgalactosaminidase deficiency type 3,Point prevalence,N/A
Clinical subtype,79282,"Methylmalonic acidemia with homocystinuria, type cblC",Cases/families,N/A
Clinical subtype,79282,"Methylmalonic acidemia with homocystinuria, type cblC",Point prevalence,N/A
Clinical subtype,79283,"Methylmalonic acidemia with homocystinuria, type cblD",Cases/families,N/A
Clinical subtype,79283,"Methylmalonic acidemia with homocystinuria, type cblD",Point prevalence,N/A
Clinical subtype,79284,Methylmalonic acidemia with homocystinuria type cblF,Cases/families,N/A
Clinical subtype,79284,Methylmalonic acidemia with homocystinuria type cblF,Point prevalence,N/A
Etiological subtype,79270,Sanfilippo syndrome type B,Point prevalence,N/A
Etiological subtype,79270,Sanfilippo syndrome type B,Prevalence at birth,N/A
Etiological subtype,79270,Sanfilippo syndrome type B,Prevalence at birth,N/A
Etiological subtype,79270,Sanfilippo syndrome type B,Prevalence at birth,N/A
Etiological subtype,79270,Sanfilippo syndrome type B,Prevalence at birth,N/A
Etiological subtype,79270,Sanfilippo syndrome type B,Prevalence at birth,N/A
Etiological subtype,79270,Sanfilippo syndrome type B,Point prevalence,N/A
Etiological subtype,79270,Sanfilippo syndrome type B,Prevalence at birth,N/A
Etiological subtype,79271,Sanfilippo syndrome type C,Prevalence at birth,N/A
Etiological subtype,79271,Sanfilippo syndrome type C,Prevalence at birth,N/A
Etiological subtype,79271,Sanfilippo syndrome type C,Prevalence at birth,N/A
Etiological subtype,79271,Sanfilippo syndrome type C,Prevalence at birth,N/A
Etiological subtype,79271,Sanfilippo syndrome type C,Point prevalence,N/A
Etiological subtype,79271,Sanfilippo syndrome type C,Prevalence at birth,N/A
Etiological subtype,79271,Sanfilippo syndrome type C,Point prevalence,N/A
Etiological subtype,79271,Sanfilippo syndrome type C,Prevalence at birth,N/A
Etiological subtype,79272,Sanfilippo syndrome type D,Prevalence at birth,N/A
Etiological subtype,79272,Sanfilippo syndrome type D,Prevalence at birth,N/A
Disease,79273,Hereditary coproporphyria,Point prevalence,N/A
Disease,79276,Acute intermittent porphyria,Annual incidence,N/A
Disease,79276,Acute intermittent porphyria,Point prevalence,N/A
Disease,79276,Acute intermittent porphyria,Annual incidence,N/A
Disease,79276,Acute intermittent porphyria,Point prevalence,N/A
Disease,79276,Acute intermittent porphyria,Annual incidence,N/A
Disease,79276,Acute intermittent porphyria,Point prevalence,N/A
Disease,79276,Acute intermittent porphyria,Annual incidence,N/A
Disease,79276,Acute intermittent porphyria,Point prevalence,N/A
Disease,79276,Acute intermittent porphyria,Annual incidence,N/A
Disease,79276,Acute intermittent porphyria,Point prevalence,N/A
Disease,79276,Acute intermittent porphyria,Annual incidence,N/A
Disease,79276,Acute intermittent porphyria,Point prevalence,N/A
Disease,79276,Acute intermittent porphyria,Annual incidence,N/A
Disease,79276,Acute intermittent porphyria,Point prevalence,N/A
Disease,79276,Acute intermittent porphyria,Annual incidence,N/A
Disease,79276,Acute intermittent porphyria,Point prevalence,N/A
Disease,79276,Acute intermittent porphyria,Annual incidence,N/A
Disease,79276,Acute intermittent porphyria,Point prevalence,N/A
Disease,79276,Acute intermittent porphyria,Annual incidence,N/A
Disease,79276,Acute intermittent porphyria,Point prevalence,N/A
Disease,79276,Acute intermittent porphyria,Annual incidence,N/A
Disease,79276,Acute intermittent porphyria,Point prevalence,N/A
Disease,79277,Congenital erythropoietic porphyria,Cases/families,N/A
Disease,79277,Congenital erythropoietic porphyria,Annual incidence,N/A
Disease,79277,Congenital erythropoietic porphyria,Point prevalence,N/A
Disease,79333,COG7-CDG,Cases/families,N/A
Disease,79333,COG7-CDG,Point prevalence,N/A
Disease,79332,B4GALT1-CDG,Cases/families,N/A
Disease,79332,B4GALT1-CDG,Point prevalence,N/A
Disease,79330,MOGS-CDG,Cases/families,N/A
Disease,79330,MOGS-CDG,Point prevalence,N/A
Disease,79329,MGAT2-CDG,Cases/families,N/A
Disease,79329,MGAT2-CDG,Point prevalence,N/A
Disease,79328,ALG9-CDG,Cases/families,N/A
Disease,79328,ALG9-CDG,Point prevalence,N/A
Disease,79327,ALG1-CDG,Cases/families,N/A
Disease,79327,ALG1-CDG,Point prevalence,N/A
Disease,79326,ALG2-CDG,Cases/families,N/A
Disease,79326,ALG2-CDG,Point prevalence,N/A
Disease,79325,ALG8-CDG,Cases/families,N/A
Disease,79325,ALG8-CDG,Point prevalence,N/A
Disease,79324,ALG12-CDG,Cases/families,N/A
Disease,79324,ALG12-CDG,Point prevalence,N/A
Disease,79323,MPDU1-CDG,Cases/families,N/A
Disease,79323,MPDU1-CDG,Point prevalence,N/A
Disease,79322,DPM1-CDG,Cases/families,N/A
Disease,79322,DPM1-CDG,Point prevalence,N/A
Disease,79321,ALG3-CDG,Cases/families,N/A
Disease,79321,ALG3-CDG,Point prevalence,N/A
Disease,79320,ALG6-CDG,Cases/families,N/A
Disease,79320,ALG6-CDG,Point prevalence,N/A
Disease,79319,MPI-CDG,Cases/families,N/A
Disease,79319,MPI-CDG,Point prevalence,N/A
Disease,79318,PMM2-CDG,Prevalence at birth,N/A
Disease,79318,PMM2-CDG,Point prevalence,N/A
Disease,79318,PMM2-CDG,Prevalence at birth,N/A
Disease,79314,L-2-hydroxyglutaric aciduria,Point prevalence,N/A
Disease,79314,L-2-hydroxyglutaric aciduria,Cases/families,N/A
Disease,79315,D-2-hydroxyglutaric aciduria,Cases/families,N/A
Disease,79315,D-2-hydroxyglutaric aciduria,Point prevalence,N/A
Clinical subtype,79312,Vitamin B12-unresponsive methylmalonic acidemia type mut-,Cases/families,N/A
Clinical subtype,79312,Vitamin B12-unresponsive methylmalonic acidemia type mut-,Point prevalence,N/A
Clinical subtype,79310,Vitamin B12-responsive methylmalonic acidemia type cblA,Cases/families,N/A
Clinical subtype,79310,Vitamin B12-responsive methylmalonic acidemia type cblA,Point prevalence,N/A
Clinical subtype,79306,Progressive familial intrahepatic cholestasis type 1,Point prevalence,N/A
Clinical subtype,79304,Progressive familial intrahepatic cholestasis type 2,Point prevalence,N/A
Clinical subtype,79305,Progressive familial intrahepatic cholestasis type 3,Point prevalence,N/A
Disease,79302,Congenital bile acid synthesis defect type 3,Cases/families,N/A
Disease,79302,Congenital bile acid synthesis defect type 3,Point prevalence,N/A
Disease,79303,Congenital bile acid synthesis defect type 2,Point prevalence,N/A
Category,79361,Inherited epidermolysis bullosa,Prevalence at birth,N/A
Category,79361,Inherited epidermolysis bullosa,Point prevalence,N/A
Category,79361,Inherited epidermolysis bullosa,Point prevalence,N/A
Category,79361,Inherited epidermolysis bullosa,Prevalence at birth,N/A
Category,79361,Inherited epidermolysis bullosa,Point prevalence,N/A
Category,79361,Inherited epidermolysis bullosa,Point prevalence,N/A
Etiological subtype,79351,"3-phosphoglycerate dehydrogenase deficiency, infantile/juvenile form",Cases/families,N/A
Etiological subtype,79351,"3-phosphoglycerate dehydrogenase deficiency, infantile/juvenile form",Point prevalence,N/A
Etiological subtype,79350,"3-phosphoserine phosphatase deficiency, infantile/juvenile form",Cases/families,N/A
Etiological subtype,79350,"3-phosphoserine phosphatase deficiency, infantile/juvenile form",Point prevalence,N/A
Malformation syndrome,79347,"Chondrodysplasia punctata, Toriello type",Cases/families,N/A
Malformation syndrome,79347,"Chondrodysplasia punctata, Toriello type",Point prevalence,N/A
Malformation syndrome,79345,Brachytelephalangic chondrodysplasia punctata,Point prevalence,N/A
Malformation syndrome,85191,Singleton-Merten dysplasia,Cases/families,N/A
Malformation syndrome,85191,Singleton-Merten dysplasia,Point prevalence,N/A
Malformation syndrome,85188,"Metaphyseal dysplasia, Braun-Tinschert type",Point prevalence,N/A
Malformation syndrome,85193,Idiopathic juvenile osteoporosis,Point prevalence,N/A
Malformation syndrome,85192,Calvarial doughnut lesions-bone fragility syndrome,Cases/families,N/A
Malformation syndrome,85192,Calvarial doughnut lesions-bone fragility syndrome,Point prevalence,N/A
Malformation syndrome,85194,Spondylo-ocular syndrome,Cases/families,N/A
Malformation syndrome,85194,Spondylo-ocular syndrome,Point prevalence,N/A
Disease,85197,Genochondromatosis type 1,Point prevalence,N/A
Malformation syndrome,85199,Craniosynostosis-anal anomalies-porokeratosis syndrome,Cases/families,N/A
Malformation syndrome,85199,Craniosynostosis-anal anomalies-porokeratosis syndrome,Point prevalence,N/A
Malformation syndrome,85198,Dysspondyloenchondromatosis,Cases/families,N/A
Malformation syndrome,85198,Dysspondyloenchondromatosis,Point prevalence,N/A
Malformation syndrome,85198,Dysspondyloenchondromatosis,Point prevalence,N/A
Malformation syndrome,85201,Genitopatellar syndrome,Cases/families,N/A
Malformation syndrome,85201,Genitopatellar syndrome,Point prevalence,N/A
Malformation syndrome,85203,Acropectoral syndrome,Cases/families,N/A
Malformation syndrome,85203,Acropectoral syndrome,Point prevalence,N/A
Malformation syndrome,85202,Keutel syndrome,Cases/families,N/A
Malformation syndrome,85202,Keutel syndrome,Point prevalence,N/A
Malformation syndrome,85273,"X-linked intellectual disability, Abidi type",Cases/families,N/A
Malformation syndrome,85273,"X-linked intellectual disability, Abidi type",Point prevalence,N/A
Clinical subtype,85212,Fetal Gaucher disease,Cases/families,N/A
Clinical subtype,85212,Fetal Gaucher disease,Point prevalence,N/A
Malformation syndrome,85274,Syndromic X-linked intellectual disability 7,Cases/families,N/A
Malformation syndrome,85274,Syndromic X-linked intellectual disability 7,Point prevalence,N/A
Malformation syndrome,85275,Microphthalmia-ankyloblepharon-intellectual disability syndrome,Point prevalence,N/A
Malformation syndrome,85276,"X-linked intellectual disability, Armfield type",Cases/families,N/A
Malformation syndrome,85276,"X-linked intellectual disability, Armfield type",Point prevalence,N/A
Malformation syndrome,85277,"X-linked intellectual disability, Cantagrel type",Cases/families,N/A
Malformation syndrome,85277,"X-linked intellectual disability, Cantagrel type",Point prevalence,N/A
Malformation syndrome,85278,Christianson syndrome,Point prevalence,N/A
Malformation syndrome,85279,KDM5C-related syndromic X-linked intellectual disability,Cases/families,N/A
Malformation syndrome,85279,KDM5C-related syndromic X-linked intellectual disability,Point prevalence,N/A
Malformation syndrome,85280,X-linked intellectual disability-cubitus valgus-dysmorphism syndrome,Cases/families,N/A
Malformation syndrome,85280,X-linked intellectual disability-cubitus valgus-dysmorphism syndrome,Point prevalence,N/A
Malformation syndrome,85282,MEHMO syndrome,Cases/families,N/A
Malformation syndrome,85282,MEHMO syndrome,Point prevalence,N/A
Malformation syndrome,85283,"X-linked intellectual disability, Miles-Carpenter type",Cases/families,N/A
Malformation syndrome,85283,"X-linked intellectual disability, Miles-Carpenter type",Point prevalence,N/A
Malformation syndrome,85284,BRESEK syndrome,Cases/families,N/A
Malformation syndrome,85284,BRESEK syndrome,Point prevalence,N/A
Malformation syndrome,85285,"X-linked intellectual disability, Schimke type",Cases/families,N/A
Malformation syndrome,85285,"X-linked intellectual disability, Schimke type",Point prevalence,N/A
Malformation syndrome,85286,"X-linked intellectual disability, Shashi type",Cases/families,N/A
Malformation syndrome,85286,"X-linked intellectual disability, Shashi type",Point prevalence,N/A
Malformation syndrome,85287,"X-linked intellectual disability, Siderius type",Cases/families,N/A
Malformation syndrome,85287,"X-linked intellectual disability, Siderius type",Point prevalence,N/A
Malformation syndrome,85288,"X-linked intellectual disability, Stocco Dos Santos type",Cases/families,N/A
Malformation syndrome,85288,"X-linked intellectual disability, Stocco Dos Santos type",Point prevalence,N/A
Malformation syndrome,85293,"X-linked intellectual disability, Cabezas type",Cases/families,N/A
Malformation syndrome,85293,"X-linked intellectual disability, Cabezas type",Point prevalence,N/A
Disease,85292,X-linked spinocerebellar ataxia type 4,Cases/families,N/A
Disease,85292,X-linked spinocerebellar ataxia type 4,Point prevalence,N/A
Malformation syndrome,85290,"X-linked intellectual disability, Wilson type",Cases/families,N/A
Malformation syndrome,85290,"X-linked intellectual disability, Wilson type",Point prevalence,N/A
Malformation syndrome,85317,X-linked intellectual disability-hypogammaglobulinemia-progressive neurological deterioration syndrome,Cases/families,N/A
Malformation syndrome,85317,X-linked intellectual disability-hypogammaglobulinemia-progressive neurological deterioration syndrome,Point prevalence,N/A
Malformation syndrome,85297,X-linked spinocerebellar ataxia type 3,Cases/families,N/A
Malformation syndrome,85297,X-linked spinocerebellar ataxia type 3,Point prevalence,N/A
Clinical subtype,85295,"HSD10 disease, atypical type",Cases/families,N/A
Clinical subtype,85295,"HSD10 disease, atypical type",Point prevalence,N/A
Disease,85294,X-linked epilepsy-learning disabilities-behavior disorders syndrome,Point prevalence,N/A
Malformation syndrome,85321,"Deafness-intellectual disability syndrome, Martin-Probst type",Point prevalence,N/A
Malformation syndrome,85321,"Deafness-intellectual disability syndrome, Martin-Probst type",Cases/families,N/A
Malformation syndrome,85320,X-linked intellectual disability-macrocephaly-macroorchidism syndrome,Point prevalence,N/A
Malformation syndrome,85320,X-linked intellectual disability-macrocephaly-macroorchidism syndrome,Cases/families,N/A
Malformation syndrome,85319,X-linked intellectual disability-epilepsy-progressive joint contractures-dysmorphism syndrome,Cases/families,N/A
Malformation syndrome,85319,X-linked intellectual disability-epilepsy-progressive joint contractures-dysmorphism syndrome,Point prevalence,N/A
Malformation syndrome,85325,"X-linked intellectual disability, Stevenson type",Cases/families,N/A
Malformation syndrome,85325,"X-linked intellectual disability, Stevenson type",Point prevalence,N/A
Malformation syndrome,85324,"X-linked intellectual disability, Shrimpton type",Cases/families,N/A
Malformation syndrome,85324,"X-linked intellectual disability, Shrimpton type",Point prevalence,N/A
Disease,85323,"X-linked intellectual disability, Seemanova type",Cases/families,N/A
Disease,85323,"X-linked intellectual disability, Seemanova type",Point prevalence,N/A
Malformation syndrome,85322,"X-linked intellectual disability, Pai type",Cases/families,N/A
Malformation syndrome,85322,"X-linked intellectual disability, Pai type",Point prevalence,N/A
Malformation syndrome,85329,X-linked intellectual disability-hypotonia-facial dysmorphism-aggressive behavior syndrome,Cases/families,N/A
Malformation syndrome,85329,X-linked intellectual disability-hypotonia-facial dysmorphism-aggressive behavior syndrome,Point prevalence,N/A
Malformation syndrome,85326,"X-linked intellectual disability, Stoll type",Cases/families,N/A
Malformation syndrome,85326,"X-linked intellectual disability, Stoll type",Point prevalence,N/A
Disease,85327,X-linked intellectual disability-acromegaly-hyperactivity syndrome,Cases/families,N/A
Disease,85327,X-linked intellectual disability-acromegaly-hyperactivity syndrome,Point prevalence,N/A
Disease,85332,X-linked intellectual disability-retinitis pigmentosa syndrome,Point prevalence,N/A
Disease,85336,"X-linked neurodegenerative syndrome, Hamel type",Cases/families,N/A
Disease,85336,"X-linked neurodegenerative syndrome, Hamel type",Point prevalence,N/A
Disease,85334,"X-linked neurodegenerative syndrome, Bertini type",Point prevalence,N/A
Disease,85334,"X-linked neurodegenerative syndrome, Bertini type",Cases/families,N/A
Malformation syndrome,85335,Fried syndrome,Point prevalence,N/A
Malformation syndrome,85335,Fried syndrome,Cases/families,N/A
Disease,85410,Oligoarticular juvenile idiopathic arthritis,Point prevalence,N/A
Disease,85414,Systemic-onset juvenile idiopathic arthritis,Point prevalence,N/A
Disease,85414,Systemic-onset juvenile idiopathic arthritis,Annual incidence,N/A
Disease,85338,X-linked intellectual disability-ataxia-apraxia syndrome,Cases/families,N/A
Disease,85338,X-linked intellectual disability-ataxia-apraxia syndrome,Point prevalence,N/A
Disease,85408,Rheumatoid factor-negative polyarticular juvenile idiopathic arthritis,Point prevalence,N/A
Disease,85443,AL amyloidosis,Point prevalence,N/A
Disease,85443,AL amyloidosis,Point prevalence,N/A
Disease,85443,AL amyloidosis,Annual incidence,N/A
Disease,85443,AL amyloidosis,Point prevalence,N/A
Disease,85443,AL amyloidosis,Annual incidence,N/A
Disease,85443,AL amyloidosis,Point prevalence,N/A
Disease,85443,AL amyloidosis,Annual incidence,N/A
Disease,85443,AL amyloidosis,Point prevalence,N/A
Disease,85443,AL amyloidosis,Annual incidence,N/A
Disease,85443,AL amyloidosis,Point prevalence,N/A
Disease,85443,AL amyloidosis,Annual incidence,N/A
Disease,85443,AL amyloidosis,Point prevalence,N/A
Disease,85443,AL amyloidosis,Annual incidence,N/A
Disease,85443,AL amyloidosis,Point prevalence,N/A
Disease,85443,AL amyloidosis,Annual incidence,N/A
Disease,85443,AL amyloidosis,Point prevalence,N/A
Disease,85443,AL amyloidosis,Annual incidence,N/A
Disease,85443,AL amyloidosis,Point prevalence,N/A
Disease,85443,AL amyloidosis,Annual incidence,N/A
Disease,85443,AL amyloidosis,Point prevalence,N/A
Disease,85443,AL amyloidosis,Annual incidence,N/A
Disease,85443,AL amyloidosis,Point prevalence,N/A
Disease,85443,AL amyloidosis,Annual incidence,N/A
Disease,85443,AL amyloidosis,Point prevalence,N/A
Disease,85443,AL amyloidosis,Annual incidence,N/A
Disease,85443,AL amyloidosis,Annual incidence,N/A
Disease,85443,AL amyloidosis,Point prevalence,N/A
Disease,85443,AL amyloidosis,Annual incidence,N/A
Disease,85443,AL amyloidosis,Point prevalence,N/A
Disease,85443,AL amyloidosis,Annual incidence,N/A
Disease,85443,AL amyloidosis,Point prevalence,N/A
Disease,85443,AL amyloidosis,Annual incidence,N/A
Disease,85443,AL amyloidosis,Point prevalence,N/A
Disease,85443,AL amyloidosis,Annual incidence,N/A
Disease,85443,AL amyloidosis,Point prevalence,N/A
Disease,85443,AL amyloidosis,Annual incidence,N/A
Disease,85443,AL amyloidosis,Point prevalence,N/A
Disease,85443,AL amyloidosis,Annual incidence,N/A
Disease,85443,AL amyloidosis,Point prevalence,N/A
Disease,85443,AL amyloidosis,Annual incidence,N/A
Disease,85443,AL amyloidosis,Point prevalence,N/A
Disease,85443,AL amyloidosis,Annual incidence,N/A
Disease,85443,AL amyloidosis,Point prevalence,N/A
Disease,85443,AL amyloidosis,Annual incidence,N/A
Disease,85443,AL amyloidosis,Point prevalence,N/A
Disease,85443,AL amyloidosis,Annual incidence,N/A
Disease,85443,AL amyloidosis,Point prevalence,N/A
Disease,85443,AL amyloidosis,Annual incidence,N/A
Disease,85443,AL amyloidosis,Point prevalence,N/A
Disease,85443,AL amyloidosis,Annual incidence,N/A
Disease,85443,AL amyloidosis,Point prevalence,N/A
Disease,85443,AL amyloidosis,Annual incidence,N/A
Disease,85443,AL amyloidosis,Point prevalence,N/A
Disease,85443,AL amyloidosis,Annual incidence,N/A
Disease,85443,AL amyloidosis,Point prevalence,N/A
Disease,85443,AL amyloidosis,Annual incidence,N/A
Disease,85443,AL amyloidosis,Point prevalence,N/A
Disease,85443,AL amyloidosis,Annual incidence,N/A
Disease,85443,AL amyloidosis,Point prevalence,N/A
Disease,85443,AL amyloidosis,Annual incidence,N/A
Disease,85443,AL amyloidosis,Point prevalence,N/A
Disease,85443,AL amyloidosis,Annual incidence,N/A
Disease,85443,AL amyloidosis,Point prevalence,N/A
Disease,85443,AL amyloidosis,Annual incidence,N/A
Disease,85443,AL amyloidosis,Point prevalence,N/A
Disease,85443,AL amyloidosis,Annual incidence,N/A
Disease,85443,AL amyloidosis,Point prevalence,N/A
Disease,85443,AL amyloidosis,Annual incidence,N/A
Disease,85443,AL amyloidosis,Point prevalence,N/A
Disease,85443,AL amyloidosis,Annual incidence,N/A
Disease,85443,AL amyloidosis,Point prevalence,N/A
Disease,85443,AL amyloidosis,Annual incidence,N/A
Disease,85443,AL amyloidosis,Point prevalence,N/A
Disease,85443,AL amyloidosis,Annual incidence,N/A
Disease,85443,AL amyloidosis,Point prevalence,N/A
Disease,85443,AL amyloidosis,Annual incidence,N/A
Disease,85443,AL amyloidosis,Point prevalence,N/A
Disease,85443,AL amyloidosis,Annual incidence,N/A
Disease,85443,AL amyloidosis,Point prevalence,N/A
Disease,85443,AL amyloidosis,Annual incidence,N/A
Disease,85443,AL amyloidosis,Annual incidence,N/A
Disease,85442,Short stature-pituitary and cerebellar defects-small sella turcica syndrome,Cases/families,N/A
Disease,85442,Short stature-pituitary and cerebellar defects-small sella turcica syndrome,Point prevalence,N/A
Disease,85446,Wild type ABeta2M amyloidosis,Point prevalence,N/A
Disease,85445,AA amyloidosis,Point prevalence,N/A
Disease,85436,Psoriasis-related juvenile idiopathic arthritis,Point prevalence,N/A
Disease,85435,Rheumatoid factor-positive polyarticular juvenile idiopathic arthritis,Point prevalence,N/A
Disease,85438,Enthesitis-related juvenile idiopathic arthritis,Point prevalence,N/A
Disease,85458,Cerebral Amyloid Angiopathy,Cases/families,N/A
Disease,85458,Cerebral Amyloid Angiopathy,Point prevalence,N/A
Disease,85453,X-linked reticulate pigmentary disorder,Cases/families,N/A
Disease,85453,X-linked reticulate pigmentary disorder,Point prevalence,N/A
Disease,86788,X-linked severe congenital neutropenia,Cases/families,N/A
Disease,86788,X-linked severe congenital neutropenia,Point prevalence,N/A
Disease,86309,DPAGT1-CDG,Cases/families,N/A
Disease,86309,DPAGT1-CDG,Point prevalence,N/A
Disease,85448,AGel amyloidosis,Cases/families,N/A
Disease,85448,AGel amyloidosis,Point prevalence,N/A
Clinical subtype,85447,ATTRV30M amyloidosis,Point prevalence,N/A
Clinical subtype,85447,ATTRV30M amyloidosis,Point prevalence,N/A
Clinical subtype,85447,ATTRV30M amyloidosis,Annual incidence,N/A
Clinical subtype,85447,ATTRV30M amyloidosis,Point prevalence,N/A
Clinical subtype,85447,ATTRV30M amyloidosis,Annual incidence,N/A
Clinical subtype,85447,ATTRV30M amyloidosis,Point prevalence,N/A
Clinical subtype,85447,ATTRV30M amyloidosis,Point prevalence,N/A
Clinical subtype,85447,ATTRV30M amyloidosis,Point prevalence,N/A
Clinical subtype,85451,ATTRV122I amyloidosis,Point prevalence,N/A
Disease,85450,Hereditary amyloidosis with primary renal involvement,Point prevalence,N/A
Disease,86812,POMT1-related limb-girdle muscular dystrophy R11,Point prevalence,N/A
Disease,86813,Helicoid peripapillary chorioretinal degeneration,Cases/families,N/A
Disease,86813,Helicoid peripapillary chorioretinal degeneration,Point prevalence,N/A
Disease,86814,Benign adult familial myoclonic epilepsy,Point prevalence,N/A
Disease,86814,Benign adult familial myoclonic epilepsy,Point prevalence,N/A
Morphological anomaly,86789,Isolated patella aplasia/hypoplasia,Point prevalence,N/A
Morphological anomaly,86789,Isolated patella aplasia/hypoplasia,Cases/families,N/A
Disease,86797,Atypical lichen myxedematosus,Cases/families,N/A
Disease,86797,Atypical lichen myxedematosus,Point prevalence,N/A
Disease,86820,Familial avascular necrosis of femoral head,Annual incidence,N/A
Disease,86820,Familial avascular necrosis of femoral head,Point prevalence,N/A
Malformation syndrome,86821,Lissencephaly type 3-familial fetal akinesia sequence syndrome,Cases/families,N/A
Malformation syndrome,86821,Lissencephaly type 3-familial fetal akinesia sequence syndrome,Point prevalence,N/A
Malformation syndrome,86822,Lissencephaly type 3-metacarpal bone dysplasia syndrome,Cases/families,N/A
Malformation syndrome,86822,Lissencephaly type 3-metacarpal bone dysplasia syndrome,Point prevalence,N/A
Clinical group,86823,Lissencephaly with cerebellar hypoplasia,Point prevalence,N/A
Disease,86816,Congenital analbuminemia,Cases/families,N/A
Disease,86816,Congenital analbuminemia,Point prevalence,N/A
Disease,86817,Hemolytic anemia due to adenylate kinase deficiency,Cases/families,N/A
Disease,86817,Hemolytic anemia due to adenylate kinase deficiency,Point prevalence,N/A
Disease,86818,Alport syndrome-intellectual disability-midface hypoplasia-elliptocytosis syndrome,Cases/families,N/A
Disease,86818,Alport syndrome-intellectual disability-midface hypoplasia-elliptocytosis syndrome,Point prevalence,N/A
Clinical group,512034,Large granular lymphocyte leukemia,Annual incidence,N/A
Disease,86843,Acute panmyelosis with myelofibrosis,Annual incidence,N/A
Disease,86841,Myelodysplastic syndrome associated with isolated del(5q) chromosome abnormality,Annual incidence,N/A
Disease,86839,Myelodysplastic neoplasm with increased blasts,Point prevalence,N/A
Disease,86839,Myelodysplastic neoplasm with increased blasts,Annual incidence,N/A
Clinical group,86836,Refractory cytopenia with multilineage dysplasia,Annual incidence,N/A
Disease,86834,Juvenile myelomonocytic leukemia,Point prevalence,N/A
Disease,86830,"Chronic myeloproliferative disease, unclassifiable",Annual incidence,N/A
Disease,86829,Chronic neutrophilic leukemia,Annual incidence,N/A
Disease,86855,Plasmacytoma,Point prevalence,N/A
Disease,86855,Plasmacytoma,Annual incidence,N/A
Disease,512260,Congenital cerebellar ataxia due to RNU12 mutation,Cases/families,N/A
Disease,512260,Congenital cerebellar ataxia due to RNU12 mutation,Point prevalence,N/A
Disease,86854,Splenic marginal zone lymphoma,Point prevalence,N/A
Disease,86852,B-cell prolymphocytic leukemia,Annual incidence,N/A
Disease,86850,Myeloid sarcoma,Point prevalence,N/A
Disease,86850,Myeloid sarcoma,Annual incidence,N/A
Disease,86849,Acute basophilic leukemia,Annual incidence,N/A
Category,86846,Therapy related acute myeloid leukemia and myelodysplastic syndrome,Annual incidence,N/A
Disease,86845,Acute myeloid leukaemia with myelodysplasia-related features,Annual incidence,N/A
Disease,86872,T-cell large granular lymphocyte leukemia,Annual incidence,N/A
Disease,86872,T-cell large granular lymphocyte leukemia,Point prevalence,N/A
Disease,86873,Aggressive NK-cell leukemia,Point prevalence,N/A
Disease,86870,Blastic plasmacytoid dendritic cell neoplasm,Point prevalence,N/A
Disease,86870,Blastic plasmacytoid dendritic cell neoplasm,Annual incidence,N/A
Disease,86871,T-cell prolymphocytic leukemia,Annual incidence,N/A
Disease,86871,T-cell prolymphocytic leukemia,Point prevalence,N/A
Disease,86867,Nodal marginal zone B-cell lymphoma,Point prevalence,N/A
Disease,86864,Heavy chain disease,Point prevalence,N/A
Disease,86864,Heavy chain disease,Annual incidence,N/A
Disease,86886,Angioimmunoblastic T-cell lymphoma,Annual incidence,N/A
Disease,86893,Nodular lymphocyte predominant Hodgkin lymphoma,Annual incidence,N/A
Disease,86893,Nodular lymphocyte predominant Hodgkin lymphoma,Annual incidence,N/A
Disease,86893,Nodular lymphocyte predominant Hodgkin lymphoma,Point prevalence,N/A
Disease,86893,Nodular lymphocyte predominant Hodgkin lymphoma,Annual incidence,N/A
Disease,86893,Nodular lymphocyte predominant Hodgkin lymphoma,Annual incidence,N/A
Disease,86893,Nodular lymphocyte predominant Hodgkin lymphoma,Annual incidence,N/A
Disease,86893,Nodular lymphocyte predominant Hodgkin lymphoma,Annual incidence,N/A
Disease,86893,Nodular lymphocyte predominant Hodgkin lymphoma,Annual incidence,N/A
Disease,86893,Nodular lymphocyte predominant Hodgkin lymphoma,Annual incidence,N/A
Disease,86893,Nodular lymphocyte predominant Hodgkin lymphoma,Annual incidence,N/A
Disease,86893,Nodular lymphocyte predominant Hodgkin lymphoma,Annual incidence,N/A
Disease,86893,Nodular lymphocyte predominant Hodgkin lymphoma,Annual incidence,N/A
Disease,86893,Nodular lymphocyte predominant Hodgkin lymphoma,Annual incidence,N/A
Disease,86893,Nodular lymphocyte predominant Hodgkin lymphoma,Annual incidence,N/A
Disease,86893,Nodular lymphocyte predominant Hodgkin lymphoma,Annual incidence,N/A
Disease,86893,Nodular lymphocyte predominant Hodgkin lymphoma,Annual incidence,N/A
Disease,86893,Nodular lymphocyte predominant Hodgkin lymphoma,Annual incidence,N/A
Disease,86893,Nodular lymphocyte predominant Hodgkin lymphoma,Annual incidence,N/A
Disease,86893,Nodular lymphocyte predominant Hodgkin lymphoma,Annual incidence,N/A
Disease,86893,Nodular lymphocyte predominant Hodgkin lymphoma,Annual incidence,N/A
Disease,86893,Nodular lymphocyte predominant Hodgkin lymphoma,Annual incidence,N/A
Disease,86893,Nodular lymphocyte predominant Hodgkin lymphoma,Annual incidence,N/A
Disease,86893,Nodular lymphocyte predominant Hodgkin lymphoma,Annual incidence,N/A
Disease,86884,Subcutaneous panniculitis-like T-cell lymphoma,Point prevalence,N/A
Disease,86880,Enteropathy-associated T-cell lymphoma,Annual incidence,N/A
Disease,86880,Enteropathy-associated T-cell lymphoma,Annual incidence,N/A
Disease,86882,Hepatosplenic T-cell lymphoma,Annual incidence,N/A
Disease,86882,Hepatosplenic T-cell lymphoma,Point prevalence,N/A
Disease,86875,Adult T-cell leukemia/lymphoma,Point prevalence,N/A
Disease,86879,Extranodal nasal NK/T cell lymphoma,Annual incidence,N/A
Disease,79502,Punctate palmoplantar keratoderma type 2,Cases/families,N/A
Disease,79502,Punctate palmoplantar keratoderma type 2,Point prevalence,N/A
Disease,79503,Ichthyosis hystrix of Curth-Macklin,Cases/families,N/A
Disease,79503,Ichthyosis hystrix of Curth-Macklin,Point prevalence,N/A
Disease,79507,Hypotonia-failure to thrive-microcephaly syndrome,Cases/families,N/A
Disease,79507,Hypotonia-failure to thrive-microcephaly syndrome,Point prevalence,N/A
Malformation syndrome,79499,Autosomal dominant deafness-onychodystrophy syndrome,Cases/families,N/A
Malformation syndrome,79499,Autosomal dominant deafness-onychodystrophy syndrome,Point prevalence,N/A
Malformation syndrome,79500,DOORS syndrome,Cases/families,N/A
Malformation syndrome,79500,DOORS syndrome,Point prevalence,N/A
Disease,79501,Punctate palmoplantar keratoderma type 1,Cases/families,N/A
Disease,79501,Punctate palmoplantar keratoderma type 1,Point prevalence,N/A
Disease,79501,Punctate palmoplantar keratoderma type 1,Point prevalence,N/A
Clinical subtype,79665,Gardner syndrome,Prevalence at birth,N/A
Clinical subtype,79651,Mild hyperphenylalaninemia,Point prevalence,N/A
Disease,79644,Autosomal recessive hyperinsulinism due to Kir6.2 deficiency,Point prevalence,N/A
Disease,83317,Scrub typhus,Point prevalence,N/A
Disease,83317,Scrub typhus,Point prevalence,N/A
Disease,83317,Scrub typhus,Point prevalence,N/A
Clinical subtype,83330,Proximal spinal muscular atrophy type 1,Annual incidence,N/A
Clinical subtype,83330,Proximal spinal muscular atrophy type 1,Point prevalence,N/A
Disease,83315,Murine typhus,Point prevalence,N/A
Disease,83316,Pseudotyphus of California,Point prevalence,N/A
Clinical subtype,83419,Proximal spinal muscular atrophy type 3,Prevalence at birth,N/A
Clinical subtype,83419,Proximal spinal muscular atrophy type 3,Point prevalence,N/A
Clinical subtype,83420,Proximal spinal muscular atrophy type 4,Annual incidence,N/A
Clinical subtype,83420,Proximal spinal muscular atrophy type 4,Point prevalence,N/A
Clinical subtype,83418,Proximal spinal muscular atrophy type 2,Prevalence at birth,N/A
Clinical subtype,83418,Proximal spinal muscular atrophy type 2,Point prevalence,N/A
Disease,83313,Boutonneuse fever,Point prevalence,N/A
Disease,83313,Boutonneuse fever,Point prevalence,N/A
Disease,83313,Boutonneuse fever,Point prevalence,N/A
Disease,83314,Epidemic typhus,Point prevalence,N/A
Disease,83311,Rocky Mountain spotted fever,Annual incidence,N/A
Disease,83311,Rocky Mountain spotted fever,Point prevalence,N/A
Disease,83312,Rickettsialpox,Cases/families,N/A
Disease,83312,Rickettsialpox,Point prevalence,N/A
Disease,83469,Desmoplastic small round cell tumor,Cases/families,N/A
Disease,83469,Desmoplastic small round cell tumor,Annual incidence,N/A
Disease,83469,Desmoplastic small round cell tumor,Point prevalence,N/A
Disease,83468,Solitary bone cyst,Point prevalence,N/A
Disease,83467,Morvan syndrome,Cases/families,N/A
Disease,83467,Morvan syndrome,Point prevalence,N/A
Disease,83465,Narcolepsy type 2,Point prevalence,N/A
Disease,83465,Narcolepsy type 2,Point prevalence,N/A
Disease,83476,West-Nile encephalitis,Point prevalence,N/A
Disease,83476,West-Nile encephalitis,Point prevalence,N/A
Disease,83476,West-Nile encephalitis,Annual incidence,N/A
Disease,83476,West-Nile encephalitis,Annual incidence,N/A
Disease,83476,West-Nile encephalitis,Annual incidence,N/A
Disease,83476,West-Nile encephalitis,Annual incidence,N/A
Disease,83476,West-Nile encephalitis,Annual incidence,N/A
Disease,83476,West-Nile encephalitis,Annual incidence,N/A
Disease,83476,West-Nile encephalitis,Annual incidence,N/A
Malformation syndrome,83473,Megalencephaly-polymicrogyria-postaxial polydactyly-hydrocephalus syndrome,Cases/families,N/A
Malformation syndrome,83473,Megalencephaly-polymicrogyria-postaxial polydactyly-hydrocephalus syndrome,Point prevalence,N/A
Malformation syndrome,83472,CAMOS syndrome,Cases/families,N/A
Malformation syndrome,83472,CAMOS syndrome,Point prevalence,N/A
Disease,83471,T-cell immunodeficiency with thymic aplasia,Point prevalence,N/A
Disease,83452,Complex regional pain syndrome,Annual incidence,N/A
Disease,83452,Complex regional pain syndrome,Point prevalence,N/A
Disease,83451,Florid cemento-osseous dysplasia,Point prevalence,N/A
Disease,83450,Regional odontodysplasia,Cases/families,N/A
Disease,83450,Regional odontodysplasia,Point prevalence,N/A
Morphological anomaly,83463,Microtia,Point prevalence,N/A
Morphological anomaly,83463,Microtia,Prevalence at birth,N/A
Morphological anomaly,83463,Microtia,Point prevalence,N/A
Morphological anomaly,83463,Microtia,Prevalence at birth,N/A
Morphological anomaly,83463,Microtia,Point prevalence,N/A
Morphological anomaly,83463,Microtia,Prevalence at birth,N/A
Morphological anomaly,83463,Microtia,Point prevalence,N/A
Morphological anomaly,83463,Microtia,Prevalence at birth,N/A
Morphological anomaly,83463,Microtia,Point prevalence,N/A
Morphological anomaly,83463,Microtia,Prevalence at birth,N/A
Morphological anomaly,83463,Microtia,Point prevalence,N/A
Morphological anomaly,83463,Microtia,Prevalence at birth,N/A
Morphological anomaly,83463,Microtia,Point prevalence,N/A
Morphological anomaly,83463,Microtia,Prevalence at birth,N/A
Morphological anomaly,83463,Microtia,Point prevalence,N/A
Morphological anomaly,83463,Microtia,Prevalence at birth,N/A
Morphological anomaly,83463,Microtia,Prevalence at birth,N/A
Malformation syndrome,83461,Congenital primary aphakia,Point prevalence,N/A
Malformation syndrome,83454,Glomuvenous malformation,Point prevalence,N/A
Disease,83453,Vulvovaginal gingival syndrome,Cases/families,N/A
Disease,83453,Vulvovaginal gingival syndrome,Point prevalence,N/A
Malformation syndrome,514352,Congenital brachyesophagus-intrathoracic stomach-vertebral anomalies syndrome,Cases/families,N/A
Malformation syndrome,514352,Congenital brachyesophagus-intrathoracic stomach-vertebral anomalies syndrome,Point prevalence,N/A
Malformation syndrome,83619,Macrostomia-preauricular tags-external ophthalmoplegia syndrome,Cases/families,N/A
Malformation syndrome,83619,Macrostomia-preauricular tags-external ophthalmoplegia syndrome,Point prevalence,N/A
Disease,83620,Enteric anendocrinosis,Cases/families,N/A
Disease,83620,Enteric anendocrinosis,Point prevalence,N/A
Malformation syndrome,83628,LUMBAR syndrome,Cases/families,N/A
Malformation syndrome,83628,LUMBAR syndrome,Point prevalence,N/A
Disease,83601,Steroid-responsive encephalopathy associated with autoimmune thyroiditis,Point prevalence,N/A
Disease,83616,Rubella panencephalitis,Cases/families,N/A
Disease,83616,Rubella panencephalitis,Point prevalence,N/A
Malformation syndrome,83617,Agammaglobulinemia-microcephaly-craniosynostosis-severe dermatitis syndrome,Cases/families,N/A
Malformation syndrome,83617,Agammaglobulinemia-microcephaly-craniosynostosis-severe dermatitis syndrome,Point prevalence,N/A
Disease,83594,Eastern equine encephalitis,Annual incidence,N/A
Disease,83594,Eastern equine encephalitis,Point prevalence,N/A
Disease,83595,Colorado tick fever,Point prevalence,N/A
Disease,83597,Acute disseminated encephalomyelitis,Annual incidence,N/A
Disease,83597,Acute disseminated encephalomyelitis,Point prevalence,N/A
Disease,83600,Encephalitis lethargica,Point prevalence,N/A
Disease,83482,Mycoplasma encephalitis,Point prevalence,N/A
Disease,83483,La Crosse encephalitis,Annual incidence,N/A
Disease,83483,La Crosse encephalitis,Point prevalence,N/A
Disease,83484,St. Louis encephalitis,Annual incidence,N/A
Disease,83484,St. Louis encephalitis,Point prevalence,N/A
Disease,83593,Western equine encephalitis,Annual incidence,N/A
Disease,83593,Western equine encephalitis,Point prevalence,N/A
Disease,84085,Hinman syndrome,Point prevalence,N/A
Disease,84081,Senior-Boichis syndrome,Point prevalence,N/A
Disease,84090,Fibronectin glomerulopathy,Cases/families,N/A
Disease,84090,Fibronectin glomerulopathy,Point prevalence,N/A
Disease,84064,Syndromic diarrhea,Cases/families,N/A
Disease,84064,Syndromic diarrhea,Point prevalence,N/A
Disease,84064,Syndromic diarrhea,Prevalence at birth,N/A
Disease,513436,Autosomal recessive spastic paraplegia type 78,Cases/families,N/A
Disease,513436,Autosomal recessive spastic paraplegia type 78,Point prevalence,N/A
Disease,83639,Hypercoagulability syndrome due to glycosylphosphatidylinositol deficiency,Cases/families,N/A
Disease,83639,Hypercoagulability syndrome due to glycosylphosphatidylinositol deficiency,Point prevalence,N/A
Disease,83629,Leukoencephalopathy-spondyloepimetaphyseal dysplasia syndrome,Cases/families,N/A
Disease,83629,Leukoencephalopathy-spondyloepimetaphyseal dysplasia syndrome,Point prevalence,N/A
Disease,513456,Intellectual disability-seizures-abnormal gait-facial dysmorphism syndrome,Cases/families,N/A
Disease,513456,Intellectual disability-seizures-abnormal gait-facial dysmorphism syndrome,Point prevalence,N/A
Disease,83642,Microcytic anemia with liver iron overload,Cases/families,N/A
Disease,83642,Microcytic anemia with liver iron overload,Point prevalence,N/A
Malformation syndrome,85163,Hypomyelination-congenital cataract syndrome,Cases/families,N/A
Malformation syndrome,85163,Hypomyelination-congenital cataract syndrome,Point prevalence,N/A
Disease,85164,Camptodactyly-tall stature-scoliosis-hearing loss syndrome,Cases/families,N/A
Disease,85164,Camptodactyly-tall stature-scoliosis-hearing loss syndrome,Point prevalence,N/A
Disease,85146,"Neurogenic scapuloperoneal syndrome, Kaeser type",Cases/families,N/A
Disease,85146,"Neurogenic scapuloperoneal syndrome, Kaeser type",Point prevalence,N/A
Disease,85162,Facial onset sensory and motor neuronopathy,Cases/families,N/A
Disease,85162,Facial onset sensory and motor neuronopathy,Point prevalence,N/A
Disease,85138,Addison disease,Annual incidence,N/A
Disease,85138,Addison disease,Point prevalence,N/A
Disease,85138,Addison disease,Point prevalence,N/A
Disease,85138,Addison disease,Point prevalence,N/A
Disease,85128,Bothnia retinal dystrophy,Point prevalence,N/A
Disease,85136,Cystic leukoencephalopathy without megalencephaly,Cases/families,N/A
Disease,85136,Cystic leukoencephalopathy without megalencephaly,Point prevalence,N/A
Disease,85110,Familial encephalopathy with neuroserpin inclusion bodies,Cases/families,N/A
Disease,85110,Familial encephalopathy with neuroserpin inclusion bodies,Point prevalence,N/A
Disease,85112,Palmoplantar keratoderma-XX sex reversal-predisposition to squamous cell carcinoma syndrome,Cases/families,N/A
Disease,85112,Palmoplantar keratoderma-XX sex reversal-predisposition to squamous cell carcinoma syndrome,Point prevalence,N/A
Disease,84132,Desmin-related myopathy with Mallory body-like inclusions,Cases/families,N/A
Disease,84132,Desmin-related myopathy with Mallory body-like inclusions,Point prevalence,N/A
Disease,84142,Isaacs syndrome,Cases/families,N/A
Disease,84142,Isaacs syndrome,Point prevalence,N/A
Disease,84093,Hereditary thermosensitive neuropathy,Cases/families,N/A
Disease,84093,Hereditary thermosensitive neuropathy,Point prevalence,N/A
Malformation syndrome,85186,Endosteal sclerosis-cerebellar hypoplasia syndrome,Cases/families,N/A
Malformation syndrome,85186,Endosteal sclerosis-cerebellar hypoplasia syndrome,Point prevalence,N/A
Malformation syndrome,85184,"Craniometadiaphyseal dysplasia, wormian bone type",Cases/families,N/A
Malformation syndrome,85184,"Craniometadiaphyseal dysplasia, wormian bone type",Point prevalence,N/A
Malformation syndrome,85179,Infantile osteopetrosis with neuroaxonal dysplasia,Point prevalence,N/A
Malformation syndrome,85175,Astley-Kendall dysplasia,Cases/families,N/A
Malformation syndrome,85175,Astley-Kendall dysplasia,Point prevalence,N/A
Malformation syndrome,85174,Pseudodiastrophic dysplasia,Cases/families,N/A
Malformation syndrome,85174,Pseudodiastrophic dysplasia,Point prevalence,N/A
Malformation syndrome,85173,IMAGe syndrome,Cases/families,N/A
Malformation syndrome,85173,IMAGe syndrome,Point prevalence,N/A
Disease,85172,"Microcephalic osteodysplastic dysplasia, Saul-Wilson type",Cases/families,N/A
Disease,85172,"Microcephalic osteodysplastic dysplasia, Saul-Wilson type",Point prevalence,N/A
Malformation syndrome,85170,"Mesomelic dysplasia, Savarirayan type",Point prevalence,N/A
Malformation syndrome,85169,Familial digital arthropathy-brachydactyly,Point prevalence,N/A
Malformation syndrome,85168,Craniofacial conodysplasia,Cases/families,N/A
Malformation syndrome,85168,Craniofacial conodysplasia,Point prevalence,N/A
Disease,85167,Spondylometaphyseal dysplasia-cone-rod dystrophy syndrome,Cases/families,N/A
Disease,85167,Spondylometaphyseal dysplasia-cone-rod dystrophy syndrome,Point prevalence,N/A
Malformation syndrome,85166,"Platyspondylic dysplasia, Torrance type",Point prevalence,N/A
Disease,85165,Severe achondroplasia-developmental delay-acanthosis nigricans syndrome,Cases/families,N/A
Disease,85165,Severe achondroplasia-developmental delay-acanthosis nigricans syndrome,Point prevalence,N/A
Malformation syndrome,603448,Cerebellar hypoplasia-intellectual disability-congenital microcephaly-dystonia-anemia-growth retardation syndrome,Cases/families,N/A
Malformation syndrome,603448,Cerebellar hypoplasia-intellectual disability-congenital microcephaly-dystonia-anemia-growth retardation syndrome,Point prevalence,N/A
Morphological anomaly,603515,Isolated female hypospadias,Point prevalence,N/A
Malformation syndrome,603494,Coloboma-osteopetrosis-microphthalmia-macrocephaly-albinism-deafness syndrome,Cases/families,N/A
Malformation syndrome,603494,Coloboma-osteopetrosis-microphthalmia-macrocephaly-albinism-deafness syndrome,Point prevalence,N/A
Malformation syndrome,603689,KLHL7-related Bohring-Opitz-like syndrome,Cases/families,N/A
Malformation syndrome,603689,KLHL7-related Bohring-Opitz-like syndrome,Point prevalence,N/A
Malformation syndrome,603684,KLHL7-related Bohring-Opitz-like and Crisponi/Cold-induced sweating-like overlap syndrome,Cases/families,N/A
Malformation syndrome,603684,KLHL7-related Bohring-Opitz-like and Crisponi/Cold-induced sweating-like overlap syndrome,Point prevalence,N/A
Disease,610573,CLCN6-related childhood-onset progressive neurodegeneration-peripheral neuropathy syndrome,Cases/families,N/A
Disease,610573,CLCN6-related childhood-onset progressive neurodegeneration-peripheral neuropathy syndrome,Point prevalence,N/A
Disease,610569,KIAA1109-related early lethal congenital brain malformations-arthrogryposis syndrome,Cases/families,N/A
Disease,610569,KIAA1109-related early lethal congenital brain malformations-arthrogryposis syndrome,Point prevalence,N/A
Disease,604680,Symptomatic form of X-linked centronuclear myopathy in female carriers,Cases/families,N/A
Disease,604680,Symptomatic form of X-linked centronuclear myopathy in female carriers,Point prevalence,N/A
Malformation syndrome,611256,Pontocerebellar hypoplasia type 12,Cases/families,N/A
Malformation syndrome,611256,Pontocerebellar hypoplasia type 12,Point prevalence,N/A
Disease,611237,Parkinsonism with polyneuropathy,Cases/families,N/A
Disease,611237,Parkinsonism with polyneuropathy,Point prevalence,N/A
Malformation syndrome,611247,Pontocerebellar hypoplasia type 11,Cases/families,N/A
Malformation syndrome,611247,Pontocerebellar hypoplasia type 11,Point prevalence,N/A
Disease,611216,Aplastic anemia-intellectual disability-dwarfism syndrome,Cases/families,N/A
Disease,611216,Aplastic anemia-intellectual disability-dwarfism syndrome,Point prevalence,N/A
Malformation syndrome,611223,EN1-related dorsoventral syndrome,Cases/families,N/A
Malformation syndrome,611223,EN1-related dorsoventral syndrome,Point prevalence,N/A
Malformation syndrome,611201,Oculogastrointestinal-neurodevelopmental syndrome,Cases/families,N/A
Malformation syndrome,611201,Oculogastrointestinal-neurodevelopmental syndrome,Point prevalence,N/A
Malformation syndrome,613267,Pontocerebellar hypoplasia type 13,Cases/families,N/A
Malformation syndrome,613267,Pontocerebellar hypoplasia type 13,Point prevalence,N/A
Category,98085,"46,XY difference of sex development",Annual incidence,N/A
Category,98085,"46,XY difference of sex development",Prevalence at birth,N/A
Malformation syndrome,613274,Pontocerebellar hypoplasia type 14,Cases/families,N/A
Malformation syndrome,613274,Pontocerebellar hypoplasia type 14,Point prevalence,N/A
Clinical group,98249,Ehlers-Danlos syndrome,Prevalence at birth,N/A
Clinical group,98249,Ehlers-Danlos syndrome,Point prevalence,N/A
Disease,600668,CCNK-related neurodevelopmental disorder-severe intellectual disability-facial dysmorphism syndrome,Cases/families,N/A
Disease,600668,CCNK-related neurodevelopmental disorder-severe intellectual disability-facial dysmorphism syndrome,Point prevalence,N/A
Malformation syndrome,600663,NRXN1-related severe neurodevelopmental disorder-motor stereotypies-chronic constipation-sleep-wake cycle disturbance,Cases/families,N/A
Malformation syndrome,600663,NRXN1-related severe neurodevelopmental disorder-motor stereotypies-chronic constipation-sleep-wake cycle disturbance,Point prevalence,N/A
Disease,600691,Combined deficiency of factor VII and factor X,Cases/families,N/A
Disease,600691,Combined deficiency of factor VII and factor X,Point prevalence,N/A
Malformation syndrome,600731,Clark-Baraitser syndrome,Cases/families,N/A
Malformation syndrome,600731,Clark-Baraitser syndrome,Point prevalence,N/A
Category,98287,Histiocytic and dendritic cell tumor,Annual incidence,N/A
Clinical group,98293,Hodgkin lymphoma,Annual incidence,N/A
Clinical group,98293,Hodgkin lymphoma,Lifetime Prevalence,N/A
Clinical group,98293,Hodgkin lymphoma,Annual incidence,N/A
Clinical group,98293,Hodgkin lymphoma,Annual incidence,N/A
Clinical group,98293,Hodgkin lymphoma,Annual incidence,N/A
Category,98292,Mastocytosis,Point prevalence,N/A
Category,98292,Mastocytosis,Point prevalence,N/A
Category,98292,Mastocytosis,Point prevalence,N/A
Clinical group,98274,Myeloproliferative neoplasm,Annual incidence,N/A
Category,98277,Acute myeloid leukemia with recurrent genetic anomaly,Annual incidence,N/A
Clinical group,98275,Myelodysplastic/myeloproliferative disease,Annual incidence,N/A
Disease,98267,Genetic non-syndromic obesity,Point prevalence,N/A
Disease,98267,Genetic non-syndromic obesity,Annual incidence,N/A
Morphological anomaly,601028,Non-syndromic anorectal malformation with rectovaginal fistula,Prevalence at birth,N/A
Morphological anomaly,601028,Non-syndromic anorectal malformation with rectovaginal fistula,Point prevalence,N/A
Morphological anomaly,601033,Non-syndromic anorectal malformation with H-type fistula,Prevalence at birth,N/A
Morphological anomaly,601033,Non-syndromic anorectal malformation with H-type fistula,Point prevalence,N/A
Morphological anomaly,601008,Non-syndromic anorectal malformation with anal stenosis,Prevalence at birth,N/A
Morphological anomaly,601008,Non-syndromic anorectal malformation with anal stenosis,Point prevalence,N/A
Morphological anomaly,601013,Non-syndromic anorectal malformation with pouch colon,Prevalence at birth,N/A
Morphological anomaly,601013,Non-syndromic anorectal malformation with pouch colon,Point prevalence,N/A
Morphological anomaly,601018,Non-syndromic anorectal malformation with rectal atresia,Prevalence at birth,N/A
Morphological anomaly,601018,Non-syndromic anorectal malformation with rectal atresia,Point prevalence,N/A
Morphological anomaly,601023,Non-syndromic anorectal malformation with rectal stenosis,Prevalence at birth,N/A
Morphological anomaly,601023,Non-syndromic anorectal malformation with rectal stenosis,Point prevalence,N/A
Morphological anomaly,600984,Non-syndromic anorectal malformation with rectovesical fistula,Prevalence at birth,N/A
Morphological anomaly,600984,Non-syndromic anorectal malformation with rectovesical fistula,Point prevalence,N/A
Morphological anomaly,600993,Non-syndromic anorectal malformation with vestibular fistula,Prevalence at birth,N/A
Morphological anomaly,600993,Non-syndromic anorectal malformation with vestibular fistula,Point prevalence,N/A
Morphological anomaly,600998,Non-syndromic cloacal malformation,Prevalence at birth,N/A
Morphological anomaly,600998,Non-syndromic cloacal malformation,Point prevalence,N/A
Morphological anomaly,601002,Non-syndromic anorectal malformation without fistula,Prevalence at birth,N/A
Morphological anomaly,601002,Non-syndromic anorectal malformation without fistula,Point prevalence,N/A
Morphological anomaly,600961,Non-syndromic anorectal malformation with rectourethral fistula,Prevalence at birth,N/A
Morphological anomaly,600961,Non-syndromic anorectal malformation with rectourethral fistula,Point prevalence,N/A
Morphological anomaly,600952,Non-syndromic anorectal malformation with perineal fistula,Prevalence at birth,N/A
Morphological anomaly,600952,Non-syndromic anorectal malformation with perineal fistula,Point prevalence,N/A
Category,97245,Congenital myopathy,Point prevalence,N/A
Disease,97244,Rigid spine syndrome,Prevalence at birth,N/A
Disease,97244,Rigid spine syndrome,Point prevalence,N/A
Disease,97244,Rigid spine syndrome,Point prevalence,N/A
Category,97242,Congenital muscular dystrophy,Point prevalence,N/A
Category,97242,Congenital muscular dystrophy,Point prevalence,N/A
Disease,97261,GRFoma,Point prevalence,N/A
Category,97253,Neuroendocrine tumor of pancreas,Annual incidence,N/A
Category,97253,Neuroendocrine tumor of pancreas,Annual incidence,N/A
Category,97253,Neuroendocrine tumor of pancreas,Point prevalence,N/A
Category,97253,Neuroendocrine tumor of pancreas,Annual incidence,N/A
Category,97253,Neuroendocrine tumor of pancreas,Annual incidence,N/A
Category,97253,Neuroendocrine tumor of pancreas,Point prevalence,N/A
Category,97253,Neuroendocrine tumor of pancreas,Point prevalence,N/A
Malformation syndrome,97249,Pontocerebellar hypoplasia type 3,Cases/families,N/A
Malformation syndrome,97249,Pontocerebellar hypoplasia type 3,Point prevalence,N/A
Disease,97279,Insulinoma,Annual incidence,N/A
Disease,97279,Insulinoma,Annual incidence,N/A
Disease,97279,Insulinoma,Point prevalence,N/A
Disease,97279,Insulinoma,Point prevalence,N/A
Disease,97278,PPoma,Point prevalence,N/A
Disease,97285,Thyroid lymphoma,Annual incidence,N/A
Disease,97283,Somatostatinoma,Annual incidence,N/A
Disease,97283,Somatostatinoma,Point prevalence,N/A
Disease,97282,VIPoma,Annual incidence,N/A
Disease,97282,VIPoma,Point prevalence,N/A
Disease,97280,Glucagonoma,Annual incidence,N/A
Disease,97280,Glucagonoma,Point prevalence,N/A
Disease,97290,Familial papillary thyroid carcinoma with renal papillary neoplasia,Cases/families,N/A
Disease,97286,Carney-Stratakis syndrome,Cases/families,N/A
Disease,97286,Carney-Stratakis syndrome,Point prevalence,N/A
Particular clinical situation in a disease or syndrome,97292,Cardiogenic shock,Point prevalence,N/A
Disease,97335,Osgood-Schlatter disease,Point prevalence,N/A
Malformation syndrome,97297,Bohring-Opitz syndrome,Cases/families,N/A
Malformation syndrome,97297,Bohring-Opitz syndrome,Point prevalence,N/A
Disease,97330,Thoracic outlet syndrome,Point prevalence,N/A
Morphological anomaly,97339,Dural sinus malformation,Point prevalence,N/A
Disease,97336,Panner disease,Point prevalence,N/A
Disease,97337,Sinding-Larsen-Johansson disease,Point prevalence,N/A
Disease,97341,Persistent placoid maculopathy,Cases/families,N/A
Disease,97341,Persistent placoid maculopathy,Point prevalence,N/A
Malformation syndrome,97340,Hunter-McAlpine syndrome,Cases/families,N/A
Malformation syndrome,97340,Hunter-McAlpine syndrome,Point prevalence,N/A
Malformation syndrome,97360,Robinow syndrome,Cases/families,N/A
Malformation syndrome,97360,Robinow syndrome,Point prevalence,N/A
Disease,97355,Caribbean parkinsonism,Point prevalence,N/A
Clinical subtype,97361,"Renal hypoplasia, unilateral",Point prevalence,N/A
Clinical subtype,97362,"Renal hypoplasia, bilateral",Point prevalence,N/A
Clinical subtype,97363,Unilateral multicystic dysplastic kidney,Prevalence at birth,N/A
Clinical subtype,97363,Unilateral multicystic dysplastic kidney,Prevalence at birth,N/A
Clinical subtype,97363,Unilateral multicystic dysplastic kidney,Prevalence at birth,N/A
Clinical subtype,97363,Unilateral multicystic dysplastic kidney,Prevalence at birth,N/A
Clinical subtype,97363,Unilateral multicystic dysplastic kidney,Prevalence at birth,N/A
Clinical subtype,97363,Unilateral multicystic dysplastic kidney,Prevalence at birth,N/A
Clinical subtype,97363,Unilateral multicystic dysplastic kidney,Prevalence at birth,N/A
Clinical subtype,97363,Unilateral multicystic dysplastic kidney,Prevalence at birth,N/A
Clinical subtype,97363,Unilateral multicystic dysplastic kidney,Point prevalence,N/A
Clinical subtype,97364,Bilateral multicystic dysplastic kidney,Point prevalence,N/A
Malformation syndrome,97548,Right sided atrial isomerism,Point prevalence,N/A
Malformation syndrome,97548,Right sided atrial isomerism,Prevalence at birth,N/A
Disease,97560,Primary membranous glomerulonephritis,Annual incidence,N/A
Disease,97560,Primary membranous glomerulonephritis,Annual incidence,N/A
Disease,97560,Primary membranous glomerulonephritis,Point prevalence,N/A
Malformation syndrome,96181,Maternal uniparental disomy of chromosome 6 syndrome,Cases/families,N/A
Malformation syndrome,96181,Maternal uniparental disomy of chromosome 6 syndrome,Point prevalence,N/A
Malformation syndrome,96178,Ring chromosome 16 syndrome,Cases/families,N/A
Malformation syndrome,96178,Ring chromosome 16 syndrome,Point prevalence,N/A
Malformation syndrome,96177,Ring chromosome 15 syndrome,Cases/families,N/A
Malformation syndrome,96177,Ring chromosome 15 syndrome,Point prevalence,N/A
Malformation syndrome,96176,Ring chromosome 13 syndrome,Prevalence at birth,N/A
Malformation syndrome,96188,Maternal uniparental disomy of chromosome 22 syndrome,Cases/families,N/A
Malformation syndrome,96188,Maternal uniparental disomy of chromosome 22 syndrome,Point prevalence,N/A
Malformation syndrome,96187,Maternal uniparental disomy of chromosome 21 syndrome,Cases/families,N/A
Malformation syndrome,96187,Maternal uniparental disomy of chromosome 21 syndrome,Point prevalence,N/A
Malformation syndrome,96186,Maternal uniparental disomy of chromosome 20 syndrome,Cases/families,N/A
Malformation syndrome,96186,Maternal uniparental disomy of chromosome 20 syndrome,Point prevalence,N/A
Etiological subtype,96184,Temple syndrome due to maternal uniparental disomy of chromosome 14,Cases/families,N/A
Etiological subtype,96184,Temple syndrome due to maternal uniparental disomy of chromosome 14,Point prevalence,N/A
Malformation syndrome,96192,Paternal uniparental disomy of chromosome 7 syndrome,Cases/families,N/A
Malformation syndrome,96192,Paternal uniparental disomy of chromosome 7 syndrome,Point prevalence,N/A
Disease,96253,Cushing disease,Point prevalence,N/A
Disease,96253,Cushing disease,Annual incidence,N/A
Malformation syndrome,96264,"49,XXXXY syndrome",Prevalence at birth,N/A
Malformation syndrome,96264,"49,XXXXY syndrome",Point prevalence,N/A
Malformation syndrome,96263,"48,XXXY syndrome",Prevalence at birth,N/A
Malformation syndrome,96263,"48,XXXY syndrome",Point prevalence,N/A
Etiological subtype,96334,Kagami-Ogata syndrome due to paternal uniparental disomy of chromosome 14,Point prevalence,N/A
Etiological subtype,96334,Kagami-Ogata syndrome due to paternal uniparental disomy of chromosome 14,Cases/families,N/A
Malformation syndrome,97214,Eisenmenger syndrome,Point prevalence,N/A
Malformation syndrome,97214,Eisenmenger syndrome,Point prevalence,N/A
Disease,97234,Glycogen storage disease due to phosphoglycerate mutase deficiency,Cases/families,N/A
Disease,97234,Glycogen storage disease due to phosphoglycerate mutase deficiency,Point prevalence,N/A
Disease,97239,Reducing body myopathy,Cases/families,N/A
Disease,97239,Reducing body myopathy,Point prevalence,N/A
Disease,97240,Zebra body myopathy,Cases/families,N/A
Disease,97240,Zebra body myopathy,Point prevalence,N/A
Malformation syndrome,97229,Riboflavin transporter deficiency,Cases/families,N/A
Malformation syndrome,97229,Riboflavin transporter deficiency,Point prevalence,N/A
Disease,97230,Solar urticaria,Point prevalence,N/A
Disease,97230,Solar urticaria,Point prevalence,N/A
Disease,97232,Fingerprint body myopathy,Cases/families,N/A
Disease,97232,Fingerprint body myopathy,Point prevalence,N/A
Etiological subtype,600194,Factor V Atlanta bleeding disorder,Cases/families,N/A
Etiological subtype,600194,Factor V Atlanta bleeding disorder,Point prevalence,N/A
Malformation syndrome,97678,Maternal uniparental disomy of chromosome 13 syndrome,Cases/families,N/A
Malformation syndrome,97678,Maternal uniparental disomy of chromosome 13 syndrome,Point prevalence,N/A
Category,97593,Pseudohypoparathyroidism,Point prevalence,N/A
Category,97593,Pseudohypoparathyroidism,Point prevalence,N/A
Category,97593,Pseudohypoparathyroidism,Point prevalence,N/A
Clinical subtype,97564,Pauci-immune glomerulonephritis without ANCA,Point prevalence,N/A
Clinical subtype,97563,Pauci-immune glomerulonephritis with ANCA,Point prevalence,N/A
Clinical subtype,97685,17q11 microdeletion syndrome,Cases/families,N/A
Clinical subtype,97685,17q11 microdeletion syndrome,Point prevalence,N/A
Morphological anomaly,95707,Idiopathic isolated micropenis,Point prevalence,N/A
Morphological anomaly,95706,Non-syndromic posterior hypospadias,Prevalence at birth,N/A
Morphological anomaly,95706,Non-syndromic posterior hypospadias,Point prevalence,N/A
Disease,95702,X-linked adrenal hypoplasia congenita,Point prevalence,N/A
Disease,95702,X-linked adrenal hypoplasia congenita,Prevalence at birth,N/A
Disease,95715,Congenital hypothyroidism due to transplacental passage of TSH-binding inhibitory antibodies,Point prevalence,N/A
Disease,95716,Familial thyroid dyshormonogenesis,Annual incidence,N/A
Disease,95716,Familial thyroid dyshormonogenesis,Point prevalence,N/A
Disease,95716,Familial thyroid dyshormonogenesis,Annual incidence,N/A
Morphological anomaly,95713,Athyreosis,Point prevalence,N/A
Category,95714,Primary congenital hypothyroidism without thyroid developmental anomaly,Point prevalence,N/A
Category,95711,Congenital hypothyroidism due to developmental anomaly,Point prevalence,N/A
Morphological anomaly,95712,Thyroid ectopia,Point prevalence,N/A
Disease,95613,Pituitary apoplexy,Point prevalence,N/A
Disease,95700,Familial adrenal hypoplasia with absent pituitary luteinizing hormone,Cases/families,N/A
Disease,95700,Familial adrenal hypoplasia with absent pituitary luteinizing hormone,Point prevalence,N/A
Disease,95699,Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency,Prevalence at birth,N/A
Disease,95699,Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency,Point prevalence,N/A
Clinical subtype,95626,Acquired arginine vasopressin deficiency,Point prevalence,N/A
Clinical group,95506,Primary hypophysitis,Point prevalence,N/A
Morphological anomaly,95496,Pituitary stalk interruption syndrome,Point prevalence,N/A
Disease,95494,"Combined pituitary hormone deficiencies, genetic forms",Point prevalence,N/A
Disease,95433,Autosomal recessive spinocerebellar ataxia-blindness-deafness syndrome,Point prevalence,N/A
Disease,95433,Autosomal recessive spinocerebellar ataxia-blindness-deafness syndrome,Cases/families,N/A
Disease,95434,Autosomal recessive cerebellar ataxia-movement disorder syndrome,Cases/families,N/A
Disease,95434,Autosomal recessive cerebellar ataxia-movement disorder syndrome,Point prevalence,N/A
Disease,95455,Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum,Annual incidence,N/A
Disease,95455,Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum,Point prevalence,N/A
Disease,95455,Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum,Annual incidence,N/A
Disease,95455,Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum,Annual incidence,N/A
Disease,95455,Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum,Annual incidence,N/A
Clinical group,95157,Acute hepatic porphyria,Point prevalence,N/A
Disease,95159,Hepatoerythropoietic porphyria,Cases/families,N/A
Disease,95159,Hepatoerythropoietic porphyria,Point prevalence,N/A
Disease,95428,COG8-CDG,Cases/families,N/A
Disease,95428,COG8-CDG,Point prevalence,N/A
Disease,95427,Secondary short bowel syndrome,Annual incidence,N/A
Disease,95427,Secondary short bowel syndrome,Point prevalence,N/A
Clinical syndrome,95409,Acute adrenal insufficiency,Point prevalence,N/A
Clinical group,95432,Primary progressive aphasia,Point prevalence,N/A
Morphological anomaly,95430,Congenital tracheomalacia,Point prevalence,N/A
Disease,95429,Angioma serpiginosum,Point prevalence,N/A
Disease,94091,Mills syndrome,Point prevalence,N/A
Disease,94093,Neuroleptic malignant syndrome,Point prevalence,N/A
Disease,94122,"Cerebellar ataxia, Cayman type",Point prevalence,N/A
Disease,94124,Spinocerebellar ataxia with axonal neuropathy type 1,Point prevalence,N/A
Disease,94124,Spinocerebellar ataxia with axonal neuropathy type 1,Cases/families,N/A
Clinical group,94145,Autosomal dominant cerebellar ataxia type I,Point prevalence,N/A
Disease,94147,Spinocerebellar ataxia type 7,Point prevalence,N/A
Clinical group,94148,Autosomal dominant cerebellar ataxia type III,Point prevalence,N/A
Malformation syndrome,94064,Deafness-infertility syndrome,Cases/families,N/A
Malformation syndrome,94064,Deafness-infertility syndrome,Point prevalence,N/A
Malformation syndrome,94063,12q14 microdeletion syndrome,Cases/families,N/A
Malformation syndrome,94063,12q14 microdeletion syndrome,Point prevalence,N/A
Malformation syndrome,94066,Severe intellectual disability-epilepsy-anal anomalies-distal phalangeal hypoplasia,Cases/families,N/A
Malformation syndrome,94066,Severe intellectual disability-epilepsy-anal anomalies-distal phalangeal hypoplasia,Point prevalence,N/A
Etiological subtype,94065,15q24 microdeletion syndrome,Cases/families,N/A
Etiological subtype,94065,15q24 microdeletion syndrome,Point prevalence,N/A
Disease,94068,Spondyloepiphyseal dysplasia congenita,Prevalence at birth,N/A
Disease,94068,Spondyloepiphyseal dysplasia congenita,Point prevalence,N/A
Malformation syndrome,94083,Partington syndrome,Cases/families,N/A
Malformation syndrome,94083,Partington syndrome,Point prevalence,N/A
Disease,94086,Blue diaper syndrome,Point prevalence,N/A
Malformation syndrome,94088,Hereditary renal hypouricemia,Point prevalence,N/A
Disease,94087,Cytophagic histiocytic panniculitis,Point prevalence,N/A
Disease,94087,Cytophagic histiocytic panniculitis,Cases/families,N/A
Disease,94090,Pseudohypoparathyroidism type 2,Point prevalence,N/A
Disease,94089,Pseudohypoparathyroidism type 1B,Point prevalence,N/A
Malformation syndrome,96175,Ring chromosome 11 syndrome,Cases/families,N/A
Malformation syndrome,96175,Ring chromosome 11 syndrome,Point prevalence,N/A
Malformation syndrome,96173,Ring chromosome 9 syndrome,Cases/families,N/A
Malformation syndrome,96173,Ring chromosome 9 syndrome,Point prevalence,N/A
Malformation syndrome,96172,Ring chromosome 3 syndrome,Cases/families,N/A
Malformation syndrome,96172,Ring chromosome 3 syndrome,Point prevalence,N/A
Malformation syndrome,96171,Ring chromosome 2 syndrome,Cases/families,N/A
Malformation syndrome,96171,Ring chromosome 2 syndrome,Point prevalence,N/A
Malformation syndrome,96170,Emanuel syndrome,Cases/families,N/A
Malformation syndrome,96170,Emanuel syndrome,Point prevalence,N/A
Malformation syndrome,96169,Koolen-De Vries syndrome,Point prevalence,N/A
Malformation syndrome,96168,Monosomy 13q34 syndrome,Prevalence at birth,N/A
Malformation syndrome,96168,Monosomy 13q34 syndrome,Point prevalence,N/A
Malformation syndrome,96167,Recombinant 8 syndrome,Point prevalence,N/A
Malformation syndrome,96148,Distal deletion 10q syndrome,Cases/families,N/A
Malformation syndrome,96148,Distal deletion 10q syndrome,Point prevalence,N/A
Etiological subtype,96147,Kleefstra syndrome due to 9q34 microdeletion,Cases/families,N/A
Etiological subtype,96147,Kleefstra syndrome due to 9q34 microdeletion,Point prevalence,N/A
Malformation syndrome,96125,Distal deletion 6p syndrome,Cases/families,N/A
Malformation syndrome,96125,Distal deletion 6p syndrome,Point prevalence,N/A
Malformation syndrome,96121,7q11.23 microduplication syndrome,Cases/families,N/A
Malformation syndrome,96121,7q11.23 microduplication syndrome,Point prevalence,N/A
Malformation syndrome,96102,Distal duplication 10q syndrome,Cases/families,N/A
Malformation syndrome,96102,Distal duplication 10q syndrome,Point prevalence,N/A
Malformation syndrome,96095,3q26 microduplication syndrome,Cases/families,N/A
Malformation syndrome,96095,3q26 microduplication syndrome,Point prevalence,N/A
Malformation syndrome,96092,8p inverted duplication/deletion syndrome,Prevalence at birth,N/A
Malformation syndrome,96092,8p inverted duplication/deletion syndrome,Cases/families,N/A
Malformation syndrome,96092,8p inverted duplication/deletion syndrome,Point prevalence,N/A
Malformation syndrome,96078,16p13.3 microduplication syndrome,Cases/families,N/A
Malformation syndrome,96078,16p13.3 microduplication syndrome,Point prevalence,N/A
Malformation syndrome,96061,Mosaic trisomy 8 syndrome,Point prevalence,N/A
Disease,95717,Idiopathic congenital hypothyroidism,Point prevalence,N/A
Morphological anomaly,95719,Thyroid hemiagenesis,Point prevalence,N/A
Morphological anomaly,95720,Thyroid hypoplasia,Point prevalence,N/A
Malformation syndrome,96055,Tetrasomy 21 syndrome,Cases/families,N/A
Malformation syndrome,96055,Tetrasomy 21 syndrome,Point prevalence,N/A
Disease,597623,IRF2BPL-related regressive neurodevelopmental disorder-dystonia-seizures syndrome,Cases/families,N/A
Disease,597623,IRF2BPL-related regressive neurodevelopmental disorder-dystonia-seizures syndrome,Point prevalence,N/A
Disease,597733,Oculocutaneous albinism type 8,Point prevalence,N/A
Disease,597733,Oculocutaneous albinism type 8,Cases/families,N/A
Malformation syndrome,597738,Luscan-Lumish syndrome,Point prevalence,N/A
Malformation syndrome,597738,Luscan-Lumish syndrome,Cases/families,N/A
Disease,597887,ALPI-related inflammatory bowel disease,Cases/families,N/A
Disease,597887,ALPI-related inflammatory bowel disease,Point prevalence,N/A
Etiological subtype,93555,Mixed cryoglobulinemia type III,Point prevalence,N/A
Etiological subtype,93554,Mixed cryoglobulinemia type II,Point prevalence,N/A
Disease,597939,Euthyroid dysprealbuminemic hyperthyroxinemia,Cases/families,N/A
Disease,597939,Euthyroid dysprealbuminemic hyperthyroxinemia,Point prevalence,N/A
Malformation syndrome,597743,SETD2-related microcephaly-severe intellectual disability-multiple congenital anomalies syndrome,Point prevalence,N/A
Malformation syndrome,597743,SETD2-related microcephaly-severe intellectual disability-multiple congenital anomalies syndrome,Cases/families,N/A
Malformation syndrome,597746,Blepharophimosis-intellectual disability syndrome/genitopatellar overlap syndrome,Cases/families,N/A
Malformation syndrome,597746,Blepharophimosis-intellectual disability syndrome/genitopatellar overlap syndrome,Point prevalence,N/A
Disease,93552,Pediatric systemic lupus erythematosus,Point prevalence,N/A
Disease,93552,Pediatric systemic lupus erythematosus,Annual incidence,N/A
Disease,597874,MTHFS-related developmental delay-microcephaly-short stature-epilepsy syndrome,Cases/families,N/A
Disease,597874,MTHFS-related developmental delay-microcephaly-short stature-epilepsy syndrome,Point prevalence,N/A
Disease,598216,Upper tract urothelial carcinoma,Point prevalence,N/A
Disease,598216,Upper tract urothelial carcinoma,Annual incidence,N/A
Malformation syndrome,598603,Facial dysmorphism-hypertrichosis-epilepsy-intellectual disability/developmental delay-gingival overgrowth syndrome,Cases/families,N/A
Malformation syndrome,598603,Facial dysmorphism-hypertrichosis-epilepsy-intellectual disability/developmental delay-gingival overgrowth syndrome,Point prevalence,N/A
Disease,598363,Multisystem inflammatory syndrome in children and adults,Annual incidence,N/A
Disease,598363,Multisystem inflammatory syndrome in children and adults,Point prevalence,N/A
Clinical subtype,93561,ALys amyloidosis,Cases/families,N/A
Clinical subtype,93561,ALys amyloidosis,Point prevalence,N/A
Histopathological subtype,93571,Dense deposit disease,Point prevalence,N/A
Disease,597201,TRIM22-related inflammatory bowel disease,Cases/families,N/A
Disease,597201,TRIM22-related inflammatory bowel disease,Point prevalence,N/A
Clinical subtype,93474,Scheie syndrome,Point prevalence,N/A
Clinical subtype,93474,Scheie syndrome,Point prevalence,N/A
Clinical subtype,93474,Scheie syndrome,Prevalence at birth,N/A
Clinical subtype,93474,Scheie syndrome,Prevalence at birth,N/A
Clinical subtype,93476,Hurler-Scheie syndrome,Prevalence at birth,N/A
Clinical subtype,93476,Hurler-Scheie syndrome,Point prevalence,N/A
Clinical subtype,93473,Hurler syndrome,Point prevalence,N/A
Clinical subtype,93473,Hurler syndrome,Point prevalence,N/A
Clinical subtype,93473,Hurler syndrome,Prevalence at birth,N/A
Clinical subtype,93473,Hurler syndrome,Prevalence at birth,N/A
Clinical subtype,93473,Hurler syndrome,Point prevalence,N/A
Clinical subtype,93473,Hurler syndrome,Prevalence at birth,N/A
Clinical subtype,93473,Hurler syndrome,Prevalence at birth,N/A
Clinical subtype,93473,Hurler syndrome,Prevalence at birth,N/A
Clinical subtype,93473,Hurler syndrome,Prevalence at birth,N/A
Clinical subtype,93473,Hurler syndrome,Point prevalence,N/A
Clinical subtype,93473,Hurler syndrome,Prevalence at birth,N/A
Disease,93398,Genochondromatosis type 2,Cases/families,N/A
Disease,93398,Genochondromatosis type 2,Point prevalence,N/A
Disease,599373,STXBP1-related encephalopathy,Point prevalence,N/A
Disease,599373,STXBP1-related encephalopathy,Cases/families,N/A
Disease,599373,STXBP1-related encephalopathy,Point prevalence,N/A
Morphological anomaly,93403,Syndactyly type 2,Point prevalence,N/A
Disease,599376,Hypomyelination of early myelinating structures,Cases/families,N/A
Disease,599376,Hypomyelination of early myelinating structures,Point prevalence,N/A
Morphological anomaly,93402,Syndactyly type 1,Prevalence at birth,N/A
Morphological anomaly,93402,Syndactyly type 1,Point prevalence,N/A
Morphological anomaly,93405,Syndactyly type 4,Cases/families,N/A
Morphological anomaly,93405,Syndactyly type 4,Point prevalence,N/A
Morphological anomaly,93404,Syndactyly type 3,Point prevalence,N/A
Disease,599480,Acquired hemophilia A,Point prevalence,N/A
Disease,599480,Acquired hemophilia A,Annual incidence,N/A
Disease,599480,Acquired hemophilia A,Point prevalence,N/A
Disease,599480,Acquired hemophilia A,Annual incidence,N/A
Disease,599480,Acquired hemophilia A,Point prevalence,N/A
Disease,599480,Acquired hemophilia A,Annual incidence,N/A
Disease,599480,Acquired hemophilia A,Point prevalence,N/A
Disease,599480,Acquired hemophilia A,Annual incidence,N/A
Disease,599480,Acquired hemophilia A,Point prevalence,N/A
Disease,599480,Acquired hemophilia A,Annual incidence,N/A
Disease,599480,Acquired hemophilia A,Point prevalence,N/A
Disease,599480,Acquired hemophilia A,Annual incidence,N/A
Disease,599480,Acquired hemophilia A,Point prevalence,N/A
Disease,599480,Acquired hemophilia A,Annual incidence,N/A
Disease,599485,Acquired hemophilia B,Point prevalence,N/A
Disease,599485,Acquired hemophilia B,Annual incidence,N/A
Morphological anomaly,93406,Syndactyly type 5,Cases/families,N/A
Morphological anomaly,93406,Syndactyly type 5,Point prevalence,N/A
Disease,599490,Acquired factor V deficiency,Point prevalence,N/A
Disease,599490,Acquired factor V deficiency,Cases/families,N/A
Disease,599490,Acquired factor V deficiency,Annual incidence,N/A
Disease,599490,Acquired factor V deficiency,Annual incidence,N/A
Malformation syndrome,93409,"Brachydactyly-syndactyly, Zhao type",Cases/families,N/A
Malformation syndrome,93409,"Brachydactyly-syndactyly, Zhao type",Point prevalence,N/A
Disease,599495,Acquired factor VII deficiency,Cases/families,N/A
Disease,599495,Acquired factor VII deficiency,Point prevalence,N/A
Disease,599501,Acquired factor X deficiency,Cases/families,N/A
Disease,599501,Acquired factor X deficiency,Point prevalence,N/A
Disease,599507,Acquired factor XI deficiency,Cases/families,N/A
Disease,599507,Acquired factor XI deficiency,Point prevalence,N/A
Disease,599513,Acquired factor XIII deficiency,Cases/families,N/A
Disease,599513,Acquired factor XIII deficiency,Point prevalence,N/A
Disease,599519,Factor V short isoforms-related bleeding disorder,Cases/families,N/A
Disease,599519,Factor V short isoforms-related bleeding disorder,Point prevalence,N/A
Category,93420,FGFR3-related chondrodysplasia,Prevalence at birth,N/A
Etiological subtype,599579,Factor V Amsterdam bleeding disorder,Cases/families,N/A
Etiological subtype,599579,Factor V Amsterdam bleeding disorder,Point prevalence,N/A
Disease,93360,"Spondyloepimetaphyseal dysplasia with joint laxity, leptodactylic type",Point prevalence,N/A
Disease,93358,Spondyloepimetaphyseal dysplasia-short limb-abnormal calcification syndrome,Cases/families,N/A
Disease,93358,Spondyloepimetaphyseal dysplasia-short limb-abnormal calcification syndrome,Point prevalence,N/A
Disease,93357,SPONASTRIME dysplasia,Cases/families,N/A
Disease,93357,SPONASTRIME dysplasia,Point prevalence,N/A
Malformation syndrome,599082,CHD3-related developmental delay-speech delay-intellectual disability-abnormalities of vision-facial dysmorphism syndrome,Cases/families,N/A
Malformation syndrome,599082,CHD3-related developmental delay-speech delay-intellectual disability-abnormalities of vision-facial dysmorphism syndrome,Point prevalence,N/A
Etiological subtype,93372,Familial hypocalciuric hypercalcemia type 1,Point prevalence,N/A
Etiological subtype,93372,Familial hypocalciuric hypercalcemia type 1,Point prevalence,N/A
Etiological subtype,93372,Familial hypocalciuric hypercalcemia type 1,Point prevalence,N/A
Malformation syndrome,93382,Brachydactyly type A6,Cases/families,N/A
Malformation syndrome,93382,Brachydactyly type A6,Point prevalence,N/A
Malformation syndrome,93383,Brachydactyly type B,Point prevalence,N/A
Malformation syndrome,93383,Brachydactyly type B,Point prevalence,N/A
Malformation syndrome,93387,Brachydactyly type E,Point prevalence,N/A
Malformation syndrome,93388,Brachydactyly type A1,Point prevalence,N/A
Malformation syndrome,93384,Brachydactyly type C,Point prevalence,N/A
Malformation syndrome,93396,Brachydactyly type A2,Point prevalence,N/A
Malformation syndrome,93396,Brachydactyly type A2,Point prevalence,N/A
Malformation syndrome,93397,Brachydactyly type A7,Cases/families,N/A
Malformation syndrome,93397,Brachydactyly type A7,Point prevalence,N/A
Malformation syndrome,93394,Brachydactyly type A4,Point prevalence,N/A
Disease,595356,Localized dystrophic epidermolysis bullosa,Point prevalence,N/A
Disease,595356,Localized dystrophic epidermolysis bullosa,Prevalence at birth,N/A
Particular clinical situation in a disease or syndrome,94059,Uremic pruritus,Point prevalence,N/A
Particular clinical situation in a disease or syndrome,94058,Neovascular glaucoma,Point prevalence,N/A
Morphological anomaly,94056,Isolated humero-ulnar synostosis,Cases/families,N/A
Morphological anomaly,94056,Isolated humero-ulnar synostosis,Point prevalence,N/A
Morphological anomaly,93976,Anotia,Point prevalence,N/A
Morphological anomaly,93976,Anotia,Prevalence at birth,N/A
Morphological anomaly,93976,Anotia,Point prevalence,N/A
Morphological anomaly,93976,Anotia,Prevalence at birth,N/A
Morphological anomaly,93976,Anotia,Point prevalence,N/A
Morphological anomaly,93976,Anotia,Prevalence at birth,N/A
Morphological anomaly,93976,Anotia,Point prevalence,N/A
Morphological anomaly,93976,Anotia,Prevalence at birth,N/A
Morphological anomaly,93976,Anotia,Point prevalence,N/A
Morphological anomaly,93976,Anotia,Prevalence at birth,N/A
Morphological anomaly,93976,Anotia,Point prevalence,N/A
Morphological anomaly,93976,Anotia,Prevalence at birth,N/A
Morphological anomaly,93976,Anotia,Point prevalence,N/A
Morphological anomaly,93976,Anotia,Prevalence at birth,N/A
Morphological anomaly,93976,Anotia,Point prevalence,N/A
Disease,93932,FG syndrome type 1,Prevalence at birth,N/A
Disease,93932,FG syndrome type 1,Point prevalence,N/A
Clinical subtype,93930,Bladder exstrophy,Prevalence at birth,N/A
Clinical subtype,93930,Bladder exstrophy,Prevalence at birth,N/A
Clinical subtype,93930,Bladder exstrophy,Point prevalence,N/A
Clinical subtype,93930,Bladder exstrophy,Prevalence at birth,N/A
Clinical subtype,93930,Bladder exstrophy,Prevalence at birth,N/A
Clinical subtype,93928,Isolated epispadias,Prevalence at birth,N/A
Clinical subtype,93928,Isolated epispadias,Point prevalence,N/A
Clinical subtype,93929,Cloacal exstrophy,Prevalence at birth,N/A
Clinical subtype,93929,Cloacal exstrophy,Point prevalence,N/A
Clinical subtype,93929,Cloacal exstrophy,Prevalence at birth,N/A
Clinical subtype,93929,Cloacal exstrophy,Prevalence at birth,N/A
Clinical subtype,93929,Cloacal exstrophy,Prevalence at birth,N/A
Clinical subtype,93926,Midline interhemispheric variant of holoprosencephaly,Point prevalence,N/A
Clinical subtype,93926,Midline interhemispheric variant of holoprosencephaly,Prevalence at birth,N/A
Clinical subtype,93926,Midline interhemispheric variant of holoprosencephaly,Prevalence at birth,N/A
Clinical subtype,93924,Lobar holoprosencephaly,Point prevalence,N/A
Clinical subtype,93925,Alobar holoprosencephaly,Point prevalence,N/A
Disease,93921,Full schwannomatosis,Point prevalence,N/A
Disease,93921,Full schwannomatosis,Annual incidence,N/A
Morphological anomaly,93953,Familial thyroglossal duct cyst,Cases/families,N/A
Morphological anomaly,93953,Familial thyroglossal duct cyst,Point prevalence,N/A
Disease,93952,"X-linked intellectual disability, Hedera type",Cases/families,N/A
Disease,93952,"X-linked intellectual disability, Hedera type",Point prevalence,N/A
Disease,595133,Perivascular epithelioid cell neoplasm,Annual incidence,N/A
Clinical subtype,93947,"X-linked intellectual disability, Golabi-Ito-Hall type",Cases/families,N/A
Clinical subtype,93947,"X-linked intellectual disability, Golabi-Ito-Hall type",Point prevalence,N/A
Clinical subtype,93946,Hamel cerebro-palato-cardiac syndrome,Cases/families,N/A
Clinical subtype,93946,Hamel cerebro-palato-cardiac syndrome,Point prevalence,N/A
Clinical subtype,93941,Laryngotracheoesophageal cleft type 4,Cases/families,N/A
Clinical subtype,93941,Laryngotracheoesophageal cleft type 4,Point prevalence,N/A
Clinical subtype,93940,Laryngotracheoesophageal cleft type 3,Cases/families,N/A
Clinical subtype,93940,Laryngotracheoesophageal cleft type 3,Point prevalence,N/A
Clinical subtype,93939,Laryngotracheoesophageal cleft type 2,Point prevalence,N/A
Clinical subtype,93938,Laryngotracheoesophageal cleft type 1,Point prevalence,N/A
Clinical subtype,93616,Hemoglobin H disease,Prevalence at birth,N/A
Clinical subtype,93616,Hemoglobin H disease,Point prevalence,N/A
Clinical subtype,93616,Hemoglobin H disease,Annual incidence,N/A
Clinical subtype,93622,Dent disease type 1,Point prevalence,N/A
Clinical subtype,93623,Dent disease type 2,Point prevalence,N/A
Disease,93672,Juvenile dermatomyositis,Annual incidence,N/A
Disease,93672,Juvenile dermatomyositis,Point prevalence,N/A
Clinical subtype,93685,Unicentric Castleman disease,Point prevalence,N/A
Clinical subtype,93685,Unicentric Castleman disease,Annual incidence,N/A
Category,93890,Rare developmental defect during embryogenesis,Point prevalence,N/A
Category,93890,Rare developmental defect during embryogenesis,Prevalence at birth,N/A
Clinical subtype,93591,Infantile nephronophthisis,Point prevalence,N/A
Clinical subtype,93598,Primary hyperoxaluria type 1,Annual incidence,N/A
Clinical subtype,93598,Primary hyperoxaluria type 1,Point prevalence,N/A
Clinical subtype,93598,Primary hyperoxaluria type 1,Prevalence at birth,N/A
Clinical subtype,93598,Primary hyperoxaluria type 1,Point prevalence,N/A
Clinical subtype,93598,Primary hyperoxaluria type 1,Annual incidence,N/A
Clinical subtype,93598,Primary hyperoxaluria type 1,Point prevalence,N/A
Clinical subtype,93583,Congenital thrombotic thrombocytopenic purpura,Annual incidence,N/A
Clinical subtype,93583,Congenital thrombotic thrombocytopenic purpura,Point prevalence,N/A
Clinical subtype,93583,Congenital thrombotic thrombocytopenic purpura,Cases/families,N/A
Clinical subtype,93585,Immune-mediated thrombotic thrombocytopenic purpura,Annual incidence,N/A
Clinical subtype,93585,Immune-mediated thrombotic thrombocytopenic purpura,Point prevalence,N/A
Clinical subtype,93610,Distal renal tubular acidosis with anemia,Point prevalence,N/A
Disease,596759,Combined immunodeficiency due to RELA haploinsufficiency,Cases/families,N/A
Disease,596759,Combined immunodeficiency due to RELA haploinsufficiency,Point prevalence,N/A
Clinical subtype,93608,Autosomal dominant distal renal tubular acidosis,Point prevalence,N/A
Clinical subtype,93607,Autosomal recessive proximal renal tubular acidosis,Point prevalence,N/A
Disease,596937,Portosinusoidal vascular disease,Point prevalence,N/A
Disease,596937,Portosinusoidal vascular disease,Annual incidence,N/A
Disease,596448,IgG4-related systemic disease,Point prevalence,N/A
Disease,596448,IgG4-related systemic disease,Annual incidence,N/A
Disease,596448,IgG4-related systemic disease,Point prevalence,N/A
Disease,596448,IgG4-related systemic disease,Annual incidence,N/A
Disease,596448,IgG4-related systemic disease,Point prevalence,N/A
Disease,596448,IgG4-related systemic disease,Annual incidence,N/A
Clinical subtype,93600,Primary hyperoxaluria type 3,Cases/families,N/A
Clinical subtype,93600,Primary hyperoxaluria type 3,Point prevalence,N/A
Clinical subtype,93599,Primary hyperoxaluria type 2,Cases/families,N/A
Clinical subtype,93599,Primary hyperoxaluria type 2,Point prevalence,N/A
Disease,93606,Nephrogenic syndrome of inappropriate antidiuresis,Cases/families,N/A
Disease,93606,Nephrogenic syndrome of inappropriate antidiuresis,Point prevalence,N/A
Disease,596753,VEXAS syndrome,Cases/families,N/A
Disease,596753,VEXAS syndrome,Point prevalence,N/A
Clinical subtype,93605,Bartter syndrome type 3,Point prevalence,N/A
Morphological anomaly,99094,Laubry-Pezzi syndrome,Point prevalence,N/A
Malformation syndrome,99063,Shone complex,Cases/families,N/A
Malformation syndrome,99063,Shone complex,Point prevalence,N/A
Morphological anomaly,99125,Congenital total pulmonary venous return anomaly,Prevalence at birth,N/A
Morphological anomaly,99125,Congenital total pulmonary venous return anomaly,Prevalence at birth,N/A
Morphological anomaly,99125,Congenital total pulmonary venous return anomaly,Point prevalence,N/A
Morphological anomaly,99125,Congenital total pulmonary venous return anomaly,Point prevalence,N/A
Morphological anomaly,99095,Congenital Gerbode defect,Point prevalence,N/A
Disease,99147,Acquired von Willebrand syndrome,Cases/families,N/A
Disease,99147,Acquired von Willebrand syndrome,Point prevalence,N/A
Clinical subtype,592873,Acute transverse myelitis with anti-MOG antibodies,Point prevalence,N/A
Clinical subtype,592873,Acute transverse myelitis with anti-MOG antibodies,Annual incidence,N/A
Malformation syndrome,99141,Lymphedema-posterior choanal atresia syndrome,Cases/families,N/A
Malformation syndrome,99141,Lymphedema-posterior choanal atresia syndrome,Point prevalence,N/A
Malformation syndrome,99329,"48,XYYY syndrome",Cases/families,N/A
Malformation syndrome,99329,"48,XYYY syndrome",Point prevalence,N/A
Malformation syndrome,99330,"49,XYYYY syndrome",Cases/families,N/A
Malformation syndrome,99330,"49,XYYYY syndrome",Point prevalence,N/A
Disease,99657,"Primary dystonia, DYT2 type",Point prevalence,N/A
Disease,99429,Complete androgen insensitivity syndrome,Annual incidence,N/A
Disease,99429,Complete androgen insensitivity syndrome,Point prevalence,N/A
Disease,99642,"Spondyloepimetaphyseal dysplasia, Handigodu type",Point prevalence,N/A
Disease,99642,"Spondyloepimetaphyseal dysplasia, Handigodu type",Cases/families,N/A
Disease,99646,Metaphyseal chondromatosis with D-2-hydroxyglutaric aciduria,Point prevalence,N/A
Malformation syndrome,99688,Dermotrichic syndrome,Point prevalence,N/A
Malformation syndrome,592574,Menke-Hennekam syndrome,Cases/families,N/A
Malformation syndrome,592574,Menke-Hennekam syndrome,Point prevalence,N/A
Disease,592564,GNAO1-related developmental delay-seizures-movement disorder spectrum,Cases/families,N/A
Disease,592564,GNAO1-related developmental delay-seizures-movement disorder spectrum,Point prevalence,N/A
Malformation syndrome,592570,TRAF7-associated heart defect-digital anomalies-facial dysmorphism-motor and speech delay syndrome,Cases/families,N/A
Malformation syndrome,592570,TRAF7-associated heart defect-digital anomalies-facial dysmorphism-motor and speech delay syndrome,Point prevalence,N/A
Malformation syndrome,99672,Fried's tooth and nail syndrome,Cases/families,N/A
Malformation syndrome,99672,Fried's tooth and nail syndrome,Point prevalence,N/A
Disease,99718,Leber plus disease,Point prevalence,N/A
Disease,590539,Isolated melanotic schwannoma,Annual incidence,N/A
Disease,590539,Isolated melanotic schwannoma,Point prevalence,N/A
Disease,99725,Pituitary gigantism,Point prevalence,N/A
Clinical subtype,589821,Congenital-onset Steinert myotonic dystrophy,Prevalence at birth,N/A
Clinical subtype,589821,Congenital-onset Steinert myotonic dystrophy,Prevalence at birth,N/A
Clinical subtype,589821,Congenital-onset Steinert myotonic dystrophy,Prevalence at birth,N/A
Clinical subtype,589821,Congenital-onset Steinert myotonic dystrophy,Prevalence at birth,N/A
Clinical subtype,589821,Congenital-onset Steinert myotonic dystrophy,Point prevalence,N/A
Clinical subtype,589827,Juvenile-onset Steinert myotonic dystrophy,Point prevalence,N/A
Clinical subtype,589827,Juvenile-onset Steinert myotonic dystrophy,Point prevalence,N/A
Clinical subtype,589824,Childhood-onset Steinert myotonic dystrophy,Point prevalence,N/A
Clinical subtype,589824,Childhood-onset Steinert myotonic dystrophy,Point prevalence,N/A
Clinical subtype,589833,Late-onset Steinert myotonic dystrophy,Point prevalence,N/A
Clinical subtype,589833,Late-onset Steinert myotonic dystrophy,Point prevalence,N/A
Clinical subtype,589830,Adult-onset Steinert myotonic dystrophy,Point prevalence,N/A
Clinical subtype,589830,Adult-onset Steinert myotonic dystrophy,Point prevalence,N/A
Disease,589905,PHIP-related behavioral problems-intellectual disability-obesity-dysmorphic features syndrome,Cases/families,N/A
Disease,589905,PHIP-related behavioral problems-intellectual disability-obesity-dysmorphic features syndrome,Point prevalence,N/A
Malformation syndrome,589856,Choanal atresia-athelia-hypothyroidism-delayed puberty-short stature syndrome,Cases/families,N/A
Malformation syndrome,589856,Choanal atresia-athelia-hypothyroidism-delayed puberty-short stature syndrome,Point prevalence,N/A
Disease,99710,Punctate acrokeratoderma freckle-like pigmentation,Cases/families,N/A
Disease,99710,Punctate acrokeratoderma freckle-like pigmentation,Point prevalence,N/A
Clinical subtype,99750,Atypical progressive supranuclear palsy syndrome,Point prevalence,N/A
Disease,99749,Kostmann syndrome,Cases/families,N/A
Disease,99749,Kostmann syndrome,Point prevalence,N/A
Disease,99749,Kostmann syndrome,Annual incidence,N/A
Disease,99748,Pontiac fever,Point prevalence,N/A
Clinical subtype,99757,Embryonal rhabdomyosarcoma,Annual incidence,N/A
Clinical subtype,99757,Embryonal rhabdomyosarcoma,Annual incidence,N/A
Clinical subtype,99757,Embryonal rhabdomyosarcoma,Annual incidence,N/A
Clinical subtype,99757,Embryonal rhabdomyosarcoma,Annual incidence,N/A
Clinical subtype,99757,Embryonal rhabdomyosarcoma,Annual incidence,N/A
Clinical subtype,99757,Embryonal rhabdomyosarcoma,Annual incidence,N/A
Clinical subtype,99757,Embryonal rhabdomyosarcoma,Annual incidence,N/A
Clinical subtype,99757,Embryonal rhabdomyosarcoma,Annual incidence,N/A
Clinical subtype,99757,Embryonal rhabdomyosarcoma,Annual incidence,N/A
Clinical subtype,99757,Embryonal rhabdomyosarcoma,Annual incidence,N/A
Clinical subtype,99757,Embryonal rhabdomyosarcoma,Annual incidence,N/A
Clinical subtype,99757,Embryonal rhabdomyosarcoma,Annual incidence,N/A
Clinical subtype,99757,Embryonal rhabdomyosarcoma,Annual incidence,N/A
Clinical subtype,99757,Embryonal rhabdomyosarcoma,Annual incidence,N/A
Clinical subtype,99757,Embryonal rhabdomyosarcoma,Annual incidence,N/A
Clinical subtype,99757,Embryonal rhabdomyosarcoma,Annual incidence,N/A
Clinical subtype,99757,Embryonal rhabdomyosarcoma,Annual incidence,N/A
Clinical subtype,99757,Embryonal rhabdomyosarcoma,Annual incidence,N/A
Clinical subtype,99757,Embryonal rhabdomyosarcoma,Annual incidence,N/A
Clinical subtype,99757,Embryonal rhabdomyosarcoma,Annual incidence,N/A
Clinical subtype,99757,Embryonal rhabdomyosarcoma,Annual incidence,N/A
Clinical subtype,99757,Embryonal rhabdomyosarcoma,Annual incidence,N/A
Clinical subtype,99757,Embryonal rhabdomyosarcoma,Annual incidence,N/A
Clinical subtype,99756,Alveolar rhabdomyosarcoma,Annual incidence,N/A
Clinical subtype,99756,Alveolar rhabdomyosarcoma,Annual incidence,N/A
Clinical subtype,99756,Alveolar rhabdomyosarcoma,Annual incidence,N/A
Clinical subtype,99756,Alveolar rhabdomyosarcoma,Annual incidence,N/A
Clinical subtype,99756,Alveolar rhabdomyosarcoma,Annual incidence,N/A
Clinical subtype,99756,Alveolar rhabdomyosarcoma,Annual incidence,N/A
Clinical subtype,99756,Alveolar rhabdomyosarcoma,Annual incidence,N/A
Clinical subtype,99756,Alveolar rhabdomyosarcoma,Annual incidence,N/A
Clinical subtype,99756,Alveolar rhabdomyosarcoma,Annual incidence,N/A
Clinical subtype,99756,Alveolar rhabdomyosarcoma,Annual incidence,N/A
Clinical subtype,99756,Alveolar rhabdomyosarcoma,Annual incidence,N/A
Clinical subtype,99756,Alveolar rhabdomyosarcoma,Annual incidence,N/A
Clinical subtype,99756,Alveolar rhabdomyosarcoma,Annual incidence,N/A
Clinical subtype,99756,Alveolar rhabdomyosarcoma,Annual incidence,N/A
Clinical subtype,99756,Alveolar rhabdomyosarcoma,Annual incidence,N/A
Clinical subtype,99756,Alveolar rhabdomyosarcoma,Annual incidence,N/A
Clinical subtype,99756,Alveolar rhabdomyosarcoma,Annual incidence,N/A
Clinical subtype,99756,Alveolar rhabdomyosarcoma,Annual incidence,N/A
Clinical subtype,99756,Alveolar rhabdomyosarcoma,Annual incidence,N/A
Clinical subtype,99756,Alveolar rhabdomyosarcoma,Annual incidence,N/A
Clinical subtype,99756,Alveolar rhabdomyosarcoma,Annual incidence,N/A
Clinical subtype,99756,Alveolar rhabdomyosarcoma,Annual incidence,N/A
Clinical subtype,99756,Alveolar rhabdomyosarcoma,Annual incidence,N/A
Disease,99734,Myotonia fluctuans,Point prevalence,N/A
Clinical subtype,99731,Isolated sulfite oxidase deficiency,Cases/families,N/A
Clinical subtype,99731,Isolated sulfite oxidase deficiency,Point prevalence,N/A
Disease,99735,Myotonia permanens,Point prevalence,N/A
Disease,99736,Acetazolamide-responsive myotonia,Point prevalence,N/A
Malformation syndrome,99741,King-Denborough syndrome,Cases/families,N/A
Malformation syndrome,99741,King-Denborough syndrome,Point prevalence,N/A
Malformation syndrome,99742,Amish lethal microcephaly,Prevalence at birth,N/A
Malformation syndrome,99742,Amish lethal microcephaly,Point prevalence,N/A
Disease,99745,Typhoid,Annual incidence,N/A
Disease,99745,Typhoid,Annual incidence,N/A
Disease,99745,Typhoid,Annual incidence,N/A
Disease,99745,Typhoid,Annual incidence,N/A
Disease,99745,Typhoid,Annual incidence,N/A
Disease,99745,Typhoid,Annual incidence,N/A
Disease,99745,Typhoid,Annual incidence,N/A
Disease,99745,Typhoid,Point prevalence,N/A
Disease,98818,Landau-Kleffner syndrome,Point prevalence,N/A
Clinical subtype,98815,Self-limited epilepsy with autonomic seizures,Annual incidence,N/A
Disease,98813,Hypohidrotic ectodermal dysplasia with immunodeficiency,Prevalence at birth,N/A
Disease,98813,Hypohidrotic ectodermal dysplasia with immunodeficiency,Point prevalence,N/A
Disease,98811,Paroxysmal exertion-induced dyskinesia,Cases/families,N/A
Disease,98811,Paroxysmal exertion-induced dyskinesia,Point prevalence,N/A
Disease,98810,Paroxysmal non-kinesigenic dyskinesia,Point prevalence,N/A
Disease,98809,Paroxysmal kinesigenic dyskinesia,Point prevalence,N/A
Disease,98808,Autosomal dominant dopa-responsive dystonia,Point prevalence,N/A
Disease,98807,"Primary dystonia, DYT13 type",Point prevalence,N/A
Disease,98807,"Primary dystonia, DYT13 type",Cases/families,N/A
Disease,98838,Primary mediastinal large B-cell lymphoma,Point prevalence,N/A
Disease,98833,Acute myeloblastic leukemia without maturation,Annual incidence,N/A
Disease,98834,Acute myeloblastic leukemia with maturation,Annual incidence,N/A
Disease,98831,Acute myeloid leukemia with 11q23 abnormalities,Annual incidence,N/A
Disease,98832,Acute myeloid leukemia with minimal differentiation,Annual incidence,N/A
Disease,98829,Acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22),Annual incidence,N/A
Disease,98827,Unclassified myelodysplastic syndrome,Annual incidence,N/A
Disease,98827,Unclassified myelodysplastic syndrome,Point prevalence,N/A
Disease,98826,Myelodysplastic neoplasm with low blasts,Point prevalence,N/A
Disease,98823,Chronic myelomonocytic leukemia,Annual incidence,N/A
Disease,98824,Atypical chronic myeloid leukemia,Annual incidence,N/A
Disease,98851,Mast cell leukemia,Point prevalence,N/A
Disease,98851,Mast cell leukemia,Annual incidence,N/A
Disease,98848,Indolent systemic mastocytosis,Point prevalence,N/A
Disease,98850,Aggressive systemic mastocytosis,Point prevalence,N/A
Disease,98849,Systemic mastocytosis with associated hematologic neoplasm,Point prevalence,N/A
Histopathological subtype,98844,"Classic Hodgkin lymphoma, mixed cellularity type",Annual incidence,N/A
Histopathological subtype,98843,"Classic Hodgkin lymphoma, nodular sclerosis type",Annual incidence,N/A
Histopathological subtype,98846,"Classic Hodgkin lymphoma, lymphocyte-depleted type",Annual incidence,N/A
Histopathological subtype,98845,"Classic Hodgkin lymphoma, lymphocyte-rich type",Annual incidence,N/A
Disease,98842,Lymphomatoid papulosis,Point prevalence,N/A
Disease,98841,Anaplastic large cell lymphoma,Point prevalence,N/A
Disease,589608,"Linear hypopigmentation and craniofacial asymmetry with acral, ocular and brain anomalies",Cases/families,N/A
Disease,589608,"Linear hypopigmentation and craniofacial asymmetry with acral, ocular and brain anomalies",Point prevalence,N/A
Etiological subtype,589595,Mixed phenotype acute leukemia with t(v;11q23.3),Annual incidence,N/A
Etiological subtype,589595,Mixed phenotype acute leukemia with t(v;11q23.3),Point prevalence,N/A
Disease,98868,Southeast Asian ovalocytosis,Point prevalence,N/A
Disease,98869,Congenital dyserythropoietic anemia type I,Point prevalence,N/A
Disease,98869,Congenital dyserythropoietic anemia type I,Point prevalence,N/A
Disease,589618,Dystonia 28,Cases/families,N/A
Disease,589618,Dystonia 28,Point prevalence,N/A
Disease,98870,Congenital dyserythropoietic anemia type III,Cases/families,N/A
Disease,98870,Congenital dyserythropoietic anemia type III,Point prevalence,N/A
Etiological subtype,589534,Mixed phenotype acute leukemia with t(9;22)(q34.1;q11.2),Annual incidence,N/A
Etiological subtype,589534,Mixed phenotype acute leukemia with t(9;22)(q34.1;q11.2),Point prevalence,N/A
Etiological subtype,98863,X-linked Emery-Dreifuss muscular dystrophy,Point prevalence,N/A
Etiological subtype,98863,X-linked Emery-Dreifuss muscular dystrophy,Prevalence at birth,N/A
Etiological subtype,98863,X-linked Emery-Dreifuss muscular dystrophy,Point prevalence,N/A
Disease,589527,Spinocerebellar ataxia type 45,Cases/families,N/A
Disease,589527,Spinocerebellar ataxia type 45,Point prevalence,N/A
Disease,589547,"GRIN2B-related developmental delay, intellectual disability and autism spectrum disorder",Cases/families,N/A
Disease,589547,"GRIN2B-related developmental delay, intellectual disability and autism spectrum disorder",Point prevalence,N/A
Disease,589542,Myeloid/lymphoid neoplasm associated with JAK2 rearrangement,Annual incidence,N/A
Disease,589542,Myeloid/lymphoid neoplasm associated with JAK2 rearrangement,Point prevalence,N/A
Malformation syndrome,589442,Short stature-skeletal dysplasia-retinal degeneration-intellectual disability-sensorineural hearing loss syndrome,Cases/families,N/A
Malformation syndrome,589442,Short stature-skeletal dysplasia-retinal degeneration-intellectual disability-sensorineural hearing loss syndrome,Point prevalence,N/A
Malformation syndrome,589435,Spondylometaphyseal dysplasia-corneal dystrophy syndrome,Cases/families,N/A
Malformation syndrome,589435,Spondylometaphyseal dysplasia-corneal dystrophy syndrome,Point prevalence,N/A
Disease,589522,Spinocerebellar ataxia type 46,Cases/families,N/A
Disease,589522,Spinocerebellar ataxia type 46,Point prevalence,N/A
Disease,589515,PUM1-associated developmental disability-ataxia-seizure syndrome,Cases/families,N/A
Disease,589515,PUM1-associated developmental disability-ataxia-seizure syndrome,Point prevalence,N/A
Disease,98856,Charcot-Marie-Tooth disease type 2B1,Point prevalence,N/A
Clinical subtype,98881,Familial dysfibrinogenemia,Point prevalence,N/A
Disease,98879,Hemophilia B,Point prevalence,N/A
Disease,98879,Hemophilia B,Point prevalence,N/A
Disease,98879,Hemophilia B,Point prevalence,N/A
Disease,98879,Hemophilia B,Point prevalence,N/A
Disease,98879,Hemophilia B,Point prevalence,N/A
Disease,98879,Hemophilia B,Point prevalence,N/A
Disease,98879,Hemophilia B,Point prevalence,N/A
Disease,98879,Hemophilia B,Point prevalence,N/A
Disease,98879,Hemophilia B,Point prevalence,N/A
Disease,98879,Hemophilia B,Point prevalence,N/A
Disease,98879,Hemophilia B,Point prevalence,N/A
Disease,98879,Hemophilia B,Point prevalence,N/A
Disease,98879,Hemophilia B,Point prevalence,N/A
Disease,98879,Hemophilia B,Point prevalence,N/A
Disease,98879,Hemophilia B,Point prevalence,N/A
Disease,98879,Hemophilia B,Point prevalence,N/A
Disease,98879,Hemophilia B,Point prevalence,N/A
Disease,98879,Hemophilia B,Point prevalence,N/A
Disease,98879,Hemophilia B,Point prevalence,N/A
Disease,98879,Hemophilia B,Point prevalence,N/A
Disease,98879,Hemophilia B,Point prevalence,N/A
Disease,98879,Hemophilia B,Point prevalence,N/A
Disease,98879,Hemophilia B,Point prevalence,N/A
Disease,98879,Hemophilia B,Point prevalence,N/A
Disease,98879,Hemophilia B,Point prevalence,N/A
Disease,98879,Hemophilia B,Point prevalence,N/A
Disease,98879,Hemophilia B,Point prevalence,N/A
Disease,98879,Hemophilia B,Point prevalence,N/A
Disease,98879,Hemophilia B,Point prevalence,N/A
Disease,98879,Hemophilia B,Point prevalence,N/A
Disease,98879,Hemophilia B,Point prevalence,N/A
Disease,98879,Hemophilia B,Point prevalence,N/A
Disease,98879,Hemophilia B,Point prevalence,N/A
Disease,98879,Hemophilia B,Point prevalence,N/A
Disease,98879,Hemophilia B,Point prevalence,N/A
Disease,98879,Hemophilia B,Point prevalence,N/A
Disease,98879,Hemophilia B,Point prevalence,N/A
Disease,98879,Hemophilia B,Point prevalence,N/A
Disease,98879,Hemophilia B,Point prevalence,N/A
Disease,98879,Hemophilia B,Point prevalence,N/A
Disease,98879,Hemophilia B,Point prevalence,N/A
Disease,98879,Hemophilia B,Point prevalence,N/A
Disease,98879,Hemophilia B,Point prevalence,N/A
Disease,98879,Hemophilia B,Point prevalence,N/A
Disease,98879,Hemophilia B,Point prevalence,N/A
Disease,98879,Hemophilia B,Point prevalence,N/A
Disease,98879,Hemophilia B,Point prevalence,N/A
Disease,98879,Hemophilia B,Point prevalence,N/A
Disease,98879,Hemophilia B,Point prevalence,N/A
Disease,98879,Hemophilia B,Point prevalence,N/A
Disease,98879,Hemophilia B,Point prevalence,N/A
Disease,98879,Hemophilia B,Point prevalence,N/A
Disease,98879,Hemophilia B,Point prevalence,N/A
Disease,98879,Hemophilia B,Point prevalence,N/A
Disease,98879,Hemophilia B,Point prevalence,N/A
Disease,98879,Hemophilia B,Point prevalence,N/A
Disease,98879,Hemophilia B,Point prevalence,N/A
Disease,98879,Hemophilia B,Point prevalence,N/A
Disease,98879,Hemophilia B,Point prevalence,N/A
Disease,98879,Hemophilia B,Point prevalence,N/A
Disease,98879,Hemophilia B,Point prevalence,N/A
Disease,98879,Hemophilia B,Point prevalence,N/A
Disease,98879,Hemophilia B,Point prevalence,N/A
Disease,98879,Hemophilia B,Point prevalence,N/A
Disease,98879,Hemophilia B,Point prevalence,N/A
Disease,98879,Hemophilia B,Point prevalence,N/A
Disease,98879,Hemophilia B,Point prevalence,N/A
Disease,98879,Hemophilia B,Point prevalence,N/A
Disease,98879,Hemophilia B,Point prevalence,N/A
Disease,98879,Hemophilia B,Point prevalence,N/A
Disease,98879,Hemophilia B,Point prevalence,N/A
Disease,98879,Hemophilia B,Point prevalence,N/A
Disease,98879,Hemophilia B,Point prevalence,N/A
Disease,98879,Hemophilia B,Point prevalence,N/A
Disease,98879,Hemophilia B,Point prevalence,N/A
Disease,98879,Hemophilia B,Point prevalence,N/A
Disease,98879,Hemophilia B,Point prevalence,N/A
Disease,98879,Hemophilia B,Point prevalence,N/A
Disease,98879,Hemophilia B,Point prevalence,N/A
Disease,98879,Hemophilia B,Point prevalence,N/A
Disease,98879,Hemophilia B,Point prevalence,N/A
Disease,98879,Hemophilia B,Point prevalence,N/A
Disease,98879,Hemophilia B,Point prevalence,N/A
Disease,98879,Hemophilia B,Point prevalence,N/A
Disease,98879,Hemophilia B,Point prevalence,N/A
Disease,98879,Hemophilia B,Point prevalence,N/A
Disease,98879,Hemophilia B,Point prevalence,N/A
Disease,98879,Hemophilia B,Point prevalence,N/A
Disease,98879,Hemophilia B,Point prevalence,N/A
Disease,98879,Hemophilia B,Point prevalence,N/A
Disease,98879,Hemophilia B,Point prevalence,N/A
Disease,98879,Hemophilia B,Point prevalence,N/A
Disease,98879,Hemophilia B,Point prevalence,N/A
Disease,98879,Hemophilia B,Point prevalence,N/A
Disease,98879,Hemophilia B,Point prevalence,N/A
Disease,98879,Hemophilia B,Point prevalence,N/A
Disease,98879,Hemophilia B,Point prevalence,N/A
Disease,98879,Hemophilia B,Point prevalence,N/A
Disease,98879,Hemophilia B,Point prevalence,N/A
Disease,98879,Hemophilia B,Prevalence at birth,N/A
Disease,98879,Hemophilia B,Point prevalence,N/A
Disease,98873,Congenital dyserythropoietic anemia type II,Point prevalence,N/A
Disease,98878,Hemophilia A,Point prevalence,N/A
Disease,98878,Hemophilia A,Prevalence at birth,N/A
Disease,98878,Hemophilia A,Point prevalence,N/A
Disease,98878,Hemophilia A,Point prevalence,N/A
Disease,98878,Hemophilia A,Point prevalence,N/A
Disease,98878,Hemophilia A,Point prevalence,N/A
Disease,98878,Hemophilia A,Point prevalence,N/A
Disease,98878,Hemophilia A,Point prevalence,N/A
Disease,98878,Hemophilia A,Point prevalence,N/A
Disease,98878,Hemophilia A,Point prevalence,N/A
Disease,98878,Hemophilia A,Point prevalence,N/A
Disease,98878,Hemophilia A,Point prevalence,N/A
Disease,98878,Hemophilia A,Point prevalence,N/A
Disease,98878,Hemophilia A,Point prevalence,N/A
Disease,98878,Hemophilia A,Point prevalence,N/A
Disease,98878,Hemophilia A,Point prevalence,N/A
Disease,98878,Hemophilia A,Point prevalence,N/A
Disease,98878,Hemophilia A,Point prevalence,N/A
Disease,98878,Hemophilia A,Point prevalence,N/A
Disease,98878,Hemophilia A,Point prevalence,N/A
Disease,98878,Hemophilia A,Point prevalence,N/A
Disease,98878,Hemophilia A,Point prevalence,N/A
Disease,98878,Hemophilia A,Point prevalence,N/A
Disease,98878,Hemophilia A,Point prevalence,N/A
Disease,98878,Hemophilia A,Point prevalence,N/A
Disease,98878,Hemophilia A,Point prevalence,N/A
Disease,98878,Hemophilia A,Point prevalence,N/A
Disease,98878,Hemophilia A,Point prevalence,N/A
Disease,98878,Hemophilia A,Point prevalence,N/A
Disease,98878,Hemophilia A,Point prevalence,N/A
Disease,98878,Hemophilia A,Point prevalence,N/A
Disease,98878,Hemophilia A,Point prevalence,N/A
Disease,98878,Hemophilia A,Point prevalence,N/A
Disease,98878,Hemophilia A,Point prevalence,N/A
Disease,98878,Hemophilia A,Point prevalence,N/A
Disease,98878,Hemophilia A,Point prevalence,N/A
Disease,98878,Hemophilia A,Point prevalence,N/A
Disease,98878,Hemophilia A,Point prevalence,N/A
Disease,98878,Hemophilia A,Point prevalence,N/A
Disease,98878,Hemophilia A,Point prevalence,N/A
Disease,98878,Hemophilia A,Point prevalence,N/A
Disease,98878,Hemophilia A,Point prevalence,N/A
Disease,98878,Hemophilia A,Point prevalence,N/A
Disease,98878,Hemophilia A,Point prevalence,N/A
Disease,98878,Hemophilia A,Point prevalence,N/A
Disease,98878,Hemophilia A,Point prevalence,N/A
Disease,98878,Hemophilia A,Point prevalence,N/A
Disease,98878,Hemophilia A,Point prevalence,N/A
Disease,98878,Hemophilia A,Point prevalence,N/A
Disease,98878,Hemophilia A,Point prevalence,N/A
Disease,98878,Hemophilia A,Point prevalence,N/A
Disease,98878,Hemophilia A,Point prevalence,N/A
Disease,98878,Hemophilia A,Point prevalence,N/A
Disease,98878,Hemophilia A,Point prevalence,N/A
Disease,98878,Hemophilia A,Point prevalence,N/A
Disease,98878,Hemophilia A,Point prevalence,N/A
Disease,98878,Hemophilia A,Point prevalence,N/A
Disease,98878,Hemophilia A,Point prevalence,N/A
Disease,98878,Hemophilia A,Point prevalence,N/A
Disease,98878,Hemophilia A,Point prevalence,N/A
Disease,98878,Hemophilia A,Point prevalence,N/A
Disease,98878,Hemophilia A,Point prevalence,N/A
Disease,98878,Hemophilia A,Point prevalence,N/A
Disease,98878,Hemophilia A,Point prevalence,N/A
Disease,98878,Hemophilia A,Point prevalence,N/A
Disease,98878,Hemophilia A,Point prevalence,N/A
Disease,98878,Hemophilia A,Point prevalence,N/A
Disease,98878,Hemophilia A,Point prevalence,N/A
Disease,98878,Hemophilia A,Point prevalence,N/A
Disease,98878,Hemophilia A,Point prevalence,N/A
Disease,98878,Hemophilia A,Point prevalence,N/A
Disease,98878,Hemophilia A,Point prevalence,N/A
Disease,98878,Hemophilia A,Point prevalence,N/A
Disease,98878,Hemophilia A,Point prevalence,N/A
Disease,98878,Hemophilia A,Point prevalence,N/A
Disease,98878,Hemophilia A,Point prevalence,N/A
Disease,98878,Hemophilia A,Point prevalence,N/A
Disease,98878,Hemophilia A,Point prevalence,N/A
Disease,98878,Hemophilia A,Point prevalence,N/A
Disease,98878,Hemophilia A,Point prevalence,N/A
Disease,98878,Hemophilia A,Point prevalence,N/A
Disease,98878,Hemophilia A,Point prevalence,N/A
Disease,98878,Hemophilia A,Point prevalence,N/A
Disease,98878,Hemophilia A,Point prevalence,N/A
Disease,98878,Hemophilia A,Point prevalence,N/A
Disease,98878,Hemophilia A,Point prevalence,N/A
Disease,98878,Hemophilia A,Point prevalence,N/A
Disease,98878,Hemophilia A,Point prevalence,N/A
Disease,98878,Hemophilia A,Point prevalence,N/A
Disease,98878,Hemophilia A,Point prevalence,N/A
Disease,98878,Hemophilia A,Point prevalence,N/A
Disease,98878,Hemophilia A,Point prevalence,N/A
Disease,98878,Hemophilia A,Point prevalence,N/A
Disease,98878,Hemophilia A,Point prevalence,N/A
Disease,98878,Hemophilia A,Point prevalence,N/A
Disease,98878,Hemophilia A,Point prevalence,N/A
Disease,98878,Hemophilia A,Point prevalence,N/A
Disease,98878,Hemophilia A,Point prevalence,N/A
Disease,98878,Hemophilia A,Point prevalence,N/A
Disease,98878,Hemophilia A,Point prevalence,N/A
Disease,98878,Hemophilia A,Point prevalence,N/A
Disease,98878,Hemophilia A,Point prevalence,N/A
Disease,98878,Hemophilia A,Point prevalence,N/A
Disease,98878,Hemophilia A,Point prevalence,N/A
Disease,98878,Hemophilia A,Point prevalence,N/A
Disease,98878,Hemophilia A,Point prevalence,N/A
Disease,98878,Hemophilia A,Point prevalence,N/A
Disease,98878,Hemophilia A,Point prevalence,N/A
Disease,98878,Hemophilia A,Point prevalence,N/A
Disease,98878,Hemophilia A,Point prevalence,N/A
Disease,98895,Becker muscular dystrophy,Point prevalence,N/A
Disease,98895,Becker muscular dystrophy,Prevalence at birth,N/A
Disease,98895,Becker muscular dystrophy,Point prevalence,N/A
Disease,98895,Becker muscular dystrophy,Prevalence at birth,N/A
Disease,98895,Becker muscular dystrophy,Point prevalence,N/A
Disease,98895,Becker muscular dystrophy,Prevalence at birth,N/A
Disease,98895,Becker muscular dystrophy,Point prevalence,N/A
Disease,98895,Becker muscular dystrophy,Point prevalence,N/A
Disease,98895,Becker muscular dystrophy,Point prevalence,N/A
Disease,98895,Becker muscular dystrophy,Point prevalence,N/A
Disease,98895,Becker muscular dystrophy,Point prevalence,N/A
Disease,98895,Becker muscular dystrophy,Point prevalence,N/A
Disease,98895,Becker muscular dystrophy,Point prevalence,N/A
Disease,98896,Duchenne muscular dystrophy,Prevalence at birth,N/A
Disease,98896,Duchenne muscular dystrophy,Point prevalence,N/A
Disease,98896,Duchenne muscular dystrophy,Prevalence at birth,N/A
Disease,98896,Duchenne muscular dystrophy,Prevalence at birth,N/A
Disease,98896,Duchenne muscular dystrophy,Prevalence at birth,N/A
Disease,98896,Duchenne muscular dystrophy,Prevalence at birth,N/A
Disease,98896,Duchenne muscular dystrophy,Prevalence at birth,N/A
Disease,98896,Duchenne muscular dystrophy,Point prevalence,N/A
Disease,98896,Duchenne muscular dystrophy,Point prevalence,N/A
Disease,98896,Duchenne muscular dystrophy,Point prevalence,N/A
Disease,98896,Duchenne muscular dystrophy,Lifetime Prevalence,N/A
Disease,98896,Duchenne muscular dystrophy,Point prevalence,N/A
Disease,98896,Duchenne muscular dystrophy,Point prevalence,N/A
Disease,98896,Duchenne muscular dystrophy,Point prevalence,N/A
Disease,98896,Duchenne muscular dystrophy,Point prevalence,N/A
Disease,98902,Amish nemaline myopathy,Point prevalence,N/A
Disease,98902,Amish nemaline myopathy,Prevalence at birth,N/A
Disease,98890,Early-onset X-linked optic atrophy,Cases/families,N/A
Disease,98890,Early-onset X-linked optic atrophy,Point prevalence,N/A
Disease,98893,Congenital muscular dystrophy type 1B,Cases/families,N/A
Disease,98893,Congenital muscular dystrophy type 1B,Point prevalence,N/A
Clinical subtype,98892,Periventricular nodular heterotopia,Point prevalence,N/A
Disease,98912,"Late-onset distal myopathy, Markesbery-Griggs type",Point prevalence,N/A
Disease,98912,"Late-onset distal myopathy, Markesbery-Griggs type",Cases/families,N/A
Disease,98916,Acute inflammatory demyelinating polyradiculoneuropathy,Point prevalence,N/A
Disease,98908,Neutral lipid storage disease with myopathy,Cases/families,N/A
Disease,98908,Neutral lipid storage disease with myopathy,Point prevalence,N/A
Disease,98907,Neutral lipid storage disease with ichthyosis,Point prevalence,N/A
Disease,98909,Desminopathy,Point prevalence,N/A
Clinical subtype,98933,"Multiple system atrophy, parkinsonian type",Point prevalence,N/A
Disease,98934,Huntington disease-like 2,Cases/families,N/A
Disease,98934,Huntington disease-like 2,Point prevalence,N/A
Disease,98919,Miller Fisher syndrome,Annual incidence,N/A
Disease,98919,Miller Fisher syndrome,Point prevalence,N/A
Disease,98920,Spinal muscular atrophy with respiratory distress type 1,Cases/families,N/A
Disease,98920,Spinal muscular atrophy with respiratory distress type 1,Point prevalence,N/A
Malformation syndrome,98938,Colobomatous microphthalmia,Prevalence at birth,N/A
Malformation syndrome,98938,Colobomatous microphthalmia,Point prevalence,N/A
Clinical subtype,98949,Complete cryptophthalmia,Point prevalence,N/A
Clinical subtype,98949,Complete cryptophthalmia,Cases/families,N/A
Clinical subtype,98950,Partial cryptophthalmia,Point prevalence,N/A
Clinical subtype,98948,Congenital symblepharon,Point prevalence,N/A
Disease,98957,Gelatinous drop-like corneal dystrophy,Point prevalence,N/A
Disease,98957,Gelatinous drop-like corneal dystrophy,Point prevalence,N/A
Disease,98955,Lisch epithelial corneal dystrophy,Cases/families,N/A
Disease,98955,Lisch epithelial corneal dystrophy,Point prevalence,N/A
Disease,98954,Meesmann corneal dystrophy,Cases/families,N/A
Disease,98954,Meesmann corneal dystrophy,Point prevalence,N/A
Disease,98964,Lattice corneal dystrophy type I,Point prevalence,N/A
Disease,98963,Granular corneal dystrophy type II,Point prevalence,N/A
Disease,98962,Granular corneal dystrophy type I,Point prevalence,N/A
Disease,98961,Reis-Bcklers corneal dystrophy,Cases/families,N/A
Disease,98961,Reis-Bcklers corneal dystrophy,Point prevalence,N/A
Disease,98960,Thiel-Behnke corneal dystrophy,Cases/families,N/A
Disease,98960,Thiel-Behnke corneal dystrophy,Point prevalence,N/A
Disease,98959,Subepithelial mucinous corneal dystrophy,Cases/families,N/A
Disease,98959,Subepithelial mucinous corneal dystrophy,Point prevalence,N/A
Disease,98971,Posterior amorphous corneal dystrophy,Cases/families,N/A
Disease,98971,Posterior amorphous corneal dystrophy,Point prevalence,N/A
Disease,98972,Central cloudy dystrophy of Franois,Cases/families,N/A
Disease,98972,Central cloudy dystrophy of Franois,Point prevalence,N/A
Disease,98973,Posterior polymorphous corneal dystrophy,Point prevalence,N/A
Disease,98973,Posterior polymorphous corneal dystrophy,Point prevalence,N/A
Disease,98974,Fuchs endothelial corneal dystrophy,Point prevalence,N/A
Disease,98967,Schnyder corneal dystrophy,Cases/families,N/A
Disease,98967,Schnyder corneal dystrophy,Point prevalence,N/A
Disease,98969,Macular corneal dystrophy,Point prevalence,N/A
Disease,98969,Macular corneal dystrophy,Point prevalence,N/A
Disease,98970,Fleck corneal dystrophy,Cases/families,N/A
Disease,98970,Fleck corneal dystrophy,Point prevalence,N/A
Disease,98976,Congenital glaucoma,Prevalence at birth,N/A
Disease,98976,Congenital glaucoma,Prevalence at birth,N/A
Disease,98976,Congenital glaucoma,Prevalence at birth,N/A
Disease,98976,Congenital glaucoma,Prevalence at birth,N/A
Disease,98976,Congenital glaucoma,Prevalence at birth,N/A
Disease,98976,Congenital glaucoma,Prevalence at birth,N/A
Disease,98976,Congenital glaucoma,Prevalence at birth,N/A
Disease,98976,Congenital glaucoma,Prevalence at birth,N/A
Disease,98976,Congenital glaucoma,Prevalence at birth,N/A
Disease,98976,Congenital glaucoma,Prevalence at birth,N/A
Disease,98976,Congenital glaucoma,Prevalence at birth,N/A
Disease,98976,Congenital glaucoma,Point prevalence,N/A
Disease,98976,Congenital glaucoma,Prevalence at birth,N/A
Disease,98976,Congenital glaucoma,Prevalence at birth,N/A
Disease,98976,Congenital glaucoma,Prevalence at birth,N/A
Disease,98976,Congenital glaucoma,Prevalence at birth,N/A
Disease,98976,Congenital glaucoma,Prevalence at birth,N/A
Disease,98976,Congenital glaucoma,Prevalence at birth,N/A
Disease,98977,Juvenile glaucoma,Point prevalence,N/A
Disease,99000,Adult-onset foveomacular vitelliform dystrophy,Point prevalence,N/A
Disease,99013,Spastic paraplegia type 7,Point prevalence,N/A
Disease,99014,X-linked Charcot-Marie-Tooth disease type 5,Point prevalence,N/A
Disease,99014,X-linked Charcot-Marie-Tooth disease type 5,Cases/families,N/A
Disease,99015,Spastic paraplegia type 2,Cases/families,N/A
Disease,99015,Spastic paraplegia type 2,Point prevalence,N/A
Disease,585867,Acute myeloid leukemia with t(9;22)(q34.1;q11.2),Annual incidence,N/A
Etiological subtype,585877,B-lymphoblastic leukemia/lymphoma with recurrent genetic abnormality,Annual incidence,N/A
Etiological subtype,585877,B-lymphoblastic leukemia/lymphoma with recurrent genetic abnormality,Point prevalence,N/A
Etiological subtype,585909,B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2),Annual incidence,N/A
Etiological subtype,585909,B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2),Point prevalence,N/A
Etiological subtype,585936,B-lymphoblastic leukemia/lymphoma with hyperdiploidy,Annual incidence,N/A
Etiological subtype,585936,B-lymphoblastic leukemia/lymphoma with hyperdiploidy,Point prevalence,N/A
Etiological subtype,585942,B-lymphoblastic leukemia/lymphoma with hypodiploidy,Annual incidence,N/A
Etiological subtype,585942,B-lymphoblastic leukemia/lymphoma with hypodiploidy,Point prevalence,N/A
Etiological subtype,585918,B-lymphoblastic leukemia/lymphoma with t(v;11q23.3),Annual incidence,N/A
Etiological subtype,585918,B-lymphoblastic leukemia/lymphoma with t(v;11q23.3),Point prevalence,N/A
Etiological subtype,585929,B-lymphoblastic leukemia/lymphoma with t(12;21)(p13.2;q22.1),Annual incidence,N/A
Etiological subtype,585929,B-lymphoblastic leukemia/lymphoma with t(12;21)(p13.2;q22.1),Point prevalence,N/A
Disease,99027,Adult-onset autosomal dominant leukodystrophy,Cases/families,N/A
Disease,99027,Adult-onset autosomal dominant leukodystrophy,Point prevalence,N/A
Etiological subtype,585956,B-lymphoblastic leukemia/lymphoma with t(1;19)(q23;p13.3),Annual incidence,N/A
Etiological subtype,585956,B-lymphoblastic leukemia/lymphoma with t(1;19)(q23;p13.3),Point prevalence,N/A
Etiological subtype,585948,B-lymphoblastic leukemia/lymphoma with t(5;14)(q31.1;q32.3),Annual incidence,N/A
Etiological subtype,585948,B-lymphoblastic leukemia/lymphoma with t(5;14)(q31.1;q32.3),Point prevalence,N/A
Disease,586130,Sporadic fatal insomnia,Cases/families,N/A
Disease,586130,Sporadic fatal insomnia,Point prevalence,N/A
Clinical subtype,99042,Congenitally uncorrected transposition of the great arteries with coarctation,Point prevalence,N/A
Morphological anomaly,99050,Abnormal origin of right or left pulmonary artery from the aorta,Cases/families,N/A
Morphological anomaly,99050,Abnormal origin of right or left pulmonary artery from the aorta,Point prevalence,N/A
Malformation syndrome,98606,Syndromic orbital border hypoplasia,Cases/families,N/A
Malformation syndrome,98606,Syndromic orbital border hypoplasia,Point prevalence,N/A
Category,98555,Microphthalmia-anophthalmia-coloboma,Prevalence at birth,N/A
Category,98555,Microphthalmia-anophthalmia-coloboma,Point prevalence,N/A
Category,98555,Microphthalmia-anophthalmia-coloboma,Prevalence at birth,N/A
Category,98555,Microphthalmia-anophthalmia-coloboma,Point prevalence,N/A
Category,98555,Microphthalmia-anophthalmia-coloboma,Prevalence at birth,N/A
Category,98555,Microphthalmia-anophthalmia-coloboma,Point prevalence,N/A
Category,98555,Microphthalmia-anophthalmia-coloboma,Prevalence at birth,N/A
Category,98555,Microphthalmia-anophthalmia-coloboma,Point prevalence,N/A
Category,98555,Microphthalmia-anophthalmia-coloboma,Prevalence at birth,N/A
Category,98555,Microphthalmia-anophthalmia-coloboma,Point prevalence,N/A
Category,98555,Microphthalmia-anophthalmia-coloboma,Prevalence at birth,N/A
Category,98555,Microphthalmia-anophthalmia-coloboma,Point prevalence,N/A
Category,98555,Microphthalmia-anophthalmia-coloboma,Prevalence at birth,N/A
Category,98555,Microphthalmia-anophthalmia-coloboma,Point prevalence,N/A
Category,98555,Microphthalmia-anophthalmia-coloboma,Prevalence at birth,N/A
Category,98555,Microphthalmia-anophthalmia-coloboma,Point prevalence,N/A
Category,98555,Microphthalmia-anophthalmia-coloboma,Prevalence at birth,N/A
Category,98555,Microphthalmia-anophthalmia-coloboma,Point prevalence,N/A
Category,98555,Microphthalmia-anophthalmia-coloboma,Prevalence at birth,N/A
Category,98555,Microphthalmia-anophthalmia-coloboma,Point prevalence,N/A
Category,98555,Microphthalmia-anophthalmia-coloboma,Prevalence at birth,N/A
Category,98555,Microphthalmia-anophthalmia-coloboma,Point prevalence,N/A
Category,98555,Microphthalmia-anophthalmia-coloboma,Prevalence at birth,N/A
Category,98555,Microphthalmia-anophthalmia-coloboma,Point prevalence,N/A
Category,98555,Microphthalmia-anophthalmia-coloboma,Prevalence at birth,N/A
Category,98555,Microphthalmia-anophthalmia-coloboma,Point prevalence,N/A
Category,98555,Microphthalmia-anophthalmia-coloboma,Prevalence at birth,N/A
Category,98555,Microphthalmia-anophthalmia-coloboma,Point prevalence,N/A
Category,98555,Microphthalmia-anophthalmia-coloboma,Prevalence at birth,N/A
Category,98555,Microphthalmia-anophthalmia-coloboma,Point prevalence,N/A
Category,98555,Microphthalmia-anophthalmia-coloboma,Prevalence at birth,N/A
Category,98555,Microphthalmia-anophthalmia-coloboma,Point prevalence,N/A
Category,98555,Microphthalmia-anophthalmia-coloboma,Prevalence at birth,N/A
Category,98555,Microphthalmia-anophthalmia-coloboma,Point prevalence,N/A
Category,98555,Microphthalmia-anophthalmia-coloboma,Prevalence at birth,N/A
Category,98555,Microphthalmia-anophthalmia-coloboma,Point prevalence,N/A
Category,98555,Microphthalmia-anophthalmia-coloboma,Prevalence at birth,N/A
Category,98555,Microphthalmia-anophthalmia-coloboma,Point prevalence,N/A
Category,98555,Microphthalmia-anophthalmia-coloboma,Prevalence at birth,N/A
Category,98555,Microphthalmia-anophthalmia-coloboma,Point prevalence,N/A
Disease,98676,Autosomal recessive isolated optic atrophy,Cases/families,N/A
Disease,98676,Autosomal recessive isolated optic atrophy,Point prevalence,N/A
Disease,98673,"Autosomal dominant optic atrophy, classic form",Point prevalence,N/A
Disease,98673,"Autosomal dominant optic atrophy, classic form",Point prevalence,N/A
Disease,98673,"Autosomal dominant optic atrophy, classic form",Point prevalence,N/A
Disease,98673,"Autosomal dominant optic atrophy, classic form",Point prevalence,N/A
Clinical group,98672,Autosomal dominant optic atrophy,Point prevalence,N/A
Clinical group,98672,Autosomal dominant optic atrophy,Point prevalence,N/A
Clinical group,98672,Autosomal dominant optic atrophy,Point prevalence,N/A
Clinical group,98672,Autosomal dominant optic atrophy,Point prevalence,N/A
Category,98627,Posterior corneal dystrophy,Point prevalence,N/A
Category,98626,Stromal corneal dystrophy,Point prevalence,N/A
Category,98625,Superficial corneal dystrophy,Point prevalence,N/A
Category,98625,Superficial corneal dystrophy,Point prevalence,N/A
Disease,583856,Isolated splenic vein thrombosis,Annual incidence,N/A
Disease,583856,Isolated splenic vein thrombosis,Point prevalence,N/A
Disease,583861,Isolated mesenteric vein thrombosis,Annual incidence,N/A
Disease,583861,Isolated mesenteric vein thrombosis,Annual incidence,N/A
Disease,583861,Isolated mesenteric vein thrombosis,Annual incidence,N/A
Disease,583861,Isolated mesenteric vein thrombosis,Point prevalence,N/A
Category,98715,Uveitis,Annual incidence,N/A
Category,98715,Uveitis,Point prevalence,N/A
Clinical group,98723,Hypoplastic right heart syndrome,Prevalence at birth,N/A
Clinical group,98723,Hypoplastic right heart syndrome,Prevalence at birth,N/A
Clinical group,98723,Hypoplastic right heart syndrome,Prevalence at birth,N/A
Clinical group,98723,Hypoplastic right heart syndrome,Prevalence at birth,N/A
Clinical group,98723,Hypoplastic right heart syndrome,Prevalence at birth,N/A
Clinical group,98723,Hypoplastic right heart syndrome,Prevalence at birth,N/A
Clinical group,98723,Hypoplastic right heart syndrome,Prevalence at birth,N/A
Clinical group,98723,Hypoplastic right heart syndrome,Prevalence at birth,N/A
Clinical group,98723,Hypoplastic right heart syndrome,Prevalence at birth,N/A
Clinical group,98723,Hypoplastic right heart syndrome,Prevalence at birth,N/A
Clinical group,98723,Hypoplastic right heart syndrome,Prevalence at birth,N/A
Clinical group,98723,Hypoplastic right heart syndrome,Prevalence at birth,N/A
Clinical group,98723,Hypoplastic right heart syndrome,Prevalence at birth,N/A
Clinical group,98723,Hypoplastic right heart syndrome,Prevalence at birth,N/A
Clinical group,98723,Hypoplastic right heart syndrome,Prevalence at birth,N/A
Clinical group,98723,Hypoplastic right heart syndrome,Prevalence at birth,N/A
Clinical group,98723,Hypoplastic right heart syndrome,Prevalence at birth,N/A
Disease,583097,Congenital infiltrating lipomatosis of the face,Cases/families,N/A
Disease,583097,Congenital infiltrating lipomatosis of the face,Point prevalence,N/A
Malformation syndrome,98791,Alpha-thalassemia-intellectual disability syndrome linked to chromosome 16,Cases/families,N/A
Malformation syndrome,98791,Alpha-thalassemia-intellectual disability syndrome linked to chromosome 16,Point prevalence,N/A
Disease,98806,"Primary dystonia, DYT6 type",Point prevalence,N/A
Disease,98806,"Primary dystonia, DYT6 type",Cases/families,N/A
Disease,98805,"Primary dystonia, DYT4 type",Point prevalence,N/A
Disease,98805,"Primary dystonia, DYT4 type",Cases/families,N/A
Disease,98784,Autosomal dominant nocturnal frontal lobe epilepsy,Cases/families,N/A
Disease,98784,Autosomal dominant nocturnal frontal lobe epilepsy,Point prevalence,N/A
Disease,98764,Spinocerebellar ataxia type 27A,Cases/families,N/A
Disease,98764,Spinocerebellar ataxia type 27A,Point prevalence,N/A
Disease,98763,Spinocerebellar ataxia type 14,Cases/families,N/A
Disease,98763,Spinocerebellar ataxia type 14,Point prevalence,N/A
Disease,98766,Spinocerebellar ataxia type 5,Cases/families,N/A
Disease,98766,Spinocerebellar ataxia type 5,Point prevalence,N/A
Disease,98765,Spinocerebellar ataxia type 4,Point prevalence,N/A
Disease,98760,Spinocerebellar ataxia type 8,Point prevalence,N/A
Disease,98759,Spinocerebellar ataxia type 17,Cases/families,N/A
Disease,98759,Spinocerebellar ataxia type 17,Point prevalence,N/A
Disease,98759,Spinocerebellar ataxia type 17,Point prevalence,N/A
Disease,98759,Spinocerebellar ataxia type 17,Point prevalence,N/A
Disease,98762,Spinocerebellar ataxia type 12,Cases/families,N/A
Disease,98762,Spinocerebellar ataxia type 12,Point prevalence,N/A
Disease,98761,Spinocerebellar ataxia type 10,Point prevalence,N/A
Disease,98772,Spinocerebellar ataxia type 19/22,Cases/families,N/A
Disease,98772,Spinocerebellar ataxia type 19/22,Point prevalence,N/A
Disease,98771,Spinocerebellar ataxia type 18,Cases/families,N/A
Disease,98771,Spinocerebellar ataxia type 18,Point prevalence,N/A
Disease,98773,Spinocerebellar ataxia type 21,Cases/families,N/A
Disease,98773,Spinocerebellar ataxia type 21,Point prevalence,N/A
Disease,98768,Spinocerebellar ataxia type 13,Cases/families,N/A
Disease,98768,Spinocerebellar ataxia type 13,Point prevalence,N/A
Disease,98767,Spinocerebellar ataxia type 11,Cases/families,N/A
Disease,98767,Spinocerebellar ataxia type 11,Point prevalence,N/A
Disease,98769,Spinocerebellar ataxia type 15/16,Cases/families,N/A
Disease,98769,Spinocerebellar ataxia type 15/16,Point prevalence,N/A
Malformation syndrome,580933,Lethal brain and heart developmental defects,Cases/families,N/A
Malformation syndrome,580933,Lethal brain and heart developmental defects,Point prevalence,N/A
Disease,98755,Spinocerebellar ataxia type 1,Point prevalence,N/A
Disease,98756,Spinocerebellar ataxia type 2,Point prevalence,N/A
Disease,98757,Spinocerebellar ataxia type 3,Point prevalence,N/A
Disease,98757,Spinocerebellar ataxia type 3,Point prevalence,N/A
Disease,98757,Spinocerebellar ataxia type 3,Point prevalence,N/A
Disease,98758,Spinocerebellar ataxia type 6,Point prevalence,N/A
Disease,98758,Spinocerebellar ataxia type 6,Point prevalence,N/A
Disease,580572,Intraductal tubulopapillary neoplasm of pancreas,Annual incidence,N/A
Clinical group,98306,Familial partial lipodystrophy,Point prevalence,N/A
Malformation syndrome,576278,SATB2-associated syndrome,Cases/families,N/A
Malformation syndrome,576278,SATB2-associated syndrome,Point prevalence,N/A
Morphological anomaly,573253,Split cord malformation type II,Point prevalence,N/A
Disease,574957,Mendelian susceptibility to mycobacterial diseases due to partial JAK1 deficiency,Point prevalence,N/A
Disease,574918,Predisposition to severe viral infection due to IRF7 deficiency,Cases/families,N/A
Disease,574918,Predisposition to severe viral infection due to IRF7 deficiency,Point prevalence,N/A
Clinical group,98375,Autoimmune hemolytic anemia,Annual incidence,N/A
Clinical group,98375,Autoimmune hemolytic anemia,Annual incidence,N/A
Clinical group,98375,Autoimmune hemolytic anemia,Point prevalence,N/A
Clinical group,98375,Autoimmune hemolytic anemia,Point prevalence,N/A
Clinical group,573278,Split cord malformation,Point prevalence,N/A
Category,98482,Idiopathic inflammatory myopathy,Point prevalence,N/A
Clinical subtype,572385,Brachydactyly type B1,Point prevalence,N/A
Clinical subtype,572361,Blepharophimosis-ptosis-epicanthus inversus syndrome type 2,Point prevalence,N/A
Category,98428,Secondary polycythemia,Point prevalence,N/A
Disease,572428,Infantile-onset pulmonary alveolar proteinosis-hypogammaglobulinemia,Cases/families,N/A
Disease,572428,Infantile-onset pulmonary alveolar proteinosis-hypogammaglobulinemia,Point prevalence,N/A
Disease,98434,Hereditary combined deficiency of vitamin K-dependent clotting factors,Cases/families,N/A
Disease,98434,Hereditary combined deficiency of vitamin K-dependent clotting factors,Point prevalence,N/A
Clinical subtype,572543,RFVT2-related riboflavin transporter deficiency,Point prevalence,N/A
Clinical subtype,572550,RFVT3-related riboflavin transporter deficiency,Point prevalence,N/A
Clinical subtype,572773,Microcephaly-short stature-limb abnormalities syndrome,Cases/families,N/A
Clinical subtype,572773,Microcephaly-short stature-limb abnormalities syndrome,Point prevalence,N/A
Disease,572798,WARS2-related combined oxidative phosphorylation defect,Cases/families,N/A
Disease,572798,WARS2-related combined oxidative phosphorylation defect,Point prevalence,N/A
Malformation syndrome,572761,DONSON-related microcephaly-short stature-limb abnormalities spectrum,Cases/families,N/A
Malformation syndrome,572761,DONSON-related microcephaly-short stature-limb abnormalities spectrum,Point prevalence,N/A
Clinical subtype,572768,Microcephaly-micromelia syndrome,Cases/families,N/A
Clinical subtype,572768,Microcephaly-micromelia syndrome,Point prevalence,N/A
Clinical group,98523,Non-syndromic pontocerebellar hypoplasia,Point prevalence,N/A
Malformation syndrome,572013,Posterior-predominant lissencephaly-broad flat pons and medulla-midline crossing defects syndrome,Cases/families,N/A
Malformation syndrome,572013,Posterior-predominant lissencephaly-broad flat pons and medulla-midline crossing defects syndrome,Point prevalence,N/A
Malformation syndrome,572333,Blepharophimosis-ptosis-epicanthus inversus syndrome plus,Point prevalence,N/A
Clinical subtype,572354,Blepharophimosis-ptosis-epicanthus inversus syndrome type 1,Point prevalence,N/A
Disease,570762,Infective endocarditis,Point prevalence,N/A
Disease,570762,Infective endocarditis,Annual incidence,N/A
Disease,570762,Infective endocarditis,Annual incidence,N/A
Disease,570762,Infective endocarditis,Annual incidence,N/A
Disease,570491,QRSL1-related combined oxidative phosphorylation defect,Point prevalence,N/A
Disease,570470,Ricin poisoning,Point prevalence,N/A
Disease,570470,Ricin poisoning,Point prevalence,N/A
Clinical subtype,570438,HHV-8-associated multicentric Castleman disease,Point prevalence,N/A
Clinical subtype,570431,Idiopathic multicentric Castleman disease,Point prevalence,N/A
Clinical subtype,570431,Idiopathic multicentric Castleman disease,Annual incidence,N/A
Disease,570422,Galactose mutarotase deficiency,Point prevalence,N/A
Disease,570422,Galactose mutarotase deficiency,Annual incidence,N/A
Disease,570422,Galactose mutarotase deficiency,Annual incidence,N/A
Clinical subtype,570371,Bartter syndrome type 5,Point prevalence,N/A
Clinical subtype,570371,Bartter syndrome type 5,Cases/families,N/A
Category,98497,Genetic peripheral neuropathy,Point prevalence,N/A
Disease,104075,Adenocarcinoma of the small intestine,Annual incidence,N/A
Disease,104075,Adenocarcinoma of the small intestine,Annual incidence,N/A
Disease,104075,Adenocarcinoma of the small intestine,Annual incidence,N/A
Disease,104075,Adenocarcinoma of the small intestine,Annual incidence,N/A
Disease,104075,Adenocarcinoma of the small intestine,Annual incidence,N/A
Disease,104075,Adenocarcinoma of the small intestine,Annual incidence,N/A
Disease,104075,Adenocarcinoma of the small intestine,Annual incidence,N/A
Disease,104075,Adenocarcinoma of the small intestine,Annual incidence,N/A
Disease,104075,Adenocarcinoma of the small intestine,Annual incidence,N/A
Disease,104075,Adenocarcinoma of the small intestine,Annual incidence,N/A
Disease,104075,Adenocarcinoma of the small intestine,Annual incidence,N/A
Disease,104075,Adenocarcinoma of the small intestine,Annual incidence,N/A
Disease,104075,Adenocarcinoma of the small intestine,Annual incidence,N/A
Disease,104075,Adenocarcinoma of the small intestine,Annual incidence,N/A
Disease,104075,Adenocarcinoma of the small intestine,Annual incidence,N/A
Disease,104075,Adenocarcinoma of the small intestine,Annual incidence,N/A
Disease,104075,Adenocarcinoma of the small intestine,Annual incidence,N/A
Disease,104075,Adenocarcinoma of the small intestine,Annual incidence,N/A
Disease,104075,Adenocarcinoma of the small intestine,Annual incidence,N/A
Disease,104075,Adenocarcinoma of the small intestine,Annual incidence,N/A
Disease,104075,Adenocarcinoma of the small intestine,Annual incidence,N/A
Disease,104075,Adenocarcinoma of the small intestine,Annual incidence,N/A
Disease,104075,Adenocarcinoma of the small intestine,Annual incidence,N/A
Disease,104075,Adenocarcinoma of the small intestine,Annual incidence,N/A
Disease,104075,Adenocarcinoma of the small intestine,Annual incidence,N/A
Clinical group,104008,Short bowel syndrome,Point prevalence,N/A
Disease,103918,Tropical pancreatitis,Point prevalence,N/A
Disease,103910,Congenital enterocyte heparan sulfate deficiency,Cases/families,N/A
Disease,103910,Congenital enterocyte heparan sulfate deficiency,Point prevalence,N/A
Disease,103908,Congenital sodium diarrhea,Cases/families,N/A
Disease,103908,Congenital sodium diarrhea,Point prevalence,N/A
Disease,103909,Trehalase deficiency,Annual incidence,N/A
Disease,103909,Trehalase deficiency,Point prevalence,N/A
Disease,103907,Chronic diarrhea due to glucoamylase deficiency,Point prevalence,N/A
Disease,102724,Acute myeloid leukemia with t(8;21)(q22;q22) translocation,Annual incidence,N/A
Category,101997,Primary immunodeficiency,Point prevalence,N/A
Category,101997,Primary immunodeficiency,Point prevalence,N/A
Category,101997,Primary immunodeficiency,Point prevalence,N/A
Category,101997,Primary immunodeficiency,Point prevalence,N/A
Category,101997,Primary immunodeficiency,Point prevalence,N/A
Category,101997,Primary immunodeficiency,Point prevalence,N/A
Category,101997,Primary immunodeficiency,Point prevalence,N/A
Category,101997,Primary immunodeficiency,Point prevalence,N/A
Category,101997,Primary immunodeficiency,Point prevalence,N/A
Category,101997,Primary immunodeficiency,Point prevalence,N/A
Category,101997,Primary immunodeficiency,Point prevalence,N/A
Category,101997,Primary immunodeficiency,Point prevalence,N/A
Category,101997,Primary immunodeficiency,Point prevalence,N/A
Category,101997,Primary immunodeficiency,Point prevalence,N/A
Disease,101685,Rare non-syndromic intellectual disability,Point prevalence,N/A
Disease,101685,Rare non-syndromic intellectual disability,Annual incidence,N/A
Category,101959,Chronic primary adrenal insufficiency,Annual incidence,N/A
Category,101959,Chronic primary adrenal insufficiency,Point prevalence,N/A
Disease,101150,Autosomal recessive dopa-responsive dystonia,Cases/families,N/A
Disease,101150,Autosomal recessive dopa-responsive dystonia,Point prevalence,N/A
Disease,101111,Spinocerebellar ataxia type 25,Cases/families,N/A
Disease,101111,Spinocerebellar ataxia type 25,Point prevalence,N/A
Disease,101112,Spinocerebellar ataxia type 26,Cases/families,N/A
Disease,101112,Spinocerebellar ataxia type 26,Point prevalence,N/A
Disease,101109,Spinocerebellar ataxia type 28,Point prevalence,N/A
Disease,101110,Spinocerebellar ataxia type 20,Cases/families,N/A
Disease,101110,Spinocerebellar ataxia type 20,Point prevalence,N/A
Disease,101108,Spinocerebellar ataxia type 23,Cases/families,N/A
Disease,101108,Spinocerebellar ataxia type 23,Point prevalence,N/A
Disease,101330,Porphyria cutanea tarda,Annual incidence,N/A
Disease,101330,Porphyria cutanea tarda,Point prevalence,N/A
Disease,101330,Porphyria cutanea tarda,Annual incidence,N/A
Disease,101330,Porphyria cutanea tarda,Point prevalence,N/A
Disease,101085,Charcot-Marie-Tooth disease type 1F,Point prevalence,N/A
Disease,101081,Charcot-Marie-Tooth disease type 1A,Point prevalence,N/A
Disease,101081,Charcot-Marie-Tooth disease type 1A,Point prevalence,N/A
Disease,101081,Charcot-Marie-Tooth disease type 1A,Point prevalence,N/A
Disease,101082,Charcot-Marie-Tooth disease type 1B,Point prevalence,N/A
Disease,101083,Charcot-Marie-Tooth disease type 1C,Point prevalence,N/A
Disease,101077,X-linked Charcot-Marie-Tooth disease type 3,Cases/families,N/A
Disease,101077,X-linked Charcot-Marie-Tooth disease type 3,Point prevalence,N/A
Disease,101078,X-linked Charcot-Marie-Tooth disease type 4,Cases/families,N/A
Disease,101078,X-linked Charcot-Marie-Tooth disease type 4,Point prevalence,N/A
Disease,101075,X-linked Charcot-Marie-Tooth disease type 1,Point prevalence,N/A
Disease,101076,X-linked Charcot-Marie-Tooth disease type 2,Cases/families,N/A
Disease,101076,X-linked Charcot-Marie-Tooth disease type 2,Point prevalence,N/A
Disease,101102,Charcot-Marie-Tooth disease type 2H,Cases/families,N/A
Disease,101102,Charcot-Marie-Tooth disease type 2H,Point prevalence,N/A
Disease,101101,Charcot-Marie-Tooth disease type 2B2,Cases/families,N/A
Disease,101101,Charcot-Marie-Tooth disease type 2B2,Point prevalence,N/A
Disease,101097,Autosomal recessive Charcot-Marie-Tooth disease with hoarseness,Point prevalence,N/A
Clinical subtype,101041,Familial hypofibrinogenemia,Point prevalence,N/A
Disease,101046,Autosomal dominant epilepsy with auditory features,Point prevalence,N/A
Disease,101068,Congenital stromal corneal dystrophy,Cases/families,N/A
Disease,101068,Congenital stromal corneal dystrophy,Point prevalence,N/A
Disease,101009,Autosomal dominant spastic paraplegia type 29,Cases/families,N/A
Disease,101009,Autosomal dominant spastic paraplegia type 29,Point prevalence,N/A
Disease,101010,Autosomal spastic paraplegia type 30,Cases/families,N/A
Disease,101010,Autosomal spastic paraplegia type 30,Point prevalence,N/A
Disease,101011,Autosomal dominant spastic paraplegia type 31,Point prevalence,N/A
Disease,101016,Romano-Ward syndrome,Point prevalence,N/A
Disease,101039,Female restricted epilepsy with intellectual disability,Cases/families,N/A
Disease,101039,Female restricted epilepsy with intellectual disability,Point prevalence,N/A
Disease,101028,Transaldolase deficiency,Cases/families,N/A
Disease,101028,Transaldolase deficiency,Point prevalence,N/A
Disease,100984,Autosomal dominant spastic paraplegia type 3,Point prevalence,N/A
Disease,100984,Autosomal dominant spastic paraplegia type 3,Point prevalence,N/A
Clinical group,100980,Autosomal dominant pure spastic paraplegia,Point prevalence,N/A
Clinical group,100980,Autosomal dominant pure spastic paraplegia,Point prevalence,N/A
Clinical group,100980,Autosomal dominant pure spastic paraplegia,Point prevalence,N/A
Clinical group,100979,Autosomal dominant complex spastic paraplegia,Point prevalence,N/A
Clinical group,100979,Autosomal dominant complex spastic paraplegia,Point prevalence,N/A
Malformation syndrome,100978,Cloverleaf skull-asphyxiating thoracic dysplasia syndrome,Point prevalence,N/A
Disease,100991,Autosomal dominant spastic paraplegia type 10,Cases/families,N/A
Disease,100991,Autosomal dominant spastic paraplegia type 10,Point prevalence,N/A
Disease,100989,Autosomal dominant spastic paraplegia type 8,Cases/families,N/A
Disease,100989,Autosomal dominant spastic paraplegia type 8,Point prevalence,N/A
Disease,100988,Autosomal dominant spastic paraplegia type 6,Cases/families,N/A
Disease,100988,Autosomal dominant spastic paraplegia type 6,Point prevalence,N/A
Disease,100986,Autosomal recessive spastic paraplegia type 5A,Point prevalence,N/A
Disease,100985,Autosomal dominant spastic paraplegia type 4,Point prevalence,N/A
Disease,100999,Autosomal dominant spastic paraplegia type 19,Cases/families,N/A
Disease,100999,Autosomal dominant spastic paraplegia type 19,Point prevalence,N/A
Disease,101000,Autosomal recessive spastic paraplegia type 20,Cases/families,N/A
Disease,101000,Autosomal recessive spastic paraplegia type 20,Point prevalence,N/A
Disease,100997,X-linked spastic paraplegia type 16,Cases/families,N/A
Disease,100997,X-linked spastic paraplegia type 16,Point prevalence,N/A
Disease,100998,Autosomal dominant spastic paraplegia type 17,Cases/families,N/A
Disease,100998,Autosomal dominant spastic paraplegia type 17,Point prevalence,N/A
Disease,100995,Autosomal recessive spastic paraplegia type 14,Cases/families,N/A
Disease,100995,Autosomal recessive spastic paraplegia type 14,Point prevalence,N/A
Disease,100996,Autosomal recessive spastic paraplegia type 15,Cases/families,N/A
Disease,100996,Autosomal recessive spastic paraplegia type 15,Point prevalence,N/A
Disease,100993,Autosomal dominant spastic paraplegia type 12,Cases/families,N/A
Disease,100993,Autosomal dominant spastic paraplegia type 12,Point prevalence,N/A
Disease,100994,Autosomal dominant spastic paraplegia type 13,Cases/families,N/A
Disease,100994,Autosomal dominant spastic paraplegia type 13,Point prevalence,N/A
Disease,101007,Autosomal recessive spastic paraplegia type 27,Cases/families,N/A
Disease,101007,Autosomal recessive spastic paraplegia type 27,Point prevalence,N/A
Disease,101008,Autosomal recessive spastic paraplegia type 28,Cases/families,N/A
Disease,101008,Autosomal recessive spastic paraplegia type 28,Point prevalence,N/A
Disease,101005,Autosomal recessive spastic paraplegia type 25,Cases/families,N/A
Disease,101005,Autosomal recessive spastic paraplegia type 25,Point prevalence,N/A
Disease,101006,Autosomal recessive spastic paraplegia type 26,Cases/families,N/A
Disease,101006,Autosomal recessive spastic paraplegia type 26,Point prevalence,N/A
Disease,101003,Autosomal recessive spastic paraplegia type 23,Cases/families,N/A
Disease,101003,Autosomal recessive spastic paraplegia type 23,Point prevalence,N/A
Disease,101004,Autosomal recessive spastic paraplegia type 24,Cases/families,N/A
Disease,101004,Autosomal recessive spastic paraplegia type 24,Point prevalence,N/A
Disease,101001,Autosomal recessive spastic paraplegia type 21,Cases/families,N/A
Disease,101001,Autosomal recessive spastic paraplegia type 21,Point prevalence,N/A
Category,100088,Rare thyroid carcinoma,Annual incidence,N/A
Category,100088,Rare thyroid carcinoma,Lifetime Prevalence,N/A
Category,100088,Rare thyroid carcinoma,Annual incidence,N/A
Category,100088,Rare thyroid carcinoma,Annual incidence,N/A
Category,100088,Rare thyroid carcinoma,Point prevalence,N/A
Category,100088,Rare thyroid carcinoma,Annual incidence,N/A
Category,100088,Rare thyroid carcinoma,Annual incidence,N/A
Category,100088,Rare thyroid carcinoma,Annual incidence,N/A
Category,100088,Rare thyroid carcinoma,Annual incidence,N/A
Category,100088,Rare thyroid carcinoma,Annual incidence,N/A
Category,100088,Rare thyroid carcinoma,Annual incidence,N/A
Category,100088,Rare thyroid carcinoma,Annual incidence,N/A
Category,100088,Rare thyroid carcinoma,Annual incidence,N/A
Category,100088,Rare thyroid carcinoma,Annual incidence,N/A
Category,100088,Rare thyroid carcinoma,Annual incidence,N/A
Category,100088,Rare thyroid carcinoma,Annual incidence,N/A
Category,100088,Rare thyroid carcinoma,Annual incidence,N/A
Category,100088,Rare thyroid carcinoma,Annual incidence,N/A
Category,100088,Rare thyroid carcinoma,Annual incidence,N/A
Category,100088,Rare thyroid carcinoma,Annual incidence,N/A
Category,100088,Rare thyroid carcinoma,Annual incidence,N/A
Category,100088,Rare thyroid carcinoma,Annual incidence,N/A
Category,100088,Rare thyroid carcinoma,Annual incidence,N/A
Category,100088,Rare thyroid carcinoma,Annual incidence,N/A
Category,100088,Rare thyroid carcinoma,Annual incidence,N/A
Category,100088,Rare thyroid carcinoma,Annual incidence,N/A
Category,100088,Rare thyroid carcinoma,Annual incidence,N/A
Disease,100085,Primary hepatic neuroendocrine carcinoma,Annual incidence,N/A
Disease,100085,Primary hepatic neuroendocrine carcinoma,Point prevalence,N/A
Category,100087,Rare thyroid tumor,Annual incidence,N/A
Category,100087,Rare thyroid tumor,Annual incidence,N/A
Category,100087,Rare thyroid tumor,Annual incidence,N/A
Category,100087,Rare thyroid tumor,Annual incidence,N/A
Disease,100924,Porphyria due to ALA dehydratase deficiency,Point prevalence,N/A
Disease,100973,FRAXE intellectual disability,Point prevalence,N/A
Disease,100974,FRAXF syndrome,Point prevalence,N/A
Disease,100976,Bathing suit ichthyosis,Cases/families,N/A
Disease,100976,Bathing suit ichthyosis,Point prevalence,N/A
Clinical subtype,100054,F12-related hereditary angioedema with normal C1Inh,Point prevalence,N/A
Etiological subtype,100051,Hereditary angioedema type 2,Point prevalence,N/A
Disease,100057,Renin-angiotensin-aldosterone system-blocker-induced angioedema,Point prevalence,N/A
Disease,100070,Progressive non-fluent aphasia,Point prevalence,N/A
Disease,100070,Progressive non-fluent aphasia,Annual incidence,N/A
Clinical subtype,100073,Neurogenic thoracic outlet syndrome,Point prevalence,N/A
Disease,100075,Neuroendocrine tumor of stomach,Point prevalence,N/A
Disease,100075,Neuroendocrine tumor of stomach,Point prevalence,N/A
Disease,100075,Neuroendocrine tumor of stomach,Point prevalence,N/A
Disease,100075,Neuroendocrine tumor of stomach,Point prevalence,N/A
Malformation syndrome,100071,Mosaic trisomy 3 syndrome,Cases/families,N/A
Malformation syndrome,100071,Mosaic trisomy 3 syndrome,Point prevalence,N/A
Clinical subtype,100020,Myelodysplastic neoplasm with increased blasts type 2,Point prevalence,N/A
Clinical subtype,100019,Myelodysplastic neoplasm with increased blasts type 1,Point prevalence,N/A
Clinical subtype,100022,Extramedullary soft tissue plasmacytoma,Annual incidence,N/A
Clinical subtype,100021,Primary plasmacytoma of the bone,Annual incidence,N/A
Clinical subtype,100024,Mu-heavy chain disease,Cases/families,N/A
Clinical subtype,100024,Mu-heavy chain disease,Point prevalence,N/A
Clinical subtype,100026,Gamma-heavy chain disease,Cases/families,N/A
Clinical subtype,100026,Gamma-heavy chain disease,Point prevalence,N/A
Clinical subtype,100025,Alpha-heavy chain disease,Cases/families,N/A
Clinical subtype,100025,Alpha-heavy chain disease,Point prevalence,N/A
Disease,100043,Autosomal dominant intermediate Charcot-Marie-Tooth disease type A,Cases/families,N/A
Disease,100043,Autosomal dominant intermediate Charcot-Marie-Tooth disease type A,Point prevalence,N/A
Disease,100044,Autosomal dominant intermediate Charcot-Marie-Tooth disease type B,Cases/families,N/A
Disease,100044,Autosomal dominant intermediate Charcot-Marie-Tooth disease type B,Point prevalence,N/A
Disease,100045,Autosomal dominant intermediate Charcot-Marie-Tooth disease type C,Point prevalence,N/A
Disease,100045,Autosomal dominant intermediate Charcot-Marie-Tooth disease type C,Cases/families,N/A
Disease,100046,Autosomal dominant intermediate Charcot-Marie-Tooth disease type D,Point prevalence,N/A
Disease,100046,Autosomal dominant intermediate Charcot-Marie-Tooth disease type D,Cases/families,N/A
Etiological subtype,100050,Hereditary angioedema type 1,Point prevalence,N/A
Etiological subtype,100050,Hereditary angioedema type 1,Point prevalence,N/A
Malformation syndrome,100012,Lissencephaly with cerebellar hypoplasia type B,Cases/families,N/A
Malformation syndrome,100012,Lissencephaly with cerebellar hypoplasia type B,Point prevalence,N/A
Malformation syndrome,100013,Lissencephaly with cerebellar hypoplasia type C,Cases/families,N/A
Malformation syndrome,100013,Lissencephaly with cerebellar hypoplasia type C,Point prevalence,N/A
Clinical subtype,100008,ACys amyloidosis,Cases/families,N/A
Clinical subtype,100008,ACys amyloidosis,Point prevalence,N/A
Clinical subtype,100006,"ABeta amyloidosis, Dutch type",Cases/families,N/A
Clinical subtype,100006,"ABeta amyloidosis, Dutch type",Point prevalence,N/A
Clinical subtype,99995,Complex regional pain syndrome type 1,Annual incidence,N/A
Clinical subtype,99995,Complex regional pain syndrome type 1,Point prevalence,N/A
Clinical subtype,99994,Complex regional pain syndrome type 2,Annual incidence,N/A
Clinical subtype,99994,Complex regional pain syndrome type 2,Point prevalence,N/A
Disease,99989,Intermediate DEND syndrome,Point prevalence,N/A
Disease,99981,Apnea of prematurity,Point prevalence,N/A
Disease,99978,Klatskin tumor,Annual incidence,N/A
Disease,99978,Klatskin tumor,Point prevalence,N/A
Disease,99977,Squamous cell carcinoma of the esophagus,Annual incidence,N/A
Disease,99977,Squamous cell carcinoma of the esophagus,Point prevalence,N/A
Disease,99977,Squamous cell carcinoma of the esophagus,Lifetime Prevalence,N/A
Disease,99977,Squamous cell carcinoma of the esophagus,Annual incidence,N/A
Disease,99977,Squamous cell carcinoma of the esophagus,Annual incidence,N/A
Disease,99977,Squamous cell carcinoma of the esophagus,Annual incidence,N/A
Disease,99977,Squamous cell carcinoma of the esophagus,Annual incidence,N/A
Disease,99977,Squamous cell carcinoma of the esophagus,Annual incidence,N/A
Disease,99977,Squamous cell carcinoma of the esophagus,Annual incidence,N/A
Disease,99977,Squamous cell carcinoma of the esophagus,Annual incidence,N/A
Disease,99977,Squamous cell carcinoma of the esophagus,Annual incidence,N/A
Disease,99977,Squamous cell carcinoma of the esophagus,Annual incidence,N/A
Disease,99977,Squamous cell carcinoma of the esophagus,Annual incidence,N/A
Disease,99977,Squamous cell carcinoma of the esophagus,Annual incidence,N/A
Disease,99977,Squamous cell carcinoma of the esophagus,Annual incidence,N/A
Disease,99977,Squamous cell carcinoma of the esophagus,Annual incidence,N/A
Disease,99977,Squamous cell carcinoma of the esophagus,Annual incidence,N/A
Disease,99977,Squamous cell carcinoma of the esophagus,Annual incidence,N/A
Disease,99977,Squamous cell carcinoma of the esophagus,Annual incidence,N/A
Disease,99977,Squamous cell carcinoma of the esophagus,Annual incidence,N/A
Disease,99977,Squamous cell carcinoma of the esophagus,Annual incidence,N/A
Disease,99977,Squamous cell carcinoma of the esophagus,Annual incidence,N/A
Disease,99977,Squamous cell carcinoma of the esophagus,Annual incidence,N/A
Disease,99977,Squamous cell carcinoma of the esophagus,Annual incidence,N/A
Disease,99977,Squamous cell carcinoma of the esophagus,Annual incidence,N/A
Disease,99977,Squamous cell carcinoma of the esophagus,Annual incidence,N/A
Disease,99977,Squamous cell carcinoma of the esophagus,Annual incidence,N/A
Disease,99977,Squamous cell carcinoma of the esophagus,Annual incidence,N/A
Disease,99976,Adenocarcinoma of the esophagus,Annual incidence,N/A
Disease,99976,Adenocarcinoma of the esophagus,Point prevalence,N/A
Disease,99976,Adenocarcinoma of the esophagus,Lifetime Prevalence,N/A
Disease,99976,Adenocarcinoma of the esophagus,Annual incidence,N/A
Disease,99976,Adenocarcinoma of the esophagus,Annual incidence,N/A
Disease,99976,Adenocarcinoma of the esophagus,Annual incidence,N/A
Disease,99976,Adenocarcinoma of the esophagus,Annual incidence,N/A
Disease,99976,Adenocarcinoma of the esophagus,Annual incidence,N/A
Disease,99976,Adenocarcinoma of the esophagus,Annual incidence,N/A
Disease,99976,Adenocarcinoma of the esophagus,Annual incidence,N/A
Disease,99976,Adenocarcinoma of the esophagus,Annual incidence,N/A
Disease,99976,Adenocarcinoma of the esophagus,Annual incidence,N/A
Disease,99976,Adenocarcinoma of the esophagus,Annual incidence,N/A
Disease,99976,Adenocarcinoma of the esophagus,Annual incidence,N/A
Disease,99976,Adenocarcinoma of the esophagus,Annual incidence,N/A
Disease,99976,Adenocarcinoma of the esophagus,Annual incidence,N/A
Disease,99976,Adenocarcinoma of the esophagus,Annual incidence,N/A
Disease,99976,Adenocarcinoma of the esophagus,Annual incidence,N/A
Disease,99976,Adenocarcinoma of the esophagus,Annual incidence,N/A
Disease,99976,Adenocarcinoma of the esophagus,Annual incidence,N/A
Disease,99976,Adenocarcinoma of the esophagus,Annual incidence,N/A
Disease,99976,Adenocarcinoma of the esophagus,Annual incidence,N/A
Disease,99976,Adenocarcinoma of the esophagus,Annual incidence,N/A
Disease,99976,Adenocarcinoma of the esophagus,Annual incidence,N/A
Disease,99976,Adenocarcinoma of the esophagus,Annual incidence,N/A
Disease,99976,Adenocarcinoma of the esophagus,Annual incidence,N/A
Disease,99976,Adenocarcinoma of the esophagus,Annual incidence,N/A
Disease,99976,Adenocarcinoma of the esophagus,Annual incidence,N/A
Histopathological subtype,99971,Well-differentiated liposarcoma,Annual incidence,N/A
Histopathological subtype,99971,Well-differentiated liposarcoma,Point prevalence,N/A
Histopathological subtype,99969,Pleomorphic liposarcoma,Annual incidence,N/A
Histopathological subtype,99969,Pleomorphic liposarcoma,Point prevalence,N/A
Histopathological subtype,99970,Dedifferentiated liposarcoma,Annual incidence,N/A
Histopathological subtype,99970,Dedifferentiated liposarcoma,Point prevalence,N/A
Histopathological subtype,99967,Myxoid/round cell liposarcoma,Annual incidence,N/A
Histopathological subtype,99967,Myxoid/round cell liposarcoma,Point prevalence,N/A
Disease,99966,Atypical teratoid rhabdoid tumor,Point prevalence,N/A
Disease,99966,Atypical teratoid rhabdoid tumor,Annual incidence,N/A
Disease,643549,Hao-Fountain syndrome,Cases/families,N/A
Disease,643549,Hao-Fountain syndrome,Point prevalence,N/A
Disease,99955,Charcot-Marie-Tooth disease type 4B1,Cases/families,N/A
Disease,99955,Charcot-Marie-Tooth disease type 4B1,Point prevalence,N/A
Disease,99956,Charcot-Marie-Tooth disease type 4B2,Point prevalence,N/A
Disease,99948,Charcot-Marie-Tooth disease type 4A,Point prevalence,N/A
Disease,99947,Autosomal dominant Charcot-Marie-Tooth disease type 2A2,Point prevalence,N/A
Disease,99950,Charcot-Marie-Tooth disease type 4D,Point prevalence,N/A
Disease,99949,Charcot-Marie-Tooth disease type 4C,Point prevalence,N/A
Disease,99952,Charcot-Marie-Tooth disease type 4F,Point prevalence,N/A
Disease,99954,Charcot-Marie-Tooth disease type 4H,Cases/families,N/A
Disease,99954,Charcot-Marie-Tooth disease type 4H,Point prevalence,N/A
Disease,99953,Charcot-Marie-Tooth disease type 4G,Point prevalence,N/A
Disease,99953,Charcot-Marie-Tooth disease type 4G,Point prevalence,N/A
Disease,99940,Autosomal dominant Charcot-Marie-Tooth disease type 2F,Cases/families,N/A
Disease,99940,Autosomal dominant Charcot-Marie-Tooth disease type 2F,Point prevalence,N/A
Disease,99939,Autosomal dominant Charcot-Marie-Tooth disease type 2E,Point prevalence,N/A
Disease,99941,Autosomal dominant Charcot-Marie-Tooth disease type 2G,Cases/families,N/A
Disease,99941,Autosomal dominant Charcot-Marie-Tooth disease type 2G,Point prevalence,N/A
Disease,99944,Autosomal dominant Charcot-Marie-Tooth disease type 2K,Cases/families,N/A
Disease,99944,Autosomal dominant Charcot-Marie-Tooth disease type 2K,Point prevalence,N/A
Disease,99946,Autosomal dominant Charcot-Marie-Tooth disease type 2A1,Cases/families,N/A
Disease,99946,Autosomal dominant Charcot-Marie-Tooth disease type 2A1,Point prevalence,N/A
Disease,99945,Autosomal dominant Charcot-Marie-Tooth disease type 2L,Cases/families,N/A
Disease,99945,Autosomal dominant Charcot-Marie-Tooth disease type 2L,Point prevalence,N/A
Disease,99931,Idiopathic pulmonary hemosiderosis,Annual incidence,N/A
Disease,99931,Idiopathic pulmonary hemosiderosis,Point prevalence,N/A
Disease,99938,Autosomal dominant Charcot-Marie-Tooth disease type 2D,Cases/families,N/A
Disease,99938,Autosomal dominant Charcot-Marie-Tooth disease type 2D,Point prevalence,N/A
Disease,99925,Invasive mole,Point prevalence,N/A
Disease,99926,Gestational choriocarcinoma,Point prevalence,N/A
Disease,99926,Gestational choriocarcinoma,Annual incidence,N/A
Disease,99926,Gestational choriocarcinoma,Lifetime Prevalence,N/A
Disease,99927,Hydatidiform mole,Point prevalence,N/A
Disease,99927,Hydatidiform mole,Annual incidence,N/A
Disease,99928,Placental site trophoblastic tumor,Annual incidence,N/A
Disease,99928,Placental site trophoblastic tumor,Lifetime Prevalence,N/A
Disease,99928,Placental site trophoblastic tumor,Point prevalence,N/A
Etiological subtype,99918,Streptococcal toxic-shock syndrome,Annual incidence,N/A
Etiological subtype,99918,Streptococcal toxic-shock syndrome,Annual incidence,N/A
Etiological subtype,99918,Streptococcal toxic-shock syndrome,Annual incidence,N/A
Etiological subtype,99918,Streptococcal toxic-shock syndrome,Annual incidence,N/A
Disease,99917,"Theca steroid-producing cell malignant tumor of ovary, not further specified",Annual incidence,N/A
Disease,99916,Malignant Sertoli-Leydig cell tumor of the ovary,Annual incidence,N/A
Disease,99915,Malignant granulosa cell tumor of the ovary,Annual incidence,N/A
Etiological subtype,99919,Staphylococcal toxic-shock syndrome,Point prevalence,N/A
Etiological subtype,99919,Staphylococcal toxic-shock syndrome,Annual incidence,N/A
Disease,99912,Ovarian dysgerminoma,Point prevalence,N/A
Disease,99912,Ovarian dysgerminoma,Annual incidence,N/A
Disease,99901,Acyl-CoA dehydrogenase 9 deficiency,Cases/families,N/A
Disease,99901,Acyl-CoA dehydrogenase 9 deficiency,Point prevalence,N/A
Etiological subtype,99905,Streptobacillary rat-bite fever,Point prevalence,N/A
Etiological subtype,99903,Spirillary rat-bite fever,Point prevalence,N/A
Clinical group,99892,ACTH-dependent Cushing syndrome,Annual incidence,N/A
Clinical group,99892,ACTH-dependent Cushing syndrome,Point prevalence,N/A
Disease,99898,Mendelian susceptibility to mycobacterial diseases due to complete IFNgammaR1 deficiency,Point prevalence,N/A
Disease,99898,Mendelian susceptibility to mycobacterial diseases due to complete IFNgammaR1 deficiency,Cases/families,N/A
Disease,99879,Familial isolated hyperparathyroidism,Cases/families,N/A
Disease,99879,Familial isolated hyperparathyroidism,Point prevalence,N/A
Disease,99880,Hyperparathyroidism-jaw tumor syndrome,Cases/families,N/A
Disease,99880,Hyperparathyroidism-jaw tumor syndrome,Point prevalence,N/A
Disease,99889,Cushing syndrome due to ectopic ACTH secretion,Point prevalence,N/A
Disease,99885,Isolated permanent neonatal diabetes mellitus,Prevalence at birth,N/A
Disease,99885,Isolated permanent neonatal diabetes mellitus,Point prevalence,N/A
Disease,99885,Isolated permanent neonatal diabetes mellitus,Prevalence at birth,N/A
Disease,99885,Isolated permanent neonatal diabetes mellitus,Prevalence at birth,N/A
Disease,99885,Isolated permanent neonatal diabetes mellitus,Prevalence at birth,N/A
Disease,99885,Isolated permanent neonatal diabetes mellitus,Prevalence at birth,N/A
Disease,99885,Isolated permanent neonatal diabetes mellitus,Prevalence at birth,N/A
Disease,99885,Isolated permanent neonatal diabetes mellitus,Prevalence at birth,N/A
Disease,99886,Transient neonatal diabetes mellitus,Prevalence at birth,N/A
Disease,99886,Transient neonatal diabetes mellitus,Point prevalence,N/A
Disease,99865,Spermatocytic seminoma,Annual incidence,N/A
Disease,99865,Spermatocytic seminoma,Point prevalence,N/A
Disease,99868,Thymic carcinoma,Point prevalence,N/A
Disease,99867,Thymoma,Annual incidence,N/A
Disease,99867,Thymoma,Lifetime Prevalence,N/A
Disease,99867,Thymoma,Point prevalence,N/A
Disease,99869,Thymic neuroendocrine carcinoma,Point prevalence,N/A
Disease,99849,Glycogen storage disease due to muscle beta-enolase deficiency,Cases/families,N/A
Disease,99849,Glycogen storage disease due to muscle beta-enolase deficiency,Point prevalence,N/A
Disease,99845,Genetic recurrent myoglobinuria,Point prevalence,N/A
Disease,99846,Autosomal dominant myoglobinuria,Cases/families,N/A
Disease,99846,Autosomal dominant myoglobinuria,Point prevalence,N/A
Clinical subtype,99843,Leukocyte adhesion deficiency type II,Cases/families,N/A
Clinical subtype,99843,Leukocyte adhesion deficiency type II,Point prevalence,N/A
Clinical subtype,99844,Leukocyte adhesion deficiency type III,Cases/families,N/A
Clinical subtype,99844,Leukocyte adhesion deficiency type III,Point prevalence,N/A
Clinical subtype,99853,Ovarioleukodystrophy,Cases/families,N/A
Clinical subtype,99853,Ovarioleukodystrophy,Point prevalence,N/A
Disease,99852,Ravine syndrome,Cases/families,N/A
Disease,99852,Ravine syndrome,Point prevalence,N/A
Disease,99832,Resistance to thyrotropin-releasing hormone syndrome,Cases/families,N/A
Disease,99832,Resistance to thyrotropin-releasing hormone syndrome,Point prevalence,N/A
Disease,99829,Yellow fever,Point prevalence,N/A
Disease,99829,Yellow fever,Annual incidence,N/A
Disease,99828,Dengue fever,Point prevalence,N/A
Disease,99828,Dengue fever,Annual incidence,N/A
Disease,99828,Dengue fever,Annual incidence,N/A
Disease,99828,Dengue fever,Point prevalence,N/A
Disease,99828,Dengue fever,Annual incidence,N/A
Disease,99828,Dengue fever,Annual incidence,N/A
Disease,99828,Dengue fever,Annual incidence,N/A
Disease,99828,Dengue fever,Annual incidence,N/A
Disease,99828,Dengue fever,Annual incidence,N/A
Disease,99828,Dengue fever,Annual incidence,N/A
Disease,99828,Dengue fever,Annual incidence,N/A
Disease,99828,Dengue fever,Annual incidence,N/A
Disease,99828,Dengue fever,Annual incidence,N/A
Disease,99828,Dengue fever,Annual incidence,N/A
Disease,99828,Dengue fever,Annual incidence,N/A
Disease,99828,Dengue fever,Annual incidence,N/A
Disease,99828,Dengue fever,Annual incidence,N/A
Disease,99828,Dengue fever,Annual incidence,N/A
Disease,99828,Dengue fever,Annual incidence,N/A
Disease,99828,Dengue fever,Annual incidence,N/A
Disease,99828,Dengue fever,Annual incidence,N/A
Disease,99828,Dengue fever,Annual incidence,N/A
Disease,99828,Dengue fever,Annual incidence,N/A
Disease,99828,Dengue fever,Annual incidence,N/A
Disease,99828,Dengue fever,Annual incidence,N/A
Disease,99828,Dengue fever,Annual incidence,N/A
Disease,99827,Crimean-Congo hemorrhagic fever,Point prevalence,N/A
Disease,99827,Crimean-Congo hemorrhagic fever,Point prevalence,N/A
Clinical subtype,99842,Leukocyte adhesion deficiency type I,Point prevalence,N/A
Disease,99812,LIG4 syndrome,Cases/families,N/A
Disease,99812,LIG4 syndrome,Point prevalence,N/A
Disease,99824,Lassa fever,Point prevalence,N/A
Disease,99824,Lassa fever,Point prevalence,N/A
Disease,99825,Nipah virus disease,Cases/families,N/A
Disease,99825,Nipah virus disease,Point prevalence,N/A
Disease,99826,Marburg hemorrhagic fever,Cases/families,N/A
Disease,99826,Marburg hemorrhagic fever,Point prevalence,N/A
Morphological anomaly,99798,Oligodontia,Point prevalence,N/A
Malformation syndrome,99802,Hemimegalencephaly,Point prevalence,N/A
Malformation syndrome,99803,Haddad syndrome,Cases/families,N/A
Malformation syndrome,99803,Haddad syndrome,Point prevalence,N/A
Malformation syndrome,99806,Oculootodental syndrome,Cases/families,N/A
Malformation syndrome,99806,Oculootodental syndrome,Point prevalence,N/A
Disease,99807,PEHO-like syndrome,Cases/families,N/A
Disease,99807,PEHO-like syndrome,Point prevalence,N/A
Etiological subtype,99810,Familial porencephaly,Point prevalence,N/A
Clinical subtype,99789,Dentin dysplasia type I,Point prevalence,N/A
Clinical subtype,99791,Dentin dysplasia type II,Cases/families,N/A
Clinical subtype,99791,Dentin dysplasia type II,Point prevalence,N/A
Disease,99792,Dentin dysplasia-sclerotic bones syndrome,Cases/families,N/A
Disease,99792,Dentin dysplasia-sclerotic bones syndrome,Point prevalence,N/A
Morphological anomaly,99772,Cleft velum,Point prevalence,N/A
Morphological anomaly,99771,Bifid uvula,Point prevalence,N/A
Malformation syndrome,99776,Mosaic trisomy 9 syndrome,Cases/families,N/A
Malformation syndrome,99776,Mosaic trisomy 9 syndrome,Point prevalence,N/A
Disease,631073,Autosomal recessive spastic paraplegia type 82,Cases/families,N/A
Disease,631073,Autosomal recessive spastic paraplegia type 82,Point prevalence,N/A
Disease,631076,Autosomal recessive spastic paraplegia type 83,Cases/families,N/A
Disease,631076,Autosomal recessive spastic paraplegia type 83,Point prevalence,N/A
Disease,631079,Autosomal recessive spastic paraplegia type 84,Cases/families,N/A
Disease,631079,Autosomal recessive spastic paraplegia type 84,Point prevalence,N/A
Disease,631082,Autosomal recessive spastic paraplegia type 85,Cases/families,N/A
Disease,631082,Autosomal recessive spastic paraplegia type 85,Point prevalence,N/A
Disease,631068,Autosomal dominant spastic paraplegia type 80,Cases/families,N/A
Disease,631068,Autosomal dominant spastic paraplegia type 80,Point prevalence,N/A
Disease,631106,Spinocerebellar ataxia type 49,Cases/families,N/A
Disease,631106,Spinocerebellar ataxia type 49,Point prevalence,N/A
Disease,631103,Spinocerebellar ataxia type 48,Cases/families,N/A
Disease,631103,Spinocerebellar ataxia type 48,Point prevalence,N/A
Disease,631095,Spinocerebellar ataxia type 44,Cases/families,N/A
Disease,631095,Spinocerebellar ataxia type 44,Point prevalence,N/A
Disease,631088,Autosomal recessive spastic paraplegia type 87,Cases/families,N/A
Disease,631088,Autosomal recessive spastic paraplegia type 87,Point prevalence,N/A
Disease,631085,Autosomal recessive spastic paraplegia type 86,Cases/families,N/A
Disease,631085,Autosomal recessive spastic paraplegia type 86,Point prevalence,N/A
Disease,631248,Mitchell Syndrome,Cases/families,N/A
Disease,631248,Mitchell Syndrome,Point prevalence,N/A
Disease,634475,Mosaic NF2-related schwannomatosis,Point prevalence,N/A
Disease,634492,Mosaic schwannomatosis,Point prevalence,N/A
Disease,634492,Mosaic schwannomatosis,Point prevalence,N/A
Disease,634492,Mosaic schwannomatosis,Prevalence at birth,N/A
Disease,634461,Mosaic neurofibromatosis type 1,Point prevalence,N/A
Disease,634461,Mosaic neurofibromatosis type 1,Point prevalence,N/A
Morphological anomaly,633228,Isolated proximal femoral focal deficiency,Point prevalence,N/A
Morphological anomaly,633228,Isolated proximal femoral focal deficiency,Prevalence at birth,N/A
Morphological anomaly,637064,Isolated optic nerve aplasia,Cases/families,N/A
Morphological anomaly,637064,Isolated optic nerve aplasia,Point prevalence,N/A
Morphological anomaly,637061,Isolated optic nerve hypoplasia,Cases/families,N/A
Morphological anomaly,637061,Isolated optic nerve hypoplasia,Point prevalence,N/A
Disease,637051,Borna virus encephalitis,Cases/families,N/A
Disease,637051,Borna virus encephalitis,Point prevalence,N/A
Disease,636945,Invasive candidiasis,Point prevalence,N/A
Disease,636945,Invasive candidiasis,Annual incidence,N/A
Disease,636941,Vascular Ehlers-Danlos-polymicrogyria syndrome,Cases/families,N/A
Disease,636941,Vascular Ehlers-Danlos-polymicrogyria syndrome,Point prevalence,N/A
Disease,636955,Endemic pemphigus foliaceus,Point prevalence,N/A
Disease,636955,Endemic pemphigus foliaceus,Annual incidence,N/A
Disease,636950,Glaucomatocyclitic crisis disease,Point prevalence,N/A
Clinical syndrome,641829,Neonatal compartment syndrome,Cases/families,N/A
Clinical syndrome,641829,Neonatal compartment syndrome,Point prevalence,N/A
Disease,641496,Childhood-onset schizophrenia,Annual incidence,N/A
Disease,641496,Childhood-onset schizophrenia,Point prevalence,N/A
Disease,641390,PsAPASH syndrome,Cases/families,N/A
Disease,641390,PsAPASH syndrome,Point prevalence,N/A
Disease,641380,PAPASH syndrome,Cases/families,N/A
Disease,641380,PAPASH syndrome,Point prevalence,N/A
Disease,641385,PASS syndrome,Cases/families,N/A
Disease,641385,PASS syndrome,Point prevalence,N/A
Disease,641368,Autosomal recessive hyper-IgE syndrome due to ZNF341 deficiency,Cases/families,N/A
Disease,641368,Autosomal recessive hyper-IgE syndrome due to ZNF341 deficiency,Point prevalence,N/A
Disease,641353,Infantile neurodegeneration-progressive spasticity-intellectual disability-white matter lesions syndrome,Cases/families,N/A
Disease,641353,Infantile neurodegeneration-progressive spasticity-intellectual disability-white matter lesions syndrome,Point prevalence,N/A
Disease,641361,Neurodevelopmental delay-hypotonia-cerebellar ataxia-cardiac conduction defects syndrome,Cases/families,N/A
Disease,641361,Neurodevelopmental delay-hypotonia-cerebellar ataxia-cardiac conduction defects syndrome,Point prevalence,N/A
Disease,641350,Immunotherapy induced hypophysitis,Annual incidence,N/A
Disease,641350,Immunotherapy induced hypophysitis,Point prevalence,N/A
Disease,642099,"Spondyloepimetaphyseal dysplasia with joint laxity, Beighton type",Cases/families,N/A
Disease,642099,"Spondyloepimetaphyseal dysplasia with joint laxity, Beighton type",Point prevalence,N/A
Disease,642085,EXOC6B-related spondyloepimetaphyseal dysplasia with joint laxity,Cases/families,N/A
Disease,642085,EXOC6B-related spondyloepimetaphyseal dysplasia with joint laxity,Point prevalence,N/A
Disease,633004,KDM3B-related intellectual disability-facial dysmorphism-short stature syndrome,Cases/families,N/A
Disease,633004,KDM3B-related intellectual disability-facial dysmorphism-short stature syndrome,Point prevalence,N/A
Disease,633014,SLC12A2-related developmental delay-intellectual disability-sensorineural deafness syndrome,Cases/families,N/A
Disease,633014,SLC12A2-related developmental delay-intellectual disability-sensorineural deafness syndrome,Point prevalence,N/A
Disease,633124,Invasive scopulariopsis infection,Point prevalence,N/A
Disease,633028,CPE-related Prader-Willi-like syndrome,Cases/families,N/A
Disease,633028,CPE-related Prader-Willi-like syndrome,Point prevalence,N/A
Disease,615970,Chronic intervillositis of unknown etiology,Point prevalence,N/A
Disease,617408,Classic eosinophilic pustular folliculitis,Point prevalence,N/A
Disease,617304,Amniotic fluid embolism,Point prevalence,N/A
Disease,617294,Twin anemia-polycythemia sequence,Point prevalence,N/A
Disease,617301,Selective intrauterine growth restriction,Point prevalence,N/A
Disease,617297,Twin-reversed arterial perfusion sequence,Point prevalence,N/A
Disease,621758,Fibrosis-neurodegeneration-cerebral angiomatosis syndrome,Cases/families,N/A
Disease,621758,Fibrosis-neurodegeneration-cerebral angiomatosis syndrome,Point prevalence,N/A
Disease,620371,Gitelman-like kidney tubulopathy due to mitochondrial DNA mutation,Cases/families,N/A
Disease,620371,Gitelman-like kidney tubulopathy due to mitochondrial DNA mutation,Point prevalence,N/A
Disease,620368,EGF-related primary hypomagnesemia with intellectual disability,Cases/families,N/A
Disease,620368,EGF-related primary hypomagnesemia with intellectual disability,Point prevalence,N/A
Disease,620363,Primary hypomagnesemia-generalized seizures-intellectual disability-obesity syndrome,Cases/families,N/A
Disease,620363,Primary hypomagnesemia-generalized seizures-intellectual disability-obesity syndrome,Point prevalence,N/A
Morphological anomaly,620205,Non-syndromic bicoronal and sagittal craniosynostosis,Point prevalence,N/A
Morphological anomaly,620212,Non-syndromic pansynostosis,Point prevalence,N/A
Morphological anomaly,620192,Non-syndromic metopic and sagittal craniosynostosis,Point prevalence,N/A
Morphological anomaly,620198,Non-syndromic bicoronal and metopic craniosynostosis,Point prevalence,N/A
Morphological anomaly,620178,Non-syndromic bilambdoid craniosynostosis,Point prevalence,N/A
Morphological anomaly,620186,Non-syndromic unicoronal and sagittal craniosynostosis,Point prevalence,N/A
Morphological anomaly,620158,Non-syndromic non-specific multisutural craniosynostosis,Point prevalence,N/A
Morphological anomaly,620139,Non-syndromic unifrontosphenoidal craniosynostosis,Point prevalence,N/A
Morphological anomaly,620146,Non-syndromic unisquamosal craniosynostosis,Point prevalence,N/A
Morphological anomaly,620102,Non-syndromic unicoronal craniosynostosis,Point prevalence,N/A
Morphological anomaly,620113,Non-syndromic unilambdoid craniosynostosis,Point prevalence,N/A
Disease,624268,Non-specific autoimmune cerebellar ataxia without characteristic antibodies,Point prevalence,N/A
Disease,624199,Non-specific autoimmune brainstem encephalitis with characteristic antibodies,Point prevalence,N/A
Disease,624190,Paraneoplastic isolated brainstem encephalitis,Point prevalence,N/A
Disease,624244,Postinfectious cerebellitis,Point prevalence,N/A
Disease,624244,Postinfectious cerebellitis,Annual incidence,N/A
Disease,624216,Non-specific autoimmune brainstem encephalitis without characteristic antibodies,Point prevalence,N/A
Disease,623789,Body integrity dysphoria,Point prevalence,N/A
Disease,623801,Acute flaccid myelitis,Point prevalence,N/A
Disease,623801,Acute flaccid myelitis,Annual incidence,N/A
Disease,623801,Acute flaccid myelitis,Annual incidence,N/A
Disease,623801,Acute flaccid myelitis,Annual incidence,N/A
Disease,624166,Non-specific autoimmune supratentorial encephalitis with characteristic antibodies,Point prevalence,N/A
Disease,624178,Non-specific autoimmune supratentorial encephalitis without characteristic antibodies,Point prevalence,N/A
Disease,623615,Autoimmune limbic encephalitis,Point prevalence,N/A
Disease,623615,Autoimmune limbic encephalitis,Annual incidence,N/A
Disease,623626,Paraneoplastic cerebellar degeneration,Point prevalence,N/A
Disease,623626,Paraneoplastic cerebellar degeneration,Annual incidence,N/A
Disease,623626,Paraneoplastic cerebellar degeneration,Point prevalence,N/A
Disease,623626,Paraneoplastic cerebellar degeneration,Annual incidence,N/A
Disease,623626,Paraneoplastic cerebellar degeneration,Point prevalence,N/A
Disease,623626,Paraneoplastic cerebellar degeneration,Annual incidence,N/A
Malformation syndrome,622925,X-linked severe syndromic thoracic aortic aneurysm and dissection,Cases/families,N/A
Malformation syndrome,622925,X-linked severe syndromic thoracic aortic aneurysm and dissection,Point prevalence,N/A
Disease,618891,Chronic neurovisceral acid sphingomyelinase deficiency,Point prevalence,N/A
Disease,617910,Conjunctival malignant melanoma,Cases/families,N/A
Disease,617910,Conjunctival malignant melanoma,Point prevalence,N/A
Disease,617916,Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia,Cases/families,N/A
Disease,617916,Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia,Point prevalence,N/A
Disease,617919,F12-associated cold autoinflammatory syndrome,Cases/families,N/A
Disease,617919,F12-associated cold autoinflammatory syndrome,Point prevalence,N/A
Disease,619941,Congenital neutropenia-combined immunodeficiency due to MKL1 deficiency,Cases/families,N/A
Disease,619941,Congenital neutropenia-combined immunodeficiency due to MKL1 deficiency,Point prevalence,N/A
Disease,619367,SAMD9L-associated autoinflammatory syndrome,Cases/families,N/A
Disease,619367,SAMD9L-associated autoinflammatory syndrome,Point prevalence,N/A
Disease,619953,Familial hyperinflammatory lymphoproliferative immunodeficiency,Cases/families,N/A
Disease,619953,Familial hyperinflammatory lymphoproliferative immunodeficiency,Point prevalence,N/A
Disease,619948,Early-onset autoimmunity-autoinflammation-immunodeficiency syndrome due to SOCS1 haploinsufficiency,Cases/families,N/A
Disease,619948,Early-onset autoimmunity-autoinflammation-immunodeficiency syndrome due to SOCS1 haploinsufficiency,Point prevalence,N/A
Disease,619979,Developmental delay-immunodeficiency-leukoencephalopathy-hypohomocysteinemia syndrome,Cases/families,N/A
Disease,619979,Developmental delay-immunodeficiency-leukoencephalopathy-hypohomocysteinemia syndrome,Point prevalence,N/A
Disease,619363,NOCARH syndrome,Cases/families,N/A
Disease,619363,NOCARH syndrome,Point prevalence,N/A
Disease,619233,Hereditary persistence of fetal hemoglobin-intellectual disability syndrome,Cases/families,N/A
Disease,619233,Hereditary persistence of fetal hemoglobin-intellectual disability syndrome,Point prevalence,N/A
